Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.8957555420614457,2.1682217438781737,0.0,0.0,0.0,57/125,3.45%,KIF11;CENPF;BUB1;KNL1;CENPE;NUSAP1;DLGAP5;NDC80;KIF4A;BUB1B;NUF2;ZWILCH;CENPA;TTK;CDCA8;SPC24;STIL;NSL1;SPC25;BIRC5;AURKB;CENPP;SKA1;TACC3;CENPK;MAD2L1;ERCC6L;KIF2C;KNTC1;PMF1;CENPN;CENPM;SPDL1;CCNB1;SKA2;KIF18A;CENPH;CDC20;CKAP5;INCENP;CENPL;PLK1;CENPI;STMN1;ESPL1;WDR62;GPSM2;RCC1;XPO1;NUP43;AURKA;NDE1;SGO1;MAD1L1;PCNT;SUN2;PTPA
prerank,mitotic sister chromatid segregation (GO:0000070),0.8881807390904681,2.1335344117996464,0.0,0.0,0.0,37/98,4.58%,CENPE;NUSAP1;KIF23;DLGAP5;PRC1;KIF18B;NDC80;NCAPG;KIF14;CDCA8;KIFC1;CDK1;NSL1;SMC4;KIF22;KNSTRN;NCAPD2;CEP55;CENPK;KIF2C;NCAPH;SPDL1;CCNB1;KIF18A;SMC2;SPAG5;PLK1;RAD21;ESPL1;NCAPD3;RB1;SGO1;MCPH1;HASPIN;CDC23;NCAPH2;NCAPG2
prerank,mitotic spindle organization (GO:0007052),0.8774420238519345,2.119044791501288,0.0,0.0,0.0,60/153,3.45%,KIF11;CENPF;BUB1;KNL1;CENPE;KIF23;TPX2;DLGAP5;PRC1;NDC80;KIF4A;BUB1B;NUF2;ZWILCH;CENPA;TTK;CDCA8;KIFC1;SPC24;STIL;NSL1;SPC25;BIRC5;AURKB;CENPP;SKA1;CENPK;MAD2L1;ERCC6L;KIF2C;KNTC1;PMF1;CENPN;CENPM;SPDL1;CCNB1;SKA2;KIF18A;CENPH;CDC20;CKAP5;INCENP;CENPL;PLK1;CENPI;STMN1;WDR62;GPSM2;CHEK2;RCC1;XPO1;NUP43;AURKA;NDE1;SGO1;MAD1L1;PCNT;FLNA;SUN2;PTPA
prerank,chromosome condensation (GO:0030261),0.9251976212462264,2.08003309971164,0.0,0.0,0.0,16/36,4.58%,TOP2A;NUSAP1;NCAPG;CDK1;SMC4;NCAPD2;NCAPH;CCNB1;INCENP;SMC2;PLK1;NCAPD3;RB1;MCPH1;NCAPH2;NCAPG2
prerank,centromere complex assembly (GO:0034508),0.9143500929485672,2.0507243064847995,0.0,0.0,0.0,20/36,4.13%,CENPF;KNL1;MIS18BP1;CENPE;DLGAP5;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;HELLS;NASP
prerank,sister chromatid segregation (GO:0000819),0.9253990605859574,2.0405977504468065,0.0,0.0,0.0,18/31,4.58%,TOP2A;NUSAP1;KIF18B;NDC80;CDCA8;KIFC1;NSL1;SMC4;KNSTRN;CENPK;KIF18A;SPAG5;PLK1;ESPL1;RB1;SGO1;CHAMP1;NCAPG2
prerank,mitotic metaphase plate congression (GO:0007080),0.8641767780838557,2.03559762755976,0.0,0.0,0.0,15/51,4.03%,CENPE;NDC80;KIF14;NUF2;CDCA8;KIFC1;KIF22;CEP55;KIF2C;SPDL1;CCNB1;KIF18A;MAD1L1;CHAMP1;CDC23
prerank,mitotic nuclear division (GO:0140014),0.8567483883825904,2.0146303609720975,0.0,0.0,0.0,23/71,4.58%,KIF11;NUSAP1;TPX2;KIF18B;NDC80;CDCA8;KIFC1;NSL1;SMC4;UBE2C;KNSTRN;CENPK;KIF18A;SPAG5;PLK1;ESPL1;CHEK2;NDE1;SGO1;FLNA;CEP192;ABRAXAS1;NCAPG2
prerank,positive regulation of cell cycle process (GO:0090068),0.8357890063301244,2.0080961399564363,0.0,0.0,0.0,31/91,8.16%,NUSAP1;KIF23;KIF20B;NDC80;KIF14;E2F7;GEN1;AURKB;ECT2;E2F8;CIT;MAD2L1;RACGAP1;CCNB1;SPAG5;CXCR5;RAD21;GPSM2;DBF4;AURKA;DDX11;PRKCE;FEN1;CEP295;XRCC3;CSPP1;TGFA;CDC25B;PKN2;DYNC1H1;RHNO1
prerank,mitotic chromosome condensation (GO:0007076),0.925407402650532,2.0054304112982666,0.0,0.0,0.0,14/26,4.58%,NUSAP1;NCAPG;CDK1;SMC4;NCAPD2;NCAPH;CCNB1;SMC2;PLK1;NCAPD3;RB1;MCPH1;NCAPH2;NCAPG2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.867297185856518,2.0020702165624007,0.0,0.0,0.0,18/56,2.09%,NUSAP1;KIF23;KIF4A;CENPA;CKAP2;AURKB;CEP55;ECT2;CIT;RACGAP1;CECR2;KIF20A;INCENP;PLK1;STMN1;ESPL1;ANLN;ALKBH4
prerank,chromatin remodeling at centromere (GO:0031055),0.9019947332907903,1.9956552676601194,0.0,0.0,0.0,17/31,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;HELLS;NASP
prerank,CENP-A containing chromatin organization (GO:0061641),0.9023966085158011,1.9851412291464183,0.0,6.438983425915943e-05,0.001,16/29,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.9023966085158011,1.9851412291464183,0.0,6.438983425915943e-05,0.001,16/29,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,mitotic cytokinesis (GO:0000281),0.8671322536386402,1.9760722685578116,0.0,0.00024038871456752856,0.004,15/47,1.89%,NUSAP1;KIF23;KIF4A;CENPA;CKAP2;CEP55;ECT2;CIT;RACGAP1;KIF20A;INCENP;PLK1;STMN1;ESPL1;ANLN
prerank,regulation of cell cycle process (GO:0010564),0.8189445792761723,1.9644903370058902,0.0,0.00039438773483735156,0.007,22/104,2.97%,KIF11;MKI67;BUB1;PRC1;KIF20B;CDC25C;KNSTRN;AURKB;ECT2;RACGAP1;NEK2;BORA;KIF20A;SPAG5;TIPIN;PLK1;RMI2;DBF4;RCC1;AURKA;FBXO5;MAD1L1
prerank,regulation of mitotic nuclear division (GO:0007088),0.834735289410517,1.9634449630779678,0.0,0.0003711884563175073,0.007,16/55,7.18%,MKI67;NUSAP1;KIF20B;CDC25C;NEK2;BORA;CCNB1;CDK5RAP2;RCC1;AURKA;FBXO5;AURKAIP1;CHEK1;LCMT1;TGFA;PIN1
prerank,positive regulation of lipid localization (GO:1905954),-0.775549863035354,-1.9592241595114277,0.003861003861003861,0.7766792913866829,0.364,5/11,7.94%,LRP1;LPL;ZC3H12A;IKBKE;VSTM2A
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.8617386417452989,1.9588477012229752,0.0,0.0004006478576125476,0.008,17/38,4.13%,KNL1;MIS18BP1;CENPA;CENPP;ASF1B;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,histone exchange (GO:0043486),0.86943665397266,1.9575820635464902,0.0,0.0003795611282645188,0.008,16/37,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,mitochondrial protein processing (GO:0034982),-0.7495984019706483,-1.957158595768071,0.0,0.3981233964569334,0.37,7/11,21.08%,IMMP1L;SPG7;STOML2;ATP23;PMPCA;OMA1;AFG3L2
prerank,positive regulation of cytokinesis (GO:0032467),0.8738164185172227,1.9554077430291696,0.0,0.0004507288398141161,0.009,12/32,7.47%,KIF23;KIF20B;KIF14;AURKB;ECT2;CIT;RACGAP1;CXCR5;PRKCE;CSPP1;CDC25B;PKN2
prerank,kinetochore organization (GO:0051383),0.9722124834604038,1.9484429941692336,0.0,0.0006438983425915944,0.011,8/13,1.14%,CENPF;CENPE;DLGAP5;NDC80;NUF2;CENPA;CENPW;CENPH
prerank,positive regulation of cell division (GO:0051781),0.8568664797615889,1.9367136109673946,0.0,0.0009014576796282321,0.016,12/38,7.47%,KIF23;KIF20B;KIF14;AURKB;ECT2;CIT;RACGAP1;CXCR5;PRKCE;CSPP1;CDC25B;PKN2
prerank,carbohydrate catabolic process (GO:0016052),-0.5384556892734089,-1.9350970828547078,0.0,0.348201181022195,0.452,21/38,20.88%,HK2;HK3;MANBA;GPI;DERA;MAN2B1;PFKL;ENO1;ALDOA;LDHA;TPI1;PGM1;PKM;PGAM1;PGAM4;ALDOC;MAN2C1;MAN2B2;ENO2;PFKFB2;PFKM
prerank,lysosome organization (GO:0007040),-0.522320668787817,-1.9258789255970616,0.0,0.2920073304825901,0.494,19/36,20.19%,CLVS1;TPCN2;ABCA1;MBTPS1;ACP2;GRN;MYO7A;HPS1;CLN5;TMEM165;HOOK2;ZKSCAN3;NAGPA;SNAPIN;TFEB;HOOK3;TMEM106B;CLN6;ATP10B
prerank,reverse cholesterol transport (GO:0043691),-0.7090917261706796,-1.9240319140399222,0.004032258064516129,0.23842248014660966,0.502,4/13,10.92%,APOE;ABCA1;ABCA5;SCARB1
prerank,mitotic spindle assembly (GO:0090307),0.8512024085716617,1.9184272542953726,0.0,0.002469210165938201,0.052,12/42,4.54%,KIF11;KIF23;TPX2;PRC1;KIF4A;KIFC1;AURKB;RACGAP1;CHEK2;FLNA;CEP192;ABRAXAS1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.9073974492718316,1.9176189789306002,0.0,0.0024790086189776387,0.055,11/21,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;FBXO5;MAD1L1
prerank,positive regulation of lipid transport (GO:0032370),-0.7248278250877468,-1.9082663851168253,0.0,0.2380712685807371,0.556,3/12,1.49%,LRP1;APOE;SPP1
prerank,apoptotic nuclear changes (GO:0030262),0.8856707959429883,1.9068825741678677,0.0,0.003497655796957541,0.073,3/24,1.06%,TOP2A;HMGB2;CECR2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.8727057006134952,1.9062116053398435,0.0,0.0034324734724305757,0.073,13/26,6.89%,CENPE;DLGAP5;UBE2C;CCNB1;PLK1;CDK5RAP2;ESPL1;RB1;FBXO5;CDC23;CDC27;LCMT1;ANAPC7
prerank,establishment of mitotic spindle localization (GO:0040001),0.8627643276649466,1.9046204895079712,0.0,0.003605830718512928,0.08,11/28,4.06%,NUSAP1;NDC80;CENPA;MAD2L1;SPDL1;PLK1;CDK5RAP2;ESPL1;GPSM2;NDE1;FBXW11
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.9058903127677568,1.897924298278405,0.0,0.003996462379685163,0.101,10/20,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;MAD1L1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.9058903127677568,1.897924298278405,0.0,0.003996462379685163,0.101,10/20,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;MAD1L1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.9058903127677568,1.897924298278405,0.0,0.003996462379685163,0.101,10/20,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;MAD1L1
prerank,regulation of nuclear division (GO:0051783),0.9013525027720135,1.89106199974681,0.0,0.005350587517793378,0.136,7/20,2.73%,MKI67;KIF20B;CDC25C;NEK2;BORA;RCC1;FBXO5
prerank,microtubule depolymerization (GO:0007019),0.9057510178093208,1.8872069355045986,0.0,0.006084839337490567,0.154,8/17,1.62%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;CCSAP;STMN1
prerank,regulation of cytokinesis (GO:0032465),0.7891399593793142,1.8792578201531829,0.0,0.007867267022210026,0.194,23/78,9.63%,KIF23;PRC1;KIF20B;KIF14;E2F7;AURKB;ECT2;E2F8;CIT;RACGAP1;KIF20A;CXCR5;PLK1;AURKA;PRKCE;CSPP1;CDC25B;PIN1;PKN2;BIRC6;KLHL9;CUL3;AHCTF1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.956419828129075,1.8760475296532493,0.0,0.008272199883647307,0.213,6/10,1.30%,KNSTRN;ECT2;RACGAP1;NEK2;CCNB1;SPAG5
prerank,cyclooxygenase pathway (GO:0019371),-0.7860343458947436,-1.8751106726221174,0.0,0.30254367745876604,0.681,4/10,5.69%,HPGDS;TBXAS1;PTGS1;PTGDS
prerank,manganese ion transport (GO:0006828),-0.6832000301429386,-1.8680767686087516,0.003937007874015748,0.28598656078191814,0.706,8/14,17.08%,TRPC5;TRPC4;TRPC1;TMEM165;SLC11A2;SLC39A14;SLC39A8;TRPC3
prerank,establishment of spindle orientation (GO:0051294),0.8416970308969918,1.8625994805226067,0.0,0.012774943117017233,0.295,11/28,5.95%,NDC80;CENPA;MAD2L1;SPDL1;PLK1;CDK5RAP2;GPSM2;NDE1;FBXW11;MAP4;CLASP1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.8654805299630782,1.8602662157699732,0.0,0.013296500774516423,0.312,9/23,4.06%,NDC80;CENPA;MAD2L1;SPDL1;PLK1;CDK5RAP2;GPSM2;NDE1;FBXW11
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.8933757004186546,1.859193304524516,0.0,0.013156409378357981,0.315,4/16,3.46%,TOP2A;EME1;ERCC4;SLX4
prerank,interstrand cross-link repair (GO:0036297),0.8104247269350683,1.8581947344935423,0.0,0.013569310335456546,0.332,20/53,7.63%,NEIL3;RAD51AP1;RAD51;UBE2T;EME1;FANCD2;RFWD3;ERCC4;RPA2;FANCA;USP1;SLX4;NUCKS1;MSH6;MCM9;XRCC3;POLN;DCLRE1C;DCLRE1B;FAAP24
prerank,recombinational repair (GO:0000725),0.7790447990505109,1.8562642667103995,0.0,0.01391480828554348,0.342,30/77,9.38%,RAD51AP1;GEN1;RAD51;POLQ;MMS22L;RFWD3;RAD54B;ERCC4;BRCA1;RPA2;BLM;BRCA2;XRCC1;RAD51B;RAD51C;TONSL;SLX4;SMC6;NUCKS1;MCM9;RBBP8;FEN1;XRCC3;HELQ;POLN;PALB2;RHNO1;HUS1;NABP2;RPA1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.9141266266204909,1.8531182622523918,0.0,0.014941661039837947,0.367,12/17,4.90%,KNL1;ZWILCH;CENPA;TTK;CDK1;AURKB;SPDL1;RB1;CHAMP1;HASPIN;CTCF;IK
prerank,negative regulation of cell cycle process (GO:0010948),0.7939769324772771,1.8517565201213948,0.0,0.015500674735070821,0.38,27/61,10.75%,E2F7;RAD51;AURKB;E2F8;RRM2;NEK2;EZH2;BRCA1;ESPL1;E2F1;UXT;FBXO5;AURKAIP1;CBX5;APAF1;SUZ12;EPC1;RBBP8;CHEK1;E2F6;TERF2;RBBP4;TFDP1;MAX;TERF1;TFDP2;EHMT1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.795633407894102,1.849515579928498,0.0,0.01609745856478986,0.396,11/50,2.55%,CCNF;CDC25C;CDKN3;CCNB2;CCNB1;CCNA2;CCNE1;CDKN2C;CDC25A;BLM;CCNE2
prerank,zinc ion homeostasis (GO:0055069),-0.5670387415055838,-1.849088074233913,0.007633587786259542,0.3137489988461278,0.78,17/28,23.11%,PRKN;SLC39A7;SLC39A14;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;SLC39A8;SLC39A6;MT2A;SLC39A12;SLC30A1;MT3
prerank,regulation of chromosome segregation (GO:0051983),0.8931731855127596,1.8435859497786804,0.0013003901170351106,0.018741934083433477,0.451,6/16,3.61%,MKI67;BUB1;AURKB;KIF2C;RMI2;SMC6
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.7780367947480076,1.8428816678451487,0.0,0.018684759177748814,0.453,37/82,11.96%,CENPF;TPX2;HMMR;KIF14;CDK1;GTSE1;NEK2;CKAP5;PLK1;CDK5RAP2;AURKA;CEP152;NDE1;PCNT;HAUS5;HAUS6;CEP192;ATAD5;TUBB4B;ODF2;CLASP1;CEP72;CEP76;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;CEP70;NINL;PCM1;PAFAH1B1;HAUS4;TUBB;ATF5;HAUS7
prerank,lytic vacuole organization (GO:0080171),-0.5186968268178594,-1.8427921906281828,0.0,0.29832913866829563,0.791,17/32,20.12%,CLVS1;TPCN2;ABCA1;MBTPS1;ACP2;GRN;MYO7A;HPS1;CLN5;HOOK2;ZKSCAN3;NAGPA;SNAPIN;TFEB;HOOK3;TMEM106B;CLN6
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.7708474516349373,1.8359003612245386,0.0010460251046025104,0.02233611806189953,0.523,24/56,11.64%,DLGAP5;CDC25C;CDK1;UBE2C;CCNB1;ESPL1;CDC25A;RAD51B;RB1;FBXO5;DTL;RAD51C;CDC23;CDC27;TFDP1;ANAPC7;BRD4;CDC25B;EGFR;CUL3;MECP2;NSMCE2;RDX;PLCB1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.8501391118103787,1.8338365921795017,0.0012239902080783353,0.02316354298522979,0.547,5/23,1.74%,BUB1;BUB1B;ZWILCH;AURKB;WEE1
prerank,cell cycle checkpoint signaling (GO:0000075),0.9248345024687418,1.8313583165390026,0.0013869625520110957,0.02422427764617994,0.574,4/12,1.74%,BUB1;BUB1B;ZWILCH;WEE1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8108282070112882,1.8304534972677196,0.0,0.02441447882326462,0.583,19/40,7.30%,GEN1;RAD51;EME1;MMS22L;RFWD3;TIPIN;BLM;POLE;DDX11;TONSL;TIMELESS;NUCKS1;POLD1;MCM9;PCNA;TRAIP;PRIMPOL;ZRANB3;RTEL1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5763116818867366,-1.8301347130921013,0.006666666666666667,0.3110274893097129,0.838,16/26,23.11%,SLC39A7;SLC39A14;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;SLC39A8;SLC39A6;MT2A;SLC39A12;SLC30A1;MT3
prerank,positive regulation of cell communication (GO:0010647),-0.5400793003138648,-1.8257833456725947,0.007246376811594203,0.29689920586438606,0.847,13/28,20.29%,RIMS1;ANK3;RIMS2;WLS;SYT1;KCTD13;CLSTN3;GRIK2;CLSTN1;DLG4;SOX11;CLSTN2;PTPN23
prerank,microtubule polymerization or depolymerization (GO:0031109),0.8451359369315301,1.8225462042944813,0.0024125452352231603,0.02974810342773166,0.647,7/24,1.62%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,protein localization to kinetochore (GO:0034501),0.9027556175350798,1.8210380113919005,0.0,0.030343065496286296,0.662,8/14,4.90%,KNL1;ZWILCH;TTK;CDK1;AURKB;SPDL1;CHAMP1;IK
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.5521836416208195,-1.8194623657872975,0.0,0.29397565903857903,0.862,15/25,23.17%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;TPI1;FOXK1;PKM;PGAM1;ALDOC;ENO2;PFKP;PFKM;ENO3
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.9377556895956571,1.8181291887957323,0.0,0.03250550338894743,0.689,6/12,3.69%,CENPE;NDC80;NUF2;KIF2C;MAD1L1;CHAMP1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.769805258527979,1.812350487474282,0.0,0.03765319384908693,0.751,9/80,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,double-strand break repair via homologous recombination (GO:0000724),0.7524730647777298,1.8113556807336493,0.0,0.03784421390892106,0.758,32/95,9.38%,RAD51AP1;GEN1;RAD51;POLQ;MMS22L;RFWD3;RAD54B;ERCC4;CDC45;RAD21;BRCA1;RPA2;BLM;BRCA2;XRCC1;RAD51B;RAD51C;TONSL;SLX4;SMC6;MCM6;NUCKS1;MCM9;RBBP8;FEN1;XRCC3;HELQ;POLN;PALB2;HUS1;NABP2;RPA1
prerank,regulation of chromosome organization (GO:0033044),0.8471185883670466,1.8107706134309527,0.0011904761904761906,0.037694285937047184,0.761,8/22,6.10%,BUB1;PIF1;RMI2;SMG6;RB1;LIG4;SMG5;TERF2
prerank,response to hexose (GO:0009746),-0.5697477327866683,-1.8091375114097883,0.006289308176100629,0.30146854001221746,0.888,13/25,21.75%,EIF2B3;LPL;SELENOT;PFKL;VAMP2;IRS2;SELENOS;EIF2B4;ZBED3;SLC2A5;GPLD1;THBS1;EIF2B2
prerank,protein depolymerization (GO:0051261),0.8250379290884641,1.808755338727901,0.0011933174224343676,0.038844630922162005,0.778,7/27,1.62%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.8487587053195188,1.8078139576509666,0.005063291139240506,0.03890755735109709,0.788,10/18,7.11%,CDC25C;CDK1;CCNB1;CDC25A;RAD51B;FBXO5;DTL;RAD51C;BRD4;CDC25B
prerank,canonical glycolysis (GO:0061621),-0.5646887591431303,-1.8075981812971664,0.0,0.2667953573610263,0.889,15/24,23.17%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;TPI1;FOXK1;PKM;PGAM1;ALDOC;ENO2;PFKP;PFKM;ENO3
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.5646887591431303,-1.8075981812971664,0.0,0.2667953573610263,0.889,15/24,23.17%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;TPI1;FOXK1;PKM;PGAM1;ALDOC;ENO2;PFKP;PFKM;ENO3
prerank,sodium ion export across plasma membrane (GO:0036376),-0.6538369246554004,-1.8052024514374345,0.0,0.2584503934744331,0.899,7/13,25.61%,SLC9A1;ATP1A1;ATP1B2;ATP1B1;ATP1A2;ATP1A3;ATP1B3
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.7993168811174339,1.8041361843819068,0.0011235955056179776,0.041277272698766417,0.805,9/34,6.89%,NUSAP1;DLGAP5;ESPL1;RB1;AURKA;CDC23;CDC27;ANAPC7;TGFA
prerank,protein localization to condensed chromosome (GO:1903083),0.9089122044598342,1.8030240335974304,0.0013966480446927375,0.041638019374552304,0.813,8/12,4.90%,KNL1;ZWILCH;TTK;CDK1;AURKB;SPDL1;CHAMP1;IK
prerank,DNA recombination (GO:0006310),0.7820905253307054,1.796956219694805,0.0011185682326621924,0.04675356779088797,0.845,16/37,9.38%,GEN1;RAD51;RAD54B;RAD21;EXO1;BLM;RAD51B;RAD51C;LIG4;HMGB3;HDAC10;XRCC3;RTEL1;HMGB1;RHNO1;RPA1
prerank,regulation of exit from mitosis (GO:0007096),0.7949132271043722,1.7964698999828073,0.0022197558268590455,0.04647014338483536,0.849,10/38,4.40%,BUB1B;UBE2C;MAD2L1;KNTC1;NEK2;CDC20;ANLN;PPP1R9B;CDC23;CDC27
prerank,regulation of G0 to G1 transition (GO:0070316),0.7930877475652073,1.7963080873049695,0.002188183807439825,0.04587089569780381,0.849,20/38,12.15%,RAD51;RRM2;EZH2;BRCA1;E2F1;UXT;CBX5;APAF1;SUZ12;EPC1;RBBP8;CHEK1;E2F6;RBBP4;TFDP1;MAX;RHNO1;TFDP2;EHMT1;RNF2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.8422237694345303,1.790777067889722,0.006257822277847309,0.05059794717913303,0.88,11/21,7.11%,CDC25C;CDK1;CCNB1;CDC25A;RAD51B;FBXO5;DTL;RAD51C;ATAD5;BRD4;CDC25B
prerank,glycerophospholipid catabolic process (GO:0046475),-0.5316102088925091,-1.7900345347417999,0.0,0.28364515034276794,0.931,7/27,6.44%,PLA2G15;GPCPD1;ABHD12;PLA2G7;ENPP2;GDE1;ABHD16A
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8938262374225135,1.7886451420055915,0.005517241379310344,0.052427633939013375,0.891,7/13,6.03%,NDC80;GEN1;MAD2L1;CCNB1;CDK5RAP2;XRCC3;LCMT1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.7732877749676785,1.7882090539252538,0.0,0.05200283989355364,0.893,16/54,6.84%,CDC25C;E2F7;CDK1;E2F8;GTSE1;CCNB1;CHEK2;E2F1;AURKA;PML;PIDD1;PCNA;CASP2;MDM4;ATM;TFDP1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.79112836821706,1.7852008287693357,0.002224694104560623,0.05437870095111228,0.902,19/36,12.15%,RAD51;RRM2;EZH2;BRCA1;E2F1;UXT;CBX5;APAF1;SUZ12;EPC1;RBBP8;CHEK1;E2F6;RBBP4;TFDP1;MAX;TFDP2;EHMT1;RNF2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.7730221886816204,1.7851692807718127,0.0022002200220022,0.05356843968942313,0.902,14/42,7.30%,RAD51AP1;RAD51;POLQ;PARPBP;RMI2;RPA2;RADX;SMCHD1;TIMELESS;ARID2;CHEK1;CGAS;MRNIP;RTEL1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.7984077006032512,1.7818338446471007,0.001142857142857143,0.056159467981615536,0.912,13/32,7.23%,CDK1;TICRR;CLSPN;PLK1;BRCA1;BLM;DTL;BABAM1;TOPBP1;ABRAXAS1;CHEK1;ATM;MRNIP
prerank,chromosome organization (GO:0051276),0.7457572685219948,1.781039543724459,0.0,0.05619528094035406,0.918,21/99,7.97%,TOP2A;NDC80;NUF2;CDCA8;HMGB2;EZH2;CENPW;CENPH;RFWD3;SUV39H1;LIG4;NUCKS1;HDAC10;MSH6;TCF7L1;HMGN2;LRWD1;PHF19;H3-3A;PHF1;SMARCA4
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4777326511655657,-1.7801839392613379,0.0,0.29470083271710124,0.94,11/43,7.45%,SIRPA;PTPN6;HAVCR2;VSIR;CD274;CD34;IGF1;TNFAIP3;ZC3H12A;TLR4;TRIM27
prerank,organonitrogen compound catabolic process (GO:1901565),-0.45645056293141295,-1.7794855249951138,0.0,0.2819225412339646,0.942,30/57,30.63%,CAPN3;PLA2G15;PLA2G7;ENPP2;PPT1;CPQ;NAGK;NPEPPS;ANPEP;CLN5;IDE;CLN8;TXN2;PLA2G6;RIDA;SIAH1;NPL;GNPDA1;CLN6;GNPDA2;TRIM24;AMDHD2;ADO;USE1;PLA2G4A;IL4I1;RENBP;SMPD2;TST;SGPL1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.755878370137584,1.7791418077495336,0.0,0.057575710059733616,0.925,20/57,7.23%,CDK1;TICRR;CLSPN;EME1;FANCD2;RFWD3;TIPIN;PLK1;BRCA1;RPA2;CHEK2;BLM;DTL;BABAM1;TOPBP1;RAD9A;ABRAXAS1;CHEK1;ATM;MRNIP
prerank,DNA integrity checkpoint signaling (GO:0031570),0.8051348444490426,1.7791384421003362,0.0,0.056753199916023137,0.925,15/36,8.81%,BRIP1;CLSPN;TIPIN;RAD1;CDC45;CHEK2;E2F1;RAD9A;PRPF19;TIMELESS;CHEK1;ATM;RHNO1;DNA2;HUS1
prerank,membrane fusion (GO:0061025),-0.520228348561631,-1.778809941286678,0.0,0.26985949908368967,0.943,14/33,9.82%,RIMS1;DNM2;NSF;USO1;VTI1B;NAPA;UBXN2A;DNM3;DNM1L;UBXN2B;RABIF;MYOF;HUWE1;VAMP2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.871819874254327,1.7764948712802868,0.00130718954248366,0.05919148876657491,0.932,7/15,6.89%,CENPE;UBE2C;TACC3;PLK1;CDC23;CDC27;ANAPC7
prerank,DNA replication (GO:0006260),0.7402561224718832,1.776016064419999,0.0,0.058895235069044496,0.933,52/105,15.00%,CDK1;BRIP1;PIF1;TICRR;CLSPN;MCM10;BARD1;PCLAF;TIPIN;POLE2;RAD1;CDC45;BRCA1;RMI2;EXO1;RPA2;DBF4;POLA1;BLM;POLE;WDHD1;TOPBP1;MCM6;RFC5;RAD9A;ORC5;TIMELESS;POLD1;MCM9;RBBP8;FEN1;DUT;CHEK1;ORC3;ATM;POLD2;RHNO1;DNA2;HUS1;RPA1;RFC2;RFC1;FAM111A;TOP3A;RPAIN;KIN;ING5;NAP1L1;CDC7;RPA3;RAD50;RNASEH2A
prerank,cellular response to radiation (GO:0071478),0.7876782668386063,1.7729322088118415,0.0,0.06192890771692581,0.942,13/40,8.81%,RAD51AP1;RAD51;ECT2;RAD1;BLM;NET1;LIG4;RAD9A;TANK;MAPK14;RHNO1;GRB2;HUS1
prerank,placenta development (GO:0001890),0.894527639059631,1.7687487654293998,0.004010695187165776,0.0659160473576806,0.956,2/12,0.44%,E2F7;E2F8
prerank,DNA replication checkpoint signaling (GO:0000076),0.8651691761692393,1.7664743210893057,0.005263157894736842,0.06817423945135109,0.962,9/16,8.81%,TICRR;CLSPN;TIPIN;CDC45;TOPBP1;RAD9A;TIMELESS;DNA2;HUS1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.7519071565419737,1.7651384469399103,0.0,0.06904454148836761,0.964,18/63,6.84%,CDC25C;E2F7;CDK1;E2F8;GTSE1;CCNB1;RFWD3;RPA2;CHEK2;E2F1;AURKA;PML;PIDD1;PCNA;CASP2;MDM4;ATM;TFDP1
prerank,replication fork processing (GO:0031297),0.7763641493163506,1.7634381698816226,0.001088139281828074,0.0705478438628536,0.966,18/38,11.27%,GEN1;RAD51;EME1;MMS22L;RFWD3;BLM;BRCA2;DDX11;TONSL;NUCKS1;PCNA;TRAIP;PRIMPOL;ZRANB3;RTEL1;DNA2;EME2;FAM111A
prerank,response to nutrient levels (GO:0031667),-0.587446351075056,-1.76269337140839,0.0043859649122807015,0.2976175931582163,0.976,4/17,9.43%,PRKAA2;CD68;ATF4;ULK1
prerank,DNA metabolic process (GO:0006259),0.7254369776160314,1.7611458535736733,0.0,0.07261357180902797,0.968,97/270,12.66%,TOP2A;NEIL3;RAD51AP1;CDK1;GEN1;RAD51;TICRR;DNTT;UBE2T;POLK;POLQ;MCM10;UHRF1;HMGB2;BARD1;MEN1;POLE2;RAD1;ERCC4;CDC45;RAD21;BRCA1;PRIM2;RMI2;PRIM1;EXO1;RPA2;DBF4;POLA1;BLM;FANCA;MUTYH;POLE;XRCC1;CHD1L;RAD51B;WDHD1;RAD51C;SLX4;TOPBP1;MCM6;LIG4;RFC5;RAD9A;HMGB3;HELLS;ORC5;TIMELESS;POLD1;POLH;MSH6;SMUG1;RBBP8;FEN1;PCNA;CHEK1;SP100;LIG1;ORC3;XRCC3;MBD4;ATM;TERF2;GMNN;LRWD1;PRIMPOL;XRCC6;ZRANB3;DCLRE1B;RTEL1;HMGB1;ASF1A;NEIL1;POLD2;DNA2;RAD18;DNASE1L1;HUS1;NABP2;TERF1;RPA1;ERCC3;LONP1;RFC2;DNMT1;PARK7;SUMO1;RFC1;TYMS;KMT5C;CTC1;POLD3;APEX1;TOP3A;PDS5B;RPAIN;TDP1
prerank,double-strand break repair (GO:0006302),0.7283319974096477,1.7588415445076284,0.0,0.0747867548390308,0.973,63/158,12.18%,RAD51AP1;BRIP1;GEN1;RAD51;DNTT;EME1;POLQ;HMGB2;BARD1;MMS22L;RFWD3;RAD54B;ERCC4;RAD21;BRCA1;TRIP13;RPA2;CHEK2;POLA1;BLM;BRCA2;SMARCA5;XRCC1;NSD2;RAD51B;RAD51C;TONSL;BABAM1;SLX4;SMC6;LIG4;PRPF19;NUCKS1;ABRAXAS1;MCM9;RBBP8;FEN1;ACTR5;XRCC3;HELQ;POLN;ATM;DCLRE1C;SETX;XRCC6;DCLRE1B;HMGB1;EYA3;BAZ1B;CIB1;TDP2;PALB2;DNA2;HUS1;NABP2;RPA1;EME2;NSMCE2;SUMO1;RNF168;RNF8;BAP1;PAXIP1
prerank,acylglycerol catabolic process (GO:0046464),-0.5121261381296301,-1.7579499247166295,0.0,0.2980935433321824,0.98,7/30,16.21%,MGLL;LPL;ABHD12;ABHD16A;ABHD6;DAGLA;LIPH
prerank,response to ionizing radiation (GO:0010212),0.7530693268868455,1.757375678533819,0.001034126163391934,0.07603795527664137,0.979,27/70,8.96%,RAD51AP1;RAD51;ECT2;TICRR;FANCD2;RFWD3;MEN1;RAD1;BRCA1;BLM;NET1;BABAM1;TOPBP1;LIG4;RAD9A;TANK;BRAT1;ABRAXAS1;STK11;ATM;MRNIP;EYA3;MAPK14;RHNO1;GRB2;HUS1;NABP2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.750103277126813,1.7566888575943103,0.0,0.07521674931727274,0.979,9/78,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.750103277126813,1.7566888575943103,0.0,0.07521674931727274,0.979,9/78,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,regulation of potassium ion transport (GO:0043266),-0.5012737381755469,-1.75650356687003,0.0,0.2901258399511301,0.984,8/31,9.86%,ANK3;DPP10;KCNIP3;KCNN2;KCNAB1;ANK2;CD63;FHL1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.7486682700869054,1.7546147691456873,0.0,0.07729728079414613,0.982,9/79,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6180889893948532,-1.7543795989261888,0.02100840336134454,0.2840599144777031,0.985,5/15,18.65%,APOE;ABCA5;PLTP;SCARB1;APOC1
prerank,negative regulation of cell division (GO:0051782),0.9062660639654461,1.7490259282952827,0.004132231404958678,0.08489799647070172,0.987,4/11,2.12%,E2F7;AURKB;E2F8;BLM
prerank,regulation of sister chromatid cohesion (GO:0007063),0.8984087786817977,1.7487900243685344,0.0,0.08417493650834446,0.987,7/12,4.82%,BUB1;RAD21;ESPL1;RB1;DDX11;CTCF;FEN1
prerank,DNA conformation change (GO:0071103),0.8375443729960587,1.7481726758990432,0.001287001287001287,0.08403472346022718,0.987,8/17,12.44%,TOP2A;HMGB2;HMGB3;HMGB1;ERCC3;KAT6A;HAT1;TOP3A
prerank,"base-excision repair, AP site formation (GO:0006285)",0.8565480958512939,1.7460977886535212,0.0,0.08582498805012237,0.989,7/17,9.01%,NEIL3;MUTYH;SMUG1;MBD4;TERF2;NEIL1;TERF1
prerank,DNA modification (GO:0006304),0.8178688111412713,1.7413879393174159,0.004767580452920143,0.09195892715934818,0.992,7/22,9.01%,NEIL3;MUTYH;SMUG1;MBD4;TERF2;NEIL1;TERF1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.7197466826997614,1.7405263127717532,0.0,0.09260705129034748,0.994,49/145,11.28%,CENPF;TPX2;HMMR;KIF14;CDC25C;CDK1;NEK2;CCNB1;CKAP5;PLK1;CDK5RAP2;CDC25A;RAD51B;AURKA;CEP152;FBXO5;NDE1;DTL;RAD51C;PSMB7;PCNT;HAUS5;PSMD11;HAUS6;CEP192;PSMF1;TUBB4B;ODF2;CLASP1;CEP72;CEP76;PSMC1;BRD4;CDC25B;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;CEP70;MECP2;NINL;PCM1;PSMC3;PAFAH1B1;HAUS4;PSMA4;TUBB
prerank,base-excision repair (GO:0006284),0.7502487906569398,1.7376163953388166,0.0010706638115631692,0.09608537245192923,0.995,21/48,12.36%,NEIL3;POLQ;RPA2;MUTYH;POLE;XRCC1;RFC5;POLD1;SMUG1;FEN1;PCNA;LIG1;MBD4;NEIL1;POLD2;DNA2;RPA1;RFC2;RFC1;POLD3;APEX1
prerank,telomere maintenance (GO:0000723),0.7395232928926528,1.7364914444224417,0.002150537634408602,0.09692155975255629,0.995,27/50,14.98%,RAD51;ERCC4;RPA2;BLM;SMC6;POLD1;PCNA;SP100;XRCC3;ATM;TERF2;XRCC6;DCLRE1B;RTEL1;POLD2;DNA2;HUS1;TERF1;RPA1;NSMCE2;TEP1;CTC1;POLD3;APEX1;PRKDC;RPA3;RAD50
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.75571275418779,1.7352704579255638,0.0021953896816684962,0.09794533658221531,0.995,10/45,8.96%,BUB1;BUB1B;ZWILCH;MAD2L1;WEE1;AURKAIP1;CHEK1;ZFP36L1;ZW10;NABP2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.7180193161404773,1.7334316034673662,0.0,0.10006180243873375,0.995,60/184,12.13%,CENPF;CENPE;TPX2;HMMR;BUB1B;KIF14;CDK1;UBE2C;MAD2L1;KNTC1;NEK2;CCNB1;CDC20;CKAP5;PLK1;CDK5RAP2;ANLN;PPP1R9B;E2F1;AURKA;CEP152;FBXO5;NDE1;PSMB7;PCNT;HAUS5;PSMD11;HAUS6;CDC23;CEP192;CDC27;PSMF1;TUBB4B;ODF2;CLASP1;CEP72;ZFP36L1;CEP76;PSMC1;ANAPC7;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;ZW10;NEDD1;CEP70;ERCC3;CUL3;NINL;PCM1;PSMC3;PAFAH1B1;HAUS4;PSMA4;TUBB;HAUS7;FZR1;PSMC4
prerank,regulation of spindle organization (GO:0090224),0.8346506825628716,1.730669728338232,0.007802340702210663,0.10352378352751879,0.998,7/18,8.25%,TPX2;TACC3;BORA;GPSM2;GNAI1;DYNC1H1;CLTC
prerank,nucleosome assembly (GO:0006334),0.7754049153569562,1.7289818023945687,0.004656577415599534,0.10546105948829654,0.998,17/31,12.09%,ASF1B;HMGB2;CHAF1A;ANP32B;SMARCA5;RSF1;NASP;NAP1L4;RBBP4;H3-3A;ASF1A;SART3;UBN1;HIRA;SPTY2D1;CHAF1B;HAT1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.7936915301769892,1.7275920061876857,0.0022624434389140274,0.1070011485350386,0.999,16/32,11.93%,E2F7;GFI1;RRM2;CCNE1;CDC45;POLA1;E2F1;RB1;FBXO5;PCNA;TFDP1;BRD4;CDK17;TFDP2;TYMS;NPAT
prerank,spindle assembly (GO:0051225),0.7281316495128982,1.7272273002444973,0.0,0.10643705984311487,0.999,25/67,13.80%,KIF11;TPX2;KIFC1;NEK2;TUBGCP6;CHEK2;RCC1;FLNA;HAUS5;HAUS6;CEP192;ABRAXAS1;TUBGCP4;CLASP1;STAG1;MAPRE3;OFD1;KIF2A;HAUS4;HAUS7;TUBGCP3;CCDC61;NUMA1;LSM14A;PIBF1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.7289792765782251,1.7252019510254324,0.0,0.1086532460384559,0.999,19/72,6.84%,CDC25C;E2F7;CDK1;E2F8;GTSE1;FOXM1;CCNB1;CHEK2;E2F1;AURKA;BATF;PML;PIDD1;PCNA;SP100;CASP2;MDM4;ATM;TFDP1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.7507527195522224,1.7228342877793843,0.0043907793633369925,0.11169880157575275,0.999,15/43,8.96%,CDK1;TICRR;CLSPN;PLK1;BRCA1;BLM;DTL;BABAM1;TOPBP1;ABRAXAS1;CHEK1;ATM;MRNIP;HUS1;NABP2
prerank,DNA replication initiation (GO:0006270),0.7652911431981128,1.7177536890318583,0.0011337868480725624,0.11950624458831474,0.999,15/37,6.79%,MCM10;POLE2;CDC45;PRIM2;PRIM1;RPA2;DBF4;POLA1;POLE;TOPBP1;MCM6;ORC5;ORC3;GMNN;LRWD1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.4879893097975455,-1.7173080322549035,0.007407407407407408,0.3837661764014849,0.998,10/33,24.56%,UBASH3B;TLR4;FBN1;TCTA;CAMK4;CSF1;CCL3;TMEM178A;MAFB;CCR1
prerank,B cell proliferation (GO:0042100),0.8188386105266333,1.7155933376157544,0.006493506493506494,0.12247328989959012,1.0,4/17,5.36%,CD19;MS4A1;CD79A;RASGRP1
prerank,positive regulation of signaling (GO:0023056),-0.4690284646550113,-1.7142999639049346,0.009174311926605505,0.3802562048915134,0.999,15/37,21.82%,RIMS1;NSF;RIMS2;WLS;SYT1;KCTD13;ECE1;CLSTN3;GRIK2;CLSTN1;DLG4;SOX11;CLSTN2;PTPN23;ANXA2
prerank,DNA geometric change (GO:0032392),0.7891036228536792,1.7115337362661054,0.011029411764705883,0.1293415013858743,1.0,11/24,8.32%,PIF1;HMGB2;BLM;DDX11;HMGB3;MCM9;ZRANB3;RTEL1;HMGB1;HNRNPA2B1;DNA2
prerank,"phagocytosis, engulfment (GO:0006911)",-0.46190782485493775,-1.7078066727071888,0.009523809523809525,0.38887721441661577,0.999,17/36,19.94%,ARHGAP25;FCGR1A;ITGAM;AIF1;GULP1;RHOBTB1;XKR6;RHOBTB2;SH3BP1;RHOG;VAMP7;RHOH;CD36;THBS1;CDC42;ADGRB1;XKR4
prerank,regulation of centrosome duplication (GO:0010824),0.7658528348259295,1.7076794281371372,0.00591016548463357,0.1360150854281782,1.0,7/29,7.68%,CCNF;STIL;GEN1;CEP295;XRCC3;CEP76;ALMS1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.7947861605502311,1.7045811266507331,0.009615384615384616,0.14103478755029772,1.0,14/24,12.32%,POLK;RPA2;POLE;XRCC1;LIG4;RFC5;POLD1;PCNA;LIG1;POLD2;RPA1;RFC2;RFC1;POLD3
prerank,DNA damage checkpoint signaling (GO:0000077),0.7895278884942775,1.7026786500973499,0.003537735849056604,0.1438812309799004,1.0,11/28,8.81%,BRIP1;CLSPN;RAD1;CHEK2;E2F1;RAD9A;PRPF19;CHEK1;ATM;RHNO1;HUS1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.7591196389144251,1.7024610916831637,0.008092485549132947,0.14293206812746884,1.0,6/32,6.64%,RNASE6;PGLYRP1;CAMP;S100A9;RPS19;HMGN2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.5974385883531167,-1.7003061639379087,0.012605042016806723,0.397682219366798,1.0,7/15,6.32%,CD84;LRFN5;HAVCR2;CD300LF;GRN;CD300A;ZC3H12A
prerank,regulation of mitotic spindle organization (GO:0060236),0.7597708773921036,1.7002961510604948,0.003393665158371041,0.14635628794861352,1.0,9/35,8.25%,TPX2;TACC3;BORA;CCSAP;PLK1;GPSM2;GNAI1;DYNC1H1;CLTC
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.45994511403220906,-1.6927823308758048,0.012048192771084338,0.4108673589900224,1.0,10/41,7.45%,SIRPA;PTPN6;HAVCR2;VSIR;CD34;IGF1;TNFAIP3;ZC3H12A;TLR4;TRIM27
prerank,glycolytic process (GO:0006096),-0.5201003351919993,-1.6918964958681997,0.013888888888888888,0.40018696671724435,1.0,17/28,23.17%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;LDHA;TPI1;PGM1;PKM;PGAM1;PGAM4;ALDOC;ENO2;PFKFB2;PFKM;ENO3
prerank,signal transduction in response to DNA damage (GO:0042770),0.7361692510817592,1.6882020165925815,0.004343105320304018,0.1707761493073484,1.0,16/49,8.81%,E2F7;BRIP1;CLSPN;RAD1;CHEK2;E2F1;BATF;RAD9A;PRPF19;CHEK1;MDM4;ATM;MAPK14;RHNO1;GRB2;HUS1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.7869413295893068,1.685973345853708,0.015873015873015872,0.17442792588109216,1.0,6/21,5.23%,UBE2C;MAD2L1;CDC20;PLK1;FBXO5;RPS7
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.8529793183265135,1.6835082093440397,0.014666666666666666,0.17551059073190384,1.0,8/12,10.73%,DLGAP5;ESPL1;RB1;CDC23;CDC27;ANAPC7;CUL3;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.8529793183265135,1.6835082093440397,0.014666666666666666,0.17551059073190384,1.0,8/12,10.73%,DLGAP5;ESPL1;RB1;CDC23;CDC27;ANAPC7;CUL3;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.8529793183265135,1.6835082093440397,0.014666666666666666,0.17551059073190384,1.0,8/12,10.73%,DLGAP5;ESPL1;RB1;CDC23;CDC27;ANAPC7;CUL3;NSMCE2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.7111808603651572,1.6830237839458793,0.0,0.17501042987331114,1.0,24/78,12.48%,CCNF;CDC25C;CDKN3;CCNB2;CCNB1;CCNA2;MEN1;CCNE1;PLK1;CDKN2C;CDC25A;BLM;CCNE2;CCNYL1;CDKN2A;MAPRE3;EGFR;CDKN2D;NR2F2;IPO7;CCNJ;CCNT1;PTEN;CDK5RAP3
prerank,positive regulation of viral genome replication (GO:0045070),0.7577666781393821,1.681753814845805,0.012835472578763127,0.17648801711949572,1.0,1/29,0.01%,TOP2A
prerank,positive regulation of nuclear division (GO:0051785),0.7635001985526193,1.6811851285765884,0.015513126491646777,0.17630160584798757,1.0,3/25,6.89%,NUSAP1;AURKA;TGFA
prerank,mitotic cell cycle phase transition (GO:0044772),0.7002188262482516,1.679262130286517,0.0,0.17936676468533816,1.0,73/203,11.96%,CCNF;CDC25C;CDK1;UBE2C;CDKN3;TACC3;FOXM1;CCNB2;NEK2;BORA;CCNB1;MASTL;CKAP5;CCNA2;CCNE1;PLK1;CDKN2C;CDK5RAP2;FBXL15;WEE1;DBF4;CHEK2;CDC25A;RCC1;POLE;E2F1;SKP2;CCNE2;RB1;AURKA;CEP152;NDE1;PCNT;HAUS5;HAUS6;CDC23;FBXW11;NASP;CEP192;CDC27;CDK6;CDKN2A;PPP1CB;TUBB4B;ODF2;CLASP1;LCMT1;CEP72;CEP76;ANAPC7;CDC25B;PIM2;DYNC1H1;ALMS1;MAX;OFD1;CEP250;PRKACA;NEDD1;PPP1R12B;CEP70;CDKN2D;CUL3;NINL;PCM1;PAFAH1B1;MELK;HAUS4;CCNJ;TUBB;PLCB1;CCDC57;HAUS7
prerank,cell cycle G2/M phase transition (GO:0044839),0.7009195712602336,1.678083416421034,0.0,0.18057661228587074,1.0,50/129,11.96%,CDC25C;CDK1;FOXM1;CCNB2;NEK2;BORA;CCNB1;MASTL;CKAP5;CCNA2;PLK1;CDK5RAP2;FBXL15;WEE1;CHEK2;CDC25A;SKP2;AURKA;CEP152;NDE1;PCNT;HAUS5;HAUS6;FBXW11;CEP192;PPP1CB;TUBB4B;ODF2;CLASP1;LCMT1;CEP72;CEP76;CDC25B;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;PPP1R12B;CEP70;NINL;PCM1;PAFAH1B1;MELK;HAUS4;TUBB;PLCB1;CCDC57;HAUS7
prerank,regulation of double-strand break repair (GO:2000779),0.7398056409482825,1.6766416409683687,0.0033444816053511705,0.182514622237272,1.0,13/39,9.17%,RAD51AP1;RAD51;FOXM1;RPA2;DDX11;TWIST1;DEK;PML;TIMELESS;CHEK1;MRNIP;RTEL1;RNF169
prerank,DNA repair (GO:0006281),0.693205025283273,1.6761988016632583,0.0,0.18222323095342122,1.0,114/284,15.00%,NEIL3;RAD51AP1;CDK1;BRIP1;RAD51;TICRR;UBE2T;EME1;POLK;POLQ;BARD1;FANCD2;RFWD3;MEN1;POLE2;RAD1;ERCC4;RAD21;BRCA1;TRIP13;RMI2;EXO1;RPA2;CHEK2;POLA1;BLM;FANCA;MUTYH;BRCA2;POLE;SMARCA5;XRCC1;CHD1L;NSD2;RAD51B;WDHD1;USP1;RAD51C;BABAM1;SLX4;TOPBP1;LIG4;RFC5;RAD9A;TIMELESS;NUCKS1;POLD1;POLH;MSH6;SMUG1;ABRAXAS1;PMS2;RBBP8;FEN1;PCNA;CHEK1;ACTR5;LIG1;XRCC3;MBD4;POLN;ATM;DCLRE1C;TRAIP;SETX;FTO;PRIMPOL;ZRANB3;DCLRE1B;EYA3;ASF1A;NEIL1;FAAP24;BAZ1B;CIB1;TDP2;POLD2;UBE2V1;RHNO1;DNA2;RAD18;HUS1;NABP2;CDKN2D;RPA1;ERCC3;RFC2;EME2;PMS1;PARK7;SUMO1;RAD23A;RNF168;FAM111A;RNF8;KMT5C;BAP1;POLD3;APEX1;PDS5B;RPAIN;TDP1;REXO4;PRKDC;APTX;FANCM;FANCL;RAD52;RPA3;VCPIP1;EYA1;TP53;RAD50;RNASEH2A
prerank,protein localization to chromosome (GO:0034502),0.7516067603868136,1.6758443137115928,0.008978675645342313,0.18146343090916314,1.0,11/34,9.38%,CENPA;PLK1;RAD21;RPA2;RB1;HASPIN;MCM9;CTCF;TERF2;MRNIP;RPA1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.7000364946617301,1.6753444893268314,0.0010204081632653062,0.18113339309753065,1.0,28/84,13.47%,BUB1B;CDK1;UBE2C;AURKB;MAD2L1;CCNB1;CDC20;PLK1;SKP2;RB1;AURKA;FBXO5;PSMB7;PSMD11;CDC23;CDC27;PSMF1;PSMC1;ANAPC7;CUL3;PTTG1;PSMC3;PSMA4;FZR1;PSMC4;BUB3;PSMD13;PSME1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.6997205968340229,1.6742125871186933,0.0,0.1821018402822769,1.0,50/128,11.96%,CDC25C;CDK1;FOXM1;CCNB2;NEK2;BORA;CCNB1;MASTL;CKAP5;CCNA2;PLK1;CDK5RAP2;FBXL15;WEE1;CHEK2;CDC25A;SKP2;AURKA;CEP152;NDE1;PCNT;HAUS5;HAUS6;FBXW11;CEP192;PPP1CB;TUBB4B;ODF2;CLASP1;LCMT1;CEP72;CEP76;CDC25B;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;PPP1R12B;CEP70;NINL;PCM1;PAFAH1B1;MELK;HAUS4;TUBB;PLCB1;CCDC57;HAUS7
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.5630548625762962,-1.6714677432075578,0.027777777777777776,0.459365913255956,1.0,9/19,22.91%,POLR3C;AR;ZC3H8;ZNF76;NAB2;TENM1;POLR3G;MAF1;ICE1
prerank,telomere organization (GO:0032200),0.7293962715021339,1.6701351852772486,0.0011148272017837235,0.19044942490096942,1.0,23/43,14.98%,ERCC4;RPA2;BLM;POLD1;PCNA;SP100;ATM;TERF2;XRCC6;DCLRE1B;RTEL1;H3-3A;POLD2;DNA2;HUS1;TERF1;RPA1;CTC1;POLD3;APEX1;PRKDC;RPA3;RAD50
prerank,regulation of DNA replication (GO:0006275),0.7210614687987253,1.667691608302359,0.0010706638115631692,0.19498384213958722,1.0,21/49,12.24%,ESCO2;CCNA2;BLM;DSCC1;FBXO5;CCDC88A;S100A11;ORC5;NUCKS1;PCNA;ORC3;ATAD5;FAF1;GMNN;DNA2;TERF1;EGFR;DHX9;BRPF3;CDAN1;CTC1
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.44386466869189284,-1.665876098423059,0.0,0.4660623091020159,1.0,9/47,14.36%,SPOCK1;SERPINE2;TIMP2;SPOCK2;BIN1;TIMP3;RECK;SERPINI1;SERPINE1
prerank,regulation of chromatin organization (GO:1902275),0.8217152308263946,1.6639394973442971,0.01453104359313078,0.20261162807324143,1.0,4/14,8.52%,MKI67;ALKBH4;TLK1;METTL4
prerank,translesion synthesis (GO:0019985),0.7263265172026198,1.6627915208925361,0.0054585152838427945,0.20359350150143338,1.0,18/42,12.32%,POLK;PCLAF;POLE2;RPA2;DTL;USP43;RFC5;POLD1;POLH;PCNA;POLN;NPLOC4;PRIMPOL;POLD2;RPA1;RFC2;RFC1;POLD3
prerank,cardiac muscle cell action potential (GO:0086001),-0.4855552485898066,-1.6619008010196485,0.006756756756756757,0.4665211110711847,1.0,13/30,18.69%,CACNA1C;SCN1A;ANK2;ATP1A1;DMD;SCN1B;HCN2;ATP1B1;FGF12;SLC8A1;KCND3;CACNA1G;ATP1A2
prerank,cellular response to ionizing radiation (GO:0071479),0.7319235938746388,1.6616327457754985,0.0010718113612004287,0.20487932649440385,1.0,16/47,8.81%,RAD51AP1;RAD51;ECT2;RAD1;BLM;NET1;LIG4;RAD9A;TANK;NUCKS1;ATM;XRCC6;MAPK14;RHNO1;GRB2;HUS1
prerank,mitotic nuclear membrane organization (GO:0101024),0.7103240005207013,1.6590352494752005,0.005307855626326964,0.2080200946292497,1.0,21/51,10.94%,CDK1;CCNB2;CCNB1;LBR;RCC1;NUP43;POM121;NDC1;REEP4;ANKLE2;NUP107;UBE2I;RANGAP1;NUP160;NUP205;AHCTF1;SEC13;NUP188;EMD;SUMO1;VRK1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.7103240005207013,1.6590352494752005,0.005307855626326964,0.2080200946292497,1.0,21/51,10.94%,CDK1;CCNB2;CCNB1;LBR;RCC1;NUP43;POM121;NDC1;REEP4;ANKLE2;NUP107;UBE2I;RANGAP1;NUP160;NUP205;AHCTF1;SEC13;NUP188;EMD;SUMO1;VRK1
prerank,bicarbonate transport (GO:0015701),0.7685472267524155,1.6582076768364702,0.009433962264150943,0.20843781839957717,1.0,3/25,1.86%,SLC4A1;RHAG;AQP1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.8087369608379393,1.6571475167141256,0.014084507042253521,0.20937902914540626,1.0,9/16,9.01%,ERCC4;SMG6;SLX4;SMG5;ATM;TERF2;RTEL1;HNRNPA2B1;TERF1
prerank,microglial cell activation (GO:0001774),-0.5325487598480857,-1.652631969342082,0.022988505747126436,0.4884134392180819,1.0,8/21,10.10%,APP;TREM2;ITGAM;AIF1;GRN;C1QA;CX3CR1;C5AR1
prerank,regulation of mitotic cell cycle (GO:0007346),0.6830314406629556,1.6514837723421802,0.0,0.22270102221724736,1.0,46/171,13.77%,MKI67;DLGAP5;KIF20B;BUB1B;CDC25C;CDK1;UBE2C;MAD2L1;NEK2;BORA;CKS2;CCNB1;CDC20;PLK1;RCC1;DYNLT3;RB1;FBXO5;PSMB7;PSMD11;CDC23;CDC27;PSMF1;PSMC1;ANAPC7;CDC25B;PIN1;PIM2;PKN2;PIM3;PRKCA;SMOC2;CAV2;ERCC3;PSMC3;PSMA4;CCDC57;FZR1;PSMC4;CDK5RAP3;BUB3;CUL9;PSMD13;HNRNPU;PSME1;INTS13
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.8318223232613234,1.650466243688499,0.016783216783216783,0.22370383997090074,1.0,4/12,4.25%,CD19;PAX5;BLK;PTPN22
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.8487002502288822,1.6485649306773582,0.02188782489740082,0.22750370007214593,1.0,4/12,3.58%,TICRR;CLSPN;CHEK2;TOPBP1
prerank,microtubule polymerization (GO:0046785),0.7581067409069777,1.647162939713106,0.01527614571092832,0.22967806184068645,1.0,11/28,13.07%,TPX2;CKAP5;TUBGCP6;NDE1;TUBGCP4;CLASP1;PIN1;SLAIN2;CCDC57;TUBGCP3;FGF13
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6920868913486936,-1.645137953772554,0.01929260450160772,0.5002674268648613,1.0,5/10,16.00%,IRF1;LAG3;ZC3H8;GLI3;MDK
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.8203773331920802,1.6429783018486779,0.021447721179624665,0.23952923653474578,1.0,8/12,12.34%,CDK1;CCNB2;CCNB1;PLK1;PRKCA;VRK1;PRKCB;CNEP1R1
prerank,establishment of spindle localization (GO:0051293),0.832338178789012,1.6425687757469984,0.013440860215053764,0.23897840486436323,1.0,5/14,7.64%,NUSAP1;ESPL1;MAP4;CLASP1;DYNC1H1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.7946882530789325,1.6423328486863855,0.014341590612777053,0.2377627291529594,1.0,6/16,5.11%,POLQ;PARPBP;RMI2;RADX;SMCHD1;CGAS
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.6951113434528168,1.641539101200652,0.007376185458377239,0.23825072501080835,1.0,23/58,12.18%,DNTT;POLQ;HMGB2;BARD1;ERCC4;BRCA1;POLA1;NSD2;BABAM1;LIG4;PRPF19;ABRAXAS1;ATM;DCLRE1C;XRCC6;DCLRE1B;HMGB1;ZBTB7A;NSMCE2;SUMO1;RNF168;RNF8;PAXIP1
prerank,negative regulation of DNA recombination (GO:0045910),0.7074552225421996,1.6403544283801612,0.006543075245365322,0.23990364448277623,1.0,14/43,9.01%,POLQ;PARPBP;RMI2;RADX;BLM;SMCHD1;POLR2I;POLR2A;MSH6;CGAS;TERF2;ZRANB3;RTEL1;TERF1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.7217864376456471,1.6399214890875213,0.008743169398907104,0.23932103064910365,1.0,19/42,12.32%,POLK;PCLAF;RPA2;POLA1;POLE;DTL;USP43;RFC5;POLD1;POLH;PCNA;POLN;PRIMPOL;POLD2;CDKN2D;RPA1;RFC2;RFC1;POLD3
prerank,error-prone translesion synthesis (GO:0042276),0.7638829582395134,1.6391830406194736,0.019347037484885126,0.23957190080148047,1.0,10/21,11.16%,POLK;POLE2;RPA2;RFC5;POLH;PCNA;PRIMPOL;RPA1;RFC2;RFC1
prerank,negative regulation of hemostasis (GO:1900047),-0.637303020273259,-1.6389437730740277,0.028169014084507043,0.5102195512555928,1.0,5/12,14.36%,SERPINE2;APOE;CD34;TFPI;SERPINE1
prerank,synaptic membrane adhesion (GO:0099560),-0.6048653641449443,-1.6386981071279694,0.030534351145038167,0.49746609651802076,1.0,6/14,10.70%,LRFN5;PTPRD;LRRC4;PTPRS;NTNG1;LRRC4B
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.812415489512561,1.6381380621166695,0.01742627345844504,0.24074593555945584,1.0,7/15,9.85%,EME1;FANCD2;TIPIN;CHEK2;RAD9A;HUS1;EME2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.6831980713749484,1.6376716857817033,0.0,0.24026351211202465,1.0,14/104,2.67%,CCNF;CDC25C;CDKN3;CCNB2;EZH2;CCNB1;CCNA2;INCENP;CCNE1;CDKN2C;CDC25A;BLM;CCNE2;RB1
prerank,synaptic vesicle localization (GO:0097479),-0.6282122691098964,-1.636591079636664,0.015444015444015444,0.49223651770750126,1.0,8/13,16.15%,DNM2;KIF5C;SYNJ1;SPG11;SYNDIG1;KIF5A;CDK5;SNAPIN
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.5481908881792958,-1.635827329644283,0.025380710659898477,0.48252706169822845,1.0,7/18,23.27%,TLR4;FBN1;TCTA;FBXW7;CCL3;TMEM178A;MAFB
prerank,regulation of telomere capping (GO:1904353),0.7741285752304367,1.6349642844953676,0.02192448233861145,0.24621606857928624,1.0,8/23,8.96%,AURKB;NEK2;MAPK1;SMG6;ATM;TERF2;RTEL1;NABP2
prerank,positive regulation of integrin activation (GO:0033625),-0.6284247263518268,-1.634735565834689,0.03484320557491289,0.4749065661456859,1.0,5/11,18.50%,RAP1B;P2RY12;FERMT2;SKAP1;PLEK
prerank,defense response to Gram-positive bacterium (GO:0050830),0.7326226009190036,1.6334271223569947,0.010011123470522803,0.24846272935561428,1.0,8/40,6.84%,IL12A;HMGB2;RNASE6;PGLYRP1;GBP4;CAMP;PPP1R11;GBP2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.44025975547071494,-1.632612736996888,0.010416666666666666,0.4706234982691916,1.0,15/40,16.15%,RIMS1;PCLO;RIMS2;SNAP47;STX4;STX3;SYT1;STX2;VAMP2;SYT7;CDK5;UNC13A;STX1A;PIP5K1C;SNAPIN
prerank,postreplication repair (GO:0006301),0.7095215827917475,1.629606963197438,0.008658008658008658,0.25762066068831313,1.0,19/45,12.32%,POLK;PCLAF;BRCA1;RPA2;DTL;USP43;RFC5;POLD1;POLH;PCNA;POLN;PRIMPOL;POLD2;UBE2V1;RAD18;RPA1;RFC2;RFC1;POLD3
prerank,mitotic DNA replication (GO:1902969),0.8542601295396861,1.6276427807279157,0.019490254872563718,0.2616541824423621,1.0,5/10,5.34%,CDC45;GINS1;POLA1;MCM6;LIG1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.7241051657762778,1.6276184334403727,0.014396456256921373,0.25998886487693973,1.0,18/35,12.36%,RPA2;MUTYH;POLE;XRCC1;RFC5;POLD1;SMUG1;FEN1;PCNA;LIG1;MBD4;NEIL1;POLD2;RPA1;RFC2;RFC1;POLD3;APEX1
prerank,regulation of telomerase activity (GO:0051972),0.7186665897943726,1.6242092633850012,0.005500550055005501,0.2682016888429916,1.0,12/45,9.01%,AURKB;PIF1;NEK2;MEN1;ERCC4;MAPK1;SMG6;ATM;CCT2;TCP1;NABP2;TERF1
prerank,nuclear membrane reassembly (GO:0031468),0.6919862432747691,1.6227894219484826,0.01053740779768177,0.27037163478598014,1.0,21/54,10.94%,CDK1;CCNB2;CCNB1;LBR;RCC1;NUP43;POM121;NDC1;REEP4;ANKLE2;NUP107;UBE2I;RANGAP1;NUP160;NUP205;AHCTF1;SEC13;NUP188;EMD;SUMO1;VRK1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.8353650015719681,1.6225309204056535,0.02247191011235955,0.26940537207100046,1.0,5/12,8.52%,TICRR;TIPIN;BLM;GMNN;METTL4
prerank,acetyl-CoA metabolic process (GO:0006084),-0.5853806157053097,-1.6225238322689663,0.038910505836575876,0.49583838843033906,1.0,8/15,26.63%,ACLY;ACACA;ACAT1;NUDT7;PMVK;MLYCD;PPCS;MVK
prerank,negative regulation of cell aging (GO:0090344),0.8050610080136567,1.6223598968640947,0.01955671447196871,0.2680569842638304,1.0,7/16,7.46%,FOXM1;FBXO5;TWIST1;RBL1;CDK6;TERF2;AKT3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.8571114031536826,1.6202132338633852,0.009831460674157303,0.27255046117642934,1.0,3/10,1.92%,E2F7;E2F8;DBF4
prerank,cellular response to DNA damage stimulus (GO:0006974),0.6674596641765363,1.6197329207006486,0.0,0.2722460351037237,1.0,116/336,14.98%,TOP2A;RAD51AP1;CDK1;RAD51;BLK;TICRR;UBE2T;POLK;POLQ;MCM10;BARD1;MASTL;RFWD3;PCLAF;MEN1;POLE2;RAD1;ERCC4;SUV39H1;BRCA1;RMI2;EXO1;CHEK2;POLA1;BLM;FANCA;MUTYH;E2F1;CHD1L;RAD51B;WDHD1;DDX11;DTL;RAD51C;BATF;CBX5;SLX4;TOPBP1;SMC6;RFC5;RAD9A;PML;MAP2K6;TIMELESS;PIDD1;TANK;POLD1;BRAT1;POLH;MSH6;MCM9;RBBP8;STK11;FEN1;FOXP1;CHEK1;CGAS;LIG1;XRCC3;MBD4;TAF1;IKBKG;FOXO1;CASP2;ATM;TRAIP;SETX;FBXO45;MRNIP;ZRANB3;RTEL1;ASF1A;BOK;BAZ1B;CIB1;PHF1;MAPK14;GRB2;RAD18;HUS1;NABP2;RNF169;RPA1;ERCC3;ALKBH7;RFC2;PPP1R15A;PARK7;SUMO1;RNF168;FAM111A;XIAP;RNF8;KMT5C;APEX1;PDS5B;RPAIN;TDP1;KIN;SIRT7;REXO4;PRKDC;NIPBL;DDIT3;MYC;BCL6;PSEN1;APTX;FANCL;CASP9;RAD52;RBBP5;CCNK;VCPIP1;TP53;RAD50
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.7957500874908088,1.6189545824504663,0.022135416666666668,0.2727891838603202,1.0,3/16,8.62%,IL12A;KLRD1;CYRIB
prerank,embryonic axis specification (GO:0000578),0.7818723725977562,1.6182226225417733,0.02834008097165992,0.2730900010094139,1.0,1/15,0.26%,STIL
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7349187076823512,1.6174573270273573,0.013498312710911136,0.2736551654790413,1.0,8/31,5.36%,E2F7;CDKN2C;JADE1;WEE1;RB1;RBL1;CDK6;CDKN2A
prerank,microtubule nucleation (GO:0007020),0.7803063006624789,1.6151946934179806,0.022871664548919948,0.2784143539214063,1.0,8/19,12.68%,TPX2;TUBGCP6;NDE1;TUBGCP4;CLASP1;SLAIN2;CCDC57;TUBGCP3
prerank,nucleosome organization (GO:0034728),0.693159111564338,1.6150764843475918,0.008501594048884165,0.27695596973428127,1.0,24/55,13.91%,HMGB2;CHAF1A;ANP32B;SMARCC2;HMGA1;SMARCA5;SMARCD2;RSF1;NASP;ARID2;CTCF;LIN54;NAP1L4;H3-3A;ASF1A;SMARCA4;SART3;SMARCC1;SPTY2D1;NFE2;CHAF1B;RNF8;ANP32E;NAP1L1
prerank,protein palmitoylation (GO:0018345),-0.4709759945684002,-1.6119520903241413,0.0,0.5241832620647526,1.0,20/30,35.77%,GLUL;ZDHHC17;ZDHHC13;ZDHHC5;GOLGA7;ZDHHC8;SELENOK;CLIP3;ZDHHC24;ZDHHC16;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;HHAT;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,B cell receptor signaling pathway (GO:0050853),0.7218176608008242,1.6105054644729533,0.02358490566037736,0.2886288318456878,1.0,10/32,11.86%,CD19;BLK;MS4A1;CD79A;CD38;CD79B;NFAM1;PLCG2;BTK;PRKCB
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.8191367492377013,1.6088206135346519,0.02676056338028169,0.29168276944909055,1.0,8/11,12.09%,ASF1B;NASP;RBBP4;H3-3A;ASF1A;UBN1;HIRA;HAT1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5827124068624301,-1.6083170207168067,0.026717557251908396,0.5261149256770514,1.0,8/13,25.61%,KCNMA1;SLC12A2;ATP1A1;ATP1B2;ATP1B1;ATP1A2;ATP1A3;ATP1B3
prerank,mitotic recombination (GO:0006312),0.7868968698284259,1.6077545914978633,0.02529960053262317,0.2929792762943879,1.0,9/15,14.98%,GEN1;RAD51;RAD54B;SMC6;XRCC3;NSMCE2;TEP1;RAD52;RAD50
prerank,negative regulation of coagulation (GO:0050819),-0.6082171726805949,-1.607556124610527,0.04032258064516129,0.5171972059175055,1.0,6/14,16.26%,SERPINE2;APOE;CD34;TFPI;SERPINE1;HS3ST5
prerank,positive regulation of telomere capping (GO:1904355),0.79565352582439,1.6071156833390166,0.02560819462227913,0.29291328225432234,1.0,5/17,8.96%,AURKB;NEK2;MAPK1;RTEL1;NABP2
prerank,cellular response to zinc ion (GO:0071294),-0.5731342832049565,-1.6056321997767893,0.024691358024691357,0.5134627692067742,1.0,12/15,23.11%,GLRA2;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;MT2A;P2RX4;MT3
prerank,regulation of DNA recombination (GO:0000018),0.7265355123896817,1.605299042615913,0.021839080459770115,0.29648669913978726,1.0,9/32,7.30%,RAD51AP1;RAD51;RPA2;BLM;IL7R;MSH6;CHEK1;ZRANB3;RTEL1
prerank,fibrinolysis (GO:0042730),-0.5911090769939624,-1.6036979127851119,0.02834008097165992,0.5093194868662186,1.0,4/13,23.54%,PLAUR;PLAU;SERPINE1;PLAT
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.5018336093711537,-1.6032549867572112,0.03488372093023256,0.5003075311981848,1.0,11/24,14.37%,ITGAM;CTNNB1;GRN;MCL1;ATF4;NF1;CDK5R1;CDK5;SRPK2;PRNP;FBXW7
prerank,negative regulation of hormone secretion (GO:0046888),-0.6514941061575602,-1.60023762292416,0.03278688524590164,0.5003259621258399,1.0,6/10,31.77%,RAB11FIP3;GJA1;RAB11FIP5;RAB11FIP1;OSM;IL1B
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.7880315668930147,1.599014406727011,0.03042328042328042,0.31388647795296054,1.0,6/15,9.53%,FAM83D;EZH2;ATAD5;DDRGK1;PLCG2;CUL3
prerank,nuclear membrane disassembly (GO:0051081),0.7915986251387939,1.5987695222107223,0.026143790849673203,0.31276263122957726,1.0,8/14,12.34%,CDK1;CCNB2;CCNB1;PLK1;PRKCA;VRK1;PRKCB;CNEP1R1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.7171352284538486,1.5984598993491566,0.020224719101123594,0.31183996731710917,1.0,8/33,5.36%,E2F7;CDKN2C;JADE1;WEE1;RB1;RBL1;CDK6;CDKN2A
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6537410808034203,-1.5977839848787079,0.04938271604938271,0.4992221543473835,1.0,4/10,12.73%,PLA2G15;PLA2G7;ENPP2;PLA2G6
prerank,glycerolipid catabolic process (GO:0046503),-0.5271067134914895,-1.5963714302366188,0.03225806451612903,0.493818899487806,1.0,5/19,7.11%,MGLL;GPCPD1;ABHD12;GDE1;ABHD6
prerank,acylglycerol metabolic process (GO:0006639),-0.4530392580231835,-1.5948829363509176,0.019417475728155338,0.48935793732206867,1.0,13/37,13.77%,DGKH;MGLL;APOE;LPL;ABHD12;DGKA;ABHD6;DGKI;DGKZ;DGKQ;LMF1;DGKB;DGAT1
prerank,chromatin disassembly (GO:0031498),0.7935426404575783,1.5944383476827368,0.032,0.32079166933405606,1.0,7/14,10.88%,SMARCC2;HMGA1;SMARCD2;ARID2;SMARCA4;SMARCC1;NFE2
prerank,nucleosome disassembly (GO:0006337),0.7935426404575783,1.5944383476827368,0.032,0.32079166933405606,1.0,7/14,10.88%,SMARCC2;HMGA1;SMARCD2;ARID2;SMARCA4;SMARCC1;NFE2
prerank,positive regulation of telomere maintenance (GO:0032206),0.7241939142198154,1.5936626628561976,0.020713463751438434,0.32130903844058917,1.0,9/31,8.96%,AURKB;NEK2;MAPK1;SLX4;PML;ATM;RTEL1;HNRNPA2B1;NABP2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.7787386614854203,1.5911476964472753,0.02860858257477243,0.3277322768750733,1.0,4/16,3.64%,RAD51;HMGA1;BLM;MCM6
prerank,mismatch repair (GO:0006298),0.7350596607324057,1.589235299757161,0.020432692307692308,0.33180937643564484,1.0,17/27,17.81%,EXO1;RPA2;MUTYH;POLD1;MSH6;MCM9;PMS2;PCNA;LIG1;POLD2;RPA1;PMS1;POLD3;RPA3;RNASEH2A;MSH5;TDG
prerank,response to acidic pH (GO:0010447),-0.5851135752613467,-1.5892057439853318,0.04132231404958678,0.49927790221498225,1.0,8/13,22.73%,CTSS;IMPACT;SLC9A1;LGMN;GPR65;RAB11FIP5;PKD2L1;CHP1
prerank,negative regulation of telomere maintenance (GO:0032205),0.7779508790831994,1.5891146842331954,0.029023746701846966,0.3303013469235514,1.0,7/15,9.01%,ERCC4;SMG6;SLX4;ATM;TERF2;RTEL1;TERF1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.768977351456496,1.5890236930566668,0.041884816753926704,0.3287641913537866,1.0,4/16,5.54%,IL12A;KLRD1;RASGRP1;RAET1E
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7460515572184145,1.5873883740412338,0.029887920298879204,0.3322639837225173,1.0,10/21,15.17%,CD19;PAX5;BLK;PTPN22;FOXP1;NFAM1;PRKCB;CBFB;ELF1;RUNX1
prerank,retinol metabolic process (GO:0042572),0.7827635979699934,1.5871195383517798,0.03504043126684636,0.33119657009166065,1.0,2/14,1.40%,LRAT;CYP1B1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.7074011270612179,1.5863776650631236,0.0330672748004561,0.33182758474494956,1.0,17/30,19.64%,PIF1;MEN1;ERCC4;DACH1;HNRNPC;TERF2;EXOSC10;DCP2;TERF1;CTC1;HNRNPU;TP53;NAT10;HNRNPA1;GNL3L;CDKN1A;XRN1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7642369243525057,1.5861405220447256,0.044270833333333336,0.33071913866584357,1.0,4/17,5.54%,IL12A;KLRD1;RASGRP1;RAET1E
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.6547742347285241,1.585850438283642,0.0,0.3298633973688508,1.0,51/148,13.63%,TPX2;CDK1;BRIP1;AURKB;BARD1;RAD1;BRCA1;RMI2;EXO1;RPA2;MBD3;CHEK2;BLM;AURKA;RPS20;TOPBP1;RFC5;RAD9A;PML;MAP2K6;RBBP8;STK11;CHEK1;BRPF1;TAF1;MDM4;ATM;RBBP4;TAF7;PIN1;TAF15;MAPK14;RHNO1;DNA2;HUS1;RPA1;RFC2;PDPK1;HIPK2;KAT6A;EHMT1;TAF6;MLST8;TTC5;MTA2;TOP3A;CDK5RAP3;ING2;ING5;PRKAG2;TAF2
prerank,outer dynein arm assembly (GO:0036158),0.7892423448484926,1.585655289196671,0.03766233766233766,0.32868342302245956,1.0,2/14,0.95%,CCDC63;DNAH8
prerank,glycine transport (GO:0015816),0.8337450340237285,1.5851796764019033,0.029871977240398292,0.32840796697840824,1.0,2/10,3.20%,SLC38A5;SLC6A5
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.6752524214976611,1.5845962965747948,0.006128702757916241,0.32837689529714326,1.0,35/83,15.27%,CDKN3;GFI1;RRM2;CCNE1;CDKN2C;CDC45;DBF4;POLA1;CDC25A;RCC1;POLE;E2F1;CCNE2;RB1;FBXO5;NASP;PCNA;CDK6;CDKN2A;TFDP1;BRD4;PIM2;CDK17;MAX;CDKN2D;CUL3;TFDP2;TYMS;NPAT;LATS1;CDK16;MYC;CDC7;E2F3;PPP6C
prerank,negative regulation of centrosome duplication (GO:0010826),0.8202634779627755,1.5805550924728182,0.03183791606367583,0.33954089394910125,1.0,3/11,1.57%,CCNF;CDK5RAP2;BRCA1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8010077683175407,1.5799470185928985,0.03225806451612903,0.3396400172186326,1.0,3/12,1.42%,UBE2C;CDC20;PLK1
prerank,activin receptor signaling pathway (GO:0032924),-0.571426708623668,-1.579779499868485,0.036290322580645164,0.5233690897984118,1.0,3/15,4.32%,ACVR1;TGFBR1;SMAD3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.8157753913795925,1.5790184488100454,0.028169014084507043,0.34088185965941775,1.0,6/11,7.26%,TIPIN;BLM;FBXO5;TIMELESS;GMNN;ZRANB3
prerank,regulation of cell cycle phase transition (GO:1901987),0.6606873722129079,1.5785344150249472,0.007121057985757884,0.3405919221324785,1.0,31/91,16.34%,BUB1B;CDK1;UBE2C;GTSE1;MAD2L1;CCNB1;CDC20;PLK1;DBF4;FBXO5;PSMB7;PSMD11;CDC23;CDC27;PSMF1;TAF1;PSMC1;ANAPC7;ERCC3;PSMC3;PSMA4;FZR1;PSMC4;BUB3;PSMD13;PSME1;PSMB1;TP53;PSMD8;TFAP4;PSME4
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.7282445969707915,1.5783568973592248,0.02962085308056872,0.3395378710220997,1.0,7/28,7.06%,SKA3;SKA1;SKA2;STMN1;CLASP1;MAPRE3;GBA2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.44713846484694986,-1.5773463001304195,0.008264462809917356,0.5221405009163103,1.0,12/34,12.99%,UBASH3B;PTPN2;PTPRZ1;PTPN6;PTPRS;PTPRJ;DUSP3;DUSP10;PTPRO;PTPRT;DUSP7;PTPN9
prerank,cholesterol efflux (GO:0033344),-0.5118157152903494,-1.5737651231171148,0.02717391304347826,0.5258931078459741,1.0,8/20,18.65%,APOE;ABCA1;ABCA5;STX12;SCARB1;NPC2;NPC1;APOC1
prerank,regulation of cell division (GO:0051302),0.6634024126410278,1.569782343872699,0.005197505197505198,0.36589165596465906,1.0,18/72,13.88%,PRC1;KIF18B;AURKB;KIF20A;PLK1;BLM;AURKA;CSPP1;PIN1;BIRC6;CIB1;KLHL9;AHCTF1;KIF13A;BECN1;RACK1;BBS4;MYC
prerank,regulation of centriole replication (GO:0046599),0.7529675067925028,1.5694025048180495,0.04145077720207254,0.3654082426943555,1.0,8/17,13.12%,STIL;CDK5RAP2;BRCA1;CEP295;CEP76;ALMS1;KAT2B;MDM1
prerank,protein sumoylation (GO:0016925),0.6808854028419133,1.5688063989924386,0.012917115177610334,0.3655576079472518,1.0,28/49,17.11%,NUP43;POM121;NDC1;SAE1;NUP107;UBE2I;RANGAP1;NUP42;UBA2;NUP50;BCL11A;NUP214;NUP160;NUP205;PIAS3;NUP188;NSMCE2;SUMO1;NUP98;RANBP2;NUP210;SUMO2;EYA1;PIAS1;TRIM28;AAAS;NUP37;TRPM4
prerank,regulation of cell cycle (GO:0051726),0.646272151302892,1.5679259627540065,0.0,0.3665646191629927,1.0,66/271,13.88%,CENPF;DLGAP5;KIF20B;PRR11;CDKN3;BIRC5;FOXM1;CCNB2;DDIAS;IL12A;CKS2;BARD1;CCNB1;MASTL;PCLAF;MEN1;PLK1;CDKN2C;BRCA1;CDC25A;PHACTR4;PPP1R9B;SKP2;DYNLT3;RB1;FBXO5;DTL;LIN9;FAP;PML;MAP2K6;STK11;CHEK1;CDK6;CDKN2A;LIN54;ATM;RBBP4;GMNN;RUNX3;BIRC2;NOTCH1;PIM2;PIM3;PRKACA;HPGD;CDKN2D;PPP1R15A;WHAMM;HIPK2;RAD23A;PUM1;TAF6;XIAP;JUN;KAT2B;RPRD1B;BAP1;CDK5RAP3;HCFC1;RACK1;RPS15A;HNRNPU;BEX2;INTS13;MYC
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.5612249153195671,-1.5670574111949285,0.02654867256637168,0.5411166768478926,1.0,9/15,39.68%,SMOX;PAOX;SAT1;DDC;ASMT;SAT2;MOXD1;SRM;AANAT
prerank,gas transport (GO:0015669),0.819435235843292,1.5657470235561777,0.030985915492957747,0.371760212925647,1.0,3/10,6.61%,RHAG;AQP1;IPCEF1
prerank,regulation of protein export from nucleus (GO:0046825),0.7240169121660056,1.565010083909626,0.03730445246690734,0.3723252551318111,1.0,15/23,17.66%,GTSE1;BARD1;ANP32B;SP100;RANGAP1;PARK7;EMD;PTPN14;SIRT7;BAG3;GSK3B;TP53;TCF7L2;XPO4;YWHAE
prerank,actin nucleation (GO:0045010),-0.5145372146485293,-1.5649854405650931,0.014705882352941176,0.5393691229305364,1.0,7/21,13.07%,TRIM27;SPIRE1;JMY;ARPC5L;WASHC1;ARPC3;ARPC2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.6635150686572924,1.5637120563156843,0.021574973031283712,0.37477987459046364,1.0,25/53,19.48%,ANKLE1;PLA2R1;BRCA1;PMAIP1;SMCHD1;BABAM1;ABRAXAS1;PCNA;ATM;EYA3;EGFR;RNF168;CCAR2;RNF8;DHX9;FXR1;SPRED2;MYC;CEBPG;EYA1;TRIM28;SIRT1;WRAP53;RPS3;NPAS2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.6938070036716286,1.5633347478193935,0.025219298245614034,0.37416472760609987,1.0,13/37,12.32%,POLK;ERCC4;RPA2;CHD1L;RFC5;POLD1;PCNA;POLD2;RPA1;ERCC3;RFC2;RFC1;POLD3
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.6977074811649162,1.562623394623157,0.020477815699658702,0.37464947239533947,1.0,14/33,15.27%,RAD51;PIF1;NOP10;TERF2;ANKRD28;DCLRE1B;RTEL1;TERF1;RPA1;RFC1;CTC1;PPP6R3;RAD50;PPP6C
prerank,synaptic vesicle transport (GO:0048489),-0.6249252349599554,-1.56257546237013,0.037800687285223365,0.5393857055589494,1.0,7/11,16.15%,DNM2;KIF5C;SYNJ1;SPG11;KIF5A;CDK5;SNAPIN
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8034798742627801,1.5622090168038238,0.042796005706134094,0.3742324159095021,1.0,1/10,0.41%,BLK
prerank,negative regulation of axon extension (GO:0030517),-0.460904923289732,-1.5620366147913136,0.013888888888888888,0.5320978599397138,1.0,13/30,24.35%,RTN4;DIP2B;SEMA3D;PTPRS;SEMA3E;SEMA4C;MAG;SEMA4G;SEMA3A;CDKL3;SEMA7A;MT3;SEMA4D
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.7215386277219176,1.559159313998149,0.04033214709371293,0.3827842984234434,1.0,14/24,19.64%,PIF1;ERCC4;SLX4;HNRNPC;TERF2;EXOSC10;DCP2;TERF1;CTC1;HNRNPU;NAT10;HNRNPA1;GNL3L;XRN1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5107473636629076,-1.5570930340069298,0.050955414012738856,0.5408739038760911,1.0,16/24,44.41%,PLA2G15;SLC27A1;CDS2;CRLS1;LPCAT1;SERAC1;PGS1;PLA2G12A;PLA2G4A;PLA2G3;ABCA3;PNPLA8;LPCAT4;PLA2G5;PLA2G4F;PLA2G2D
prerank,V(D)J recombination (GO:0033151),0.7933469512975347,1.5560189808069236,0.040787623066104076,0.39157969416530963,1.0,5/11,7.33%,HMGB2;LIG4;LIG1;TCF3;HMGB1
prerank,DNA duplex unwinding (GO:0032508),0.6686724371215548,1.555987462187289,0.02462526766595289,0.3897615975411499,1.0,11/50,9.42%,RAD51;PIF1;HMGA1;BLM;CHD1L;DDX11;MCM6;MCM9;RTEL1;RPA1;ERCC3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.6787746219892695,1.5522103966194412,0.013963480128893663,0.4009790862869105,1.0,18/51,13.32%,AURKB;PIF1;NEK2;MAPK1;SMG6;SMG5;CCT7;HNRNPC;ATM;TERF2;CCT2;TCP1;EXOSC10;DCP2;TERF1;CCT5;CTC1;HNRNPU
prerank,regulation of telomere maintenance (GO:0032204),0.7041561886581296,1.5520234035316,0.04689331770222743,0.3996477181945912,1.0,7/26,7.30%,PIF1;ERCC4;SMG6;PML;SMG5;TERF2;RTEL1
prerank,neurotransmitter secretion (GO:0007269),-0.4171750758007004,-1.5512891298776808,0.04,0.5530507025045815,1.0,20/44,25.99%,RIMS1;PCLO;RIMS2;SYT1;VAMP2;GAD2;CDK5;UNC13A;STX1A;PIP5K1C;SNAPIN;RAB3A;STXBP1;PTPRN2;PDZD11;CPLX1;SLC32A1;DVL1;CPLX2;SNAP25
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.6601444471393204,1.5510153154439574,0.00932642487046632,0.4012723969200025,1.0,30/72,17.70%,ANKLE1;POLK;RNASE6;ERCC4;RPA2;CHD1L;RFC5;POLD1;FEN1;PCNA;PDE12;DCP1B;POLD2;DNA2;DNASE1L1;EDC3;RPA1;ERCC3;RFC2;RFC1;DCP1A;POLD3;DXO;REXO4;RPA3;RAD50;MEI4;RNASE1;UBA52;DDB2
prerank,positive regulation of neuron migration (GO:2001224),0.7948850782731426,1.550242359345655,0.05263157894736842,0.40209409865953927,1.0,1/11,0.11%,KIF20B
prerank,positive regulation of DNA repair (GO:0045739),0.673268909725645,1.5500777604978588,0.02547065337763012,0.40068043456213503,1.0,26/46,20.53%,FOXM1;BRCA1;SMCHD1;XRCC1;DDX11;BABAM1;TIMELESS;HDAC10;ABRAXAS1;PCNA;HMGB1;EYA3;EGFR;RNF168;RNF8;DHX9;CEBPG;EYA1;TRIM28;SIRT1;WRAP53;SLF1;RPS3;NPAS2;ZCWPW1;UBE2N
prerank,intracellular pH reduction (GO:0051452),-0.43492644201052943,-1.5498974257551366,0.032520325203252036,0.5492070861331705,1.0,15/33,22.04%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;DMXL2;RAB20;ATP6V0B;TCIRG1;ATP6V1H;ATP6V1A;ATP6V1F;ATP6V1G2;ATP6V0C;TMEM9;RAB38
prerank,dendritic cell differentiation (GO:0097028),0.7221341678060427,1.54970718593364,0.039951573849878935,0.40009043450630405,1.0,3/22,3.17%,BLK;PRTN3;BATF
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.7847721601269835,1.5489277856469814,0.024161073825503355,0.40087562977198354,1.0,4/14,7.23%,RAD51AP1;TIMELESS;ARID2;MRNIP
prerank,regulation of DNA repair (GO:0006282),0.672809423044619,1.5486950129283508,0.024390243902439025,0.3997037472303745,1.0,25/44,19.48%,BRCA1;RADX;SMCHD1;USP1;BABAM1;DEK;PML;POLH;ABRAXAS1;PCNA;EYA3;UBE2V1;EGFR;RNF168;RNF8;DHX9;SIRT7;CEBPG;RAD52;EYA1;TRIM28;SIRT1;WRAP53;RPS3;NPAS2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.6849104718768263,1.5485783808884128,0.02714440825190011,0.39823824692604926,1.0,13/39,12.32%,POLK;ERCC4;RPA2;CHD1L;RFC5;POLD1;PCNA;POLD2;RPA1;ERCC3;RFC2;RFC1;POLD3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7823197795184064,1.548069174554037,0.04979253112033195,0.3982050449641185,1.0,2/13,8.62%,IL12A;CYRIB
prerank,regulation of multicellular organismal development (GO:2000026),0.7162223170435007,1.546434852615241,0.035842293906810034,0.4021649334035781,1.0,3/25,1.31%,CDK1;RACGAP1;CCSAP
prerank,response to UV (GO:0009411),0.6501540232692037,1.546323954743437,0.00909090909090909,0.4005857854092555,1.0,28/95,11.34%,AURKB;POLK;IL12A;PCLAF;MEN1;ERCC4;AQP1;CDC25A;USP1;DTL;EIF2S1;USF1;POLD1;POLH;MSH6;COPS9;FEN1;PCNA;TAF1;PRIMPOL;ZRANB3;UBE4B;RHNO1;EGFR;CDKN2D;ERCC3;RUVBL2;CCAR2
prerank,glycerolipid metabolic process (GO:0046486),-0.6133530312463193,-1.5462942488452447,0.04560260586319218,0.553192951459048,1.0,5/11,13.70%,PLA2G15;DGKA;DGKZ;DGKQ;DGKB
prerank,protein localization to microtubule organizing center (GO:1905508),0.7623559542558401,1.5462808927796106,0.03674540682414698,0.39886132388298323,1.0,8/15,13.80%,STIL;SPAG5;CEP83;CEP192;NEDD1;PCM1;BBS4;PIBF1
prerank,T-helper cell differentiation (GO:0042093),0.7761115495243596,1.5453080548917564,0.04105960264900662,0.40036460889460757,1.0,6/14,10.65%,LEF1;BATF;ZFPM1;FOXP1;HMGB1;ATP7A
prerank,nitric oxide metabolic process (GO:0046209),0.7902204190322278,1.5441962737321226,0.03650586701434159,0.40209185926602614,1.0,2/14,2.63%,CYP1B1;DDAH2
prerank,histone H4 acetylation (GO:0043967),0.6679895245623253,1.542691841038743,0.02040816326530612,0.4053402379356918,1.0,19/47,14.81%,KANSL1;JADE1;NAA40;BRCA2;LEF1;EPC1;BRD8;KANSL3;MSL2;YEATS4;RUVBL2;RUVBL1;HAT1;HCFC1;KMT2A;ING3;ING5;KANSL2;TADA3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.5152801259298688,-1.5413160078151655,0.054945054945054944,0.5618472816127063,1.0,8/20,17.38%,SLC27A1;HAGH;CNDP2;PTDSS2;GSS;PLOD2;CHAC2;OPLAH
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.7371284203936408,1.539893035939868,0.040740740740740744,0.4127973201112272,1.0,12/19,19.64%,PIF1;HNRNPC;TERF2;EXOSC10;DCP2;TERF1;CTC1;HNRNPU;NAT10;HNRNPA1;GNL3L;XRN1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.6599607368923313,1.5378142441329508,0.023429179978700747,0.41672749515250207,1.0,29/50,22.39%,NUP43;POM121;NDC1;POLR2I;NUP107;POLR2A;NUP42;NUP50;PUM2;H3-3A;NUP214;NUP160;NUP205;SEC13;NUP188;PUM1;NUP98;RANBP2;NUP210;POLR2K;AAAS;NUP37;POLR2J;NUP85;AGO2;TPR;NUP93;AGO1;POLR2B
prerank,regulation of gene silencing by RNA (GO:0060966),0.6599607368923313,1.5378142441329508,0.023429179978700747,0.41672749515250207,1.0,29/50,22.39%,NUP43;POM121;NDC1;POLR2I;NUP107;POLR2A;NUP42;NUP50;PUM2;H3-3A;NUP214;NUP160;NUP205;SEC13;NUP188;PUM1;NUP98;RANBP2;NUP210;POLR2K;AAAS;NUP37;POLR2J;NUP85;AGO2;TPR;NUP93;AGO1;POLR2B
prerank,chromatin assembly (GO:0031497),0.6808044992818614,1.5354153358024003,0.030612244897959183,0.4233139209689516,1.0,19/38,16.94%,HMGB2;CHAF1A;ANP32B;SMARCA5;RSF1;CTCF;LIN54;NAP1L4;RBBP4;H3-3A;ASF1A;SART3;SPTY2D1;CHAF1B;CDAN1;NAP1L1;TP53;ATRX;SIRT1
prerank,telomere maintenance via recombination (GO:0000722),0.785181682236407,1.5349380446161127,0.04005722460658083,0.42296231903349507,1.0,7/11,14.98%,RAD51;ERCC4;SMC6;XRCC3;NSMCE2;TEP1;RAD50
prerank,protein-DNA complex disassembly (GO:0032986),0.7435764391477564,1.5331331558205077,0.047619047619047616,0.42737583077728963,1.0,8/16,13.88%,SMARCC2;HMGA1;SMARCD2;ARID2;SMARCA4;SMARCC1;NFE2;MYC
prerank,regulation of embryonic development (GO:0045995),0.6897222985268447,1.53288780818283,0.03910614525139665,0.4263250926298946,1.0,13/34,14.47%,CDK1;RACGAP1;FOXA2;CCSAP;WDPCP;CLASP1;RBM19;NR2C2;EHMT1;PLCB1;RPS6KA6;NIPBL;DAG1
prerank,DNA-dependent DNA replication (GO:0006261),0.6333597872118062,1.5317792999785032,0.0030272452068617556,0.42821643669486703,1.0,49/128,16.92%,RAD51;MCM10;POLE2;CDC45;PRIM2;GINS1;PRIM1;RPA2;DBF4;HMGA1;POLA1;BLM;POLE;WDHD1;PSMB7;TOPBP1;PSMD11;MCM6;RFC5;ORC5;POLD1;PSMF1;ORC3;GMNN;PSMC1;LRWD1;PRIMPOL;POLD2;DNA2;RPA1;RFC2;PSMC3;PSMA4;RFC1;PSMC4;POLD3;TEFM;RPAIN;PSMD13;SIRT7;PSME1;CDC7;PSMB1;RPA3;PSMD8;MCM3;PSME4;BAZ1A;PSMD4
prerank,cellular response to amyloid-beta (GO:1904646),-0.43177771507932566,-1.530836518409689,0.021052631578947368,0.5909115874506514,1.0,17/35,18.37%,IGF1R;APP;TREM2;LRP1;CASP4;IGF1;ABCC1;GRM5;TLR4;LGMN;CDK5;PRNP;GJA1;CD36;EPHA4;SNX6;ADRB2
prerank,cellular response to cAMP (GO:0071320),0.6928863988426038,1.530063947200027,0.03990610328638498,0.4323566536531973,1.0,8/30,7.51%,SLC5A5;AQP1;EZR;HCN3;CRHBP;ZFP36L1;PDE2A;AHR
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.6453066957316839,1.5299970038159052,0.008072653884964682,0.43065850010997025,1.0,40/94,15.93%,CDK1;NEK2;KIF24;CKAP5;PLK1;CDK5RAP2;CEP152;NDE1;PCNT;HAUS5;HAUS6;CEP83;CEP192;TUBB4B;ODF2;CEP89;CLASP1;CEP72;CEP76;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;CEP70;NINL;PCM1;PAFAH1B1;HAUS4;TUBB;CEP162;HAUS7;SCLT1;MKS1;CNTRL;DYNLL1;CEP57;SDCCAG8;MARK4
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.6209883725396963,-1.526590755350656,0.04745762711864407,0.5981369075424916,1.0,5/10,13.80%,TREM2;APPL2;CD300A;RAB31;NCKAP1L
prerank,ion homeostasis (GO:0050801),0.6914638441233012,1.5264051075116196,0.03058823529411765,0.4417221705413392,1.0,2/30,0.51%,SLC4A1;RHAG
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6423669794206883,-1.5244926963748135,0.05944055944055944,0.5977359078554798,1.0,5/10,11.76%,LRP1;PTPN2;APOD;PTPRJ;NDRG4
prerank,regulation of centrosome cycle (GO:0046605),0.707814184417311,1.523394727392824,0.049689440993788817,0.4505398879860717,1.0,10/21,17.24%,GEN1;AURKA;XRCC3;ATF5;CHMP1B;MARK4;SIRT1;CHMP3;NAT10;CHMP2B
prerank,regulation of lymphocyte differentiation (GO:0045619),0.7350947251572929,1.522840765297367,0.054637865311308764,0.4507210010516845,1.0,8/18,15.99%,CD2;IKZF3;CCR2;ZFP36L1;XRCC6;PRKDC;SLAMF8;ZFP36L2
prerank,heterochromatin assembly (GO:0031507),0.7119977997244366,1.522244998313131,0.04054054054054054,0.4509981063937452,1.0,7/20,7.36%,SUV39H1;HMGA1;SMCHD1;HELLS;CDKN2A;MBD2;H3-3A
prerank,replicative senescence (GO:0090399),0.7931734663955332,1.5220678148600257,0.04005722460658083,0.4496991575507476,1.0,5/12,5.98%,PLA2R1;CHEK2;CHEK1;CDKN2A;ATM
prerank,positive regulation of DNA metabolic process (GO:0051054),0.6407533626820855,1.521634557928831,0.02335456475583864,0.4493089472457746,1.0,31/61,20.91%,RAD51;BRCA1;SMCHD1;BABAM1;PML;ABRAXAS1;PCNA;RTEL1;HMGB1;EYA3;SMOC2;EGFR;MECP2;RNF168;RNF8;DHX9;MYC;CEBPG;EYA1;RAD50;TRIM28;ATRX;SIRT1;USP7;WRAP53;RPS3;NPAS2;PRKD2;ZCWPW1;UBE2N;WRN
prerank,lymphocyte proliferation (GO:0046651),0.7147908150049246,1.520423544261144,0.041666666666666664,0.45169578800893095,1.0,6/22,11.65%,MS4A1;CD79A;HELLS;RASGRP1;MSN;FLT3
prerank,somite development (GO:0061053),-0.6051045940880782,-1.5201739940592243,0.06872852233676977,0.6055174098961515,1.0,4/11,19.03%,SMO;PPP2R3A;LOXL3;SOX11
prerank,regulation of interferon-alpha production (GO:0032647),-0.4843823208971978,-1.5197544790269053,0.040229885057471264,0.598578987670679,1.0,6/23,7.25%,HAVCR2;HSPD1;PTPRS;TLR7;MAVS;TLR4
prerank,regulation of B cell apoptotic process (GO:0002902),0.7782972335072931,1.5194235161837817,0.060085836909871244,0.4535406205765309,1.0,6/12,13.90%,AURKB;BLK;FOXP1;ORMDL3;BTK;BCL6
prerank,Golgi ribbon formation (GO:0090161),-0.5772479646377608,-1.5175666164861426,0.047619047619047616,0.598084029050431,1.0,8/13,20.42%,STX6;STX16;TRIP11;OPTN;GOLGA2;PRMT5;FHDC1;MYO18A
prerank,DNA double-strand break processing (GO:0000729),0.7254635704494816,1.5175321318058683,0.0607661822985469,0.458586036623418,1.0,7/18,8.32%,BARD1;BRCA1;BLM;SLX4;RBBP8;ATM;DNA2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5376532930664581,-1.517403306256488,0.03669724770642202,0.5903447167806127,1.0,5/18,5.69%,HPGDS;TBXAS1;DAGLB;PTGS1;PTGDS
prerank,regulation of catabolic process (GO:0009894),0.7322437135705193,1.5166795969554034,0.062034739454094295,0.45952661033301945,1.0,8/18,15.64%,FAM83D;CHEK2;FAP;FAF1;NEDD4L;HPGD;ZDHHC7;HGS
prerank,lipid droplet formation (GO:0140042),-0.6336116068403919,-1.5165171123790882,0.060810810810810814,0.5854384916376364,1.0,5/10,20.42%,CDS1;AUP1;CDS2;ZFYVE1;SQLE
prerank,cellular response to alkaloid (GO:0071312),0.7416767653067169,1.5162414666007222,0.056338028169014086,0.45923966084825324,1.0,3/17,4.05%,RAD51;BLM;CRHBP
prerank,regulation of axon extension (GO:0030516),-0.4162262670568318,-1.5157401837036542,0.03333333333333333,0.5805426837711261,1.0,17/37,20.29%,RTN4;DNM2;RUFY3;MACF1;MAP3K13;DIP2B;APOE;PTPRS;LIMK1;MAG;GOLGA4;SEMA3A;L1CAM;TWF2;CTTN;CDKL3;SEMA7A
prerank,regulation of spindle assembly (GO:0090169),0.6977633712914044,1.5156206620084203,0.053864168618266976,0.45954351176930924,1.0,13/25,18.26%,SPAG5;CCSAP;PLK1;GPSM2;DYNC1H1;CHMP1B;HNRNPU;NUMA1;CHMP3;CHMP2B;RNF4;DRG1;SENP6
prerank,telomere maintenance via telomere trimming (GO:0090737),0.8032917781398823,1.5132527642917197,0.0357653791130186,0.4627383421245352,1.0,6/10,9.01%,EXO1;BLM;SLX4;XRCC3;DNA2;TERF1
prerank,t-circle formation (GO:0090656),0.8032917781398823,1.5132527642917197,0.0357653791130186,0.4627383421245352,1.0,6/10,9.01%,EXO1;BLM;SLX4;XRCC3;DNA2;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.8032917781398823,1.5132527642917197,0.0357653791130186,0.4627383421245352,1.0,6/10,9.01%,EXO1;BLM;SLX4;XRCC3;DNA2;TERF1
prerank,negative regulation of double-strand break repair (GO:2000780),0.6868119697916485,1.5127959110316964,0.037209302325581395,0.4626592426852453,1.0,7/30,5.11%,POLQ;PARPBP;RMI2;RADX;SMCHD1;TWIST1;CGAS
prerank,cell-cell junction maintenance (GO:0045217),0.7796732090721602,1.512476239440598,0.05233380480905234,0.46198597731340796,1.0,2/11,1.29%,PRTN3;CD177
prerank,nitric oxide biosynthetic process (GO:0006809),0.7902220665363978,1.5121987034533368,0.04429530201342282,0.46115263412589885,1.0,2/13,2.63%,CYP1B1;DDAH2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.5687522550373623,-1.5106877985380511,0.05860805860805861,0.5905899752435456,1.0,9/12,23.43%,PPT1;GRN;CLN5;TMEM165;ATP6AP2;TMEM199;CLN6;TMEM9;CCDC115
prerank,regulation of DNA metabolic process (GO:0051052),0.6529893815161901,1.5101332014136255,0.041666666666666664,0.46720059700894895,1.0,11/44,8.02%,PIF1;TICRR;RADX;SMG6;USP1;IL7R;SMG5;NUCKS1;POLH;TERF2;UBE2V1
prerank,protein localization to chromatin (GO:0071168),0.7138619118217794,1.5098559277041594,0.06658291457286432,0.46624340093192823,1.0,9/18,16.19%,PLK1;RAD21;MCM9;LRWD1;MRNIP;RUVBL2;NIPBL;WAPL;TASOR
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.6650707452478918,1.508478388233975,0.038202247191011236,0.4694995150463749,1.0,14/40,14.29%,ANKLE1;RFWD3;RPA2;RADX;USP1;FBXO5;POLH;ARMT1;UBE2V1;FXR1;ING2;SIRT7;MYC;CASP9
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.7244523441411558,1.5082192652703204,0.06806282722513089,0.4684828496972359,1.0,2/18,0.41%,CD19;BLK
prerank,androgen metabolic process (GO:0008209),0.72311145019179,1.5079560805221432,0.060411311053984576,0.46765821503753424,1.0,2/18,1.35%,HSD17B3;SRD5A2
prerank,cell cycle G1/S phase transition (GO:0044843),0.6489857334650572,1.5064317891808752,0.022964509394572025,0.47130793345662514,1.0,24/61,15.27%,CDKN3;CCNA2;CCNE1;CDKN2C;DBF4;CDC25A;RCC1;POLE;E2F1;CCNE2;RB1;NASP;CDK6;CDKN2A;PIM2;MAX;CDKN2D;CUL3;MAP3K11;LATS1;MYC;CDC7;E2F3;PPP6C
prerank,positive regulation of cellular protein localization (GO:1903829),0.64431307377102,1.506363493862718,0.023958333333333335,0.4697059548554961,1.0,22/69,16.10%,NDC80;CDK1;GTSE1;PLK1;CARD10;CCDC88A;FYN;SNX33;TFRC;GPD1L;DDRGK1;CEP250;ABCA7;PARK7;ORMDL3;CDK5RAP3;NUMA1;TYROBP;CENPQ;GSK3B;MARK4;LIMK2
prerank,granulocyte differentiation (GO:0030851),0.7292419312210068,1.506301981586235,0.04580152671755725,0.46804894171400874,1.0,5/18,3.86%,LBR;LEF1;E2F1;DEK;PML
prerank,piRNA metabolic process (GO:0034587),0.7232210412885588,1.5035141299966968,0.049429657794676805,0.4766262283505223,1.0,1/19,1.37%,MYBL1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.629985022499597,1.50091623158742,0.03112033195020747,0.48460950805551595,1.0,33/62,22.39%,NUP43;POM121;NDC1;POLR2I;NUP107;POLR2A;NUP42;NUP50;PUM2;H3-3A;NUP214;NUP160;NUP205;SEC13;NUP188;PUM1;DHX9;NUP98;RANBP2;FXR1;NUP210;LIMD1;POLR2K;AAAS;NUP37;POLR2J;ELAVL1;NUP85;AGO2;TPR;NUP93;AGO1;POLR2B
prerank,regulation of coagulation (GO:0050818),0.7775884090870808,1.500795871610996,0.06105834464043419,0.4831461030901219,1.0,2/11,5.28%,FOXA2;CAV1
prerank,RNA biosynthetic process (GO:0032774),0.6788296942086648,1.5007236587899944,0.052571428571428575,0.48153273608841624,1.0,9/31,7.12%,PRIM2;PRIM1;POLA1;SMARCA5;RSF1;POLR2A;SETX;BRF1;TAF7
prerank,hyaluronan catabolic process (GO:0030214),0.7342402502644756,1.499892836478477,0.058898847631242,0.482828420057312,1.0,2/18,3.89%,HMMR;CD44
prerank,acylglycerol homeostasis (GO:0055090),-0.4810477972460129,-1.4996902522333828,0.05555555555555555,0.6222113622480147,1.0,7/20,29.86%,APOE;LPL;SCARB1;IL18;MTLN;MLXIPL;ANGPTL3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.6530513024053172,1.4993082468314511,0.04673913043478261,0.48302121182797986,1.0,17/42,13.14%,CECR2;SMARCC2;MBD3;SMARCA5;ARID1B;SMARCD2;NASP;ACTR5;HNRNPC;MBD2;RBBP4;SMARCA4;SMARCC1;SPTY2D1;RNF8;MTA2;ANP32E
prerank,natural killer cell mediated immunity (GO:0002228),0.7473693855732867,1.4987242096722153,0.04467805519053877,0.48332346922251995,1.0,7/15,13.89%,ULBP1;KLRD1;RAET1E;TUBB4B;SLAMF7;TUBB;CEBPG
prerank,vasodilation (GO:0042311),-0.577653846459514,-1.4975063569747036,0.07723577235772358,0.6217602556270851,1.0,6/13,33.43%,KCNMA1;ADRB1;ADRB2;KLF2;SOD2;NOS1
prerank,prostaglandin metabolic process (GO:0006693),-0.45849951769778685,-1.4973078779145403,0.05142857142857143,0.6145948361853653,1.0,7/26,8.42%,HPGDS;TBXAS1;DAGLB;PTGS1;PTGDS;PLAA;PTGR2
prerank,phagosome acidification (GO:0090383),-0.45592450234099074,-1.497075508140912,0.041666666666666664,0.6078907758094075,1.0,13/26,22.04%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;RAB20;ATP6V0B;TCIRG1;ATP6V1H;ATP6V1A;ATP6V1F;ATP6V1G2;ATP6V0C;RAB38
prerank,regulation of cation transmembrane transport (GO:1904062),-0.45006773535715167,-1.4968258279257958,0.03676470588235294,0.6014265782785433,1.0,8/29,15.83%,DPP10;KCNIP3;KCNN2;KCNAB1;CD63;SNTA1;FGF12;DLG1
prerank,embryonic heart tube development (GO:0035050),-0.5513194572577587,-1.4957561111662203,0.09266409266409266,0.5979468689005766,1.0,3/14,11.76%,ACVR1;RYR2;NDRG4
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.5931777785689175,-1.4955140845096075,0.060810810810810814,0.5916494321819962,1.0,4/10,14.65%,IQSEC1;EPB41L4B;ADAM9;MAP4K4
prerank,oligodendrocyte development (GO:0014003),-0.5190321869830781,-1.4942829511877862,0.06382978723404255,0.588673589900224,1.0,7/15,23.59%,PLP1;EIF2B3;B4GALT5;EIF2B4;EIF2B2;SOX10;CNTNAP1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.6690093424447593,1.4940716625131745,0.05393258426966292,0.49887220608361005,1.0,9/35,7.87%,AURKB;NEK2;MAPK1;CCT7;ATM;CCT2;TCP1;RTEL1;HNRNPA2B1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.6722335267783847,1.4934855478548383,0.03690888119953864,0.4992905714563789,1.0,7/33,8.37%,KIF14;FAM83D;EZH2;E2F1;TAF1;DDRGK1;PLCG2
prerank,regulation of protein localization to nucleus (GO:1900180),0.654763763581191,1.4919944891575423,0.04343105320304017,0.5031402062749347,1.0,14/43,16.10%,CDK1;GTSE1;PLK1;CARD10;CTNNA1;TFRC;PIN1;PARK7;ORMDL3;CDK5RAP3;LATS1;GSK3B;SIN3A;LIMK2
prerank,response to ethanol (GO:0045471),-0.5503020515357689,-1.4909537892052132,0.06060606060606061,0.5931697725394373,1.0,4/14,9.84%,ADCY7;GRIN3A;GOT2;GLRA2
prerank,negative regulation of platelet activation (GO:0010544),-0.5321539593629874,-1.4906071309722482,0.07111111111111111,0.587830148740606,1.0,7/16,32.35%,SERPINE2;APOE;SH2B3;PRKG1;CEACAM1;PDGFRA;THBD
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5199110832526437,-1.4902571577216637,0.06046511627906977,0.582492167477654,1.0,7/16,16.23%,RASGRF1;SH3BP1;STMN3;ARHGAP44;ALS2;PIK3CB;ARHGAP24
prerank,midbody abscission (GO:0061952),0.7094191025692029,1.4892464752717978,0.06829896907216494,0.5118504021828485,1.0,2/17,1.19%,CEP55;KIF20A
prerank,liver development (GO:0001889),0.6754004686370768,1.4888578326810882,0.05536332179930796,0.5113986425166426,1.0,15/32,21.24%,E2F7;E2F8;AURKA;PHF2;ARID5B;CDK5RAP3;CEBPG;PRKCSH;XBP1;NKX2-8;PROX1;PKD2;MET;CITED2;PCK2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.775430076063826,1.4885783763914984,0.04105571847507331,0.5105266622090039,1.0,7/10,16.84%,DCLRE1C;TERF2;DCLRE1B;RTEL1;APEX1;TFIP11;RIF1
prerank,Rap protein signal transduction (GO:0032486),-0.6079267641369925,-1.4884756225185887,0.06862745098039216,0.5817910812461821,1.0,8/10,27.20%,RAP1B;RAP2A;RAP2B;RAP1A;RAP2C;RAPGEF1;RAPGEF3;PLK2
prerank,negative regulation of blood coagulation (GO:0030195),-0.4043707152216707,-1.4881208499402303,0.010309278350515464,0.5765056111137804,1.0,8/38,16.96%,SERPINE2;APOE;CD34;PLAUR;TFPI;PLAU;SERPINE1;F8
prerank,B cell activation involved in immune response (GO:0002312),0.7553573256554795,1.4878844285285762,0.06765899864682003,0.5112581779428611,1.0,6/13,11.39%,CD19;BATF;LIG4;MSH6;RNF168;RNF8
prerank,protein localization to centrosome (GO:0071539),0.7177657837604396,1.4878424226705036,0.06369426751592357,0.5095455897617999,1.0,8/17,13.80%,STIL;SPAG5;CEP83;CEP192;NEDD1;PCM1;BBS4;PIBF1
prerank,antibacterial humoral response (GO:0019731),0.7314901135226177,1.487101979795958,0.061855670103092786,0.5104093595780536,1.0,3/16,5.04%,RNASE6;CAMP;SLPI
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5414507349970463,-1.4869797931746143,0.09152542372881356,0.5739800447973936,1.0,4/13,4.90%,CACNB2;CACNA1C;KCNN2;ANK2
prerank,negative regulation of cellular senescence (GO:2000773),0.7525380946902736,1.4868544175343648,0.07466666666666667,0.5093970410971801,1.0,6/13,7.46%,FBXO5;TWIST1;RBL1;CDK6;TERF2;AKT3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5381330057474658,-1.4865462633372784,0.05803571428571429,0.5687807903763921,1.0,8/15,27.19%,BCL2L1;GHITM;HGF;IGF1;PRKN;GPX1;PRELID1;PSMD10
prerank,chromatin assembly or disassembly (GO:0006333),0.7581226624704006,1.4856199804640804,0.0782967032967033,0.5121843033976274,1.0,7/11,14.97%,CHAF1A;HIRIP3;RBBP4;CHAF1B;MTA2;CDAN1;TP53
prerank,response to light stimulus (GO:0009416),0.6384473572403028,1.4855982203568625,0.03397027600849257,0.5104073267150925,1.0,15/55,11.34%,PCLAF;MEN1;ERCC4;USP1;DTL;USF1;POLD1;MSH6;CPT1B;PRIMPOL;ZRANB3;UBE4B;CDKN2D;ERCC3;CCAR2
prerank,tRNA export from nucleus (GO:0006409),0.6651552524791097,1.485226513837309,0.06002265005662514,0.5080437822842016,1.0,18/32,20.21%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NUP85;TPR
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6651552524791097,1.485226513837309,0.06002265005662514,0.5080437822842016,1.0,18/32,20.21%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NUP85;TPR
prerank,nucleotide-excision repair (GO:0006289),0.6268378562815807,1.4851173055346616,0.010111223458038422,0.5066061038393628,1.0,36/101,17.70%,BRIP1;POLK;ERCC4;RPA2;POLA1;BRCA2;POLE;XRCC1;CHD1L;SLX4;LIG4;RFC5;POLR2I;PRPF19;POLR2A;POLD1;PCNA;LIG1;POLD2;HUS1;RPA1;ERCC3;RFC2;RAD23A;RFC1;POLD3;RPA3;RNF111;TP53;FANCC;POLR2K;SIRT1;POLR2J;UBA52;USP7;DDB2
prerank,indolalkylamine catabolic process (GO:0046218),0.7676427798811645,1.484560342260146,0.07439198855507868,0.5069686941094731,1.0,2/10,3.74%,HAAO;KMO
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.6129802739903988,1.4834751280584224,0.0,0.509372404387765,1.0,96/306,15.00%,CDK1;BRIP1;MRPL36;PIF1;TICRR;CLSPN;MCM10;BARD1;PCLAF;TIPIN;POLE2;RAD1;CDC45;BRCA1;RMI2;NR4A2;EXO1;RPA2;DBF4;POLA1;BLM;RPL7;POLE;E2F1;RPL18A;RPS20;MRPL18;ALAS2;TOPBP1;MCM6;RFC5;RAD9A;POLR2I;ORC5;RPL36;RPL14;POLR2A;TIMELESS;POLD1;MCM9;EPC1;RBBP8;RPS19;FEN1;DUT;CHEK1;RPS7;EXT1;ORC3;RPS4X;RPS18;MRPL10;ATM;PTMA;RPL23A;EEF1B2;RPL28;POLD2;ST3GAL2;MRPL37;RHNO1;RPS14;DNA2;RPL41;RPLP2;HUS1;RPA1;RNPS1;RPS27;MRPL51;MRPS7;RFC2;MRPL43;RPS5;DHPS;RPS29;RPLP0;RPS11;FAM111A;MRPS17;TYMS;IGF2BP3;RPL27A;POLD3;TOP3A;KIN;RPS9;RPS15A;ING5;MRPL24;NAP1L1;CDC7;RPL12;RPA3;RAD50;RNASEH2A
prerank,regulation of macrophage migration (GO:1905521),-0.605881489694726,-1.481612411513648,0.06785714285714285,0.5780920559878887,1.0,8/10,34.22%,P2RY12;CX3CR1;CD200;CSF1;CD81;PTK2B;MTUS1;EMILIN1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.4537077511830711,-1.4814521775314393,0.028368794326241134,0.572313003724358,1.0,9/27,13.80%,SIRPA;PTPN6;ARRB1;TNFAIP3;ZC3H12A;TLR4;SELENOS;CD200;NCKAP1L
prerank,histone H4-K16 acetylation (GO:0043984),0.709059179648879,1.4810787776754812,0.05867665418227216,0.516742780252503,1.0,7/19,13.88%,KANSL1;JADE1;KANSL3;MSL2;HCFC1;KMT2A;KANSL2
prerank,DNA biosynthetic process (GO:0071897),0.7301542928254706,1.4786172614778401,0.06580645161290323,0.5242606458104577,1.0,10/16,16.94%,POLA1;POLE;POLD1;POLH;POLD2;CDKN2D;TYMS;POLD3;PPIA;SIRT1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.7042669532887297,1.4783553893925223,0.07604562737642585,0.5234024262507164,1.0,7/18,12.32%,GINS1;POLA1;POLE;PCNA;LIG1;POLD2;POLD3
prerank,apoptotic DNA fragmentation (GO:0006309),0.7272768584064614,1.4778682821844136,0.06675392670157068,0.5235063092804721,1.0,3/16,7.33%,HMGB2;CECR2;HMGB1
prerank,regulation of nervous system development (GO:0051960),0.6657297619199041,1.4768169906313091,0.040313549832026875,0.5257032668283024,1.0,3/37,2.10%,KIF14;HMGB2;HEY2
prerank,phagosome maturation (GO:0090382),-0.4169564283396873,-1.4754938193181029,0.03076923076923077,0.5863044749736804,1.0,16/35,22.04%,RAB14;ATP6V1B2;ATP6V1C1;ATP6V0D2;MCOLN1;ATP6V0A1;RAB20;ATP6V0B;TCIRG1;RAB31;ATP6V1H;ATP6V1A;ATP6V1F;ATP6V1G2;ATP6V0C;RAB38
prerank,cellular protein-containing complex assembly (GO:0034622),0.6131676544859919,1.4744841295991968,0.0020100502512562816,0.5329844640580731,1.0,24/159,9.63%,CENPF;CENPE;DLGAP5;CENPA;CENPW;ANLN;FMOD;NDC1;STXBP6;TIAM1;EIF4B;PSMD11;AXIN1;NUP107;CHCHD4;CCT2;TCP1;SNX9;CLTC;VBP1;NUP205;NDUFAF1;LONP1;AHCTF1
prerank,response to cAMP (GO:0051591),0.6530396735760109,1.4727027070307952,0.05298759864712514,0.5379036064102772,1.0,8/37,7.51%,SLC5A5;AQP1;EZR;HCN3;CRHBP;ZFP36L1;PDE2A;AHR
prerank,inorganic anion transport (GO:0015698),0.6442202759280241,1.4722865745226208,0.03644158628081458,0.5375249808200049,1.0,5/53,4.27%,SLC4A1;RACGAP1;SLC5A5;ANO10;CLIC5
prerank,vacuolar acidification (GO:0007035),-0.4720167124210204,-1.4714110144746817,0.06451612903225806,0.5955650323119956,1.0,13/21,23.43%,ATP6V0D2;PPT1;GRN;ATP6V0A1;DMXL2;CLN5;TCIRG1;ATP6V1H;ATP6AP2;TMEM199;CLN6;TMEM9;CCDC115
prerank,positive regulation of protein kinase activity (GO:0045860),0.6152244080477527,1.4711423716858794,0.0030120481927710845,0.5400897722446756,1.0,23/148,8.51%,CENPE;TPX2;KIF14;ECT2;CLSPN;BORA;EZH2;INCENP;CCDC88A;ERBB3;CCN1;AXIN1;NEDD9;STK11;GPRC5B;MMD2;MAPRE3;MMD;XRCC6;MRNIP;CIB1;SNX9;MARK2
prerank,hyaluronan metabolic process (GO:0030212),0.6951808754895071,1.4698229731207395,0.07904191616766468,0.5432586021282906,1.0,3/23,3.94%,HMMR;CD44;HAS1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6240051767525416,1.4697704957988544,0.022892819979188347,0.5415319206683348,1.0,16/66,11.97%,KIF14;E2F7;CDKN2C;JADE1;WEE1;E2F1;RB1;RBL1;CDK6;CDKN2A;TFDP1;EGFR;CDKN2D;RDX;PLCB1;PTEN
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5256884745282324,-1.4687454803836182,0.06896551724137931,0.5984237426186112,1.0,8/15,31.00%,LPL;IL18;CSF1;CD36;AGT;PF4;MAPK9;PLA2G3
prerank,protein K11-linked ubiquitination (GO:0070979),0.6825233993240859,1.4684875120421357,0.053003533568904596,0.5449389654120798,1.0,6/27,6.89%,UBE2C;UBE2T;RNF26;CDC23;CDC27;ANAPC7
prerank,signal release from synapse (GO:0099643),-0.39377690607471044,-1.4679093266482452,0.03571428571428571,0.5949079092380455,1.0,19/43,25.99%,RIMS1;PCLO;SYT1;VAMP2;GAD2;CDK5;UNC13A;STX1A;PIP5K1C;SNAPIN;RAB3A;STXBP1;PTPRN2;PDZD11;CPLX1;SLC32A1;DVL1;CPLX2;SNAP25
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7095529941390074,1.4675257668702202,0.08774193548387096,0.5470356047459847,1.0,4/16,7.51%,IL12A;IKZF3;PTPN22;AHR
prerank,cell junction maintenance (GO:0034331),0.7349122561819867,1.4658231820598009,0.06815203145478375,0.551710686688759,1.0,2/14,1.29%,PRTN3;CD177
prerank,mitotic sister chromatid cohesion (GO:0007064),0.731162976041064,1.4640961191383515,0.07207207207207207,0.5564185783828576,1.0,5/16,3.80%,RAD21;DSCC1;RB1;SGO1;HASPIN
prerank,regulation of T cell differentiation (GO:0045580),0.66423888631775,1.4635048065745555,0.05293440736478711,0.5568793273995538,1.0,5/33,5.31%,TNFRSF18;CD2;FANCA;IL2RA;CCR2
prerank,histone H4-K5 acetylation (GO:0043981),0.7171251959466299,1.4630526952037268,0.08651399491094147,0.5548853991704832,1.0,5/15,13.88%,KANSL1;JADE1;KANSL3;HCFC1;KANSL2
prerank,histone H4-K8 acetylation (GO:0043982),0.7171251959466299,1.4630526952037268,0.08651399491094147,0.5548853991704832,1.0,5/15,13.88%,KANSL1;JADE1;KANSL3;HCFC1;KANSL2
prerank,dopaminergic neuron differentiation (GO:0071542),0.7145161800319807,1.4624543317969976,0.061635220125786164,0.555297930650991,1.0,2/19,1.81%,FOXA2;NR4A2
prerank,anion transport (GO:0006820),0.6732830321911283,1.4619038036984642,0.05823068309070549,0.5556014517552429,1.0,6/33,11.15%,SLC4A1;VDAC2;TSPO;LRRC8B;LRRC8C;SLC19A1
prerank,intracellular sterol transport (GO:0032366),-0.541295584034446,-1.4618967725630447,0.07142857142857142,0.6094647002356227,1.0,6/13,15.80%,OSBPL2;ABCA1;OSBP;NPC2;NPC1;SERAC1
prerank,tRNA transport (GO:0051031),0.6456603721098441,1.4616371706252276,0.06873614190687362,0.5547443509349776,1.0,18/35,20.21%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NUP85;TPR
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.6611277655543227,1.4613671422289956,0.06838565022421525,0.5540256392101779,1.0,7/29,15.36%,FANCD2;RAD21;TRIP13;TEX11;SIRT7;P3H4;MEI4
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.6094622608319842,1.4608100472107683,0.01616161616161616,0.5543634195231096,1.0,50/96,20.99%,NUP43;POM121;NDC1;SMG6;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;EIF4A3;NUP214;SRSF3;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;SRSF7;THOC7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,regulation of cell projection organization (GO:0031344),-0.5500169796833253,-1.4607054350978372,0.07586206896551724,0.6075047851761352,1.0,4/13,6.21%,TREM2;MACF1;MYO9A;NTNG1
prerank,synaptic vesicle cycle (GO:0099504),-0.4360327308450711,-1.4603012092442584,0.05925925925925926,0.603070397067807,1.0,15/30,25.99%,RIMS1;PCLO;SYNDIG1;SLC17A6;VAMP2;SYT7;CDK5;STX1A;PIP5K1C;SNAPIN;RAB3A;CPLX1;SLC32A1;CPLX2;SNAP25
prerank,positive regulation of chromosome organization (GO:2001252),0.7293114974593176,1.45924915411277,0.07228915662650602,0.558688130296636,1.0,6/15,7.30%,RAD21;DDX11;LIG4;PML;FEN1;RTEL1
prerank,cellular response to light stimulus (GO:0071482),0.6215407162583603,1.4586924891686055,0.037460978147762745,0.5591127085137886,1.0,16/66,14.97%,AURKB;POLK;ERCC4;AQP1;CDC25A;EIF2S1;POLD1;COPS9;PCNA;TAF1;RHNO1;RUVBL2;CREBBP;MYC;CASP9;TP53
prerank,regulation of neuroblast proliferation (GO:1902692),-0.5244091114251954,-1.458349166223475,0.07563025210084033,0.6035970653876628,1.0,7/15,14.08%,TAFA1;KDM1A;CTNNB1;CX3CR1;NF1;FZD3;VEGFA
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5152378248124959,-1.4581106944595692,0.06694560669456066,0.5984615568890965,1.0,7/16,17.53%,KLK2;KLK3;BMPR2;GSK3A;DDAH1;GPR37L1;SLC2A5
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.6601622184059046,1.4577425505608719,0.06043329532497149,0.5610636896711875,1.0,7/32,7.21%,AURKB;NEK2;MAPK1;CCT7;ATM;CCT2;TCP1
prerank,negative regulation of peptidase activity (GO:0010466),-0.3773689377575842,-1.4574931643127333,0.04,0.5946240755348109,1.0,9/47,17.06%,SPOCK1;LRP1;SERPINE2;TIMP2;SPOCK2;TIMP3;SERPINI1;SERPINE1;CST7
prerank,protein acetylation (GO:0006473),0.6634322601203761,1.4572267679415154,0.06192660550458716,0.5612819490637863,1.0,12/30,16.99%,ESCO2;NAA40;DSCC1;FOXO1;KAT6A;KAT2B;NAA16;HAT1;ING5;CREBBP;SIRT1;NAT10
prerank,vasoconstriction (GO:0042310),0.7479450423806439,1.4569513436045924,0.08898305084745763,0.5605027404012379,1.0,1/11,0.98%,KEL
prerank,regulation of dendritic spine development (GO:0060998),-0.48791486934014827,-1.4565101822257758,0.06666666666666667,0.591902448193224,1.0,6/19,4.64%,TANC2;CAMK1;APOE;PPFIA2;GRIN3A;PTPRS
prerank,photoreceptor cell development (GO:0042461),-0.5436999456685917,-1.4559527940482906,0.09803921568627451,0.5884442272449603,1.0,4/14,14.08%,AHI1;MYO7A;DCX;VEGFA
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.6290611297159617,1.45427737697911,0.056745182012847964,0.569196876181991,1.0,25/48,20.83%,NUP43;POM121;NDC1;NOA1;NUP107;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;RUBCNL;AAAS;NUP37;NUP85;PNPT1;TPR;EIF6;PRKAG1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.7359171571169032,1.4541499531195707,0.08677685950413223,0.5678067570849201,1.0,3/13,5.98%,PLA2R1;PMAIP1;ATM
prerank,B cell mediated immunity (GO:0019724),0.7481202032190589,1.4533126247619403,0.08797653958944282,0.5692412565787471,1.0,3/10,10.74%,CD19;CD74;CARD9
prerank,cellular response to inorganic substance (GO:0071241),0.6914857230249448,1.452814637129444,0.08088235294117647,0.5693186607749174,1.0,9/21,16.28%,AQP1;BLM;DDX11;TIMELESS;FOXO1;DPEP1;KCNC2;MTR;ATRX
prerank,RNA export from nucleus (GO:0006405),0.6048571886490623,1.452744034023679,0.017137096774193547,0.5677962051898366,1.0,51/100,20.99%,NUP43;POM121;NDC1;SMG6;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;EIF4A3;NUP214;SRSF3;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;SRSF7;THOC7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;HNRNPA1;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.5606258586203503,-1.4502434352487479,0.09059233449477352,0.6024035684236005,1.0,5/12,17.38%,HAGH;CNDP2;GSS;CHAC2;OPLAH
prerank,synaptonemal complex organization (GO:0070193),0.7123217286183554,1.4500930008278148,0.09358974358974359,0.5746243743017386,1.0,3/15,6.09%,RAD21;TRIP13;TEX11
prerank,synaptonemal complex assembly (GO:0007130),0.7123217286183554,1.4500930008278148,0.09358974358974359,0.5746243743017386,1.0,3/15,6.09%,RAD21;TRIP13;TEX11
prerank,positive regulation of myelination (GO:0031643),-0.5795296864892661,-1.4497233780625485,0.058419243986254296,0.5984476275840808,1.0,6/11,30.45%,TNFRSF1B;CST7;PARD3;TENM4;EGR2;NCMAP
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.42682351298697224,-1.4495001643707963,0.048,0.593659042059775,1.0,12/30,11.29%,NSF;ANK3;MACF1;SEC16A;GGA3;OPTN;GOLGA7;PREPL;VAMP5;VAMP2;GOLGA4;RAB31
prerank,regulation of cellular senescence (GO:2000772),0.6662552680735366,1.4480400895316772,0.06526806526806526,0.5811896384460639,1.0,11/28,13.30%,HMGA1;FBXO5;TWIST1;RBL1;CGAS;CDK6;CDKN2A;TERF2;AKT3;B2M;ING2
prerank,inorganic ion transmembrane transport (GO:0098660),0.7505582865243569,1.4479324680701207,0.0849933598937583,0.5797894448704447,1.0,1/12,0.51%,RHAG
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.4082618442186757,-1.4466906612592736,0.036036036036036036,0.5966085645592464,1.0,11/34,16.40%,ANK2;SLC9A1;ZC3H12A;SRI;RYR2;ADRA1A;ATP1B1;SMAD7;ASB3;CALM1;SLC8A1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5020514269535987,-1.446681344050558,0.084,0.5912122174709835,1.0,3/17,9.12%,ANK2;SNTA1;SCN1B
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5741770168393769,-1.4465161879519866,0.07692307692307693,0.5864012723780592,1.0,6/12,22.21%,DPYD;ALDH6A1;UMPS;CRMP1;DPYSL2;DPYSL3
prerank,error-free translesion synthesis (GO:0070987),0.6737589788202519,1.4460262279540173,0.08254716981132075,0.5855468439007383,1.0,10/22,14.58%,RPA2;RFC5;POLD1;POLH;PCNA;NPLOC4;RPA1;RFC2;RFC1;RPA3
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6973709348212703,1.4452320743719986,0.08108108108108109,0.5868175695820427,1.0,1/17,0.10%,DLGAP5
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6784159894378531,1.4448948573608742,0.08312958435207823,0.5863768927350823,1.0,11/21,19.39%,CDK1;MAPK1;ZFP36L1;ITGAV;MYC;EGF;MAP2K1;ZFP36L2;PTGER4;LGALS9;SOX9
prerank,protein-DNA complex assembly (GO:0065004),0.5968069401420166,1.4425983715666806,0.020181634712411706,0.5939528895170619,1.0,40/116,17.70%,RAD51;HMGB2;CHAF1A;ANP32B;RPA2;SMARCA5;CHD1L;PSMB7;RSF1;PSMD11;MCM6;ORC5;PSMF1;ORC3;NAP1L4;GMNN;PSMC1;H3-3A;ASF1A;SART3;RPA1;ERCC3;SPTY2D1;PSMC3;PSMA4;CHAF1B;PSMC4;PSMD13;PSME1;NAP1L1;PSMB1;RPA3;PSMD8;TCF4;ATRX;MCM3;PSME4;PSMD4;UBA52;DDB2
prerank,tryptophan catabolic process (GO:0006569),0.7382809132939794,1.442399643977225,0.09282700421940929,0.5927889621106391,1.0,2/11,3.74%,HAAO;KMO
prerank,isotype switching (GO:0045190),0.7636819810662645,1.4423825428428465,0.08611111111111111,0.5910097400405132,1.0,6/10,11.39%,BATF;LIG4;MSH6;CCR6;RNF168;RNF8
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6699784915874569,1.4417115762722565,0.08823529411764706,0.5919347433875328,1.0,4/23,5.54%,IL12A;KLRD1;RASGRP1;RAET1E
prerank,natural killer cell activation (GO:0030101),0.6825114282119054,1.4405141864477877,0.07975460122699386,0.5949340729745205,1.0,5/23,7.76%,CD2;ULBP1;RASGRP1;IL21R;SLAMF7
prerank,regulation of B cell activation (GO:0050864),0.658824357335646,1.4400054252074306,0.08792497069167643,0.5952551120727786,1.0,5/25,7.51%,CD19;IKZF3;BANK1;ZFP36L1;AHR
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.6752859209564441,1.439987881802145,0.08886107634543179,0.59347633274932,1.0,7/22,13.15%,PLA2R1;PMAIP1;RPS20;RPS7;ATM;CDK5RAP3;SPRED2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5536280558250621,-1.4387678667141315,0.09259259259259259,0.6070091631032376,1.0,9/12,33.43%,ANK3;DMD;ATP1B2;ATP1B1;GLRX;ATP1B3;WNK2;FXYD1;NOS1
prerank,sympathetic nervous system development (GO:0048485),-0.5184242787581628,-1.4385129958925518,0.08558558558558559,0.6024499381017511,1.0,7/15,19.03%,NRP2;CTNNB1;NF1;FZD3;SEMA3A;SOX4;SOX11
prerank,positive regulation by host of viral transcription (GO:0043923),0.7182752521675795,1.438484912609977,0.09857328145265888,0.597666441593518,1.0,8/15,21.60%,LEF1;NUCKS1;SMARCA4;JUN;CCNT1;TFAP4;CHD1;TAF11
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6896772328975864,1.4384565939044838,0.09653465346534654,0.5959409520472357,1.0,10/20,17.78%,MEN1;PLK1;CDKN2A;NR2F2;IPO7;PTEN;LATS1;IPO5;TFAP4;HEXIM1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.6530486988515458,1.4374588939794488,0.07359813084112149,0.598044116523515,1.0,14/29,18.99%,PIF1;NOP10;TERF2;ANKRD28;RTEL1;TERF1;RPA1;RFC1;PPP6R3;PPIA;RAD50;PPP6C;DKC1;WRAP53
prerank,positive regulation of intracellular transport (GO:0032388),0.6385993208286427,1.4372419109039534,0.07054871220604703,0.5971470040890979,1.0,14/38,15.07%,KIF20B;SPAG5;PCNT;STK11;MLC1;DYNC1H1;PCM1;ACTN2;EIPR1;OAZ1;NUMA1;PGAP1;PDCD10;RIPOR1
prerank,neuron fate commitment (GO:0048663),-0.5446386564561448,-1.437224910182411,0.08088235294117647,0.6017336805667192,1.0,3/14,14.46%,TGFBR1;MYT1L;ID2
prerank,intestinal absorption (GO:0050892),-0.5435186727685488,-1.436927264220425,0.06538461538461539,0.5975090382725557,1.0,7/13,32.25%,F11R;TJP2;CD36;SLC2A5;SLC26A6;SLC46A1;ADRA2A
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6658968530368375,1.436383735551694,0.09587378640776699,0.5988528585396548,1.0,7/24,7.30%,ERCC4;BLM;MSH6;DACH1;TERF2;ZRANB3;RTEL1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5104844870276499,-1.4363278193040454,0.09615384615384616,0.5946288627219682,1.0,3/13,10.51%,GLUL;GOT2;GLUD1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.626705214941254,1.4343264593844396,0.06847826086956521,0.6055282452358514,1.0,23/41,21.99%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;AAAS;NUP37;NUP85;TPR;EIF6;PRKAG1;NUP93
prerank,glutathione biosynthetic process (GO:0006750),-0.560636753848331,-1.4321187765172105,0.1111111111111111,0.6025915657681084,1.0,5/11,17.38%,HAGH;CNDP2;GSS;CHAC2;OPLAH
prerank,endocrine system development (GO:0035270),-0.4659023932324875,-1.431720875247648,0.07514450867052024,0.5987604443846225,1.0,10/21,35.69%,TGFBR1;SALL1;NF1;MDK;TG;HOXD3;WNT4;PAX8;GLI2;DKK3
prerank,nuclear migration (GO:0007097),0.723313300188568,1.4316530253053128,0.10225763612217796,0.6146171140950469,1.0,7/13,10.90%,SYNE2;SUN2;FBXW11;DYNC1H1;PCM1;PAFAH1B1;SYNE3
prerank,spermatid development (GO:0007286),0.638199401560433,1.4308819455563984,0.07003444316877153,0.6158177807149479,1.0,8/32,15.34%,CCDC63;CIB1;JAM2;RFX2;RNF8;ING2;BBS4;CEP57
prerank,regulation of lymphocyte activation (GO:0051249),0.7444963767872377,1.4308782335210144,0.08452722063037249,0.6139901347111103,1.0,2/12,2.79%,CD19;IKZF3
prerank,steroid hormone biosynthetic process (GO:0120178),0.6550239632154155,1.4306464730490451,0.06993006993006994,0.6131558596276089,1.0,9/29,18.63%,HSD17B3;SRD5A2;TSPO;SRD5A3;DHCR7;STARD3NL;TSPOAP1;MED1;FDXR
prerank,mRNA transport (GO:0051028),0.594343145076883,1.4300011316136827,0.02416918429003021,0.6138684615608062,1.0,51/101,20.99%,NUP43;POM121;NDC1;SMG6;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;ZFP36L1;EIF4A3;NUP214;SRSF3;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;SRSF7;THOC7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.6351859874886232,1.4298719139640579,0.09205983889528194,0.6125512249464269,1.0,17/32,24.20%,CDCA2;ITGA1;PTPA;ANKLE2;PPP2R5A;PIN1;PPP1R15A;CNEP1R1;PPIA;CAMTA1;SPPL3;CALM3;PPP1R15B;PPP1R16B;PRKCD;SMPD1;PTBP1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.7562762358474243,1.4285521188189563,0.09495548961424333,0.6161396366543861,1.0,6/10,16.05%,FOXM1;SP100;HIPK2;RPS6KA6;TP53;TFAP4
prerank,triglyceride catabolic process (GO:0019433),-0.47572309735970486,-1.427657122730466,0.08035714285714286,0.606845520859535,1.0,7/19,41.14%,LPL;LIPH;FABP4;FABP7;PNPLA3;LIPC;FABP3
prerank,secretion (GO:0046903),-0.5375458413166059,-1.4275812068855553,0.08527131782945736,0.6019766239055183,1.0,2/14,3.49%,RIMS1;PRKCI
prerank,lipid phosphorylation (GO:0046834),-0.5862811081477657,-1.4269070613537906,0.125,0.598805353473649,1.0,6/10,13.70%,DGKH;DGKA;DGKI;DGKZ;DGKQ;DGKB
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6534840815861124,1.4261721689682283,0.08862275449101796,0.6241314254839053,1.0,12/26,19.39%,KNSTRN;ZFP36L1;EGFR;PDPK1;STAT5B;ZFP36L2;DUSP22;PLCG1;PDE8A;IQGAP1;MED1;SOX9
prerank,ncRNA export from nucleus (GO:0097064),0.6293977773320917,1.4261495464062277,0.0779510022271715,0.62236744568221,1.0,19/36,20.21%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NCBP2;NUP85;TPR
prerank,response to amyloid-beta (GO:1904645),-0.37706345908722505,-1.4260267321325788,0.05405405405405406,0.5967471083649619,1.0,17/44,18.37%,IGF1R;APP;TREM2;LRP1;CASP4;IGF1;ABCC1;GRM5;TLR4;LGMN;CDK5;PRNP;GJA1;CD36;EPHA4;SNX6;ADRB2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.49058300925356846,-1.4251655375871664,0.0779816513761468,0.5945510079413562,1.0,9/17,21.88%,CACNB2;CACNA1C;ANK2;SCN1B;HCN2;SLC8A1;CACNA1G;ATP1A2;SCN3B
prerank,positive regulation of dephosphorylation (GO:0035306),0.6474051203118208,1.4249152739122317,0.08851674641148326,0.6255135298556805,1.0,15/27,24.20%,CDCA2;PTPA;ANKLE2;PPP2R5A;PIN1;CNEP1R1;PPIA;CAMTA1;SPPL3;CALM3;PPP1R16B;PRKCD;SRC;SMPD1;PTBP1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.7416791919559844,1.424864987224474,0.08345534407027819,0.6239144571390567,1.0,6/11,16.05%,FOXM1;SP100;HIPK2;RPS6KA6;TP53;TFAP4
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7120530708106281,1.4248004802704717,0.10666666666666667,0.6223906317540817,1.0,3/14,5.66%,ADAMTS7;RFLNB;PTHLH
prerank,regulation of DNA binding (GO:0051101),0.6231245073398856,1.4247758993628834,0.0728051391862955,0.6206812080672918,1.0,17/44,16.05%,HMGB2;HJURP;LEF1;E2F1;RSF1;SP100;EDF1;HMGB1;JAK2;ZBTB7A;TXN;SUMO1;JUN;SKI;CEBPG;EGF;TFAP4
prerank,immunoglobulin mediated immune response (GO:0016064),0.7337306833604758,1.42408868156967,0.08794326241134752,0.6216625112805985,1.0,3/10,10.74%,CD19;CD74;CARD9
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6711765517185602,1.4232727070897606,0.10327455919395466,0.6231607099417286,1.0,3/21,7.77%,TPX2;CLASP1;CIB1
prerank,neural tube development (GO:0021915),0.6968870933485647,1.4213274069358564,0.10889774236387782,0.6293164644031242,1.0,1/15,0.26%,STIL
prerank,tryptophan metabolic process (GO:0006568),0.7274605315545699,1.4205196745508617,0.11001410437235543,0.6308489169303807,1.0,3/11,10.65%,HAAO;KMO;ATP7A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.590290012620466,1.4197453850819994,0.025278058645096056,0.6321782825868711,1.0,62/110,23.67%,RPL7;RPL18A;SMG6;RPS20;SMG5;RPL36;RPL14;RPS19;RPS7;EIF3E;RPS4X;RPS18;UPF2;SMG8;RPL23A;EIF4A3;RPL28;RPS14;RPL41;RPLP2;NCBP1;CASC3;RNPS1;RPS27;RPS5;RPS29;RPLP0;RPS11;RPL27A;DCP1A;UPF3B;SMG9;RPS9;RPS15A;HELZ2;RPL12;PYM1;RPL3;GSPT1;UBA52;RPL18;RPL5;RPS6;RPS17;NCBP2;RPS3;RPL21;PPP2CA;RPL17;RPL23;SMG7;RPL24;RPL8;RPL27;DHX34;RPL13A;RPS12;RPS8;RPL15;RPL10;RPS21;SMG1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5829849893117541,-1.419008952818655,0.1180327868852459,0.6097000413817565,1.0,5/10,17.58%,APP;SYNGR1;CAMK2B;SHANK3;DLG4
prerank,cGMP metabolic process (GO:0046068),0.7313349722510738,1.418972744085882,0.10164835164835165,0.6335051960486517,1.0,3/12,6.74%,NPPC;GUCY1A1;PDE2A
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.6318746872132526,1.4188454441692844,0.09944134078212291,0.632176817163057,1.0,8/37,9.24%,SKA3;SKA1;SKA2;STMN1;CLASP1;MAPRE3;MARK2;EPHA3
prerank,neuron projection extension (GO:1990138),-0.39991092803943457,-1.418265063462124,0.034782608695652174,0.6073752474037875,1.0,14/32,22.81%,IMPACT;NRP2;HSP90AA1;SPG11;CTNNB1;USP9X;ULK1;CDK5;SH3GL2;SEMA3A;CDKL3;ULK2;FLRT3;CYFIP1
prerank,telomere maintenance via telomerase (GO:0007004),0.6482272938671653,1.4179242976265514,0.09004739336492891,0.6341125553587721,1.0,13/28,18.99%,PIF1;NOP10;TERF2;ANKRD28;RTEL1;TERF1;RPA1;RFC1;PPP6R3;RAD50;PPP6C;DKC1;WRAP53
prerank,positive regulation of DNA replication (GO:0045740),0.6900652739792362,1.4167237927355292,0.09210526315789473,0.6374432617071137,1.0,9/16,15.38%,PCNA;ATAD5;FAF1;DNA2;EGFR;DHX9;BRPF3;CTC1;EGF
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.48817521861096724,-1.4161478860082217,0.08035714285714286,0.6096148781646644,1.0,8/16,6.32%,ABCD2;SIRPA;TREM2;APPL2;ADCY7;APOD;PYCARD;ZC3H12A
prerank,mRNA export from nucleus (GO:0006406),0.588984073607951,1.4158395514406652,0.02716297786720322,0.6393454523278306,1.0,51/102,20.99%,NUP43;POM121;NDC1;SMG6;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;EIF4A3;NUP214;SRSF3;IWS1;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;SRSF7;THOC7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,peptidyl-lysine modification (GO:0018205),0.5914570287738611,1.4155227167570588,0.024390243902439025,0.6387795326601784,1.0,44/99,19.21%,NUP43;POM121;NDC1;SENP1;SAE1;PLOD3;NUP107;HDAC10;UBE2I;RANGAP1;NUP42;UBA2;NUP50;BCL11A;HDAC6;NUP214;NUP160;NUP205;PIAS3;NUP188;ATP7A;NSMCE2;PARK7;SUMO1;KAT2B;NUP98;RANBP2;NUP210;SIRT7;VPS33B;SUMO2;P3H4;EYA1;PIAS1;NDUFAB1;TRIM28;AAAS;SIRT1;NUP37;TRPM4;HDAC4;SENP6;GCSH;NUP85
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5267603902581415,-1.4154788496483839,0.08097165991902834,0.6069244007907686,1.0,7/14,35.96%,DAGLB;SLC5A7;DAGLA;CHAT;NOS1;MOXD1;ACHE
prerank,muscle tissue morphogenesis (GO:0060415),0.691954750318843,1.4153562911829067,0.0990990990990991,0.6377190950604927,1.0,4/16,12.53%,HEY2;ZFPM1;NOTCH1;EFEMP2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.638896521823639,1.4148882725052618,0.08975834292289989,0.6377737117834942,1.0,7/31,11.97%,UBE2C;CDC20;PLK1;AXIN1;PIN1;FZR1;PTEN
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.6911431285273193,1.4127433090791486,0.11601513240857503,0.6446306191380711,1.0,4/17,7.04%,DHDDS;ALG8;ALG14;NUS1
prerank,cell proliferation in forebrain (GO:0021846),0.7496496830409973,1.4115467816383573,0.1001410437235543,0.6477300773096311,1.0,1/10,0.17%,KIF14
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.7309032707185057,1.410793675706305,0.10504201680672269,0.6490771505982768,1.0,7/12,16.82%,BRCA1;RBM15;SMCHD1;PCGF5;HNRNPU;PCGF3;LRIF1
prerank,negative regulation of B cell proliferation (GO:0030889),0.7257875042744776,1.4103147650239323,0.11468531468531469,0.6492849099486745,1.0,6/11,17.59%,BLK;ATM;TNFRSF13B;TYROBP;RC3H1;FCGR2B
prerank,nerve growth factor signaling pathway (GO:0038180),0.7677905759248637,1.410024598500909,0.091164095371669,0.6486674710913768,1.0,2/10,6.07%,NTF4;KIDINS220
prerank,cellular response to nitrogen compound (GO:1901699),0.670044140397369,1.4092293038173005,0.10085054678007291,0.6501178313891242,1.0,10/20,22.48%,BLM;DDX11;TIMELESS;PDE12;RIOK3;ROCK2;ATRX;EPG5;ATP2B4;SPIDR
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.6045317750818056,1.4088541119037465,0.08537886872998933,0.6498069524515739,1.0,18/49,15.85%,HMGB2;RBM15;ZFPM1;DPY30;TNRC6C;TNRC6B;H3-3A;KMT2C;CIB1;NFE2;KAT2B;CNOT4;CBFB;KMT2A;RBBP5;KMT2B;RUNX1;SIN3A
prerank,regulation of protein dephosphorylation (GO:0035304),0.6123032330125436,1.4086697962948742,0.10302351623740201,0.648779587334856,1.0,20/37,24.20%,CDCA2;PTPA;ANKLE2;PPP1R8;PPP2R5A;PIN1;PPP1R15A;CNEP1R1;PPP6R3;PPP1R2;PPIA;CAMTA1;HSP90B1;SPPL3;PPP1R16A;CALM3;PPP1R16B;PRKCD;SMPD1;PTBP1
prerank,covalent chromatin modification (GO:0016569),0.7192899104158378,1.4085721347123341,0.09278350515463918,0.6474367844972662,1.0,11/14,23.35%,AURKB;HELLS;MBD2;PARK7;SIRT7;SIRT1;HDAC1;CHD1;HLCS;SETD5;UFL1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6911686361685594,1.4078537045344144,0.09848484848484848,0.6487194874496217,1.0,9/15,17.66%,GTSE1;ANP32B;EMD;BAG3;GSK3B;TP53;TCF7L2;XPO4;YWHAE
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.6031428132933454,1.4077084489272997,0.05827263267429761,0.6475585625434053,1.0,20/66,16.25%,CDK1;ECT2;GTSE1;PLK1;CARD10;FLNA;TFRC;CCT7;CCT2;TCP1;EFCAB7;PARK7;ORMDL3;CCT5;CDK5RAP3;PSEN1;BAG3;IPO5;LIMK2;TRIM28
prerank,positive regulation of histone methylation (GO:0031062),0.6519335841890246,1.4064876255486656,0.10332541567695962,0.6509136850230801,1.0,11/24,16.94%,MYB;BRCA1;PHF19;PHF1;DNMT1;SMAD4;PAXIP1;KMT2A;JARID2;RIF1;SIRT1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.6148416906294113,1.404760483119324,0.07978142076502732,0.6562831775420269,1.0,23/41,21.99%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;AAAS;NUP37;NUP85;TPR;EIF6;PRKAG1;NUP93
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5029169848039705,-1.4045371132571214,0.07792207792207792,0.6366258399511301,1.0,9/16,25.03%,UPP2;NT5M;DPYD;CRMP1;TET2;NT5C;DPYSL2;DPYSL3;NT5E
prerank,positive regulation of immune effector process (GO:0002699),0.6360239883016243,1.4045024637568873,0.09965635738831616,0.6555278427651149,1.0,4/27,5.31%,MYB;DHX58;RPS19;CCR2
prerank,positive regulation of double-strand break repair (GO:2000781),0.6226647716675412,1.403454685657495,0.07906458797327394,0.6581928857971278,1.0,7/39,7.23%,RAD51AP1;FOXM1;SMCHD1;DDX11;TIMELESS;ARID2;MRNIP
prerank,renal system development (GO:0072001),0.6030124320089365,1.4030317849036305,0.07822410147991543,0.6581586137885704,1.0,3/52,3.96%,CENPF;LRP4;SULF2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4514883511188069,-1.4021853217918163,0.07567567567567568,0.6390416956713216,1.0,8/22,15.02%,RAP2A;PDGFD;RAP2C;PDGFC;TOM1L1;VEGFA;MRE11;CALM1
prerank,neuron remodeling (GO:0016322),-0.577325668771027,-1.4007894225240047,0.1362126245847176,0.6384331563366382,1.0,3/10,4.64%,APP;FARP2;C1QA
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5076423923051929,-1.4004035728013966,0.1062992125984252,0.6348005427914589,1.0,6/15,13.07%,TRIM27;JMY;ARPC5L;WASHC1;ARPC3;ARPC2
prerank,regulation of plasminogen activation (GO:0010755),-0.5483076922657868,-1.4003384450690133,0.0830188679245283,0.6301738953369986,1.0,5/12,18.07%,PLGRKT;SERPINE2;ENO1;SERPINE1;THBS1
prerank,epithelial structure maintenance (GO:0010669),-0.558161595961866,-1.400119852135652,0.08552631578947369,0.6263184901777963,1.0,4/11,25.91%,STRAP;CXADR;NOD2;RBP4
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6992899865785516,1.398926701189424,0.1241565452091768,0.6733598853628375,1.0,3/15,5.39%,IL12A;CCR2;NKAP
prerank,regulation of establishment of cell polarity (GO:2000114),0.6899459277122414,1.3981583897854757,0.1031331592689295,0.674801331068017,1.0,6/16,13.08%,KIF20B;RIPOR2;GSN;CYRIB;ROCK2;RACK1
prerank,meiosis I (GO:0007127),0.6586966165828839,1.3978460097057386,0.11610486891385768,0.6742566899418782,1.0,5/23,13.30%,MYBL1;SGO1;FOXJ3;PTTG1;ING2
prerank,cardiac muscle cell differentiation (GO:0055007),-0.44618508910828836,-1.3974378568113073,0.08571428571428572,0.6303049444287421,1.0,5/21,18.84%,ACVR1;VEGFA;SLC8A1;CXADR;KDM6B
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6997626535711782,1.3957644071094204,0.11952191235059761,0.6816674328731306,1.0,3/14,3.29%,CD177;PHACTR4;FLNA
prerank,actin filament-based transport (GO:0099515),0.6611799946317358,1.3953115256061668,0.1120584652862363,0.6817937241992476,1.0,4/21,3.39%,MYO5C;MYO15A;SYNE2;SUN2
prerank,negative regulation of developmental growth (GO:0048640),-0.4118683573773664,-1.3952967981986533,0.051094890510948905,0.6325487544967081,1.0,14/30,27.08%,RTN4;DIP2B;WWC2;PTPRS;MAG;ULK1;DUSP10;CDKL3;ULK2;WWC1;MT3;DCC;NKD1;FGFR3
prerank,signal transduction by p53 class mediator (GO:0072331),0.6347629300537797,1.3952011143433352,0.08247422680412371,0.6804455355553579,1.0,6/30,7.58%,E2F7;PMAIP1;BATF;STK11;MDM4;BOK
prerank,protein polymerization (GO:0051258),0.6032924561798908,1.3948777548605056,0.07470651013874066,0.6800867885974162,1.0,7/55,8.54%,DIAPH3;UBE2C;CKAP5;GSN;PIN1;UBE2K;JAK2
prerank,zinc ion transmembrane transport (GO:0071577),-0.46077021609288327,-1.3938273468642912,0.09467455621301775,0.6321254806137482,1.0,10/22,22.63%,SLC39A11;SLC30A4;SLC39A7;SLC39A14;SLC39A8;SLC39A6;SLC39A12;SLC39A3;SLC39A1;SLC30A1
prerank,DNA packaging (GO:0006323),0.6953681209351835,1.3933787100465636,0.11756935270805813,0.6844080206872187,1.0,7/16,14.97%,CHAF1A;RBBP4;KAT6A;CHAF1B;CDAN1;HAT1;TP53
prerank,regulation of ATP metabolic process (GO:1903578),0.5970259203948576,1.3923164172167497,0.07473684210526316,0.6871473549422321,1.0,25/54,20.83%,NUP43;POM121;NDC1;NUP107;ABCD1;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;ATP7A;FIS1;NUP98;RANBP2;NUP210;PRKAG2;AAAS;NUP37;NUP85;TPR;EIF6;PRKAG1
prerank,diol metabolic process (GO:0034311),-0.47737505922538936,-1.391587616503966,0.0975609756097561,0.6348615992401981,1.0,8/19,23.92%,HSP90AA1;PTS;SGPP1;CALM1;PRKG2;SPHK2;PLPP3;DEGS2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5009583858727711,-1.390824487014156,0.10628019323671498,0.6326607349959718,1.0,10/17,44.41%,CRLS1;LPCAT1;SERAC1;PLA2G12A;PLA2G4A;PLA2G3;LPCAT4;PLA2G5;PLA2G4F;PLA2G2D
prerank,muscle cell development (GO:0055001),-0.4243952183248909,-1.3903272883502384,0.07751937984496124,0.6298309857916965,1.0,13/30,16.69%,KDM1A;NEBL;ANK2;IGF1;SGCZ;BIN1;MYOF;DMD;ENG;NRAP;VEGFA;SLC8A1;CXADR
prerank,response to X-ray (GO:0010165),0.7113065895722189,1.3901796148942585,0.12717536813922356,0.6947619291021662,1.0,6/14,13.53%,BLM;LIG4;NUCKS1;ATM;XRCC6;NIPBL
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5743833144787632,-1.389403411232151,0.12871287128712872,0.628331826511912,1.0,2/10,6.57%,CTNNB1;RYK
prerank,regulation of lipase activity (GO:0060191),-0.5198826707114614,-1.3886785057263973,0.08560311284046693,0.6259251961510633,1.0,4/13,11.99%,LPL;PCSK5;PCSK6;LMF1
prerank,nitrogen compound transport (GO:0071705),0.5807399200162374,1.387895676225952,0.01710261569416499,0.7025038514264179,1.0,33/141,19.08%,CENPF;RHAG;SLC6A12;SLC38A5;AQP1;SLC1A5;NDC1;RAMP1;SLC7A1;SLC6A2;RCN3;PICK1;ABCC2;SLC25A47;SLC16A10;SLC43A2;SLC3A1;CALCRL;SLC52A1;SLC44A1;CHMP1B;VPS33B;ATP11B;SCAMP1;CHMP3;CHMP2B;TMEM30A;HSP90B1;ARL6IP5;SLC22A4;RUFY1;SLC7A14;SEC14L1
prerank,homologous chromosome segregation (GO:0045143),0.6652719716338078,1.3871053927100465,0.11097410604192355,0.7040689658881784,1.0,7/20,20.13%,FANCD2;SGO1;PTTG1;SIRT7;MEI4;CENPC;ZCWPW1
prerank,microtubule-based transport (GO:0099111),0.7068448905154916,1.3868763699944757,0.11869031377899045,0.7033055744033542,1.0,2/12,7.02%,SPA17;SPEF2
prerank,mitotic cytokinetic process (GO:1902410),0.6542261058634207,1.3868295388775702,0.1273176761433869,0.7016540221655548,1.0,2/20,1.19%,CEP55;KIF20A
prerank,cGMP biosynthetic process (GO:0006182),0.7315786077584382,1.3867760510827492,0.12160228898426323,0.70008321486973,1.0,2/10,6.31%,NPPC;GUCY1A1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6084517343507524,1.3857790369332386,0.10376282782212087,0.7025189804636779,1.0,8/33,11.64%,FAM83D;EZH2;TFDP1;DDRGK1;PLCG2;EGFR;RDX;PLCB1
prerank,positive regulation of macrophage activation (GO:0043032),-0.47731294861470325,-1.3856978501129924,0.10480349344978165,0.6302834281191118,1.0,7/17,19.64%,TREM2;HSPD1;TLR4;TNIP2;TTBK1;THBS1;CCL3
prerank,axonemal dynein complex assembly (GO:0070286),0.6425592708872281,1.3851596443787704,0.11225658648339061,0.7035077696183515,1.0,2/27,0.95%,CCDC63;DNAH8
prerank,positive regulation of telomerase activity (GO:0051973),0.6244160983889229,1.3848794979387857,0.09920182440136831,0.7029890585933641,1.0,5/33,7.21%,AURKB;NEK2;MAPK1;CCT2;TCP1
prerank,positive regulation of DNA binding (GO:0043388),0.6283606217961702,1.3844564392639604,0.08610792192881746,0.7030032700450123,1.0,10/31,15.38%,HMGB2;RB1;TWIST1;EDF1;HMGB1;TXN;PARK7;SKI;CEBPG;EGF
prerank,positive regulation of nervous system process (GO:0031646),-0.47870099127012994,-1.3843130235443653,0.10747663551401869,0.6301177576241718,1.0,8/18,30.45%,RIMS1;RIMS2;TNFRSF1B;CST7;PARD3;TENM4;EGR2;NCMAP
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7181225156778448,1.3831521840806227,0.13194444444444445,0.706901495777244,1.0,6/11,17.48%,CYP1B1;MAP3K5;PRODH;STK24;PDCD10;ARL6IP5
prerank,regulation of phosphate metabolic process (GO:0019220),0.6751106239671223,1.382864855933935,0.10276679841897234,0.7062978264523306,1.0,8/16,21.11%,BARD1;SMG6;SMG5;PSEN1;CD24;SMG7;MCM7;IKBKB
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.579620512819037,1.3827864803104246,0.0602655771195097,0.7048621147050457,1.0,30/87,19.04%,E2F7;CDKN2C;JADE1;WEE1;RB1;AURKA;FBXO5;PSMB7;PSMD11;PSMF1;RBL1;CDK6;CDKN2A;ZFP36L1;PSMC1;CDKN2D;PSMC3;PSMA4;PTEN;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;ZFP36L2;PSME4;PSMD4;AVEN;BRD7;CDKN1A
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5494710348135081,-1.3815588954826297,0.1174496644295302,0.634240005429987,1.0,4/11,5.62%,PJA2;TREM2;MFHAS1;TNFAIP3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6426101519775078,1.3803644381596756,0.1,0.7137422403308625,1.0,9/27,13.15%,PLA2R1;PMAIP1;TWIST1;CD74;CD44;ATM;DYRK1A;YJU2;SPRED2
prerank,positive regulation of lipid storage (GO:0010884),-0.4591777671465429,-1.3800107415589555,0.09523809523809523,0.6345891264508248,1.0,5/21,10.92%,LPL;ZC3H12A;IKBKE;VSTM2A;SCARB1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5541677127793121,-1.3799320515612485,0.13109756097560976,0.6304178877164207,1.0,9/10,44.62%,TXN2;MTRR;ADO;TST;MPST;CBS;GADL1;CTH;BLMH
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5903540278309701,1.379385867527425,0.07660020986358866,0.7161512162575833,1.0,21/60,16.37%,CDK1;CCNB1;HEY2;LEF1;PPM1D;CDKN2A;MED30;TNRC6C;TNRC6B;MED31;MECP2;MED8;PTEN;CBFB;PAXIP1;MED14;ATF7IP;TP53;TCF7L2;TRIM28;CDK8
prerank,endochondral bone morphogenesis (GO:0060350),-0.5608381994438927,-1.3791501139795126,0.13245033112582782,0.6283205631672338,1.0,10/11,38.56%,BMPR2;BMPR1B;INPPL1;TRPV4;FGFR3;MEF2C;FOXC1;COL13A1;SCX;BMP4
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.6302015143472963,1.3791011779533984,0.10756501182033097,0.7155598489645452,1.0,10/27,16.89%,RRM2;AK9;RRM1;DUT;RRM2B;NUDT13;NME4;TYMS;AK5;AK6
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6277167238280585,1.3789139006690212,0.0944700460829493,0.7146022634122274,1.0,14/30,17.17%,DDIAS;FBXO5;TWIST1;CD74;CD44;RTEL1;CDKN2D;DYRK1A;CCAR2;YJU2;THOC5;TPT1;SIRT1;DDX39B
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6763977662060113,1.3788007863996397,0.14435695538057744,0.7115611121261469,1.0,8/15,20.77%,ZFP36L1;TNRC6C;TNRC6B;CPEB3;CNOT1;ZFP36L2;AGO2;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6763977662060113,1.3788007863996397,0.14435695538057744,0.7115611121261469,1.0,8/15,20.77%,ZFP36L1;TNRC6C;TNRC6B;CPEB3;CNOT1;ZFP36L2;AGO2;CNOT7
prerank,sodium ion homeostasis (GO:0055078),0.6532875232336182,1.37858457975338,0.11230585424133811,0.7107510478678783,1.0,4/21,7.95%,TMPRSS3;SLC12A3;SLC12A1;NEDD4L
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.48909590436314415,-1.377961643878288,0.08267716535433071,0.627655071075963,1.0,2/15,2.77%,TREM2;LPL
prerank,nucleoside catabolic process (GO:0009164),-0.5438183610020748,-1.3774652922435981,0.1174496644295302,0.6253619938256674,1.0,4/11,6.37%,DERA;UPP2;NT5M;DPYD
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.38985568034884616,-1.3767376751251175,0.03759398496240601,0.6235811525147628,1.0,15/32,20.33%,ARHGAP6;ADAM15;NEXMIF;APOD;SEMA3E;CLASP2;CORO1C;RCC2;SERPINE1;MAP4K4;ACVRL1;JAG1;THBS1;RASA1;PHLDB2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6184998020504252,1.3760156035441935,0.09596510359869138,0.7201503219889748,1.0,5/42,4.77%,HMGB2;RNASE6;AQP1;CAMP;RPS19
prerank,response to gamma radiation (GO:0010332),0.643162822597278,1.3758638566572152,0.11506524317912219,0.7191283572357338,1.0,9/24,16.40%,FANCD2;MEN1;LIG4;ATM;XRCC6;MYC;TP53;MAP3K20;TMEM109
prerank,cellular response to UV (GO:0034644),0.5856943219973179,1.375507771296411,0.07083333333333333,0.7187920076354459,1.0,13/76,5.63%,AURKB;POLK;ERCC4;AQP1;CDC25A;EIF2S1;POLD1;COPS9;STK11;PCNA;CHEK1;ACTR5;TAF1
prerank,histone mRNA metabolic process (GO:0008334),0.6348084773226027,1.3748391926028958,0.11150652431791222,0.7198506832367578,1.0,15/27,20.17%,SLBP;SNRPF;ATM;CPSF2;EXOSC10;DCP2;NCBP1;TUT4;ERI1;TUT1;SNRPG;TENT2;NCBP2;XRN1;SNRPB
prerank,regulation of cell aging (GO:0090342),0.7091891746282187,1.3746010387340049,0.14203730272596843,0.7190990079889554,1.0,1/11,0.50%,FOXM1
prerank,C-terminal protein amino acid modification (GO:0018410),0.7142801501716329,1.373915066590239,0.13416320885200553,0.7201450823013361,1.0,3/11,6.05%,AGBL1;LCMT1;AGTPBP1
prerank,defense response to bacterium (GO:0042742),0.581956834832461,1.3737907429091611,0.045317220543806644,0.7188638914913784,1.0,14/105,6.84%,IL12A;HMGB2;RNASE6;PGLYRP1;AQP1;SPN;GBP4;CAMP;PPP1R11;S100A9;RPS19;SLPI;S100A8;GBP2
prerank,cellular response to hydroxyurea (GO:0072711),0.7217125224268724,1.372538195640306,0.13532763532763534,0.7224092295982099,1.0,3/10,4.15%,BLM;DDX11;TIMELESS
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.396670739045945,-1.3720926201922652,0.07086614173228346,0.6333470934960173,1.0,16/32,30.07%,APP;TREM2;ARNT;PRKAA2;IGF1;ENO1;PINK1;PFKFB4;PFKFB2;PPARGC1A;HIF1A;BEND3;INSR;PFKFB1;MLXIPL;GAPDHS
prerank,regulation of B cell proliferation (GO:0030888),0.6017282711047602,1.3715704450563326,0.08982683982683982,0.7248291400300506,1.0,8/44,7.51%,BLK;IKZF3;TNFSF13B;CD38;CD74;TFRC;ATM;AHR
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6505403698475958,1.3712937000450847,0.12378640776699029,0.7243091822790024,1.0,11/22,19.04%,MEN1;PLK1;CDKN2A;NR2F2;IPO7;PTEN;LATS1;IPO5;TFAP4;HEXIM1;CDKN1A
prerank,regulation of viral entry into host cell (GO:0046596),0.6139661625786113,1.3688361837399419,0.12962962962962962,0.7327822573461447,1.0,9/30,14.46%,TMPRSS4;CD74;SNX3;GSN;LY6E;TRIM11;TRIM68;IFITM3;TRIM5
prerank,macromolecule catabolic process (GO:0009057),-0.4228743924707443,-1.3682870377384495,0.06976744186046512,0.6410436292319068,1.0,12/26,21.47%,CAPN3;PPT1;SH3GLB1;CLN5;IDE;LGMN;CLN8;SIAH1;UVRAG;PIK3R4;CLN6;TRIM24
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.7240203567618881,1.3676831209774052,0.13967310549777118,0.7359299687510249,1.0,8/10,19.61%,MYB;BRCA1;DNMT1;JARID2;ATRX;RIF1;SIRT1;DNMT3B
prerank,regulation of cellular response to heat (GO:1900034),0.5758046499805143,1.3665702118880676,0.07365145228215768,0.7387859397015027,1.0,32/77,17.66%,RPA2;NUP43;MAPK1;POM121;NDC1;NUP107;NUP42;ATM;NUP50;NUP214;NUP160;NUP205;RPA1;SEC13;NUP188;CCAR2;MLST8;NUP98;RANBP2;NUP210;CREBBP;DNAJC7;BAG1;BAG3;RPA3;GSK3B;DNAJC2;AAAS;SIRT1;DNAJB1;NUP37;YWHAE
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.545605158235044,-1.3664780697675485,0.1254355400696864,0.6426187869568516,1.0,5/11,33.43%,CACNB2;BIN1;CACNB1;CAMK2D;NOS1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.6418002773701643,1.3658225869094238,0.12192118226600986,0.7402205696440287,1.0,4/23,8.71%,HMGB2;CECR2;HMGB1;DNASE1L1
prerank,regulation of mRNA metabolic process (GO:1903311),0.6997591670144798,1.3657691953446867,0.1527777777777778,0.7386470550044149,1.0,8/11,20.01%,PTCD2;IWS1;NCBP1;DHX9;SRPK1;SAFB;CDK11B;SLTM
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5048644621333644,-1.3657146770394586,0.1141732283464567,0.6411240073304826,1.0,9/15,25.15%,BMP2K;SNAP91;WASL;TNK2;PIK3CB;SMAP1;HIP1R;AAK1;SCYL2
prerank,RNA catabolic process (GO:0006401),0.5969559769775856,1.364512436977852,0.10267379679144385,0.7423385094442617,1.0,14/46,15.99%,SLFN14;RNASE6;LSM6;FEN1;PPP1R8;DCP2;DNA2;NCBP1;LSM2;LSM5;METTL16;DXO;RNASEH2A;ZFP36L2
prerank,water transport (GO:0006833),0.7023117563444641,1.36436029383221,0.13861386138613863,0.7411901498158587,1.0,1/12,1.86%,AQP1
prerank,neuron maturation (GO:0042551),-0.46056164012342665,-1.3635162091990645,0.11057692307692307,0.6436591246773208,1.0,6/18,8.96%,APP;FARP2;C1QA;CLN5;B4GALT5;SRRM4
prerank,regulation of DNA damage checkpoint (GO:2000001),0.7169589963375633,1.3630552360657122,0.15273775216138327,0.7449740928261323,1.0,5/10,17.17%,RFWD3;RPA2;CCAR2;THOC5;DDX39B
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.662396443966006,1.3630200593580006,0.14209115281501342,0.7433377099658229,1.0,4/15,10.75%,MAD2L1;FBXO5;RPS7;PARK7
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5657074621531374,-1.3627912567213565,0.1611842105263158,0.6420321100198926,1.0,2/10,2.55%,WHRN;IFT88
prerank,fluid transport (GO:0042044),0.7010536522508629,1.362408887729973,0.16061452513966482,0.7441972097407835,1.0,1/12,1.86%,AQP1
prerank,tube closure (GO:0060606),0.6159396901740188,1.3623953075821889,0.13333333333333333,0.742476432356546,1.0,5/31,7.70%,STIL;PHACTR4;DEAF1;LMO4;FUZ
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.5848560140205312,1.3622447650881693,0.08955223880597014,0.7413882049838914,1.0,21/59,16.37%,CDK1;CCNB1;LEF1;PPM1D;TWIST1;CDKN2A;MED30;SETX;TNRC6C;TNRC6B;MED31;MECP2;MED8;JUN;PTEN;CBFB;MED14;TP53;TCF7L2;TRIM28;CDK8
prerank,zinc ion transport (GO:0006829),-0.4524545799228506,-1.3620615721803382,0.0875,0.6402820134703454,1.0,10/21,23.11%,SLC39A11;SLC30A4;SLC39A7;SLC39A14;SLC39A8;SLC39A6;SLC39A3;SLC39A1;SLC30A1;MT3
prerank,nuclear transport (GO:0051169),0.6632418697777859,1.361774378826264,0.15494791666666666,0.7417040710261912,1.0,7/16,17.71%,HMGA1;XPO1;NUP205;NUP98;PSIP1;AAAS;RSRC1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5383168773002995,-1.3616805309762547,0.12452830188679245,0.6376014166080279,1.0,3/11,8.44%,ATG10;APOE;WIPI1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.6547864752987752,1.3613212816085871,0.13384813384813385,0.7419123967953944,1.0,9/18,11.87%,NOP10;CCT7;CCT2;TCP1;EXOSC10;DCP2;RUVBL2;RUVBL1;CCT5
prerank,primary neural tube formation (GO:0014020),0.6184652970569818,1.3611269067419718,0.13599062133645956,0.7409833999695302,1.0,5/30,7.70%,STIL;PHACTR4;DEAF1;LMO4;FUZ
prerank,regulation of microtubule depolymerization (GO:0031114),0.6296752436677175,1.3608879658574793,0.13797313797313798,0.7402023120801214,1.0,3/25,7.77%,TPX2;CLASP1;CIB1
prerank,positive regulation of cilium assembly (GO:0045724),0.648227762454102,1.3606589271439813,0.12237330037082818,0.7394691045342897,1.0,10/18,22.61%,CCDC88A;ARHGAP35;FUZ;TAPT1;HAP1;BBS4;MARK4;SEPTIN9;CROCC;CEP135
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6634280493901741,1.3600311801599727,0.13438735177865613,0.7403615187687953,1.0,6/16,13.89%,ULBP1;RAET1E;TUBB4B;SLAMF7;TUBB;CEBPG
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.7114543954676527,1.3590884459458894,0.14627285513361463,0.742578908213569,1.0,5/10,14.97%,HMGB1;PSMC3;PSMC4;ATF7IP;TP53
prerank,chromatin organization (GO:0006325),0.5675955751008614,1.3581687355554715,0.029175050301810865,0.7447650926567512,1.0,61/132,23.92%,MYB;HMGB2;EZH2;SUV39H1;HIRIP3;SMARCC2;SMARCA5;CHD1L;RB1;DDX11;SMARCD2;RSF1;NPM3;NUCKS1;HDAC10;BAZ2B;RBBP4;TCF7L1;HMGN2;LRWD1;PHF19;BAZ1B;PHF1;SMARCA4;ZBTB7A;SMARCC1;RUVBL2;EHMT1;RUVBL1;KAT2B;MTA2;CDAN1;SETDB2;HCFC1;SATB2;MYC;TADA2A;KDM4C;JARID2;ATRX;BAZ1A;SIRT1;HDAC4;SETDB1;HDAC1;SAFB;SOX9;HDAC8;ACTL6A;SETD7;CHD1;PADI4;PBRM1;SMARCAD1;SETD5;ZBTB1;GATAD1;KDM6A;MTF2;NPM1;HMGA2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4516261022659291,-1.358095794544088,0.0966183574879227,0.6439951591152707,1.0,13/20,31.41%,CACNA1C;ANK2;SLC9A1;DMD;RYR2;ATP1B1;CALM1;SLC8A1;ATP1A2;GSTO1;FKBP1B;CAMK2D;CALM2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.4164178744372647,-1.3580754860688775,0.05917159763313609,0.6400078191814295,1.0,11/24,17.91%,IQSEC1;PIK3R1;PTPRJ;DUSP3;TSC1;FERMT2;PPM1F;VEGFA;MAP4K4;COL16A1;THY1
prerank,maintenance of protein location in nucleus (GO:0051457),0.6478939153312574,1.35806392939851,0.1275,0.7435168687176273,1.0,12/20,19.94%,BARD1;SUN2;PML;SP100;RANGAP1;PARK7;CHCHD10;HNRNPU;BBS4;SYNE1;MORC3;TAF3
prerank,activation of protein kinase activity (GO:0032147),0.5680526781832681,1.358049154484564,0.04939516129032258,0.7418476231238949,1.0,31/106,19.61%,TPX2;KIF14;ECT2;CLSPN;BORA;CARD10;CCDC88A;AXIN1;STK11;PRKACA;MARK2;JAK2;PDPK1;TXN;PARK7;MLST8;PIBF1;PPIA;TLR6;STK4;PAK5;PAK2;TGFB2;ADCY8;MAP3K7;TAOK1;MALT1;STK3;TRAF6;MAPKAP1;PRKAR2A
prerank,regulation of chemokine production (GO:0032642),-0.3815269030633758,-1.3579019536634862,0.04081632653061224,0.6364346232503785,1.0,8/36,7.25%,APP;TREM2;CSF1R;LPL;AIF1;PYCARD;TLR7;TLR4
prerank,response to hydroxyurea (GO:0072710),0.7066576107880471,1.3570474073383125,0.15308988764044945,0.7445168055329557,1.0,3/11,4.15%,BLM;DDX11;TIMELESS
prerank,mRNA stabilization (GO:0048255),0.5928172574469359,1.3564726256052264,0.11712707182320442,0.7452588953884658,1.0,21/40,23.67%,E2F1;HNRNPC;BOLL;TAF15;ELAVL4;MAPK14;DHX9;HNRNPA0;MYD88;HNRNPU;PAIP1;ANGEL2;ELAVL1;EIF4ENIF1;THRAP3;SYNCRIP;TENT5D;TARDBP;YBX1;GDNF;CIRBP
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.49081387200104154,-1.3564651944075892,0.12396694214876033,0.6366499392897276,1.0,7/14,22.35%,LRP1;AIF1;NDRG4;SERPINE1;PRKG1;CORO1B;TRIB1
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3720995847500662,-1.3552496008501755,0.02727272727272727,0.6362716176156444,1.0,12/36,11.29%,NSF;ANK3;MACF1;GGA3;OPTN;GOLGA7;PREPL;AFDN;VAMP5;VAMP2;GOLGA4;RAB31
prerank,nucleic acid metabolic process (GO:0090304),0.576492744016076,1.3545444590697406,0.08057851239669421,0.7517330022705302,1.0,33/69,22.39%,ANKLE1;DNTT;TOPBP1;POLR2I;POLR2A;FEN1;HNRNPC;HNRNPM;HNRNPL;HNRNPA3;PDE12;HNRNPA2B1;DNA2;DNASE1L1;NCBP1;PCBP2;HNRNPA0;HNRNPR;WDR74;DXO;HNRNPU;RAD50;METTL14;POLR2K;POLR2J;HNRNPA1;NCBP2;DDX54;MMS19;WRN;RBFOX2;WTAP;POLR2B
prerank,telomere capping (GO:0016233),0.6593343796987566,1.3543339928111764,0.14453125,0.7509596294391316,1.0,8/16,14.98%,DCLRE1C;TERF2;DCLRE1B;TERF1;CTC1;PRKDC;TFIP11;RAD50
prerank,cellular senescence (GO:0090398),0.6298111527501808,1.354234777384688,0.11059907834101383,0.7496526180033491,1.0,12/27,19.47%,HMGA1;SMC6;PML;CDKN2A;TERF2;MAPK14;KAT6A;NSMCE2;MAP2K1;SIRT1;CDKN1A;SMC5
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6112642562332113,1.3538689437904872,0.13333333333333333,0.7494686293479522,1.0,4/32,7.77%,TPX2;STMN1;CLASP1;CIB1
prerank,negative regulation of protein depolymerization (GO:1901880),0.628634049679855,1.3535426484531219,0.15356265356265356,0.7491318194455978,1.0,4/24,10.17%,TPX2;CLASP1;CIB1;LIMA1
prerank,myofibril assembly (GO:0030239),0.5914247461712643,1.3530286567682452,0.11686879823594266,0.7494894942897258,1.0,6/42,13.94%,TMOD4;CSRP3;CSRP1;FLII;ACTN2;CFLAR
prerank,male meiosis I (GO:0007141),0.654538120337602,1.35231205662488,0.1608108108108108,0.7508265487587698,1.0,3/16,13.30%,MYBL1;FOXJ3;ING2
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.5308321892444483,-1.3515270411991387,0.13758389261744966,0.6436533218111655,1.0,8/12,18.05%,ACLY;ACO2;GLUD1;ACO1;IDH1;IDH3B;IDH3G;IDH3A
prerank,melanocyte differentiation (GO:0030318),-0.5369925147094022,-1.3510015469145822,0.1413427561837456,0.6414309102015883,1.0,2/11,4.02%,MITF;LRMDA
prerank,positive regulation of response to stimulus (GO:0048584),0.5963497662708843,1.350272355325815,0.09857612267250822,0.7579244541423247,1.0,12/40,17.59%,ANKLE1;HMGA1;CGAS;CDKN2A;B2M;DHX9;FXR1;MYC;TAF9;TGFB2;SIRT1;FCGR2B
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.5088847424322023,-1.3498540206022875,0.16917293233082706,0.6410124897881079,1.0,4/12,19.64%,TREM2;IL18;TTBK1;CCL3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.634968645764696,1.349376846917624,0.1475211608222491,0.7583953329974344,1.0,5/21,9.42%,ERCC4;RPA2;CHD1L;RPA1;ERCC3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.634968645764696,1.349376846917624,0.1475211608222491,0.7583953329974344,1.0,5/21,9.42%,ERCC4;RPA2;CHD1L;RPA1;ERCC3
prerank,establishment of vesicle localization (GO:0051650),-0.46008496190777076,-1.3492310141180388,0.10300429184549356,0.6391209273572587,1.0,9/18,16.15%,DNM2;KIF5C;SYNJ1;SPG11;CCDC186;KIF5A;CDK5;RAB11A;SNAPIN
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5922761484050548,1.349200788276267,0.10930735930735931,0.7574811439937975,1.0,10/48,14.12%,IL12A;CD2;ZFPM1;PTPN22;CCR2;RASGRP1;CYRIB;IL1R1;CEBPG;IL27
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5225358916287163,-1.348089551361878,0.14482758620689656,0.6383091020158826,1.0,7/12,28.64%,UBASH3B;ANK2;RYR2;ANXA6;FKBP1B;MTLN;PTK2B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6123101670854603,1.3479357700736356,0.14385964912280702,0.7612840354718126,1.0,5/29,8.62%,IL12A;KLRD1;RASGRP1;RAET1E;CYRIB
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6385327025030633,1.3474452888443973,0.1425091352009744,0.7617216783742532,1.0,6/22,15.39%,CYP1B1;IL7R;OCIAD2;NOTCH1;IL10RA;F2R
prerank,regulation of integrin activation (GO:0033623),0.6671858497049457,1.347315516242383,0.14398943196829592,0.7605953806073047,1.0,1/15,0.17%,KIF14
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.6928439969105561,1.3473043244730292,0.18454935622317598,0.7589512431540251,1.0,3/11,12.51%,IL12A;JAK2;CANX
prerank,protein export from nucleus (GO:0006611),0.6217488195334676,1.3467811652498418,0.13866039952996476,0.7595070776507648,1.0,6/27,7.41%,ANKLE1;XPO1;CCHCR1;NUP42;DESI1;NUP214
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5368288394893801,-1.3465317814566573,0.13310580204778158,0.6393059898139547,1.0,5/11,17.39%,ACVR1;TGFBR1;SMAD7;TGFBR3;TGFBR2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.684484405095489,1.3465001251153628,0.1444141689373297,0.7590134056191896,1.0,5/13,15.85%,HEY2;TAF1;DDIT3;PSEN1;SIN3A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5560479025101245,1.3462492522542602,0.02702702702702703,0.7583647053036686,1.0,85/168,22.85%,RPL7;RPL18A;SMG6;RPS20;SMG5;RPL36;RPL14;RPS19;DCPS;RPS7;EIF3E;RPS4X;RPS18;EXOSC8;ATM;UPF2;SMG8;PDE12;ZFP36L1;RPL23A;CSDE1;EIF4A3;DCP1B;RPL28;EXOSC10;DCP2;RPS14;RPL41;RPLP2;NCBP1;CASC3;RNPS1;RPS27;RPS5;PNLDC1;RPS29;RPLP0;RPS11;TUT4;RPL27A;CNOT4;ERI1;DCP1A;UPF3B;SMG9;RPS9;RPS15A;DXO;HELZ2;RPL12;CNOT1;RC3H1;CNOT6;PYM1;SAMD4A;TUT1;RPL3;GSPT1;UBA52;RPL18;TENT2;RPL5;RPS6;RPS17;NCBP2;RPS3;THRAP3;RPL21;XRN1;PPP2CA;RPL17;RPL23;CNOT8;SMG7;CNOT7;RPL24;RPL8;RPL27;DHX34;RPL13A;AGO1;RPS12;RPS8;RPL15;RPL10
prerank,positive regulation of DNA recombination (GO:0045911),0.6133317285939902,1.3452549433131913,0.14335664335664336,0.76087595016709,1.0,7/27,12.18%,RAD51AP1;TIMELESS;ARID2;TFRC;MRNIP;KMT5C;PAXIP1
prerank,sulfate transport (GO:0008272),0.668725950217269,1.3443264882034909,0.14456233421750664,0.7632255834406686,1.0,1/14,0.69%,RACGAP1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.653754034520181,1.3440851933662954,0.13636363636363635,0.762573890539193,1.0,9/18,16.96%,MAPK1;EZR;SNX3;MTMR2;MSN;RDX;DNAJC13;MAP2K1;CHMP3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.578605355697944,1.3436366313889825,0.09312169312169312,0.7627614130468319,1.0,9/55,10.93%,HMMR;FMOD;HSPG2;CD44;GALNS;HPSE2;DCN;CEMIP2;OGN
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7007908359418866,1.3434984414734132,0.175,0.7617100885555594,1.0,2/10,7.90%,IL12A;DCN
prerank,cellular response to alcohol (GO:0097306),0.582244618541369,1.3434348486939582,0.11925601750547046,0.7602882286223992,1.0,8/42,7.55%,RAD51;BRCA1;BLM;CTNNA1;MAP4K1;MLC1;AHR;GNAI1
prerank,negative regulation of chemotaxis (GO:0050922),-0.389325212168507,-1.342987745867052,0.11409395973154363,0.6464624384634734,1.0,12/31,20.68%,PTPN2;AIF1;SEMA3D;SEMA3E;SEMA4C;ROBO1;DUSP3;SEMA4G;SEMA3A;THBS1;SEMA7A;CORO1B
prerank,purine-containing compound salvage (GO:0043101),-0.5024124466348767,-1.3429346037262944,0.14285714285714285,0.642787583905804,1.0,5/12,17.24%,HPRT1;GMPR2;AMPD2;DCK;APRT
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.48217100751272546,-1.3427210387756772,0.10599078341013825,0.639663025102641,1.0,3/16,1.47%,TREM2;LRP1;APOE
prerank,amino acid transport (GO:0006865),0.5863885045537124,1.3425209017046944,0.11027027027027027,0.7625724465566399,1.0,8/49,10.11%,SLC6A12;SLC38A5;SLC1A5;SLC7A1;SLC25A47;SLC16A10;SLC43A2;SLC3A1
prerank,negative regulation of transferase activity (GO:0051348),0.6172935732205761,1.3417177066140589,0.14853801169590644,0.7644165579282197,1.0,9/28,14.97%,PIF1;MEN1;ERCC4;FBXO5;TERF1;PARK7;HNRNPU;GSK3B;TP53
prerank,positive regulation of macrophage migration (GO:1905523),-0.45420749688412176,-1.341250590502258,0.11363636363636363,0.6403071175596131,1.0,11/19,20.09%,TREM2;CSF1R;CMKLR1;AKIRIN1;P2RY12;PTK2;CSF1;MDK;THBS1;CCL3;P2RX4
prerank,histone H2A acetylation (GO:0043968),0.6580341510710244,1.3399913130852155,0.14720812182741116,0.770059491183374,1.0,7/16,13.29%,NAA40;EPC1;BRD8;YEATS4;RUVBL2;RUVBL1;ING3
prerank,regulation of myelination (GO:0031641),0.6167888240916615,1.3397143539477478,0.15165876777251186,0.7695294455642817,1.0,1/25,0.17%,KIF14
prerank,cation transmembrane transport (GO:0098655),0.5907178305209043,1.3391099400156838,0.10140237324703344,0.7706433478558016,1.0,4/44,3.20%,RHAG;SLC38A5;SLC7A1;SLC6A5
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5167270917207464,-1.3390476628156682,0.1685823754789272,0.6429593804197473,1.0,5/12,13.48%,SNAP47;STX4;STX3;STX2;STX1A
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7094947294117292,1.3387363677007496,0.15736766809728184,0.7705291907915613,1.0,7/10,20.98%,STK26;TXN;PARK7;NFE2L2;PDE8A;LRRK2;RIPK1
prerank,response to nitric oxide (GO:0071731),0.6780315792009137,1.338355723945299,0.1598360655737705,0.7704290648815826,1.0,6/13,14.41%,AQP1;FOXO1;DPEP1;TXN;KCNC2;MTR
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4392292781148305,-1.3382987271709361,0.06486486486486487,0.6415130116065975,1.0,12/21,31.41%,CACNA1C;ANK2;SRI;DMD;RYR2;CALM1;SLC8A1;ATP1A2;GSTO1;FKBP1B;CAMK2D;CALM2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6490570359106544,1.3382285806296739,0.14987405541561713,0.7693410458663583,1.0,5/18,13.08%,KIF20B;RIPOR2;CYRIB;ROCK2;RACK1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6978878729812026,1.3381812644332762,0.167621776504298,0.767903257246388,1.0,2/10,7.15%,PHACTR4;NOTCH1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.570607424224458,1.337992220400766,0.08521560574948665,0.7671327970252065,1.0,23/72,18.40%,POLK;ERCC4;RPA2;XRCC1;RFC5;POLR2I;PRPF19;POLR2A;POLD1;PCNA;LIG1;POLD2;RPA1;ERCC3;RFC2;RFC1;POLD3;RPA3;POLR2K;POLR2J;UBA52;USP7;PPIE
prerank,diacylglycerol metabolic process (GO:0046339),-0.41651278424812277,-1.3373387783491424,0.1,0.6408613317043372,1.0,10/23,18.09%,DGKH;PLA2G15;DGKA;DGKI;DGKZ;DGKQ;DGKB;DGAT1;DAGLA;ANG
prerank,negative regulation of nuclear division (GO:0051784),0.6919682528719712,1.3361220259271152,0.17783857729138167,0.7734852130321578,1.0,3/11,5.08%,FBXO5;AURKAIP1;CHEK1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6884615199789512,1.3361031083050987,0.17287630402384502,0.7719195508116758,1.0,4/11,12.45%,BARD1;ZFP36L1;NCBP1;ZC3H3
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.6624820203584052,1.335952735628888,0.14805194805194805,0.7709468522184963,1.0,4/14,16.28%,BRCA2;TERF2;NABP2;ATRX
prerank,negative regulation of transposition (GO:0010529),0.6549188330963116,1.3358839922904946,0.17161290322580644,0.7695951946476871,1.0,4/16,13.34%,MYBL1;UBR2;TUT4;SIRT7
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5942044351147442,1.3349074353275223,0.11288483466362599,0.7721175206960877,1.0,7/32,17.91%,CD19;CAV1;NPSR1;PDPK1;F2R;PLCG1;SNCA
prerank,rRNA catabolic process (GO:0016075),0.6519930588611679,1.3346004571991537,0.15405405405405406,0.7718679192161602,1.0,3/16,7.55%,SLFN14;EXOSC8;EXOSC10
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5490558605238672,-1.3338602965160415,0.13688212927756654,0.6473858132383545,1.0,6/11,31.43%,HSP90AA1;PTS;CALM1;PRKG2;DHFR;SPR
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.6868940456278682,1.3333487821543253,0.15244755244755245,0.7756721384029641,1.0,2/11,5.36%,BLK;CDKN2A
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.6147980513828742,1.333134227873869,0.1341743119266055,0.7749361099516054,1.0,4/31,5.02%,HSD17B3;SRD5A2;PYCR3;LSS
prerank,response to hydrogen peroxide (GO:0042542),0.5874554950083541,1.332511567946533,0.13071895424836602,0.775898580477001,1.0,14/45,14.92%,ECT2;CYP1B1;STK26;AQP1;FYN;NET1;SETX;HDAC6;MAP3K5;STK24;PARK7;NFE2L2;APTX;PDCD10
prerank,regulation of cellular component size (GO:0032535),0.5988190130141842,1.3322292749264226,0.1378132118451025,0.7754192167471007,1.0,15/30,18.03%,EZR;RIN3;RAB22A;RAP1GAP2;PEX11B;MTPN;LARS1;PPP1R15A;MSN;RDX;PTEN;LAMTOR4;RAC1;PPP1CA;RARG
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4574770968853498,-1.331743005323746,0.12385321100917432,0.6502346715353517,1.0,12/17,31.10%,CACNA1C;ATP1A1;ATP1B2;RYR2;ATP1B1;GJA1;SLC8A1;ATP1A2;ATP1A3;FKBP1B;GJC1;GJD3
prerank,neural tube closure (GO:0001843),0.5929787749993795,1.3314691571264987,0.15393386545039908,0.7769081549297638,1.0,11/34,19.35%,STIL;PHACTR4;DEAF1;LMO4;FUZ;BBS4;SKI;TGFB2;KDM2B;MTHFD1L;PAX2
prerank,positive regulation of vacuole organization (GO:0044090),-0.5418616057923311,-1.3314561466173755,0.13157894736842105,0.6474597830204455,1.0,4/10,7.96%,PIP4K2B;GRN;SH3GLB1;RAB3GAP2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5663883424030256,1.3308949961844323,0.12460732984293194,0.777689976587383,1.0,15/60,14.21%,AURKB;NEK2;MAPK1;DSCC1;RFC5;PCNA;CCT7;ATM;CCT2;TCP1;SMOC2;RFC2;CCT5;MYC;CHTF18
prerank,negative regulation of wound healing (GO:0061045),-0.38601284811733083,-1.3300825043760074,0.10144927536231885,0.6478682685128622,1.0,9/28,14.36%,SERPINE2;APOE;SLC12A2;CD34;CLASP2;TFPI;ALOX5;FGF2;SERPINE1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.6521275526135812,1.3296641925328498,0.16905071521456436,0.7812122023377392,1.0,6/16,15.22%,NAA40;KAT2B;NAA16;NAA25;CREBBP;NAA20
prerank,pyruvate metabolic process (GO:0006090),-0.3350231506592365,-1.3293765052997661,0.09523809523809523,0.6462597731330387,1.0,19/52,14.49%,HK2;HK3;GPI;PDHX;HAGH;PFKL;ENO1;ALDOA;LDHA;TPI1;PGM1;PKM;PDHB;SLC16A3;PGAM1;PGAM4;ME1;ALDOC;HOGA1
prerank,regulation of cellular component organization (GO:0051128),0.5540845277161561,1.3285737756215497,0.03819095477386935,0.7842420520684569,1.0,25/135,13.59%,MKI67;KIF14;HJURP;RAB33B;CD177;ALKBH4;AURKA;NET1;STK11;TFRC;STON1;STK38L;ARFGAP1;METTL4;RIT2;SOCS2;PARK7;ATF5;BAP1;PACSIN2;HCFC1;ROCK2;STON2;HNRNPU;LATS1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6941450267800593,1.3279094442836312,0.15300546448087432,0.7853689281539593,1.0,2/12,2.25%,IL12A;MAPK1
prerank,negative regulation of phagocytosis (GO:0050765),0.6466414054408732,1.3269483786919165,0.15089514066496162,0.7878870227244714,1.0,8/17,17.59%,PRTN3;CD47;SNX3;HMGB1;PIP4P2;RACK1;APPL1;FCGR2B
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.6956794825398647,1.3261166018500796,0.16033755274261605,0.7897882184258903,1.0,4/11,10.75%,STK26;FYN;UBQLN1;PARK7
prerank,striated muscle cell development (GO:0055002),0.6595008076503862,1.3258324662823322,0.16489361702127658,0.789399270984836,1.0,2/14,9.26%,TMOD4;FLII
prerank,negative regulation of viral entry into host cell (GO:0046597),0.6703255051747465,1.3256567188583577,0.17887323943661973,0.7885279382626741,1.0,6/12,14.46%,SNX3;GSN;LY6E;TRIM11;IFITM3;TRIM5
prerank,protein kinase A signaling (GO:0010737),0.6782148558910626,1.3250134736373669,0.16946778711484595,0.7895902841826697,1.0,4/12,11.59%,EZR;MYOM1;PRKACA;RDX
prerank,Golgi inheritance (GO:0048313),0.6883951939218852,1.3241717469539245,0.17755681818181818,0.7915957444152543,1.0,5/11,14.92%,CDK1;STX5;VRK1;VCPIP1;PDCD10
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6374890601710005,1.323660251076127,0.16687898089171974,0.7921646567960754,1.0,1/16,2.11%,CLDN18
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5793532199112768,1.322754981063129,0.11361200428724544,0.794202538063034,1.0,17/46,17.66%,ECT2;GTSE1;ANP32B;FLNA;EFCAB7;EMD;DHX9;PSEN1;BAG3;GSK3B;TP53;IPO5;TCF7L2;TRIM28;XPO4;HCLS1;YWHAE
prerank,DNA strand elongation (GO:0022616),0.636632049968056,1.3227541174277933,0.1613316261203585,0.7925952365971035,1.0,7/18,16.32%,GINS1;POLA1;DCLRE1B;POLD2;POLD3;RAD50;MCM3
prerank,regulation of neuron projection arborization (GO:0150011),-0.47785103105646587,-1.3224303289468535,0.1214574898785425,0.663244020487759,1.0,5/15,9.31%,MACF1;MAP3K13;MYO9A;NTNG1;DVL3
prerank,negative regulation of cell migration (GO:0030336),-0.2641288610160962,-1.3221954662246982,0.0,0.6603353195068948,1.0,48/137,17.91%,LDLRAD4;MITF;TMEFF2;LRP1;ADARB1;LIMCH1;PTPRG;EVL;SCAI;ADAM15;NAV3;NEXMIF;PTPRK;ARHGAP4;RAP2A;PTPRJ;RAP2B;CLASP2;CORO1C;ROBO1;BST2;AFDN;DUSP3;NF1;MIA3;ENG;ATP1B2;RAP2C;SULF1;DUSP10;FLCN;SINHCAF;RECK;PTPRT;NDRG4;SMAD7;HMOX1;FGF2;SERPINE1;GJA1;ADORA3;ACVRL1;PFN2;EPHA4;JAG1;DAB2IP;MCC;THY1
prerank,chromatin remodeling (GO:0006338),0.5535676210902645,1.3221514019779235,0.07171717171717172,0.7934980860206098,1.0,37/100,19.39%,MYB;CECR2;SMARCC2;MBD3;SMARCA5;CHD1L;RB1;ARID1B;SMARCD2;RSF1;NPM3;ACTR5;HNRNPC;MBD2;BAZ2B;RBBP4;BAZ1B;SMARCA4;ZBTB7A;SMARCC1;RUVBL2;RUVBL1;KAT2B;MTA2;HCFC1;SATB2;MYC;TADA2A;KDM4C;JARID2;ATRX;BAZ1A;SIRT1;HDAC4;HDAC1;GATAD2B;SOX9
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6022834954558155,1.3217301333610418,0.1423611111111111,0.7937070805765885,1.0,4/27,3.20%,SLC38A5;SLC25A12;SLC7A1;SLC6A5
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.6539255092417244,1.3211189334593734,0.15132408575031525,0.7947167300672529,1.0,8/18,19.08%,DHX58;NPLOC4;BIRC2;PUM2;PUM1;USP15;GPATCH3;SEC14L1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.6132211812552131,1.3208571133196216,0.13959085439229843,0.7942749056598798,1.0,9/24,10.21%,EZH2;PPM1D;SUZ12;EPC1;RBBP4;PHF19;H3-3A;PHF1;DNMT1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.6635372984253151,1.320660695054267,0.1753681392235609,0.7935416103784404,1.0,6/13,17.53%,PRPF19;SART3;LSM2;PRPF31;SRSF10;PRPF8
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.6716670825699315,1.320451600108524,0.1908713692946058,0.7928022215141647,1.0,8/11,19.42%,CCT7;CCT2;TCP1;TERF1;CCT5;DKC1;WRAP53;CCT6A
prerank,glycine metabolic process (GO:0006544),0.6699264191828969,1.3198003010358899,0.17941585535465926,0.793935413432895,1.0,1/12,1.10%,GCAT
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.546112574856617,1.319468858282186,0.0,0.7937703729055373,1.0,86/417,12.29%,CENPF;DEPDC1;BIRC5;FOXM1;GFI1;MYB;HMGB2;EZH2;RCOR2;MEN1;SUV39H1;BRCA1;SMARCC2;HMGA1;DAP;HEY2;RBM15;DEAF1;LEF1;E2F1;RB1;RIOX1;NIF3L1;RSF1;CBX5;CD38;TWIST1;PML;BCL7A;FBXW11;TIMELESS;PA2G4;HDAC10;UBE2I;MTA3;RPS6KA5;EPC1;CTCF;SCMH1;FOXP1;DACH1;CDKN2A;NR1D1;NKAP;MBD2;FOXO1;PBXIP1;MBD1;ARID4A;GMNN;HDAC6;KLF10;TAF7;NOTCH1;XRCC6;AHR;SFMBT1;SPEN;SAP18;PSPC1;SMARCA4;CIR1;CIPC;ZBTB16;ZBTB7A;NONO;ZNF148;MECP2;PFDN5;TFDP2;NR2F2;KAT6A;ID4;ZEB1;TRIM33;EHMT1;ARID5B;SUMO1;SMAD4;CCAR2;JUN;ATF5;PLCB1;FOXP2;BAP1;SETDB2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6093994288352395,1.3192011466439089,0.15230224321133412,0.7934048678780529,1.0,9/24,16.94%,DDIAS;CD74;CD44;CDKN2D;CCAR2;ING2;TPT1;TAF9;SIRT1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.57957829234716,1.3189834849199702,0.12840043525571274,0.792786329092214,1.0,2/45,0.90%,TTK;INHBC
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6053889606842477,1.3187105861265869,0.15058823529411763,0.7923473168695793,1.0,8/31,17.59%,BLK;SPN;GLMN;ATM;TNFRSF13B;TYROBP;RC3H1;FCGR2B
prerank,determination of bilateral symmetry (GO:0009855),0.6102480460265173,1.3180284386568317,0.1625916870415648,0.793702248280196,1.0,2/24,7.15%,STIL;NOTCH1
prerank,negative regulation of bone remodeling (GO:0046851),-0.5215567536672374,-1.317797719590601,0.14084507042253522,0.6700478606145919,1.0,2/11,5.62%,UBASH3B;TNFAIP3
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3559700454409526,-1.317219901976485,0.06097560975609756,0.6680206706400964,1.0,13/50,10.44%,IGF1R;ADAP2;CSF1R;PLCB2;PIK3CD;PIK3R1;IGF1;KCNH1;PI4KA;PIK3C2B;PLCL2;PLCB4;IRS2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5928548589614461,1.3164301583596443,0.16292134831460675,0.7988856916744861,1.0,10/33,12.99%,ECT2;CYP1B1;AQP1;NET1;SETX;HDAC6;MAP3K5;PARK7;SIGMAR1;NFE2L2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5406517360749173,1.316167304472404,0.04116465863453815,0.7983625698888165,1.0,42/153,14.91%,TTK;CDK1;CLSPN;MASTL;PLK1;MAPK1;AURKA;PRKCE;RPS6KA5;MAP4K1;MAPKAPK3;TLK1;TAF1;ATM;CSNK1A1;STK38L;AKT3;PKN2;CSNK1G2;PRKX;MAPK14;PRKCA;PRKACA;STK38;MARK2;MAST2;PDPK1;HIPK2;DYRK1A;VRK1;PRKCB;RPS6KA6;LMTK2;GRK2;ROCK2;PRKDC;LATS1;STK39;CDC7;GSK3B;SGK3;STK4
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.6288703426857989,1.315868485282665,0.15914489311163896,0.7980296070748235,1.0,1/22,0.93%,LRAT
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6135515008240663,1.3151208714270084,0.16,0.7995823356100498,1.0,5/24,8.28%,ADAMTS7;SOX6;PTHLH;MBOAT2;ZBTB16
prerank,negative regulation of DNA binding (GO:0043392),0.6046747716447128,1.3150459051796308,0.1559953434225844,0.7983362237709954,1.0,10/28,16.05%,HEY2;LEF1;E2F1;RSF1;SP100;JAK2;SUMO1;JUN;SIN3A;TFAP4
prerank,defense response to protozoan (GO:0042832),0.6740404620185094,1.3147011235624804,0.17969821673525377,0.7982151957876006,1.0,4/12,11.92%,GBP4;BATF;GBP2;MYD88
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.407830395784246,-1.3144149505863467,0.125,0.6728291064824851,1.0,14/25,33.19%,HPRT1;PRPS2;GMPR2;PPAT;AMPD2;DCK;APRT;GART;PRPSAP2;SHMT2;AMPD3;SHMT1;PRPS1;PRPS1L1
prerank,myelination (GO:0042552),-0.34679119890443205,-1.3141021541092917,0.015151515151515152,0.67009234970714,1.0,21/46,23.59%,ABCD2;PLP1;MBP;SCN8A;SLC8A3;PLLP;CMTM8;B4GALT5;NF1;EPB41L3;NFASC;DEGS1;MAL;EIF2B4;ADGRG6;ARHGEF10;TNFRSF21;EIF2B2;PARD3;SOX10;CNTNAP1
prerank,organic anion transport (GO:0015711),0.5604748551186388,1.31297743724488,0.10408163265306122,0.8040034139542043,1.0,14/76,12.39%,SLC4A1;RHAG;AQP1;SLC2A8;SLCO4C1;SLC35A2;CYB5RL;SLC35A1;SLCO4A1;LRRC8C;SLC52A1;SLC19A1;ABCC4;SLCO2A1
prerank,positive regulation of embryonic development (GO:0040019),0.6346169581421824,1.3129592251973512,0.16209476309226933,0.8025011732528243,1.0,5/19,13.08%,FOXA2;RBM19;NR2C2;PLCB1;RACK1
prerank,prostanoid metabolic process (GO:0006692),-0.49851357813941216,-1.3124766346952597,0.14925373134328357,0.671235758198053,1.0,4/13,8.42%,HPGDS;PTGS1;PLAA;PTGR2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3682463839494716,-1.3115230257943586,0.10843373493975904,0.6706946311002512,1.0,14/39,19.29%,SPOCK1;EFNA5;GCNT2;ADAM15;NEXMIF;SEMA3E;CORO1C;CORO2B;PTPRO;RCC2;MAP4K4;JAG1;THBS1;RASA1
prerank,regulation of dephosphorylation (GO:0035303),0.6375349006932973,1.3108457096457051,0.17632241813602015,0.8097404990565629,1.0,8/15,23.20%,SMG6;SMG5;MTMR2;CDK5RAP3;PPP1R16A;SMG7;PPP1R16B;SRC
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6427227676745739,1.3106861862913526,0.18882978723404256,0.808873599922259,1.0,9/15,19.42%,NOP10;CCT7;CCT2;TCP1;RUVBL2;RUVBL1;CCT5;DKC1;CCT6A
prerank,regulation of intracellular protein transport (GO:0033157),0.5873141873596358,1.3100327092876576,0.16147635524798154,0.8100208705312126,1.0,8/32,15.07%,KIF20B;PCNT;PCM1;PTPN14;OAZ1;SIRT7;PDCD10;RIPOR1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.43787955810991885,-1.30997288614362,0.15228426395939088,0.6718149117448478,1.0,6/19,14.75%,TREM2;IGF1;TNFRSF1B;CD200;IL18;DAGLA
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.544538360507905,-1.309737920907158,0.17549668874172186,0.6656321523111383,1.0,3/10,25.28%,MBP;MAPK7;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.544538360507905,-1.309737920907158,0.17549668874172186,0.6656321523111383,1.0,3/10,25.28%,MBP;MAPK7;KLF4
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.46228719901922005,-1.3096569648990404,0.16267942583732056,0.6623782541677085,1.0,6/17,18.65%,LPL;PCSK5;PCSK6;LMF1;SORT1;APOC1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6564219080441074,1.3091725181986602,0.17305151915455746,0.812039006157488,1.0,6/14,12.75%,MYB;BRCA1;DNMT1;SMAD4;PAXIP1;KMT2A
prerank,cotranslational protein targeting to membrane (GO:0006613),0.5414486313186696,1.308868239803209,0.1,0.8117104325314994,1.0,47/91,22.90%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;ARL6IP1;RPL28;RPS14;RPL41;RPLP2;RPS27;RPS5;RPS29;RPLP0;RPS11;RPL27A;RPS9;RPS15A;RPL12;SSR1;RPL3;SEC63;UBA52;RPL18;RPL5;RPS6;RPS17;RPS3;RPL21;RPL17;RPL23;RPL24;RPL8;RPL27;SEC62;RPL13A;RPS12;SSR2;RPS8;RPL15;RPL10;SRP68
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.46356749290524585,-1.308308780505397,0.11818181818181818,0.6631070918010694,1.0,4/17,6.74%,NLRP3;HAVCR2;CD86;FCER1G
prerank,outflow tract septum morphogenesis (GO:0003148),-0.42840137436412623,-1.3077626688480393,0.15483870967741936,0.6614355841674107,1.0,7/24,9.25%,ACVR1;NRP2;ZFPM2;BMPR2;ROBO1;SMAD6;ENG
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5413248127702177,1.3070934278784265,0.09887869520897044,0.8174206335522153,1.0,44/87,22.90%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;RPL28;RPS14;RPL41;RPLP2;RPS27;RPS5;RPS29;RPLP0;RPS11;RPL27A;RPS9;RPS15A;ZFAND2B;RPL12;RPL3;SEC63;UBA52;RPL18;RPL5;RPS6;RPS17;RPS3;RPL21;RPL17;RPL23;RPL24;RPL8;RPL27;RPL13A;RPS12;RPS8;RPL15;RPL10;SRP68
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6365522376241473,1.3069064006225395,0.18463611859838275,0.8166582491345886,1.0,3/15,11.99%,HAAO;KMO;FAH
prerank,exit from mitosis (GO:0010458),0.672035555198559,1.3062578499119395,0.18834688346883469,0.8179041453686403,1.0,2/12,5.95%,UBE2C;CLASP1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.5462087461903748,1.3057884292366264,0.10542476970317298,0.8183318838257322,1.0,21/88,16.92%,CCNF;KIF14;FBXL15;SKP2;PSMB7;PSMD11;FBXW11;PSMF1;FBXO44;PSMC1;FBXO17;PSMC3;PSMA4;FBXL4;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6181669855428775,1.305758088013108,0.1745635910224439,0.816901638730484,1.0,10/22,22.51%,CDKN2C;ANKLE2;CDKN2A;CDKN2D;TP53;DYNLL1;SIRT1;CDKN1A;ROCK1;CDKN1B
prerank,regulation of cholesterol storage (GO:0010885),-0.45649667694820056,-1.305229815564853,0.16153846153846155,0.6655331180731302,1.0,4/15,10.92%,TREM2;ABCA1;LPL;SCARB1
prerank,engulfment of apoptotic cell (GO:0043652),-0.47455834492681986,-1.3050290529471746,0.15207373271889402,0.6626666956082223,1.0,9/15,23.03%,RHOBTB1;XKR6;RHOBTB2;RHOG;RHOH;THBS1;ADGRB1;XKR4;MEGF10
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.49059494990058294,-1.3049748634598894,0.18072289156626506,0.6594187198805402,1.0,3/13,13.01%,TREM2;ENO1;PINK1
prerank,positive regulation of programmed cell death (GO:0043068),0.540386105706291,1.303630590312134,0.013,0.8241731666518605,1.0,69/272,18.18%,TOP2A;ECT2;USP27X;BARD1;CYP1B1;ARHGEF5;PMAIP1;IAPP;E2F1;PDCD2;DAPK2;TIAM1;NET1;PTPA;APAF1;PIDD1;TFPT;TNFSF10;ARHGEF18;PHLDA3;FOXO1;CASP2;FAF1;ATM;ARHGEF3;TRADD;HDAC6;MAP3K5;UBE2Z;HMGB1;BOK;SAP18;TNFAIP8;SOS1;RNPS1;ERCC3;PRR7;PAWR;MAP3K11;MELK;ATF6;CCAR2;JUN;FAS;FGD3;RACK1;ING3;ING5;LATS1;BCL6;PSEN1;HTATIP2;CASP9;STK4;TP53;MAP3K20;MARK4;TFAP4;NLRP2B;SIRT1;ANO6;ARL6IP5;PNMA2;UBA52;SNCA;STK17B;RARG;LRRK2;ARHGEF7
prerank,positive regulation of locomotion (GO:0040017),-0.4163362917303923,-1.3029631170626421,0.10884353741496598,0.6617778937448391,1.0,10/27,12.72%,TREM2;CSF1R;AIF1;STX4;STX3;P2RY12;SPOCK2;AKT2;CFAP20;PPM1F
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.5761638516011015,1.3026689216920344,0.16095890410958905,0.8267448671406443,1.0,9/32,21.85%,CD19;NPSR1;PDPK1;HAP1;F2R;PLCG1;SNCA;PKD2;CALM3
prerank,monoacylglycerol metabolic process (GO:0046462),-0.4898280032494331,-1.3022762764032927,0.1593625498007968,0.6605235919364691,1.0,6/13,13.77%,MGLL;ABHD12;ABHD16A;ABHD6;MOGAT3;DGAT1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.6845959035246255,1.3021987915479707,0.21508379888268156,0.8272176696970241,1.0,6/10,24.66%,BATF;TP53;HOXB4;LMBR1L;UFL1;MLLT3
prerank,regulation of hormone secretion (GO:0046883),-0.47356008261770566,-1.3021931041792538,0.156,0.6574695490172837,1.0,5/15,29.81%,VAMP2;SNX6;SOX11;ANXA1;OSM
prerank,histone mRNA catabolic process (GO:0071044),0.6370388819638287,1.301835714616973,0.17716535433070865,0.8271652508965179,1.0,8/15,19.64%,ATM;EXOSC10;DCP2;TUT4;ERI1;TUT1;TENT2;XRN1
prerank,UV-damage excision repair (GO:0070914),0.6610672199671856,1.3010330676118518,0.19385026737967914,0.8289108240926965,1.0,5/12,17.70%,POLA1;ACTR5;POLD3;SIRT1;DDB2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5347893040492209,-1.3005476177296948,0.15100671140939598,0.658894258393463,1.0,3/10,4.87%,HK2;HK3;PFKL
prerank,positive regulation of viral life cycle (GO:1903902),0.6053240833947477,1.3004048819542517,0.15421686746987953,0.8299579417797608,1.0,7/22,21.47%,TMPRSS4;CD74;TRIM11;CHMP3;CHMP2B;LGALS9;VPS4A
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.265306799383911,-1.2999705599654656,0.0,0.6573983527478777,1.0,44/107,27.96%,SLC24A3;TPCN2;HTR2C;ANK2;SLC8A3;ATP2B2;ATP13A1;SLC8B1;TMEM165;CCL15;RYR2;ATP1B1;SLC39A7;SLC41A1;SLC39A14;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;ATP2B3;TRPV4;SLC8A1;SLC39A8;STOML2;SLC39A6;MT2A;CCL3;SLC39A12;STIM1;SLC30A1;CHERP;MT3;CD40;CCR1;RMDN3;CCL14;ATP13A4;CHRNA7;STIM2;ATP2C1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5072539648320868,-1.2994166761513894,0.16095890410958905,0.6555408147376238,1.0,3/13,10.65%,CLPTM1;ZC3H8;CAMK4
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6918824061116469,1.2992163784365782,0.1871345029239766,0.8334503515862413,1.0,6/10,17.29%,RUNX3;HMGB1;CBFB;ZBTB7B;RUNX1;SH3RF1
prerank,arachidonate transport (GO:1903963),-0.5354632186793874,-1.298741928992627,0.17034700315457413,0.6512587672215929,1.0,8/10,46.48%,ANXA1;DRD2;PNPLA8;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,arachidonic acid secretion (GO:0050482),-0.5354632186793874,-1.298741928992627,0.17034700315457413,0.6512587672215929,1.0,8/10,46.48%,ANXA1;DRD2;PNPLA8;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,regulation of water loss via skin (GO:0033561),0.6426275390758219,1.2982905270288476,0.18900804289544235,0.8341821641126687,1.0,1/15,1.62%,STMN1
prerank,establishment of skin barrier (GO:0061436),0.6426275390758219,1.2982905270288476,0.18900804289544235,0.8341821641126687,1.0,1/15,1.62%,STMN1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6556617197590131,1.29708595112639,0.18132611637347767,0.8378262682198776,1.0,2/13,3.03%,PMAIP1;VDAC2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.673660097111073,1.2969474266402286,0.21613832853025935,0.8367907520373732,1.0,5/10,23.12%,OXSR1;CCR2;STK39;ADAM10;ADAM17
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4492638311290894,-1.296939971073742,0.1277533039647577,0.6503227291950566,1.0,8/16,20.33%,ARHGAP6;APOD;CLASP2;CORO1C;RCC2;ACVRL1;THBS1;PHLDB2
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4492638311290894,-1.296939971073742,0.1277533039647577,0.6503227291950566,1.0,8/16,20.33%,ARHGAP6;APOD;CLASP2;CORO1C;RCC2;ACVRL1;THBS1;PHLDB2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6192690618387383,1.2959439732507134,0.1760299625468165,0.8395098448777051,1.0,8/19,20.21%,CCSAP;PLK1;CHMP1B;HNRNPU;CHMP3;CHMP2B;DRG1;TPR
prerank,chordate embryonic development (GO:0043009),0.5630797513228215,1.2958692256755893,0.1439232409381663,0.8383001418612938,1.0,5/55,3.96%,STIL;BRCA1;DEAF1;LIG4;SULF2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.4463337628912176,-1.2950997712590369,0.15942028985507245,0.6523964890846542,1.0,9/18,17.20%,HAVCR2;NAV3;CD34;TNFAIP3;TRIM27;HDAC7;PRNP;ZFP36;KAT5
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6245662072727642,1.295057525509937,0.17861635220125785,0.8402005247170333,1.0,1/19,0.81%,CHRNB4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6509202632438297,1.2946836726129067,0.19696969696969696,0.8402674695867015,1.0,8/12,19.42%,CCT7;CCT2;TCP1;CCT5;DKC1;GNL3L;WRAP53;CCT6A
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6434460630112384,1.2943746629562343,0.1828793774319066,0.8400180705024014,1.0,6/16,12.75%,MYB;BRCA1;DNMT1;SMAD4;PAXIP1;KMT2A
prerank,histone lysine methylation (GO:0034968),0.5850793016551394,1.2938238355242389,0.17420814479638008,0.8408229651107199,1.0,10/33,14.94%,EZH2;MEN1;SUV39H1;WDR5B;DPY30;PAXIP1;SETDB2;KMT2A;RBBP5;KMT2B
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6190814051369007,1.2936093001869782,0.15625,0.8385202994533024,1.0,7/19,17.19%,POLR2I;POLR2A;TERF2;TERF1;ATRX;POLR2K;POLR2J
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6190814051369007,1.2936093001869782,0.15625,0.8385202994533024,1.0,7/19,17.19%,POLR2I;POLR2A;TERF2;TERF1;ATRX;POLR2K;POLR2J
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5779576150783978,1.2925354234888244,0.19217081850533807,0.8415016131461445,1.0,15/29,23.13%,LSM6;DCPS;EXOSC8;DCP1B;DCP2;LSM2;EDC3;LSM5;DCP1A;LSM7;CNOT6;CNOT8;CNOT7;DIS3;LSM3
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.45299996440835233,-1.292514932947059,0.1469387755102041,0.6564860924455305,1.0,9/16,31.96%,TREM2;ENO1;FLCN;PINK1;SPHK2;PPARGC1A;ANTKMT;DNAJC30;AK4
prerank,estrogen metabolic process (GO:0008210),0.6450199277900727,1.2922274721829743,0.18880208333333334,0.8412472664126222,1.0,1/15,1.40%,CYP1B1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6135627192900086,1.2921784626995332,0.16646415552855406,0.8398839849826532,1.0,7/23,15.39%,CYP1B1;OCIAD2;NOTCH1;JAK2;IL10RA;PIBF1;F2R
prerank,regulation of chemotaxis (GO:0050920),-0.38823876404454066,-1.2899148386230554,0.13953488372093023,0.6607580738085794,1.0,13/30,21.12%,TREM2;PTPN2;AIF1;STX4;STX3;P2RY12;ZSWIM6;DUSP3;PPM1F;ZSWIM8;THBS1;P2RX4;EFNB2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5679794465899967,1.2897849574173195,0.1514161220043573,0.8485061215677253,1.0,21/48,18.42%,ATAD2;POLR1B;HMGA1;SMARCA5;ARID1B;DEK;CDCA4;CHEK1;ASF1A;BAZ1B;PHF2;POLR1A;KAT2B;POLR1F;SERTAD2;POLR1C;ELOF1;POLR2K;TAF1C;TAF1D;POLR1G
prerank,regulation of transposition (GO:0010528),0.6524704421367096,1.28939021758385,0.2029769959404601,0.8486474212302674,1.0,3/13,13.34%,MYBL1;UBR2;SIRT7
prerank,regulation of biomineral tissue development (GO:0070167),0.595969317597319,1.289289777113799,0.18496420047732698,0.8475018185117977,1.0,5/26,7.15%,HEY2;FBXO5;SGMS2;TWIST1;NOTCH1
prerank,ribosomal small subunit assembly (GO:0000028),0.6289626139049962,1.2891656852599953,0.20630749014454666,0.8464966751609896,1.0,6/16,13.52%,RPS19;RPS14;RPS27;MRPS7;RPS5;PRKDC
prerank,regulation of intracellular signal transduction (GO:1902531),0.5346784968684104,1.2883388213323481,0.003,0.8484355779264625,1.0,110/420,15.21%,TPX2;CDK1;BRIP1;AURKB;ECT2;FAM83D;RACGAP1;BARD1;RAD1;BRCA1;DEPDC1B;ARHGEF5;RMI2;EXO1;RPA2;MBD3;ARHGAP15;CHEK2;ARHGAP11A;BLM;MAPK1;ARHGAP33;AURKA;DAPK2;TIAM1;NET1;AKAP12;EZR;RCN3;TOPBP1;RFC5;RAD9A;ULK4;PML;MAP2K6;PIDD1;AKAP7;PTPN22;ARHGEF18;RBBP8;ARHGDIB;STK11;CHEK1;BRPF1;TAF1;IKBKG;MDM4;ATM;ARHGEF3;TTI1;GPAT3;RBBP4;FAM13A;PDE2A;TRAF3;MOB3B;PIP5K1B;BIRC2;TAF7;PIN1;TAF15;GNAI1;ARHGAP35;MAPK14;RHNO1;ENTPD5;DNA2;PLCG2;HUS1;SOS1;ITGAV;ARHGAP19;EGFR;RPA1;GMIP;PEX5L;RFC2;PDPK1;HIPK2;KAT6A;RIT2;RHOU;STARD8;EHMT1;ARHGAP39;ARHGAP30;TAF6;XIAP;MLST8;TTC5;CRK;MTA2;PTEN;FGD3;TOP3A;ARHGAP9;RAC2;ING2;ARHGAP45;ING5;PRKAG2;TAF2;SGMS1;RPA3;ARHGAP26;STK4;TP53;RAD50;ARHGAP31;BCR
prerank,nuclear export (GO:0051168),0.5476834357373996,1.2883292741215555,0.10253807106598985,0.8469464846599326,1.0,33/80,20.21%,ANKLE1;XPO1;POM121;DHX38;CCHCR1;NUP42;WASHC4;U2AF1;DESI1;EIF4A3;NUP214;SRSF3;SRSF4;NCBP1;CASC3;RNPS1;U2AF1L4;NUP188;THOC3;UPF3B;THOC5;THOC2;XPO4;SRSF7;THOC7;CDC40;DDX39B;POLDIP3;MALT1;HNRNPA1;NCBP2;SRSF2;TPR
prerank,peptide catabolic process (GO:0043171),-0.3983134550904237,-1.288023090048293,0.13872832369942195,0.6635413607496455,1.0,7/23,10.34%,XPNPEP1;CPQ;NPEPPS;ANPEP;IDE;ECE1;GGT5
prerank,positive regulation of organelle assembly (GO:1902117),0.5607935020206626,1.2876119900224319,0.1611170784103115,0.8483761933625871,1.0,16/44,20.49%,SPAG5;GPSM2;CCDC88A;ARHGAP35;DYNC1H1;FUZ;TAPT1;NUMA1;BBS4;CNOT1;CNOT6;MARK4;PIP4K2A;G3BP1;PLK4;CROCC
prerank,positive regulation of cellular senescence (GO:2000774),0.6893273878340316,1.2872376537768038,0.18758815232722145,0.8484200176673203,1.0,5/10,16.94%,HMGA1;CGAS;CDKN2A;B2M;SIRT1
prerank,regulation of microtubule nucleation (GO:0010968),0.6791991387670104,1.285965396513895,0.18876080691642652,0.8523363719881291,1.0,5/10,22.05%,CKAP5;MECP2;ARHGEF7;EML2;DCTN1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5139428706416008,-1.2856565954722272,0.1695501730103806,0.6670405098069583,1.0,3/11,12.48%,MERTK;SELENOS;AXL
prerank,termination of RNA polymerase II transcription (GO:0006369),0.5764567880242026,1.2854291490068495,0.17836593785960875,0.8531379237520874,1.0,17/33,21.82%,SLBP;SNRPF;CPSF2;SETX;NCBP1;CSTF3;SCAF8;SNRPG;PCF11;CPSF1;CLP1;TTF2;NCBP2;SNRPB;CPSF7;WDR33;PAPOLA
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5919817562089883,1.285105213001324,0.1906474820143885,0.8513790351385797,1.0,9/23,19.40%,PMAIP1;E2F1;YWHAH;TFDP1;TFDP2;PPP3CC;TP53;YWHAE;CASP8
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5919817562089883,1.285105213001324,0.1906474820143885,0.8513790351385797,1.0,9/23,19.40%,PMAIP1;E2F1;YWHAH;TFDP1;TFDP2;PPP3CC;TP53;YWHAE;CASP8
prerank,double-strand break repair via break-induced replication (GO:0000727),0.6561218699462555,1.2844635401960212,0.2094017094017094,0.8526287219817029,1.0,4/12,16.32%,CDC45;MCM6;CDC7;MCM3
prerank,axon development (GO:0061564),-0.30103022765750376,-1.2843312546901529,0.09523809523809523,0.6677146135796618,1.0,31/78,24.11%,RTN4;PAK3;APP;ANK3;PLP1;ZDHHC17;CAMSAP2;DSCAML1;NTNG1;RYK;S100B;BAIAP2;MAP1A;CDK5R1;CTNNA2;ACTB;CDK5;GAP43;L1CAM;MAP1S;LLGL1;ADGRB1;SVBP;MAPK8IP3;RAB3A;AFG3L2;PARD3;SLITRK4;BRSK2;DCC;ATL1
prerank,regulation of neuron migration (GO:2001222),0.5991542757892625,1.2838616736794883,0.18906064209274673,0.8536223680883176,1.0,2/26,3.78%,KIF20B;ULK4
prerank,cilium-dependent cell motility (GO:0060285),0.6000235988585071,1.2836522504514192,0.19754601226993865,0.853059060707335,1.0,2/22,8.10%,DNAH8;CFAP44
prerank,negative regulation of proteolysis (GO:0045861),-0.3699815191669147,-1.2834193400411726,0.09734513274336283,0.6671292864144563,1.0,11/34,17.06%,SERPINE2;TIMP2;CAMK2N1;TIMP3;BAG6;CLN8;CDK5;PRNP;DNAJC1;EPHA4;CST7
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.39584481286295736,-1.2824544892174248,0.15333333333333332,0.6668141813163193,1.0,8/27,12.14%,RIMS1;RIMS2;SYT1;SYT4;VAMP2;SYT7;SYT9;VAMP7
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5710894120877968,1.2818477617262989,0.18047673098751418,0.8592434288233954,1.0,12/31,19.40%,PMAIP1;E2F1;YWHAH;TFDP1;BOK;TFDP2;CHCHD10;PPP3CC;GSK3B;TP53;YWHAE;CASP8
prerank,negative regulation of viral life cycle (GO:1903901),0.6345988230933652,1.2815877787107999,0.21808510638297873,0.8587828013960095,1.0,7/15,14.46%,SNX3;GSN;LY6E;TRIM11;IFITM3;PPIA;TRIM5
prerank,primary alcohol metabolic process (GO:0034308),0.5897171901310191,1.2813473659667323,0.17696969696969697,0.8582149308649645,1.0,5/25,14.52%,LRAT;CYP1B1;NAPEPLD;RDH10;GPD2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.44494007097156907,-1.2803557851493024,0.1596958174904943,0.6698106291997556,1.0,8/15,13.79%,SRPRA;SPCS2;ZFAND2A;RAB3GAP2;RYR2;SEC61G;SEC61A1;SRPRB
prerank,response to UV-B (GO:0010224),0.6534790826595698,1.280055066972807,0.2,0.8620636593626346,1.0,2/12,4.80%,IL12A;STK11
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5028515610935396,-1.279651344434755,0.19931271477663232,0.6687542326811745,1.0,5/11,9.11%,EGLN1;OGFOD1;P4HA1;P3H2;EGLN3
prerank,regulation of cellular localization (GO:0060341),0.5491731932179941,1.2788631370448411,0.16286644951140064,0.8657088995047805,1.0,7/46,7.64%,BLK;FOXA2;SPAG5;MAD1L1;NR1D1;GSN;DYNC1H1
prerank,carboxylic acid transport (GO:0046942),0.5586695210432184,1.278542210107701,0.14528101802757157,0.8655331576817755,1.0,6/55,7.49%,SLC6A12;SLC38A5;SLC1A5;SLC7A1;SLC16A12;SLC16A1
prerank,organelle assembly (GO:0070925),0.5294917466526041,1.2774430651284776,0.014,0.8687428742072267,1.0,96/384,17.24%,CENPF;CENPE;DLGAP5;CENPA;TMOD4;NEK2;KIF24;CENPW;EMC6;ANLN;TUBGCP6;RCC1;IFT80;EXOC2;ATG13;POC1B;PCNT;FLNA;EIF2S1;EIF2A;HAUS5;WDPCP;HAUS6;CEP83;EXOC4;TUBGCP4;BBIP1;CEP89;RAB1B;GSN;WDR90;DISC1;SSX2IP;ARF4;HDAC6;CSDE1;MAPRE3;NOTCH1;MRPL22;DYNC1H1;FUZ;RP2;OFD1;PTPDC1;RAB8A;CEP250;CFAP44;DBNL;UBQLN1;TMEM237;CYS1;FLII;EDC3;ABLIM3;PCM1;PDE6D;RFX2;TMEM41B;HAUS4;CCDC28B;CEP162;BECN1;AMBRA1;ABCC4;RAB8B;CCDC57;HAUS7;DHX29;SCLT1;RAB43;TUBGCP3;CCDC61;ARL13B;CHMP1B;BBS4;LSM14A;PIBF1;PRRC2C;EXOC5;TP53INP2;MKS1;DYNLL1;RC3H1;LIMD1;ATG101;HGS;DYNLT2B;UBAP2L;PARVA;IFT172;ATG2B;CHMP3;ATP6V0D1;IFT140;BBS9;CHMP2B
prerank,peptidyl-serine modification (GO:0018209),0.5244787701253388,1.2774248370355488,0.05905905905905906,0.8672990992785167,1.0,42/166,14.91%,TTK;CDK1;CLSPN;MASTL;PLK1;MAPK1;AURKA;PRKCE;RPS6KA5;MAP4K1;MAPKAPK3;TLK1;TAF1;ATM;CSNK1A1;STK38L;AKT3;PKN2;CSNK1G2;PRKX;MAPK14;PRKCA;PRKACA;STK38;MARK2;MAST2;PDPK1;HIPK2;DYRK1A;VRK1;PRKCB;RPS6KA6;LMTK2;GRK2;ROCK2;PRKDC;LATS1;STK39;CDC7;GSK3B;SGK3;STK4
prerank,response to unfolded protein (GO:0006986),-0.33311501092057755,-1.2767553842680985,0.1111111111111111,0.6736732691218763,1.0,14/48,19.83%,HSP90AA1;STT3B;HSPD1;OPTN;ERN1;TM7SF3;TOR1B;HSPH1;ERP44;PRKN;HSPA5;DAB2IP;DNAJC4;HSPA13
prerank,rRNA 3'-end processing (GO:0031125),0.6760895967747658,1.2763721576796931,0.22014388489208633,0.8702884733206647,1.0,4/10,11.85%,ERI2;EXOSC8;EXOSC10;ERI1
prerank,histone methylation (GO:0016571),0.5881751276790851,1.276367321821141,0.17703349282296652,0.8687790479893581,1.0,7/26,13.75%,EZH2;SUV39H1;EHMT1;FBL;NSD3;SIRT7;CREBBP
prerank,regulation of membrane repolarization (GO:0060306),0.6264025519911145,1.2762434009186918,0.22807017543859648,0.8677816835439067,1.0,4/13,17.66%,CAV1;NEDD4L;KCNJ2;YWHAE
prerank,homeostasis of number of cells (GO:0048872),0.6575151512420574,1.2760867408519363,0.2062841530054645,0.8668870928094822,1.0,6/12,16.15%,OCIAD2;NOTCH1;NAPEPLD;CARD9;F2R;UBAP2L
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5664955496840459,1.2758930781297149,0.16083150984682712,0.866230035017001,1.0,16/46,17.49%,KIF14;ITGB7;ATRNL1;ATRN;LAMA5;LAMC1;LAMB2;LAMB3;ITGAV;NTNG2;ITGA8;NRP1;PARVB;RAC1;PARVA;FN1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5006243154963596,-1.2753341426944944,0.1903114186851211,0.6746751374465486,1.0,9/11,41.61%,ITPKB;IP6K1;FGF2;IPMK;IPPK;ITPKC;ITPKA;IP6K2;IP6K3
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4792912125681993,-1.2751789846798842,0.17263843648208468,0.672092255726594,1.0,9/13,51.77%,KCND3;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNA5;KCNE2
prerank,RNA transport (GO:0050658),0.5367198293904736,1.2734777179017822,0.14138286893704852,0.874870960014249,1.0,31/71,20.21%,CKAP5;POM121;DHX38;SLBP;U2AF1;ZFP36L1;EIF4A3;NUP214;SRSF3;HNRNPA2B1;SRSF4;NCBP1;CASC3;RNPS1;U2AF1L4;NUP188;THOC3;UPF3B;THOC5;FLOT1;THOC2;SRSF7;THOC7;CDC40;DDX39B;POLDIP3;HNRNPA1;NCBP2;SRSF2;PNPT1;TPR
prerank,regulation of T cell chemotaxis (GO:0010819),0.6562073066455526,1.2733062807428313,0.225531914893617,0.8740800179598012,1.0,5/11,23.12%,OXSR1;CCR2;STK39;ADAM10;ADAM17
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6457466298767043,1.2730645679796726,0.225531914893617,0.8735516173271018,1.0,2/12,7.90%,IL12A;DCN
prerank,regulation of macrophage cytokine production (GO:0010935),0.6402302552388941,1.2730355818857262,0.20949720670391062,0.8721688977911602,1.0,5/13,16.94%,CD74;GPRC5B;PLCG2;TGFB2;SIRT1
prerank,negative regulation of DNA replication (GO:0008156),0.6449078249842956,1.272610676409698,0.21837549933422104,0.8724254396519698,1.0,5/13,15.66%,S100A11;GMNN;TERF1;CDAN1;WAPL
prerank,endothelial cell proliferation (GO:0001935),-0.4482899741200685,-1.272513739050761,0.13901345291479822,0.6762721083942831,1.0,7/17,19.62%,BMPR2;CD34;ERN1;HMOX1;ACVRL1;DLG1;BMPER
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.4253420008073898,-1.2724603512025034,0.1813953488372093,0.6733609933954434,1.0,5/19,14.52%,HSPD1;TLR7;MAVS;TLR4;CHUK
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6009659472499225,1.2724115970970316,0.19133574007220217,0.8717749669130123,1.0,6/22,14.59%,MASTL;PTPA;PPP1R11;PPP1R15A;ROCK2;GSK3B
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5340193189028817,1.2722886298264742,0.1269191402251791,0.8708112269956296,1.0,18/86,16.38%,TTK;INHBC;MEN1;FBXL15;CCN1;UBE2O;STK11;NOTCH1;JAK2;HIPK2;SMAD4;BMPR1A;ING2;NUMA1;CREBBP;RNF111;BMP3;TGFB2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5402945580986024,1.2722660946636857,0.13963039014373715,0.8694055062276125,1.0,21/73,15.39%,ANP32B;DAP;PDCD2;SENP1;APAF1;PIDD1;S100A9;TNFSF10;S100A8;CASP2;TRADD;BOK;JAK2;IFT57;BCL2L13;FAS;F3;RACK1;CFLAR;CASP9;F2R
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.44270412477218685,-1.271967731313604,0.16279069767441862,0.671759315821625,1.0,5/18,9.15%,RIMS1;RAP1B;RIMS2;PREPL;RAP1A
prerank,regulation of fibrinolysis (GO:0051917),0.6430985583224619,1.2718393928079073,0.2191780821917808,0.8696495440460237,1.0,2/13,3.70%,FAP;USF1
prerank,apical junction assembly (GO:0043297),0.5417996622784833,1.2713695927461046,0.16684266103484688,0.8701911689253806,1.0,6/53,8.93%,ECT2;CLDN18;PECAM1;CTNNA1;PKN2;STRN
prerank,methylguanosine-cap decapping (GO:0110156),0.6577068220853338,1.2713468254537308,0.22562674094707522,0.8687952746608804,1.0,5/10,12.28%,DCPS;DCP1B;DCP2;EDC3;DCP1A
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.5411102475715348,1.2710132560035154,0.12162162162162163,0.868749404914063,1.0,30/73,18.42%,EZH2;POLR1B;SMARCA5;GLMN;PPM1D;DEK;SUZ12;EPC1;CTCF;RBBP4;HDAC6;PHF19;H3-3A;BAZ1B;PHF1;PHF2;POLR1A;MECP2;DNMT1;KAT2B;POLR1F;POLR1C;JARID2;TASOR;POLR2K;TAF1C;TDG;HDAC4;TAF1D;POLR1G
prerank,zymogen activation (GO:0031638),-0.3499171607386753,-1.2708635465148814,0.11956521739130435,0.6720918319418991,1.0,8/39,11.47%,ASPH;KLK2;KLK3;VSIR;TBC1D10A;MMP14;PLAU;LGMN
prerank,amide transport (GO:0042886),0.5719854226962217,1.2692889600547332,0.22208588957055214,0.8743462629972287,1.0,5/26,11.15%,SLC38A5;ABCA13;SLC14A2;TAP1;SLC19A1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5940231615314935,1.269017455991712,0.21382842509603073,0.8740515233238957,1.0,12/20,22.08%,TNRC6C;TNRC6B;CNOT1;LIMD1;CNOT6;AGO2;HELZ;CNOT8;EIF6;CNOT7;CELF1;AGO1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.4515171761739426,-1.2677693852239418,0.1674641148325359,0.6776962390732022,1.0,8/17,20.51%,SYNGR1;SNAP47;STX4;STX3;STX2;STX1A;SYNGR2;AP3D1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5603801845563405,1.2676969420254438,0.20653442240373396,0.8780259123230657,1.0,15/31,23.13%,LSM6;DCPS;EXOSC8;DCP1B;DCP2;LSM2;EDC3;LSM5;DCP1A;LSM7;CNOT6;CNOT8;CNOT7;DIS3;LSM3
prerank,vesicle transport along microtubule (GO:0047496),0.595648849179082,1.2673409370809678,0.20072115384615385,0.8780473287494657,1.0,10/23,19.28%,NDE1;FBXW11;DYNC1H1;PAFAH1B1;KIF13A;HAP1;KIFAP3;FYCO1;CLN3;TRAK2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5698299186224165,1.2658477967014217,0.20278099652375434,0.8827577804062492,1.0,12/31,21.35%,MEN1;RIOX1;TWIST1;CDK6;NOTCH1;SKI;LIMD1;TRPM4;SUFU;CRIM1;SOX9;NBR1
prerank,protein localization to mitochondrion (GO:0070585),-0.5205714897171106,-1.2658018732713756,0.22262773722627738,0.6803270837650263,1.0,5/11,19.58%,HK2;RALA;PINK1;MAIP1;COX18
prerank,negative regulation of catabolic process (GO:0009895),0.5527732402989037,1.264553214874913,0.16268980477223427,0.8867491239519969,1.0,7/47,9.19%,MAD2L1;FLNA;AZIN1;SNX3;MDM4;PIN1;EGFR
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6302915712934917,1.264058921067258,0.2222222222222222,0.8873815397794427,1.0,8/14,18.78%,HNRNPC;BOLL;ELAVL4;MAPK14;HNRNPA0;MYD88;ANGEL2;ELAVL1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.606825416366676,1.2636234409584561,0.20828258221680876,0.8877457938436678,1.0,7/22,19.36%,IL12A;CYRIB;B2M;MAP3K7;MALT1;CD55;TRAF6
prerank,actin filament polymerization (GO:0030041),0.5834101422848089,1.2632456060310797,0.19030732860520094,0.8878128883865867,1.0,3/29,8.54%,DIAPH3;GSN;JAK2
prerank,oligosaccharide metabolic process (GO:0009311),-0.33771449522402347,-1.26299536319066,0.12658227848101267,0.6854369031926181,1.0,18/46,23.55%,MANBA;ST8SIA1;MAN2B1;ST3GAL6;ST6GALNAC4;ST6GAL2;ST6GALNAC6;ST3GAL4;MAN2C1;ST8SIA5;MAN2B2;GLA;ST6GALNAC3;ST8SIA3;MAN1B1;GAL3ST4;B3GALT5;B3GALT2
prerank,negative regulation of protein metabolic process (GO:0051248),0.5456437906655702,1.2626755322872956,0.17475728155339806,0.888741823653241,1.0,11/48,9.92%,MAD2L1;IAPP;FLNA;AZIN1;SNX3;MDM4;PIN1;ITGAV;VBP1;EGFR;PFDN5
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.592156305315321,1.261980660290193,0.21142162818955043,0.8902166838648143,1.0,5/21,9.87%,MASTL;PTPA;PPP1R11;PPP1R8;PPP1R15A
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5133508271128775,-1.2617895558083774,0.2079207920792079,0.6857761855348344,1.0,2/10,2.30%,SALL1;BASP1
prerank,negative regulation of binding (GO:0051100),0.5301973128096655,1.2615087717254954,0.1522633744855967,0.8907821255328023,1.0,27/81,19.04%,AURKB;LEF1;E2F1;AURKA;DDX11;RSF1;ZFPM1;SLPI;SP100;CAV1;DISC1;PIN1;JAK2;PARK7;SUMO1;JUN;RACK1;TFIP11;GSK3B;WAPL;TFAP4;STYX;PEX14;PPP1CA;LRRK2;GNL3L;CDKN1A
prerank,neuromuscular process (GO:0050905),0.6243770741565465,1.261230205163355,0.21092757306226176,0.8904065320540607,1.0,7/16,22.05%,AGTPBP1;KCNA1;PAFAH1B1;TIFAB;CLN3;NRXN1;DCTN1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5082208475733738,-1.2610082294451397,0.20205479452054795,0.685157047621577,1.0,7/11,23.65%,KMT2D;CTR9;SETD1B;PRDM9;TET2;OGT;BEND3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6523690144302118,1.2602690692605467,0.22988505747126436,0.8928975940160027,1.0,7/10,19.42%,CCT7;CCT2;TCP1;CCT5;DKC1;WRAP53;CCT6A
prerank,histone acetylation (GO:0016573),0.5381473445548852,1.2596277011442536,0.15583075335397317,0.894140848128583,1.0,26/69,18.55%,JADE1;NAA40;BRCA2;LEF1;EPC1;BRD8;BRD1;BRPF1;YEATS4;KAT6A;RUVBL2;RUVBL1;TAF6;BRPF3;KAT2B;HAT1;ING3;ING5;CREBBP;TADA2A;TADA3;YEATS2;TAF9;MAP3K7;PHF20;PHF20L1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5820257035547355,1.2593860708160505,0.2091020910209102,0.8921930306849433,1.0,7/23,14.62%,MEN1;STK11;HIPK2;SMAD4;ING2;CREBBP;RNF111
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5820257035547355,1.2593860708160505,0.2091020910209102,0.8921930306849433,1.0,7/23,14.62%,MEN1;STK11;HIPK2;SMAD4;ING2;CREBBP;RNF111
prerank,positive regulation of macroautophagy (GO:0016239),-0.32094622281899926,-1.2592835929432362,0.07462686567164178,0.6872343718183669,1.0,16/48,19.07%,WAC;SCOC;SPTLC1;PIP4K2B;PRKAA2;OPTN;GNAI3;SH3GLB1;RAB3GAP2;IRGM;PINK1;SESN3;UVRAG;TSC2;ADRB2;VPS13D
prerank,regulation of phosphorylation (GO:0042325),0.5231642539170713,1.258969023507236,0.11883182275931521,0.8925402748869677,1.0,49/120,21.99%,BARD1;CDKN2C;NUP43;POM121;NDC1;CCDC88A;GLMN;ANKLE2;PML;NUP107;CDKN2A;NUP42;CCDC88C;NUP50;PIN1;NUP214;NUP160;ZBTB7A;EGFR;CDKN2D;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;NRP1;PRKAG2;PSEN1;DYNLL1;EGF;SLAMF8;CD24;AAAS;SIRT1;NUP37;FN1;CDKN1A;NUP85;PPP2CA;TPR;ILK;EIF6;PRKAG1;MCM7;ROCK1;IKBKB;CADM4;NUP93
prerank,in utero embryonic development (GO:0001701),0.5865013961705483,1.2589554357260864,0.20308788598574823,0.8911088260677318,1.0,2/25,3.65%,STIL;LIG4
prerank,negative regulation of B cell activation (GO:0050869),0.6023405027839328,1.2582732956097522,0.2128463476070529,0.8924475728700306,1.0,7/21,17.59%,BLK;BANK1;ATM;TNFRSF13B;TYROBP;RC3H1;FCGR2B
prerank,histone H2B ubiquitination (GO:0033523),-0.5199462883145789,-1.258168749661315,0.20774647887323944,0.6874058096180987,1.0,4/10,5.80%,WAC;UBE2E1;CTR9;DTX3L
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5577799738296862,1.2578277035158956,0.1723009814612868,0.8928700308089356,1.0,16/48,16.94%,BRCA1;CHEK2;E2F1;PML;MSH6;PHLDA3;CASP2;ATM;BOK;HIPK2;PRKDC;CASP9;TP53;TMEM109;CRIP1;SIRT1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5683145904700457,1.2577100706177045,0.20498301245753114,0.8918832189024278,1.0,13/35,16.71%,CYP1B1;OCIAD2;CAV1;NOTCH1;JAK2;IL10RA;ADIPOR1;PIGU;EGF;F2R;HGS;JAK3;VHL
prerank,regulation of multicellular organism growth (GO:0040014),-0.45701608958050205,-1.2562114798371284,0.19433198380566802,0.6899595355263607,1.0,3/15,7.52%,APP;IGF1;PPIB
prerank,negative regulation of histone modification (GO:0031057),0.624822070491192,1.2560931697158102,0.21756756756756757,0.8971965128991999,1.0,5/14,17.91%,BRCA1;TWIST1;TAF7;JARID2;SNCA
prerank,positive regulation of protein sumoylation (GO:0033235),0.6547754250120205,1.2552571201119775,0.25107604017216645,0.899339476115017,1.0,5/10,17.98%,SAE1;UBA2;PIAS3;PIAS1;HDAC4
prerank,mRNA metabolic process (GO:0016071),0.5240139533872298,1.255196383558325,0.1299897645854657,0.898134108609406,1.0,38/90,20.20%,SLFN14;LSM6;AURKAIP1;SCAF11;SLBP;SNRPF;U2AF1;DCP2;HNRNPA2B1;PRKACA;SRSF4;NCBP1;LSM2;NONO;CSTF3;PCBP2;HNRNPA0;LSM5;METTL16;KIN;PRMT9;HNRNPR;DXO;PCBP3;TP53;ZFP36L2;SRSF7;TCERG1;SNRPG;PCF11;PRPF8;ALKBH5;HIPK3;NCBP2;SRSF2;SF3A2;SNRPB;PNPT1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.5180991965803142,1.2546136586697774,0.004,0.8990705134651577,1.0,152/497,21.30%,CENPF;DEPDC1;BIRC5;FOXM1;GFI1;MYB;HMGB2;EZH2;RCOR2;MEN1;SUV39H1;BRCA1;SMARCC2;HMGA1;DAP;HEY2;RBM15;DEAF1;LEF1;E2F1;RB1;RIOX1;RSF1;CBX5;CD38;S100A11;TWIST1;PML;BCL7A;FBXW11;TIMELESS;PA2G4;HDAC10;UBE2I;MTA3;RPS6KA5;EPC1;CTCF;SCMH1;FOXP1;DACH1;CDKN2A;NR1D1;NKAP;MBD2;FOXO1;PBXIP1;MBD1;ARID4A;GMNN;HDAC6;KLF10;TAF7;NOTCH1;XRCC6;EIF4A3;AHR;SFMBT1;SPEN;SAP18;PSPC1;SMARCA4;CIR1;CIPC;ZBTB16;TERF1;ZBTB7A;NONO;ZNF148;MECP2;PFDN5;TFDP2;CPEB3;NR2F2;KAT6A;ID4;ZEB1;TRIM33;EHMT1;ARID5B;SUMO1;SMAD4;CCAR2;TYMS;JUN;ATF5;PLCB1;IGF2BP3;CDAN1;FOXP2;BAP1;SETDB2;ZBTB33;FXR1;SP3;RACK1;NIPBL;DDIT3;LSM14A;BCL6;GSK3B;CNOT1;YEATS2;LIMS1;ATF7IP;TP53;LIMD1;POU2F1;JARID2;WAPL;SIN3A;TCF7L2;SAMD4A;TFAP4;FOXK2;TRIM28;SIRT1;GCFC2;PEX14;EPRS1;HEXIM1;MBTD1;HDAC4;FOXE1;DPF2;EIF4ENIF1;PROX1;HDAC1;BRD7;CDKN1A;RPS3;PAX2;TRAF6;SOX9;ZHX3;ZBTB18;DAPK1;CNOT8;RBPJ;SYNCRIP;PHF10;PPARD;SMAD2;CNOT7;CITED2;GATAD2A;KCTD1;MDM2;GAPDH;PDS5A;CBFA2T3;USP47
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3826745984293719,-1.2542773562010547,0.1871345029239766,0.6927615974604369,1.0,7/25,12.16%,CTSS;ANK3;ANK2;DMD;COX17;ATP1B2;ATP1B1
prerank,histone modification (GO:0016570),0.520927899176483,1.2541486632073628,0.12701612903225806,0.8995840617058676,1.0,33/109,19.37%,AURKB;UHRF1;EZH2;RCOR2;CCNA2;INCENP;HDAC10;MTA3;RPS6KA5;BRD8;HDAC6;EYA3;BAZ1B;SIN3B;KAT6A;RUVBL2;EHMT1;PARK7;RUVBL1;TAF6;NSD3;MTA2;SIRT7;CREBBP;EYA1;SIN3A;USP21;SIRT1;HDAC4;PHF20;PHF20L1;HDAC1;TBL1XR1
prerank,prostanoid biosynthetic process (GO:0046457),-0.47329390022557916,-1.253835110971559,0.17120622568093385,0.6912356022303382,1.0,4/15,5.69%,TBXAS1;DAGLB;PTGS1;PTGDS
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.27314211383913983,-1.2533688251614197,0.0,0.6897097832951968,1.0,44/118,22.50%,TANC2;PAK3;RUFY3;EFNA5;TNIK;LARP4;EGLN1;PPFIA2;HECW1;CTNNB1;RAP2A;KNDC1;TNFAIP3;CLASP2;CDH2;FMNL2;INF2;NF1;CDK5R1;STRIP1;POGLUT1;ARHGAP44;SPARC;FERMT2;CDK5;HMOX1;WTIP;FGF2;ZMYM6;VASH1;EPHA4;ABI2;SHANK3;MYO19;CFL1;BMPER;KIF1A;ZDHHC15;PHLDB2;CAPZB;SH3D19;TSPAN12;CEACAM1;LZTS1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.47774812983947756,-1.253082659694235,0.1796875,0.6876315994319134,1.0,6/13,18.75%,ABCA1;LPL;CDH13;FCER1G;CD36;CD81
prerank,cellular response to interleukin-7 (GO:0098761),0.6189632838782682,1.2526777161011222,0.2176696542893726,0.9029596197035735,1.0,7/17,16.70%,IL2RG;IL7R;SMARCA4;SOCS2;STAT5B;IRS1;JAK3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6189632838782682,1.2526777161011222,0.2176696542893726,0.9029596197035735,1.0,7/17,16.70%,IL2RG;IL7R;SMARCA4;SOCS2;STAT5B;IRS1;JAK3
prerank,cytoplasmic translation (GO:0002181),0.5189745027226922,1.252597164379006,0.13936927772126145,0.9018549073212064,1.0,45/91,22.85%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;RPL28;RPS14;RPL41;RPS27;RPS5;RPS29;RPLP0;RPS11;TMA7;RPL27A;RPS9;RPS15A;RPL12;RPL22L1;ZC3H15;RPL3;GSPT1;UBA52;RPL18;DRG1;RPL5;RPS6;RPS17;RPS3;RPL21;RPL17;RPL23;RPL24;RPL8;RPL27;RPL13A;RPS12;RPS8;RPL15;RPL10
prerank,regulation of cellular response to stress (GO:0080135),0.518647571979758,1.2520152113621605,0.1122345803842265,0.90288010960323,1.0,46/115,20.21%,RPA2;NUP43;MAPK1;POM121;NDC1;NUP107;CRHBP;ABCD1;NUP42;MBTPS2;ARMT1;ATM;NUP50;NUP214;NUP160;NUP205;RPA1;SEC13;AMFR;NUP188;CCAR2;MLST8;NUP98;RANBP2;NUP210;ROCK2;ING2;CREBBP;DNAJC7;BAG1;BAG3;CASP9;RPA3;GSK3B;DNAJC2;AAAS;SIRT1;DNAJB1;NUP37;ADCY8;YWHAE;CLN3;NUP85;NPAS2;PNPT1;TPR
prerank,kidney development (GO:0001822),0.5338898812524878,1.251951105358458,0.15287958115183245,0.9016958280914078,1.0,5/65,8.28%,CENPF;LRP4;SULF2;PRKX;ZBTB16
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6503133793306595,1.2517845304450441,0.23583662714097497,0.8994931135380568,1.0,5/11,21.45%,IL2RG;IL2RA;STAT5B;JAK3;SYK
prerank,cellular response to interleukin-2 (GO:0071352),0.6503133793306595,1.2517845304450441,0.23583662714097497,0.8994931135380568,1.0,5/11,21.45%,IL2RG;IL2RA;STAT5B;JAK3;SYK
prerank,cilium movement (GO:0003341),0.5480001220038494,1.2516797012532337,0.18642241379310345,0.8985206723494433,1.0,5/47,10.61%,CCDC63;SPA17;CFAP206;SPEF2;CFAP73
prerank,positive regulation of chromatin organization (GO:1905269),0.6490065397885535,1.2516032418124334,0.23505434782608695,0.8973641036917562,1.0,8/12,24.79%,TERF2;H3-3A;TERF1;SIN3A;ATRX;UBE2N;MIER1;TINF2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6405117716425379,1.2505966459156324,0.24929577464788732,0.9001605660860017,1.0,3/11,11.59%,BLK;PRKCA;RDX
prerank,cellular response to pH (GO:0071467),-0.4244436156114234,-1.250409467069041,0.15763546798029557,0.6926288404182688,1.0,8/17,22.73%,IMPACT;MCOLN1;SLC9A1;RAB11FIP5;GPLD1;HYAL1;PKD2L1;CHP1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.45538414211105716,-1.2484277935823833,0.17120622568093385,0.695442985561403,1.0,7/14,25.03%,UPP2;NT5M;DPYD;UMPS;NT5C;DHODH;NT5E
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6363172116821604,1.2475482063946794,0.22877697841726619,0.9114446152699561,1.0,4/11,13.69%,CAV1;NEDD4L;ACTN2;STK39
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6388697165280413,1.2473967621676767,0.2402088772845953,0.9107048440630082,1.0,5/14,14.31%,DHX58;PUM2;PUM1;TLR5;USP15
prerank,positive regulation of cell junction assembly (GO:1901890),-0.30564978225505557,-1.246740106207051,0.043478260869565216,0.6973744654856445,1.0,19/56,20.72%,CNTNAP2;PTPRD;SYNDIG1;PTPRJ;IL1RAP;CLSTN3;LRRC4B;CLSTN1;TSC1;CUX2;FERMT2;PPM1F;NPHP1;VEGFA;MAP4K4;COL16A1;THY1;CLSTN2;AGT
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5269245485598145,1.2465498411656253,0.18723849372384938,0.9127482567740398,1.0,17/59,15.76%,CDK1;CIT;MAPK1;OXSR1;CHEK1;TAF1;PRKCA;MARK2;PDPK1;HIPK2;DYRK1A;LMTK2;ROCK2;PRKDC;STK39;GSK3B;MAP2K1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5351647836755093,1.246282038455408,0.18401682439537329,0.9124378949751415,1.0,17/55,20.98%,FOXM1;CYP1B1;BRCA1;DCXR;ARF4;MAPK14;GRB2;DHRS4;RAC2;MPV17;TP53;RAC1;SNCA;CDKN1A;PAX2;EIF6;RIPK1
prerank,macrophage activation (GO:0042116),-0.3615420127176641,-1.2461385460835859,0.1568627450980392,0.6963045141274014,1.0,9/34,10.10%,APP;TREM2;ITGAM;SBNO2;AIF1;C1QA;TLR4;NMI;C5AR1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3822756755934512,-1.245258846213358,0.1357142857142857,0.6958653856833453,1.0,9/27,20.77%,ABCA1;ABCA5;LPL;ITGB3;IL18;CSF1;CD36;AGT;NFKBIA
prerank,positive regulation of developmental growth (GO:0048639),-0.3141544307266275,-1.2450999004260679,0.0945945945945946,0.6935034729292517,1.0,11/49,10.35%,RIMS1;RUFY3;RIMS2;MACF1;MAP3K13;SYT1;PPIB;LIMK1;PLAA;SYT4;GOLGA4
prerank,epithelial cell differentiation (GO:0030855),0.5259783768690236,1.2450181019303452,0.14634146341463414,0.9163151974293138,1.0,5/88,5.60%,E2F7;CDK1;E2F8;PCNA;EDF1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4247622737609403,-1.2444405434833101,0.17346938775510204,0.6924810478984949,1.0,8/19,16.26%,HS6ST3;NDST3;B3GAT3;EXT2;HS6ST2;EXTL3;XYLT2;HS3ST5
prerank,eosinophil migration (GO:0072677),-0.46550416662012156,-1.2443272896053281,0.18503937007874016,0.6871754101047425,1.0,5/14,33.03%,CCL4;CCL3;CCL13;CCL2;CCL5
prerank,eosinophil chemotaxis (GO:0048245),-0.46550416662012156,-1.2443272896053281,0.18503937007874016,0.6871754101047425,1.0,5/14,33.03%,CCL4;CCL3;CCL13;CCL2;CCL5
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.44240196351758543,-1.243556938134995,0.2,0.6865505627703486,1.0,11/16,31.41%,CACNA1C;ANK2;DMD;RYR2;CALM1;SLC8A1;ATP1A2;GSTO1;FKBP1B;CAMK2D;CALM2
prerank,heme biosynthetic process (GO:0006783),0.588972222239726,1.2432912848426372,0.22721749696233293,0.9219500519759593,1.0,13/22,28.48%,ALAS2;ABCB10;TSPO;NFE2L1;COX10;PPOX;UROS;FXN;CPOX;PGRMC1;COX15;ALAS1;ATP5IF1
prerank,wound healing (GO:0042060),-0.32399089937813963,-1.2425368054255292,0.20512820512820512,0.6866772814156501,1.0,18/62,15.81%,DST;TGFBR1;MACF1;SMAD3;AHNAK2;IGF1;FUT10;MYOF;NF1;MIA3;ITGB3;SYT7;SCARB1;EPB41L4B;HMOX1;FGF2;DCBLD2;HPSE
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6001171480877233,1.2425273649718265,0.24378109452736318,0.9237418854478496,1.0,6/18,9.71%,STMN1;RIPOR2;ARHGAP35;TNFAIP1;CUL3;HEG1
prerank,positive regulation of synapse assembly (GO:0051965),-0.3896013982472627,-1.2416577699046873,0.11940298507462686,0.6861622175936489,1.0,9/27,19.26%,PTPRD;SYNDIG1;IL1RAP;CLSTN3;LRRC4B;CLSTN1;CUX2;AGRN;CLSTN2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.5664201762097819,1.2415769749798142,0.22904368358913813,0.9263150174226792,1.0,12/28,22.05%,CKAP5;CDK5RAP2;CLASP1;MECP2;SLAIN2;NUMA1;RAC1;DRG1;RPS3;MET;MAPT;DCTN1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5289751360290793,-1.2413866738399542,0.2255892255892256,0.6842604764813683,1.0,6/10,25.71%,GALNT3;POGLUT1;GALNT1;POGLUT3;GALNT2;MGAT5B
prerank,neutrophil migration (GO:1990266),0.5376097487874839,1.240394685443383,0.19788359788359788,0.9298914549018307,1.0,5/58,5.77%,PRTN3;CD177;PECAM1;S100A9;S100A8
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5793331615034965,1.2401112900643272,0.2331288343558282,0.929605410403206,1.0,7/23,15.38%,PLK1;MAPK1;AXIN1;UBE2K;S1PR2;PRKAG2;EGF
prerank,intracellular cholesterol transport (GO:0032367),-0.4375876689031848,-1.2399079798468016,0.18875502008032127,0.6858220386626981,1.0,6/15,15.80%,OSBPL2;ABCA1;OSBP;NPC2;NPC1;SERAC1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6187290421167068,1.239415915294256,0.2193211488250653,0.9311189127266473,1.0,4/15,12.37%,NTF4;GRB2;SOS1;HAP1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.52496050916705,1.239034817635706,0.17823834196891192,0.9312626573575177,1.0,19/72,19.12%,SHCBP1;MAPK1;POLR2I;POLR2A;FLRT2;HNRNPM;SETX;GRB2;NCBP1;FGF9;SPRED2;CEP57;FGFR1;FIBP;POLR2K;POLR2J;KIF16B;HNRNPA1;NCBP2
prerank,transepithelial transport (GO:0070633),-0.442522961646561,-1.2388072961992165,0.17083333333333334,0.6861766103305506,1.0,11/15,36.85%,SLC12A2;SLC1A2;ABCC1;SLC1A3;CXADR;GPLD1;SLC1A1;SLC26A6;SLC23A1;SLC23A2;BEST1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5895430443365022,1.2386405717253623,0.23067331670822944,0.9314087884861793,1.0,4/21,10.14%,CHST3;CSGALNACT2;DCN;CHST12
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.48533223130997416,-1.2377791424141398,0.22181818181818183,0.6866949616212052,1.0,5/12,13.40%,RIMS1;RIMS2;SYT1;SYT7;UNC13A
prerank,apoptotic cell clearance (GO:0043277),-0.3580357070823438,-1.2377387045416588,0.15384615384615385,0.6841395870110005,1.0,14/30,19.94%,TREM2;LRP1;RHOBTB1;XKR6;RHOBTB2;ITGB3;SCARB1;RHOG;TGM2;RHOH;RARA;THBS1;ADGRB1;XKR4
prerank,positive regulation of neuron differentiation (GO:0045666),0.5408716863494404,1.2375249599298364,0.20655737704918034,0.9345805798094149,1.0,10/40,16.04%,ECT2;GPRC5B;MMD2;TCF3;MMD;ZEB1;NRCAM;SIN3A;TCF4;FGFR1
prerank,histone H3-K9 demethylation (GO:0033169),-0.5015107327847097,-1.2374046330630974,0.27586206896551724,0.6824542455711667,1.0,5/11,6.81%,KDM1A;KDM7A;KDM4A;PHF8;KDM4B
prerank,positive regulation of secretion (GO:0051047),0.6438843957107602,1.2371404914227209,0.27310924369747897,0.9346715128164182,1.0,1/11,1.86%,AQP1
prerank,microtubule bundle formation (GO:0001578),0.5450123349901371,1.236731494082024,0.21139101861993428,0.9349147586186974,1.0,5/42,5.95%,KIF20A;PLK1;CDK5RAP2;CFAP206;CLASP1
prerank,negative regulation of axonogenesis (GO:0050771),-0.36835097597419686,-1.2366543187593737,0.15172413793103448,0.6817580940745266,1.0,15/27,25.53%,RTN4;RUFY3;DIP2B;GDI1;PTPRS;MAG;ULK1;EFNB3;THY1;CDKL3;ULK2;MT3;MCF2;DCC;OMG
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5455999810866484,1.2364378810668921,0.2022099447513812,0.9346620761938185,1.0,12/40,13.59%,XPO1;GLMN;PML;AXIN1;RPS7;TAF1;DESI1;HIPK2;RAD23A;PTEN;CDK5RAP3;LATS1
prerank,hepaticobiliary system development (GO:0061008),0.5963510920518267,1.2362943177101695,0.24405506883604505,0.9338059250506414,1.0,12/20,20.79%,PHF2;ARID5B;CDK5RAP3;NIPBL;CEBPG;PRKCSH;XBP1;NKX2-8;PROX1;PKD2;MET;CITED2
prerank,positive regulation of apoptotic process (GO:0043065),0.5115103355253207,1.2357206613669298,0.05,0.9346695744209003,1.0,68/293,18.18%,TOP2A;ECT2;USP27X;BARD1;CYP1B1;ARHGEF5;PMAIP1;IAPP;E2F1;PDCD2;DAPK2;FAP;TIAM1;NET1;PTPA;APAF1;PIDD1;TFPT;TNFSF10;ARHGEF18;PHLDA3;FOXO1;CASP2;FAF1;ATM;ARHGEF3;TRADD;MAP3K5;UBE2Z;HMGB1;BOK;SAP18;TNFAIP8;SOS1;RNPS1;ERCC3;PRR7;PAWR;MAP3K11;MELK;ATF6;CCAR2;JUN;FAS;FGD3;RACK1;ING3;ING5;DDIT3;LATS1;BCL6;PSEN1;CASP9;STK4;TP53;MAP3K20;TFAP4;TGFB2;NLRP2B;SIRT1;ANO6;ARL6IP5;PNMA2;UBA52;SNCA;STK17B;RARG;ARHGEF7
prerank,sensory organ development (GO:0007423),0.5326216813660063,1.234538698334979,0.20300751879699247,0.9382573725685697,1.0,11/51,16.38%,NTF4;SMCHD1;PBX4;PBX3;SHROOM2;SALL2;HIPK2;ATF6;SMG9;PBX2;TGFB2
prerank,transition metal ion homeostasis (GO:0055076),0.5676063577366812,1.2344740599689976,0.22979214780600463,0.9370729687313046,1.0,6/28,11.30%,TFR2;CUTC;HEPH;CYBRD1;B2M;XIAP
prerank,mononuclear cell differentiation (GO:1903131),0.5684675486526269,1.2342133736376324,0.24186046511627907,0.9367699046033585,1.0,2/24,1.15%,BLK;LY6D
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.622992059336253,1.2341948344177456,0.2398921832884097,0.9353860309935885,1.0,4/13,10.75%,BARD1;SP100;RANGAP1;PARK7
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.585864992682207,1.2341329807041441,0.23493975903614459,0.9342045950583184,1.0,3/22,2.74%,TNFRSF18;FANCA;IL2RA
prerank,negative regulation of cell cycle (GO:0045786),0.5242848420033004,1.2340090909872714,0.19111570247933884,0.9332399843113844,1.0,20/73,17.78%,MAD2L1;MEN1;PLK1;RB1;NPPC;CDK6;CDKN2A;GMNN;RUNX3;HPGD;NR2F2;IPO7;TAF6;PTEN;LATS1;IPO5;ANGEL2;TFAP4;NLRP2B;HEXIM1
prerank,negative regulation of secretion (GO:0051048),0.6405215464237992,1.233351511616877,0.24504249291784702,0.9344833051133775,1.0,4/10,15.38%,ERBB3;CD74;TIFAB;EGF
prerank,retinoic acid metabolic process (GO:0042573),-0.4719922105106054,-1.2330692236104948,0.23809523809523808,0.6893781307269395,1.0,10/14,49.74%,BCO2;ALDH1A2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1
prerank,positive regulation of cell aging (GO:0090343),0.6509969308157585,1.2329741576822786,0.24585635359116023,0.9346852152400451,1.0,5/11,16.94%,HMGA1;CGAS;CDKN2A;B2M;SIRT1
prerank,thyroid hormone generation (GO:0006590),0.6521591290274372,1.2329487244946955,0.24861111111111112,0.9333581866233223,1.0,3/10,18.19%,SLC5A5;CTSK;FOXE1
prerank,negative regulation of cartilage development (GO:0061037),0.6306052813042433,1.2328947765275318,0.2574931880108992,0.932162629840331,1.0,2/13,5.66%,ADAMTS7;PTHLH
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6426663162597404,1.2328424613420728,0.2621502209131075,0.9309389405219635,1.0,3/10,11.60%,FAP;NOTCH1;DPP4
prerank,cilium assembly (GO:0060271),0.5126051538410391,1.232751414300317,0.039,0.9298846574826035,1.0,92/296,18.70%,CDK1;NEK2;KIF24;CKAP5;PLK1;CDK5RAP2;IFT80;EXOC2;CEP152;NDE1;POC1B;PCNT;CFAP206;FLNA;HAUS5;WDPCP;HAUS6;CEP83;CEP192;EXOC4;TNPO1;BBIP1;TUBB4B;ODF2;CEP89;GSN;CLASP1;WDR90;DISC1;CEP72;SSX2IP;ARF4;HDAC6;CEP76;NOTCH1;DYNC1H1;ALMS1;FUZ;RP2;OFD1;PTPDC1;RAB8A;CEP250;CFAP44;PRKACA;NEDD1;GORAB;CEP70;TMEM237;CYS1;TBC1D32;ABLIM3;NINL;PCM1;PDE6D;RFX2;PAFAH1B1;HAUS4;CCDC28B;TUBB;CEP162;IFT57;ABCC4;RAB8B;CCDC57;HAUS7;SCLT1;ARL13B;BBS4;PIBF1;EXOC5;MKS1;CNTRL;DYNLL1;CEP57;KIFAP3;DYNLT2B;SDCCAG8;MARK4;PARVA;IFT172;ATP6V0D1;IFT140;BBS9;C2CD3;YWHAE;HAUS3;TXNDC15;ATAT1;FAM161A;BBOF1;CEP63
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5165914358514617,1.2322357550325667,0.14343434343434344,0.9305992977669172,1.0,42/108,21.45%,PMAIP1;ANP32B;DAP;PDCD2;SENP1;APAF1;PIDD1;S100A9;TNFSF10;S100A8;CASP2;GSN;TRADD;MAP3K5;HMGB1;BOK;JAK2;PRR7;CARD9;IFT57;BCL2L13;FAS;FIS1;F3;RACK1;UACA;MYC;CFLAR;CASP9;F2R;SIRT1;ARL6IP5;SNCA;MALT1;RPS3;GRAMD4;LGALS9;CASP8;DAPK1;RIPK1;MAPT;SYK
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6339595082424245,1.2318967138251857,0.2767732962447844,0.9305960948848565,1.0,3/12,10.74%,RASGRP1;PAEP;CARD9
prerank,protein import into peroxisome membrane (GO:0045046),0.5824373941298838,1.231083741508038,0.24058323207776428,0.9326788968251123,1.0,9/22,12.03%,PEX26;ABCD1;ACBD5;PEX11B;PXMP4;GDAP1;PEX2;RAB8B;FIS1
prerank,regulation of epithelial cell migration (GO:0010632),-0.3142893749007554,-1.230905649335416,0.13114754098360656,0.6926627172981394,1.0,24/51,22.89%,RTN4;GLUL;MACF1;PTPRG;EVL;RREB1;BMPR2;ENPP2;PFN1;CLASP2;CORO1C;DUSP10;PPM1F;RAB11A;PTK2;PFN2;DAB2IP;MCC;BMPER;PTPN23;CEACAM1;HYAL1;HIF1A;CAPN7
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.565048227260073,1.2302917853393658,0.22018348623853212,0.9345564065775043,1.0,9/27,19.04%,AQP1;E2F1;LIG4;CD74;CDK6;DHX9;MYC;FN1;CDKN1A
prerank,positive regulation of intracellular protein transport (GO:0090316),0.5139843439064848,1.2299378508014884,0.117,0.9345430944656513,1.0,41/144,17.66%,KIF20B;ECT2;GTSE1;PMAIP1;ANP32B;E2F1;C2CD5;ATG13;FYN;PCNT;FLNA;SAE1;YWHAH;TFDP1;UBL5;CIB1;EFCAB7;ABLIM3;TFDP2;PCM1;RHOU;EMD;FIS1;OAZ1;BAP1;RAC2;PSEN1;BAG3;ARIH2;PPP3CC;GSK3B;PDCD10;TP53;RIPOR1;IPO5;TCF7L2;TRIM28;XPO4;TMEM30A;HCLS1;YWHAE
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6039800614079432,1.22987480255609,0.24262734584450402,0.9333643569838141,1.0,1/16,0.73%,IL12A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3441773563679419,-1.2296350738994926,0.1523809523809524,0.6938123462497318,1.0,15/35,28.31%,BMP2K;MKLN1;SNAP91;PPT1;TNK2;PIK3CB;SMAP1;SERPINE1;APOC1;HIP1R;ARF1;AAK1;VTN;PICALM;ARF6
prerank,regulation of glucose import (GO:0046324),-0.36177344899259384,-1.229528650011688,0.17532467532467533,0.6914159297025515,1.0,10/30,15.10%,APPL2;PRKCI;PIK3R1;IGF1;AKT2;IRS2;GSK3A;SELENOS;RHOQ;GRB10
prerank,phospholipid biosynthetic process (GO:0008654),0.5427814346976975,1.2291970986717016,0.22359550561797753,0.9348280039141063,1.0,12/36,18.69%,DHDDS;SGMS2;AGPAT4;PCYT2;NUS1;IDI1;AGPAT3;SGMS1;FDPS;SRD5A3;FAR1;CLN3
prerank,response to thyroid hormone (GO:0097066),-0.45368602174297923,-1.22875169664178,0.24489795918367346,0.6908083518818884,1.0,3/13,0.68%,CTSS;LMO2;CTSB
prerank,cellular response to dsRNA (GO:0071359),0.606014575969122,1.228504019466205,0.2445019404915912,0.9363022238256622,1.0,7/15,17.76%,CGAS;CAV1;PDE12;RIOK3;DHX9;FLOT1;COLEC12
prerank,cellular response to interleukin-12 (GO:0071349),0.5237497104509048,1.2283917101078614,0.20815450643776823,0.9352950238594737,1.0,13/48,16.43%,IL12A;LMNB1;CD47;CNN2;TCP1;HNRNPA2B1;JAK2;MSN;RPLP0;PLCB1;PPIA;PAK2;MTAP
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5102198298373265,1.2282124308349098,0.044,0.9346362170313816,1.0,82/314,17.88%,CCNF;BUB1B;KIF14;CDK1;UBE2C;AURKB;MAD2L1;CCNB1;CDC20;PLK1;FBXL15;SKP2;RB1;AURKA;FBXO5;PSMB7;PSMD11;PML;CDC23;FBXW11;CDC27;PSMF1;TAF1;FAF1;NPLOC4;FBXO44;PSMC1;ANAPC7;FBXO45;BIRC2;SPSB3;UBE2K;UBE4B;NEDD4L;FAF2;DNAJC18;FBXO17;UBQLN1;TNFAIP1;CUL3;PTTG1;PSMC3;PCBP2;DERL2;AMFR;RAD23A;UBR2;PSMA4;SPSB4;TRIM3;FZR1;FBXL4;PSMC4;ARRB2;PCNP;BUB3;NFE2L2;PSMD13;SPOP;PSME1;DDIT3;RHBDD2;DCAF11;ZFAND2B;PSMB1;RBCK1;ARMC8;PSMD8;YOD1;PSME4;DNAJB9;KLHL22;PSMD4;SIRT1;RNF103-CHMP3;UBXN1;RNF4;HSP90B1;UBA52;FAM8A1;SYVN1;FEM1C
prerank,positive regulation of natural killer cell activation (GO:0032816),0.611390209775913,1.2276723874781106,0.25136612021857924,0.935446978524576,1.0,1/13,0.73%,IL12A
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6452850846978059,1.2259979425508667,0.25578231292517006,0.9409455927223229,1.0,5/11,11.88%,EZR;MTMR2;MSN;RDX;EIPR1
prerank,plasma membrane organization (GO:0007009),-0.3012035379676814,-1.2253661605246866,0.057692307692307696,0.6974613587506471,1.0,18/61,15.46%,ABCD2;NSF;ANK3;OSBPL2;STX4;AHNAK2;ANK2;BIN1;STX2;MYOF;BIN3;SYT7;EPB41L3;TLCD2;SERP1;PLSCR4;DEGS1;PACSIN1
prerank,regulation of protein catabolic process (GO:0042176),0.5176791711474867,1.2248930177262456,0.17378048780487804,0.9440468176004578,1.0,16/99,9.19%,MAD2L1;FAM83D;BARD1;CHEK2;DTL;FLNA;AXIN1;AZIN1;SNX3;FOXO1;FAF1;MDM4;STX5;PIN1;NEDD4L;EGFR
prerank,macrophage activation involved in immune response (GO:0002281),-0.46777498728006,-1.2246101588300438,0.20238095238095238,0.6970242793201883,1.0,5/13,7.90%,TREM2;SBNO2;GRN;CX3CR1;NMI
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5579635120398925,1.2245312901215228,0.23286052009456265,0.9441870439447633,1.0,6/25,17.91%,CD19;NPSR1;PDPK1;F2R;PLCG1;SNCA
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.45914116416118866,-1.22394741624669,0.21543408360128619,0.6960602728568519,1.0,3/12,0.68%,CTSS;LMO2;CTSB
prerank,nucleus organization (GO:0006997),0.5295315068941511,1.2237921673796868,0.23010752688172043,0.9458652662502773,1.0,14/47,17.24%,CEP55;NDC1;REEP4;SUN2;RPS19;NUP205;IRAG2;TOR1A;NUP98;CHMP1B;NUMA1;SYNE1;CHMP3;CHMP2B
prerank,cellular response to interleukin-4 (GO:0071353),0.6558489978171008,1.2235661283893207,0.2768115942028985,0.9454108157295674,1.0,3/10,17.05%,LEF1;JAK3;XBP1
prerank,positive regulation of binding (GO:0051099),0.5156667366892502,1.223493582554683,0.18993839835728954,0.9442890285435831,1.0,27/84,15.90%,HMGB2;MEN1;STMN1;DDX11;TIAM1;EPB41;CAV1;EDF1;TAF1;GMNN;PIN1;HMGB1;NCBP1;TXN;HIPK2;AMFR;B2M;DHX9;FLOT1;ADD2;SKI;CEBPG;PSEN1;GSK3B;STK4;EGF;TCF7L2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.457845569872251,-1.2230836794349595,0.20164609053497942,0.6959441776835215,1.0,9/13,37.72%,LTBP1;FSTL1;FBN1;GREM2;CD46;NBL1;CHRDL1;GREM1;BMP2
prerank,response to molecule of bacterial origin (GO:0002237),0.5197295709474427,1.2229915396026112,0.1875,0.9449748437988993,1.0,17/69,17.91%,IL12A;HMGB2;PTPN22;S100A9;MAPKAPK3;SLPI;FOXP1;S100A8;JAK2;CYRIB;HNRNPA0;OTUD5;F2R;TNFRSF11A;CD24;FCGR2B;SNCA
prerank,carbohydrate transport (GO:0008643),0.6339815999718105,1.2227995090097956,0.26264044943820225,0.9443694797973208,1.0,1/11,1.86%,AQP1
prerank,innate immune response in mucosa (GO:0002227),0.6568801609912556,1.222586763815161,0.2503556187766714,0.9438221721858574,1.0,1/10,3.69%,CAMP
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.28625293389522893,-1.2224581422572671,0.043478260869565216,0.6950084557759701,1.0,28/90,18.84%,IGF1R;KDM1A;EBF2;CMKLR1;APPL2;LPIN1;ESRRG;IL4R;ACADL;GNAS;PPARGC1B;MFN2;PRLR;HDAC3;PDGFC;ELOVL6;VEGFA;IL18;EPAS1;GJA1;GRB10;HADH;CD36;ADRB1;KDM3A;PER2;ADRB2;KDM6B
prerank,vasculogenesis (GO:0001570),0.5395825186826303,1.2220462913341628,0.23880597014925373,0.9446326875749369,1.0,5/32,7.15%,HEY2;GLMN;CAV1;CCM2;NOTCH1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.40893709759072483,-1.2219226490822206,0.17857142857142858,0.6937978717806162,1.0,6/19,15.83%,PATJ;PRKCI;ERBIN;DLG2;LRRC7;DLG1
prerank,microtubule anchoring at centrosome (GO:0034454),0.6439875404503866,1.2216465168387163,0.25523012552301255,0.9448384941576601,1.0,4/10,13.42%,NIN;NINL;PCM1;BBS4
prerank,regulation of lipid kinase activity (GO:0043550),0.639518846093579,1.2214660619575846,0.27926657263751764,0.9442089100294178,1.0,3/11,5.70%,RB1;RBL1;PPP2R5A
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5248159872882479,1.2202602453626294,0.21281216069489686,0.9477795551953029,1.0,12/46,16.43%,IL12A;LMNB1;CNN2;TCP1;HNRNPA2B1;JAK2;MSN;RPLP0;PLCB1;PPIA;PAK2;MTAP
prerank,cardiac ventricle development (GO:0003231),0.5856519957338032,1.2202040499885005,0.2728380024360536,0.9466076794583435,1.0,4/20,7.15%,HEY2;MDM4;PDE2A;NOTCH1
prerank,regulation of ERAD pathway (GO:1904292),-0.481126184078304,-1.2200087170163958,0.24920127795527156,0.6963705358363953,1.0,5/11,16.73%,USP19;RNF185;BAG6;ATXN3;TMEM259
prerank,inhibitory synapse assembly (GO:1904862),-0.47745862354454105,-1.2196228274698473,0.20394736842105263,0.6949624505794215,1.0,5/11,14.68%,GABRB3;GABRG2;GABRA2;LGI2;GABRA1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.6346191097581243,1.2191451974635135,0.24358974358974358,0.9496557939157481,1.0,5/12,23.23%,POU2AF1;MFNG;FCGR2B;GPR183;DOCK10
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5447412355965794,1.2189537135479145,0.22879464285714285,0.9490639248240107,1.0,9/35,14.63%,MASTL;ITGA1;PTPA;PPP1R11;PPP1R15A;PPP6R3;PPP1R2;GSK3B;PPP1R12A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.4574962330487193,-1.2187980246005077,0.22134387351778656,0.694624005067988,1.0,13/14,54.29%,ECE1;CORIN;ENPEP;RASL10B;AVPR2;ACE;ACE2;OXTR;EDN3;EDN2;AVPR1A;AGTR1;EDN1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.38672240966703264,-1.2184318668757699,0.16666666666666666,0.6929494913519691,1.0,8/23,16.96%,HAVCR2;VSIR;CD274;ZC3H12A;TLR4;AXL;PRNP;RARA
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.45715205516722346,-1.2184117090192077,0.21568627450980393,0.6904627546803693,1.0,7/13,32.74%,SYNGR1;SHISA6;GRIK2;RAB3A;SHISA7;SLC8A2;PPFIA3
prerank,protein targeting to ER (GO:0045047),0.5028752740124464,1.218260950842464,0.1612576064908722,0.950626173096824,1.0,48/99,22.90%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;RPL28;SPCS1;RPS14;RPL41;RPLP2;RPS27;GET3;RPS5;RPS29;RPLP0;RPS11;RPL27A;RPS9;RPS15A;ZFAND2B;RPL12;RPL3;SEC63;UBA52;RPL18;RPL5;RPS6;RPS17;RPS3;RPL21;RPL17;RPL23;SPCS3;RPL24;RPL8;RPL27;SEC62;RPL13A;RPS12;RPS8;RPL15;RPL10;SRP68
prerank,epiboly involved in wound healing (GO:0090505),0.607299709506864,1.2182480254147667,0.2620599739243807,0.9492904516375965,1.0,6/16,14.92%,FLNA;CCN1;CD44;ARHGAP35;TOR1A;PDCD10
prerank,atrial septum development (GO:0003283),0.6101374934527414,1.2181250847415703,0.26359832635983266,0.9483968317780102,1.0,3/13,5.92%,HEY2;ZFPM1;MDM4
prerank,regulation of myoblast fusion (GO:1901739),0.6370828262049907,1.2179546447778535,0.270687237026648,0.9477773164823459,1.0,4/11,13.94%,RIPOR2;MAPK14;FLOT1;CFLAR
prerank,regulation of presynapse assembly (GO:1905606),-0.41867849674906316,-1.2178847411920595,0.2048780487804878,0.6868841257596904,1.0,3/18,2.36%,APP;LRFN5;PTPRD
prerank,regulation of presynapse organization (GO:0099174),-0.41867849674906316,-1.2178847411920595,0.2048780487804878,0.6868841257596904,1.0,3/18,2.36%,APP;LRFN5;PTPRD
prerank,modification-dependent protein catabolic process (GO:0019941),0.5051069529953952,1.2178039892395738,0.11311311311311312,0.9470516982682318,1.0,55/193,18.62%,BUB1B;UBE2C;AURKB;MAD2L1;UHRF1;CDC20;PLK1;AURKA;DTL;PSMD11;PPP1R11;CDC23;UBE2I;CDC27;PSMF1;TAF1;NPLOC4;ANAPC7;FBXO45;BIRC6;UBE2K;UBE4B;UBE3B;NEDD4L;UBQLN1;CUL3;LONP1;KCTD21;PTTG1;AMFR;UBE3C;RNF168;MIB1;RNF8;SPSB4;CNOT4;FZR1;FBXL4;BUB3;FBXO11;PSMD13;ARIH2;RNF20;RNF111;RC3H1;MYLIP;UBE2R2;XBP1;RNF19A;UBA52;SYVN1;FEM1C;UBE2G1;RBBP6;RNF43
prerank,neurotrophin signaling pathway (GO:0038179),0.5862705964625416,1.217455149857894,0.22639225181598063,0.9471140143527268,1.0,5/21,12.37%,NTF4;KIDINS220;GRB2;SOS1;HAP1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.542898952988463,1.2173165022724624,0.23863636363636365,0.9463573577672697,1.0,9/35,13.52%,HMGB2;ZFPM1;ABCB10;BRD1;CDK6;ZFP36L1;MAPK14;STAT5B;PRKDC
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5031474788758168,-1.2172905604918853,0.25245901639344265,0.6860448136835675,1.0,5/10,27.63%,CD34;RAP1A;TMEM100;CEACAM1;KDR
prerank,T cell homeostasis (GO:0043029),0.6504866665552135,1.217135039562815,0.27167630057803466,0.9457430983982243,1.0,4/10,16.70%,PMAIP1;PPP2R3C;FAS;JAK3
prerank,regulation of protein kinase activity (GO:0045859),0.5112462731375207,1.2162096849745703,0.14530776992936428,0.948091433002672,1.0,26/106,17.93%,CENPE;ECT2;RB1;CCN1;MMD2;SMG8;MAPRE3;MMD;TAF7;XRCC6;MRNIP;CEP85;TAB1;SNX9;PDPK1;PARK7;RELN;PRKAG2;ADCYAP1;PPIA;DTNBP1;TARBP2;PAK2;SIRT1;SNCA;IQGAP1
prerank,plasma membrane repair (GO:0001778),-0.4624159381863804,-1.21581923647441,0.24719101123595505,0.6874257434508159,1.0,7/13,29.16%,AHNAK2;MYOF;SYT7;RAB3A;ANXA6;DYSF;SYT11
prerank,regulation of macrophage activation (GO:0043030),-0.3541540608363853,-1.2157312646169038,0.1357142857142857,0.6852374930808096,1.0,11/30,20.42%,PJA2;LRFN5;MFHAS1;HSPD1;ZC3H12A;TLR4;TNIP2;CD200;IL31RA;THBS1;MYO18A
prerank,steroid metabolic process (GO:0008202),0.5178816773541254,1.2154539655626042,0.20144628099173553,0.9498502794994051,1.0,10/72,12.97%,HSD17B3;SRD5A2;CYP1B1;LSS;CYP2A6;GBA2;TSPO;CYP27A1;CYP46A1;DHRS4
prerank,gene expression (GO:0010467),0.5002983289905127,1.2146882245565693,0.056,0.9515270656544716,1.0,131/348,21.41%,MRPL36;ADAD1;NR4A2;NUP43;RPL7;POM121;E2F1;RPL18A;NDC1;SMG6;RPS20;DHX38;MRPL18;RBM3;POLR2I;SMG5;NUP107;RPL36;RPL14;POLR2A;SLBP;EPC1;RPS19;RPS7;NUP42;RPS4X;HNRNPL;RPS18;MRPL10;NUP50;UPF2;PTMA;CPSF2;SETX;U2AF1;RPL23A;DNAJB11;EIF4A3;NUP214;SRSF3;RPL28;ELAVL4;HNRNPA2B1;MRPL37;RPS14;RPL41;TSPAN33;RPLP2;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;RPS27;U2AF1L4;MRPL51;MRPS7;MRPL43;SEC13;RPS5;DHPS;RBMS2;NUP188;RPS29;RPLP0;RPS11;MRPS17;IGF2BP3;RPL27A;THOC3;NUP98;RANBP2;UPF3B;NUP210;RPS9;RPS15A;THOC5;HNRNPU;PRPF4;TFIP11;MRPL24;RPL12;THOC2;DARS1;SNRNP40;POLR2K;AAAS;SRSF7;THOC7;CDC40;NUP37;RPL3;DDX39B;POLR2J;POLDIP3;CPSF1;GSPT1;CLP1;RPL18;DRG1;TSPAN5;DKC1;ALKBH5;YARS2;NKX2-8;RPL5;RPS6;RPS17;NCBP2;NUP85;RPS3;DDX54;RPL21;AGO2;SRSF2;GOLPH3;SRBD1;RPL17;RPL23;TPR;FYTTD1;SMG7;SYNCRIP;MMS19;WDR33;GLE1;RSL24D1;RPL24;RPL8;RPL27
prerank,hexose biosynthetic process (GO:0019319),-0.32000086104459075,-1.2141670833379188,0.16483516483516483,0.6867142649960667,1.0,18/42,23.17%,GPI;GOT2;ENO1;ALDOA;AKR1B1;ATF4;TPI1;PGM1;PGAM1;G6PC3;SLC25A11;ALDOC;SLC39A14;PER2;ENO2;CRY1;PPARGC1A;ENO3
prerank,epithelial to mesenchymal transition (GO:0001837),0.5237534933416725,1.213803959389597,0.22043010752688172,0.9537878190044542,1.0,16/47,21.69%,FAM83D;HEY2;LEF1;NOTCH1;ROCK2;HNRNPAB;GSK3B;LIMS1;FGFR1;TASOR;TRIM28;TGFB2;SOX9;RBPJ;ROCK1;AKNA
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6335598518606381,1.2137125460535796,0.2612359550561798,0.9528082472487286,1.0,3/11,16.74%,STMN1;NRP1;RAC1
prerank,retinal metabolic process (GO:0042574),0.6100011728378998,1.2130589640507723,0.26323119777158777,0.9541526870448865,1.0,2/12,13.06%,CYP1B1;RDH10
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6042138865570905,1.2130469798415708,0.26517150395778366,0.9528316879371745,1.0,8/15,22.19%,TNRC6C;TNRC6B;CPEB3;CNOT1;EIF4ENIF1;AGO2;CNOT7;TENT4A
prerank,bicellular tight junction assembly (GO:0070830),0.5237380352671626,1.2124793122880877,0.22017353579175705,0.953805689739632,1.0,3/46,2.61%,ECT2;CLDN18;PECAM1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5641724136977927,1.2124470520002464,0.25229357798165136,0.9525601126805574,1.0,5/26,8.09%,RRM2;RRM1;ALG8;RRM2B;ST3GAL2
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6420411999932526,1.2122543743833718,0.2719546742209632,0.9506509602997899,1.0,1/10,8.02%,CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6420411999932526,1.2122543743833718,0.2719546742209632,0.9506509602997899,1.0,1/10,8.02%,CEP250
prerank,actin-myosin filament sliding (GO:0033275),0.5366663831427922,1.2119055563416306,0.24888888888888888,0.9493416712953318,1.0,6/38,16.42%,DES;MYL1;MYBPC1;ACTN2;TPM4;VIM
prerank,muscle filament sliding (GO:0030049),0.5366663831427922,1.2119055563416306,0.24888888888888888,0.9493416712953318,1.0,6/38,16.42%,DES;MYL1;MYBPC1;ACTN2;TPM4;VIM
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5104110174080921,1.2118539471443908,0.19644723092998956,0.9482256122380045,1.0,20/65,17.74%,AURKB;AURKA;PSMB7;PSMD11;PSMF1;CHEK1;PSMC1;NABP2;PSMC3;PSMA4;PSMC4;CDK5RAP3;PSMD13;PSME1;PABIR1;PSMB1;PSMD8;PSME4;PSMD4;AVEN
prerank,response to interleukin-4 (GO:0070670),0.6504649501982249,1.2109647587459316,0.2861230329041488,0.9505621182963452,1.0,3/10,17.05%,LEF1;JAK3;XBP1
prerank,base conversion or substitution editing (GO:0016553),0.6321031698499846,1.210953737342297,0.26685393258426965,0.9492387780875041,1.0,1/11,0.80%,ADAD1
prerank,negative regulation of mRNA processing (GO:0050686),0.5938487810262905,1.2105104273059155,0.24521072796934865,0.9497029274439099,1.0,6/15,16.59%,BARD1;SAP18;SRSF4;RNPS1;SRSF10;SRSF7
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.6448795210942382,1.2103858255549869,0.2744252873563218,0.9488467735683485,1.0,5/10,19.08%,DHX58;NPLOC4;RIOK3;GPATCH3;SEC14L1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.5005656180815642,-1.2101535035427233,0.22302158273381295,0.6953071861938198,1.0,4/10,20.16%,CD84;SLC8B1;SARAF;STIM1
prerank,positive regulation of phagocytosis (GO:0050766),-0.3212655141501562,-1.2099390069575713,0.11538461538461539,0.6934582773365913,1.0,9/47,6.74%,MERTK;SIRPA;TREM2;APPL2;CD300LF;IL15RA;PTPRJ;PYCARD;FCER1G
prerank,regulation of actin filament-based movement (GO:1903115),-0.49938019057122135,-1.2093420170568845,0.24281150159744408,0.6926777696376281,1.0,2/10,7.63%,ANK2;SRI
prerank,macrophage chemotaxis (GO:0048246),-0.49876065190723334,-1.2093215727696855,0.2347266881028939,0.6902534908607252,1.0,5/10,33.03%,EDNRB;CCL3;CXCL17;CCL2;CCL5
prerank,modulation by host of symbiont process (GO:0051851),0.5565331472691724,1.2088547557004852,0.2379862700228833,0.9536695474119612,1.0,14/31,23.92%,AQP1;LEF1;NUCKS1;SMARCA4;NAPEPLD;CARD9;JUN;CCNT1;TFAP4;HDAC1;CHD1;TAF11;TARDBP;HMGA2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.6342470061534519,1.2087054485295052,0.2885714285714286,0.9529107958591029,1.0,1/10,0.73%,IL12A
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5047774795265162,1.2086894941968234,0.19878296146044624,0.9516417905096515,1.0,22/87,19.12%,SHCBP1;MAPK1;POLR2I;CD44;POLR2A;FLRT2;HNRNPM;SETX;ZFP36L1;GRB2;NCBP1;FGF9;SPRED2;CEP57;ZFP36L2;FGFR1;FIBP;POLR2K;POLR2J;KIF16B;HNRNPA1;NCBP2
prerank,plasma membrane invagination (GO:0099024),0.5541516994895165,1.2086622396013331,0.2629757785467128,0.9504017529972302,1.0,5/29,7.99%,AURKB;ALKBH4;SNX33;GSN;SNX9
prerank,neurogenesis (GO:0022008),0.5294784124686122,1.2084104844536545,0.24216216216216216,0.950140197947058,1.0,14/43,21.48%,CIT;CDK5RAP2;WDR62;CDK6;HAP1;METTL14;LPAR1;THOC2;TGFB2;CXCR4;TRAK2;BTBD1;MAPT;BTBD2
prerank,RNA 3'-end processing (GO:0031123),0.5108876569413933,1.2084069928234444,0.18988648090815274,0.948815860114881,1.0,35/69,22.19%,DHX38;CPSF2;U2AF1;EIF4A3;SRSF3;SRSF4;NCBP1;CASC3;RNPS1;U2AF1L4;CSTF3;TUT4;RPRD1B;THOC3;UPF3B;THOC5;THOC2;SRSF7;THOC7;CDC40;TUT1;DDX39B;POLDIP3;PCF11;CPSF1;CLP1;TENT2;NCBP2;SRSF2;CPSF7;PNPT1;WDR33;RPRD2;PAPOLA;TENT4A
prerank,regulation of focal adhesion assembly (GO:0051893),-0.2909196626540118,-1.2079694282079838,0.08064516129032258,0.6914258306693059,1.0,22/54,18.07%,ARHGAP6;EFNA5;LIMCH1;MACF1;APOD;PTPRJ;SLC9A1;CLASP2;CORO1C;LDB1;DUSP3;TSC1;FERMT2;RCC2;PPM1F;PTK2;VEGFA;MAP4K4;ACVRL1;COL16A1;THY1;THBS1
prerank,insulin receptor signaling pathway (GO:0008286),-0.28016911555927304,-1.2070254735762582,0.16326530612244897,0.6915988195513952,1.0,22/69,15.10%,IGF1R;BCAR3;PTPN2;ATP6V1B2;ATP6V1C1;ATP6V0D2;PIK3R1;ATP6V0A1;ATP6V0B;AKT2;BAIAP2;IDE;SH2B2;TCIRG1;GAB1;IRS2;GSK3A;ATP6V1H;ATP6V1A;RHOQ;SLC39A14;GRB10
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.5754198962100494,1.2069277039813944,0.24632352941176472,0.9534147670676741,1.0,1/22,0.14%,SHCBP1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5552504896635265,1.2068567421870353,0.28290993071593534,0.9523837257983782,1.0,3/26,9.29%,CYP1B1;DDAH2;ABCA2
prerank,response to axon injury (GO:0048678),-0.4008855203937798,-1.2062822148511776,0.19907407407407407,0.6911790802602107,1.0,10/18,28.92%,TREM2;APOD;P2RY12;GAP43;P2RX4;MAPK8IP3;DPYSL3;FLRT3;DHFR;MORN4
prerank,histone H3 acetylation (GO:0043966),0.5380244107637664,1.2055421616687525,0.26600441501103755,0.9562486556300275,1.0,15/40,17.72%,JADE1;BRCA2;LEF1;BRD1;BRPF1;KAT6A;BRPF3;KAT2B;ING5;PHF14;TADA2A;TADA3;YEATS2;TAF9;MAP3K7
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5560928986363021,1.2048927596482986,0.2781136638452237,0.9575746792041951,1.0,6/25,13.52%,HMGB2;ABCB10;BRD1;MAPK14;STAT5B;PRKDC
prerank,ganglion development (GO:0061548),-0.47821705451054397,-1.2045483268878514,0.2568493150684932,0.6933200507494948,1.0,4/11,15.01%,NRP2;CTNNB1;FZD3;SEMA3A
prerank,filopodium assembly (GO:0046847),0.5988527235848856,1.2043844250490279,0.26871657754010697,0.9583161483918404,1.0,5/16,12.54%,PPP1R9B;EZR;FGD6;FGD3;S1PR2
prerank,synaptic vesicle endocytosis (GO:0048488),-0.34111484349175525,-1.2040837978320424,0.15254237288135594,0.6921787326608758,1.0,13/33,15.46%,DNM2;OPHN1;GAK;SYNJ1;SYNJ2;SNAP91;DNM3;SYT1;VAMP2;CDK5;STX1A;PIP5K1C;PACSIN1
prerank,organic substance transport (GO:0071702),0.5054805747437529,1.2037562933958783,0.1798994974874372,0.9596004444521645,1.0,26/121,19.16%,CENPF;ABCA13;NDC1;RAMP1;SLC6A2;RCN3;ABCD1;TAP1;PICK1;ABCA2;NME4;ABCA7;CALCRL;SLC19A1;ATP8A1;SLCO2A1;CHMP1B;VPS33B;SCAMP1;CHMP3;CHMP2B;HSP90B1;ARL6IP5;SLC22A4;RUFY1;DISP1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6109220899614713,1.2036052380924998,0.2700135685210312,0.9588738888612988,1.0,7/13,20.77%,TNRC6C;TNRC6B;CPEB3;CNOT1;EIF4ENIF1;AGO2;CNOT7
prerank,actomyosin structure organization (GO:0031032),0.5060714273533036,1.2032500699054032,0.2039337474120083,0.9589043222870963,1.0,14/75,13.07%,CIT;TMOD4;ALKBH4;CSRP3;EPB41;SORBS1;MYH10;CSRP1;FLII;TNFAIP1;CUL3;ACTN2;FAM171A1;ROCK2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5882718440325337,1.2030133179026519,0.2717815344603381,0.9585458317112073,1.0,4/16,14.56%,DDIAS;CDKN2D;CCAR2;TPT1
prerank,cellular response to interleukin-6 (GO:0071354),-0.3738898908598576,-1.2025386075043487,0.18354430379746836,0.6939250661779678,1.0,8/26,12.39%,SBNO2;CTR9;ST3GAL6;RELA;SELPLG;SPI1;PTPRT;STAT3
prerank,negative regulation of bone mineralization (GO:0030502),0.6017228764556617,1.2024175182934256,0.2797385620915033,0.9596691220067738,1.0,1/13,1.49%,RFLNB
prerank,regulation of keratinocyte migration (GO:0051547),-0.44988057574962614,-1.2023628542411766,0.23809523809523808,0.6919874781491167,1.0,4/12,14.65%,IQSEC1;EPB41L4B;ADAM9;MAP4K4
prerank,regulation of gastrulation (GO:0010470),0.6142333547756444,1.2023410419651437,0.2612859097127223,0.9586484988631802,1.0,4/14,14.47%,FOXA2;CLASP1;RACK1;DAG1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5321344287875326,1.2019605420735344,0.2532608695652174,0.9588546355888706,1.0,11/37,14.97%,PMAIP1;S100A9;RPS7;CAV1;S100A8;BOK;BECN1;FIS1;RACK1;DDIT3;TP53
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6132754904138699,1.2018516951413647,0.2857142857142857,0.957974724276262,1.0,4/11,13.34%,DDX11;SMARCA4;NOL11;SIRT7
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5264971200152093,1.2018068180129553,0.22653721682847897,0.956853868221805,1.0,14/49,16.74%,KIF14;IAPP;MEFV;LCMT1;PMEPA1;HDAC6;HMGB1;RIOK3;PARK7;TFIP11;GSK3B;AIDA;NLRC3;NLRP2B
prerank,regulation of glycolytic process (GO:0006110),0.5065151056759246,1.2013453507609584,0.22474226804123712,0.9574050943528892,1.0,28/68,21.99%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;ENTPD5;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;PSEN1;AAAS;NUP37;HDAC4;NUP85;ZBTB20;TPR;EIF6;PRKAG1;CBFA2T3;NUP93
prerank,mRNA catabolic process (GO:0006402),0.5250356568461794,1.2013183387703472,0.238562091503268,0.9562038979410389,1.0,17/44,22.08%,SLFN14;LSM6;PDE12;EXOSC10;DCP2;LSM2;TUT4;LSM5;METTL16;DXO;RC3H1;ZFP36L2;THRAP3;XRN1;PNPT1;DHX34;AGO1
prerank,sprouting angiogenesis (GO:0002040),0.5226417966459145,1.1997368429497832,0.24101479915433405,0.9611764686268135,1.0,3/51,4.65%,E2F7;E2F8;PGF
prerank,positive regulation of protein maturation (GO:1903319),0.6101498539122001,1.199648889894395,0.2750352609308886,0.960236424960594,1.0,2/11,14.78%,TFR2;CCBE1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.5151500365019149,1.1995817158367243,0.23191489361702128,0.9592064644152505,1.0,19/52,19.88%,PMAIP1;E2F1;ATG13;SAE1;YWHAH;TFDP1;UBL5;ABLIM3;TFDP2;RHOU;BAP1;RAC2;ARIH2;PPP3CC;TP53;YWHAE;CASP8;SREBF2;HPS4
prerank,protein localization to vacuole (GO:0072665),-0.45844007235105944,-1.1995789186827377,0.24596774193548387,0.6969559960398543,1.0,7/13,18.75%,RTN4;RNF128;MFSD1;SH3GLB1;GLMP;LAMTOR5;CD81
prerank,mucosal immune response (GO:0002385),0.6043368916060684,1.1993221653119115,0.278580814717477,0.9589576256931527,1.0,1/15,3.69%,CAMP
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5731162754023351,1.1993135484868707,0.26941747572815533,0.9576899455809215,1.0,4/26,5.31%,CYP1B1;BRCA1;SULF2;CCR2
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.45654367289054293,-1.1992891175291152,0.26639344262295084,0.695352348084565,1.0,6/14,17.06%,TREM2;GRN;IGF1;TNFRSF1B;CD200;CST7
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3506322178619578,-1.1989910502116055,0.216,0.6937854578622773,1.0,7/29,17.58%,APP;SYNGR1;APOE;SHISA6;GRIK2;CAMK2B;DLG4
prerank,determination of left/right symmetry (GO:0007368),0.5304321061039747,1.1982198107907016,0.24914675767918087,0.9608052810623943,1.0,3/36,7.93%,STIL;NOTCH1;OFD1
prerank,protein modification by small protein conjugation (GO:0032446),0.4937721781382102,1.1973421505177004,0.062,0.9630720054125634,1.0,102/361,17.78%,CCNF;UBE2C;UBE2T;UHRF1;TRIM58;BARD1;RFWD3;RNF26;PLK1;BRCA1;FBXL15;MEFV;NUP43;POM121;NDC1;SAE1;NUP107;CDC23;FBXW11;MKRN1;UBE2I;CDC27;PCNA;RANGAP1;NUP42;UBA2;NUP50;BCL11A;TRAIP;MSL2;ANAPC7;FBXO45;UBE2Z;DDRGK1;NUP214;BIRC6;UBE2K;NEDD4L;TRIM11;RNF157;RAD18;NUP160;KLHL9;NUP205;TNFAIP1;ASB1;CUL3;PIAS3;TRIM47;CBLL1;AMFR;TRIM33;NUP188;TRIM44;NSMCE2;SUMO1;UBR2;RNF168;RTF1;MIB1;RNF8;SPSB4;PEX2;CNOT4;EIPR1;TRIM68;ARRB2;PCNP;NUP98;RANBP2;CDK5RAP3;RNF152;CUL9;NUP210;FBXO11;NFE2L2;RACK1;PRKDC;NFX1;SUMO2;ARIH2;RNF20;TRIM5;RNF111;VCPIP1;EYA1;PIAS1;MYLIP;TRIM28;UBE2R2;AAAS;VHL;SIRT1;RNF103-CHMP3;NUP37;TRPM4;PEX14;CAND2;UBA52;UBE2M;USP7;SYVN1
prerank,negative regulation of phosphatase activity (GO:0010923),0.559822696671091,1.197156217060611,0.26273148148148145,0.9625265381965251,1.0,7/25,16.38%,MASTL;PTPA;PPP1R11;PPP1R15A;PPP1R35;GSK3B;TGFB2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3725423988338562,-1.197007869878486,0.18478260869565216,0.6968835441507294,1.0,6/23,8.34%,NLRP3;PPM1A;RELA;ZC3H12A;NMI;SPI1
prerank,regulation of monocyte differentiation (GO:0045655),0.605064592346616,1.1967939513098702,0.2696335078534031,0.9627433472507188,1.0,5/14,13.88%,CD74;FOXP1;CDK6;ZFP36L1;MYC
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4981052485441786,-1.196710032534701,0.265993265993266,0.6953374640020944,1.0,3/10,5.06%,SIRPA;PTPRS;PYCARD
prerank,epithelial cell migration (GO:0010631),0.5337902047072917,1.196232519481763,0.25711159737417943,0.9637034545552986,1.0,7/37,13.01%,CYP1B1;ANLN;FAP;PKN2;PRKX;DPP4;NRP1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.521370736332527,1.1956020783584647,0.24782608695652175,0.964936646056072,1.0,22/44,23.77%,FTO;ZFP36L1;TNRC6C;TNRC6B;CPEB3;PUM1;METTL16;ROCK2;CNOT1;METTL14;RC3H1;ZFP36L2;EIF4ENIF1;AGO2;CNOT8;PNPT1;PRR5L;CNOT7;ROCK1;CELF1;ZC3HAV1;MEX3D
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.49066777836998765,-1.1955563651587577,0.24695121951219512,0.6959754656616589,1.0,3/10,25.28%,SH2B3;MAPK7;KLF4
prerank,neuron apoptotic process (GO:0051402),0.5686900925605622,1.1954974877026645,0.2824242424242424,0.9640115334781101,1.0,3/19,3.65%,CIT;ERBB3;LIG4
prerank,positive regulation of synaptic transmission (GO:0050806),-0.28058404148935634,-1.1953720683046916,0.0625,0.6940818570555896,1.0,17/72,11.60%,RIMS1;APP;RIMS2;SQSTM1;STX4;SLC8A3;SYT1;KCTD13;CACNG7;CACNG2;VAMP2;SHANK2;CLSTN3;GRIK2;LGMN;CLSTN1;ADRA1A
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.579111530128375,1.1949774614011544,0.26616915422885573,0.9647640962712737,1.0,3/24,3.96%,CYP1B1;BRCA1;SULF2
prerank,cellular copper ion homeostasis (GO:0006878),-0.42976398946769534,-1.1947945838338365,0.2204724409448819,0.6931081698680965,1.0,7/14,21.90%,APP;SLC31A2;PRNP;COX19;CCDC22;MT2A;ARF1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.39301534473966615,-1.1947622500738058,0.2275132275132275,0.6908580682456449,1.0,6/21,10.38%,TREM2;LRP1;APOE;PLTP;ZDHHC8;GPS2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5456754963906919,1.1947177640863695,0.26721120186697783,0.9645378489566109,1.0,12/29,23.67%,E2F1;TAF15;HNRNPU;PAIP1;ELAVL1;EIF4ENIF1;THRAP3;TENT5D;DHX34;YBX1;GDNF;CIRBP
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.48949852654611553,-1.1941760390980651,0.2305194805194805,0.6901886189558761,1.0,5/10,14.08%,KDM1A;CTNNB1;CX3CR1;FZD3;VEGFA
prerank,aortic valve morphogenesis (GO:0003180),0.5387255602063099,1.1936671277125512,0.2537142857142857,0.9674630660950083,1.0,10/30,22.26%,HEY2;RB1;TWIST1;NOTCH1;SLIT3;ROCK2;ELN;SOX9;ROCK1;EFNA1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5062271790803297,1.1933206584756417,0.22842105263157894,0.9675633644976362,1.0,11/72,11.17%,TPX2;STMN1;IAPP;CLASP1;CIB1;CYRIB;VBP1;PFDN5;LIMA1;DYRK1A;SMAD4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.4669414657476406,-1.1932868645871597,0.2841726618705036,0.6900805538586846,1.0,5/12,27.56%,ZC3H12A;STAT3;LIN28B;BCDIN3D;ZC3H10
prerank,actin filament bundle organization (GO:0061572),0.5427947352584107,1.1932305488526194,0.24211711711711711,0.9666627151179047,1.0,7/33,13.46%,RFLNB;EZR;NEDD9;SHROOM2;LIMA1;PAWR;ADD2
prerank,nucleoside salvage (GO:0043174),0.6224097189744813,1.1931998612643513,0.29310344827586204,0.9654780923181835,1.0,2/10,3.25%,TK1;UCK2
prerank,regulation of cell development (GO:0060284),0.5376476086343975,1.192852837827282,0.2609182530795073,0.965593919653937,1.0,4/36,5.78%,HMGB2;HEY2;RPS19;FOXO1
prerank,cytosolic transport (GO:0016482),-0.276053521677152,-1.1928514276006077,0.0,0.6888330610447359,1.0,38/108,20.70%,RAB14;GAK;STX6;STX16;GBF1;WDR91;SNX5;VTI1B;RAB6B;EEA1;LAMP1;VPS13C;TBC1D23;VPS50;ANKRD27;TBC1D10A;PREPL;TRIM27;TBC1D5;SNX16;CLN5;GOSR2;ARL1;WASHC1;YKT6;HOOK2;TBC1D17;GOSR1;SNX6;HOOK3;EPS15;VPS51;SORT1;MYO1D;TBC1D10B;PLEKHJ1;PTPN23;VPS26A
prerank,peptide biosynthetic process (GO:0043043),0.49614611238317946,1.1928037447266076,0.1533066132264529,0.9644898180773174,1.0,60/153,22.85%,MRPL36;RPL7;RHD;RPL18A;RPS20;MRPL18;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;MRPL10;RPL23A;RPL28;MRPL37;RPS14;RPL41;RPLP2;RPS27;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;RPLP0;RPS11;MRPS17;IGF2BP3;RPL27A;RPS9;RPS15A;MRPL24;RPL12;PCSK1;DARS1;RPL3;GSPT1;RPL18;YARS2;RPL5;RPS6;RPS17;RPS3;RPL21;AGO2;SRBD1;RPL17;RPL23;RSL24D1;RPL24;RPL8;RPL27;RPL13A;MRPS12;RPS12;RPS8;RPL15;RPL10
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.27788150935151057,-1.1924489888838186,0.18181818181818182,0.6876436705813818,1.0,25/78,15.83%,NUMB;TREM2;LRP1;SQSTM1;DPP10;BCL2L1;VTI1B;STX4;PRKCI;STX3;PIK3R1;ZDHHC5;AR;MMP14;ZDHHC8;VAMP8;RHOG;ACTB;CLIP3;CDK5;PTPN9;AP2M1;RHOQ;PPFIA1;DLG1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5235832139836943,1.192207346579678,0.25555555555555554,0.9656224503545605,1.0,5/36,5.78%,FOXM1;MEN1;EZR;PTPN22;FOXO1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.5351598812172423,1.191567139162413,0.2791519434628975,0.9668734585799209,1.0,13/27,21.92%,TNRC6B;PUM2;EGFR;PUM1;DHX9;FXR1;TP53;LIMD1;MAP2K1;EIF4ENIF1;AGO2;RIPK1;EIF4E2
prerank,apical protein localization (GO:0045176),-0.4860656515768534,-1.1909463455941303,0.28620689655172415,0.6889310438679787,1.0,6/10,15.61%,ATP8B1;SHROOM3;INSC;ACTB;GOPC;MAL
prerank,vesicle transport along actin filament (GO:0030050),0.5734303525608786,1.1909138231443992,0.28201970443349755,0.9682411695369885,1.0,2/19,2.63%,MYO5C;MYO15A
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.6166019889012203,1.1906259159139323,0.3258426966292135,0.9681187967910598,1.0,8/11,24.46%,DNMT1;SETDB2;ATF7IP;TASOR;TRIM28;SETDB1;TPR;RESF1
prerank,lymphocyte chemotaxis (GO:0048247),-0.345732625142296,-1.1902913582940855,0.1834862385321101,0.6882046747902132,1.0,11/34,33.03%,SLC12A2;PIK3CD;CCL15;CH25H;CCL4;CCL3;CCL14;CYP7B1;CCL13;CCL2;CCL5
prerank,negative regulation of developmental process (GO:0051093),0.5086316891742853,1.1893495127309652,0.2290794979079498,0.9719114457687382,1.0,10/69,7.70%,FOXM1;ANP32B;HEY2;SUZ12;TFRC;CDK6;BCL11A;NOTCH1;SFMBT1;FUZ
prerank,regulation of protein binding (GO:0043393),0.4958292483318186,1.1891891051085777,0.19071644803229063,0.9712716315436315,1.0,43/114,21.04%,AURKB;MEN1;PLK1;AURKA;DDX11;TIAM1;ZFPM1;EPB41;SLPI;CAV1;TAF1;DISC1;PIN1;PRKACA;MARK2;HIPK2;AMFR;PARK7;B2M;CRK;RACK1;FLOT1;ADD2;TFIP11;PSEN1;GSK3B;STK4;TCF7L2;STYX;PEX14;LDLRAP1;SPPL3;PPP1CA;HDAC4;LRRK2;GNL3L;CDKN1A;STK3;AKTIP;PPP2CA;PRMT7;BTBD1;ROCK1
prerank,cardiac atrium morphogenesis (GO:0003209),0.5787054536329936,1.1891366257502762,0.2793733681462141,0.9701786044079442,1.0,3/16,7.15%,HEY2;ZFPM1;NOTCH1
prerank,mitochondrial fission (GO:0000266),-0.414658749395458,-1.1890535439875127,0.22566371681415928,0.689239949127252,1.0,7/16,16.72%,DNM2;DNM3;DNM1L;MIEF1;PRKN;MFF;MTFR1L
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6012711433102136,1.1886254225882344,0.28493894165535955,0.9709366956025414,1.0,1/13,0.72%,GFI1
prerank,pancreas development (GO:0031016),0.6124354196612448,1.1880542180949962,0.29083094555873923,0.971934522235151,1.0,1/12,0.89%,NKX6-1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5678127323106836,1.18790516125191,0.28697850821744625,0.9712409695031996,1.0,1/17,0.89%,NKX6-1
prerank,regulation of platelet aggregation (GO:0090330),0.5709222707376657,1.1878909711214607,0.3116036505867014,0.9700112201659679,1.0,2/17,8.22%,BLK;PRKCA
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.6047425440780115,1.1878838561874516,0.2844950213371266,0.9687669150833154,1.0,3/12,14.72%,EZH2;ASXL1;CNOT1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5485063785126418,1.1877191902252466,0.2672209026128266,0.9681477793725026,1.0,9/25,22.95%,HEY2;RB1;TWIST1;ZBTB7A;PARK7;SIN3A;TRAF6;NIBAN2;NSD1
prerank,regulation of synapse maturation (GO:0090128),0.6217786666076524,1.1876637722331933,0.3022598870056497,0.9670901869879364,1.0,2/10,11.03%,CDC20;RELN
prerank,regulation of nervous system process (GO:0031644),-0.40610500497768565,-1.1872403535544613,0.22439024390243903,0.6918277576149581,1.0,5/18,9.58%,APP;DLGAP4;HTR2C;SLC8A3;DLGAP2
prerank,regulation of histone modification (GO:0031056),-0.43186116870110225,-1.1871066704490076,0.2550607287449393,0.6898880330468662,1.0,4/13,10.19%,PARG;AKAP8L;MTHFR;FLCN
prerank,axonal transport (GO:0098930),0.5370428814482745,1.1868020997263484,0.2684782608695652,0.9692276848197853,1.0,8/36,14.43%,KIF4A;BLOC1S4;FBXW11;DYNC1H1;PAFAH1B1;AP3M2;HAP1;DTNBP1
prerank,lipoprotein transport (GO:0042953),-0.48597761392209016,-1.186652581225328,0.23905723905723905,0.6888210140500917,1.0,5/10,20.34%,LRP1;ZDHHC17;MIA3;CD36;UNC119B
prerank,tight junction assembly (GO:0120192),0.509673569038686,1.1865576247239258,0.2459546925566343,0.9689549133496104,1.0,3/49,2.61%,ECT2;CLDN18;PECAM1
prerank,regulation of extracellular matrix organization (GO:1903053),0.5761736730053786,1.1864721067012804,0.2928388746803069,0.9680441751873857,1.0,5/15,15.17%,RB1;FAP;NOTCH1;EFEMP2;RUNX1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.48625418252674013,-1.1861808394087219,0.27335640138408307,0.6878290977456987,1.0,4/10,9.41%,APOE;ABCA1;PRKACB;ZDHHC8
prerank,regulation of peptidase activity (GO:0052547),0.5718825906055841,1.1861680027151444,0.2813299232736573,0.9679901991031435,1.0,3/19,5.28%,NRDC;RCN3;CAV1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4745301944893931,-1.186081920044473,0.2597864768683274,0.6858676335546928,1.0,5/11,25.13%,CSNK1E;CSNK1D;RSPO3;WNT5B;NKD1
prerank,peptide cross-linking (GO:0018149),0.5524693298304271,1.185662238491839,0.27928994082840236,0.9687226417149114,1.0,4/25,17.71%,EPB42;ABCA7;FN1;F13A1
prerank,transport along microtubule (GO:0010970),-0.44522896316507554,-1.1855789832827717,0.26506024096385544,0.684944830850882,1.0,4/13,12.16%,APP;SPG11;COPG2;CLIP3
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5450593955974716,1.185381995526731,0.2819025522041763,0.9685564143364976,1.0,13/29,18.96%,MEN1;LEF1;TCF7L1;SMARCA4;TLE4;RUVBL1;BCL9L;CREBBP;MYC;RBBP5;TCF7L2;TLE3;HDAC1
prerank,mesenchyme development (GO:0060485),-0.43053899238146437,-1.1851925350321795,0.25102880658436216,0.6837529564713437,1.0,2/15,3.19%,TGFBR1;BMPR2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2744892636476965,-1.18468946261901,0.13157894736842105,0.6828235707413038,1.0,19/75,12.73%,CSF1R;DGKH;SYNJ1;PLA2G15;GPCPD1;ABHD12;PLCB2;PLA2G7;GDE1;PIGB;HDHD5;PIGN;ABHD6;CRLS1;AGK;PIGX;PIGP;ABHD3;PLA2G6
prerank,regulation of cellular metabolic process (GO:0031323),0.5195085648920561,1.1844063888855403,0.2566079295154185,0.9711782218305322,1.0,9/45,14.69%,FOXM1;CYP1B1;PANK2;AGPAT1;ARF4;ABCA2;FASN;FLOT1;MPV17
prerank,cellular response to reactive oxygen species (GO:0034614),0.5116342654314168,1.1842285045937029,0.2512980269989616,0.970665044214236,1.0,24/59,23.15%,ECT2;CYP1B1;AQP1;MAPK1;NET1;SETX;HDAC6;MAP3K5;EGFR;PARK7;JUN;NFE2L2;MPV17;ERCC6L2;SIRT1;RPS3;PAX2;PKD2;RIPK1;MAPT;PLEKHA1;PXN;OSER1;PRKCD
prerank,calcium ion transmembrane transport (GO:0070588),-0.28763799240730364,-1.1840459210924597,0.16,0.6823411164589567,1.0,27/86,21.08%,SLC24A3;TRPM3;CACNA1C;TRPC5;MCOLN1;NALCN;SLC8A3;MCUR1;TRPC4;TRPC1;SLC8B1;TMEM165;LETM1;PKD1;MCOLN3;ATP2B3;SPG7;TRPV4;SLC8A1;TRPC3;STOML2;MAIP1;CACNA1G;PMPCA;ORAI1;P2RX4;AFG3L2
prerank,regulation of neuron projection development (GO:0010975),-0.22428848180161443,-1.183990078481275,0.0,0.6803326410099777,1.0,57/163,20.25%,TANC2;PAK3;SPOCK1;RUFY3;GAK;CAMSAP2;CAMK1;APOE;STMN2;PRAG1;PPFIA2;PRKCI;PRKD1;KNDC1;HDAC2;PTPRS;MBOAT1;NTNG1;CDH2;MAG;SCN1B;RAP1A;CDK5R1;ATP1B2;ARHGAP44;PTPRO;FES;GSK3A;NDRG4;CTNNA2;SCARB2;CDK5;SERPINI1;FKBP4;PTPN9;CAMK2G;PAQR3;CBFA2T2;LRRC7;SEMA3A;CAMK2B;TRPV4;MDK;EPHA4;ABI2;SHANK3;DAB2IP;NCS1;RTN4IP1;CRMP1;TWF2;RAPGEF1;PLXNB3;CFL1;ABL2;KIF1A;ZDHHC15
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5422835721841877,1.1830228855984177,0.2912621359223301,0.9741378511989846,1.0,5/24,10.64%,CD177;PECAM1;EZR;GFUS;MSN
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.45817944578293296,-1.18182097084969,0.2673611111111111,0.6836431570563627,1.0,9/12,22.66%,SEC61A2;SGTA;SEC61G;SEC61A1;SGTB;HSPA5;CHMP4B;CHMP4A;SEC61B
prerank,regulation of hippo signaling (GO:0035330),0.5720733468732158,1.1816227404439954,0.2949367088607595,0.9784680882152288,1.0,3/17,8.10%,CIT;MOB3B;MAPK14
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.48633537990188197,-1.1814989877852575,0.2833333333333333,0.6823412374332519,1.0,3/10,15.02%,CACNB2;SRI;CALM1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4985766742809397,1.1811972202353047,0.24555903866248693,0.978886247078318,1.0,20/62,15.85%,RBM15;ZFPM1;CDK6;DPY30;TNRC6C;TNRC6B;H3-3A;KMT2C;ZBTB16;NFE2;KAT2B;CNOT4;PRKCB;CBFB;KMT2A;CREBBP;RBBP5;KMT2B;RUNX1;SIN3A
prerank,embryonic organ development (GO:0048568),0.5077450497731412,1.1810326767063049,0.2598091198303287,0.9782469661052974,1.0,6/61,3.81%,STIL;HEY2;TEAD4;PBX4;ZFPM1;PBX3
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.4579122465633042,-1.1791087844202714,0.2912621359223301,0.6861831468055923,1.0,9/11,54.23%,PLA2G7;AGT;PLA2G3;LIPC;PLA2G5;ABCG1;PLA2G10;APOA2;AGTR1
prerank,ncRNA catabolic process (GO:0034661),0.5308181280575093,1.1784707392767344,0.28773584905660377,0.9871357070136978,1.0,8/28,19.64%,SLFN14;EXOSC8;EXOSC10;TUT4;RBM7;DIS3L;ZCCHC8;XRN1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.5812074472443972,1.1781149663972845,0.3015267175572519,0.9872448532431621,1.0,12/16,26.09%,DCPS;SNRPC;SNRNP200;CWC15;PSIP1;SART1;NCBP2;WBP11;RBM22;DDX23;SFSWAP;PRPF39
prerank,intestinal lipid absorption (GO:0098856),0.6071317823123705,1.1776660322646513,0.2981715893108298,0.9877737026741276,1.0,2/11,10.17%,CEL;LIMA1
prerank,regulation of cell morphogenesis (GO:0022604),-0.3476180972775164,-1.1770458873962888,0.1956521739130435,0.6892790428243423,1.0,11/30,14.38%,EFNA5;MACF1;MYO9A;LARP4;NTNG1;FMNL2;STRIP1;SPARC;FERMT2;WTIP;ZMYM6
prerank,positive regulation of protein import (GO:1904591),0.5407181651506293,1.1767655205392162,0.2839224629418472,0.9900172065069794,1.0,9/30,17.44%,ECT2;ARHGEF5;FLNA;EFCAB7;PSEN1;BAG3;IPO5;TRIM28;HCLS1
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.42342897077043984,-1.1765969073159634,0.21610169491525424,0.6881739767868051,1.0,5/14,9.32%,OPHN1;MYO9A;PATJ;RAP2A;SH3BP1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4587598265580374,-1.175342308765724,0.26223776223776224,0.6891999459538667,1.0,2/11,9.21%,ITGB5;JUP
prerank,regulation of cytokine production (GO:0001817),0.4912872630093294,1.17498998140879,0.19899497487437187,0.9957612620235383,1.0,21/126,11.66%,ERMAP;RNF26;PLA2R1;POLA1;CD47;GLMN;BATF;PPP1R11;CCN4;RPS6KA5;FOXP1;AGPAT1;CCR2;TRAF3;NFAM1;MAPK14;MAST2;ASB1;BTN3A3;CARD9;IGF2BP3
prerank,intraciliary retrograde transport (GO:0035721),-0.4429434560827843,-1.1747480973975413,0.2689393939393939,0.6886909776632758,1.0,6/12,19.89%,DYNC2H1;IFT43;DYNC2I1;WDR35;DYNC2I2;WDR19
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5329825279074738,1.1745410726521537,0.2826603325415677,0.9962239960566369,1.0,7/28,14.45%,IL12A;CD47;CCR2;XRCC6;CYRIB;PRKDC;TYROBP
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5181602593008032,1.1744924807139778,0.2823920265780731,0.9951250191410498,1.0,8/42,16.77%,RBM15;OXSR1;CCR2;GPR75;CIB1;STK39;GPR35;CCL25
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5363227174740908,1.1742516972910142,0.2954279015240328,0.9947781463758332,1.0,7/27,9.08%,SMG6;SMG5;DACH1;ATM;TERF2;NABP2;SMOC2
prerank,mesenchymal cell development (GO:0014031),0.5683264142791211,1.1736280059085251,0.29987293519695046,0.9959576148252239,1.0,5/18,11.80%,HEY2;PEF1;NOTCH1;TCOF1;TAPT1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6275496072177154,1.1736117658750425,0.3026315789473684,0.9947562498328164,1.0,4/10,17.91%,BRCA1;TAF7;SIRT1;SNCA
prerank,connective tissue development (GO:0061448),0.5238407979678633,1.1732717548691718,0.2861878453038674,0.9947889808436525,1.0,8/35,10.86%,SOX6;CD44;SULF2;DDRGK1;ZBTB16;PGRMC2;ATP7A;ARID5B
prerank,negative regulation of lipid storage (GO:0010888),-0.386237545651943,-1.1730354570302874,0.22972972972972974,0.6910231243061479,1.0,3/19,1.79%,TREM2;PTPN2;ABCA1
prerank,regulation of cell size (GO:0008361),0.5494692790452635,1.1727093605174792,0.2882991556091677,0.995664594720271,1.0,10/23,18.03%,EZR;RAP1GAP2;MTPN;LARS1;MSN;RDX;PTEN;LAMTOR4;RAC1;RARG
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.556765200710972,1.172555071272217,0.3111111111111111,0.994960718822301,1.0,7/21,20.57%,MEFV;FYN;BIRC2;DELE1;USP50;EPHA7;AIM2
prerank,leukocyte tethering or rolling (GO:0050901),0.56564714427984,1.171545284025587,0.31094527363184077,0.9976516795100838,1.0,8/17,22.31%,SPN;ITGB7;JAM2;ADD2;GOLPH3;GCNT1;ROCK1;ITGA4
prerank,regulation of mast cell degranulation (GO:0043304),0.5753590784486007,1.1713661045438994,0.31020408163265306,0.9970887433070188,1.0,1/14,0.41%,BLK
prerank,peroxisomal membrane transport (GO:0015919),0.5452420742006445,1.1712465702981452,0.2819593787335723,0.9963298244379162,1.0,12/27,18.79%,PEX26;ABCD1;ACBD5;PEX11B;PXMP4;GDAP1;PEX2;RAB8B;FIS1;PEX14;ATAD1;ABCD4
prerank,regulation of striated muscle contraction (GO:0006942),-0.3573890474482511,-1.1709299203962646,0.19480519480519481,0.6945115802016637,1.0,10/27,20.09%,ANK2;SLC8A3;SRI;DMD;RYR2;SMAD7;ASB3;CALM1;ATP1A2;P2RX4
prerank,response to sterol (GO:0036314),-0.457648479207764,-1.1708514115520035,0.2755102040816326,0.6925876641135285,1.0,6/11,19.80%,TGFBR1;CCR5;TGFBR2;INSIG1;CCL3;PMVK
prerank,positive regulation of vascular permeability (GO:0043117),0.5981844142133623,1.1704930856890037,0.31710709318497915,0.99806636352174,1.0,3/12,6.74%,FGFBP3;TJP3;PDE2A
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.4427794413430971,-1.1704031625164866,0.28063241106719367,0.691575896353872,1.0,4/13,18.62%,HSP90AA1;PTS;CALM1;PRKG2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5758681075627281,1.168583744566553,0.3005464480874317,1.0,1.0,8/13,23.12%,HMGB1;AKT3;PDPK1;FGFR1;PLCG1;APLN;ITGA4;ADAM17
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5010370054658603,1.1685613268989716,0.25906735751295334,1.0,1.0,21/70,18.94%,KIF14;ITGB7;RB1;ATRNL1;ATRN;LAMA5;LAMC1;LAMB2;LAMB3;ITGAV;NTNG2;RELN;ARL13B;ITGA8;NRP1;PARVB;RAC1;PARVA;FN1;TBCD;PROX1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.26429462532187753,-1.1684378463722547,0.11538461538461539,0.6946393996626185,1.0,23/87,15.58%,ACVR1;ITGB5;TGFBR1;GCNT2;APPL2;F11R;NLK;PTPRK;SMAD1;SMAD3;ZFYVE9;USP9X;SMAD6;ZMIZ2;ENG;LPXN;FERMT2;SMAD7;ZMIZ1;ADAM9;PTK2;TGFBR3;ACVRL1
prerank,protein monoubiquitination (GO:0006513),0.5197309559872968,1.1679210494330123,0.29625425652667425,1.0,1.0,10/36,16.77%,UBE2T;UHRF1;DTL;UBE2O;RAD18;CUL3;FANCL;RNF20;UBE2R2;KLHL22
prerank,second-messenger-mediated signaling (GO:0019932),0.4934463788847176,1.1672691847533287,0.2242798353909465,1.0,1.0,21/82,18.13%,CXCR5;PPP1R9B;SAMD14;DDAH2;RCAN3;CCR2;GUCY1A1;INPP5A;PLCG2;NUDT4;PDPK1;CCR6;BTK;CHRM3;DGKD;MCU;PLCG1;TRPM4;MCTP1;CXCR4;LRRK2
prerank,erythrocyte development (GO:0048821),0.6132831027631744,1.1671098596665648,0.32756132756132755,1.0,1.0,3/10,9.12%,ALAS2;ABCB10;ZBTB7A
prerank,tRNA modification (GO:0006400),-0.2993145915978105,-1.1670218296508745,0.14893617021276595,0.6961239626324179,1.0,31/62,27.77%,PUS10;PUS7;ANKRD16;TRMT1;DTWD2;NSUN2;DUS2;WDR4;QTRT1;ELP5;TRIT1;TYW5;TRMT61B;MTO1;METTL2A;METTL2B;TPRKB;METTL1;FTSJ1;THADA;THUMPD1;ALKBH1;TRMT10A;TRMT12;LCMT2;THUMPD2;GTPBP3;TRMT9B;TRMT13;BCDIN3D;DTWD1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.37308797520806264,-1.1669189369330617,0.1952662721893491,0.6942825875043865,1.0,16/22,41.34%,ROBO1;MIA3;VEGFA;FGF2;GPLD1;EFNB2;KDR;SRF;NR4A1;EGR3;ID1;EMP2;GREM1;EPHB4;CDH5;SLIT2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5628292022924041,1.1662991364170332,0.30051150895140666,1.0,1.0,3/17,4.25%,UBASH3A;EZR;PTPN22
prerank,regulation of apoptotic process (GO:0042981),0.48204296145474096,1.165992968511883,0.032,1.0,1.0,160/676,19.40%,TOP2A;KIF14;CDK1;STIL;BIRC5;ECT2;MAD2L1;USP27X;BARD1;CYP1B1;PLK1;ARHGEF5;STK26;PMAIP1;ANP32B;AQP1;IAPP;LEF1;E2F1;SKP2;DDAH2;PDCD2;IKZF3;DAPK2;TIAM1;NET1;FLNA;SLK;CD38;PTPA;CD74;ANKLE2;CD44;GLS2;APAF1;PIDD1;TFPT;PA2G4;TNFSF10;ARHGEF18;UBE2O;PHLDA3;TFRC;FOXO1;CASP2;FAF1;ATM;ARHGEF3;LCMT1;TRADD;DPEP1;PTMA;SETX;ARF4;BIRC2;ARL6IP1;MAP3K5;UBE2Z;DDRGK1;PIM2;HMGB1;BIRC6;BOK;PIM3;SAP18;CIB1;TNFAIP8;RNF157;ERC1;JAK2;SOS1;ZBTB7A;EGFR;RNPS1;ERCC3;PIM1;PRR7;ACTN2;SOCS2;PAWR;MAP3K11;MELK;PARK7;SIGMAR1;ATF6;XIAP;CCAR2;JUN;ATF5;IFT57;FLT3;FAS;MYD88;NAA16;TOMM70;FGD3;APEX1;FBXO11;RACK1;ANP32E;ING3;ING5;BEX2;ACTN4;PRKDC;LATS1;GLO1;CREBBP;MYC;BCL6;CFLAR;PSEN1;BAG1;BAG3;PPIA;MYDGF;HTATIP2;CASP9;TPT1;GSK3B;STK4;PDCD10;TP53;MAP3K20;TFAP4;PAK2;TAF9;ARHGDIA;STEAP3;JAK3;VHL;NLRP2B;SIRT1;XBP1;SH3RF1;HSP90B1;ANO6;ARL6IP5;PNMA2;UBA52;AVEN;NDRG1;SNCA;STK17B;RARG;RBM25;MED1;ARHGEF7;MALT1;ADAM10;CLN3;HDAC1;RPS6;HIPK3;RPS3;STK3;PAX2;TRAF6;SOX9;CASP8
prerank,B cell differentiation (GO:0030183),0.5086516342021252,1.1653947373199287,0.2714285714285714,1.0,1.0,17/46,23.12%,MS4A1;CD79A;TCF3;CD79B;NFAM1;PLCG2;ZBTB7A;FLT3;CEBPG;DNAJB9;JAK3;SYVN1;HDAC4;NHEJ1;ITGA4;HDAC9;ADAM17
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.4961428227966992,1.1647833449849956,0.27052631578947367,1.0,1.0,19/61,16.94%,PSMB7;PSMD11;PSMF1;PANK2;AZIN1;CAV1;PSMC1;PSMC3;PSMA4;PSMC4;OAZ1;PSMD13;PSME1;PRKAG2;PSMB1;PSMD8;PSME4;PSMD4;SIRT1
prerank,lipoprotein localization (GO:0044872),-0.4613889476292925,-1.1647668696552331,0.2596491228070175,0.6976110771736916,1.0,6/11,24.57%,LRP1;ZDHHC17;MIA3;CD36;UNC119B;ZDHHC3
prerank,negative regulation of histone acetylation (GO:0035067),0.6112076854819606,1.1646562921371324,0.30239099859353025,1.0,1.0,5/11,17.91%,BRCA1;TAF7;SIN3A;SIRT1;SNCA
prerank,protein modification by small protein removal (GO:0070646),0.4805647104951919,1.1645237885930586,0.141,1.0,1.0,86/252,21.36%,CDK1;CLSPN;USP27X;BARD1;CDC20;CCNA2;BRCA1;CDC25A;SKP2;USP1;SENP1;PSMB7;BABAM1;PSMD11;TFPT;ABRAXAS1;PSMF1;SNX3;ACTR5;INO80D;IKBKG;MDM4;USP38;TRAF3;PSMC1;BIRC2;DESI2;DESI1;TAB1;USP48;USP31;ASXL1;PSMC3;RAD23A;TOR1A;PSMA4;RUVBL1;SMAD4;BECN1;KAT2B;PTEN;PSMC4;BAP1;ARRB2;HCFC1;UCHL5;USP14;PSMD13;PSME1;MYC;USP24;USP15;PSMB1;VCPIP1;TADA3;TP53;OTUD5;HGS;PSMD8;USP50;YOD1;FOXK2;PSME4;USP21;USP25;PSMD4;USP40;UBA52;USP7;DDB2;MAP3K7;SENP6;STAM;TRAF6;COPS3;USP34;ACTL6A;KEAP1;SMAD2;INO80E;RIPK1;MDM2;OTUD7A;USP47;USP46;COPS2
prerank,extracellular transport (GO:0006858),0.6027768258426733,1.164352679743883,0.2998624484181568,1.0,1.0,2/12,7.02%,SPA17;SPEF2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5578448309664783,1.1643230877707123,0.2884371029224905,1.0,1.0,3/18,7.93%,SPA17;SPEF2;OFD1
prerank,negative regulation of transport (GO:0051051),0.501171607385208,1.1638704428342368,0.27641408751334046,1.0,1.0,16/51,17.91%,PRTN3;ERBB3;SNX33;SNX3;MTMR2;ITGAV;EPHA3;ABCA7;PIP4P2;PTEN;RACK1;EGF;ARL6IP5;FCGR2B;MCTP1;SNCA
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.428514971808176,-1.16367141047109,0.27715355805243447,0.6983319793225763,1.0,7/14,26.84%,ANK3;SLC9A1;DMD;ATP1B1;GLRX;CHP1;WNK2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5605629725165083,1.1636671936131175,0.3147410358565737,1.0,1.0,6/17,22.05%,ITGA1;PTPA;PPP1R15A;PPP1R12A;CALM3;PPP1R15B
prerank,positive regulation of B cell proliferation (GO:0030890),0.536752243352216,1.1633896775429167,0.30127462340672073,1.0,1.0,4/29,5.04%,TNFSF13B;CD38;CD74;TFRC
prerank,cellular response to organic cyclic compound (GO:0071407),0.4814870730674438,1.1632696196877526,0.2122122122122122,1.0,1.0,22/141,10.64%,RAD51;SLC5A5;CYP1B1;BRCA1;AQP1;BLM;CTNNA1;EZR;HCN3;CRHBP;TAF1;PDE12;ZFP36L1;PDE2A;AHR;GNAI1;EGFR;P2RY1;EGR1;RIOK3;RUVBL2;MSN
prerank,peptidyl-threonine modification (GO:0018210),0.4910427971474698,1.1632057463517227,0.27424400417101147,1.0,1.0,17/66,15.76%,CDK1;CIT;MAPK1;OXSR1;CHEK1;TAF1;PRKCA;MARK2;PDPK1;HIPK2;DYRK1A;LMTK2;ROCK2;PRKDC;STK39;GSK3B;MAP2K1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.38401822685029785,-1.1631510811367665,0.26011560693641617,0.6975252114137676,1.0,8/19,18.07%,CSF1R;CMKLR1;AKIRIN1;MPP1;PTK2;CSF1;MDK;THBS1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6201362061362549,1.162884225982904,0.3092485549132948,1.0,1.0,1/10,1.40%,CYP1B1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.43783493638366255,-1.1622169564467768,0.2669039145907473,0.6978442731063379,1.0,8/12,33.19%,HPRT1;PRPS2;PPAT;AMPD2;GART;PRPSAP2;PRPS1;PRPS1L1
prerank,regulation of programmed cell death (GO:0043067),0.4825473957685511,1.1620823064919261,0.1843687374749499,1.0,1.0,51/161,20.98%,BIRC5;STK26;PMAIP1;ANP32B;SKP2;IKZF3;DAPK2;SLK;GLS2;APAF1;PIDD1;DCPS;CASP2;ATM;LCMT1;BIRC2;JAK2;ZBTB7A;ACTN2;IFT57;FLT3;FAS;TOMM70;APEX1;FBXO11;ANP32E;BEX2;ACTN4;CREBBP;BCL6;HTATIP2;TPT1;TP53;MARK4;ACER3;STEAP3;JAK3;SIRT1;NDRG1;RARG;RBM25;LRRK2;MALT1;RPS3;PAX2;SOX9;ALK;DAPK1;BNIP3;WRN;RIPK1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.38489286992605876,-1.1618777391408233,0.21739130434782608,0.696615672747358,1.0,12/20,28.31%,FHOD1;FMNL2;STRIP1;NCKAP1L;RHOQ;FHOD3;DLG1;LLGL1;PLEK;FMNL3;LLGL2;ARF6
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5638634247651736,1.1616291599406636,0.31683168316831684,1.0,1.0,6/19,16.74%,DAPK2;CD74;RIPOR2;RAC2;MCU;RAC1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5983481444320635,1.161599939760626,0.3157894736842105,1.0,1.0,2/12,3.25%,TK1;UCK2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4881950148816942,1.1607879936113288,0.24897959183673468,1.0,1.0,20/85,16.46%,UHRF1;RAB33B;DEAF1;CDK6;NR1D1;ZFP36L1;RUNX3;TGFA;LAMC1;EGFR;B2M;MTSS1;PEX2;FGF9;PRKDC;MYC;LIMS1;TCF7L2;TGFB2;NLRC3
prerank,serine family amino acid metabolic process (GO:0009069),-0.3958103989631123,-1.160689781600986,0.24267782426778242,0.697762277190711,1.0,11/16,42.91%,SARS1;CDO1;PSPH;SHMT2;SHMT1;SEPHS2;SRR;CBS;THNSL2;CTH;DAO
prerank,detection of calcium ion (GO:0005513),-0.4310752054267064,-1.1606313424186103,0.2792452830188679,0.6958334351455916,1.0,7/13,33.95%,SYT1;RYR2;CALM1;STIM1;KCNMB2;CALM2;KCNMB4
prerank,regulation of interleukin-12 production (GO:0032655),0.5124214821036344,1.1602585607493328,0.289587852494577,1.0,1.0,10/47,13.80%,MEFV;CD47;IL16;FOXP1;HMGB1;MAPK14;PLCG2;MAST2;PLCB1;PIBF1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.48971118072655406,1.1602478257945807,0.2579001019367992,1.0,1.0,20/85,16.38%,KIF14;FOXM1;ARHGEF18;ARHGDIB;MMD2;RASGRP1;CRKL;DENND4C;NOTCH1;ARFGAP1;GRB2;JAK2;STARD8;RDX;ARHGEF28;DENND1A;PDCD10;BCR;ARHGDIA;TGFB2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5681694863676141,1.1601875856731299,0.3138020833333333,1.0,1.0,2/17,2.65%,CCNE1;PDCD2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5563243399712948,1.159729765887918,0.2962962962962963,1.0,1.0,8/18,26.30%,AQP1;ZFP36L1;HNRNPU;ZFP36L2;PCK2;KLF9;BCL2L11;UBE2L3
prerank,regulation of interferon-gamma production (GO:0032649),0.49272496310503777,1.1594926112997208,0.26109391124871,1.0,1.0,13/71,14.12%,IL12A;CD2;CD47;ZFPM1;PTPN22;CCR2;RASGRP1;HMGB1;CYRIB;IL1R1;DDIT3;CEBPG;IL27
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5790811085523604,1.1593806936272513,0.32684824902723736,1.0,1.0,3/14,5.33%,PISD;CHKB;PCYT2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.526521020119593,1.1593774698308807,0.29689298043728424,1.0,1.0,6/29,13.15%,FOXA2;VASN;FUZ;ADIPOR1;PTEN;SPRED2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.47789885121084125,1.1592682209041503,0.022,1.0,1.0,162/807,16.25%,CENPF;DEPDC1;E2F7;BIRC5;AURKB;E2F8;FOXM1;UHRF1;GFI1;NKX6-1;MYB;HMGB2;EZH2;RCOR2;MEN1;PLK1;SUV39H1;BRCA1;SMARCC2;NR4A2;HMGA1;DAP;HEY2;RBM15;DEAF1;LEF1;E2F1;UXT;RB1;RIOX1;RSF1;FLNA;ELK4;CBX5;CD38;EZR;TWIST1;ZFPM1;MCPH1;PML;BCL7A;FBXW11;TIMELESS;PA2G4;HDAC10;UBE2I;MTA3;RPS6KA5;EPC1;CTCF;SCMH1;FOXP1;ETS2;DACH1;SP100;CAV1;CDKN2A;NR1D1;NKAP;TAF1;MBD2;FOXO1;MDM4;E2F6;BCL11A;PBXIP1;MBD1;TCF3;ARID4A;GMNN;RUNX3;HDAC6;PDE2A;KLF10;TAF7;NOTCH1;XRCC6;HMGB1;AHR;SFMBT1;SPEN;SAP18;MAX;PSPC1;NEDD4L;SMARCA4;CIR1;CIPC;RPS14;ZBTB16;ETV6;NCOA5;ZBTB7A;SIN3B;NONO;ZNF148;MECP2;PFDN5;TFDP2;CPEB3;ZBTB32;IRF2BPL;NR2C2;NR2F2;KAT6A;ID4;ZEB1;TRIM33;CUX1;MXI1;EHMT1;ARID5B;SUMO1;RTF1;SMAD4;CCAR2;PEX2;JUN;ATF5;PLCB1;MTA2;FOXP2;ZNF25;CBFB;RNF2;BAP1;SETDB2;PRDM6;HCFC1;ZBTB33;SP3;ZBTB7B;HNRNPU;SIRT7;NIPBL;DDIT3;CREBBP;SKI;MYC;BCL6;NFX1;PSEN1;POU6F1;CNOT1;YEATS2;LIMS1;ATF7IP;MOSPD1;TP53;LRRFIP1;RUNX1;LIMD1;IRF8;POU2F1;JARID2;SIN3A;TCF7L2;HIVEP1;TFAP4;DUSP22;FOXK2;TRIM28
prerank,regulation of organelle assembly (GO:1902115),0.4957209611313379,1.158900861726734,0.26163391933815927,1.0,1.0,24/72,19.50%,STIL;CDKL1;TBC1D1;EZR;TBC1D22B;CEP295;EVI5;RAB1B;GSN;CEP76;ALMS1;MSN;RDX;NPRL3;DYNLT2B;SDCCAG8;RAB5A;IFT140;ADPRH;RNF4;SENP6;STAM;RABEP2;SGSM3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5037129350523821,1.1588669271979952,0.2946236559139785,1.0,1.0,2/51,0.92%,KIF20B;NTF4
prerank,organelle fusion (GO:0048284),-0.38297543822516994,-1.1586754180409844,0.2512820512820513,0.6990167219836533,1.0,12/22,28.35%,EEA1;STX4;MFN2;MIEF1;MIGA2;MFF;SPG7;VPS11;AFG3L2;USP30;MFN1;MIEF2
prerank,neutral amino acid transport (GO:0015804),0.5326510415906731,1.158527443411022,0.3136574074074074,1.0,1.0,2/28,2.20%,SLC38A5;SLC1A5
prerank,protein deubiquitination (GO:0016579),0.47818159018377,1.1583698219235774,0.149,1.0,1.0,69/242,17.72%,CDK1;CLSPN;USP27X;BARD1;CDC20;CCNA2;BRCA1;CDC25A;SKP2;USP1;PSMB7;BABAM1;PSMD11;TFPT;ABRAXAS1;PSMF1;SNX3;ACTR5;INO80D;IKBKG;MDM4;USP38;TRAF3;PSMC1;BIRC2;DESI2;TAB1;USP48;USP31;ASXL1;PSMC3;RAD23A;PSMA4;RUVBL1;SMAD4;BECN1;KAT2B;PTEN;PSMC4;BAP1;ARRB2;HCFC1;UCHL5;USP14;SPATA2;PSMD13;PSME1;MYC;USP24;USP15;PSMB1;VCPIP1;TADA3;TP53;OTUD5;HGS;PSMD8;USP50;YOD1;FOXK2;PSME4;USP21;USP25;PSMD4;USP40;UBA52;USP7;DDB2;MAP3K7
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5470398592713361,1.1575514662575384,0.3137973137973138,1.0,1.0,4/20,10.75%,RB1;TWIST1;DDRGK1;PARK7
prerank,regulation of dendrite extension (GO:1903859),-0.3911511524833782,-1.1566106087656105,0.25,0.7027734526645293,1.0,6/18,13.40%,RIMS1;RIMS2;SYT1;PLAA;SYT4;UNC13A
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3657011916953484,-1.1565860489429425,0.2411764705882353,0.7007536557808639,1.0,5/23,2.96%,CSF1R;CMKLR1;STK10;AKIRIN1;AIF1
prerank,apoptotic process (GO:0006915),0.4791526162018464,1.156566771546985,0.174,1.0,1.0,51/203,15.68%,CIT;CD2;JADE1;ESPL1;PMAIP1;DAP;IAPP;IL2RA;TCHP;DAPK2;ERBB3;FAP;PRKCE;LIG4;APAF1;PIDD1;BRAT1;STK11;CHEK1;CYFIP2;IKBKG;FOXO1;CASP2;TRADD;TRAIP;PAEP;AHR;BOK;CIB1;ZBTB16;JAK2;RFK;ERCC3;TNFAIP1;PPP1R15A;PAWR;MELK;IFT57;BCL2L13;FAS;MYD88;RNF152;FXR1;MAGI3;MYC;CFLAR;PPIA;CASP9;STK4;PLAGL1;PAK5
prerank,regulation of cartilage development (GO:0061035),0.5560135568366662,1.1556067066120632,0.3235294117647059,1.0,1.0,5/18,11.80%,SOX6;PTHLH;MBOAT2;ZBTB16;TAPT1
prerank,positive regulation of calcium ion import (GO:0090280),-0.45686559574269836,-1.1553153735459458,0.23826714801444043,0.7019110711847354,1.0,8/12,49.08%,CCL3;SPHK2;CCL2;PDGFRB;CXCL12;STC1;RAMP3;ATP2A1
prerank,nuclear pore complex assembly (GO:0051292),0.608397919449895,1.1553140436318727,0.34770114942528735,1.0,1.0,5/10,12.33%,NDC1;NUP107;NUP205;AHCTF1;NUP98
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5655280591450025,1.155005852094631,0.32697201017811706,1.0,1.0,4/16,19.39%,SOX6;HOXB4;TGFB2;SOX9
prerank,regulation of cell population proliferation (GO:0042127),0.47668190843504904,1.1548837447657598,0.035,1.0,1.0,125/691,17.11%,PRC1;KIF20B;SHCBP1;KIF14;TTK;E2F7;CDKN3;BIRC5;PRTN3;FOXM1;UHRF1;HMGB2;EZH2;RAB33B;TIPIN;MEN1;CYP1B1;CDKN2C;HMGA1;ITGA1;PPP1R9B;LEF1;CD47;FBXO5;IL7R;CCDC88A;ERBB3;GLMN;TIAM1;S100A11;PPM1D;PML;TIMELESS;ARID2;COPS9;PGF;CTCF;STK11;TFRC;CDK6;CDKN2A;CRKL;PTHLH;RPS4X;MDM4;RBBP4;ZFP36L1;TGFA;BIRC2;KLF10;CDC25B;NOTCH1;XRCC6;TSPO;DDRGK1;PIM2;BIRC6;BOK;FUZ;CIB1;JAK2;ITGAV;STRN;EGFR;CDKN2D;CAPN1;CUL3;MECP2;DHPS;DERL2;PTPN14;XIAP;JUN;FGF9;ATF5;KAT2B;RPRD1B;DPP4;FLT3;PTEN;BAP1;S1PR2;PDS5B;BMPR1A;STAT5B;RPS9;RPS15A;ING5;PRKDC;SLURP1;TMEM115;SKI;MYC;BCL6;NAP1L1;CDC7;IRS1;SGK3;KDM4C;LIMS1;ADAMTS1;PDCD10;TP53;JUNB;RUNX1;EGF;F2R;PIAS1;PTPRU;ELN;HGS;MAP2K1;TNFRSF11A;CNOT6;TCF7L2;FGFR1;TFAP4;DUSP22;TGFB2;ACER3;VHL;SIRT1;SSR1;XBP1;TRPM4
prerank,anion transmembrane transport (GO:0098656),0.49713374270456234,1.1545085976222427,0.2631578947368421,1.0,1.0,17/67,18.00%,SLC38A5;SLC25A21;SLC25A12;SLC7A1;SLC6A5;SLC16A12;SLC35A2;SLC35A1;LRRC8B;LRRC8C;SLC19A1;SLC25A22;SLC35C2;SLC25A13;SFXN1;ARL6IP5;SLC35B1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.47373281654794547,1.1544663854632746,0.199,1.0,1.0,38/175,16.94%,TNFRSF18;ADAMTS7;EDARADD;BRCA1;TNFSF13B;PSMB7;PSMD11;CRHBP;TANK;PSMF1;NR1D1;TRADD;ZFP36L1;TRAF3;PSMC1;GBP2;BIRC2;CIB1;JAK2;PSMC3;TNFRSF13B;PSMA4;DHX9;PSMC4;NFE2L2;PSMD13;PSME1;ACTN4;PSMB1;LIMS1;TP53;PSMD8;TNFRSF11A;ZFP36L2;PSME4;CCL25;PSMD4;SIRT1
prerank,negative regulation of protein catabolic process (GO:0042177),0.509129835631413,1.1539957346731862,0.3031973539140022,1.0,1.0,9/40,13.00%,MAD2L1;FLNA;AZIN1;SNX3;MDM4;PIN1;EGFR;CDK5RAP3;NELL1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5355766718058516,1.1534788575133004,0.30186480186480186,1.0,1.0,6/27,7.07%,MAPK1;FBXW11;IKBKG;CCDC88C;CCM2;MAP3K5
prerank,non-motile cilium assembly (GO:1905515),0.5236190657870788,1.1534413881421393,0.3244803695150115,1.0,1.0,11/30,13.80%,CEP89;DISC1;FUZ;CEP250;GORAB;TBC1D32;PCM1;IFT57;ARL13B;BBS4;PIBF1
prerank,regulation of neuron differentiation (GO:0045664),0.4918256482677725,1.153389438519184,0.2515527950310559,1.0,1.0,17/76,18.13%,ECT2;NTF4;CDK5RAP2;TIAM1;GPRC5B;MMD2;YWHAH;TCF3;MMD;ZEB1;CDK5RAP3;NRCAM;SIN3A;TCF4;FGFR1;MED1;LRRK2
prerank,regulation of establishment of protein localization (GO:0070201),-0.44267103043826395,-1.1532070687104046,0.27626459143968873,0.705092163083532,1.0,4/13,8.22%,CTSD;TREM2;CORO2B;PTP4A3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.500721548283539,1.1530518915452392,0.28739316239316237,1.0,1.0,16/47,19.38%,FOXM1;MAPK1;ULK4;RASGRP1;FOXO1;EGFR;CARD9;FAS;MYC;PPIA;PDCD10;MAP2K1;TGFB2;ARL6IP5;TAOK1;LGALS9
prerank,cell chemotaxis (GO:0060326),0.4929516556003202,1.152962062405246,0.2900523560209424,1.0,1.0,12/60,17.65%,HMGB2;CXCR5;LEF1;CCR2;CCR6;ARRB2;NRP1;LPAR1;ELMO2;CCL25;PARVA;CXCR4
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5207226917153905,1.1526165162918385,0.29282407407407407,1.0,1.0,5/29,10.57%,IL12A;CCR2;HMGB1;JAM2;CCR6
prerank,L-amino acid transport (GO:0015807),0.5283083518229881,1.152283172114327,0.30787037037037035,1.0,1.0,3/28,2.84%,SLC38A5;SLC25A12;SLC7A1
prerank,ion transport (GO:0006811),0.48400422752459515,1.152225995835534,0.23356926188068755,1.0,1.0,11/111,7.26%,SLC4A1;CHRNB4;SLC12A3;SLC5A5;P2RX1;VDAC2;ANO10;KCNN4;SLC12A7;SLC12A1;TSPO
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5101581749471346,1.1520884453073812,0.31520532741398444,1.0,1.0,12/34,20.48%,FLNA;NEDD9;CRKL;CIB1;CRK;NRP1;LIMS1;TRIOBP;RAC1;ARHGEF7;S100A10;ILK
prerank,peptidyl-arginine modification (GO:0018195),0.56439819162036,1.1519781070873345,0.32396251673360105,1.0,1.0,6/15,21.42%,ART3;KRTCAP2;PARK7;NDUFAF5;PRMT7;PADI4
prerank,regulation of cellular pH (GO:0030641),0.5202086682014653,1.1519459055719365,0.3087400681044268,1.0,1.0,8/29,19.26%,SLC4A1;SLC9A8;SLC9A9;ATP6AP1;ATP5F1B;CLN3;SLC9A7;SLC9A6
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3869063091267072,-1.1519088333739373,0.24175824175824176,0.7063709610005465,1.0,11/21,16.26%,HS6ST3;NDST3;HS3ST4;B3GAT3;EXT2;SULF1;HS6ST2;EXTL3;XYLT2;HPSE;HS3ST5
prerank,regulation of Golgi organization (GO:1903358),0.5632553968403162,1.151644641477209,0.3181818181818182,1.0,1.0,7/17,18.96%,RAB33B;MAPK1;STX5;ARMH3;PDCD10;MAP2K1;PDE4DIP
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4667409494256267,-1.1507383843707233,0.28846153846153844,0.707422886564522,1.0,3/10,6.37%,UPP2;NT5M;DPYD
prerank,motile cilium assembly (GO:0044458),-0.44328446805708954,-1.1507125138116856,0.2805755395683453,0.7054758136693611,1.0,7/12,35.08%,E2F4;SPATA6;BBS5;CCDC39;DNAAF3;CCDC40;RSPH9
prerank,phospholipid catabolic process (GO:0009395),-0.36566575814577873,-1.1504680620606127,0.25,0.7040592104680709,1.0,6/24,14.96%,GPCPD1;ABHD12;ENPP2;GDE1;PLBD2;SMPDL3A
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4500018680220727,-1.1504426360194042,0.2627986348122867,0.7020896112654971,1.0,5/11,18.07%,CD34;CD200;ATP6AP2;CD46;THBS1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.44795140892086044,-1.1502165033306384,0.3088803088803089,0.7007473219268394,1.0,6/12,25.47%,PARP6;PARP16;PARP2;TNKS2;PARP3;TNKS
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4984624944067157,1.1500942498854874,0.28407908428720086,1.0,1.0,6/63,5.04%,IL12A;SLC7A1;TNFSF13B;CD38;CD74;TFRC
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5806316707210611,1.1499008435385274,0.34,1.0,1.0,5/11,15.26%,PUM2;PUM1;DHX9;FXR1;LIMD1
prerank,protein phosphorylation (GO:0006468),0.473830980924894,1.1498525741220804,0.088,1.0,1.0,112/478,16.38%,TTK;CDK1;BIRC5;AURKB;BLK;CLSPN;CIT;NEK2;MASTL;CCNA2;INCENP;CCNE1;PLK1;STK26;CHEK2;MAPK1;CDKL1;AURKA;OXSR1;DAPK2;FYN;SLK;PRKCE;HASPIN;MAP2K6;RSKR;ERG;RPS6KA5;MAP4K1;STK11;MAPKAPK3;CHEK1;CDK6;GRK6;TLK1;GMFG;TAF1;SIK2;ATM;RUNX3;CSNK1A1;STK38L;MAP3K5;CDC25B;PIM2;CDK17;AKT3;PKN2;BIRC6;CSNK1G2;PIM3;MAP3K1;BAZ1B;MAP4K2;PRKX;HCST;MAPK14;PRKCA;PRKACA;ERC1;STK38;PICK1;MARK2;JAK2;LMTK3;MAST2;STK24;EGFR;EPHA3;PIM1;PDPK1;MAP4K5;CDK19;HIPK2;TESK2;MAP3K11;MELK;DYRK1A;VRK1;BTK;RELN;FLT3;CCNT1;PRKCB;RPS6KA6;BMPR1A;LMTK2;GRK2;ROCK2;PRKDC;PRKAG2;LATS1;CDK16;STK39;FAM20A;NRBP1;HTATIP2;CDC7;USP15;GSK3B;SGK3;STK4;MAP3K20;BCR;PAK5;MAP2K1;MARK4;FGFR1;LIMK2;PAK2;CDK8;TGFB2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3969258504525903,-1.1496183757074547,0.24528301886792453,0.7002907758094074,1.0,13/17,41.34%,ROBO1;MIA3;VEGFA;FGF2;GPLD1;EFNB2;KDR;SRF;NR4A1;EGR3;GREM1;EPHB4;SLIT2
prerank,nucleotide biosynthetic process (GO:0009165),0.5622658525793078,1.149392937213615,0.34615384615384615,1.0,1.0,3/18,5.88%,RRM2;RRM1;RRM2B
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.47001361393815366,-1.149335061595737,0.2916666666666667,0.6990475903751534,1.0,6/10,20.99%,TREM2;CD68;TLR4;MIA3;CD36;TICAM1
prerank,RNA destabilization (GO:0050779),0.5582523662245785,1.1491281619563238,0.3240152477763659,1.0,1.0,11/18,25.28%,ZC3H18;FTO;PUM1;METTL16;ROCK2;DXO;METTL14;ROCK1;CELF1;MEX3D;GIGYF2
prerank,negative regulation of potassium ion transport (GO:0043267),0.5792586065836898,1.1485866649459362,0.32793522267206476,1.0,1.0,4/13,13.69%,CAV1;NEDD4L;ACTN2;STK39
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.26511808458109676,-1.1483311976430877,0.16129032258064516,0.6998370678069639,1.0,22/80,13.86%,STX6;TBC1D14;STX16;GBF1;SNX5;VTI1B;RAB6B;TBC1D23;VPS50;TMED9;TBC1D10A;PREPL;TRIM27;SGSM2;TBC1D5;CLN5;GOSR2;ARL1;WASHC1;YKT6;TBC1D17;GOSR1
prerank,positive regulation of immune system process (GO:0002684),0.5610297292390258,1.148258206098104,0.3235294117647059,1.0,1.0,1/16,0.75%,TNFRSF18
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5943112790936795,1.1477797990224574,0.33558863328822736,1.0,1.0,2/11,7.51%,KLRD1;AHR
prerank,Golgi to lysosome transport (GO:0090160),-0.45967652276729,-1.1476560289392006,0.28618421052631576,0.6996957745302279,1.0,2/11,3.57%,GAK;LAMP1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5016771212185906,1.1476095053301072,0.30612244897959184,1.0,1.0,18/46,21.75%,RB1;NRDC;MAP2K6;STK11;ACOT11;NR1D1;NOTCH1;LAMA4;NOVA2;ACOT13;DDIT3;LGR4;ADAMTS5;TLE3;ACVR2B;RBPJ;PLCL1;NR1H3
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.5976085208620076,1.1475053057100661,0.3497191011235955,1.0,1.0,1/11,1.81%,NR4A2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5778326070280854,1.14708762262023,0.3314285714285714,1.0,1.0,2/12,1.91%,RFWD3;RPA2
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5325840496836928,1.1468691391199506,0.31597633136094677,1.0,1.0,10/25,20.76%,FBXL15;CCN1;UBE2O;NOTCH1;SMAD4;BMPR1A;NUMA1;ACVR2B;RBPJ;SMAD2
prerank,positive regulation of protein transport (GO:0051222),0.48982589591537695,1.1460409474799236,0.290625,1.0,1.0,13/67,15.07%,KIF20B;ARHGEF5;PCNT;EZR;MYOM1;MYH10;PCM1;CNST;OAZ1;RACK1;PPIA;PDCD10;RIPOR1
prerank,spliceosomal snRNP assembly (GO:0000387),0.5090953962762466,1.1458921643608253,0.30201342281879195,1.0,1.0,15/38,20.50%,PRPF19;GEMIN8;SNRPF;SNRPC;SART3;LSM2;PRPF31;CLNS1A;SRSF10;SART1;GEMIN7;SNRPG;PRPF8;SNRPB;PRMT7
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5642540379617615,1.1457506744340342,0.33376455368693403,1.0,1.0,7/17,24.16%,PANK2;CAV1;ADIPOR1;PRKAG2;EIF6;PPARD;PRKAB2
prerank,ncRNA transcription (GO:0098781),0.5796637393062,1.1457026411552669,0.3365650969529086,1.0,1.0,7/13,20.59%,BRF1;SNAPC3;NIFK;SIRT7;POLR1G;RPAP2;SPIN1
prerank,lysine metabolic process (GO:0006553),0.5867234749492641,1.1455259989542201,0.3328729281767956,1.0,1.0,1/12,1.71%,SLC25A21
prerank,lysine catabolic process (GO:0006554),0.5867234749492641,1.1455259989542201,0.3328729281767956,1.0,1.0,1/12,1.71%,SLC25A21
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5358777302755591,1.1452590599013603,0.3197604790419162,1.0,1.0,7/24,17.90%,SDHAF4;COQ10B;COX10;GFPT2;MYC;SLC25A13;NDUFS1
prerank,response to lipid (GO:0033993),0.47612344045686494,1.145186405156989,0.25353535353535356,1.0,1.0,28/105,21.34%,IL12A;HMGB2;ALPL;PTPN22;S100A9;MAPKAPK3;SLPI;FOXP1;S100A8;FOXO1;JAK2;CDKN2D;ABCA2;ASXL1;SOCS2;HNRNPA0;STAT5B;OTUD5;F2R;TNFRSF11A;RXRB;SNCA;RARG;LGALS9;SOX9;PPARD;PCK2;RPS6KA3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3406703630028377,-1.1449924211128157,0.1968503937007874,0.7046908979841173,1.0,15/31,20.25%,TANC2;PPFIA2;CDK5R1;ARHGAP44;CUX2;CDK5;CAMK2B;LRP8;EPHA4;ABI2;SHANK3;CAPRIN1;CFL1;KIF1A;ZDHHC15
prerank,gluconeogenesis (GO:0006094),-0.30951606596275694,-1.1446473765715492,0.20202020202020202,0.7036795907666377,1.0,17/39,23.17%,GPI;GOT2;ENO1;ALDOA;ATF4;TPI1;PGM1;PGAM1;G6PC3;SLC25A11;ALDOC;SLC39A14;PER2;ENO2;CRY1;PPARGC1A;ENO3
prerank,nuclear envelope organization (GO:0006998),0.5426690732330988,1.144541248459558,0.3231939163498099,1.0,1.0,5/20,10.91%,NEMP1;REEP4;SUN2;EMD;TOR1A
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5822670935949473,1.1445353350925982,0.34346103038309117,1.0,1.0,5/13,16.70%,IL2RG;GRB2;PLCB1;STAT5B;JAK3
prerank,cellular response to interleukin-15 (GO:0071350),0.5822670935949473,1.1445353350925982,0.34346103038309117,1.0,1.0,5/13,16.70%,IL2RG;GRB2;PLCB1;STAT5B;JAK3
prerank,modulation by symbiont of entry into host (GO:0052372),0.5555909008660544,1.1443497936010496,0.32645161290322583,1.0,1.0,4/16,14.46%,EXOC2;CAV1;TRIM68;TRIM5
prerank,organic acid transport (GO:0015849),0.4807262704587992,1.1439722060708049,0.27411167512690354,1.0,1.0,13/94,11.68%,SLC6A12;SLC38A5;SLC1A5;SLC7A1;SLC16A1;ABCC2;SLC25A47;SLC16A10;SLC43A2;SLC3A1;SLC19A1;STARD5;ABCC4
prerank,glutathione metabolic process (GO:0006749),-0.30879161687938855,-1.143919694671975,0.22321428571428573,0.703685962678042,1.0,9/38,17.38%,HPGDS;CTNS;HAGH;CNDP2;GGT5;GSS;CHAC2;GPX1;OPLAH
prerank,T cell proliferation (GO:0042098),0.5747584495635875,1.1433052410327427,0.327027027027027,1.0,1.0,3/13,16.94%,RASGRP1;MSN;LMBR1L
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5478090070768697,1.142330499336237,0.33251833740831294,1.0,1.0,8/20,15.40%,ERBB3;CASP2;BOK;ITGAV;FAS;CASP9;GSK3B;APPL1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5908831499247735,1.142228772169799,0.33,1.0,1.0,6/12,19.02%,STMN1;DYRK1A;SNCA;ARHGEF7;TBCD;EML2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.573472848042704,1.141783736995197,0.34370771312584575,1.0,1.0,5/13,16.35%,CD74;AGPAT1;TRIM44;DHX9;TAF9
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6008679695345798,1.1414035355009093,0.32535211267605635,1.0,1.0,2/10,3.54%,PMAIP1;PRKCE
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5857020046486862,1.1413178937301072,0.33793103448275863,1.0,1.0,6/13,19.49%,NKAP;RUNX3;CBFB;ZBTB7B;RUNX1;PNP
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4728352138086252,1.1410459519324843,0.21342685370741482,1.0,1.0,37/170,14.55%,TCF19;TRIM58;TMPRSS4;AFF3;MEFV;AFF1;CTCF;FOXP1;CDK6;NKAP;PTHLH;ZFP36L1;ZUP1;PIN1;MTMR2;AHR;NOVA2;TRIM11;SART3;PCBP2;TRIM44;ZNF462;PRDM10;ATXN7L3B;UBAP2;IGF2BP3;NPAT;TRIM68;PRDM6;NELL1;ROCK2;FLOT1;MYC;PSEN1;HNRNPAB;TRIM5;PCBP3
prerank,actin polymerization or depolymerization (GO:0008154),0.4937613303818085,1.1407508100735693,0.3081896551724138,1.0,1.0,5/50,9.26%,DIAPH3;GSN;JAK2;CFL2;FLII
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.49227019416024503,1.14042444903527,0.30148619957537154,1.0,1.0,7/56,12.63%,TTK;INHBC;PMEPA1;PIN1;SMAD4;SNX25;BMPR1A
prerank,import into nucleus (GO:0051170),0.4832699019159478,1.1401143433053569,0.28378378378378377,1.0,1.0,32/73,22.65%,POM121;NUP107;GEMIN8;BACH2;TNPO1;SNRPF;IPO13;NUP50;NUP214;SEC13;IPO7;NUP188;RANBP6;RPAIN;HTATIP2;E2F3;APPL1;IPO5;GEMIN7;KPNB1;SNRPG;HNRNPA1;EIF4ENIF1;NUP85;MMP12;SNRPB;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2
prerank,protein autoubiquitination (GO:0051865),0.48631695811629977,1.1393644009005637,0.3075313807531381,1.0,1.0,25/61,24.33%,UBE2T;UHRF1;BRCA1;RNF157;RAD18;RNF141;CUL3;AMFR;RNF8;CNOT4;TRIM68;NFX1;RNF115;SH3RF1;RNF4;TRIM37;DDB2;TRAF6;RNF213;MDM2;LRSAM1;UHRF2;OBI1;ITCH;RNF41
prerank,response to interleukin-6 (GO:0070741),0.6027167136205719,1.1390901250955603,0.3362193362193362,1.0,1.0,1/10,0.77%,FOXA2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4859008691441908,1.1387081179746463,0.29381443298969073,1.0,1.0,4/69,3.65%,KIF14;NTF4;ERBB3;LIG4
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4676977436380264,1.1376041120930906,0.24448897795591182,1.0,1.0,41/163,17.72%,CD19;BLK;ERMAP;MS4A1;CD79A;GRAP2;PSMB7;FYN;CD38;PSMD11;FBXW11;PTPN22;PSMF1;IKBKG;CD79B;PSMC1;NFAM1;PLCG2;BTN3A3;PDPK1;PSMC3;BTK;PSMA4;PRKCB;PSMC4;PRAM1;DENND1B;PSMD13;PSME1;THEMIS;PSMB1;RBCK1;RC3H1;PSMD8;PAK2;PSME4;PLCG1;PIK3CA;PSMD4;SPPL3;MAP3K7
prerank,T cell differentiation in thymus (GO:0033077),0.5757021017853223,1.1375342170710547,0.3575418994413408,1.0,1.0,4/14,15.99%,LIG4;ZFP36L1;CCR6;ZFP36L2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5816257539712117,1.136962031220697,0.35704323570432356,1.0,1.0,4/12,17.51%,SERINC5;SERINC3;SEPHS1;PHGDH
prerank,extracellular matrix assembly (GO:0085029),0.5236255255497972,1.1369268941549415,0.3157248157248157,1.0,1.0,6/23,12.53%,HAS1;LAMB2;LAMB3;NTNG2;ATP7A;EFEMP2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.4583516414537694,-1.136910521474924,0.314878892733564,0.7199695767764805,1.0,6/11,54.17%,RTP4;PKD2L1;PKD1L3;LPO;RTP2;TAS1R3
prerank,regulation of organelle organization (GO:0033043),0.4815525767993814,1.1369088121349074,0.2899590163934426,1.0,1.0,27/80,19.75%,RAB33B;ARHGEF5;PISD;MAPK1;EZR;S100A9;S100A8;STX5;PDE2A;ARL6IP1;MARK2;MSN;RDX;FIS1;ARMH3;SIRT7;DIAPH1;PDCD10;TBC1D25;MTM1;PAK2;LMAN1;TAOK1;CLN3;PDE4DIP;SAR1B;GOLPH3
prerank,regulation of platelet activation (GO:0010543),0.5311051129687148,1.1369039312854012,0.3440993788819876,1.0,1.0,1/21,0.41%,BLK
prerank,positive regulation of neutrophil migration (GO:1902624),0.5621066408624015,1.1368481761815141,0.3290978398983482,1.0,1.0,6/18,16.74%,DAPK2;CD74;RIPOR2;RAC2;MCU;RAC1
prerank,regulation of synapse assembly (GO:0051963),-0.3187314306241308,-1.1364417734792518,0.17045454545454544,0.7192071547706479,1.0,9/46,11.81%,APP;LRFN5;PTPRD;SYNDIG1;IL1RAP;CLSTN3;LRRC4B;CLSTN1;CUX2
prerank,negative regulation of metabolic process (GO:0009892),0.49187661236820523,1.1363287718774084,0.3058201058201058,1.0,1.0,20/54,21.75%,RB1;NRDC;MAP2K6;STK11;ACOT11;NR1D1;NOTCH1;LAMA4;NOVA2;ACOT13;FIS1;ZDHHC7;DDIT3;LGR4;ADAMTS5;TLE3;ACVR2B;RBPJ;PLCL1;NR1H3
prerank,glucan biosynthetic process (GO:0009250),0.5698215859853735,1.1361841831357935,0.3267605633802817,1.0,1.0,2/12,5.37%,PGM2;NR1D1
prerank,glycogen biosynthetic process (GO:0005978),0.5698215859853735,1.1361841831357935,0.3267605633802817,1.0,1.0,2/12,5.37%,PGM2;NR1D1
prerank,sensory perception of taste (GO:0050909),-0.4666488543230264,-1.1360357224010453,0.2786259541984733,0.7182381927725275,1.0,4/10,34.39%,CD36;PKD2L1;ASIC1;PKD1L3
prerank,positive regulation of histone acetylation (GO:0035066),0.5335839723217661,1.135713142157869,0.3412604042806183,1.0,1.0,8/23,19.01%,BRCA1;RPS6KA5;RUVBL2;SMAD4;PAXIP1;TADA2A;GLYR1;BRD7
prerank,protein localization to lysosome (GO:0061462),-0.3377787413887814,-1.1354885151254193,0.25517241379310346,0.7177665643993817,1.0,9/28,14.09%,RTN4;GGA3;RNF128;MFSD1;SNX16;SCARB2;GLMP;LAMTOR5;NAGPA
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.5849969585866444,1.1354706149795832,0.35704125177809387,1.0,1.0,2/12,10.58%,CCR2;IL1R1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.49597930320338274,1.1353649346207175,0.3288888888888889,1.0,1.0,2/39,1.86%,BLK;TFR2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.4676822125047907,1.1352327503035797,0.183,1.0,1.0,94/241,20.84%,RBM15;LSM6;DHX38;POLR2I;SNRNP25;PRPF19;POLR2A;IK;SNRPF;HNRNPC;SNRPC;HNRNPM;HNRNPL;HNRNPA3;CPSF2;CRNKL1;PPIL3;U2AF1;SNRNP200;UBL5;EIF4A3;SRSF3;SPEN;TXNL4A;RNPC3;HNRNPA2B1;PSPC1;NOVA2;SART3;SRSF4;NCBP1;PRPF38A;LSM2;SNRNP35;RALY;NONO;CASC3;RNPS1;U2AF1L4;PPWD1;SRRT;CSTF3;RBM19;PCBP2;PRPF31;DHX9;HNRNPA0;LSM5;U2SURP;UPF3B;ZMAT2;HNRNPR;CWC15;HNRNPU;SF3B5;PRPF4;TFIP11;SRRM2;PDCD7;LSM7;METTL14;SRSF10;SART1;GEMIN7;DNAJC8;SNRNP40;ESS2;POLR2K;SRSF7;CDC40;DDX39B;POLR2J;SNRPG;GCFC2;PCF11;CPSF1;PRPF8;RSRC1;CLP1;PPIE;HNRNPA1;PPIH;ELAVL1;NCBP2;ZCCHC8;SRSF2;SF3A2;SNRNP48;SNRPB;CPSF7;PPIL1;RBM4B;SYNCRIP;WDR33
prerank,regulation of mRNA stability (GO:0043488),0.4647693231168686,1.1349717740856413,0.26834170854271355,1.0,1.0,65/145,26.60%,XPO1;E2F1;PSMB7;PSMD11;PSMF1;TNPO1;EXOSC8;FTO;PDE12;ZFP36L1;PSMC1;PUM2;TAF15;NUP214;DCP2;PRKCA;PSMC3;PSMA4;PUM1;IGF2BP3;PSMC4;DCP1A;APEX1;METTL16;FXR1;ROCK2;PSMD13;HNRNPU;PSME1;PAIP1;PSMB1;METTL14;RC3H1;PSMD8;SAMD4A;ZFP36L2;PSME4;VIM;PSMD4;UBA52;ELAVL1;EIF4ENIF1;THRAP3;XRN1;ROCK1;TENT5D;CELF1;PSME2;DIS3;PRKCD;YBX1;GDNF;CIRBP;NPM1;MEX3D;PSME3;PSMD6;GIGYF2;FASTKD1;SET;YWHAZ;KHSRP;PSMA1;PSMD9;CARHSP1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.30624098673783645,-1.1348902579333446,0.23214285714285715,0.7174526947350868,1.0,13/39,18.52%,BMP2K;EPN2;MAML1;PRKCI;ROBO1;MAML3;POGLUT1;STAT3;ZMIZ1;TSPAN14;TM2D3;JAG1;NEPRO
prerank,calcium ion import into cytosol (GO:1902656),0.5620172846265229,1.1348867730311492,0.35071707953063885,1.0,1.0,1/15,1.22%,MS4A1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.47077985884597323,1.134833000990915,0.2598984771573604,1.0,1.0,30/105,18.23%,MUC19;PSMB7;FYN;PSMD11;FBXW11;RPS6KA5;PSMF1;KLRD1;IKBKG;PSMC1;TAB1;PRKACA;PLCG2;TAB3;PDPK1;PSMC3;CARD9;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;TYROBP;PSMB1;PSMD8;PAK2;PSME4;PSMD4;MAP3K7;MALT1
prerank,histone H3-K4 methylation (GO:0051568),0.5254243590776396,1.134642929250028,0.3234946871310508,1.0,1.0,8/26,14.94%,MEN1;WDR5B;DPY30;KMT2C;PAXIP1;KMT2A;RBBP5;KMT2B
prerank,negative regulation of histone methylation (GO:0031061),0.6003913693569775,1.1346028925736709,0.3429811866859624,1.0,1.0,5/10,19.61%,BRCA1;PHF1;DNMT1;JARID2;DNMT3B
prerank,action potential (GO:0001508),-0.3061412146627136,-1.134579720429753,0.1927710843373494,0.7163001696870969,1.0,11/44,11.07%,ANK3;SCN8A;GNA15;SCN1A;KCND2;GNA14;SRI;SCN9A;DMD;SCN3A;KCNA2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.35876404640786386,-1.1345384456654768,0.21022727272727273,0.7124466599391827,1.0,13/22,35.77%,GOLGA7;ZDHHC8;CLIP3;ZDHHC24;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.35876404640786386,-1.1345384456654768,0.21022727272727273,0.7124466599391827,1.0,13/22,35.77%,GOLGA7;ZDHHC8;CLIP3;ZDHHC24;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,actin filament network formation (GO:0051639),-0.4499215239239414,-1.134535354529749,0.3345070422535211,0.7104922900353566,1.0,3/11,15.33%,FHOD1;SPIRE1;FHOD3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5784630310306098,1.1341012254493663,0.3562585969738652,1.0,1.0,6/13,16.94%,TWIST1;CD74;CD44;DYRK1A;YJU2;SIRT1
prerank,cellular response to lectin (GO:1990858),0.47079132494336645,1.1340398328825092,0.2609137055837564,0.9999779596181199,1.0,30/104,18.23%,MUC19;PSMB7;FYN;PSMD11;FBXW11;RPS6KA5;PSMF1;KLRD1;IKBKG;PSMC1;TAB1;PRKACA;PLCG2;TAB3;PDPK1;PSMC3;CARD9;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;TYROBP;PSMB1;PSMD8;PAK2;PSME4;PSMD4;MAP3K7;MALT1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.47079132494336645,1.1340398328825092,0.2609137055837564,0.9999779596181199,1.0,30/104,18.23%,MUC19;PSMB7;FYN;PSMD11;FBXW11;RPS6KA5;PSMF1;KLRD1;IKBKG;PSMC1;TAB1;PRKACA;PLCG2;TAB3;PDPK1;PSMC3;CARD9;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;TYROBP;PSMB1;PSMD8;PAK2;PSME4;PSMD4;MAP3K7;MALT1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.478926558025592,1.1336290836750893,0.2894736842105263,1.0,1.0,25/94,16.41%,CYP1B1;BRCA1;PMAIP1;CHEK2;E2F1;ITPR1;PML;APAF1;MSH6;STK11;CASP2;ATM;MAP3K5;PRODH;BOK;STK24;CUL3;PPP1R15A;HIPK2;PRKDC;DDIT3;CASP9;TP53;CD24;CRIP1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.4776470451454992,1.1335306502884226,0.31780538302277433,0.9996382222008989,1.0,27/68,21.82%,POLR1B;POLR2A;SLBP;SNRPF;CPSF2;SETX;NCBP1;POLR1A;ERCC3;CSTF3;POLR1F;POLR1C;POLR2K;SCAF8;SNRPG;PCF11;CPSF1;TAF1C;CLP1;TTF2;TAF1D;POLR1G;NCBP2;SNRPB;CPSF7;WDR33;PAPOLA
prerank,sarcomere organization (GO:0045214),0.5197360812225653,1.133408960436519,0.3238434163701068,0.9989765789201464,1.0,3/27,10.21%,CSRP3;CSRP1;ACTN2
prerank,positive regulation of cellular process (GO:0048522),0.46748008434994226,1.1326909414429402,0.094,1.0,1.0,105/565,17.76%,PRC1;KIF20B;KIF14;TTK;BIRC5;PRTN3;FOXM1;ANKLE1;IL12A;TNFRSF18;EZH2;SPAG5;TIPIN;IL2RG;LEF1;CD47;FBXO5;IL7R;ERBB3;TIAM1;PPP3CA;SMC6;PA2G4;S100A9;BRAT1;COPS9;PGF;RPS19;DDX49;CHEK1;MLC1;AGPAT1;CAV1;CRKL;PTHLH;RPS4X;S100A8;FAF1;ATM;CSPP1;ZFP36L1;TGFA;CDC25B;NOTCH1;PRODH;DDRGK1;H3-3A;DYNC1H1;CIB1;PRKCA;RAD18;MTPN;ITGAV;NCBP1;EGFR;CAPN1;CUL3;MECP2;PRR7;DHPS;DERL2;ABCA7;RAD23A;FGF9;RPRD1B;DPP4;FLT3;FASN;PTEN;HCFC1;S1PR2;FXR1;RPS9;RPS15A;FLOT1;NUMA1;ACTN4;MYC;NAP1L1;PABIR1;CDC7;IRS1;KDM4C;PDCD10;EGF;F2R;TNFRSF11A;CNOT6;FGFR1;TGFB2;ACER3;VHL;CAPN10;RAC1;KLHL22;SIRT1;CYBA;SSR1;XBP1;TRPM4;HCLS1;FN1;FCGR2B;KITLG;COLEC12
prerank,heme catabolic process (GO:0042167),-0.42640901082346055,-1.1322586778455992,0.2874493927125506,0.7122529317746296,1.0,5/14,20.76%,ABCC1;HMOX2;SLCO2B1;HMOX1;BLVRA
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.42640901082346055,-1.1322586778455992,0.2874493927125506,0.7122529317746296,1.0,5/14,20.76%,ABCC1;HMOX2;SLCO2B1;HMOX1;BLVRA
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3948832562604886,-1.1318851409875657,0.26609442060085836,0.7112774467488509,1.0,11/16,40.23%,PTPRJ;PDGFD;PDGFC;PLAT;FER;PDGFRA;PTPN1;PDGFRB;BCAR1;PDGFA;RGS14
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5638844206272261,1.1315763624511703,0.3448275862068966,1.0,1.0,6/17,16.74%,DAPK2;CD74;RIPOR2;RAC2;MCU;RAC1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5704845572466104,1.1314015898513163,0.3523936170212766,1.0,1.0,4/13,12.60%,STK11;ATM;SZT2;RNF152
prerank,positive regulation of cell adhesion (GO:0045785),0.4804587693530266,1.1313169600882802,0.3154639175257732,1.0,1.0,10/74,8.84%,IL12A;TNFRSF18;ECM2;CD47;PPP3CA;ATM;CIB1;PRKCA;JAK2;ITGAV
prerank,regulation of microtubule polymerization (GO:0031113),0.5087885241495087,1.1309572272216706,0.31614349775784756,1.0,1.0,18/40,22.94%,CDK5RAP2;STMN1;CLASP1;MAPRE3;GBA2;DYRK1A;SLAIN2;NUMA1;RAC1;DRG1;SNCA;TBCD;EML2;RPS3;MET;MAPT;DCTN1;CAMSAP1
prerank,negative regulation of hippo signaling (GO:0035331),0.5768318729484924,1.1308256634404006,0.3533424283765348,1.0,1.0,2/12,8.10%,CIT;MAPK14
prerank,smoothened signaling pathway (GO:0007224),0.5083560644374652,1.129624495365706,0.3181818181818182,1.0,1.0,1/32,0.26%,STIL
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5657243698325595,1.129350935528945,0.3643835616438356,1.0,1.0,5/13,16.70%,IL7R;JAK2;PIGU;EGF;JAK3
prerank,positive regulation of chemotaxis (GO:0050921),-0.3044796674029261,-1.129275669682319,0.24761904761904763,0.715913811900882,1.0,14/43,20.09%,TREM2;AIF1;STX4;PRKD1;STX3;P2RY12;CDH13;LGMN;PPM1F;VEGFA;FGF2;MDK;THBS1;P2RX4
prerank,rRNA modification (GO:0000154),0.5340171987979373,1.1292051120616053,0.3388746803069054,1.0,1.0,9/21,17.98%,ZCCHC4;NOP10;TFB1M;TFB2M;FBL;NSUN3;DIMT1;NAT10;DKC1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4807655065558814,1.1292018339405856,0.31385281385281383,1.0,1.0,18/52,15.98%,LSM6;DCPS;EXOSC8;PDE12;DCP1B;DCP2;LSM2;EDC3;PNLDC1;TUT4;CNOT4;LSM5;DCP1A;CNOT1;LSM7;RC3H1;CNOT6;SAMD4A
prerank,rRNA methylation (GO:0031167),0.5379128736174594,1.1291617707972275,0.35135135135135137,1.0,1.0,9/22,15.24%,ZCCHC4;TFB1M;TFB2M;EMG1;METTL15;FBL;METTL16;NSUN3;DIMT1
prerank,phagolysosome assembly (GO:0001845),-0.43888681699797416,-1.128747135718688,0.3111888111888112,0.715277256912167,1.0,3/12,10.81%,RAB14;RAB20;SYT7
prerank,positive regulation of cell population proliferation (GO:0008284),0.46694622494696936,1.1285988501970696,0.118,1.0,1.0,74/423,17.70%,PRC1;KIF20B;KIF14;TTK;BIRC5;PRTN3;FOXM1;EZH2;TIPIN;AQP1;LEF1;E2F1;CD47;FBXO5;IL7R;ERBB3;TIAM1;CCN1;LIG4;CD74;CCN4;COPS9;PGF;FOXP1;CDK6;CRKL;PTHLH;RPS4X;TGFA;CDC25B;NOTCH1;DDRGK1;CIB1;LAMC1;ITGAV;EGFR;CAPN1;CUL3;PIM1;MECP2;DHPS;DERL2;DHX9;FGF9;RPRD1B;DPP4;FLT3;PTEN;S1PR2;BMPR1A;RPS9;RPS15A;HNRNPU;MYC;NAP1L1;CDC7;IRS1;KDM4C;PDCD10;EGF;F2R;TNFRSF11A;CNOT6;TCF7L2;FGFR1;TGFB2;ACER3;SIRT1;SSR1;XBP1;TRPM4;HCLS1;FN1;KITLG
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.38139180937199774,-1.1280274270408244,0.30288461538461536,0.7151907531292784,1.0,5/17,12.31%,ZDHHC17;PCSK6;FSTL1;SULF1;DOK5
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.47341817327585095,1.128025421966051,0.25325325325325326,1.0,1.0,33/140,15.42%,ECT2;FOXM1;RACGAP1;DEPDC1B;ARHGEF5;ARHGAP15;ARHGAP11A;ARHGAP33;TIAM1;NET1;ARHGEF18;ARHGDIB;ARHGEF3;FAM13A;ARHGAP35;CYRIB;SOS1;ITGAV;ARHGAP19;GMIP;RHOU;STARD8;ARHGAP39;RELN;ARHGAP30;FGD3;ARHGAP9;RAC2;ARHGAP45;ARHGAP26;ARHGAP31;BCR;FAM13B
prerank,negative regulation of protein binding (GO:0032091),0.47791605102380524,1.1279352241376162,0.296218487394958,1.0,1.0,20/71,19.04%,AURKB;AURKA;DDX11;ZFPM1;SLPI;CAV1;DISC1;PIN1;PARK7;B2M;ARRB2;RACK1;TFIP11;GSK3B;STYX;PEX14;PPP1CA;LRRK2;GNL3L;CDKN1A
prerank,negative regulation of defense response to virus (GO:0050687),0.593449589602382,1.1272308325014837,0.3538681948424069,1.0,1.0,4/10,18.87%,RNF26;PCBP2;TARBP2;PPM1B
prerank,B cell activation (GO:0042113),0.4816243651138434,1.1268886484683382,0.3037578288100209,1.0,1.0,25/68,23.12%,MS4A1;CD79A;BANK1;RASGRP1;TCF3;CD79B;NFAM1;PLCG2;FCRL1;ZBTB7A;BTK;FLT3;PRKCB;CEBPG;DNAJB9;JAK3;HDAC4;MALT1;CASP8;NHEJ1;GPR183;ITGA4;HDAC9;PHB2;ADAM17
prerank,regulation of protein metabolic process (GO:0051246),0.49752174785970865,1.126708502784631,0.31641468682505397,1.0,1.0,10/44,15.64%,FAM83D;CHEK2;FAF1;TRAF3;NEDD4L;MTPN;ABCA7;ROCK2;SPOP;HGS
prerank,brain morphogenesis (GO:0048854),0.5840174913444325,1.1264289231333418,0.352,1.0,1.0,5/12,13.42%,FBXW11;SPEF2;PAFAH1B1;PTEN;BBS4
prerank,amino acid import across plasma membrane (GO:0089718),0.5338212277178906,1.1249714306583543,0.32689987937273823,1.0,1.0,3/24,3.20%,SLC1A5;SLC7A1;SLC6A5
prerank,glycosphingolipid metabolic process (GO:0006687),-0.30920655611189873,-1.1248984571213647,0.23943661971830985,0.7215119549604584,1.0,15/42,21.67%,HEXB;CTSA;PSAP;ST8SIA1;LARGE1;ST6GALNAC6;B4GALNT1;GALC;ST8SIA5;CERK;GLA;ST6GALNAC3;CLN6;ST8SIA3;GLB1
prerank,pre-replicative complex assembly (GO:0036388),0.474750523695213,1.1246852614252556,0.31524008350730687,1.0,1.0,19/64,17.60%,PSMB7;PSMD11;MCM6;ORC5;PSMF1;ORC3;GMNN;PSMC1;PSMC3;PSMA4;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;MCM3;PSME4;PSMD4;UBA52
prerank,skeletal system morphogenesis (GO:0048705),0.49848668391385537,1.1244531296591151,0.3198247535596933,1.0,1.0,9/42,16.04%,RAB33B;RFLNB;SPEF2;FUZ;HHIP;SKI;ANKRD11;HOXB4;FGFR1
prerank,small GTPase mediated signal transduction (GO:0007264),0.47215000244148553,1.1241689385937654,0.2909090909090909,1.0,1.0,35/103,19.84%,CCNA2;RRAD;ARHGAP33;RB1;CCDC88A;GRAP2;TIAM1;NTN1;ARHGEF18;RASGRP1;CDKN2A;CRKL;CCDC88C;MAPK14;GRB2;SOS1;DNMT1;RIT2;PARK7;ARHGAP30;JUN;PLD2;PLD1;TP53;ARHGAP31;BCR;USP50;TRIM28;RAC1;RASSF1;SETDB1;CDKN1A;KSR1;ARHGAP1;G3BP1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.47252988245800354,1.1241411026115744,0.3142559833506764,1.0,1.0,22/73,17.70%,MYB;PDCD2;PSMB7;PSMD11;PSMF1;TCF3;PSMC1;PSMC3;PSMA4;CBFB;PSMC4;KMT2A;PSMD13;PSME1;PRKDC;PSMB1;METTL14;RUNX1;PSMD8;PSME4;PSMD4;KITLG
prerank,regulation of stem cell proliferation (GO:0072091),0.5437677179752242,1.1241304436822799,0.35657894736842105,1.0,1.0,2/17,6.62%,HMGB2;ZFP36L1
prerank,steroid biosynthetic process (GO:0006694),0.48416298266958213,1.1237849054535431,0.32150537634408605,1.0,1.0,9/56,13.57%,HSD17B3;LBR;SRD5A2;LSS;OSBPL3;CYP27A1;SLC27A2;CYP46A1;PRKAG2
prerank,positive regulation of heart rate (GO:0010460),-0.3971686457961232,-1.1237229489292095,0.3056768558951965,0.7226871059577461,1.0,5/17,21.88%,RYR2;ADRA1A;ADRA1B;ADRB1;SCN3B
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5861688040439655,1.123416546537187,0.3561253561253561,1.0,1.0,5/10,28.49%,TYROBP;CD24;FN1;LAPTM4B;HSP90AB1
prerank,protein localization to cilium (GO:0061512),-0.3181113107440807,-1.1233401325696024,0.2882882882882883,0.7217033519222811,1.0,15/32,27.22%,TULP3;ZNF423;ARL6;WDR35;INVS;TCTN1;CSNK1D;RABEP1;WDR19;TULP2;SNX10;ARL3;TCTN2;BBS1;TUB
prerank,positive regulation of chemokine production (GO:0032722),-0.29661211760609285,-1.1230047473162268,0.19298245614035087,0.7206482007071721,1.0,9/44,7.25%,APP;CSF1R;MBP;LPL;AIF1;PYCARD;TLR7;MAVS;TLR4
prerank,positive regulation of metabolic process (GO:0009893),-0.2506060193058073,-1.1228517459181415,0.15789473684210525,0.7191640375148226,1.0,30/103,18.84%,IGF1R;KDM1A;EBF2;CMKLR1;APPL2;LPIN1;ESRRG;ACLY;IL4R;ACACA;ACADL;GNAS;PPARGC1B;MFN2;PRLR;HDAC3;PDGFC;ELOVL6;VEGFA;IL18;EPAS1;GJA1;GRB10;HADH;CD36;ADRB1;KDM3A;PER2;ADRB2;KDM6B
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4824205513296155,1.1227442530702008,0.3188097768331562,1.0,1.0,11/52,13.32%,MBNL3;RBM15;HNRNPL;SAP18;NOVA2;ZBTB7A;RNPS1;RBFOX3;RBM7;FXR1;HNRNPU
prerank,defense response to fungus (GO:0050832),0.5454668160197474,1.1222095630180409,0.362002567394095,1.0,1.0,4/17,10.74%,S100A9;S100A8;PLCG2;CARD9
prerank,regulation of blood coagulation (GO:0030193),0.5134579326904565,1.1221302087029283,0.35487661574618096,1.0,1.0,3/27,5.28%,FOXA2;FAP;CAV1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.32398928993655,-1.1220964860020703,0.26495726495726496,0.719052497658318,1.0,11/32,22.81%,RREB1;AKIRIN1;ENPP2;PIK3R1;CORO1C;ARPC2;ABI2;TWF2;CDC42;CORO1B;CYFIP1
prerank,"transcription, DNA-templated (GO:0006351)",0.46457394231228216,1.1220496389312486,0.24899598393574296,1.0,1.0,62/207,19.94%,PAX5;PMF1;TRIP13;NR4A2;GTF3C5;DEAF1;E2F1;SMARCA5;RSF1;GTF2E1;DEK;POLR2I;POLR2A;EPC1;TAF1;MBD1;PTMA;SETX;IRF9;BRF1;TFDP1;TAF7;TAF15;IWS1;TFB2M;GTF2A1;NCBP1;SNAPC3;RNPS1;ERCC3;KLF13;BTF3;RTF1;TAF6;NELFA;CCNT1;CBFB;ARRB2;TEFM;ZBTB7B;TAF2;NFX1;POLR1C;GMEB2;CCNK;TP53;NELFB;TAF9;POLR2K;PIR;MLLT1;XBP1;POLR2J;TAF1C;DRG1;TTF2;NKX2-8;HIPK3;NCBP2;NCOA6;GTF2A2;TAF3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4274039991279073,-1.121875195483076,0.30935251798561153,0.71768055212571,1.0,7/13,28.98%,SEC16A;EDEM2;BCAP31;CD81;EDEM1;SAR1A;SORL1
prerank,alcohol catabolic process (GO:0046164),0.5893493971096042,1.1218638861086587,0.3635077793493635,1.0,1.0,4/10,15.32%,CEL;CYP27A1;CYP46A1;SRD5A3
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5748237915381961,1.1217711721520578,0.3756906077348066,1.0,1.0,3/13,11.17%,HEY2;NOTCH1;SMAD4
prerank,regulation of interferon-beta production (GO:0032648),-0.3024629945805801,-1.1216755866181491,0.24193548387096775,0.7162879369487758,1.0,11/46,7.88%,SIRPA;HSP90AA1;POLR3C;PTPRS;PYCARD;TLR7;RNF135;POLR3A;MAVS;TLR4;IRF1
prerank,protein targeting to peroxisome (GO:0006625),0.5148293668887018,1.1216212178097287,0.32590855803048063,1.0,1.0,9/29,12.03%,PEX26;ABCD1;ACBD5;PEX11B;PXMP4;GDAP1;PEX2;RAB8B;FIS1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4692709144895586,1.1215102211305508,0.27895266868076535,1.0,1.0,39/122,17.26%,ZCCHC4;RBM3;ABCB10;PCNA;EIF3E;ATAD5;SLC25A37;RPS4X;FAF1;SORBS1;EIF4A3;NIBAN1;DNA2;JAK2;MTPN;SMOC2;EGFR;CPEB3;DHX9;BRPF3;CTC1;UPF3B;FXR1;PRKDC;MYC;IRS1;PLD1;METTL14;EGF;PYM1;SAMD4A;EEF2;TGFB2;VIM;SIRT1;NAT10;XBP1;LARP4B;POLDIP3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5256947576132501,1.1214204867156132,0.3485221674876847,1.0,1.0,6/22,11.85%,ERI2;KRI1;EXOSC8;EXOSC10;URB1;ERI1
prerank,macrophage differentiation (GO:0030225),-0.43044862044810384,-1.121142230278479,0.29856115107913667,0.7157707640444353,1.0,5/13,18.87%,CSF1R;VEGFA;CSF1;IL31RA;CDC42
prerank,activation of protein kinase A activity (GO:0034199),-0.39245859085251766,-1.1209596636676642,0.3055555555555556,0.7143825938109967,1.0,4/16,4.86%,PRKACB;PRKAR1A;ADCY7;ADCY2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5382780935916884,1.1204171964118934,0.3506815365551425,1.0,1.0,8/18,22.31%,SPN;ITGB7;JAM2;ADD2;GOLPH3;GCNT1;ROCK1;ITGA4
prerank,protein K63-linked ubiquitination (GO:0070534),0.4936493718847727,1.1203844943252192,0.34075723830734966,1.0,1.0,20/41,24.60%,UBE2T;PRPF19;UBE2O;TRAF3;UBE2V1;RNF168;RNF8;RNF152;ARIH2;TRIM5;RNF115;TRAF3IP2;RNF4;UBE2G1;TRAF6;UBE2N;HECTD1;NEDD4;ITCH;UBE2S
prerank,RNA modification (GO:0009451),-0.2802610774720758,-1.1203091755336905,0.2647058823529412,0.714241532971096,1.0,22/54,18.53%,ADARB1;ADAR;PUS7;ANKRD16;TRMT1;DTWD2;NSUN2;NSUN4;JMJD6;WDR4;QTRT1;ELP5;TRIT1;TYW5;NOP2;METTL1;FTSJ1;MEPCE;THUMPD1;FTSJ3;ALKBH1;PARN
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4653236075631973,-1.120050587022534,0.33003300330033003,0.7129476268123784,1.0,1/11,0.60%,TREM2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.4365953193667578,-1.1199785826057131,0.3368055555555556,0.7112546447178628,1.0,7/11,29.94%,CD34;ITGB3;VEGFA;HPSE;NDNF;KDR;SRF
prerank,endocytic recycling (GO:0032456),-0.28358560635493535,-1.119879367894236,0.2923076923076923,0.7096805434382132,1.0,18/50,20.70%,RAB14;STX6;VPS39;EHD4;ACAP2;RAB11FIP3;VPS50;ANKRD27;SNX27;CMTM6;WASHC1;CCDC22;EPS15;VPS51;VPS26C;ENTR1;PTPN23;VPS26A
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5004046287359248,1.1192610152482105,0.34555555555555556,1.0,1.0,7/37,10.95%,RNASE6;PPP1R8;ENTPD3;ENTPD5;DNASE1L1;NCBP1;NUDT9
prerank,regulation of response to stress (GO:0080134),0.5859661540734306,1.1189724136038022,0.35520684736091296,1.0,1.0,2/10,5.16%,CRHBP;MLC1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.3954051762744969,-1.118605243913758,0.3089430894308943,0.7110466300142537,1.0,10/15,44.89%,TRIM27;ATP1A2;CBARP;SLC30A1;PACSIN3;ADRA2A;NOS1;PLN;EPO;STC1
prerank,digestive tract development (GO:0048565),-0.3409534765421853,-1.118550146442565,0.2932330827067669,0.7093287721441662,1.0,9/32,20.59%,SALL1;SMO;PCSK5;CLMP;PKD1;GLI3;EDNRB;PKDCC;CCDC39
prerank,necroptotic process (GO:0070266),-0.38882364877733605,-1.118547082379079,0.2834008097165992,0.7074989317625759,1.0,9/16,27.42%,ITPK1;DNM1L;TLR4;LY96;TICAM1;IPMK;TICAM2;MLKL;CD14
prerank,nucleocytoplasmic transport (GO:0006913),0.4973966759338165,1.1183348837416076,0.3461962513781698,1.0,1.0,16/40,20.17%,XPO1;GEMIN8;BACH2;SNRPF;NCBP1;NUP205;NUP98;HTATIP2;GEMIN7;AAAS;SNRPG;RSRC1;MALT1;HNRNPA1;NCBP2;SNRPB
prerank,regulation of interleukin-17 production (GO:0032660),0.5024326027731095,1.1181486590754408,0.34502262443438914,1.0,1.0,5/31,13.56%,IL12A;CARD9;MYD88;ZBTB7B;DDIT3
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.46081700058688685,1.1178886342462233,0.212,1.0,1.0,100/264,20.84%,RBM15;LSM6;DHX38;POLR2I;SNRNP25;PRPF19;GEMIN8;POLR2A;SCAF11;IK;DCPS;SNRPF;HNRNPC;SNRPC;HNRNPM;HNRNPL;HNRNPA3;CPSF2;CRNKL1;PPIL3;U2AF1;SNRNP200;UBL5;EIF4A3;SRSF3;SPEN;TXNL4A;RNPC3;HNRNPA2B1;PSPC1;NOVA2;SART3;SRSF4;NCBP1;PRPF38A;LSM2;SNRNP35;RALY;NONO;CASC3;RNPS1;U2AF1L4;PPWD1;SRRT;CSTF3;RBM19;PCBP2;PRPF31;DHX9;HNRNPA0;LSM5;U2SURP;UPF3B;ZMAT2;HNRNPR;CWC15;HNRNPU;SF3B5;PRPF4;TFIP11;CLNS1A;SRRM2;PDCD7;LSM7;METTL14;SRSF10;SART1;GEMIN7;DNAJC8;SNRNP40;ESS2;POLR2K;SRSF7;CDC40;SRPK1;DDX39B;POLR2J;SNRPG;GCFC2;PCF11;CPSF1;PRPF8;RSRC1;CLP1;PPIE;HNRNPA1;PPIH;ELAVL1;NCBP2;ZCCHC8;SRSF2;SF3A2;SNRNP48;SNRPB;CPSF7;PPIL1;RBM4B;PRMT7;SYNCRIP;WDR33
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5042161285880404,1.1174164906167978,0.3485714285714286,1.0,1.0,9/32,16.94%,PMAIP1;PML;STK11;PHLDA3;BOK;HIPK2;TP53;TMEM109;SIRT1
prerank,cellular response to increased oxygen levels (GO:0036295),0.5772982224282788,1.1173867349169557,0.34153005464480873,1.0,1.0,5/11,17.11%,CAV1;FOXO1;FAS;ATP6AP1;ATP6V0D1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.520829444887808,1.1169110663199477,0.3480278422273782,1.0,1.0,6/26,10.93%,FMOD;ST3GAL1;SLC35D2;ST3GAL2;B3GNT2;OGN
prerank,mitochondrial translational termination (GO:0070126),0.4725419233096647,1.116841452986988,0.3166496424923391,1.0,1.0,21/88,17.25%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MTRF1L;MRPS34;MRPL38
prerank,xenobiotic transport (GO:0042908),-0.38611559451001887,-1.1168293834770178,0.3055555555555556,0.709941315098679,1.0,3/17,6.30%,ABCC5;ABCC3;ABCC1
prerank,activation of phospholipase C activity (GO:0007202),0.5098962129267013,1.116591792000792,0.352046783625731,1.0,1.0,3/29,3.43%,NTF4;S1PR4;HTR2A
prerank,positive regulation of dendrite extension (GO:1903861),-0.39115955187814866,-1.1165084685853195,0.30660377358490565,0.709007702044852,1.0,6/17,13.40%,RIMS1;RIMS2;SYT1;PLAA;SYT4;UNC13A
prerank,mitochondrial translational elongation (GO:0070125),0.47035123552372793,1.1153316599964371,0.31568228105906315,1.0,1.0,20/88,17.25%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MRPS34;MRPL38
prerank,global genome nucleotide-excision repair (GO:0070911),0.5191309246380736,1.1152122060906606,0.37132784958871917,1.0,1.0,6/26,17.70%,ERCC4;CHD1L;ERCC3;RNF111;UBA52;DDB2
prerank,peripheral nervous system development (GO:0007422),0.528717430340367,1.1151073848490858,0.36395759717314485,1.0,1.0,3/23,9.64%,NTF4;ERBB3;PMP22
prerank,supramolecular fiber organization (GO:0097435),0.4633352631302702,1.1147663350288777,0.202,1.0,1.0,45/333,11.42%,KIF18B;KIF14;KIF2C;MYO5C;TMOD4;SPTA1;KIF24;KIF18A;CKAP5;CYP1B1;STMN1;DES;TUBGCP6;IAPP;PPP1R9B;SAMD14;MYO15A;CCDC88A;SLK;HSPG2;PLOD3;CRTAP;TUBGCP4;GSN;CCDC88C;COL1A2;RND3;PIN1;SHROOM2;H3-3A;DYNC1H1;CIB1;COL4A4;TSPAN33;LAMB3;FLII;PCM1;WHAMM;KIF2A;ATP7A;SHROOM4;B2M;SLAIN2;GGA1;TLL2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.40043783101059377,-1.1147450740065834,0.2793522267206478,0.7114529964996474,1.0,9/15,29.54%,SMAD1;ITGA5;PKM;VEGFA;FGF2;BMPER;KLF4;JMJD8;TJP1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5744168731647846,1.1146033762108207,0.34401114206128136,1.0,1.0,5/13,23.15%,CD177;TYROBP;MAPT;SYK;PRKCD
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.28998477655728666,-1.1144712524142975,0.2692307692307692,0.7103311811788294,1.0,9/48,12.97%,TREM2;PTPN2;RFFL;PADI2;YTHDF2;ROBO1;SH2B3;GPS2;CARD16
prerank,protein localization to nucleus (GO:0034504),0.46398776529042784,1.1142670617947683,0.3086294416243655,1.0,1.0,40/102,21.99%,PLK1;POM121;PML;NUP107;TNPO1;IPO13;NUP50;GBP2;NUP214;ZBTB7A;SEC13;IPO7;NUP188;ABCA7;TOR1A;RANBP6;CNEP1R1;RPAIN;CHCHD10;HNRNPU;BBS4;INTS13;NOL8;E2F3;APPL1;IPO5;KPNB1;YWHAE;MORC3;EIF4ENIF1;NUP85;MMP12;TAF3;TPR;TNPO2;WRN;MDM2;TNPO3;SYK;NUP93
prerank,plasma membrane tubulation (GO:0097320),0.5636808912594409,1.1142648832817663,0.3864864864864865,1.0,1.0,4/13,12.41%,SNX33;SNX9;WHAMM;PACSIN2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4766663947435345,1.113894680729978,0.322884012539185,1.0,1.0,20/67,19.13%,ECM2;FLNA;NEDD9;PLEKHA2;CDK6;CRKL;CIB1;JAK2;CRK;NRP1;RSU1;GSK3B;LIMS1;TRIOBP;RAC1;CCL25;UTRN;FN1;ARHGEF7;S100A10
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5145084206833443,1.1137923794663398,0.35040745052386496,1.0,1.0,7/26,11.91%,CCNB1;CDC25B;PKN2;PRKCA;SMOC2;CUL3;CCDC57
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5681011239134754,1.1133229863964031,0.38268156424581007,1.0,1.0,7/12,17.78%,RNF168;RNF8;NELFA;HNRNPU;NELFB;TCERG1;HEXIM1
prerank,regulation of actin nucleation (GO:0051125),0.5682877260306795,1.1132423174058013,0.36633663366336633,1.0,1.0,3/12,10.19%,GSN;PICK1;WHAMM
prerank,positive regulation of kinase activity (GO:0033674),0.4662171276557875,1.1132136944844269,0.31536113936927773,1.0,1.0,18/107,13.65%,CENPE;ERBB3;CCN1;LMO4;CD74;MMD2;MAPRE3;MMD;XRCC6;MRNIP;SNX9;EGFR;EPHA3;RELN;FLT3;LMTK2;PRKAG2;ADCYAP1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.5524512084949167,1.113106908728817,0.3581890812250333,1.0,1.0,8/14,26.31%,FASTKD5;TFB1M;TFB2M;TEFM;PNPT1;TFAM;FASTKD1;FOXO3
prerank,positive regulation of leukocyte migration (GO:0002687),0.5147555428664768,1.1130086807362423,0.32857142857142857,1.0,1.0,1/27,0.75%,TNFRSF18
prerank,negative regulation of intracellular protein transport (GO:0090317),0.523032604488149,1.1129486953261196,0.3485221674876847,1.0,1.0,7/22,18.66%,BARD1;SP100;RANGAP1;PARK7;LMAN1;LRRK2;SUFU
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.3422700989297068,-1.112128562002764,0.33793103448275863,0.7146083894342311,1.0,9/30,14.50%,CACNA1C;SCN1A;ANK2;ATP1A1;SNTA1;SCN1B;RYR2;FGF12;GJA1
prerank,male gonad development (GO:0008584),0.4934612796394729,1.1120594801325845,0.3416856492027335,1.0,1.0,7/34,19.39%,SRD5A2;CSDE1;FGF9;ING2;TGFB2;KITLG;SOX9
prerank,rRNA transcription (GO:0009303),0.5370441442835882,1.11198340589012,0.3468586387434555,1.0,1.0,7/17,20.59%,GTF3C5;BRF1;NIFK;TCOF1;SIRT7;POLR1G;SPIN1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5739918389390872,1.1119512801810367,0.36054421768707484,1.0,1.0,7/13,20.34%,TXN;PARK7;NFE2L2;RACK1;PDE8A;LRRK2;MET
prerank,protein K48-linked ubiquitination (GO:0070936),0.4824383570906676,1.111863540496165,0.35401069518716577,1.0,1.0,15/54,18.21%,UBE2C;UBE2T;SKP2;UBE2K;NEDD4L;CUL3;AMFR;RNF8;RNF152;ARIH2;RNF115;UBE2R2;RNF4;SYVN1;UBE2G1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5794626183682032,1.1115086728462968,0.38231292517006804,1.0,1.0,5/11,14.80%,ARID1B;CDCA4;CHEK1;SERTAD2;ELOF1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.5409449790436124,1.1114544832102375,0.37755102040816324,1.0,1.0,8/19,16.38%,HEY2;ZFPM1;MDM4;NOTCH1;SMAD4;SLIT3;BMPR1A;TGFB2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.37471223631032735,-1.1113258261485477,0.29850746268656714,0.7148435291037613,1.0,5/21,9.32%,ARHGAP25;RASAL3;LZTR1;MFN2;SH3BP1
prerank,regulation of histone acetylation (GO:0035065),0.5025054574779644,1.1111865498197366,0.34576271186440677,1.0,1.0,13/33,19.01%,BRCA1;RPS6KA5;CHEK1;TAF7;IWS1;RUVBL2;PARK7;PAXIP1;KMT2A;TADA2A;GLYR1;SNCA;BRD7
prerank,regulation of protein autophosphorylation (GO:0031952),-0.31957642704689343,-1.110123050133706,0.2647058823529412,0.7160464636949921,1.0,12/36,15.02%,IMPACT;PPP2R5C;RAP2A;PDGFD;ENG;RAP2C;PDGFC;MVP;TOM1L1;VEGFA;MRE11;CALM1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4851342446717631,1.1096860978686047,0.3296943231441048,1.0,1.0,6/49,13.80%,IL12A;TNFRSF18;JAK2;PARP14;FLT3;PIBF1
prerank,regulation of cell adhesion (GO:0030155),0.46438118284585284,1.1094814931776327,0.31180625630676084,1.0,1.0,16/129,9.97%,KIF14;IL12A;TNFRSF18;SPN;ERBB3;PPP3CA;RIPOR2;CYTIP;ARHGDIB;PPP1CB;ATM;PRKX;PRKCA;PLXNA2;ITGAV;CBLL1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5217839247837318,1.1093044062238664,0.372289156626506,1.0,1.0,5/24,9.89%,ALAS2;ABCB10;TSPO;NFE2L1;COX10
prerank,positive regulation of translation (GO:0045727),0.4613032340138516,1.1091715465475296,0.3248730964467005,1.0,1.0,31/94,20.89%,ZCCHC4;RBM3;JMJD4;EIF3E;RPS4X;BOLL;MPV17L2;EIF4A3;NIBAN1;CPEB3;DHX9;UPF3B;FXR1;RPS9;PRKDC;EIF5A2;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;TRUB2;NAT10;LARP4B;POLDIP3;ELAVL1;RPL5;AGO2;EIF6;EIF2B5
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5246850849193117,1.1089835148383629,0.3726937269372694,1.0,1.0,6/21,21.04%,HEY2;NOTCH1;ROCK2;TRPM4;SOX9;ROCK1
prerank,response to cholesterol (GO:0070723),-0.3832061382901225,-1.1089209015601542,0.29596412556053814,0.7172738543020072,1.0,9/17,19.80%,TGFBR1;SMO;OSBPL7;CCR5;GRAMD1B;TGFBR2;GPLD1;CCL3;PMVK
prerank,cellular response to exogenous dsRNA (GO:0071360),0.567933221969187,1.1089057852448516,0.3699186991869919,1.0,1.0,5/12,17.76%,CGAS;CAV1;DHX9;FLOT1;COLEC12
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3889509501394207,-1.1086160084316918,0.34080717488789236,0.7162239044872143,1.0,4/17,4.86%,PRKACB;PRKAR1A;ADCY7;ADCY2
prerank,adherens junction organization (GO:0034332),-0.283511242228324,-1.1080872597773246,0.22058823529411764,0.7159052467250391,1.0,18/48,19.52%,CDH11;CDH8;CTNNB1;CTNND1;CDH13;CDH2;CDH12;AFDN;JUP;ACTB;FERMT2;SMAD7;NECTIN4;CADM2;PIP5K1C;CADM1;ANG;CSK
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5496227124746632,1.1080406767984468,0.3602080624187256,1.0,1.0,1/14,0.97%,MYB
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.24956363704086099,-1.1079890025531316,0.25,0.7143521924513263,1.0,26/92,14.65%,RTN4;IQSEC1;ANXA3;NRP2;RREB1;GPI;BMPR2;ENPP2;PFN1;PIK3CD;PRKD1;GRN;CLASP2;ZC3H12A;ANGPT1;ITGB3;SCARB1;EPB41L4B;SPARC;PPM1F;PIK3CB;RAB11A;ADAM9;VEGFA;FGF2;MAP4K4
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.49609928902203493,1.107942314406115,0.3516609392898053,1.0,1.0,9/33,20.98%,LEF1;CD74;ZFP36L1;PRKCA;RUNX1;HCLS1;TRAF6;CASP8;RIPK1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.4665523431041423,1.1074674247857856,0.34332988624612204,1.0,1.0,31/69,22.87%,GTF2E1;POLR2I;POLR2A;INTS4;INTS9;GTF2A1;NCBP1;NABP2;SNAPC3;SRRT;INTS1;TAF6;INTS14;RPRD1B;CCNT1;INTS13;CCNK;POU2F1;TAF9;POLR2K;POLR2J;POU2F2;NCBP2;SNAPC5;GTF2A2;RPAP2;INTS12;RPRD2;TAF11;POLR2B;INTS11
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.32448811572453956,-1.1073301951469154,0.24528301886792453,0.7143007892240677,1.0,18/34,27.42%,TREM2;CD300LF;MFHAS1;PTPRS;TNFAIP3;CD300A;TLR4;GPS2;GPR108;LY96;DAB2IP;TICAM1;CACTIN;TICAM2;SMPDL3B;LYN;TYRO3;CD14
prerank,organophosphate catabolic process (GO:0046434),-0.4464746257041893,-1.1072520227488853,0.3568904593639576,0.7126954098747172,1.0,3/11,10.36%,ABHD12;ENPP2;PLBD2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.595380938097397,1.1071056073686898,0.38226744186046513,1.0,1.0,4/10,12.75%,BRCA1;CHEK1;SMAD4;KMT2A
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4263152812954092,-1.1069415770362172,0.33984375,0.7116700305436774,1.0,7/13,46.23%,NAXD;PARP16;NAXE;NAPRT;NUDT12;NAMPT;PARP10
prerank,pore complex assembly (GO:0046931),0.5321208867750475,1.1064958275449002,0.36755386565272496,1.0,1.0,10/19,21.99%,NDC1;NUP107;TSPAN33;NUP205;AHCTF1;NUP98;ANO6;ADAM10;TPR;NUP93
prerank,lymphocyte differentiation (GO:0030098),0.4754427083075,1.1061800453897654,0.34410844629822734,1.0,1.0,15/68,17.98%,LY6D;MS4A1;CD79A;PTPN22;TCF3;CD79B;NFAM1;PLCG2;ZBTB7A;FLT3;CEBPG;DNAJB9;JAK3;LMBR1L;HDAC4
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4649853647356897,1.1061625961742851,0.32896064581231077,1.0,1.0,31/101,19.40%,UHRF1;PLK1;ZCCHC4;AURKAIP1;EZR;RBM3;FBXW11;CYFIP2;EIF3E;RPS4X;FAF1;EIF4A3;NIBAN1;CPEB3;MSN;RDX;UPF3B;FXR1;PRKDC;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;NAT10;LARP4B;POLDIP3;ELAVL1;RPL5;CASP8
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2657239055640559,-1.1061038744593918,0.2,0.7119897994780916,1.0,33/75,26.02%,PAK3;APP;OPHN1;ANK3;ZDHHC17;DSCAML1;MINK1;NTNG1;RYK;S100B;BAIAP2;MAP1A;MAP6;MEF2A;CTNNA2;ACTB;CDK5;FARP1;MAP1S;LLGL1;TMEM106B;ADGRB1;RAB3A;AFG3L2;CELSR2;PARD3;SLITRK4;BRSK2;DCC;ATL1;DVL1;KLF7;SLITRK3
prerank,regulation of cell differentiation (GO:0045595),0.46131199286593205,1.105983264072359,0.2891566265060241,1.0,1.0,31/148,16.71%,HEMGN;NTF4;CDK5RAP2;ANP32B;HEY2;PDCD2;TIAM1;PA2G4;SUZ12;CDK6;NR1D1;PTHLH;CLASP1;YWHAH;ZFP36L1;MBOAT2;RUNX3;BIRC2;PRKACA;EPHA3;PRKCB;CBFB;CDK5RAP3;CREBBP;BCL6;DAG1;RUNX1;ST7;FGFR1;CD24;VHL
prerank,positive regulation of ion transport (GO:0043270),-0.2874583132468611,-1.1058644989211794,0.24444444444444444,0.7108027850971167,1.0,17/48,22.27%,ANK3;CACNB2;CNKSR3;ANK2;SCN1B;FHL1;VAMP8;VAMP7;CCL4;DLG1;WFS1;CCL3;ORAI1;P2RX4;RAB3B;SCN3B;AHCYL1
prerank,negative regulation of reproductive process (GO:2000242),0.5478239742940791,1.1056964256924715,0.3772845953002611,1.0,1.0,3/17,6.98%,NPPC;ARHGDIB;PAEP
prerank,regulation of autophagosome assembly (GO:2000785),-0.323778974390654,-1.1056788501181922,0.24615384615384617,0.7095208174488525,1.0,8/33,7.96%,TBC1D14;IFT88;TBC1D12;PIP4K2B;FEZ2;FEZ1;SH3GLB1;RAB3GAP2
prerank,Notch signaling involved in heart development (GO:0061314),0.5639917831871906,1.1052474318388432,0.37397260273972605,1.0,1.0,2/11,7.15%,HEY2;NOTCH1
prerank,protein import (GO:0017038),0.46574667813518894,1.105169701910759,0.33504624871531347,1.0,1.0,38/84,23.66%,PEX26;POM121;NUP107;SNX33;ABCD1;TNPO1;IPO13;ACBD5;NUP50;NUP214;PEX11B;PXMP4;SEC13;IPO7;NUP188;GDAP1;RANBP6;PEX2;RAB8B;FIS1;RPAIN;E2F3;APPL1;IPO5;KPNB1;PEX14;ATAD1;EIF4ENIF1;NUP85;MMP12;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2;PEX3;IPO8
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.35412636792207136,-1.105128550209735,0.2905027932960894,0.7091505470644804,1.0,7/22,14.08%,PJA2;MFHAS1;MINK1;ZC3H12A;SPI1;NCF1;VEGFA
prerank,protein destabilization (GO:0031648),0.5032552418633597,1.1049163944408147,0.3581081081081081,1.0,1.0,11/32,17.91%,PLK1;FBXW11;NR1D1;GSN;CCDC88C;CUL3;RAD23A;PEX2;CREBBP;SIRT1;SNCA
prerank,negative regulation of programmed cell death (GO:0043069),0.4573666412076025,1.104711031223165,0.225,1.0,1.0,90/355,21.34%,KIF14;CDK1;STIL;BIRC5;MAD2L1;BARD1;PLK1;AQP1;LEF1;DDAH2;FLNA;CD38;CD74;ANKLE2;CD44;PIDD1;PA2G4;UBE2O;DCPS;TFRC;FOXO1;CASP2;DPEP1;PTMA;SETX;ARF4;BIRC2;ARL6IP1;UBE2Z;DDRGK1;PIM2;BIRC6;PIM3;CIB1;TNFAIP8;RNF157;ERC1;EGFR;PIM1;SOCS2;PARK7;XIAP;ATF5;FAS;MYD88;NAA16;PRKDC;GLO1;MYC;CFLAR;PSEN1;BAG1;BAG3;MYDGF;HTATIP2;TPT1;GSK3B;PDCD10;TP53;PAK2;TAF9;ARHGDIA;VHL;SIRT1;XBP1;SH3RF1;HSP90B1;UBA52;AVEN;SNCA;MED1;MALT1;ADAM10;CLN3;HDAC1;HIPK3;PAX2;TRAF6;SOX9;GOLPH3;DSTYK;ARAF;MET;CITED2;BNIP3;RIPK1;DNAJC3;IKBKB;USP47;RPS6KA3
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.44557093202617304,-1.1044650973859123,0.33962264150943394,0.7092095054940911,1.0,5/11,20.09%,TREM2;CDH13;CCL4;CCL3;P2RX4
prerank,regulation of protein localization to centrosome (GO:1904779),0.5834319686508564,1.1039944696383392,0.3848396501457726,1.0,1.0,4/10,15.93%,CEP72;CEP250;GSK3B;MARK4
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5681705363414948,1.1038553919053251,0.3771186440677966,1.0,1.0,4/12,23.93%,CCR2;CARD9;ZBTB1;PRKCQ
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3609172158385363,-1.1038423381290876,0.3170731707317073,0.7073775693836781,1.0,11/20,30.07%,APP;ARNT;PRKAA2;IGF1;PFKFB4;PFKFB2;HIF1A;INSR;PFKFB1;MLXIPL;GAPDHS
prerank,positive regulation of glycolytic process (GO:0045821),-0.3609172158385363,-1.1038423381290876,0.3170731707317073,0.7073775693836781,1.0,11/20,30.07%,APP;ARNT;PRKAA2;IGF1;PFKFB4;PFKFB2;HIF1A;INSR;PFKFB1;MLXIPL;GAPDHS
prerank,protein-containing complex subunit organization (GO:0043933),0.4622399460526748,1.1030190823010637,0.3155241935483871,1.0,1.0,33/109,18.59%,KNTC1;CARD10;FANCA;NDC1;CD74;PML;NAPG;TUBGCP4;IKBKG;MDM4;KPNA3;SNX9;LAMC1;ZW10;NUP205;NDUFAF1;NIFK;FAS;MAGI1;NUP98;KMT2A;CHCHD10;ADD2;CREBBP;TP53;KIFAP3;FANCC;TFAP4;DARS1;PEX14;EPRS1;PPIH;SLC2A1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.39752747660558746,-1.1029348369591785,0.3463414634146341,0.707813048738127,1.0,4/16,16.00%,RELA;ALOX5;ST3GAL4;MDK
prerank,negative regulation of vascular permeability (GO:0043116),-0.4350630694902312,-1.1027968276314588,0.32950191570881227,0.7063879091844614,1.0,6/12,14.08%,PTPRJ;ANGPT1;FERMT2;SH3GL2;DDAH1;VEGFA
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.4505617445840264,-1.1021548109316368,0.34563758389261745,0.706214258682599,1.0,4/10,15.10%,APPL2;GSK3A;SELENOS;GRB10
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.4486707759634759,-1.1021319456857024,0.32441471571906355,0.7045325985015018,1.0,5/10,12.82%,PADI2;APOD;WASL;MIA3;CD200
prerank,protein K63-linked deubiquitination (GO:0070536),0.4949071917270317,1.1017432198620631,0.3690205011389522,1.0,1.0,9/31,17.64%,USP27X;BABAM1;ABRAXAS1;SPATA2;OTUD5;USP50;YOD1;USP25;USP7
prerank,glycerol metabolic process (GO:0006071),-0.45272174770510115,-1.101658732971684,0.3368421052631579,0.7039149284447633,1.0,7/10,37.03%,COQ2;TPI1;COQ3;ANGPTL3;TKFC;PDXP;GK5
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5027128775050095,1.1012881668269672,0.3598130841121495,1.0,1.0,4/29,5.28%,PMAIP1;PML;TNFSF10;CAV1
prerank,regulation of mast cell activation (GO:0033003),-0.46130411377830205,-1.1010897940440436,0.35906040268456374,0.7034788316784528,1.0,2/10,2.50%,CD84;CD300LF
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.38262768526107455,-1.1009783416865884,0.31336405529953915,0.7020595586955046,1.0,9/16,27.20%,TMEM50B;VPS36;LEPROTL1;TMEM50A;CHMP7;LEPROT;CHMP4B;CHMP4A;VPS28
prerank,cellular response to virus (GO:0098586),0.5016163182756121,1.1003779276441967,0.36941176470588233,1.0,1.0,5/30,12.08%,IL12A;POU2AF1;MAPK14;RIOK3;TOMM70
prerank,regulation of intracellular pH (GO:0051453),0.496093556566549,1.1000760099656044,0.36302142051860203,1.0,1.0,8/34,19.26%,SLC4A1;SLC9A8;SLC9A9;ATP5F1B;LRRK2;CLN3;SLC9A7;SLC9A6
prerank,regulation of protein kinase C signaling (GO:0090036),0.5507499292645801,1.0998893700467096,0.38430311231393777,1.0,1.0,4/14,14.77%,ULK4;GPD1L;DGKD;ADGRV1
prerank,nucleic acid-templated transcription (GO:0097659),0.4865260512061887,1.0995777009227388,0.3730512249443207,1.0,1.0,7/42,9.41%,NR4A2;E2F1;POLR2I;POLR2A;EPC1;PTMA;RNPS1
prerank,snRNA transcription (GO:0009301),0.46249868194624794,1.0994803391403465,0.35263702171664946,1.0,1.0,31/70,22.87%,GTF2E1;POLR2I;POLR2A;INTS4;INTS9;GTF2A1;NCBP1;NABP2;SNAPC3;SRRT;INTS1;TAF6;INTS14;RPRD1B;CCNT1;INTS13;CCNK;POU2F1;TAF9;POLR2K;POLR2J;POU2F2;NCBP2;SNAPC5;GTF2A2;RPAP2;INTS12;RPRD2;TAF11;POLR2B;INTS11
prerank,tRNA processing (GO:0008033),-0.2640374800618017,-1.0993668502204546,0.28888888888888886,0.7043756504331316,1.0,35/61,37.12%,ANKRD16;SARS1;TRMT1;DTWD2;NSUN2;WDR4;QTRT1;ELP5;TRIT1;TYW5;TSEN15;METTL1;FTSJ1;THUMPD1;TRMT10B;RPP21;RTRAF;FAM98B;TRMT10A;LCMT2;ELAC2;TRMT9B;DDX1;DTWD1;RPP40;NSUN6;POP5;CTU2;AARS2;TSEN54;POP7;THG1L;QTRT2;TRMT61A;CTU1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5571559691229429,1.099338874519558,0.3872752420470263,1.0,1.0,6/13,20.18%,CPSF2;NCBP1;TUT1;CPSF1;NCBP2;CPSF7
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.38826298598675046,-1.0990078807930401,0.3191489361702128,0.703539965227198,1.0,5/17,5.78%,RTN4;APOE;GGA3;IGF1;BIN1
prerank,sodium ion transport (GO:0006814),0.47125293142586155,1.0982828017746336,0.3346938775510204,1.0,1.0,8/85,7.95%,SLC6A12;SLC12A3;SLC5A5;SLC6A2;SLC6A5;HCN3;SLC12A1;NEDD4L
prerank,regulation of protein sumoylation (GO:0033233),0.5265831057261943,1.0977952111778557,0.38413098236775817,1.0,1.0,8/17,18.74%,SAE1;UBA2;PIAS3;EGR1;PARK7;PIAS1;HDAC4;GNL3L
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.5589457222742737,1.0977821012050828,0.38767123287671235,1.0,1.0,5/12,16.94%,CD74;CD44;ING2;TAF9;SIRT1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5647991711162402,1.097754884253924,0.38896366083445494,1.0,1.0,4/12,13.42%,NIN;NINL;PCM1;BBS4
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5602426394072917,1.0977209873309255,0.3770053475935829,1.0,1.0,4/13,7.57%,SMUG1;DUT;MBD4;NEIL1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3805195364924615,-1.0972341439208368,0.32644628099173556,0.7063575675806331,1.0,8/16,20.65%,ST8SIA1;ST6GALNAC4;LARGE1;ST6GALNAC6;B4GALNT1;ST8SIA5;ST6GALNAC3;ST8SIA3
prerank,negative regulation of secretion by cell (GO:1903531),0.4778474629460644,1.0970464360963779,0.3781979977753059,1.0,1.0,3/38,7.15%,IL12A;STXBP6;NOTCH1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3356319838954642,-1.096785444775974,0.30344827586206896,0.7056723788702054,1.0,4/26,5.31%,RIMS1;APP;RIMS2;SLC8A3
prerank,regulation of T cell cytokine production (GO:0002724),0.5520564678400098,1.096768207904253,0.37371134020618557,1.0,1.0,7/15,19.36%,CCR2;B2M;TRPM4;MAP3K7;MALT1;CD55;TRAF6
prerank,positive regulation of proteolysis (GO:0045862),0.47198977653245167,1.0966084615718703,0.374869109947644,1.0,1.0,9/55,7.99%,PLK1;NRDC;AURKAIP1;RCN3;FBXW11;SNX33;TANK;CYFIP2;SNX9
prerank,cilium organization (GO:0044782),0.45803075388234615,1.0965007162999822,0.2832832832832833,1.0,1.0,58/209,18.31%,KIF24;TSGA10IP;IFT80;EXOC2;RTTN;POC1B;PCNT;FLNA;WDPCP;CEP83;MNS1;EXOC4;BBIP1;ODF2;CEP89;GSN;WDR90;DISC1;SSX2IP;ARF4;HDAC6;NOTCH1;FUZ;RP2;OFD1;PTPDC1;RAB8A;CEP250;CFAP44;TMEM237;CYS1;ABLIM3;PCM1;PDE6D;RFX2;CCDC28B;CEP162;ABCC4;RAB8B;CCDC57;SCLT1;ARL13B;BBS4;PIBF1;EXOC5;MKS1;DYNLL1;KIFAP3;DYNLT2B;MARK4;PARVA;IFT172;ATP6V0D1;IFT140;BBS9;TXNDC15;ATAT1;FAM161A
prerank,mRNA destabilization (GO:0061157),0.480740236730624,1.0964553010762184,0.376536312849162,1.0,1.0,13/38,15.99%,DCPS;FTO;PDE12;ZFP36L1;CPEB3;TUT4;PUM1;METTL16;ROCK2;CNOT1;METTL14;RC3H1;ZFP36L2
prerank,histone H2A monoubiquitination (GO:0035518),0.5343211458503099,1.0964188762649356,0.38701298701298703,1.0,1.0,7/17,18.10%,PCGF5;RNF168;RNF2;PCGF3;TRIM37;DDB2;KDM2B
prerank,negative regulation of cell differentiation (GO:0045596),0.4509089003685564,1.0962988135578837,0.293,1.0,1.0,34/181,17.11%,FOXA2;ADAMTS7;MYB;MEN1;ANP32B;E2F1;RB1;RIOX1;VASN;TWIST1;ZFPM1;SUZ12;CDK6;CAV1;PTHLH;FOXO1;LRP3;NOTCH1;ZBTB16;ITGAV;EGFR;ASXL1;ADIPOR1;PTEN;SPRED2;HNRNPU;SKI;ADGRV1;METTL14;LIMD1;NELFB;ZFP36L2;SIRT1;TRPM4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.46545080042187353,1.0962577533412483,0.354639175257732,1.0,1.0,14/74,14.47%,FOXA2;EZH2;LEF1;TIAM1;VASN;TWIST1;CLASP1;EPHA3;SMAD4;ADIPOR1;PTEN;BCL9L;SPRED2;DAG1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5522752560505718,1.0957712854096742,0.38780804150453957,1.0,1.0,3/14,14.92%,CARD10;NOTCH1;PDCD10
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5241798686071639,1.094952691491937,0.3598531211750306,1.0,1.0,5/19,15.53%,FOXA2;NOTCH1;FLOT1;DENND6A;PTPRU
prerank,nuclear pore organization (GO:0006999),0.5495153455169732,1.0945857094045437,0.38088829071332436,1.0,1.0,5/14,12.33%,NDC1;NUP107;NUP205;AHCTF1;NUP98
prerank,regulation of cation channel activity (GO:2001257),-0.2549109843716611,-1.0938150312205737,0.2,0.7113884266434175,1.0,22/89,15.83%,CTSS;APP;ANK3;CACNB2;GRIA1;GRIA4;KCNAB1;ANK2;DLG2;MINK1;SHISA6;CACNG7;DMD;CACNG2;VAMP2;FGF12;CACNB4;LRRC7;CALM1;JPH4;CAMK2B;DLG1
prerank,regulation of immune response (GO:0050776),0.45692243999467314,1.0936044023807876,0.335678391959799,1.0,1.0,20/135,11.30%,CD19;ICAM4;ULBP1;SPN;ITGB7;DHX58;PTPN22;KLRD1;FOXP1;RAET1E;COL1A2;TRAF3;BIRC2;AHR;SLAMF7;HCST;TREML1;PILRA;B2M;XIAP
prerank,mRNA 3'-end processing (GO:0031124),0.4559481860272925,1.0935089254084178,0.32340862422997946,1.0,1.0,33/78,20.93%,DHX38;SLBP;CPSF2;U2AF1;EIF4A3;SRSF3;SRSF4;NCBP1;CASC3;RNPS1;U2AF1L4;CSTF3;RPRD1B;THOC3;UPF3B;THOC5;THOC2;SRSF7;THOC7;CDC40;TUT1;SCAF8;DDX39B;POLDIP3;PCF11;CPSF1;CLP1;TENT2;NCBP2;SRSF2;CPSF7;WDR33;RPRD2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5643556028331567,1.0931561164011958,0.40551724137931033,1.0,1.0,5/11,16.94%,CD74;CD44;ING2;TAF9;SIRT1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.4695036023364626,1.0927620334160968,0.3566810344827586,1.0,1.0,15/50,16.92%,PSMB7;PSMD11;PSMF1;AZIN1;PSMC1;PSMC3;PSMA4;PSMC4;OAZ1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4
prerank,mRNA processing (GO:0006397),0.4507813051301504,1.0927124858223558,0.266,1.0,1.0,111/287,20.93%,RBM15;LSM6;AURKAIP1;DHX38;POLR2I;SNRNP25;PRPF19;POLR2A;SCAF11;IK;SNRPF;HNRNPC;SNRPC;HNRNPM;HNRNPL;HNRNPA3;CPSF2;CMTR2;CRNKL1;PPIL3;U2AF1;SNRNP200;UBL5;EIF4A3;SRSF3;SPEN;TXNL4A;RNPC3;HNRNPA2B1;PSPC1;NOVA2;PRKACA;SART3;SRSF4;NCBP1;PRPF38A;LSM2;SNRNP35;RALY;NONO;CASC3;RNPS1;ERCC3;U2AF1L4;PPWD1;SRRT;CSTF3;RBM19;PCBP2;PRPF31;DHX9;RPRD1B;HNRNPA0;THOC3;LSM5;U2SURP;UPF3B;KIN;ZMAT2;PRMT9;HNRNPR;THOC5;CWC15;HNRNPU;SF3B5;PRPF4;TFIP11;SRRM2;PDCD7;LSM7;METTL14;THOC2;SRSF10;SART1;GEMIN7;DNAJC8;SNRNP40;ESS2;POLR2K;SRSF7;THOC7;CDC40;TCERG1;DDX39B;POLR2J;POLDIP3;SNRPG;GCFC2;PCF11;CPSF1;PRPF8;RSRC1;CLP1;PPIE;ALKBH5;HNRNPA1;PPIH;ELAVL1;NCBP2;ZCCHC8;SRSF2;SF3A2;SNRNP48;SNRPB;CPSF7;PPIL1;RNMT;RBM4B;SYNCRIP;WDR33;RPRD2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.234871885702753,-1.0926331456309784,0.18181818181818182,0.712640521278762,1.0,28/128,17.83%,ACVR1;ITGB5;TGFBR1;GCNT2;APPL2;F11R;NLK;PTPRK;SMAD1;BMPR2;SMAD3;ZFYVE9;USP9X;SMAD6;ZMIZ2;BMPR1B;ENG;LPXN;FERMT2;SMAD7;ZMIZ1;ADAM9;PTK2;TGFBR3;ACVRL1;TGFBR2;BMP6;SMURF2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3860456274791646,-1.0924161176746194,0.34210526315789475,0.7115091072395046,1.0,3/17,9.82%,ANK3;KCNAB1;VAMP2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.44988020775983806,1.0923034923089545,0.052,1.0,1.0,317/1646,16.28%,CENPF;DEPDC1;E2F7;BRIP1;BIRC5;PAX5;E2F8;FOXM1;E2F2;GFI1;FOXA2;RRM2;NKX6-1;VAX2;MYB;HMGB2;EZH2;RCOR2;SPIB;MYBL1;MEN1;CCNE1;ATAD2;SUV39H1;CDC45;RAD21;CDK5RAP2;BRCA1;DMRTA1;SPIN4;SMARCC2;NR4A2;HMGA1;SOX6;CHEK2;DAP;POLA1;HEY2;BLM;RBM15;BRCA2;MYRFL;DEAF1;LEF1;E2F1;SMARCA5;UXT;NSD2;RB1;FBXO5;TEAD4;RIOX1;ARID1B;IKZF3;PBX4;NIF3L1;LIN9;SMARCD2;BATF;RSF1;ELK4;CBX5;CD38;TWIST1;DEK;CD74;USF1;HMGB3;PBX3;PML;AXIN1;NUP107;BCL7A;FBXW11;POLR2A;TIMELESS;PA2G4;NUCKS1;HDAC10;ERG;BACH2;UBE2I;MTA3;LCORL;RPS6KA5;EPC1;CTCF;RBBP8;BRD9;SCMH1;PCNA;FOXP1;ETS2;DACH1;BRPF1;ACTR5;SP100;CDKN2A;NR1D1;NKAP;MED30;HOMEZ;EDF1;MBD2;NFXL1;FOXO1;LIN54;FOXJ3;MDM4;ATF7;BAZ2B;KDM3B;E2F6;ZBTB26;YWHAH;BCL11A;PBXIP1;MBD1;EBF1;TCF7L1;TCF3;ARID4A;GMNN;ZFP41;IRF9;RUNX3;HDAC6;TFDP1;TGFA;MAPRE3;EBF3;PHF19;KLF10;BRD4;MAP3K5;TAF7;NOTCH1;MED31;TAF15;XRCC6;PIM2;HMGB1;PCBD2;CDK17;MLF2;AHR;CAMTA2;SFMBT1;ZNF326;BAZ1B;SPEN;SAP18;ILF2;MAX;PSPC1;DMTF1;PHF1;PHF2;SMARCA4;UBE2V1;CIR1;YEATS4;MAPK14;CIPC;SEC14L2;ZBTB16;PCGF5;RLF;ERC1;E2F5;METTL4;NCOA7;ETV6;PLAG1;NFE2L1;NRF1;ZBTB7A;EGFR;FLI1;ABCA2;NONO;ZNF148;PIAS3;MECP2;SP110;SRRT;KLF13;EGR1;PFDN5;IFRD1;TFDP2;SMARCC1;HIRA;SALL2;ZBTB32;MYNN;SPTY2D1;IRF2BPL;NR2C2;RFX2;HIPK2;NR2F2;KAT6A;ID4;ZEB1;TRIM33;TSHZ1;DBX2;CUX1;MXI1;NFYC;TRIM44;RUVBL2;DYRK1A;EHMT1;ARID5B;SUMO1;NFE2;RUVBL1;SMAD4;ATF6;MED8;CCAR2;TYMS;DHX9;JUN;ATF5;PLCB1;NSD3;CRK;CCNT1;PRKCB;NPAT;NAA16;FOXP2;ZNF25;CBFB;BAP1;SETDB2;HCFC1;RAI1;SATB2;ZBTB33;STAT5B;KMT2A;SP3;NFE2L2;ZBTB7B;ING2;HIVEP2;ING5;CC2D1A;REXO4;NIPBL;SP140;DDIT3;CDK16;PSIP1;CREBBP;MYC;CEBPG;BCL6;PHF14;GABPA;NFX1;PSEN1;MED14;POU6F1;HNRNPAB;ZNF112;TADA2A;HTATIP2;RNF20;TP53INP2;CAMTA1;PBX2;RNF111;E2F3;GMEB2;CCNK;KDM4C;ELF1;TADA3;YEATS2;LIMS1;ATF7IP;DNAJC2;KMT2B;TP53;JUNB;LRRFIP1;GPATCH3;GON4L;RUNX1;LIMD1;IRF8;EGF;F2R;HOXB4;POU2F1;PIAS1;SRSF10;PLAGL1;JARID2;MAP2K1;SIN3A;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;PURG;RFX7;FOXK2;TRIM28;RFX4;ATRX
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5696986926307059,1.0922510642373964,0.39275766016713093,1.0,1.0,5/11,11.79%,GSN;PRR7;PARK7;CAAP1;FAS
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5789012576016936,1.092032895760757,0.4086181277860327,1.0,1.0,2/10,8.28%,SOX6;ZBTB16
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5180213019533443,1.0919032988754829,0.3872901678657074,1.0,1.0,10/24,20.53%,MAP2K6;IKBKG;TAB1;UBE2V1;TAB3;UBA52;MAP3K7;TRAF6;CASP8;UBE2N
prerank,alpha-amino acid metabolic process (GO:1901605),0.47700343009007146,1.0916190506923302,0.3747276688453159,1.0,1.0,12/45,17.21%,SLC25A12;PYCR3;DDAH2;KMO;GLS2;DPEP1;RIMKLB;ATP7A;SLC25A13;KYAT3;ASS1;NAALAD2
prerank,positive regulation of cell development (GO:0010720),0.4879098873164733,1.0908594724715932,0.3732876712328767,1.0,1.0,9/31,22.58%,NKX6-1;LIG4;SPEN;NAP1L1;TYROBP;ATP6AP1;MME;NUMBL;NIBAN2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4368013161162729,-1.0908457839933154,0.33916083916083917,0.7137643880986777,1.0,3/11,5.24%,IGF1R;PIK3R1;IGF1
prerank,protein import into peroxisome matrix (GO:0016558),0.5559179390081306,1.0900369253494429,0.3793584379358438,1.0,1.0,4/12,17.48%,PEX26;PEX5L;PEX2;PEX14
prerank,amino acid transmembrane transport (GO:0003333),0.47810526871209325,1.0899931655036148,0.3691639522258415,1.0,1.0,3/45,2.84%,SLC38A5;SLC25A12;SLC7A1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4934689157628541,1.0897953011639527,0.3914053426248548,1.0,1.0,5/29,10.75%,PLK1;FBXO5;AXIN1;PIN1;PARK7
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3618294125905131,-1.0897687994765908,0.32432432432432434,0.7149628435802677,1.0,10/20,22.15%,SLC8A3;MCUR1;SLC8B1;LETM1;SPG7;STOML2;MAIP1;PMPCA;AFG3L2;SMDT1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3609416827595934,-1.0897010133762843,0.31088082901554404,0.7117789356426749,1.0,8/20,20.02%,ECHS1;ACADSB;HIBCH;ACAD8;ALDH6A1;ACAT1;BCKDHA;SLC25A44
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3609416827595934,-1.0897010133762843,0.31088082901554404,0.7117789356426749,1.0,8/20,20.02%,ECHS1;ACADSB;HIBCH;ACAD8;ALDH6A1;ACAT1;BCKDHA;SLC25A44
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.371212430143099,-1.0895915304444421,0.35148514851485146,0.7103836916838027,1.0,7/20,14.18%,TGFBR1;HSP90AA1;WASHC1;PRKN;PINK1;ZMIZ1;EPAS1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.3426505077954426,-1.0894846513540406,0.3556701030927835,0.7090267081927155,1.0,9/23,24.60%,SMO;PIK3CD;VEGFA;FGF2;GJA1;MDK;SOX8;AGT;WNT5B
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3865039536286178,-1.0891281535979054,0.30638297872340425,0.7083020569882221,1.0,8/15,35.06%,ATF3;ZC3H12A;ZFAND1;MKNK2;GSTO1;GSTO2;PPIF;DHX36
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.5746201377272228,1.0890369451536293,0.3810930576070901,1.0,1.0,2/10,10.21%,CFL2;ACTN2
prerank,protein import into nucleus (GO:0006606),0.4619769105690571,1.0886928542997836,0.3777544596012592,1.0,1.0,28/66,22.65%,POM121;NUP107;TNPO1;IPO13;NUP50;KPNA3;NUP214;SEC13;IPO7;NUP188;RANBP6;RANBP2;RPAIN;E2F3;APPL1;IPO5;KPNB1;EIF4ENIF1;NUP85;MMP12;RPL23;TPR;TNPO2;TNPO3;SYK;NUP93;KPNA4;PHB2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5026240594634053,1.088108272874497,0.3949483352468427,1.0,1.0,8/28,17.44%,ECT2;FLNA;EFCAB7;PSEN1;BAG3;IPO5;TRIM28;HCLS1
prerank,cellular response to osmotic stress (GO:0071470),0.5077308884840326,1.0880896402886568,0.375,1.0,1.0,3/21,6.62%,AQP1;OXSR1;ZFP36L1
prerank,regulation of immunoglobulin production (GO:0002637),-0.3442070514607181,-1.0878463117820127,0.2974683544303797,0.7098999733721786,1.0,3/23,3.48%,GPI;CD86;STX4
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5063353662313105,1.0877908262998077,0.38461538461538464,1.0,1.0,4/23,12.59%,SLC12A3;SLC12A7;SLC12A1;SLC12A6
prerank,response to organic cyclic compound (GO:0014070),0.46906433858102703,1.0876242145622401,0.3769063180827887,1.0,1.0,7/52,12.73%,CYP1B1;ALPL;PMAIP1;CDKN2D;ABCA2;SOCS2;STAT5B
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.45858507292318607,1.0874983383116352,0.3556701030927835,1.0,1.0,16/70,16.38%,IL12A;ERBB3;CASP2;TRADD;BOK;CIB1;JAK2;ITGAV;PDPK1;FAS;DELE1;BAG3;CASP9;GSK3B;APPL1;TGFB2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.48337406817788925,1.0872771212788517,0.39816933638443935,1.0,1.0,6/33,13.52%,HMGB2;ABCB10;BRD1;MAPK14;STAT5B;PRKDC
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.49783377388921146,1.0872738236059138,0.38443396226415094,1.0,1.0,8/29,11.03%,MMD2;RASGRP1;CRKL;NOTCH1;GRB2;JAK2;ITGAV;RELN
prerank,regulation of B cell differentiation (GO:0045577),0.533975660159158,1.087226831510597,0.3914780292942743,1.0,1.0,7/17,17.05%,IKZF3;ZFP36L1;PPP2R3C;BTK;SLAMF8;ZFP36L2;XBP1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5516144552656866,1.0871826579635668,0.3972972972972973,1.0,1.0,4/13,7.14%,SAE1;UBA2;DESI2;DESI1
prerank,negative regulation of protein transport (GO:0051224),0.4910911724491873,1.0864505311178978,0.399284862932062,1.0,1.0,2/25,4.60%,IL12A;SNX3
prerank,respiratory electron transport chain (GO:0022904),0.5406697276811941,1.0859400128627033,0.3878378378378378,1.0,1.0,9/14,24.50%,SLC25A12;SLC25A22;SLC25A13;GPD2;NDUFA5;ETFRF1;ETFDH;ETFB;ETFA
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5104650355542105,1.0858634155629883,0.4040284360189573,1.0,1.0,11/26,20.53%,MAP2K6;IKBKG;TAB1;UBE2V1;TAB3;TIFA;UBA52;MAP3K7;TRAF6;CASP8;UBE2N
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4048458613993512,-1.0855399447653291,0.38596491228070173,0.7141928030572091,1.0,2/15,0.96%,IGF1R;TEC
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.4489887874777085,1.0853459265370593,0.254,1.0,1.0,85/341,17.88%,BUB1B;KIF14;UBE2C;AURKB;MAD2L1;UHRF1;CDC20;PLK1;SKP2;AURKA;DTL;PSMB7;PSMD11;PML;PPP1R11;CDC23;FBXW11;UBE2I;CDC27;PSMF1;TAF1;FAF1;NPLOC4;PSMC1;ANAPC7;FBXO45;BIRC2;SPSB3;BIRC6;UBE2K;UBE4B;UBE3B;NEDD4L;UBQLN1;TNFAIP1;CUL3;KCTD21;PTTG1;PSMC3;PCBP2;AMFR;UBE3C;RAD23A;PSMA4;RNF168;MIB1;RNF8;SPSB4;TRIM3;CNOT4;FZR1;FBXL4;PSMC4;ARRB2;PCNP;BUB3;FBXO11;NFE2L2;PSMD13;SPOP;PSME1;DDIT3;DCAF11;ARIH2;RNF20;ZFAND2B;PSMB1;RNF111;RBCK1;RC3H1;ARMC8;PSMD8;MYLIP;PSME4;RNF115;UBE2R2;KLHL22;PSMD4;SIRT1;XBP1;UBXN1;RNF4;RNF19A;SYVN1;FEM1C
prerank,translation (GO:0006412),0.4501977012822761,1.0845733909465747,0.311,1.0,1.0,80/208,23.53%,MRPL36;RPL7;VARS1;RPL18A;RPS20;MRPL18;NOA1;RPL36;RPL14;GATC;MRPL47;RPS19;RPS7;RPS4X;MRPL16;RPS18;MRPL10;RPL23A;EEF1B2;RPL28;MRPL37;PPA2;RPS14;RPL41;RPLP2;LARS1;RPS27;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;RPLP0;RPS11;MRPS17;IGF2BP3;TMA7;RPL27A;GFM2;RPS9;RPS15A;MRPL24;RPL12;RPL22L1;ZC3H15;EEF2;DARS1;MRPS34;RPL3;GSPT1;UBA52;EPRS1;RPL18;DRG1;YARS2;RPL5;RPS6;RPS17;RPS3;RPL21;AGO2;PTCD3;SRBD1;RPL17;RPL23;RSL24D1;RPL24;RPL8;RPL27;RPL13A;TRMT112;MRPS12;RPS12;RPS8;RPL15;RPL10;ABCE1;KARS1;RPS21
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.321885841623587,-1.0845023005127465,0.27927927927927926,0.715071171729169,1.0,15/33,20.53%,PTPRG;APOE;EVL;CORO1C;KRIT1;DUSP10;VASH1;ACVRL1;PFN2;DAB2IP;MCC;THBS1;ADGRB1;PTPN23;SVBP
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5355657902292529,1.0840059856147555,0.3777490297542044,1.0,1.0,5/14,19.36%,CARD10;TLR6;MAP3K7;MALT1;TRAF6
prerank,regulation of stem cell differentiation (GO:2000736),0.45664077962811933,1.0838999277142296,0.375,1.0,1.0,25/89,16.92%,MYB;PSMB7;PSMD11;PSMF1;TCF3;PSMC1;NOTCH1;PSMC3;PSMA4;CBFB;PSMC4;BMPR1A;KMT2A;PSMD13;HNRNPU;PSME1;PRKDC;PSMB1;RUNX1;NELFB;HOXB4;PSMD8;ZFP36L2;PSME4;PSMD4
prerank,protein localization to phagophore assembly site (GO:0034497),0.5724629896425627,1.083465737618553,0.4146341463414634,1.0,1.0,2/11,3.98%,ATG13;STX17
prerank,heterotypic cell-cell adhesion (GO:0034113),0.50675799403018,1.0834071189082743,0.4013921113689095,1.0,1.0,3/25,8.84%,CD2;ITGB7;ITGAV
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4794521951880858,1.0833684337768588,0.38487208008898777,1.0,1.0,8/38,14.59%,BRCA1;PMAIP1;TNFSF10;SP100;TRADD;FAS;CFLAR;GSK3B
prerank,regulation of lymphocyte migration (GO:2000401),0.5693828059445362,1.083357154992029,0.40869565217391307,1.0,1.0,4/10,10.64%,SPN;JAM2;CCR6;MSN
prerank,protein insertion into membrane (GO:0051205),-0.3159367014016703,-1.0821334605480135,0.2713178294573643,0.7193844204620015,1.0,16/32,24.63%,APP;SGTA;VAMP2;SEC61G;HMOX1;STX1A;TRAM1;SERP1;PRNP;RTP4;MAIP1;GET4;COX18;SEC61B;REEP1;GET1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.563902664643867,1.0821323017633386,0.4143258426966292,1.0,1.0,4/10,19.38%,KLRD1;ARRB2;FCGR2B;LGALS9
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4799513707378123,1.0816692601466595,0.3854748603351955,1.0,1.0,6/36,10.59%,GFI1;CD74;AGPAT1;UBE2K;PARP14;TRIM44
prerank,regulation of cholesterol efflux (GO:0010874),-0.3247892894762621,-1.0815499260911603,0.32061068702290074,0.7191899788522067,1.0,7/30,10.38%,TREM2;LRP1;APOE;ABCA5;PLTP;ZDHHC8;GPS2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3865478519598943,-1.0812356124964233,0.3168724279835391,0.7183132007803417,1.0,5/16,17.88%,DAGLB;SLC27A1;SCARB1;CTDNEP1;GPLD1
prerank,negative regulation of response to stimulus (GO:0048585),0.4622589769610053,1.0806254102150479,0.38195173137460653,1.0,1.0,9/60,7.63%,FOXA2;FBXO5;ERBB3;TWIST1;RBL1;CDK6;TERF2;AKT3;PIM3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.49776398140137645,1.0804995757655191,0.38941176470588235,1.0,1.0,5/24,9.79%,CGAS;PDE2A;GNAI1;RNF157;PEX5L
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4670146833425867,1.0803854232327503,0.3704474505723205,1.0,1.0,22/72,16.74%,STMN1;NET1;RIPOR2;ARHGEF18;LPAR4;ARHGDIB;ARHGEF3;ARHGAP35;TNFAIP1;CUL3;HEG1;RIT2;STARD8;ARHGEF28;NRP1;PDCD10;BCR;F2R;LPAR1;GPR35;ARHGDIA;RAC1
prerank,regulation of defense response to virus (GO:0050688),0.5327848511169306,1.0802761729598631,0.3967611336032389,1.0,1.0,4/14,11.45%,RNF26;TRAF3;PCBP2;DHX9
prerank,negative regulation of cell development (GO:0010721),0.49988572537799647,1.0802538874934489,0.3854415274463007,1.0,1.0,6/25,14.59%,RFLNB;PTHLH;NOTCH1;PCM1;B2M;GSK3B
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3831226038982266,-1.0802140348644513,0.3073170731707317,0.7192051622325673,1.0,6/17,16.00%,SERPINE2;PTPRZ1;BIN1;TNFRSF1B;ID2;MDK
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4733724270497467,1.0798507947535114,0.39019189765458423,1.0,1.0,13/49,14.97%,PMAIP1;DAPK2;S100A9;CAV1;S100A8;BOK;UBQLN1;BECN1;FIS1;RACK1;DDIT3;SGMS1;TP53
prerank,regulation of superoxide anion generation (GO:0032928),0.5463788210340502,1.0795100018212713,0.3958904109589041,1.0,1.0,1/14,1.29%,CD177
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.44525375584712007,1.0794624889621731,0.237,1.0,1.0,120/476,19.48%,FOXM1;FOXA2;MYB;HMGB2;MYBL1;ATAD2;CDK5RAP2;BRCA1;SMARCC2;HMGA1;CHEK2;HEY2;BLM;BRCA2;MYRFL;DEAF1;LEF1;E2F1;ARID1B;PBX4;NIF3L1;RSF1;CD38;CD74;PML;AXIN1;FBXW11;EPC1;CTCF;ETS2;BRPF1;SP100;NR1D1;MED30;EDF1;FOXO1;YWHAH;TCF3;RUNX3;MAPRE3;EBF3;BRD4;MAP3K5;NOTCH1;TAF15;XRCC6;PIM2;PCBD2;AHR;ILF2;SMARCA4;UBE2V1;YEATS4;SEC14L2;ZBTB16;RLF;EGFR;FLI1;EGR1;SMARCC1;HIPK2;NR2F2;KAT6A;TRIM44;DYRK1A;NFE2;SMAD4;JUN;ATF5;PLCB1;NSD3;NPAT;NAA16;HCFC1;RAI1;KMT2A;SP3;ING2;ING5;DDIT3;CREBBP;MYC;PSEN1;MED14;HNRNPAB;RNF20;TP53INP2;RNF111;ELF1;TADA3;ATF7IP;DNAJC2;KMT2B;TP53;GPATCH3;RUNX1;EGF;F2R;MAP2K1;TCF4;TFAP4;FOXK2;TRIM28;VHL;USP21;RNF4;RXRB;CAND2;HDAC4;MED1;FOXE1;CREB1;HDAC1;BRD7;NUP85;PAX2;TBL1XR1;SOX9;THRAP3;NPAS2
prerank,vascular transport (GO:0010232),0.4619348959778577,1.0791538727753667,0.38390092879256965,1.0,1.0,15/81,12.41%,SLC38A5;SLC5A5;SLC1A5;SLC7A1;SLC2A4;SLC16A12;TFRC;LRP3;SLC16A1;ABCC2;ABCA2;SLC19A1;ATP8A1;ABCC4;SLC44A1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.2769070006127883,-1.0790717660279083,0.27586206896551724,0.7205728985109257,1.0,13/51,12.61%,VWC2L;SMAD1;BMPR2;SPART;SMAD6;FSTL1;BMPR1B;UBE2D1;SKIL;LEMD2;FBN1;SMAD7;GREM2
prerank,actin crosslink formation (GO:0051764),0.5511536843223285,1.0789411136080789,0.4054441260744986,1.0,1.0,2/12,3.41%,FLNA;GAS2L3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.515668296925446,1.078835491312081,0.3992583436341162,1.0,1.0,3/22,7.77%,NTF4;KIDINS220;CIB1
prerank,artery development (GO:0060840),-0.34510252373094574,-1.078676128917459,0.29775280898876405,0.7199607475302955,1.0,8/23,15.58%,TGFBR1;BMPR2;ROBO1;NF1;ENG;SMAD7;VEGFA;ACVRL1
prerank,nuclear membrane organization (GO:0071763),0.5125736800341371,1.0786065043996556,0.3871763255240444,1.0,1.0,4/19,10.91%,PLK1;NEMP1;EMD;TOR1A
prerank,epithelium development (GO:0060429),0.45107356620708955,1.0784085928144813,0.36004056795131845,1.0,1.0,5/107,4.98%,CDK1;STIL;RCN3;TIMELESS;PCNA
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3509333954460834,-1.078304412843598,0.31097560975609756,0.7192448598756496,1.0,7/24,14.83%,NUMB;BCL2L1;GDI1;LZTFL1;AP2M1;RHOQ;PPFIA1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.44478638779578694,1.0776776369007741,0.232,1.0,1.0,146/572,20.82%,E2F7;AURKB;E2F8;FOXM1;UHRF1;GFI1;NKX6-1;MYB;EZH2;MEN1;PLK1;SUV39H1;NR4A2;HEY2;DEAF1;E2F1;UXT;RB1;ELK4;CBX5;EZR;TWIST1;ZFPM1;MCPH1;HDAC10;UBE2I;MTA3;EPC1;CTCF;FOXP1;ETS2;DACH1;SP100;CAV1;NR1D1;NKAP;TAF1;MBD2;MDM4;E2F6;BCL11A;TCF3;RUNX3;PDE2A;KLF10;TAF7;NOTCH1;HMGB1;SPEN;MAX;NEDD4L;SMARCA4;CIR1;RPS14;ZBTB16;ETV6;NCOA5;ZBTB7A;SIN3B;ZNF148;MECP2;CPEB3;ZBTB32;IRF2BPL;NR2C2;NR2F2;ID4;ZEB1;TRIM33;CUX1;MXI1;ARID5B;SUMO1;RTF1;SMAD4;PEX2;JUN;MTA2;FOXP2;ZNF25;CBFB;RNF2;PRDM6;HCFC1;ZBTB7B;HNRNPU;SIRT7;CC2D1A;NIPBL;DDIT3;CREBBP;SKI;MYC;BCL6;NFX1;PSEN1;BAG3;POU6F1;CNOT1;YEATS2;MOSPD1;TP53;LRRFIP1;RUNX1;IRF8;SIN3A;TCF7L2;HIVEP1;DUSP22;ATRX;NFATC3;VHL;RIF1;TCERG1;SIRT1;DNAJB1;TRIM37;UBA52;HEXIM1;SNCA;HDAC4;RARG;KDM2B;MED1;FOXE1;DPF2;SUFU;PROX1;HDAC1;GATAD2B;TRAF6;TBL1XR1;SOX9;SREBF2;DNMT3B;HDAC8;ZBTB18;TAF3;RPL23;TPR;ACVR2B;RBPJ;PPARD;SMAD2;CITED2;GATAD2A
prerank,protein-containing complex assembly (GO:0065003),0.44794458409485793,1.0775209203541058,0.315,1.0,1.0,85/259,19.40%,KNTC1;F5;MEN1;CARD10;MEFV;BLM;FANCA;LEF1;TIAM1;CD74;PML;AXIN1;NAPG;TUBGCP4;IKBKG;RAB1B;MDM4;TRADD;STX5;TCF7L1;ANKRD28;PEF1;CSNK1A1;TGFA;KPNA3;TRAPPC9;BOK;SMARCA4;SNX9;SEC24B;DBNL;LAMC1;TSPAN33;ZW10;SEC24A;TLE4;NDUFAF1;CUL3;SEC13;NIFK;TRAPPC4;BET1;RUVBL1;DHX9;FAS;MAGI1;SEC31A;BCL9L;ZNHIT6;KMT2A;PPP6R3;CHCHD10;ADD2;CREBBP;MYC;MCU;RBBP5;GSK3B;TP53;PPP6C;CNIH1;KIFAP3;FANCC;TCF7L2;TFAP4;DARS1;LMAN1;GORASP1;ADCY8;ANO6;PEX14;FN1;CAND2;EPRS1;LRRK2;ADAM10;TLE3;PPIH;SLC2A1;PDE4DIP;HDAC1;SAR1B;TRAPPC3;SOX9;CASP8
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5590140509121657,1.0770164429049016,0.4041666666666667,1.0,1.0,1/11,0.60%,E2F2
prerank,regulation of protein acetylation (GO:1901983),0.5428531333109414,1.0769504170708213,0.40620592383638926,1.0,1.0,6/12,18.31%,CEP295;PARK7;GSK3B;SIRT1;TAOK1;FAM161A
prerank,anterograde axonal transport (GO:0008089),0.487520847746173,1.0769122696769662,0.38706140350877194,1.0,1.0,2/37,3.51%,KIF4A;BLOC1S4
prerank,response to metal ion (GO:0010038),0.4588828721944986,1.0768234476756415,0.39057591623036647,1.0,1.0,19/67,17.91%,TFR2;SLC25A12;HAAO;PPP3CA;CAV1;PEF1;NEDD4L;PPP2CB;SEC31A;SLC25A13;ANXA11;ATP5F1D;GPHN;HVCN1;CRIP1;SLC30A5;NDRG1;PPP1CA;SNCA
prerank,N-terminal protein amino acid modification (GO:0031365),0.5415965400193314,1.0765144354573923,0.4076517150395778,1.0,1.0,3/14,12.05%,NAA40;METAP2;NAA16
prerank,negative regulation of organelle assembly (GO:1902116),0.47719745428035537,1.0763904280048633,0.38047138047138046,1.0,1.0,10/35,18.13%,CDK5RAP2;BRCA1;TCHP;SMAD4;KAT2B;MDM1;MTM1;LIMK2;TRIM37;LRRK2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.3982309300360465,-1.0763047176524179,0.3691275167785235,0.7223860748661018,1.0,6/13,31.65%,ZFYVE28;ZGPAT;SNX6;SOCS5;ERRFI1;CHMP6
prerank,positive regulation of leukocyte activation (GO:0002696),0.516677042802331,1.076038275304607,0.40445026178010474,1.0,1.0,1/18,0.99%,CD2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.431979032154079,-1.0757812372900897,0.3620689655172414,0.7220750152718387,1.0,7/10,24.58%,ARNT;ITGA5;ITGB3;GRB10;HIF1A;MT3;VTN
prerank,brain development (GO:0007420),0.45009710705628275,1.0756656017700328,0.3608040201005025,1.0,1.0,23/136,14.60%,CENPF;CDK5RAP2;SOX6;PBX4;HSPG2;UTP3;PBX3;FBXW11;SPEF2;SHROOM2;PAFAH1B1;SHROOM4;RELN;PTEN;HAP1;CDK5RAP3;SMG9;MDGA1;BBS4;NIPBL;POU6F1;ADGRL3;PBX2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5314865414955565,1.0756635982792984,0.4144385026737968,1.0,1.0,5/14,12.43%,RPL7;DDX18;URB1;NIFK;ZNHIT6
prerank,neurotransmitter transport (GO:0006836),-0.26186061296131746,-1.0755854201426958,0.30952380952380953,0.7208472331306784,1.0,27/73,27.39%,RIMS1;GLUL;SYNJ1;PPFIA2;SLC1A2;GABRA2;SYT1;SLC17A6;VAMP2;SLC1A3;GAD2;UNC13A;STX1A;SLC5A7;PPFIA1;SNAPIN;ATP1A2;RAB3A;STXBP1;PTPRN2;PDZD11;CPLX1;SLC32A1;DVL1;SNAP25;SLC38A1;SLC1A1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.553864887186808,1.0755520657488573,0.3876967095851216,1.0,1.0,6/11,19.42%,CCT7;CCT2;TCP1;CCT5;DKC1;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.553864887186808,1.0755520657488573,0.3876967095851216,1.0,1.0,6/11,19.42%,CCT7;CCT2;TCP1;CCT5;DKC1;CCT6A
prerank,aggrephagy (GO:0035973),0.49720645978804023,1.0755106783876334,0.39044289044289043,1.0,1.0,11/27,17.60%,PCNT;ACBD5;HDAC6;DYNC1H1;UBE2V1;UBQLN1;PARK7;ARL13B;DYNLL1;VIM;UBA52
prerank,negative regulation of neuron projection development (GO:0010977),-0.2783050763938275,-1.0752795476442878,0.3333333333333333,0.7199485207738469,1.0,22/56,17.95%,RTN4;SPOCK1;RUFY3;GAK;APOE;STMN2;PRAG1;GDI1;HDAC2;PTPRS;MAG;EFNB3;PTPRO;FKBP4;PTPN9;PAQR3;CBFA2T2;SEMA3A;TRPV4;EPHA4;THY1;CRMP1
prerank,positive regulation of protein binding (GO:0032092),0.4642037688054854,1.0747114441781151,0.3875802997858672,1.0,1.0,21/56,19.69%,MEN1;TIAM1;EPB41;CAV1;TAF1;PIN1;PPP2CB;HIPK2;AMFR;B2M;FLOT1;ADD2;PSEN1;GSK3B;STK4;TCF7L2;SPPL3;LRRK2;STK3;AKTIP;PPP2CA
prerank,heart looping (GO:0001947),0.47475516232841397,1.0747075407829914,0.41037204058624577,1.0,1.0,4/39,13.42%,STIL;NOTCH1;SETDB2;BBS4
prerank,keratan sulfate catabolic process (GO:0042340),0.5569175921663556,1.0745818265605438,0.4191374663072776,1.0,1.0,3/11,10.93%,FMOD;GALNS;OGN
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.49101612094534147,1.0745714759675067,0.39600470035252644,1.0,1.0,7/26,17.28%,FOXA2;NR1D1;PIM3;BAIAP3;CDK16;TRPM4;ADCY8
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.49022825797097436,1.0741849350234458,0.40945790080738176,1.0,1.0,7/29,17.70%,RPA2;CHD1L;RPA1;ERCC3;RPA3;UBA52;DDB2
prerank,regulation of fibroblast proliferation (GO:0048145),0.4731611662361476,1.0741657356014964,0.36688311688311687,1.0,1.0,15/45,19.04%,AQP1;E2F1;LIG4;CD74;CDK6;EMD;DHX9;PEX2;SKI;MYC;TP53;NLRC3;FN1;MORC3;CDKN1A
prerank,generation of neurons (GO:0048699),0.44944842332707946,1.0738564176577685,0.328,1.0,1.0,32/190,17.29%,CIT;RACGAP1;VAX2;HMGB2;NR4A2;HEY2;NIF3L1;CDK6;DISC1;RUNX3;PIN1;IER2;MYEF2;MARK2;MTPN;PAFAH1B1;DNER;RELN;NRP1;MDGA1;FGF13;NRCAM;ADGRL3;RUNX1;THOC2;MAP2K1;SDCCAG8;LRP12;FGFR1;TGFB2;RAC1;SH3RF1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5138883614521478,1.073855176792809,0.4056372549019608,1.0,1.0,11/20,23.78%,PPIL3;PIN1;PPWD1;PPIG;PPIA;PPIE;PPIH;PPIL1;FKBP1A;CWC27;NKTR
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4438275890630786,1.073404547660134,0.36464646464646466,1.0,1.0,25/114,16.92%,TNFRSF18;EDARADD;TNFSF13B;PSMB7;PSMD11;PSMF1;TRADD;TRAF3;PSMC1;BIRC2;JAK2;PSMC3;TNFRSF13B;PSMA4;PSMC4;PSMD13;PSME1;ACTN4;PSMB1;LIMS1;TP53;PSMD8;TNFRSF11A;PSME4;PSMD4
prerank,negative regulation of signaling (GO:0023057),-0.3199958715415687,-1.0733009012670793,0.3617021276595745,0.723301022765037,1.0,3/25,5.25%,ACVR1;UBASH3B;OPTN
prerank,nuclear body organization (GO:0030575),0.5522733422902875,1.0732444047309866,0.37655172413793103,1.0,1.0,6/12,23.08%,PML;HIPK2;USP50;WRAP53;AFF2;ZPR1
prerank,cellular response to ketone (GO:1901655),0.4700906548928193,1.0731835107464573,0.3948256467941507,1.0,1.0,14/35,23.20%,AQP1;MAP4K1;DCPS;AHR;GNAI1;MSN;ROCK2;ADCY8;PTGER4;GOLPH3;PCK2;GNB1;KLF9;SRC
prerank,hexose transmembrane transport (GO:0008645),0.5078527712492104,1.072828673134705,0.40609137055837563,1.0,1.0,7/21,24.05%,SLC2A4;SLC2A8;SLC2A12;SLC2A3;SLC2A1;PPARD;SLC5A3
prerank,protein deacylation (GO:0035601),0.4980240826948856,1.072689157200579,0.39858490566037735,1.0,1.0,10/23,18.96%,ABHD17A;HDAC10;HDAC6;LYPLA1;ABHD17B;SIRT7;SIN3A;SIRT1;HDAC4;HDAC1
prerank,negative regulation of catalytic activity (GO:0043086),0.4997896854425184,1.0726485397583339,0.40024038461538464,1.0,1.0,8/24,18.69%,HDAC6;NOTCH1;CCAR2;PPP1R12A;TP53;NOSIP;SIRT1;CLN3
prerank,protein autophosphorylation (GO:0046777),0.44355814327043525,1.072351954553154,0.34904714142427284,1.0,1.0,33/157,14.91%,AURKB;NEK2;STK26;CHEK2;AURKA;OXSR1;DAPK2;SLK;MAP4K1;STK11;MAPKAPK3;TAF1;SIK2;ATM;PIM2;PIM3;PRKX;MARK2;JAK2;STK24;EGFR;PIM1;PDPK1;MAP3K11;MELK;DYRK1A;VRK1;FLT3;LMTK2;STK39;HTATIP2;GSK3B;STK4
prerank,response to purine-containing compound (GO:0014074),-0.37942560119434776,-1.072118115541179,0.3648068669527897,0.7245772589938747,1.0,8/17,29.80%,RYR2;DGKQ;TRPC3;P2RX4;VGF;NDUFS4;ABCC9;TRPM2
prerank,response to alcohol (GO:0097305),-0.32061617796718545,-1.0720627113627523,0.3184713375796178,0.7230504691371583,1.0,8/27,19.80%,TGFBR1;GRIN3A;GOT2;CCR5;TGFBR3;TGFBR2;CCL3;PMVK
prerank,dendritic cell chemotaxis (GO:0002407),0.5476478758090707,1.0719156970412151,0.41379310344827586,1.0,1.0,6/14,22.25%,CCR2;HMGB1;CCR6;TRPM4;CXCR4;GPR183
prerank,response to tumor necrosis factor (GO:0034612),0.44942510980659034,1.0719095963232035,0.37962962962962965,1.0,1.0,20/91,19.40%,ADAMTS7;BRCA1;AFF3;CRHBP;TANK;NR1D1;TRADD;ZFP36L1;GBP2;CIB1;JAK2;DHX9;NFE2L2;TNFRSF11A;ZFP36L2;CCL25;SIRT1;ADAM10;RPS3;CASP8
prerank,transport across blood-brain barrier (GO:0150104),0.45721259370053646,1.07161048519508,0.39835728952772076,1.0,1.0,15/83,12.41%,SLC38A5;SLC5A5;SLC1A5;SLC7A1;SLC2A4;SLC16A12;TFRC;LRP3;SLC16A1;ABCC2;ABCA2;SLC19A1;ATP8A1;ABCC4;SLC44A1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5801743530282183,1.0713868728131202,0.4110787172011662,1.0,1.0,3/10,8.95%,EMC6;EMC10;EMC3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.45173997545580263,1.0712786344978178,0.40187891440501045,1.0,1.0,19/70,16.92%,MYB;PSMB7;PSMD11;PSMF1;TCF3;PSMC1;PSMC3;PSMA4;CBFB;PSMC4;KMT2A;PSMD13;PSME1;PRKDC;PSMB1;RUNX1;PSMD8;PSME4;PSMD4
prerank,positive regulation of transferase activity (GO:0051347),0.4449393460789251,1.0711166300731456,0.37525150905432597,1.0,1.0,20/142,9.82%,AURKB;NEK2;PLK1;MAPK1;DSCC1;ERBB3;LMO4;CD74;RFC5;AXIN1;UBE2I;PCNA;SERINC5;CCT2;PIN1;TCP1;HNRNPA2B1;EGFR;EPHA3;RFC2
prerank,neuromuscular synaptic transmission (GO:0007274),0.5132361699429446,1.0708742880943278,0.4035532994923858,1.0,1.0,2/18,8.39%,CHRNB4;ERC1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5278992124731502,1.0707116350206654,0.42467532467532465,1.0,1.0,10/16,29.48%,RBM3;NCBP1;NUP98;DAZAP1;THRAP3;NCL;CIRBP;PRDX6;TRA2A;SNW1
prerank,mRNA methylation (GO:0080009),0.5338547657857179,1.0703912473766313,0.39765319426336376,1.0,1.0,7/15,22.24%,CBLL1;METTL8;METTL16;VIRMA;METTL14;WTAP;TRMT10C
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.2993385152359753,-1.0702153334793678,0.27586206896551724,0.7260461031472315,1.0,8/41,8.53%,CTSS;ANK3;KCNMA1;KCNN2;ANK2;KCNJ6;GABBR1;GABBR2
prerank,positive regulation of nervous system development (GO:0051962),-0.3003308258579678,-1.0701701858326222,0.2962962962962963,0.7245868376565961,1.0,10/42,11.81%,NUMB;PTPRD;SYNDIG1;CX3CR1;IL1RAP;CLSTN3;LRRC4B;TGM2;CLSTN1;CUX2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5095990990727081,1.0701601711554647,0.4108723135271808,1.0,1.0,6/20,20.14%,FGFBP3;SULF2;SMOC2;APLN;PRKD2;DSTYK
prerank,protein autoprocessing (GO:0016540),0.5160270980725312,1.0698367128850579,0.40430925221799746,1.0,1.0,3/17,11.27%,MYRFL;PIDD1;FAM111A
prerank,mRNA modification (GO:0016556),0.5028406994794614,1.0694661791627573,0.3992673992673993,1.0,1.0,11/22,23.86%,CBLL1;PUS3;METTL8;METTL16;VIRMA;METTL14;TRUB2;DKC1;WTAP;TRMT10C;TRUB1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.5134746447929432,1.0692468890605404,0.41146496815286626,1.0,1.0,6/18,17.21%,SLC25A12;MSRA;SMS;SLC25A13;ASS1;NAALAD2
prerank,copper ion transport (GO:0006825),0.5565885770478496,1.0692361272358333,0.40896358543417366,1.0,1.0,5/11,17.17%,CUTC;ATP7A;STEAP2;STEAP3;ATOX1
prerank,translational termination (GO:0006415),0.4507369024441969,1.0684545887773063,0.3861788617886179,1.0,1.0,22/95,17.49%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MTRF1L;MRPS34;MRPL38;GSPT1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.33016993589833876,-1.0677620768979619,0.3103448275862069,0.7288759926695174,1.0,8/28,18.08%,PTPN2;APPL2;PTPRE;PIP4K2B;GSK3A;GRB10;TSC2;SLC27A4
prerank,phosphorylation (GO:0016310),0.44121429031701564,1.0676063546384889,0.291,1.0,1.0,126/384,21.46%,CDK1;BIRC5;AURKB;NEK2;CCNE1;PLK1;STK26;CHEK2;MAPK1;CDKL1;AURKA;OXSR1;DAPK2;FYN;PRKCE;HASPIN;RSKR;ERG;RPS6KA5;MAP4K1;PANK2;STK11;CHEK1;CDK6;GRK6;TLK1;GMFG;TAF1;SIK2;ATM;RUNX3;CSNK1A1;STK38L;MAP3K5;CDC25B;PIM2;CDK17;AKT3;PKN2;BIRC6;CSNK1G2;PIM3;MAP3K1;MAP4K2;HCST;PRKCA;PRKACA;STK38;PICK1;MARK2;JAK2;LMTK3;MAST2;STK24;PIM1;PDPK1;MAP4K5;CDK19;HIPK2;TESK2;MAP3K11;MELK;DYRK1A;VRK1;BTK;FGGY;CCNT1;PRKCB;BMPR1A;LMTK2;GRK2;ROCK2;DGKD;PRKDC;PRKAG2;LATS1;CDK16;STK39;FAM20A;NRBP1;GSK3B;SGK3;STK4;MAP3K20;BCR;LIMD1;PAK5;MAP2K1;MARK4;FGFR1;LIMK2;PAK2;CDK8;TGFB2;JAK3;PIK3CA;SRPK1;PGK1;FAM20B;MORC3;STK17B;TAOK1;LRRK2;ADAM10;CREB1;NIM1K;HIPK3;STK3;NADK;CDK11B;PRKD2;ALK;DAPK1;PLK4;EPHA7;MARK1;ACVR2B;ILK;PRKAG1;ROCK1;IKBKB;TYK2;DGKE;COPS2;SYK;GRK3
prerank,ribosome assembly (GO:0042255),0.4662524371961965,1.0667579271845502,0.4043243243243243,1.0,1.0,20/47,23.75%,EIF2A;RPS19;RPL23A;MPV17L2;MRPL22;RPS14;RPS27;MRPS7;RPS5;RPLP0;DHX29;RPL3;RPL5;EIF6;RSL24D1;RPL24;EFL1;RPL10;MRPL20;NPM1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.36489081662698963,-1.0662498278168504,0.37623762376237624,0.7310106134177219,1.0,12/20,36.86%,SEMA3D;SEMA3E;SEMA4C;SEMA4G;SEMA3A;SEMA7A;SEMA4D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4859254109183965,1.0658889168829626,0.4055619930475087,1.0,1.0,7/29,15.17%,BRCA1;AXIN1;DDRGK1;CBFB;LATS1;CNOT1;RUNX1
prerank,regulation of interleukin-1 production (GO:0032652),0.5269595213032797,1.0656654500027376,0.40341655716162944,1.0,1.0,3/15,7.33%,MEFV;FOXP1;HMGB1
prerank,skeletal muscle tissue development (GO:0007519),0.475769599400557,1.0653282596024076,0.39635535307517084,1.0,1.0,7/32,21.08%,CSRP3;CAV1;CAV2;SKI;CFLAR;ZBTB18;SVIL
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.49981962804746627,1.0652760550923472,0.4326241134751773,1.0,1.0,9/26,18.13%,GFI1;BIRC2;LRRC14;FLOT1;TLR5;APPL1;LGR4;NLRP2B;FLOT2
prerank,regulation of acute inflammatory response (GO:0002673),-0.3644469669801533,-1.0645351967678174,0.33755274261603374,0.7336207534107106,1.0,10/18,51.56%,NLRP3;PTGES;OSM;OSMR;IL6;PLA2G2D;GSTP1;KLKB1;F12;DNASE1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.325514320694427,-1.0644925665867442,0.36666666666666664,0.7321609726298851,1.0,8/27,10.38%,TREM2;LRP1;APOE;ABCA5;PLTP;SCP2;ZDHHC8;GPS2
prerank,glutathione derivative metabolic process (GO:1901685),-0.35478347434672,-1.0642812947390885,0.39215686274509803,0.7295099499569152,1.0,8/20,33.70%,HPGDS;GSTO1;GSTA3;MGST1;AKR1A1;GSTA4;GSTO2;GSTZ1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.35478347434672,-1.0642812947390885,0.39215686274509803,0.7295099499569152,1.0,8/20,33.70%,HPGDS;GSTO1;GSTA3;MGST1;AKR1A1;GSTA4;GSTO2;GSTZ1
prerank,cellular response to organonitrogen compound (GO:0071417),0.4410707469462362,1.0642103340809055,0.40040444893832156,1.0,1.0,26/99,19.98%,SLC5A5;BRCA1;AQP1;CTNNA1;EZR;HCN3;CRHBP;TAF1;ZFP36L1;PDE2A;AHR;LARS1;P2RY1;EGR1;CPEB3;LAMTOR4;DIAPH1;LAMTOR3;IPO5;XBP1;HSP90B1;GLRA1;SOX9;GABRB2;GOLPH3;PKD2
prerank,regulation of urine volume (GO:0035809),-0.4443723401149543,-1.0641141654460684,0.37373737373737376,0.7282976326631664,1.0,7/10,45.38%,NPR3;HAS2;NPR1;TFAP2B;HYAL2;ADCY6;ADM
prerank,mesoderm development (GO:0007498),0.5115500243040985,1.06410600629104,0.4174135723431498,1.0,1.0,3/18,11.00%,IKZF3;JAK2;BTK
prerank,Notch signaling pathway (GO:0007219),0.45196633396560726,1.0638849657266902,0.3968421052631579,1.0,1.0,8/59,14.04%,DLGAP5;HEY2;NOTCH1;MIB1;KAT2B;CREBBP;MYC;PSEN1
prerank,positive regulation of transmembrane transport (GO:0034764),0.5508442720140942,1.063876180010376,0.42359249329758714,1.0,1.0,4/13,17.46%,C2CD5;AZIN1;ACSL5;ANO6
prerank,regulation of hemopoiesis (GO:1903706),0.5541406996451632,1.063870269219705,0.42550143266475643,1.0,1.0,6/10,25.75%,PRKCB;CBFB;CREBBP;RUNX1;PURB;PTN
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5574638649393133,1.0638233870797582,0.430939226519337,1.0,1.0,1/11,1.98%,SOX6
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5422611443400377,1.063623921038128,0.4116059379217274,1.0,1.0,3/13,11.64%,RAMP1;ABCA2;PLCB1
prerank,pentose-phosphate shunt (GO:0006098),0.5609149231913337,1.0631465633790798,0.4112676056338028,1.0,1.0,2/11,4.01%,PGM2;H6PD
prerank,RNA stabilization (GO:0043489),0.47603609348301884,1.0630293477029964,0.39431818181818185,1.0,1.0,15/33,24.75%,E2F1;TRDMT1;TAF15;HNRNPU;PAIP1;DKC1;TENT2;ELAVL1;EIF4ENIF1;THRAP3;TENT5D;YBX1;GDNF;CIRBP;ZCCHC17
prerank,aortic valve development (GO:0003176),0.4715023787573019,1.0629719316231134,0.413677130044843,1.0,1.0,10/34,22.26%,HEY2;RB1;TWIST1;NOTCH1;SLIT3;ROCK2;ELN;SOX9;ROCK1;EFNA1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.5070557359785033,1.0625716624917254,0.4108433734939759,1.0,1.0,7/23,16.74%,DAPK2;CD74;RIPOR2;DPP4;RAC2;MCU;RAC1
prerank,transcription by RNA polymerase I (GO:0006360),0.47486549635635755,1.0622059159210864,0.40451977401129946,1.0,1.0,11/34,18.42%,POLR1B;TAF1;POLR1A;ERCC3;TCOF1;POLR1F;POLR1C;POLR2K;TAF1C;TAF1D;POLR1G
prerank,regulation of osteoblast differentiation (GO:0045667),0.4459720699583507,1.0621177841881324,0.39525283797729616,1.0,1.0,22/82,20.41%,HEMGN;MEN1;FBXO5;RIOX1;CCN1;TWIST1;CCN4;CDK6;LRP3;NOTCH1;PRKACA;BMPR1A;NELL1;SKI;LIMD1;ATP6AP1;TRPM4;SUFU;CRIM1;SOX9;ZHX3;ACVR2B
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5261216245080154,1.0615300470250484,0.42748091603053434,1.0,1.0,5/18,18.59%,C2CD5;PRKCB;PRKAG2;APPL1;SLC2A1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4626043937777423,1.0613218566655243,0.41594827586206895,1.0,1.0,18/47,24.33%,CD177;DCXR;MAPK14;GRB2;PLCG2;DHRS4;TLR6;TYROBP;TP53;CYBA;CDKN1A;RAB27A;RIPK1;MAPT;SYK;PRKCD;SLC5A3;RNF41
prerank,regulation of JUN kinase activity (GO:0043506),0.4800282166471746,1.061081127979656,0.4126436781609195,1.0,1.0,12/33,21.40%,ARHGEF5;PTPN22;MAP3K5;MAP3K11;TLR6;AIDA;TNFRSF11A;MAP3K7;HIPK3;RPS3;TRAF6;SASH1
prerank,regulation of cytoplasmic transport (GO:1903649),0.5649671025113066,1.0606776350046891,0.4235127478753541,1.0,1.0,6/11,18.13%,MAPK1;DNAJC13;MAP2K1;CHMP3;USP7;LRRK2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3032237580455895,-1.0606219417027214,0.31724137931034485,0.7357579061134345,1.0,10/31,15.83%,OPHN1;MYO9A;PRKCI;RAP2A;ERBIN;DLG2;SH3BP1;PDCD6IP;LRRC7;DLG1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5476035088675032,1.0598816436939649,0.41244573082489144,1.0,1.0,5/11,16.47%,NOVA2;PCBP2;IGF2BP3;PCBP3;ZNF445
prerank,myeloid leukocyte differentiation (GO:0002573),0.45691350479096104,1.0597970198867683,0.415625,1.0,1.0,18/65,19.40%,PRTN3;LEF1;E2F1;BATF;DEK;PML;FOXP1;MAPK14;THOC5;GLO1;TYROBP;RUNX1;TNFRSF11A;PIR;SIRT1;CDKN1A;LGALS9;CASP8
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5589740714471099,1.0597697148281386,0.4207492795389049,1.0,1.0,6/10,23.07%,PRKCE;NEDD4L;STK39;HECW2;NEDD4;OSR1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5061378609587596,1.0595956504400588,0.42021924482338613,1.0,1.0,7/21,18.13%,PMAIP1;BOK;PARK7;DDIT3;XBP1;SYVN1;LRRK2
prerank,regulation of tube diameter (GO:0035296),0.5333945668023055,1.0595146948515552,0.4240331491712707,1.0,1.0,5/13,24.01%,ROCK2;ROCK1;GCLM;GCLC;ITGB1BP1
prerank,vascular process in circulatory system (GO:0003018),0.5333945668023055,1.0595146948515552,0.4240331491712707,1.0,1.0,5/13,24.01%,ROCK2;ROCK1;GCLM;GCLC;ITGB1BP1
prerank,positive regulation of mRNA processing (GO:0050685),0.49881349783469625,1.0586438808418626,0.43283582089552236,1.0,1.0,9/21,23.67%,RBM3;NCBP1;NUP98;DAZAP1;NCBP2;THRAP3;LEO1;NCL;CIRBP
prerank,calcium-mediated signaling (GO:0019722),0.44135084488284776,1.0584871795286257,0.41590214067278286,1.0,1.0,23/93,18.13%,CXCR5;PPP1R9B;SAMD14;PPP3CA;RCAN3;CCR2;PRKACA;PLCG2;NUDT4;EGFR;PDPK1;CCR6;BTK;FIS1;CHRM3;MCU;PPP3CC;STIMATE;PLCG1;TRPM4;MCTP1;CXCR4;LRRK2
prerank,protein secretion (GO:0009306),-0.26177923219304233,-1.0581003936036653,0.3275862068965517,0.7403797275718311,1.0,17/56,14.82%,RIMS2;TMEM167A;ABCA1;WLS;PCSK5;MON1A;TANGO2;COPG2;MIA3;MTTP;CYB5R4;PDIA4;RAB12;CAMK2G;OLFM2;NAGPA;PTPRN
prerank,protein complex oligomerization (GO:0051259),0.44845184373354957,1.0575999640036646,0.4195519348268839,1.0,1.0,15/85,14.01%,ECT2;POLQ;MS4A1;BLM;CUTC;ATL2;BOK;MPP2;LRRC8C;TIFA;CARD9;KCNC2;ZNHIT6;MICU1;MCU
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4677866866636532,1.0567321926555058,0.42728297632469,1.0,1.0,8/37,15.38%,PLK1;MAPK1;AXIN1;UBE2K;S1PR2;SPRED2;PRKAG2;EGF
prerank,regulation of receptor recycling (GO:0001919),-0.37568501539177457,-1.0566565549749238,0.3436123348017621,0.7424946257831413,1.0,3/16,8.76%,NSF;OPTN;ECE1
prerank,long-term memory (GO:0007616),0.49884276477436207,1.0560852899945108,0.42341220423412207,1.0,1.0,2/19,3.16%,NTF4;SLC2A4
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5040702036078879,1.0560487069204296,0.42509603072983354,1.0,1.0,7/19,21.80%,IL12A;DCN;SMOC2;CCBE1;CADM4;ADAMTS3;SEMA6A
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.32095988251524,-1.056014001367095,0.3103448275862069,0.7425922699154114,1.0,6/27,9.74%,CACNA1C;ANK2;SRI;CTNNA3;JUP;RYR2
prerank,keratan sulfate metabolic process (GO:0042339),0.4825935138297721,1.0553992561444694,0.4178935447338618,1.0,1.0,7/31,10.93%,FMOD;GALNS;ST3GAL1;SLC35D2;ST3GAL2;B3GNT2;OGN
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.48923177665402634,1.0553320838130815,0.4160839160839161,1.0,1.0,4/25,9.89%,CSGALNACT2;HAS1;EXT1;B3GNT2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4847070184490508,1.055325690237684,0.42018779342723006,1.0,1.0,4/27,10.14%,CHST3;CSGALNACT2;DCN;CHST12
prerank,mitochondrial translation (GO:0032543),0.44413268767372366,1.0551779005208926,0.42206477732793524,1.0,1.0,23/104,17.25%,MRPL36;AURKAIP1;MRPL18;NOA1;GATC;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MTRF1L;MRPS34;MRPL38
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5190328838284222,1.0551326831753527,0.4230271668822768,1.0,1.0,3/15,7.99%,NRDC;SNX33;SNX9
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.42269097694470004,-1.055094693056459,0.38434163701067614,0.7432732015496758,1.0,6/12,15.83%,CACNA1C;BIN1;CTNNA3;JUP;RYR2;DLG1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4468660994370083,1.054854699957543,0.41521068859198357,1.0,1.0,29/80,21.45%,PMAIP1;AQP1;CD44;TNFSF10;DPEP1;ARL6IP1;MAP3K5;HMGB1;CDKN2D;CARD9;XIAP;FIS1;DELE1;UACA;MYC;F2R;SIRT1;SH3RF1;ARL6IP5;YWHAE;SNCA;MALT1;GRAMD4;PAX2;DAPK1;EPHA7;USP47;RPS6KA3;SYK
prerank,response to progesterone (GO:0032570),0.5134614008841059,1.0547011521741305,0.4282115869017632,1.0,1.0,2/18,5.28%,CATSPERB;CAV1
prerank,positive regulation of viral transcription (GO:0050434),0.4867084324646188,1.05451265190824,0.4227053140096618,1.0,1.0,9/25,17.19%,RSF1;POLR2I;POLR2A;NELFA;DHX9;CCNT1;NELFB;POLR2K;POLR2J
prerank,positive regulation of protein metabolic process (GO:0051247),0.44268641310879603,1.0542454826896508,0.40968718466195764,1.0,1.0,21/110,14.59%,UHRF1;BARD1;TFR2;DTL;AXIN1;ABCB10;RASGRP1;SLC25A37;FOXO1;RAB1B;STX5;PAEP;NEDD4L;MTPN;ABCA2;CARD9;FZR1;OAZ1;ROCK2;PSEN1;GSK3B
prerank,ribosomal small subunit biogenesis (GO:0042274),0.4641413342293803,1.0542043884538996,0.40513392857142855,1.0,1.0,11/39,12.66%,LSM6;RPS19;RPS7;RPS14;NOL11;RPS27;EMG1;MRPS7;RPS5;RIOK3;SRFBP1
prerank,chloride transport (GO:0006821),0.4485680875386765,1.0541764849116786,0.4039460020768432,1.0,1.0,11/74,12.59%,SLC4A1;SLC12A3;ANO10;CLIC5;SLC12A7;SLC12A1;GABRA4;CLIC1;GABRA5;ANO3;SLC12A6
prerank,stem cell differentiation (GO:0048863),0.4697239430337594,1.0539066866210363,0.42414174972314506,1.0,1.0,17/39,26.06%,BATF;PSMD11;PUM1;TP53;NELFB;HOXB4;JARID2;TGFB2;LMBR1L;PAX2;FGFR2;OSR1;UFL1;MTF2;HMGA2;MLLT3;SETD2
prerank,mitochondrial gene expression (GO:0140053),0.4654274255798035,1.0533027477964796,0.41830065359477125,1.0,1.0,11/42,12.35%,FASTKD5;NOA1;GATC;MRPL47;MRPL16;TFB2M;MRPL51;MRPS7;MRPS17;GFM2;TEFM
prerank,establishment of endothelial barrier (GO:0061028),0.4839826495053132,1.0531854842936885,0.4061032863849765,1.0,1.0,7/29,11.59%,PECAM1;EZR;TJP3;RAB1B;PDE2A;MSN;RDX
prerank,positive regulation of phosphatase activity (GO:0010922),0.49651834169158016,1.0528508935541898,0.4454203262233375,1.0,1.0,3/21,9.87%,ITGA1;PTPA;PPP1R15A
prerank,cellular sodium ion homeostasis (GO:0006883),0.5240185445527464,1.0524913305923693,0.4358322744599746,1.0,1.0,2/15,7.95%,TMPRSS3;NEDD4L
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5453718564374568,1.052009535243758,0.42510699001426533,1.0,1.0,3/11,10.21%,SNX33;NEDD4L;ACTN2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5186726495196499,1.05199124229661,0.41388518024032045,1.0,1.0,3/15,10.14%,CSGALNACT2;DCN;CHST12
prerank,regulation of mRNA catabolic process (GO:0061013),0.43303408050044245,1.0518250873601476,0.40080563947633435,1.0,1.0,38/121,20.77%,XPO1;PSMB7;PSMD11;PSMF1;TNPO1;EXOSC8;ZFP36L1;PSMC1;PUM2;NUP214;DCP2;PRKCA;PSMC3;PSMA4;PUM1;IGF2BP3;PSMC4;DCP1A;APEX1;FXR1;PSMD13;PSME1;PSMB1;CNOT1;RC3H1;PSMD8;SAMD4A;ZFP36L2;PSME4;VIM;PSMD4;UBA52;ELAVL1;XRN1;CNOT8;PNPT1;PRR5L;CNOT7
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.46762853963428025,1.0513526448813204,0.425531914893617,1.0,1.0,8/36,14.11%,NR4A2;RB1;DAPK2;BCL2L12;FAS;ING5;SGMS1;PPIA
prerank,positive regulation of JUN kinase activity (GO:0043507),0.493693296567111,1.0511992437203648,0.4393203883495146,1.0,1.0,9/23,21.40%,ARHGEF5;MAP3K5;MAP3K11;TLR6;TNFRSF11A;MAP3K7;RPS3;TRAF6;SASH1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.47065244110007765,1.051107149431186,0.42444444444444446,1.0,1.0,9/40,16.38%,EZH2;LEF1;TIAM1;TWIST1;NOTCH1;SMAD4;BCL9L;TCF7L2;TGFB2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4327045054124006,1.0509375476293439,0.271,1.0,1.0,203/834,20.79%,DLGAP5;CKAP2;E2F7;E2F8;FOXM1;E2F2;UHRF1;FOXA2;NKX6-1;MYB;HMGB2;SPIB;POU2AF1;MYBL1;MEN1;ATAD2;BRCA1;NR4A2;TFR2;HMGA1;HEY2;LEF1;E2F1;SMARCA5;SENP1;SMARCD2;RSF1;ELK4;PPP3CA;CCN1;TWIST1;ZFPM1;CSRP3;BCLAF3;USF1;ERG;RPS6KA5;EPC1;RBL1;BRD8;NR1D1;MED30;IKBKG;FOXO1;FOXJ3;ATM;KANSL3;TCF3;BCL2L12;SETX;ARF4;TFDP1;KLF10;BRD4;TAF7;NOTCH1;PIN1;XRCC6;DDRGK1;HMGB1;AHR;CAMTA2;KMT2C;MAX;DCN;SMARCA4;YEATS4;SSBP3;GABPB2;GABPB1;PCGF5;RLF;EFCAB7;E2F5;IER2;NCOA7;PLAG1;NRF1;EGFR;ASXL1;EGR1;TFDP2;SALL2;IRF2BPL;NR2C2;HIPK2;PSMC3;NR2F2;KAT6A;RUVBL2;PARK7;ZNF462;PRDM10;SMAD4;ATF6;TAF6;MLLT10;DHX9;JUN;ATF5;KAT2B;RPRD1B;CCNT1;NPAT;PELP1;PAXIP1;NFATC2IP;BCL9L;APEX1;HCFC1;SATB2;BMPR1A;STAT5B;KMT2A;SP3;NFE2L2;HNRNPU;SIRT7;BEX1;HELZ2;PRKDC;DDIT3;CEBPZ;ADCYAP1;CREBBP;SKI;MYC;CEBPG;GABPA;MED14;MYDGF;HTATIP2;PBX2;RNF111;PPP1R12A;E2F3;CCNK;ELF1;SS18;MOSPD1;TP53;JUNB;RUNX1;IRF8;HOXB4;POU2F1;PLAGL1;SIN3A;TCF7L2;TCF4;HIVEP1;FOXK2;RFX4;ATRX;TAF9;CDK8;TGFB2;NFATC3;TCERG1;SIRT1;XBP1;TMF1;APLN;RNF4;RXRB;MLXIP;HCLS1;GLYR1;UBA52;ZBED4;POU2F2;HDAC4;RARG;MED1;CREB1;DPF2;NKX2-8;PROX1;HDAC1;PAX2;TRAF6;TBL1XR1;SOX9;THRAP3;NPAS2;SREBF2;AGO2;NCOA6;HDAC8;ZBTB18;MMP12;PRKD2;PKD2;NCOA2;MET;MED13;FIZ1;RBPJ;PRDM4;PHF10;PPARD;SMAD2;CITED2
prerank,translational elongation (GO:0006414),0.440161876434111,1.0504705764056306,0.4080808080808081,1.0,1.0,23/101,17.25%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;EEF1B2;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;RACK1;MRPL24;MRPL48;MRPS10;EEF2;MRPS34;MRPL38
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5269230501105836,1.0502839665927661,0.45989304812834225,1.0,1.0,4/14,18.32%,OXSR1;CCR2;STK39;ADAM10
prerank,regulation of postsynapse organization (GO:0099175),-0.3131211827500668,-1.050204653430054,0.36231884057971014,0.7541504873708533,1.0,13/28,20.25%,TANC2;PPFIA2;CDK5R1;ARHGAP44;CDK5;EPHA4;ABI2;SHANK3;ABHD17C;ARHGAP22;CFL1;KIF1A;ZDHHC15
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5326405819972033,1.0500969949032004,0.4366754617414248,1.0,1.0,5/13,14.80%,ARID1B;CDCA4;CHEK1;SERTAD2;ELOF1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.34996920065524195,-1.0496450366527552,0.36818181818181817,0.7539348869751423,1.0,7/19,14.37%,CAMKK2;DNM1L;HTRA2;GSK3A;PRKN;PINK1;FBXW7
prerank,regulation of acrosome reaction (GO:0060046),0.5496705093359978,1.0493918382680727,0.42037302725968434,1.0,1.0,2/10,19.27%,PLCB1;GLRA1
prerank,histone deacetylation (GO:0016575),0.4534086815622946,1.0492412392629837,0.4306326304106548,1.0,1.0,14/43,19.79%,RCOR2;ELK4;HDAC10;MTA3;HDAC6;SIN3B;MTA2;SIRT7;SIN3A;SIRT1;HDAC4;HDAC1;TBL1XR1;HDAC8
prerank,regulation of cell growth (GO:0001558),0.43521694929981336,1.049183682942147,0.392,1.0,1.0,40/204,16.94%,KIF14;RAB33B;CDKN2C;JADE1;PPP1R9B;RB1;TCHP;NET1;PML;S100A9;BRAT1;STK11;DDX49;TFRC;CDKN2A;S100A8;H3-3A;CIB1;SMARCA4;MTPN;NCBP1;EGFR;CDKN2D;DERL2;SOCS2;SMAD4;CCAR2;SLIT3;BAP1;RACK1;SERTAD2;BCL6;PABIR1;SGK3;TP53;PAK5;NDRG3;TGFB2;KLHL22;SIRT1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5135602411544128,1.0489732372324618,0.428,1.0,1.0,2/15,3.54%,PMAIP1;PRKCE
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4425473582598827,1.048548676745971,0.4201424211597152,1.0,1.0,35/84,25.64%,MBNL3;RBM15;RBM3;HNRNPL;SRSF3;SAP18;NOVA2;SRSF4;NCBP1;ZBTB7A;RNPS1;RBFOX3;NUP98;METTL16;RBM7;FXR1;HNRNPU;DAZAP1;SRSF10;SRSF7;SRPK1;RBM25;HNRNPA1;THRAP3;CELF1;RBFOX2;WTAP;NCL;CIRBP;HNRNPK;PTBP1;NSRP1;SFSWAP;YTHDC1;KHDRBS3
prerank,negative regulation of apoptotic process (GO:0043066),0.43407647136783906,1.0485330744514127,0.352,1.0,1.0,93/444,19.39%,KIF14;CDK1;STIL;BIRC5;MAD2L1;NTF4;BARD1;PLK1;NR4A2;AQP1;MAPK1;LEF1;DDAH2;RB1;ERBB3;FLNA;CD38;LIG4;CD74;ANKLE2;CD44;PIDD1;PA2G4;UBE2O;TFRC;CAV1;FOXO1;CASP2;DPEP1;PTMA;SETX;ARF4;BIRC2;ARL6IP1;NOTCH1;UBE2Z;DDRGK1;PIM2;BIRC6;PIM3;CIB1;PRKCA;TNFAIP8;RNF157;ERC1;EGFR;CDKN2D;PIM1;SOCS2;PARK7;XIAP;ATF5;FAS;MYD88;NAA16;PRKDC;GLO1;MYC;CFLAR;PSEN1;BAG1;BAG3;MYDGF;HTATIP2;TPT1;GSK3B;PDCD10;TP53;F2R;PAK2;TAF9;ARHGDIA;VHL;PIK3CA;SIRT1;XBP1;SH3RF1;HCLS1;HSP90B1;UBA52;YWHAE;AVEN;SNCA;KDM2B;MED1;MALT1;ADAM10;CLN3;HDAC1;HIPK3;PAX2;TRAF6;SOX9
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.44795294020518456,1.0485070080011765,0.41239316239316237,1.0,1.0,15/53,16.92%,PSMB7;PSMD11;PSMF1;AZIN1;PSMC1;PSMC3;PSMA4;PSMC4;OAZ1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4
prerank,positive regulation of actin nucleation (GO:0051127),0.547045424230878,1.0482697099446057,0.45557122708039494,1.0,1.0,3/11,14.64%,GSN;WHAMM;BRK1
prerank,regulation of cardiac conduction (GO:1903779),-0.26741830563388685,-1.0479820252553134,0.2857142857142857,0.7567077988189778,1.0,32/54,38.26%,ITPR2;ASPH;ANK2;SLC8A3;ATP2B2;ATP1A1;TRPC1;ATP1B2;RYR2;ATP1B1;ATP2B3;SLC8A1;ITPR3;ATP1A2;STIM1;AGT;AHCYL1;ATP1A3;ATP1B3;FKBP1B;ABCC9;SLC8A2;FXYD1;NPR2;NOS1;ATP2A3;CORIN;ATP2B1;DMPK;FXYD2;FXYD6;NPR1
prerank,transcription by RNA polymerase II (GO:0006366),0.4329774063305685,1.0476802429417387,0.368,1.0,1.0,105/305,22.91%,PAX5;E2F2;PMF1;TRIP13;NR4A2;DEAF1;TEAD4;GTF2E1;DEK;POLR2I;POLR2A;HDAC10;SLBP;INTS4;SNRPF;NR1D1;INTS9;TAF1;MBD1;CPSF2;SETX;IRF9;TFDP1;TAF7;NOTCH1;TAF15;IWS1;GTF2A1;NCBP1;NABP2;SNAPC3;ERCC3;SRRT;KLF13;CSTF3;BTF3;NR2C2;INTS1;RTF1;TAF6;INTS14;NELFA;KAT2B;RPRD1B;CCNT1;CBFB;ARRB2;ZBTB7B;TAF2;CREBBP;INTS13;NRBP1;NFX1;E2F3;GMEB2;CCNK;ELOF1;NELFB;POU2F1;TAF9;POLR2K;PIR;MLLT1;XBP1;SCAF8;POLR2J;SNRPG;RXRB;PCF11;CPSF1;TAF1C;CLP1;POU2F2;RARG;MED1;TTF2;NKX2-8;HDAC1;NCBP2;TBL1XR1;PRRX1;SNAPC5;GTF2A2;TAF3;SNRPB;CPSF7;RPAP2;NRBF2;RNMT;RBPJ;INTS12;PPARD;WDR33;RPRD2;COPS2;TAF11;NR1H3;PAPOLA;MED23;POLR2B;HDAC9;ELP4;INTS11;RXRG;ZBTB1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5514868047296458,1.0472472961185981,0.4364963503649635,1.0,1.0,6/10,23.07%,PRKCE;NEDD4L;STK39;HECW2;NEDD4;OSR1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.44821220465617434,1.047112358788035,0.43007360672975814,1.0,1.0,21/57,21.45%,PMAIP1;MEFV;FYN;TNFSF10;CYFIP2;MAP3K5;HMGB1;CARD9;FIS1;UACA;MYC;F2R;USP50;SIRT1;ARL6IP5;MALT1;GRAMD4;CASP8;DAPK1;AIM2;SYK
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4009955508953712,-1.0468752748636792,0.38976377952755903,0.7579927988167787,1.0,10/13,35.42%,APP;SQSTM1;LGMN;SHANK3;AKAP5;SHISA7;CHRNA7;ADCY1;EIF2AK4;EPHB2
prerank,determination of heart left/right asymmetry (GO:0061371),0.4612120541790715,1.0468214953954875,0.441340782122905,1.0,1.0,4/42,13.42%,STIL;NOTCH1;SETDB2;BBS4
prerank,glycoprotein metabolic process (GO:0009100),-0.2711536271964126,-1.046789641886195,0.3389830508474576,0.7565570745476377,1.0,23/53,22.79%,MANBA;ST8SIA1;MAN1C1;NGLY1;MAN2A2;GANAB;STT3B;MAN2B1;LARGE1;PCSK6;B4GALT5;ERP44;ST6GALNAC6;ST3GAL4;B4GALT7;HPSE;ST8SIA5;ST6GALNAC3;AGA;ST8SIA3;MAN1B1;GAL3ST4;HIF1A
prerank,negative regulation of phosphorylation (GO:0042326),0.44155095008523687,1.0463240370135263,0.43705220061412486,1.0,1.0,31/85,23.03%,MEN1;CDKN2C;ANKLE2;CDKN2A;CRKL;NIBAN1;CIB1;IBTK;CDKN2D;PARK7;PTEN;CDK5RAP3;HNRNPU;PRKDC;PPIA;DYNLL1;FKBP8;SIRT1;PTPN13;HDAC4;LRRK2;CDKN1A;PRR5L;ROCK1;CBFA2T3;MAPT;CADM4;PPP1R15B;NTRK3;CDKN1B;TARDBP
prerank,membrane repolarization (GO:0086009),-0.38020105072979404,-1.0463065388081472,0.3769230769230769,0.7561342240263792,1.0,5/15,18.69%,ATP1A1;ATP1B2;ATP1B1;KCND3;ATP1A2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.28915466770311427,-1.0462692318985014,0.3434343434343434,0.7546182092753153,1.0,11/39,15.92%,PIK3CD;PIP4K2B;ITPKB;PIK3R1;IP6K1;PI4KA;PIK3C2B;SOCS7;PIK3CB;TMEM150A;TTC7B
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.40847507127220284,-1.0462664698311372,0.4107142857142857,0.7514029938025052,1.0,3/12,12.58%,EFNA5;CORO1C;RCC2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.40847507127220284,-1.0462664698311372,0.4107142857142857,0.7514029938025052,1.0,3/12,12.58%,EFNA5;CORO1C;RCC2
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2999363852505716,-1.0461901395390216,0.39622641509433965,0.7499902077881818,1.0,8/33,7.88%,HSP90AA1;POLR3C;TLR7;RNF135;POLR3A;MAVS;TLR4;IRF1
prerank,mesenchymal cell differentiation (GO:0048762),0.4516045693519416,1.0457229771330752,0.43088552915766737,1.0,1.0,16/51,22.74%,FAM83D;HEY2;LEF1;NOTCH1;ROCK2;HNRNPAB;GSK3B;LIMS1;FGFR1;TRIM28;TGFB2;SOX9;RBPJ;ROCK1;AKNA;FGFR2
prerank,RNA processing (GO:0006396),0.42906407432211185,1.0447389471808863,0.4114114114114114,1.0,1.0,58/176,20.17%,ADAD1;PPP1R9B;FASTKD5;LSM6;AURKAIP1;RBM3;SNRNP25;SCAF11;SNRPF;HNRNPC;HNRNPL;SETX;U2AF1;ELAVL4;RNPC3;HNRNPA2B1;PRKACA;SRSF4;NCBP1;SNRNP35;NONO;RNPS1;CSTF3;RBMS2;TUT4;CCAR2;HNRNPA0;LSM5;YJU2;KIN;PRMT9;HNRNPR;PPIG;HNRNPU;PRPF4;TFIP11;PDCD7;SNRNP40;SRSF7;TUT1;SRPK1;TCERG1;DDX39B;SNRPG;PRPF8;RSRC1;CLP1;DKC1;TENT2;ALKBH5;NCBP2;DDX54;ZCCHC8;PPP2CA;SRSF2;SF3A2;SNRNP48;SNRPB
prerank,cytoskeleton organization (GO:0007010),0.43654170333764436,1.0446616756900753,0.4324596774193548,1.0,1.0,22/114,15.68%,DIAPH3;CECR2;DES;WDPCP;NEDD9;CNN2;ANK1;RND3;PPP2R3C;MAST2;FGD6;RHOU;SYNE3;PDZD8;FGD3;PACSIN2;PLD2;RAC2;PALLD;DIAPH1;LIMD1;PAK5
prerank,chondroitin sulfate metabolic process (GO:0030204),0.47073143449296734,1.0444565686682314,0.44087256027554533,1.0,1.0,6/30,16.29%,CHST3;CSGALNACT2;DCN;CHST12;ARSB;CHSY1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4963403911303795,1.0443739978223616,0.4454428754813864,1.0,1.0,9/20,25.56%,PRKCE;NEDD4L;ACTN2;STK39;YWHAE;HECW2;NEDD4;OSR1;CAB39
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.43072991778306463,1.044054998119136,0.4184184184184184,1.0,1.0,53/166,22.88%,E2F2;NR4A2;POLR1B;SMARCA5;TEAD4;RSF1;GTF2E1;POLR2I;POLR2A;HDAC10;NR1D1;TAF1;BRF1;TAF7;NOTCH1;TAF15;TFB1M;TFB2M;GTF2A1;POLR1A;ERCC3;NR2C2;TAF6;KAT2B;POLR1F;TAF2;CREBBP;NRBP1;POLR1C;E2F3;TAF9;POLR2K;POLR2J;RXRB;TAF1C;RARG;MED1;TAF1D;POLR1G;HDAC1;TBL1XR1;NCOA6;GTF2A2;TAF3;NRBF2;RBPJ;PPARD;TAF11;NR1H3;MED23;POLR2B;HDAC9;RXRG
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4771956451779677,1.0438802874598327,0.4593967517401392,1.0,1.0,1/27,0.38%,CD19
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.43456441921002964,1.0435873510018823,0.384,1.0,1.0,72/259,18.31%,KIF24;STK26;IFT80;EXOC2;PPP1R9B;CCDC88A;POC1B;PCNT;NTN1;FLNA;EZR;WDPCP;CEP83;EXOC4;BBIP1;CEP89;GSN;WDR90;DISC1;SSX2IP;ARF4;HDAC6;NOTCH1;FXYD5;FUZ;RP2;OFD1;PTPDC1;RAB8A;CEP250;CFAP44;FGD6;TMEM237;CYS1;ABLIM3;PMP22;PCM1;PDE6D;RFX2;WHAMM;ACTN2;CCDC28B;MTSS1;CEP162;ABCC4;RAB8B;CCDC57;FGD3;SCLT1;S1PR2;ARL13B;EMP1;NRP1;BBS4;PIBF1;EXOC5;MKS1;PARVB;DYNLL1;DYNLT2B;RAC1;PARVA;IFT172;ATP6V0D1;IFT140;BBS9;ANO6;TXNDC15;ARHGEF7;ATAT1;ABLIM2;FAM161A
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.42852223791336974,1.0432606997446756,0.374,1.0,1.0,69/366,15.55%,ESCO2;MYB;EZH2;CCNA2;MYBL1;SPIN4;HMGA1;SOX6;CHEK2;BRCA2;E2F1;DSCC1;NSD2;RB1;FBXO5;CCDC88A;EIF2A;RBM3;PML;NUP107;ORC5;POLR2A;NUCKS1;HDAC10;RPS6KA5;ACTR5;ORC3;EDF1;NFXL1;LIN54;ATF7;TCF7L1;TCF3;GMNN;RUNX3;PHF19;NOTCH1;MLF2;AHR;PSPC1;DMTF1;PHF1;UBE2V1;ERC1;PLAG1;MTPN;NONO;SRRT;PFDN5;SPTY2D1;PUM3;NR2C2;NFYC;TCOF1;CCAR2;ATF5;NSD3;HCFC1;SP3;ING2;REXO4;DDIT3;CREBBP;NFX1;RNF20;TP53;GON4L;LIMD1;SRSF10
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.45279615188318745,1.0432229345261461,0.4399574920297556,1.0,1.0,8/57,9.53%,MRPL36;XPO1;RPL7;RPL14;RPS19;RPS7;URB2;EMG1
prerank,magnesium ion transport (GO:0015693),0.5334458839924857,1.0432158568699466,0.46227709190672156,1.0,1.0,7/12,23.49%,MAGT1;TUSC3;NIPAL4;NIPA2;NIPAL3;MMGT1;CNNM4
prerank,glutamate receptor signaling pathway (GO:0007215),-0.29639528224222744,-1.0431023142806388,0.2916666666666667,0.75617664903365,1.0,9/37,14.75%,APP;DAGLB;GRIA4;GRIN3A;GRM5;CDK5R1;GRIK2;GRM8;DAGLA
prerank,cell differentiation in spinal cord (GO:0021515),0.534458556409177,1.0430597995807445,0.4410919540229885,1.0,1.0,2/10,13.03%,SOX6;MDGA1
prerank,negative regulation of type I interferon production (GO:0032480),-0.27425751352732197,-1.0428763659651819,0.3979591836734694,0.7551016708883087,1.0,11/40,11.39%,SIRPA;HAVCR2;PTPRS;PYCARD;TNFAIP3;RNF135;IKBKE;UBA7;MAVS;TRIM25;TRAF3IP1
prerank,protein deacetylation (GO:0006476),0.45635780798449865,1.0427709332333046,0.43425414364640885,1.0,1.0,13/41,19.37%,RCOR2;FLNA;HDAC10;MTA3;HDAC6;SIN3B;MTA2;SIRT7;SIN3A;SIRT1;HDAC4;HDAC1;TBL1XR1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.43096006377332546,1.0427101537091983,0.42264914054600605,1.0,1.0,9/98,8.51%,CDK1;UHRF1;CCNB1;DCXR;AGPAT1;RAB1B;MAPK14;GRB2;PICK1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.35560425158925313,-1.042443235591688,0.38073394495412843,0.7545733721255293,1.0,5/19,5.78%,RTN4;APOE;GGA3;IGF1;BIN1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5287435575667264,1.0423552940198366,0.43391188251001334,1.0,1.0,6/12,19.50%,H6PD;MBTPS2;SEC14L2;ABCA2;KPNB1;SREBF2
prerank,negative regulation of dephosphorylation (GO:0035305),0.503455084987345,1.0422947144889922,0.4629156010230179,1.0,1.0,4/18,10.26%,PTPA;PPP1R8;PPP1R15A;PPP1R35
prerank,positive regulation of histone modification (GO:0031058),0.4704117063316413,1.0422944353519599,0.45067264573991034,1.0,1.0,12/33,20.53%,BRCA1;RPS6KA5;SART3;RUVBL2;PAXIP1;ZBTB7B;ING2;NIPBL;TADA2A;GLYR1;BRD7;UBE2N
prerank,RNA methylation (GO:0001510),0.4473932110357141,1.0416423310641931,0.4276663146779303,1.0,1.0,16/60,15.24%,RBM15;ZCCHC4;TRMO;TRDMT1;TFB1M;TFB2M;TRMT5;CBLL1;METTL8;TYW3;FBL;METTL16;VIRMA;NSUN3;METTL14;DIMT1
prerank,negative regulation of cell communication (GO:0010648),-0.32622726444431016,-1.0414605219922755,0.41621621621621624,0.7556956997343411,1.0,2/21,0.65%,ACVR1;UBASH3B
prerank,cardiac muscle cell development (GO:0055013),0.5017175753881385,1.041196892407402,0.423500611995104,1.0,1.0,2/20,3.63%,HEY2;CSRP3
prerank,regulation of cell motility (GO:2000145),0.43412259273687276,1.0410571499184786,0.4215291750503018,1.0,1.0,22/121,15.38%,KIF14;ERBB3;NTN1;FLNA;SLK;TWIST1;LMO4;AMOTL2;CDK6;PIN1;PKN2;PRKX;PLXNA2;CYRIB;EGFR;KIF2A;FGF9;CRK;ROCK2;DIAPH1;SGK3;EGF
prerank,positive regulation of T cell migration (GO:2000406),0.49206375519651246,1.040931750786714,0.4560099132589839,1.0,1.0,3/20,5.31%,SPN;OXSR1;CCR2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5389317458905656,1.0408775764798988,0.45493562231759654,1.0,1.0,3/11,10.75%,FYN;ABCD1;PARK7
prerank,cochlea morphogenesis (GO:0090103),0.5492773048651343,1.040568984087838,0.44035346097201766,1.0,1.0,3/10,19.39%,TIFAB;PAX2;SOX9
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3529056488895682,-1.0404261060549538,0.39037433155080214,0.7568037652492854,1.0,2/18,0.73%,RIMS1;RIMS2
prerank,DNA methylation (GO:0006306),0.49007926675096036,1.0398681503449667,0.46219512195121953,1.0,1.0,10/23,20.82%,PPM1D;HELLS;PICK1;METTL4;DNMT1;EHMT1;ATF7IP;ATRX;DNMT3B;GATAD2A
prerank,atrioventricular valve development (GO:0003171),0.5223323611829692,1.0396718287497142,0.4432576769025367,1.0,1.0,6/14,16.38%,ZFPM1;MDM4;NOTCH1;SLIT3;BMPR1A;TGFB2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.4836468662104413,1.0393554711108401,0.43556085918854415,1.0,1.0,10/25,19.97%,GLMN;CCR2;PLCG2;RUNX1;MAP3K7;MALT1;RPS3;TRAF6;PNP;PRKD2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3538665017625359,-1.0393542217540395,0.38636363636363635,0.7578152692666302,1.0,9/17,40.12%,GPLD1;APOC1;SORL1;IL1B;ADRA2A;PDE3B;PRKAA1;MFSD2A;HCAR2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.49301634257262955,1.0393479886704329,0.43818849449204406,1.0,1.0,4/21,10.75%,BRCA1;ABCD1;HDAC6;PARK7
prerank,positive regulation of signaling receptor activity (GO:2000273),0.46789760911359546,1.0383750672952634,0.45970488081725314,1.0,1.0,9/36,15.38%,CCR2;TAF1;HDAC6;TGFA;JAK2;PARK7;RELN;NRP1;EGF
prerank,RNA metabolic process (GO:0016070),0.43216144416355434,1.0383116179704153,0.43693239152371344,1.0,1.0,47/127,22.39%,ADAD1;RNASE6;RBM3;POLR2I;POLR2A;PPP1R8;HNRNPC;HNRNPM;HNRNPL;HNRNPA3;SETX;FTO;ELAVL4;HNRNPA2B1;NCBP1;RBMS2;PCBP2;DHX9;HNRNPA0;HNRNPR;WDR74;HNRNPU;PRPF4;TFIP11;PCBP3;RNASEH2A;METTL14;SNRNP40;POLR2K;RNASE1;DDX39B;POLR2J;CLP1;DKC1;TENT2;HNRNPA1;NCBP2;DDX54;AGO2;PNPT1;SYNCRIP;PAPOLA;RBFOX2;RNASEH2B;AGO1;WTAP;POLR2B
prerank,protein polyubiquitination (GO:0000209),0.42852307772373605,1.0382531757795757,0.396,1.0,1.0,72/297,18.55%,CCNF;UBE2C;UBE2T;BARD1;RNF26;BRCA1;FBXL15;SKP2;DTL;PSMB7;PSMD11;PRPF19;CDC23;FBXW11;MKRN1;CDC27;UBE2O;PSMF1;TAF1;FBXO44;TRAF3;PSMC1;ANAPC7;BIRC2;UBE2K;UBE4B;UBE3B;NEDD4L;UBE2V1;FBXO17;CUL3;PSMC3;AMFR;UBE3C;UBR2;PSMA4;RNF168;RNF8;TRIM3;FZR1;TRIM68;FBXL4;CBFB;PSMC4;RNF152;FBXO11;PSMD13;SPOP;PSME1;ARIH2;RNF20;TRIM5;PSMB1;RBCK1;HECTD2;RC3H1;PSMD8;MYLIP;PSME4;RNF115;TRAF3IP2;UBE2R2;PSMD4;RNF4;HERC6;RNF19A;UBA52;DDB2;SYVN1;UBE2G1;FBXW8;RBBP6
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.35517636329489644,-1.0381190800946107,0.3901345291479821,0.759375902835172,1.0,6/18,18.51%,CDH8;NAPA;SLC17A6;GRIK2;UNC13A;GRIK4
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.4244977231516477,-1.0379937955118759,0.3890784982935154,0.7580742294604975,1.0,3/10,14.27%,PRKAR1A;CD274;PRNP
prerank,organophosphate ester transport (GO:0015748),-0.3301664850307394,-1.037529073724288,0.3977272727272727,0.7576848965987891,1.0,8/24,13.34%,OSBPL2;PLTP;PRELID2;SCP2;MTTP;SCARB1;PITPNB;NPC2
prerank,regulation of endothelial cell migration (GO:0010594),-0.24282351829295037,-1.0374262549049387,0.42857142857142855,0.7563576224648428,1.0,30/85,20.72%,ANXA3;GLUL;NRP2;APOE;GPI;BMPR2;PIK3CD;PRKD1;GRN;ZC3H12A;KRIT1;ANGPT1;NF1;SH3BP1;ITGB3;SCARB1;SPARC;PIK3CB;PTK2;VEGFA;FGF2;VASH1;ACVRL1;DAB2IP;GPLD1;THBS1;BMPER;ADGRB1;SVBP;AGT
prerank,skeletal system development (GO:0001501),0.4318944963217327,1.037093648720397,0.4371859296482412,1.0,1.0,23/148,12.76%,RAB33B;RFLNB;ALPL;SOX6;DEAF1;TEAD4;CD44;SULF2;HAPLN2;ETS2;EXT1;PTHLH;COL1A2;SPEF2;DDRGK1;SLC10A7;ZBTB16;ATP7A;DYM;TCOF1;BPNT2;PAPSS2;HHIP
prerank,regulation of protein kinase A signaling (GO:0010738),0.4958556187249259,1.036901502317992,0.4392059553349876,1.0,1.0,3/20,4.22%,IAPP;AKAP12;AKAP7
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.4441600447139067,1.036532828840728,0.4370208105147864,1.0,1.0,16/45,23.20%,RPS6KA5;TGFA;GRB2;SOS1;EGFR;PDPK1;DGKD;EGF;PLCG1;PIK3CA;IQGAP1;KIF16B;SOX9;PTPN11;ADAM17;SRC
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.523372568508861,1.035986057548093,0.4557463672391017,1.0,1.0,7/13,23.35%,DDRGK1;PPP1R15A;ABCA7;RACK1;DNAJB9;PPP1R15B;UFL1
prerank,Fc receptor signaling pathway (GO:0038093),0.4279190974524916,1.0354241029546796,0.43711967545638947,1.0,1.0,34/110,18.23%,MAPK1;GRAP2;PSMB7;PPP3CA;PSMD11;FBXW11;PSMF1;IKBKG;PSMC1;MAP3K1;TAB1;GRB2;PLCG2;SOS1;TAB3;PDPK1;PSMC3;BTK;PSMA4;JUN;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PAK2;PSME4;PLCG1;NFATC3;RAC1;PIK3CA;PSMD4;MAP3K7;MALT1
prerank,respiratory tube development (GO:0030323),-0.3003082758859164,-1.0353855896442576,0.38620689655172413,0.7600249643657097,1.0,16/28,38.56%,PCSK5;BAG6;NPHP3;VEGFA;FGF2;LOXL3;CCDC39;RBP4;PDPN;ITGA3;CCDC40;ABCA3;GLI2;WNT7B;FGF7;BMP4
prerank,regulation of Notch signaling pathway (GO:0008593),-0.24694578958267094,-1.0350209276822515,0.3235294117647059,0.7592678763063613,1.0,22/76,18.52%,BMP2K;EPN2;PRAG1;MAML1;GALNT11;PRKCI;ARRDC1;ARRB1;YTHDF2;MMP14;MAML3;POGLUT1;STAT3;ZMIZ1;TSPAN15;FBXW7;TSPAN14;TM2D3;JAG1;CD46;LLGL1;NEPRO
prerank,regulation of mRNA polyadenylation (GO:1900363),0.5031468828899509,1.0348663526449444,0.45618556701030927,1.0,1.0,8/17,20.18%,NCBP1;CPEB3;CCNT1;ZC3H3;VIRMA;RNF20;NCBP2;CPSF7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4284007832311611,1.0348562698307835,0.4457953394123607,1.0,1.0,34/109,18.23%,MAPK1;GRAP2;PSMB7;PPP3CA;PSMD11;FBXW11;PSMF1;IKBKG;PSMC1;MAP3K1;TAB1;GRB2;PLCG2;SOS1;TAB3;PDPK1;PSMC3;BTK;PSMA4;JUN;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PAK2;PSME4;PLCG1;NFATC3;RAC1;PIK3CA;PSMD4;MAP3K7;MALT1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4290647372989055,-1.0348368551438247,0.4181184668989547,0.7581516842113267,1.0,4/10,17.48%,RC3H2;ZC3H12A;SMAD7;NFKBID
prerank,membrane lipid catabolic process (GO:0046466),0.5487760575055968,1.0346091713791696,0.4426705370101596,1.0,1.0,1/10,1.40%,CYP1B1
prerank,sensory perception (GO:0007600),-0.2658918217398903,-1.0345553944117876,0.4157303370786517,0.7572738395615876,1.0,27/45,40.01%,WHRN;GNAS;MYO7A;SCN9A;TTC8;C5AR1;KCNA2;PCDH15;NIPSNAP1;CDH23;PENK;P2RX4;PTGES;CHRNA7;GNAL;NTSR2;CHRNA4;CCL2;OPRL1;OPRK1;CLRN1;USH2A;PNOC;ALOXE3;PDYN;KCNK4;CHRNB2
prerank,pharyngeal system development (GO:0060037),-0.3759254383675499,-1.033757716349669,0.379182156133829,0.7577120008885434,1.0,2/15,3.19%,TGFBR1;BMPR2
prerank,protein ubiquitination (GO:0016567),0.42530618281037497,1.0336924175453739,0.391,1.0,1.0,113/471,17.78%,CCNF;UBE2C;UBE2T;UHRF1;TRIM58;BARD1;RFWD3;RNF26;PLK1;BRCA1;FBXL15;MEFV;SKP2;DTL;PSMB7;PSMD11;PRPF19;CDC23;FBXW11;MKRN1;CDC27;UBE2O;PSMF1;PCNA;TAF1;TRAIP;FBXO44;MSL2;PSMC1;ANAPC7;FBXO45;BIRC2;UBE2Z;BIRC6;UBE2K;UBE4B;UBE3B;NEDD4L;UBE2V1;TRIM11;RNF157;RAD18;FBXO17;KLHL9;RNF141;TNFAIP1;ASB1;CUL3;TRIM47;CBLL1;PSMC3;AMFR;UBE3C;TRIM33;TRIM44;UBR2;PSMA4;RNF168;RTF1;MIB1;RNF8;SPSB4;PEX2;TRIM3;CNOT4;EIPR1;TRIM68;FBXL4;CBFB;PSMC4;ARRB2;PCNP;RNF152;CUL9;FBXO11;NFE2L2;RACK1;PSMD13;SPOP;PSME1;PRKDC;NFX1;ARIH2;FANCL;RNF20;TRIM5;PSMB1;RNF111;RBCK1;VCPIP1;HECTD2;RC3H1;PSMD8;MYLIP;PSME4;RNF115;UBE2R2;VHL;KLHL22;PSMD4;SIRT1;RNF103-CHMP3;SH3RF1;RNF4;HERC6;RNF19A;PEX14;TRIM37;CAND2;UBA52;USP7;DDB2;SYVN1
prerank,positive regulation of lyase activity (GO:0051349),-0.3919208611853089,-1.0332781115450314,0.4008438818565401,0.757422138813142,1.0,6/14,24.40%,CACNA1C;NF1;ISCU;ORAI1;STIM1;AKAP5
prerank,embryonic digestive tract development (GO:0048566),-0.348741638711492,-1.0327508287296139,0.4039408866995074,0.7571520522083204,1.0,6/18,19.03%,SALL1;PCSK5;GLI3;ID2;PKDCC;SOX11
prerank,positive chemotaxis (GO:0050918),-0.353322943672993,-1.0327029591923904,0.39035087719298245,0.7557116827371148,1.0,5/17,18.90%,PTPRJ;ANGPT1;VEGFA;TSC2;PLXNB3
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5361465456060216,1.0326398275681472,0.4654696132596685,1.0,1.0,5/10,23.20%,ABCD1;DCN;RACK1;LRRK2;SRC
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.34574547811917805,-1.0323291396202063,0.41899441340782123,0.7551593578817709,1.0,11/21,24.16%,RAP1GDS1;SLC8A3;MCUR1;SLC8B1;LETM1;TGM2;BCAP31;MAIP1;AFG3L2;SMDT1;ANXA6
prerank,monocyte differentiation (GO:0030224),-0.4356203066643966,-1.0321790882213322,0.4259927797833935,0.7540490772561409,1.0,5/10,17.91%,CSF1R;PDE1B;VEGFA;MT1G;IL31RA
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4754516042652874,1.032069813561477,0.4556213017751479,1.0,1.0,10/27,18.55%,BRD8;KAT6A;RUVBL2;RUVBL1;TAF6;KAT2B;CREBBP;ATAT1;PHF20;PHF20L1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.23572816728915003,-1.03189427987118,0.3684210526315789,0.753182930447683,1.0,39/91,23.43%,APP;NDFIP1;FTH1;CUL1;HMOX2;SLC11A2;SLC31A2;ACO1;HMOX1;SLC39A7;ISCU;FTL;ATP6V1A;PRNP;SLC39A14;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;TMEM199;COX19;SLC39A8;CCDC22;BMP6;SLC39A6;MT2A;SLC39A12;SLC22A17;GLRX3;ARF1;NUBP1;FRRS1;SLC30A1;MT3;CCDC115
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4250365119599592,1.0318704443881195,0.422,1.0,1.0,67/348,16.94%,CENPE;TTK;INHBC;NTF4;PLK1;MAPK1;PECAM1;CCN1;CD74;CD44;AXIN1;BRAT1;RPS6KA5;PGF;TFRC;CAV1;BANK1;MMD2;RASGRP1;CRKL;HDAC6;MAPRE3;MMD;PIN1;XRCC6;MRNIP;DDRGK1;NIBAN1;UBE2K;CIB1;SNX9;PLCG2;JAK2;EGFR;P2RY1;TXN;PARK7;RELN;SMAD4;WDFY2;FGF9;FAS;S1PR2;BMPR1A;FXR1;NRP1;ROCK2;RACK1;FLOT1;PRKAG2;LATS1;ADCYAP1;FAM20A;PPIA;MYDGF;STK4;PDCD10;TP53;RAD50;EGF;BMP3;LIMK2;PAK2;TGFB2;RAC1;PDE8A;SIRT1
prerank,axon extension (GO:0048675),-0.3214813166820409,-1.031082671148461,0.4025157232704403,0.7537917829420715,1.0,7/23,15.01%,NRP2;HSP90AA1;SPG11;USP9X;ULK1;CDK5;SEMA3A
prerank,atrial septum morphogenesis (GO:0060413),0.5381186594946429,1.03084446918041,0.4568081991215227,1.0,1.0,2/10,3.56%,HEY2;ZFPM1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.38393471298887655,-1.0305506135223599,0.39271255060728744,0.7535751995271939,1.0,3/13,15.27%,PFN1;P2RY12;EPS8
prerank,motor neuron axon guidance (GO:0008045),0.5051055537517576,1.030510458432819,0.4372574385510996,1.0,1.0,5/15,16.74%,NTN1;SLIT1;TMEFF1;RAC2;RAC1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.40844949006526443,-1.0303160358512184,0.3767605633802817,0.7527244439873563,1.0,7/11,31.40%,UQCRC2;UQCRQ;UQCRFS1;UQCRB;CYCS;UQCR11;UQCC3
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.42444209081432666,1.0300972385778395,0.342,1.0,1.0,234/1082,17.60%,CKAP2;E2F7;E2F8;FOXM1;E2F2;UHRF1;FOXA2;NKX6-1;MYB;HMGB2;SPIB;POU2AF1;MYBL1;MEN1;ATAD2;CDK5RAP2;BRCA1;SMARCC2;NR4A2;TFR2;HMGA1;CHEK2;HEY2;BLM;BRCA2;MYRFL;DEAF1;LEF1;E2F1;SMARCA5;SENP1;ARID1B;PBX4;NIF3L1;SMARCD2;RSF1;ELK4;CD38;PPP3CA;CCN1;TWIST1;ZFPM1;CSRP3;BCLAF3;CD74;USF1;PML;AXIN1;FBXW11;ERG;RPS6KA5;EPC1;CTCF;RBL1;CDCA4;BRD8;ETS2;CHEK1;BRPF1;SP100;NR1D1;MED30;EDF1;IKBKG;FOXO1;FOXJ3;ATM;YWHAH;KANSL3;TCF3;BCL2L12;SETX;ARF4;RUNX3;TFDP1;MAPRE3;EBF3;KLF10;BRD4;MAP3K5;TAF7;NOTCH1;PIN1;TAF15;XRCC6;DDRGK1;PIM2;HMGB1;PCBD2;AHR;CAMTA2;ASF1A;KMT2C;ILF2;MAX;DCN;SMARCA4;UBE2V1;YEATS4;SSBP3;SEC14L2;GABPB2;GABPB1;ZBTB16;PCGF5;RLF;EFCAB7;E2F5;IER2;NCOA7;PLAG1;NRF1;EGFR;FLI1;ASXL1;EGR1;TFDP2;SMARCC1;SALL2;IRF2BPL;NR2C2;HIPK2;PSMC3;NR2F2;KAT6A;TRIM44;RUVBL2;DYRK1A;PARK7;ZNF462;PRDM10;NFE2;SMAD4;ATF6;TAF6;MLLT10;DHX9;JUN;ATF5;KAT2B;RPRD1B;PLCB1;NSD3;CCNT1;NPAT;PELP1;NAA16;NFATC2IP;BCL9L;APEX1;HCFC1;RAI1;SATB2;BMPR1A;STAT5B;KMT2A;SP3;NFE2L2;CHCHD10;THOC5;ING2;HNRNPU;SIRT7;ING5;BEX1;HELZ2;PRKDC;DDIT3;CEBPZ;SERTAD2;ADCYAP1;CREBBP;SKI;MYC;CEBPG;GABPA;PSEN1;MED14;MYDGF;HNRNPAB;HTATIP2;RNF20;TP53INP2;PBX2;RNF111;PPP1R12A;E2F3;CCNK;ELOF1;ELF1;TADA3;SS18;ATF7IP;DNAJC2;KMT2B;MOSPD1;TP53;JUNB;GPATCH3;RUNX1;IRF8;EGF;F2R;HOXB4;POU2F1;PLAGL1;MAP2K1;SIN3A;TCF7L2;TCF4;HIVEP1;TFAP4;FOXK2;TRIM28;RFX4;ATRX;TAF9;CDK8;NFATC3;VHL;USP21;TCERG1;SIRT1;XBP1;SCAF8;TMF1;DDX39B;RNF4;RXRB;MLXIP;HCLS1;GLYR1;CAND2;UBA52
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.42408017693616895,-1.0300562484687672,0.4095238095238095,0.7519136961806799,1.0,6/10,14.68%,GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,regulation of phagocytosis (GO:0050764),0.4447057741050576,1.029869716820644,0.45532831001076424,1.0,1.0,8/53,13.08%,PRTN3;IL2RG;CD47;SNX3;ITGAV;ABCA7;PIP4P2;RACK1
prerank,response to glucagon (GO:0033762),-0.3417414365430478,-1.0298353579882216,0.4312796208530806,0.7509450621054775,1.0,4/19,4.86%,PRKACB;PRKAR1A;ADCY7;ADCY2
prerank,positive regulation of organelle organization (GO:0010638),-0.28981479281860667,-1.0297308086287702,0.3435114503816794,0.7497041795574122,1.0,9/32,9.35%,TREM2;SYNJ1;SORBS3;TMED9;AKT2;SHCBP1L;RAB3GAP2;IRGM;HTRA2
prerank,sulfur compound transport (GO:0072348),0.47314086296153457,1.0294587157912922,0.4444444444444444,1.0,1.0,1/27,0.69%,RACGAP1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3746761546754892,-1.028912879178219,0.3963963963963964,0.7501824533025889,1.0,7/14,18.07%,CSF1R;CMKLR1;AKIRIN1;PTK2;CSF1;MDK;THBS1
prerank,neuron migration (GO:0001764),0.4484423865314747,1.0288524544729372,0.4563829787234043,1.0,1.0,18/48,20.31%,NR4A2;DISC1;MARK2;PAFAH1B1;DNER;RELN;NRP1;MDGA1;FGF13;NRCAM;ADGRL3;SDCCAG8;LRP12;FGFR1;RAC1;SH3RF1;ELP3;MARK1
prerank,ether lipid metabolic process (GO:0046485),-0.3794380616409326,-1.0283902887257728,0.39271255060728744,0.7499606146025765,1.0,8/14,24.06%,PLA2G7;DHRS7B;GNPAT;NCEH1;PLA2G6;TMEM86B;AGMO;PEDS1
prerank,endothelial cell development (GO:0001885),0.4770305522434283,1.0273289882798864,0.4535840188014101,1.0,1.0,5/25,11.59%,PECAM1;EZR;PDE2A;MSN;RDX
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.2779758553688194,-1.02728848386174,0.36046511627906974,0.751392661927398,1.0,9/37,16.79%,TENM2;PTPRD;FAT4;CD164;TENM1;NECTIN4;CADM1;CXADR;ITGAL
prerank,rRNA metabolic process (GO:0016072),0.4224834394082481,1.0272401295078089,0.45536609829488467,1.0,1.0,57/160,23.10%,SLFN14;RPL7;RPL18A;UTP3;RPL36;RPL14;RPS19;DDX49;RPS7;HELQ;EXOSC8;RPL23A;RPL28;EXOSC10;RPS14;RPL41;NOL11;RPLP2;RPS27;EMG1;NIFK;UTP6;RPLP0;FBL;RPL27A;PELP1;WDR74;RPS9;NOL8;RPL12;NOP58;POP4;RPL3;UBA52;RPL18;DKC1;PES1;MPHOSPH6;RPL5;RPS6;RPS17;DIS3L;DDX54;RPL21;XRN1;RPL17;RPL23;RPL24;MAPT;RPL8;RPL27;RPL13A;DIS3;RPL15;RPL10;RPF1;NOP14
prerank,regulation of wound healing (GO:0061041),0.45210275114455944,1.0269286308571874,0.46229508196721314,1.0,1.0,5/42,11.74%,FOXA2;PRKCE;CAV1;INSL3;CRK
prerank,lipid droplet organization (GO:0034389),-0.33023686698120513,-1.0266352059445194,0.4010416666666667,0.7515124740378741,1.0,4/22,9.72%,CDS1;AUP1;CDS2;ZFYVE1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.28769857779637203,-1.026105644128878,0.3939393939393939,0.75132836587058,1.0,18/39,33.41%,PRKCI;TNFAIP3;KRIT1;ANGPT1;TNIP2;SERPINE1;ECSCR;THBS1;MAPK7;PDCD4;CD40;NDNF;RGCC;KDR;ICAM1;CCL2;PAK4;TEK
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.525733966866155,1.0255829688503855,0.4563758389261745,1.0,1.0,5/12,18.96%,FOXP1;SMARCA4;ZBTB7A;SIRT1;HDAC1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.366784519052595,-1.0255555301227657,0.3852813852813853,0.7513368882442131,1.0,7/15,31.77%,PTPN2;YTHDF2;USP18;CACTIN;MUL1;TTLL12;ISG15
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.48353336957757104,1.0253140883398717,0.4663402692778458,1.0,1.0,9/21,23.93%,PRTN3;PSEN1;DAG1;SPPL3;ADAM10;ERAP1;ADAM17;MYH9;PRKCQ
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5196412783041661,1.0247053063117206,0.46684350132625996,1.0,1.0,1/13,1.11%,CHST3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.42199233288216725,1.0245401683100699,0.35,1.0,1.0,393/1668,20.82%,CKAP2;E2F7;CDK1;BRIP1;PAX5;AURKB;E2F8;FOXM1;E2F2;UHRF1;GFI1;FOXA2;NKX6-1;VAX2;MYB;HMGB2;EZH2;CCNB1;RCOR2;SPIB;POU2AF1;MYBL1;MEN1;PLK1;ATAD2;SUV39H1;RAD21;BRCA1;DMRTA1;SMARCC2;NR4A2;TFR2;HMGA1;SOX6;HEY2;DEAF1;LEF1;E2F1;SMARCA5;UXT;RB1;SENP1;TEAD4;ARID1B;IKZF3;PBX4;LIN9;SMARCD2;BATF;RSF1;ELK4;CBX5;EZR;PPM1D;PPP3CA;CCN1;TWIST1;ZFPM1;MCPH1;DEK;CSRP3;BCLAF3;USF1;HMGB3;PBX3;NUCKS1;HDAC10;ERG;BACH2;UBE2I;MTA3;LCORL;RPS6KA5;EPC1;CTCF;RBL1;RBBP8;BRD8;BRD9;FOXP1;ETS2;DACH1;SP100;CAV1;CDKN2A;NR1D1;NKAP;MED30;HOMEZ;TAF1;MBD2;IKBKG;FOXO1;FOXJ3;MDM4;ATF7;ATM;BAZ2B;KDM3B;E2F6;ZBTB26;BCL11A;KANSL3;EBF1;TCF7L1;TCF3;ARID4A;BCL2L12;SETX;ZFP41;IRF9;ARF4;RUNX3;PDE2A;TNRC6C;TFDP1;TGFA;TNRC6B;EBF3;KLF10;BRD4;TAF7;NOTCH1;MED31;PIN1;XRCC6;DDRGK1;HMGB1;AHR;CAMTA2;KMT2C;BAZ1B;SPEN;SAP18;MAX;DCN;DMTF1;PHF2;NEDD4L;SMARCA4;CIR1;YEATS4;MAPK14;SSBP3;GABPB2;GABPB1;RPS14;ZBTB16;PCGF5;RLF;EFCAB7;E2F5;IER2;NCOA7;ETV6;PLAG1;NCOA5;NFE2L1;NRF1;ZBTB7A;EGFR;FLI1;SIN3B;ABCA2;ZNF148;ASXL1;PIAS3;MECP2;SP110;KLF13;EGR1;IFRD1;TFDP2;CPEB3;SMARCC1;HIRA;SALL2;ZBTB32;MYNN;IRF2BPL;NR2C2;RFX2;HIPK2;PSMC3;NR2F2;KAT6A;ID4;ZEB1;TRIM33;TSHZ1;DBX2;CUX1;MXI1;NFYC;RUVBL2;PARK7;ZNF462;PRDM10;ARID5B;SUMO1;NFE2;RUVBL1;RTF1;SMAD4;ATF6;MED8;TAF6;MLLT10;DHX9;PEX2;JUN;ATF5;KAT2B;RPRD1B;CRK;MTA2;CCNT1;PRKCB;NPAT;PELP1;PTEN;FOXP2;ZNF25;CBFB;RNF2;NFATC2IP;PRDM6;BCL9L;APEX1;HCFC1;RAI1;SATB2;BMPR1A;ZBTB33;STAT5B;KMT2A;SP3;NFE2L2;ZBTB7B;HNRNPU;HIVEP2;SIRT7;CC2D1A;BEX1;HELZ2;PRKDC;NIPBL;SP140;DDIT3;CEBPZ;ADCYAP1;PSIP1;CREBBP;SKI;MYC;CEBPG;BCL6;PHF14;GABPA;NFX1;PSEN1;MED14;MYDGF;POU6F1;ZNF112;TADA2A;HTATIP2;CAMTA1;PBX2;RNF111;PPP1R12A;CNOT1;E2F3;GMEB2;CCNK;KDM4C;ELF1;TADA3;SS18;YEATS2;MOSPD1;TP53;JUNB;LRRFIP1;RUNX1;IRF8;HOXB4;POU2F1;PIAS1;PLAGL1;SIN3A;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;PURG;DUSP22;RFX7;FOXK2;TRIM28;RFX4;ATRX;TAF9;CDK8;ZNF445;BAZ1A;NFATC3;PCGF3;VHL;RIF1;TCERG1;SIRT1;SMARCAL1;DNAJB1;XBP1;TMF1;RNF4;RXRB;MLXIP;HCLS1;TRIM37;GLYR1;UBA52;HEXIM1;ZBED4;ZNF467;SNCA;POU2F2;HDAC4;RARG;KDM2B;MED1;REPIN1;FOXE1;ZBTB34;PHF20;CREB1;ZNF740;DPF2;RFX1;PHF20L1;SUFU;GMEB1;NKX2-8;PROX1;HDAC1;GATAD2B;BRD7;CDKN1A;SAFB;ARID3B;ZBTB20;PAX2;TRAF6;TBL1XR1;SOX9;THRAP3;NPAS2;SREBF2;ELP3;DNMT3B;PRRX1;ZHX3;AGO2;NCOA6;HDAC8;ZBTB18;ZFX;MMP12;TAF3;PRKD2;PKD2;SLTM;RPL23;ACTL6A;BRD3;MYT1;TPR;RPAP2;NCOA2;MET;ACVR2B;KDM2A;MED13;FIZ1;RBPJ;PRDM4;PHF10;PPARD;SMAD2;CITED2;GATAD2A
prerank,presynapse assembly (GO:0099054),0.5046084281991469,1.0241838950007747,0.4666666666666667,1.0,1.0,4/16,11.97%,CEL;LRP4;BSN;PTEN
prerank,secondary palate development (GO:0062009),0.5132102659548511,1.0240044407717495,0.4601889338731444,1.0,1.0,4/14,20.76%,LEF1;SMAD4;TGFB2;SMAD2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5187364384327934,1.0235958698459593,0.4786795048143054,1.0,1.0,7/13,17.78%,RNF168;RNF8;NELFA;HNRNPU;NELFB;TCERG1;HEXIM1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5190063575942019,1.0235584108055982,0.48010973936899864,1.0,1.0,6/12,23.00%,NUP214;PTPN14;SIRT7;AAAS;TPR;NEDD4
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.4449322397349192,1.0234959465876765,0.4777542372881356,1.0,1.0,15/55,16.20%,PMAIP1;PML;S100A9;TNFSF10;CAV1;S100A8;BOK;BECN1;FAS;FIS1;RACK1;ING5;DDIT3;TP53;PAK2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.5290211566757834,1.0232634127500615,0.44413012729844414,1.0,1.0,5/11,21.48%,TAF7;JAK2;SIRT1;XBP1;CIITA
prerank,glutamine family amino acid metabolic process (GO:0009064),0.46025445708978263,1.023214095475904,0.4605714285714286,1.0,1.0,5/33,8.05%,PYCR3;DDAH2;GLS2;PRODH;RIMKLB
prerank,cellular response to decreased oxygen levels (GO:0036294),0.43736701224426205,1.0230604829629344,0.4559748427672956,1.0,1.0,15/65,17.81%,SUV39H1;PMAIP1;AQP1;TWIST1;TBL2;MDM4;ZFP36L1;PICK1;UBQLN1;HIPK2;MYC;TP53;SIRT1;PGK1;NDRG1
prerank,regulation of histone methylation (GO:0031060),-0.38965660182384765,-1.0229489691136053,0.39194139194139194,0.7562619396631816,1.0,4/13,17.29%,CTR9;MTHFR;CHTOP;PIH1D1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.2481182362479472,-1.0229358876561685,0.3877551020408163,0.7548121903210481,1.0,15/69,10.44%,IGF1R;CSF1R;PIK3R5;PLCB2;MYO16;PIK3CD;PIK3R1;IGF1;KCNH1;PI4KA;PIK3C2B;NF1;PLCL2;PLCB4;IRS2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4337264247206353,1.022634019600773,0.4462025316455696,1.0,1.0,16/55,17.74%,AURKA;PSMB7;PSMD11;PSMF1;PSMC1;PSMC3;PSMA4;ATF5;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4;AVEN
prerank,T cell activation (GO:0042110),0.4377278881976264,1.02229953967738,0.4669421487603306,1.0,1.0,6/69,5.36%,CD2;PPP3CA;CD74;CD44;PTPN22;RASGRP1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4288399071629117,1.0217311631484092,0.4662638469284995,1.0,1.0,36/136,20.57%,GFI1;FOXA2;MEN1;CYP1B1;DAP;RB1;FLNA;SP100;CDKN2A;TAF1;TRAF3;LRRC14;PIM1;SUMO1;RNF2;PAXIP1;ARRB2;CDK5RAP3;DDIT3;CEBPG;RBCK1;TCF7L2;NLRC3;COMMD6;NLRP2B;SIRT1;PEX14;TRIM37;USP7;HDAC4;SUFU;PROX1;TAF3;PKD2;KEAP1;AIM2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5073272800754735,1.0216462573032894,0.45910290237467016,1.0,1.0,1/15,0.72%,SLFN14
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.48777557852207665,1.0215498015888296,0.45080946450809467,1.0,1.0,7/21,19.97%,KCNN4;FOXP1;IKBKG;NFAM1;PRKCB;RPS3;PRKD2
prerank,mammary gland epithelium development (GO:0061180),-0.3803723436747156,-1.0214172188375796,0.4189723320158103,0.7570581394364237,1.0,4/14,14.46%,CSF1R;ERBB4;AKT2;ID2
prerank,actin filament bundle assembly (GO:0051017),0.46126466882663264,1.0214088367657825,0.45514950166112955,1.0,1.0,8/33,17.46%,EZR;NEDD9;SHROOM2;LIMA1;PAWR;ADD2;CALD1;HSP90B1
prerank,innate immune response (GO:0045087),0.4255757549267298,1.0212507054036846,0.459,1.0,1.0,30/217,12.01%,BLK;TRIM58;RNASE6;PGLYRP1;MEFV;SKP2;TRIM59;FYN;DHX58;CD74;CAMP;PML;KLRD1;ANKHD1;SLPI;SP100;IKBKG;SERINC5;SERINC3;HMGB1;TRIM11;PLCG2;TREML1;TIFA;CARD9;BTK;B2M;CLPB;MYD88;TRIM68
prerank,negative regulation of autophagy (GO:0010507),-0.2663181440527712,-1.0212308293918995,0.4074074074074074,0.7560646994767735,1.0,15/54,13.04%,CTSA;TREM2;TBC1D14;KDM4A;SNRNP70;HGF;MCL1;FOXK1;EIF4G3;TSC1;GOLGA2;WASHC1;STAT3;PINK1;ZKSCAN3
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.39667866638548854,-1.020962052728176,0.392,0.7553008088351352,1.0,5/12,27.29%,MTTP;DGAT1;APOC1;SOAT2;ACSL3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.28427446562447656,-1.0209612477610677,0.39090909090909093,0.753813996219318,1.0,4/34,3.48%,LACC1;GPI;CD86;STX4
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5057004729087686,1.0209519682085824,0.47503201024327785,1.0,1.0,3/16,10.65%,ABCD1;PDE12;ATP7A
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.49850310219734956,1.0194457118130777,0.5037037037037037,1.0,1.0,6/20,21.46%,STMN1;RNF157;GRK2;SNCA;MET;GRK3
prerank,thymus development (GO:0048538),-0.38461343765175826,-1.0186126439090393,0.40714285714285714,0.7581497516300963,1.0,1/13,0.54%,TGFBR1
prerank,gliogenesis (GO:0042063),0.5102318741532392,1.0183449957428177,0.47164948453608246,1.0,1.0,5/15,19.35%,CDK6;RELN;METTL14;TGFB2;PAX2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.29161436520205586,-1.0172227991366916,0.4016393442622951,0.7601103692790494,1.0,11/31,13.35%,NDST3;BMPR2;CHST8;IGF1;B3GAT3;BMPR1B;EXT2;CHST11;EXTL3;XYLT2;B4GALT7
prerank,regulation of leukocyte migration (GO:0002685),0.5096624910294738,1.0169876553268018,0.4635678391959799,1.0,1.0,1/16,0.75%,TNFRSF18
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.23535347433720358,-1.0169530815747734,0.46153846153846156,0.7593533777960018,1.0,18/72,14.30%,IGF1R;TREM2;PTPN6;PIK3R5;PIK3CD;FLT1;PIK3R1;HGF;IGF1;PDGFD;PDGFC;GAB1;IRS2;PIK3CB;NCF1;PTK2;IL18;FGF2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.31578309757289624,-1.0167230139330212,0.422680412371134,0.758458231521075,1.0,4/23,5.24%,APP;ARNT;PRKAA2;IGF1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5146281244318194,1.0163237797276994,0.478796169630643,1.0,1.0,4/12,16.94%,BRCA1;PIBF1;WDTC1;SIRT1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.43843143082486585,1.015962040058121,0.4631803628601921,1.0,1.0,9/48,17.91%,CD19;NPSR1;PRKACA;PDPK1;JPH1;DIAPH1;F2R;PLCG1;SNCA
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3766346339152504,-1.0156864882801473,0.4223826714801444,0.7595646960338468,1.0,4/13,10.20%,IRAK2;UNC93B1;TLR7;TNIP2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.39173345339734716,-1.0151937082631617,0.43666666666666665,0.7593988623965735,1.0,4/12,25.91%,TLR4;STRAP;NOD2;RBP4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.45666314019173687,1.015070775348023,0.45310734463276836,1.0,1.0,10/32,18.42%,POLR1B;TAF1;POLR1A;ERCC3;POLR1F;POLR1C;POLR2K;TAF1C;TAF1D;POLR1G
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.26885395694239883,-1.0148511008368855,0.4878048780487805,0.7587981899164349,1.0,9/40,7.06%,BCL2L1;GHITM;HGF;PYCARD;PLAUR;FAM162A;IGF1;DNM1L;MLLT11
prerank,regulation of neuron death (GO:1901214),0.43366589608040385,1.0146573387778515,0.48114169215086644,1.0,1.0,11/82,10.81%,KIF14;FYN;EIF2S1;IKBKG;INPP5A;GPR75;MAP3K5;NENF;EGR1;PARK7;SIGMAR1
prerank,cell junction organization (GO:0034330),-0.2572547146017633,-1.0145968041873805,0.5238095238095238,0.7580481595658537,1.0,17/71,9.32%,PAK3;APP;OPHN1;FBLIM1;MYO9A;CAPZA1;PPFIA2;PRKCI;VASP;SMAD3;APBB2;C1QA;SLC8A3;SEMA3E;GRM5;TJP2;SH3BP1
prerank,cGMP-mediated signaling (GO:0019934),0.5119531212776451,1.0144475184194421,0.47820343461030385,1.0,1.0,3/13,11.12%,AQP1;PDE2A;KCNC2
prerank,negative regulation of immune effector process (GO:0002698),0.5091961408246879,1.0144335201196828,0.4607190412782956,1.0,1.0,6/13,19.21%,CD47;RPS19;RC3H1;APPL1;SLAMF8;CD55
prerank,lipid oxidation (GO:0034440),-0.402359563428604,-1.0142914556324556,0.426056338028169,0.7573709042228258,1.0,2/12,8.61%,PLA2G7;ALOX5
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.45557137487160293,1.0137428966787378,0.46810933940774485,1.0,1.0,7/30,14.59%,BRCA1;TNFSF10;TRADD;PARK7;FAS;CFLAR;GSK3B
prerank,regulation of lipid storage (GO:0010883),-0.311779101812978,-1.0135714702194534,0.384180790960452,0.7577045683435422,1.0,6/22,9.90%,PTPN2;LPL;ZC3H12A;IKBKE;VSTM2A;ITGB3
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4260640893409494,1.0134378732640885,0.4786235662148071,1.0,1.0,20/72,19.36%,CARD10;PSMB7;PSMD11;FBXW11;PSMF1;PSMC1;BIRC2;PSMC3;PSMA4;PSMC4;PSMD13;PSME1;TLR6;PSMB1;PSMD8;PSME4;PSMD4;MAP3K7;MALT1;TRAF6
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3095845222443243,-1.0133666330558633,0.4519774011299435,0.7567434672429358,1.0,13/26,32.25%,APP;ZFYVE28;ZGPAT;NCF1;FBXW7;SNX6;NCK2;SOCS5;ERRFI1;HBEGF;CHMP6;BTC;ADRA2A
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.377529099014198,-1.0131056647816585,0.4426229508196721,0.7559568441332644,1.0,4/14,12.97%,PTPN2;RFFL;GPS2;CARD16
prerank,positive regulation of RNA splicing (GO:0033120),0.4606458207804293,1.0130508487564809,0.46744186046511627,1.0,1.0,13/29,24.63%,RBM3;POLR2A;SETX;NCBP1;DYRK1A;NUP98;DAZAP1;HNRNPLL;THRAP3;ZPR1;NCL;CIRBP;RBM22
prerank,gonad development (GO:0008406),0.44476388292738867,1.0123801766989486,0.4765625,1.0,1.0,8/41,19.39%,SRD5A2;NUP107;CSDE1;NR2F2;FGF9;TGFB2;KITLG;SOX9
prerank,RNA splicing (GO:0008380),0.42183948631200513,1.0123488499092845,0.4775510204081633,1.0,1.0,34/95,20.61%,PPP1R9B;LSM6;SNRNP25;SCAF11;SNRPF;HNRNPC;U2AF1;TXNL4A;RNPC3;SRSF4;NCBP1;SNRNP35;NONO;RNPS1;CCAR2;YJU2;PPIG;PRPF4;PDCD7;SRSF10;SNRNP40;SRSF7;SRPK1;TCERG1;DDX39B;SNRPG;PRPF8;RSRC1;NCBP2;PPP2CA;SRSF2;SNRNP48;SNRPB;SYNCRIP
prerank,embryonic limb morphogenesis (GO:0030326),0.4562798831568819,1.0120889132691255,0.472,1.0,1.0,13/34,23.10%,AFF3;TWIST1;WDPCP;NIPBL;CREBBP;SKI;MAP3K20;TGFB2;RARG;HDAC1;MEGF8;OSR1;INTU
prerank,gene silencing by miRNA (GO:0035195),0.44901963903671793,1.0118608553950597,0.4539170506912442,1.0,1.0,14/32,22.08%,ZC3H7A;TNRC6C;TNRC6B;PUM2;PUM1;CNOT1;LIMD1;TARBP2;CNOT6;AGO2;CNOT8;EIF6;CNOT7;AGO1
prerank,triglyceride homeostasis (GO:0070328),-0.3007322552327365,-1.0118489441059104,0.3885350318471338,0.7576375960425713,1.0,11/26,37.24%,APOE;LPL;SCARB1;IL18;MTLN;FITM2;MLXIPL;ANGPTL3;DGAT2;C1QTNF3;LIPC
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.354332690181809,-1.011766937132088,0.44541484716157204,0.7564024463028107,1.0,9/16,27.41%,ACLY;PPT1;ACACA;PPT2;ACAT1;MLYCD;GCDH;PPCS;SCD
prerank,modulation by symbiont of host process (GO:0044003),0.5448910579992781,1.0116283566187838,0.4781382228490832,1.0,1.0,4/10,17.60%,B2M;HGS;PGK1;UBA52
prerank,positive regulation of cell cycle (GO:0045787),0.431929346134966,1.011520875230709,0.4708333333333333,1.0,1.0,22/62,23.12%,CCNB1;CCNYL1;CHEK1;MAPRE3;CDC25B;PKN2;PRKCA;SMOC2;EGFR;RAD23A;CCDC57;HCFC1;RPS15A;TGFB2;PROX1;PKD2;CCND3;CITED2;MDM2;CDKN1B;FGFR2;ADAM17
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.33050464372623745,-1.0113048428750173,0.45410628019323673,0.7561505388652237,1.0,5/19,6.32%,NLRP3;IGF1;TNFAIP3;CX3CR1;ZC3H12A
prerank,positive regulation of reproductive process (GO:2000243),-0.2990036023114102,-1.0112075297238075,0.44545454545454544,0.7549717739115026,1.0,7/31,19.36%,LHFPL2;CFAP69;PRDM9;PGAM4;VEGFA;SMURF2;TACR3
prerank,negative regulation of macrophage activation (GO:0043031),-0.3641396219652979,-1.0109042813938096,0.4472573839662447,0.7542676929342292,1.0,6/16,17.91%,LRFN5;GRN;ZC3H12A;CD200;CST7;IL31RA
prerank,BMP signaling pathway (GO:0030509),-0.24840242030304205,-1.01064727222169,0.43478260869565216,0.7534775800116601,1.0,11/62,15.58%,ACVR1;SMAD1;BMPR2;SMAD3;USP9X;SMAD6;BMPR1B;ENG;SMAD7;TGFBR3;ACVRL1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.44890091661838755,1.0100861117773146,0.46360582306830905,1.0,1.0,7/39,13.51%,MYO5C;MYO15A;NDE1;FBXW11;PAFAH1B1;HAP1;ACTN4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.30113341111191383,-1.0098592312851649,0.40145985401459855,0.7539843027521765,1.0,14/29,32.57%,PTPN2;PTPN6;YTHDF2;MAVS;RNASEL;CDC37;ZBP1;USP18;CACTIN;MUL1;TTLL12;WNT5A;ISG15;PTPN1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4303876570877098,1.0098476166176582,0.4890738813735692,1.0,1.0,14/68,18.13%,NR4A2;LEF1;AXIN1;CAV1;TCF7L1;CSNK1A1;PTEN;BCL9L;GSK3B;TCF7L2;RAB5A;PPP1CA;RARG;LRRK2
prerank,oogenesis (GO:0048477),0.5010747407225509,1.0092567119510405,0.4585492227979275,1.0,1.0,1/15,1.66%,TRIP13
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.34220687765732033,-1.009220877296152,0.3981042654028436,0.7541071064956222,1.0,4/18,3.74%,MANBA;NGLY1;DERA;STT3B
prerank,regulation of endocytosis (GO:0030100),0.4308311705310015,1.0088320255572931,0.5020833333333333,1.0,1.0,18/61,18.53%,CD177;TFR2;SNX33;STON1;MTMR2;ARFGAP1;NEDD4L;EPHA3;CBLL1;RIT2;ABCA7;PACSIN2;FLOT1;STON2;RAB5A;MCTP1;SNCA;RUFY1
prerank,organelle disassembly (GO:1903008),0.4611591198926832,1.0087463484157466,0.4668218859138533,1.0,1.0,5/33,12.25%,CDK1;STX5;DDRGK1;VRK1;GFM2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.3160529256965578,-1.008559909306925,0.4307692307692308,0.7542436727242073,1.0,10/22,27.20%,MVB12B;PLAA;VPS36;TOM1L1;UBAP1L;PTPN23;VPS37C;RNF126;UBAP1;VPS28
prerank,regulation of transferase activity (GO:0051338),0.48648517465376523,1.0083654570955076,0.48081841432225064,1.0,1.0,4/17,15.88%,SMG6;ATM;NABP2;SLAMF8
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4465185363353737,1.0083529221814658,0.4989384288747346,1.0,1.0,11/52,9.84%,CNPY4;GPSM2;PRKCE;EPB41;SORBS1;GNAI1;CIB1;EFCAB7;EGFR;EPHA3;PDPK1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.45917747640074213,1.0083441660944032,0.5011363636363636,1.0,1.0,1/29,0.38%,CD19
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.46478394437953957,1.0083223901909346,0.4887039239001189,1.0,1.0,7/26,18.96%,BRCA1;FOXP1;SMARCA4;ZBTB7A;CNOT1;SIRT1;HDAC1
prerank,ear morphogenesis (GO:0042471),0.4829795478204352,1.0081920782837006,0.48792270531400966,1.0,1.0,6/20,23.07%,TWIST1;TIFAB;NIPBL;PAX2;FGFR2;OSR1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4506580494025311,1.0081526365391476,0.49434389140271495,1.0,1.0,10/38,16.94%,PHLPP2;PHLDA3;BANK1;CIB1;PTEN;ARRB2;RACK1;DDIT3;DAG1;SIRT1
prerank,rRNA processing (GO:0006364),0.41502483945423996,1.0081313367904183,0.49648946840521563,1.0,1.0,63/172,23.10%,RPL7;RPL18A;LSM6;UTP3;RPL36;RPL14;RPS19;DDX49;RPS7;HELQ;EXOSC8;RPL23A;RPL28;EXOSC10;TFB1M;RPS14;RPL41;NOL11;RPLP2;RPS27;EMG1;RIOK3;UTP6;RPLP0;FBL;RPL27A;ERI1;PELP1;SRFBP1;WDR74;RPS9;PRKDC;NOL8;NSA2;RPL12;NOP58;SART1;POP4;NAT10;RPL3;UBA52;RPL18;DKC1;PES1;RIOK1;MPHOSPH6;RPL5;RPS6;RPS17;DDX54;RPL21;RPL17;RPL23;EIF6;RPL24;RPL8;RPL27;RPL13A;DIS3;RPL15;RPL10;RPF1;NOP14
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.31429307951683616,-1.0079944061163877,0.40993788819875776,0.7542803241087587,1.0,8/25,16.69%,CACNA1C;ANK2;CTNNA3;JUP;RYR2;CALM1;DLG1;CXADR
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.32080874157745576,-1.0078685275724106,0.43157894736842106,0.7531262897657397,1.0,7/22,22.45%,ANK2;SLC9A1;RYR2;ATP1B1;CALM1;STAC2;GSTO1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4348016377883088,1.007868526465706,0.49514563106796117,1.0,1.0,4/47,5.28%,GFI1;BRCA1;FYN;CAV1
prerank,negative regulation of protein processing (GO:0010955),-0.3954500493640806,-1.0078616915850998,0.4552238805970149,0.7517276146995466,1.0,5/12,25.31%,SERPINE2;PRNP;SERPINE1;THBS1;GAS1
prerank,regulation of transport (GO:0051049),-0.28917187892782625,-1.0078168703354606,0.42342342342342343,0.750430203972168,1.0,15/36,22.36%,MBTPS1;REEP5;MYO6;VAMP2;FES;ACTB;PRKN;CDK5;PINK1;RAB11A;ICA1L;YRDC;POFUT2;LEPR;WWC1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.42475557151025983,1.0076598487438386,0.4766355140186916,1.0,1.0,17/66,19.36%,EZH2;ARHGEF5;RASGRP1;MAP3K5;EGFR;MAP3K11;FLT3;TLR6;PDCD10;EGF;TNFRSF11A;FGFR1;CD24;MAP3K7;LRRK2;RPS3;TRAF6
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.48686654122122847,1.0075635659404303,0.47588832487309646,1.0,1.0,5/17,14.89%,S100A11;CCN4;FGF9;NRP1;ADAMTS1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4525304547915108,1.0073179918416288,0.4735632183908046,1.0,1.0,5/33,5.73%,UBASH3A;EZR;PTPN22;KCNN4;IKBKG
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.45099898974152014,1.0072322056817569,0.4519906323185012,1.0,1.0,4/27,9.73%,SLFN14;RNASE6;PDE12;CSTF3
prerank,skeletal muscle organ development (GO:0060538),0.46412263866115255,1.0071756320206764,0.4746760895170789,1.0,1.0,7/26,21.08%,CSRP3;CAV1;FXR1;CFLAR;DISP1;ZBTB18;SVIL
prerank,O-glycan processing (GO:0016266),0.4330394428534085,1.006702493732346,0.48187633262260127,1.0,1.0,6/54,9.89%,MUC19;GALNT10;GXYLT1;ST3GAL1;ST3GAL2;B3GNT2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.4345011529405791,1.0064615758985116,0.4752688172043011,1.0,1.0,9/44,15.83%,LBR;SRD5A2;OSBPL3;CYP27A1;SLC27A2;PARK7;CYP46A1;PRKAG2;DHCR7
prerank,metal ion export (GO:0070839),-0.29570115819862675,-1.0063013976262183,0.45,0.7527427856291425,1.0,8/31,25.61%,SLC9A1;ATP1A1;ATP1B2;ATP1B1;KCND3;ATP1A2;ATP1A3;ATP1B3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.47876238520391146,1.0060925624587442,0.49501246882793015,1.0,1.0,7/20,19.01%,BRCA1;RPS6KA5;RUVBL2;PAXIP1;TADA2A;GLYR1;BRD7
prerank,cellular lipid catabolic process (GO:0044242),0.4664794637194388,1.0059010396605708,0.4782608695652174,1.0,1.0,5/27,10.99%,CYP1B1;CEL;ACBD5;NUDT19;PLBD1
prerank,dendrite morphogenesis (GO:0048813),-0.29261952182301126,-1.00496191923089,0.4406779661016949,0.7547372433046546,1.0,17/35,27.59%,PAK3;PHACTR1;MINK1;WASL;MAP6;MEF2A;CTNNA2;FARP1;SHANK3;DLG4;CDC42;TMEM106B;CELSR2;DVL1;KLF7;ABITRAM;CHRNA7
prerank,regulation of actin filament depolymerization (GO:0030834),0.5182138538195243,1.0031294631072782,0.4744318181818182,1.0,1.0,4/12,16.78%,MTPN;CFL2;LIMA1;PIK3CA
prerank,synapse organization (GO:0050808),-0.23161192780915688,-1.0026675224777108,0.4,0.7592993736266742,1.0,32/125,16.01%,PAK3;APP;ANK3;LRFN5;CACNB2;PTPRD;PPFIA2;LRRC4;DNM3;APBB2;PTPRS;C1QA;SLC8A3;SEMA3E;SPOCK2;NTNG1;CX3CR1;RYK;CDH2;C1QC;GRM5;PDZRN3;SHANK2;C5AR1;LRRC4B;CDK5;UNC13A;CACNB4;PPFIA1;FARP1;L1CAM;AGRN
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3815856747109472,-1.0024999009089643,0.44656488549618323,0.7582890353316974,1.0,6/13,28.98%,SEC16A;CD81;INSIG1;BRSK2;SAR1A;SORL1
prerank,cellular response to estradiol stimulus (GO:0071392),0.48144316621664296,1.0021270726683407,0.4665809768637532,1.0,1.0,3/18,10.60%,CRHBP;EGFR;RUVBL2
prerank,proteasome assembly (GO:0043248),0.5165815989121071,1.0017402019651858,0.48575498575498577,1.0,1.0,6/11,23.32%,PSMD11;POMP;PSMD13;PSMD4;PSMG1;PSMG2
prerank,L-glutamate transmembrane transport (GO:0015813),0.5272540010755408,1.001299363460468,0.5050071530758226,1.0,1.0,4/10,17.48%,SLC25A12;SLC25A22;SLC25A13;ARL6IP5
prerank,response to exogenous dsRNA (GO:0043330),0.4804642948076588,1.0012749407833772,0.4835443037974684,1.0,1.0,5/18,17.76%,CGAS;CAV1;DHX9;FLOT1;COLEC12
prerank,ceramide catabolic process (GO:0046514),-0.37748786359020625,-1.0006072457176978,0.42448979591836733,0.7616217716241289,1.0,1/14,0.15%,HEXB
prerank,regulation of astrocyte differentiation (GO:0048710),-0.38136067739158236,-1.00009840804503,0.44280442804428044,0.7614514355528404,1.0,4/12,16.30%,SERPINE2;BIN1;ID2;EPHA4
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5314455319959692,0.999901158461311,0.4871060171919771,1.0,1.0,2/10,8.38%,PDE2A;RNF157
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4432349325524241,0.9997824135834507,0.47474747474747475,1.0,1.0,3/40,3.43%,NTF4;S1PR4;HTR2A
prerank,response to interferon-gamma (GO:0034341),0.4233529734049204,0.9995572698362493,0.49480249480249483,1.0,1.0,18/67,21.77%,MEFV;CD47;GBP4;CD74;SP100;PDE12;GBP2;IFITM3;IRF8;CCL25;EPRS1;SNCA;LGALS9;DAPK1;SYNCRIP;GAPDH;CIITA;RPL13A
prerank,protein K48-linked deubiquitination (GO:0071108),0.46266586259902315,0.9995385498939054,0.4845605700712589,1.0,1.0,10/23,22.24%,USP27X;BAP1;VCPIP1;OTUD5;USP50;YOD1;USP25;USP34;OTUD7A;MINDY2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3225149468680665,-0.9992723051951619,0.42592592592592593,0.7622071449580308,1.0,8/22,25.02%,CACNB2;SRI;DMD;GNB5;CACNB4;STAC2;CBARP;CACNB1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4765318402618502,0.9990343198378356,0.4765432098765432,1.0,1.0,8/19,23.30%,PML;PHLDA3;HIPK2;TP53;TMEM109;SIRT1;AEN;HIPK1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3290059649462595,-0.9982512939447541,0.4010152284263959,0.7633662678110289,1.0,5/20,18.37%,ADRA1A;LMBRD2;ADRA1B;ADRB1;ADRB2
prerank,regulation of intracellular transport (GO:0032386),0.4364070873814444,0.9978028289035091,0.4789356984478936,1.0,1.0,14/38,22.78%,SPAG5;MLC1;NUP214;DYNC1H1;HAP1;RAB11B;NUMA1;DYNLT2B;AAAS;CAPN10;LRRK2;INPP5F;NEFH;ATPSCKMT
prerank,myeloid dendritic cell activation (GO:0001773),0.5111104896380532,0.9977958053698353,0.485054347826087,1.0,1.0,2/12,7.33%,BATF;HMGB1
prerank,lung epithelium development (GO:0060428),0.5196215715695868,0.9968260646357928,0.4868035190615836,1.0,1.0,1/10,3.54%,RCN3
prerank,positive regulation of cell death (GO:0010942),0.4325068304864559,0.996648016119375,0.4979035639412998,1.0,1.0,20/59,22.51%,FYN;EIF2S1;FAF1;MAP3K5;PRODH;PRR7;EGR1;HTATIP2;TYROBP;GSK3B;MARK4;FCGR2B;SNCA;RARG;LRRK2;BNIP3;RIPK1;MAPT;CELF1;CDKN1B
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5089505666743422,0.9959143598137562,0.48660084626234135,1.0,1.0,4/11,20.98%,EGFR;TP53;MAP2K1;RIPK1
prerank,basement membrane organization (GO:0071711),0.49127633079458527,0.9957269177893238,0.4773371104815864,1.0,1.0,5/14,10.78%,FLRT2;LAMB2;LAMB3;NTNG2;NID1
prerank,"wound healing, spreading of cells (GO:0044319)",0.468928577919771,0.9956929993438666,0.4909963985594238,1.0,1.0,6/24,14.92%,FLNA;CCN1;CD44;ARHGAP35;TOR1A;PDCD10
prerank,maturation of SSU-rRNA (GO:0030490),0.44655554627673455,0.9952804585706343,0.497737556561086,1.0,1.0,12/34,19.59%,LSM6;UTP3;RPS19;NOL10;RPS14;NOL11;RIOK3;UTP6;SRFBP1;NAT10;RIOK1;HELB
prerank,neuronal action potential (GO:0019228),-0.3144727649199921,-0.9948258215461818,0.4906832298136646,0.7704585699247342,1.0,6/22,11.07%,ANK3;SCN8A;SCN1A;SCN9A;SCN3A;KCNA2
prerank,positive regulation of protein catabolic process (GO:0045732),0.42037987867804527,0.9946217285085158,0.5071138211382114,1.0,1.0,15/84,12.14%,BARD1;NRDC;DTL;EZR;AXIN1;SNX33;FOXO1;FAF1;STX5;NEDD4L;SNX9;MSN;RDX;FZR1;OAZ1
prerank,negative regulation of gene expression (GO:0010629),0.4076037652761204,0.9942635926813614,0.517,1.0,1.0,91/302,22.09%,SLFN14;EZH2;HEY2;RB1;AURKA;LSM6;PPM1D;HELLS;PPP1R11;PTPN22;SUZ12;RPS6KA5;EPC1;RBL1;FOXP1;CRKL;TAF1;TERF2;RBBP4;TNRC6C;LRP3;TNRC6B;PHF19;NOTCH1;EIF4A3;DDRGK1;H3-3A;DCP2;PHF1;ABCC2;LSM2;ZNF148;ASB1;PARP14;MECP2;CPEB3;DNMT1;PARK7;TYMS;KAT2B;IGF2BP3;LSM5;SETDB2;METTL16;BMPR1A;FXR1;ROCK2;RACK1;DXO;LSM14A;PSEN1;CNOT1;PDCD10;RUNX1;JARID2;MAP2K1;LGR4;SAMD4A;ZFP36L2;TASOR;TGFB2;VHL;SIRT1;CNPY2;APLN;FCGR2B;EPRS1;FLOT2;ADAM10;PTGER4;SETDB1;EIF4ENIF1;HDAC1;RPS3;LGALS9;DNMT3B;AGO2;DAPK1;CNOT8;PNPT1;SYNCRIP;PTBP2;CNOT7;CITED2;GAPDH;MAPT;CELF1;RPL13A;EIF4E2;AGO1;ATP2B4
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.3504649264441619,-0.994040549002434,0.42543859649122806,0.7709717569420773,1.0,8/16,16.52%,GBF1;SEC16A;ANK2;UBAC2;MIA3;RYR2;BCAP31;HSPA5
prerank,negative regulation of translation (GO:0017148),0.4171669707109857,0.9939481391245487,0.49743062692702983,1.0,1.0,36/87,25.28%,EIF3E;FTO;EIF4EBP3;EIF4A3;CPEB3;PUM1;TYMS;IGF2BP3;METTL16;FXR1;ROCK2;RACK1;LSM14A;CNOT1;METTL14;SAMD4A;EPRS1;EIF4ENIF1;RPS3;AGO2;DAPK1;CNOT8;TPR;SYNCRIP;CNOT7;ROCK1;GAPDH;CELF1;RPL13A;EIF4E2;YBX1;NCL;MEX3D;DAPK3;EIF2AK2;GIGYF2
prerank,signal peptide processing (GO:0006465),-0.40300403430968323,-0.9939318848539469,0.43322475570032576,0.769811850946854,1.0,4/11,8.27%,PCSK5;SPCS2;HM13;CLN5
prerank,positive regulation of cell migration (GO:0030335),0.4115155636881789,0.9936184192690867,0.511,1.0,1.0,29/253,8.37%,KIF20B;GTSE1;ARHGEF39;TNFRSF18;LEF1;PECAM1;FBXO5;SYNE2;TIAM1;S100A11;SUN2;PPP3CA;CCN1;PRKCE;CCN4;NEDD9;CAV1;CCR2;CRKL;CLASP1;ATM;TRADD;HDAC6;NOTCH1;DDRGK1;CIB1;PRKCA;INSL3;PLCG2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3058210238043731,-0.9936095202508531,0.46629213483146065,0.7691975183962608,1.0,5/23,6.32%,NLRP3;IGF1;TNFAIP3;CX3CR1;ZC3H12A
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4684774849666954,0.9931672355412471,0.49433962264150944,1.0,1.0,7/18,21.47%,PLK1;ABCA2;ZDHHC7;APPL1;LDLRAP1;CLN3;VPS4A
prerank,cellular macromolecule catabolic process (GO:0044265),0.4410748129726772,0.9931295377167753,0.5026852846401718,1.0,1.0,7/49,8.88%,RNASE6;CHEK2;PPP1R8;FBXO44;FBXO17;DNASE1L1;NCBP1
prerank,myeloid cell development (GO:0061515),0.4839724513368482,0.9931072100304962,0.4604409857328145,1.0,1.0,3/18,5.05%,ALAS2;ABCB10;FOXP1
prerank,L-serine metabolic process (GO:0006563),0.5240663641041083,0.9930486327621421,0.5,1.0,1.0,2/10,5.97%,SERINC5;SERINC3
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.41355395031155295,0.9922664485590381,0.5165165165165165,1.0,1.0,50/166,19.98%,ZCCHC4;DDAH2;RBM3;ABCB10;PCNA;EIF3E;NR1D1;ATAD5;SLC25A37;RPS4X;FAF1;SORBS1;EIF4A3;NIBAN1;DNA2;SMOC2;EGFR;EGR1;CPEB3;ATP7A;PARK7;DHX9;BRPF3;CTC1;CNEP1R1;UPF3B;FXR1;PRKDC;MYC;TLR6;ELOVL5;IRS1;PLD1;METTL14;EGF;APPL1;ASS1;PYM1;SAMD4A;EEF2;VIM;SIRT1;NAT10;LARP4B;POLDIP3;SNCA;ELAVL1;RPL5;PRKD2;PKD2
prerank,regulation of neurogenesis (GO:0050767),0.43310202979507284,0.9920741997069307,0.4973488865323436,1.0,1.0,7/55,11.13%,HMGB2;HEY2;LIG4;NOTCH1;SPEN;PCM1;B2M
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.47292485355226227,0.9919211679295816,0.4980744544287548,1.0,1.0,4/18,13.69%,CAV1;NEDD4L;SLC43A2;STK39
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4318508894463405,0.9918141100847089,0.5097826086956522,1.0,1.0,16/48,21.56%,FLNA;NEDD9;CRKL;CIB1;CUX1;CRK;NRP1;PRKDC;LIMS1;TRIOBP;RAC1;ARHGEF7;FBXW8;S100A10;ILK;CAPRIN2
prerank,negative regulation of cellular component movement (GO:0051271),0.49266102132197076,0.9916651040528552,0.4906166219839142,1.0,1.0,3/15,11.74%,SP100;PIN1;CRK
prerank,actin filament organization (GO:0007015),0.41199390543272596,0.9908404193105517,0.5366098294884654,1.0,1.0,16/151,10.76%,MYO5C;TMOD4;SPTA1;RFLNB;PPP1R9B;SAMD14;MYO15A;FLNA;GAS2L3;NEDD9;GSN;RND3;SHROOM2;FLII;WHAMM;SHROOM4
prerank,histone H2A ubiquitination (GO:0033522),0.48265437705882064,0.9907502982041944,0.4901185770750988,1.0,1.0,7/17,18.10%,UBR2;RNF168;RNF8;RNF2;TRIM37;DDB2;KDM2B
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5115086497244671,0.9896184624569755,0.504225352112676,1.0,1.0,8/12,25.76%,DNMT1;SETDB2;ATF7IP;TASOR;TRIM28;SETDB1;RESF1;TET1
prerank,negative regulation of cell activation (GO:0050866),-0.37361061854250843,-0.9895341060439821,0.4796747967479675,0.7777682126466487,1.0,2/14,1.47%,TREM2;APOE
prerank,regulation of complement activation (GO:0030449),0.4483822292845345,0.9893380650074624,0.5147864184008762,1.0,1.0,1/40,0.38%,CD19
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.46847619036105526,0.9892993259780075,0.4795031055900621,1.0,1.0,5/21,17.86%,AXIN1;CAV1;CSNK1A1;GSK3B;PPP1CA
prerank,negative regulation of cellular protein localization (GO:1903828),0.4450607773163615,0.9890915649277153,0.5152887882219706,1.0,1.0,10/34,16.60%,CTNNA1;RIPOR2;SNX33;NEDD4L;ACTN2;ROCK2;LATS1;GSK3B;SIN3A;ANKRD13A
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.415696996062894,-0.9890142867790637,0.4790996784565916,0.7776836702444276,1.0,4/10,22.24%,SERPINE2;SH2B3;PRKG1;CEACAM1
prerank,cellular response to fatty acid (GO:0071398),-0.38002590687875404,-0.9884430770134844,0.4866920152091255,0.7777697318844781,1.0,2/12,6.32%,LPL;ZC3H12A
prerank,cellular response to mechanical stimulus (GO:0071260),0.4285377097531823,0.988429933109709,0.5,1.0,1.0,10/46,13.25%,AQP1;CHEK1;CNN2;CASP2;PDE2A;MAP3K1;FAS;MYD88;TMEM150C;TLR5
prerank,snRNA metabolic process (GO:0016073),0.48045166621982205,0.9878963694221303,0.5089743589743589,1.0,1.0,8/17,22.87%,INTS4;INTS9;INTS1;RBM7;TUT1;ZCCHC8;INTS12;INTS11
prerank,potassium ion homeostasis (GO:0055075),0.46195672469637455,0.9876752192891247,0.5237529691211401,1.0,1.0,5/23,13.00%,SLC12A3;SLC12A7;SLC12A1;SLC12A6;KCNJ2
prerank,response to ketone (GO:1901654),0.4626874504890487,0.9875909599911452,0.5155131264916468,1.0,1.0,6/24,21.75%,CATSPERB;CAV1;SLIT3;TGFB2;ABHD2;NR1H3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.44675602595694835,0.9874676483591821,0.5148401826484018,1.0,1.0,13/33,27.42%,NTF4;CEL;RELN;BCR;BTBD9;CACNA1B;GRIK5;GRIK3;PXK;BDNF;ABR;NLGN2;NLGN1
prerank,central nervous system neuron development (GO:0021954),0.49067556814960533,0.9873495604107067,0.5045632333767927,1.0,1.0,4/15,11.97%,GBA2;ARHGAP35;ATP7A;PTEN
prerank,histone monoubiquitination (GO:0010390),0.4570520987894311,0.98726307170531,0.5097560975609756,1.0,1.0,7/24,18.10%,UHRF1;RNF168;RNF2;RNF20;TRIM37;DDB2;KDM2B
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3239189217801161,-0.9869202690532526,0.44970414201183434,0.779826761157344,1.0,6/21,16.00%,KDM1A;CTNNB1;CX3CR1;FZD3;VEGFA;MDK
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.4156520354886407,0.9863939741053295,0.518022657054583,1.0,1.0,24/80,18.93%,ZCCHC4;RBM3;EIF3E;RPS4X;EIF4A3;NIBAN1;ABCA2;CPEB3;UPF3B;FXR1;ROCK2;RACK1;PRKDC;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;NAT10;LARP4B;POLDIP3;ELAVL1;RPL5
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4063063118996823,0.9858437968550413,0.563,1.0,1.0,113/532,17.72%,BIRC5;PRTN3;IL12A;TNFRSF18;LMNB1;EDARADD;IL2RG;IL7R;IL2RA;GRAP2;TNFSF13B;PSMB7;FYN;IL18RAP;BATF;TWIST1;PSMD11;PML;CD44;FBXW11;IL16;RPS6KA5;PSMF1;SP100;CCR2;IL21R;CNN2;CRKL;LAMA5;IKBKG;FOXO1;TRADD;COL1A2;IRF9;TRAF3;PSMC1;GBP2;BIRC2;GPR75;TCP1;HNRNPA2B1;TAB1;SMARCA4;UBE2V1;PRKACA;GRB2;JAK2;IL20RA;SOS1;TAB3;XAF1;IL17RA;PIM1;EGR1;PSMC3;ZEB1;SOCS2;IL22;RHOU;IL1R1;MSN;TNFRSF13B;RPLP0;PSMA4;B2M;SMAD4;IL10RA;PLCB1;FLT3;CRK;MYD88;ADIPOR1;TRIM68;PSMC4;CANX;F3;STAT5B;PSMD13;PSME1;ACTN4;IFITM3;MYC;BCL6;PPIA;IL27;TRIM5;PSMB1;IRS1;LIMS1;TP53;JUNB;IRF8;APPL1;POU2F1;GPR35;PSMD8;TNFRSF11A;PAK2;PSME4;VIM;MTAP;TRAF3IP2;JAK3;MAOA;CCL25;PIK3CA;PSMD4;SIRT1;HSP90B1;FN1;UBA52;F13A1;MAP3K7
prerank,regulation of receptor internalization (GO:0002090),-0.27926729401529043,-0.9858370040001446,0.47115384615384615,0.7810963469761759,1.0,7/35,8.51%,MKLN1;AHI1;ATXN2;CD63;ARRB1;TBC1D5;ANGPT1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4882348252239834,0.9856580278574592,0.5085413929040736,1.0,1.0,1/15,1.11%,CHST3
prerank,lipid translocation (GO:0034204),0.46722613252260625,0.985193192809803,0.49257425742574257,1.0,1.0,9/21,20.69%,ATP11C;ATP8B4;ABCA7;RFT1;ATP8A1;ATP11B;TMEM30A;ATP11A;ATP8B2
prerank,negative regulation of endocytosis (GO:0045806),0.4522584585167489,0.9847878311461539,0.4963942307692308,1.0,1.0,9/24,23.03%,SNX33;CAV1;MTMR2;EPHA3;ABCA7;RAC1;MCTP1;NR1H3;LRSAM1
prerank,cellular component assembly (GO:0022607),0.4093381533096045,0.9845207238729833,0.557,1.0,1.0,57/253,17.66%,KNTC1;CHAF1A;RAD21;TRIP13;CARD10;FANCA;CFAP206;FLNA;EZR;CD74;PML;HAS1;NEDD9;NAPG;TUBGCP4;IKBKG;MDM4;GSN;TEX11;RBBP4;KPNA3;ARL6IP1;SHROOM2;SNX9;LAMC1;ZW10;BSN;NDUFAF1;NIFK;LIMA1;PAWR;RHOU;CHAF1B;FAS;CDAN1;MAGI1;KMT2A;CHCHD10;RAC2;ADD2;CREBBP;P3H4;VCPIP1;LIMS1;PDCD10;TP53;PARVB;KIFAP3;FANCC;RTN3;TFAP4;DARS1;RAC1;PARVA;CALD1;PEX14;EPRS1
prerank,positive regulation of cyclase activity (GO:0031281),-0.378565266661613,-0.984380595447237,0.4851063829787234,0.7832245564514787,1.0,6/14,24.40%,CACNA1C;NF1;MAPK8;ORAI1;STIM1;AKAP5
prerank,mitochondrial fusion (GO:0008053),-0.34070877819556145,-0.9841358958204139,0.46153846153846156,0.7824110205129567,1.0,10/18,28.35%,MFN2;MIEF1;MIGA2;MFF;SPG7;STOML2;AFG3L2;USP30;MFN1;MIEF2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.49875208446429137,0.9839018390681049,0.49463806970509383,1.0,1.0,1/13,1.29%,CD177
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.38818912679690537,-0.9837684844973924,0.4358108108108108,0.7818045668597233,1.0,4/10,9.32%,OPHN1;MYO9A;RAP2A;SH3BP1
prerank,response to histamine (GO:0034776),-0.39853179455510873,-0.9832910787518013,0.46735395189003437,0.7815181861686762,1.0,2/10,3.00%,GABRB3;GABRG2
prerank,cellular respiration (GO:0045333),0.43444398770124454,0.983014785740257,0.5130434782608696,1.0,1.0,15/41,24.50%,SDHAF4;NDUFS8;COQ10B;ME3;COX10;SLC25A13;ATP5F1D;NDUFA5;MDH2;NDUFS1;ETFRF1;UQCRH;ETFDH;ETFB;ETFA
prerank,blood vessel diameter maintenance (GO:0097746),0.4400120198736121,0.9827605564255021,0.5028184892897407,1.0,1.0,1/34,0.98%,KEL
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.40976687591671157,0.982673578694915,0.5040404040404041,1.0,1.0,26/124,16.74%,BLK;STMN1;TSGA10IP;PPP1R9B;SAMD14;RB1;BLOC1S4;WDPCP;MNS1;FRY;MAP4;ODF2;HMGB1;FRYL;LIMA1;TOR1A;VAPA;RAB35;ADCYAP1;CDK16;DTNBP1;GSK3B;KIFAP3;MARK4;LRP12;RAC1
prerank,monocarboxylic acid transport (GO:0015718),0.4297247178742156,0.9824113530925687,0.5187165775401069,1.0,1.0,7/51,12.39%,SLC6A12;SLC16A12;SLC16A1;ABCC2;STARD5;ABCC4;SLCO2A1
prerank,positive regulation of protein acetylation (GO:1901985),-0.3678934244195864,-0.9823709648964788,0.48417721518987344,0.7823366452585756,1.0,3/12,4.50%,DIP2B;CAMK1;PRKAA2
prerank,regulation of humoral immune response (GO:0002920),0.43890219081984627,0.9823628785416451,0.5167930660888408,1.0,1.0,1/44,0.38%,CD19
prerank,positive regulation of ATPase activity (GO:0032781),0.42799738694999256,0.9819513246612729,0.5072625698324023,1.0,1.0,8/41,17.04%,UHRF1;MSH6;DNAJB11;AHSA1;DHX9;HNRNPU;DYNLL1;DNAJB1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.47306181988551477,0.9818885279179798,0.5063775510204082,1.0,1.0,2/20,5.93%,PLA2R1;GSN
prerank,glucose transmembrane transport (GO:1904659),0.47433567807021365,0.9812597848687807,0.5050761421319797,1.0,1.0,6/18,24.05%,SLC2A4;SLC2A8;SLC2A3;SLC2A1;PPARD;SLC5A3
prerank,peptidyl-methionine modification (GO:0018206),0.5031222717467999,0.9812584940981746,0.5048275862068966,1.0,1.0,4/12,15.22%,METAP2;NAA16;NAA25;NAA20
prerank,cellular response to hypoxia (GO:0071456),0.40577985430239427,0.981087112662192,0.5357502517623364,1.0,1.0,31/126,17.81%,SUV39H1;PMAIP1;AQP1;PSMB7;TWIST1;PSMD11;TBL2;PSMF1;MDM4;ZFP36L1;PSMC1;UBQLN1;HIPK2;PSMC3;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;MYC;PSMB1;TP53;LIMD1;PSMD8;PSME4;VHL;PSMD4;SIRT1;PGK1;UBA52;NDRG1
prerank,snRNA processing (GO:0016180),0.4816856713018113,0.9809336026384322,0.5143229166666666,1.0,1.0,7/16,22.87%,INTS4;INTS9;INTS1;INTS14;TUT1;INTS12;INTS11
prerank,positive regulation of receptor internalization (GO:0002092),-0.32273413557246633,-0.9809209872447918,0.4639175257731959,0.7845626013544692,1.0,5/22,8.51%,AHI1;CD63;ARRB1;TBC1D5;ANGPT1
prerank,positive regulation of gene expression (GO:0010628),0.40516372234441556,0.980596900439096,0.58,1.0,1.0,124/442,22.34%,PLA2R1;BRCA1;TFR2;POLR1B;HEY2;MAPK1;LEF1;E2F1;SMARCA5;ZCCHC4;GLMN;BATF;EZR;TWIST1;RBM3;DEK;CD74;POLR2A;PTPN22;CTCF;TFRC;AGPAT1;RPS7;EIF3E;RPS4X;GSN;ATM;TERF2;MYOM1;SETX;EPHX2;PDE2A;TNRC6C;LRP3;TNRC6B;NOTCH1;NFAM1;EIF4A3;DDRGK1;NIBAN1;BAZ1B;ELAVL4;PHF2;MAPK14;PLCG2;EGFR;POLR1A;EGR1;CPEB3;DNMT1;MSN;DYRK1A;CARD9;PARK7;FGF9;KAT2B;RDX;MYD88;POLR1F;HCFC1;UPF3B;F3;FXR1;NFE2L2;ROCK2;ZBTB7B;FLOT1;PRKDC;MYC;GABPA;PSEN1;POLR1C;TLR6;DTNBP1;TYROBP;GSK3B;TADA3;LIMS1;PDCD10;PLD1;TP53;METTL14;EGF;HGS;MAP2K1;PYM1;SAMD4A;EEF2;VIM;POLR2K;NAT10;LARP4B;POLDIP3;FN1;TAF1C;MED1;TAF1D;POLR1G;PTGER4;ELAVL1;RPL5;HNRNPLL;RPS3;LGALS9;SOX9;DNMT3B;AGO2;RPL23;RAB27A;RBPJ;EIF6;CITED2;PRKAG1;RIPK1;ROCK1;GAPDH;CELF1;CALCOCO1;FGR;AGO1;ACTG1;TENT4A;MED23;NTRK3
prerank,regulation of oxidoreductase activity (GO:0051341),0.5004196508932495,0.9802342662866655,0.5174731182795699,1.0,1.0,5/13,21.03%,HDAC6;ATP7A;SZT2;SLAMF8;SIRT4
prerank,negative regulation of cellular process (GO:0048523),0.40469823451537473,0.9799892380720311,0.593,1.0,1.0,94/521,16.94%,E2F7;CDKN3;PRTN3;FOXM1;MYBL1;MEN1;CYP1B1;CDKN2C;JADE1;ANP32B;HMGA1;ITGA1;BLM;PPP1R9B;SPN;RB1;FBXO5;TCHP;ERBB3;GLMN;S100A11;PPM1D;CCN1;PML;CCN4;RIPOR2;SUZ12;ARID2;SNX3;CTCF;ARHGDIB;STK11;CDK6;SP100;CDKN2A;PTHLH;MDM4;RBBP4;GMNN;PDE12;RUNX3;KLF10;NOTCH1;PIM2;FUZ;CIB1;SMARCA4;HPGD;RAD18;PLXNA2;JAK2;STRN;JAM2;CDKN2D;CBLL1;PIP4P2;PARK7;UBR2;SMAD4;PTPN14;TAF6;CCAR2;ATF5;BECN1;KAT2B;SLIT3;PTEN;BAP1;PDS5B;RACK1;SIRT7;ING5;SERTAD2;SLURP1;TMEM115;SKI;MYC;BCL6;ADAMTS1;TP53;TGFBI;F2R;PTPRU;HGS;MAP2K1;TFAP4;NDRG3;ARHGDIA;TGFB2;TMEM109;VHL;NLRP2B;PDE8A;SIRT1
prerank,negative regulation of nervous system development (GO:0051961),0.47952662281484343,0.9799802408050512,0.4993678887484197,1.0,1.0,4/17,11.67%,NOTCH1;PCM1;B2M;SLIT1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.45773067786698285,0.9799679663417618,0.5012315270935961,1.0,1.0,3/22,4.25%,UBASH3A;EZR;PTPN22
prerank,negative regulation of T cell activation (GO:0050868),0.4493025137036638,0.9797099681662919,0.5302857142857142,1.0,1.0,4/35,4.25%,SPN;GLMN;RIPOR2;PTPN22
prerank,positive regulation of transport (GO:0051050),0.4169396021565433,0.9794080375212866,0.5390946502057613,1.0,1.0,20/85,17.91%,SPAG5;TFR2;IL2RG;C2CD5;CD47;MLC1;BOK;DYNC1H1;NEDD4L;CBLL1;ABCA7;KMT2A;CHCHD10;FLOT1;NUMA1;GSK3B;CAPN10;CYBA;FCGR2B;SNCA
prerank,DNA methylation or demethylation (GO:0044728),0.4699458094724013,0.9793826684433956,0.5131086142322098,1.0,1.0,8/19,20.82%,PPM1D;HELLS;DNMT1;EHMT1;ATF7IP;ATRX;DNMT3B;GATAD2A
prerank,DNA alkylation (GO:0006305),0.4699458094724013,0.9793826684433956,0.5131086142322098,1.0,1.0,8/19,20.82%,PPM1D;HELLS;DNMT1;EHMT1;ATF7IP;ATRX;DNMT3B;GATAD2A
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.37551797539964543,-0.9793474345333243,0.4858156028368794,0.7869535132906125,1.0,3/12,9.90%,ABCA1;ABCA5;ITGB3
prerank,regulation of protein transport (GO:0051223),-0.2971757542378621,-0.9788023303521685,0.49324324324324326,0.7869027309769816,1.0,14/27,32.57%,NDFIP1;STXBP5L;NDFIP2;PPM1F;STXBP5;DNAJC1;LLGL1;CHP1;RHBDF2;GAPVD1;LLGL2;P3H1;RHBDF1;PTPN1
prerank,cell-cell junction organization (GO:0045216),0.41271842850388724,0.9783915380935975,0.5302564102564102,1.0,1.0,14/79,16.38%,PRTN3;CD177;SDK1;CTNNA1;TJP3;CDH18;CDH24;NECTIN1;GJA4;LIMS1;F2R;CTNND2;CDH4;TGFB2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4664914368654496,0.9774515870071026,0.5043695380774033,1.0,1.0,1/19,1.71%,SLC25A21
prerank,regulation of endopeptidase activity (GO:0052548),-0.2477246554437831,-0.9771890659846052,0.46153846153846156,0.7894586174150324,1.0,10/59,15.55%,SPOCK1;SERPINE2;TIMP2;VSIR;SPOCK2;TIMP3;SERPINI1;SERPINE1;PSMB8;APH1A
prerank,embryonic organ morphogenesis (GO:0048562),-0.26388362950544786,-0.9771782765930105,0.5,0.7880623091020159,1.0,17/42,30.03%,ACVR1;DSCAML1;RYR2;FBN1;DYNC2I1;ID2;EFEMP1;SOX11;HOXC4;HOXD4;HOXA3;RBP4;HOXD3;HOXC9;HOXA9;HOXB9;PDGFRA
prerank,selective autophagy (GO:0061912),0.4217971418761008,0.9765576134363335,0.5286624203821656,1.0,1.0,17/56,17.60%,ATG13;PCNT;ACBD5;ATM;HDAC6;DDRGK1;DYNC1H1;UBE2V1;UBQLN1;PARK7;BECN1;AMBRA1;ARL13B;DYNLL1;VIM;ATG2B;UBA52
prerank,response to cadmium ion (GO:0046686),0.4550196545597347,0.976334172534714,0.5121668597914253,1.0,1.0,5/26,11.47%,MAPK1;HAAO;EGFR;SUMO1;JUN
prerank,post-translational protein modification (GO:0043687),0.4036867820320261,0.9759870100893104,0.569,1.0,1.0,73/332,18.89%,CCNF;ESCO2;F5;MEN1;FBXL15;FN3KRP;DSCC1;SKP2;DTL;PSMB7;CCN1;PSMD11;FBXW11;PSMF1;LRRC41;RAB1B;FBXO44;PSMC1;ASB7;STT3A;SPSB3;RAB8A;ZBTB16;FBXO17;LAMC1;LAMB2;KLHL9;ASB1;CUL3;PSMC3;SOCS2;DCAF17;PSMA4;SPSB4;DCAF7;FBXL4;PSMC4;RAB11B;CUL9;FBXO11;PSMD13;SUMF1;PSME1;RAB2A;DCAF11;PSMB1;RBBP5;PRKCSH;CHML;PRSS23;PSMD8;WDTC1;DCAF8;ASB8;PSME4;RAB5A;DCAF5;VHL;KLHL22;PSMD4;SCG3;DCAF4;HSP90B1;FN1;UBE2M;DDB2;FEM1C;SDC2;SUMF2;ADAM10;FBXW8;CKAP4;ICMT
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.5144833225505434,0.975731812177889,0.5207756232686981,1.0,1.0,3/11,16.38%,HEY2;BMPR1A;TGFB2
prerank,positive regulation of growth (GO:0045927),0.41439560798859826,0.9756269000566338,0.5327783558792925,1.0,1.0,19/64,23.12%,S100A9;BRAT1;DDX49;S100A8;H3-3A;CIB1;MTPN;NCBP1;EGFR;DERL2;PLCB1;PABIR1;TGFB2;KLHL22;ADAM10;USP47;RPS6KA3;ZPR1;ADAM17
prerank,neurotransmitter uptake (GO:0001504),-0.3820634551641289,-0.9756186369836934,0.4607142857142857,0.7903735910980153,1.0,6/12,32.29%,GLUL;SLC1A3;ATP1A2;SNAP25;SLC38A1;SLC1A6
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.44085203851618454,0.9756014111667064,0.5155709342560554,1.0,1.0,8/30,14.14%,ATG13;SAE1;UBL5;ABLIM3;RHOU;BAP1;RAC2;ARIH2
prerank,regulation of T cell activation (GO:0050863),0.43458288038671505,0.9754155251747298,0.5320304017372421,1.0,1.0,5/42,8.62%,CD2;CD47;PTPN22;CCR2;CYRIB
prerank,negative regulation of viral release from host cell (GO:1902187),0.4938946399943565,0.9754133662993375,0.5140562248995983,1.0,1.0,5/13,16.96%,PML;TRIM11;TRIM5;TRIM28;CHMP3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4848023063727635,0.9752608729500556,0.5061224489795918,1.0,1.0,3/14,8.37%,CD74;GPRC5B;PLCG2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4614533429582317,0.9751329946742681,0.5161691542288557,1.0,1.0,8/21,20.52%,TWIST1;MED30;SETX;JUN;PAXIP1;MED14;MED1;MED13
prerank,nitric oxide mediated signal transduction (GO:0007263),0.49524849553229466,0.9749782581893803,0.5447570332480819,1.0,1.0,3/16,11.12%,DDAH2;GUCY1A1;KCNC2
prerank,glycoprotein biosynthetic process (GO:0009101),-0.22940392323150716,-0.974890319433953,0.4642857142857143,0.7907054350354459,1.0,30/79,24.18%,GCNT2;ST8SIA1;BMPR2;CHST8;COG7;ST3GAL6;IGF1;LARGE1;FUT10;B4GALT5;BMPR1B;ALG5;B3GALNT2;ST3GAL4;CHST11;MGAT1;GOLGA2;B4GALT7;SERP1;NPC1;ST8SIA5;TMEM106A;ALG1;ST8SIA3;DAD1;GAL3ST4;B3GALT5;DDOST;B3GALT2;COG3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4806019074477281,0.974468777109705,0.5026109660574413,1.0,1.0,8/16,19.72%,CAV1;PARP14;ADIPOR1;PIBF1;HGS;VHL;PPP2CA;INPP5F
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.34995189195390036,-0.9743341443770827,0.5084745762711864,0.7906805218140448,1.0,3/15,9.54%,HDAC2;EDA;ROGDI
prerank,regulation of type I interferon production (GO:0032479),0.40606921748784824,0.974209556179992,0.5493387589013224,1.0,1.0,21/84,16.99%,RNF26;POLA1;DHX58;PTPN22;CGAS;NPLOC4;TRAF3;PIN1;XRCC6;PCBP2;DHX9;MYD88;PRKDC;CREBBP;POLR1C;LRRFIP1;GPATCH3;OTUD5;IRF8;POLR2K;NLRX1
prerank,positive regulation of dendrite development (GO:1900006),-0.4069247650049725,-0.9739467611448056,0.47157190635451507,0.7902286919940906,1.0,5/10,20.25%,PACSIN1;LRP8;DAB2IP;VLDLR;ZDHHC15
prerank,peptidyl-tyrosine modification (GO:0018212),0.41624683928470896,0.9734856454745523,0.5392781316348195,1.0,1.0,10/56,11.65%,BLK;FYN;TPST1;JAK2;EGFR;EPHA3;DYRK1A;BTK;RELN;FLT3
prerank,regulation of developmental growth (GO:0048638),-0.2937597864560308,-0.9731759410188552,0.48299319727891155,0.7907561706337407,1.0,4/29,5.24%,DNM2;APP;APOE;IGF1
prerank,regulation of filopodium assembly (GO:0051489),-0.2666873295562686,-0.9728983027116629,0.5242718446601942,0.7901356052936619,1.0,12/38,16.01%,TENM2;ARAP1;RALA;PIK3R1;WASL;ARHGAP44;TENM1;GAP43;FXR2;MYO10;RHOQ;AGRN
prerank,receptor clustering (GO:0043113),0.4567281904107254,0.9727407958250337,0.534994068801898,1.0,1.0,13/27,27.47%,ITGB7;LRP4;FLNA;PICK1;NRXN2;NRXN1;DLG3;ITGA4;ITGB1BP1;DNAJA3;PTN;NLGN1;SAV1
prerank,positive regulation of vasoconstriction (GO:0045907),0.49299451039889125,0.9726394860074613,0.5146276595744681,1.0,1.0,3/13,17.11%,CAV1;F2R;TRPM4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.48585647650190955,0.9725310534113891,0.5203679369250985,1.0,1.0,3/14,13.15%,CAV1;ZEB1;SPRED2
prerank,regulation of pH (GO:0006885),-0.38097830349983264,-0.972529431310863,0.49295774647887325,0.7896207606506935,1.0,2/11,5.60%,LACC1;SLC9A1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.2801114261514687,-0.9724333081616737,0.5,0.7884293322549839,1.0,7/38,9.21%,CACNB2;CACNA1C;ANK2;BIN1;CTNNA3;SCN1B;JUP
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4578091345811347,0.9723737661501989,0.5160891089108911,1.0,1.0,5/20,18.63%,TSPO;CYP46A1;STARD3NL;TSPOAP1;FDXR
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4452438288772492,0.9718451405532061,0.5219399538106235,1.0,1.0,8/30,16.97%,MAGT1;ALG8;STT3A;MGAT2;FUT8;OST4;TUSC3;LMAN1
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.3190022706138561,-0.9717165611696295,0.5336538461538461,0.7888239986343917,1.0,8/19,17.91%,PTPRJ;TSC1;FERMT2;PPM1F;VEGFA;MAP4K4;COL16A1;THY1
prerank,stress granule assembly (GO:0034063),0.46057060942130545,0.9710814272259247,0.5182481751824818,1.0,1.0,11/20,25.61%,EIF2S1;CSDE1;DYNC1H1;LSM14A;PRRC2C;UBAP2L;G3BP1;MAPT;ATXN2L;CIRBP;RPS23
prerank,regulation of membrane depolarization (GO:0003254),0.47206901764268344,0.9706234762344853,0.5031928480204342,1.0,1.0,3/18,7.95%,ABCD1;GPD1L;NEDD4L
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.509522518262258,0.9699995925430207,0.5201109570041609,1.0,1.0,4/10,16.35%,RUVBL2;RUVBL1;ZNHIT6;TAF9
prerank,organelle organization (GO:0006996),0.400680868215283,0.9697539857898739,0.598,1.0,1.0,65/388,14.31%,DIAPH3;KIF4A;CDCA8;CEP55;CENPW;CECR2;DES;TSGA10IP;PTCD2;ATP8B4;LIG4;WDPCP;MNS1;STX17;NEDD9;ATL2;TMCC1;ABCD1;CAV1;CNN2;ODF2;CLASP1;AGTPBP1;ANK1;NPLOC4;CSNK1A1;TFB1M;FAF2;GABPB1;TFB2M;PEX11B;ZW10;BLZF1;MAST2;NRF1;FGD6;CAV2;LONP1;IRAG2;RHOU;ATP7A;PARK7;DYM;SYNE3;TOR1A;HPS3;PDZD8;PEX2;VAPA;FGD3;SEC31A;PACSIN2;PLD2;RAB43;HCFC1;PI4K2B;CHCHD10;CHMP1B;NUMA1;PALLD;MYC;RAB2A;GABPA;PPIA;DIAPH1
prerank,membrane protein proteolysis (GO:0033619),0.42913775061758475,0.9692982110869931,0.5157657657657657,1.0,1.0,9/37,19.36%,PRTN3;NAPSA;MBTPS2;PSEN1;DAG1;SPPL3;ADAM10;ERAP1;TRAF6
prerank,peptidyl-asparagine modification (GO:0018196),0.44318748818056025,0.9692892470237289,0.5361653272101033,1.0,1.0,8/31,16.97%,MAGT1;ALG8;STT3A;MGAT2;FUT8;OST4;TUSC3;LMAN1
prerank,positive regulation of immune response (GO:0050778),0.41254608626390266,0.969165809011561,0.5518324607329843,1.0,1.0,13/64,20.37%,MYB;CD177;CD74;RIOK3;DHX9;TGFB2;SIRT1;CYBA;XBP1;FCGR2B;LGALS9;IFI35;POLR3B
prerank,positive regulation of cytokine production (GO:0001819),0.4030908731901612,0.9689889093752589,0.586,1.0,1.0,54/292,15.40%,IL12A;CD2;POU2AF1;CYP1B1;PLA2R1;BRCA1;GLMN;BATF;DHX58;TWIST1;ZFPM1;CD74;SULF2;IL16;PTPN22;FOXP1;CGAS;AGPAT1;CCR2;RASGRP1;PAEP;NFAM1;XRCC6;HMGB1;MAPK14;PLCG2;CYRIB;IL17RA;EGR1;IL1R1;CARD9;PARK7;DHX9;PLCB1;MYD88;F3;ROCK2;ZBTB7B;FLOT1;TLR5;PRKDC;DDIT3;CREBBP;PIBF1;CEBPG;IL27;POLR1C;TLR6;TYROBP;CCBE1;LRRFIP1;RUNX1;F2R;APPL1
prerank,endosome organization (GO:0007032),0.4254774692023071,0.9682144547607325,0.5335497835497836,1.0,1.0,13/41,20.47%,RNF26;SNX33;SNX3;TMCC1;WASHC4;RAB22A;DNAJC13;PI4K2B;VPS33B;USP50;CHMP2B;AKTIP;RAB27A
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.3297556823536888,-0.9681245747521916,0.4489795918367347,0.7961306026213977,1.0,6/20,14.83%,NUMB;BCL2L1;LZTFL1;AP2M1;RHOQ;PPFIA1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.37121692344554597,-0.9676522450079691,0.49808429118773945,0.7958118423882053,1.0,5/13,17.39%,CTNNB1;SEMA3E;ENG;VEGFA;TGFBR2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4203953528291924,0.9675611147262839,0.5111583421891605,1.0,1.0,16/50,21.34%,AQP1;CD44;DPEP1;BCL2L12;ARL6IP1;CDKN2D;PARK7;XIAP;CAAP1;PAK2;SH3RF1;YWHAE;SNCA;PAX2;USP47;RPS6KA3
prerank,stress-activated MAPK cascade (GO:0051403),0.4166898153771335,0.9674950454574196,0.5447839831401475,1.0,1.0,21/61,21.11%,MAPK1;FBXW11;CRKL;IKBKG;CCM2;ZFP36L1;MAP3K5;MAP4K2;TAB1;UBE2V1;MAPK14;TAB3;MAP3K11;MAP3K20;UBA52;MAP3K7;PTGER4;TRAF6;LGALS9;UBE2N;IKBKB
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.43523783824439877,0.9672888750299005,0.5418060200668896,1.0,1.0,4/32,7.77%,CARD10;NOTCH1;AKT3;CIB1
prerank,negative regulation of protein modification process (GO:0031400),0.40773765380853866,0.9669947105126482,0.5614754098360656,1.0,1.0,28/79,23.03%,MEN1;XRCC1;PTPA;CRTAP;PPP1R8;CRKL;NIBAN1;CIB1;IBTK;PPP1R15A;PARK7;PTEN;CDK5RAP3;PRKDC;PPIA;GSK3B;FKBP8;SIRT1;PTPN13;LRRK2;PRR5L;MAPT;CADM4;PPP1R15B;ATP2B4;PPP1R16B;NTRK3;TARDBP
prerank,substantia nigra development (GO:0021762),-0.27535634520016916,-0.9668936638291101,0.48,0.7963731027677271,1.0,17/37,19.71%,PLP1;MBP;SEC16A;PADI2;BASP1;COX6B1;CNP;SUDS3;GLUD1;ACTB;CKB;NDUFS3;CALM1;HSPA5;TTBK1;CDC42;NDRG2
prerank,regulation of cilium assembly (GO:1902017),0.4192161055668021,0.9664512052801134,0.546694648478489,1.0,1.0,20/62,21.67%,CDKL1;TBC1D1;CCDC88A;TCHP;TBC1D22B;EVI5;ARHGAP35;FUZ;TAPT1;BBS4;DYNLT2B;SDCCAG8;MARK4;LIMK2;IFT140;RABEP2;SGSM3;CROCC;TBC1D15;EVI5L
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4052034093068868,0.9663885498078546,0.5402892561983471,1.0,1.0,19/73,22.34%,NTF4;CD44;AXIN1;TFRC;CAV1;HDAC6;EGFR;TXN;PARK7;LATS1;STK4;PDCD10;HCLS1;SNCA;PRKD2;ARAF;CAPRIN2;ATP2B4;NTRK3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4802326891067516,0.9663834096048417,0.5240572171651495,1.0,1.0,6/17,17.37%,EMC6;EMC10;EMC3;GET3;EMC1;CAMLG
prerank,regulation of viral transcription (GO:0046782),0.4273546950093906,0.9660359718676185,0.5226519337016574,1.0,1.0,13/39,17.78%,RSF1;POLR2I;POLR2A;TRIM11;NELFA;DHX9;CCNT1;IFITM3;NELFB;TARBP2;POLR2K;POLR2J;HEXIM1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5086936727934259,0.9657637202959025,0.5067466266866567,1.0,1.0,4/10,21.35%,MAPK1;FAS;MAP2K1;NBR1
prerank,regulation of cholesterol transport (GO:0032374),0.45801261104386837,0.9653267009012068,0.5183374083129584,1.0,1.0,4/20,9.29%,ABCA13;NUS1;TSPO;ABCA2
prerank,proteasomal protein catabolic process (GO:0010498),0.40125995777907636,0.9648840038609707,0.5795795795795796,1.0,1.0,51/201,18.21%,KIF14;PMAIP1;SKP2;PSMB7;RCN3;PSMD11;PML;PRPF19;FBXW11;PSMF1;NR1D1;FAF1;FBXO44;PSMC1;FBXO45;BIRC2;SPSB3;UBE2K;UBE4B;NEDD4L;TNFAIP1;CUL3;PSMC3;PCBP2;RAD23A;PSMA4;SPSB4;TRIM3;PSMC4;ARRB2;PCNP;NFE2L2;PSMD13;SPOP;PSME1;DDIT3;DCAF11;ZFAND2B;PSMB1;RBCK1;ARMC8;PSMD8;PSME4;KLHL22;PSMD4;SIRT1;UBXN1;RNF4;SYVN1;FEM1C;UBE2G1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4829261129918181,0.9648352690761587,0.5269541778975741,1.0,1.0,4/13,19.24%,PALM;CCR2;ADGRV1;GRM3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.48171093693987654,0.9647372714423932,0.5235531628532974,1.0,1.0,6/14,20.18%,CPSF2;NCBP1;TUT1;CPSF1;NCBP2;CPSF7
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.49257125910191035,0.9647075673871138,0.5185185185185185,1.0,1.0,3/12,7.33%,CD74;FOXP1;HMGB1
prerank,regulation of hydrolase activity (GO:0051336),0.407187854658019,0.9645051926842237,0.5525494276795005,1.0,1.0,15/71,13.57%,ARHGEF5;ARHGAP15;FBXW11;CAV1;PLXNA2;FGD6;EPHA3;PAFAH1B1;CFAP73;RDX;CRK;FGD3;CDK5RAP3;ARHGAP9;ADAP1
prerank,regulation of mRNA processing (GO:0050684),0.43446996274356336,0.9643761079486818,0.5334846765039728,1.0,1.0,16/32,25.64%,PTCD2;ZFP36L1;SRSF3;IWS1;NCBP1;DHX9;METTL16;SRSF10;SRPK1;SAFB;CDK11B;SLTM;PAPOLA;HNRNPK;YTHDC1;KHDRBS3
prerank,phospholipid transport (GO:0015914),-0.25380257626150066,-0.9641718699038758,0.5606060606060606,0.801773712394763,1.0,15/52,13.34%,APOE;ATP8A2;OSBPL2;ABCA1;ATP9A;ATP8B1;PLTP;PRELID2;ABCC1;SCP2;MTTP;SCARB1;PITPNB;SCARB2;NPC2
prerank,gland development (GO:0048732),0.4157405844598513,0.9640776524549031,0.5630965005302226,1.0,1.0,19/59,22.91%,EZR;CAV1;ARHGAP35;PHF2;MSN;ARID5B;CDK5RAP3;CEBPG;PRKCSH;XBP1;FOXE1;NKX2-8;PROX1;SOX9;PKD2;MET;CITED2;FGFR2;ZBTB1
prerank,regulation of immune effector process (GO:0002697),0.4344858811593418,0.9636733654948505,0.5507088331515813,1.0,1.0,1/41,0.38%,CD19
prerank,regulation of brown fat cell differentiation (GO:0090335),0.46664172511580865,0.963345725386201,0.5274869109947644,1.0,1.0,6/16,16.94%,FTO;PIM1;NAPEPLD;ZBTB7B;HNRNPU;SIRT1
prerank,mitochondrion localization (GO:0051646),0.45762321671603745,0.9624874225706017,0.5006435006435006,1.0,1.0,8/19,22.50%,BRAT1;MARK2;HAP1;MTM1;LRRK2;TRAK2;MARK1;ATCAY
prerank,osteoclast differentiation (GO:0030316),-0.31175534533692145,-0.9624512348055644,0.49122807017543857,0.8044335712263659,1.0,4/22,2.72%,TREM2;CSF1R;FARP2;SBNO2
prerank,Wnt signaling pathway (GO:0016055),0.4044979646118132,0.9623519822955476,0.5783009211873081,1.0,1.0,21/92,20.25%,NR4A2;LEF1;AXIN1;SNX3;NXN;CCDC88C;TCF7L1;CSNK1A1;CSNK1G2;PLCG2;STRN;PTEN;BCL9L;GSK3B;TCF7L2;CD24;UBA52;RARG;LRRK2;USP34;DIXDC1
prerank,regulation of calcium ion transport (GO:0051924),-0.2484112079220267,-0.9622730061589216,0.5714285714285714,0.8034690988287163,1.0,16/54,20.16%,CD84;CACNB2;CTNNB1;ANK2;PLPP4;SRI;SLC8B1;CAMK2G;CCL4;CAMK2B;SARAF;WFS1;CCL3;ORAI1;P2RX4;STIM1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.42874166338491077,0.9613509399539749,0.5303687635574837,1.0,1.0,7/41,15.53%,FOXA2;CD47;CD44;MAGI1;FLOT1;DENND6A;PTPRU
prerank,organelle transport along microtubule (GO:0072384),0.43125237597407706,0.9610962854661538,0.521689497716895,1.0,1.0,10/31,21.28%,UXT;NDE1;FBXW11;PAFAH1B1;HAP1;PEX14;RAB6A;CLN3;TRAK2;MAPT
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4694003701126028,0.9608453144871437,0.5324503311258278,1.0,1.0,7/17,23.12%,CCNYL1;MAPRE3;EGFR;PROX1;PKD2;CCND3;ADAM17
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.37760654539836314,-0.9607638095755786,0.5090252707581228,0.8056934432905722,1.0,4/12,11.50%,TMEFF2;HDAC2;AR;SELENOS
prerank,negative regulation of neuron death (GO:1901215),0.406287666350842,0.9606592783766871,0.5596330275229358,1.0,1.0,6/93,6.33%,KIF14;NTF4;ERBB3;LIG4;IKBKG;INPP5A
prerank,P-body assembly (GO:0033962),0.4813212768208844,0.9604384498335365,0.532520325203252,1.0,1.0,7/12,23.13%,DYNC1H1;EDC3;LSM14A;RC3H1;LIMD1;EIF4ENIF1;LSM3
prerank,positive regulation of establishment of protein localization (GO:1904951),0.45604803420422296,0.9603788374227705,0.5228426395939086,1.0,1.0,8/18,19.42%,CEP295;CCT7;CCT2;TCP1;CCT5;DKC1;WRAP53;CCT6A
prerank,protein oxidation (GO:0018158),0.5120218540303568,0.9602496052617473,0.5389876880984952,1.0,1.0,2/11,13.20%,CHCHD4;SUMF1
prerank,cellular protein modification process (GO:0006464),0.39574999354461177,0.9602127435639696,0.675,1.0,1.0,232/982,18.39%,CCNF;CDK1;BIRC5;AURKB;EPB42;NEK2;F5;MEN1;CCNE1;PLK1;STK26;FBXL15;CHEK2;MAPK1;FN3KRP;CDKL1;SKP2;AURKA;ART3;OXSR1;DTL;DAPK2;CEL;PSMB7;FYN;PIGH;PPM1D;PTPRA;PPP3CA;CCN1;PRKCE;PSMD11;HASPIN;FBXW11;PTPN22;RSKR;ERG;JMJD4;UBE2I;RPS6KA5;MAP4K1;PSMF1;LRRC41;PPP2R5E;STK11;CHEK1;CDK6;GRK6;TLK1;GMFG;PPP1CB;TAF1;SIK2;PPP2R5A;MSRA;RAB1B;ATM;LCMT1;FBXO44;ARF4;RUNX3;CSNK1A1;PSMC1;MPI;STK38L;ASB7;STT3A;NUS1;MAP3K5;CDC25B;UBL5;MTMR2;PIM2;METAP2;ST3GAL1;SPSB3;CDK17;AKT3;PKN2;BIRC6;CSNK1G2;PIM3;MAP3K1;MAP4K2;TAB1;RAB8A;SLC35A1;HCST;ST3GAL2;PRKCA;PRKACA;ZBTB16;STK38;FBXO17;LAMC1;LAMB2;PICK1;MARK2;JAK2;LMTK3;KLHL9;ST8SIA4;MAST2;ENGASE;STK24;ASB1;CUL3;PIM1;SEPHS1;PARP14;PPP2CB;PDPK1;MAP4K5;B3GNT2;ATG4B;CDK19;HIPK2;PSMC3;TESK2;SOCS2;MAP3K11;DCAF17;ABCA7;PIGT;MELK;DYRK1A;PARK7;VRK1;BTK;PSMA4;PTPN7;PTPN14;PPP1CC;SPSB4;DCAF7;MTMR6;CCNT1;PRKCB;PTEN;FBXL4;PHKA2;PSMC4;BAP1;RAB11B;BMPR1A;LMTK2;CUL9;FBXO11;GRK2;ROCK2;PSMD13;SUMF1;CHRM3;SIRT7;PSME1;PRKDC;PRKAG2;LATS1;CDK16;STK39;PGAP1;RAB2A;FAM20A;NRBP1;DCAF11;PPP3CC;PIGU;PSMB1;RBBP5;GSK3B;PPP1R12A;PRKCSH;SGK3;CHML;STK4;PRSS23;NTAQ1;PTPN5;MAP3K20;BCR;PPP6C;MTM1;ST3GAL5;PTPRU;PSMD8;PAK5;MAP2K1;WDTC1;PMM2;PPP2R5D;MARK4;DCAF8;FGFR1;TRIOBP;LIMK2;PAK2;ASB8;PSME4;CDK8;TGFB2;RAB5A;DCAF5;JAK3;VHL;KLHL22;USP25;SRPK1;DUSP12;PSMD4;SIRT1;SCG3;ADPRH;DCAF4;HSP90B1;FN1;UBA52;UBE2M;DDB2;F13A1;PTPN13;PPP1CA;FEM1C;SDC2;FAM20B;MORC3;STK17B;TAOK1;LRRK2;ILKAP;SUMF2;ADAM10;CREB1
prerank,smooth muscle tissue development (GO:0048745),-0.4036471162672388,-0.9601811655640436,0.5273972602739726,0.8056822885842873,1.0,3/10,9.25%,SMO;NF1;ENG
prerank,phospholipid dephosphorylation (GO:0046839),0.42199903653797183,0.9597601774039414,0.5389830508474577,1.0,1.0,9/37,15.29%,PLPPR3;MTMR12;EPHX2;MTMR2;PIP4P2;MTMR6;PTEN;PLPPR4;MTM1
prerank,muscle organ development (GO:0007517),-0.24001409087638637,-0.9594975872009832,0.5625,0.8058951284419765,1.0,12/54,11.89%,SGCD;CAPN3;SGCE;SPEG;IGF1;LARGE1;FKTN;SRI;VAMP5;DMD;FHL1;MEF2A
prerank,regulation of gene expression (GO:0010468),0.3930008200669772,0.959422960731104,0.685,1.0,1.0,163/903,15.76%,MBNL3;TCF19;TRIM58;TMPRSS4;MYB;EZH2;ERMAP;MYBL1;BRCA1;SPIN4;AFF3;HMGA1;SOX6;CHEK2;MEFV;HEY2;BRCA2;MAPK1;LEF1;E2F1;NSD2;RB1;AURKA;GLMN;AFF1;EZR;TWIST1;CD74;PML;NUP107;POLR2A;CCN4;PTPN22;HDAC10;RPS6KA5;CTCF;RBL1;TFRC;FOXP1;ZC3H7A;ACTR5;CDK6;RPS7;NKAP;CRKL;EDF1;TAF1;PTHLH;NFXL1;HNRNPL;LIN54;GSN;ATF7;ATM;TERF2;MYOM1;TCF7L1;TCF3;ZFP36L1;RUNX3;HDAC6;EPHX2;PDE2A;TRAF3;TNRC6C;LRP3;TNRC6B;PHF19;ZUP1;PUM2;NOTCH1;PIN1;DDRGK1;MLF2;AHR;ZNF326;PSPC1;DMTF1;PHF1;NOVA2;UBE2V1;TRIM11;MAPK14;PLCG2;ERC1;METTL4;SART3;PLAG1;CLK4;ABCC2;NONO;ZNF148;PARP14;MECP2;SRRT;BTN3A3;EGR1;PFDN5;SPTY2D1;NR2C2;DNMT1;PCBP2;RBM38;NFYC;TRIM44;MSN;PARK7;ZNF462;PRDM10;PUM1;ATXN7L3B;UBAP2;CCAR2;FGF9;ATF5;RDX;IGF2BP3;NSD3;MYD88;NPAT;TRIM68;SETDB2;PRDM6;METTL16;HCFC1;F3;BMPR1A;SP3;NFE2L2;NELL1;ROCK2;RACK1;ZBTB7B;ING2;REXO4;DDIT3;CREBBP;MYC;BCL6;GABPA;NFX1;PSEN1;HNRNPAB;TLR6;RNF20;DTNBP1;TYROBP;TRIM5;PCBP3;GSK3B;TADA3;LIMS1;PDCD10;TP53;RC3H1;GON4L;RUNX1;LIMD1;EGF;SRSF10;AHNAK;HGS;MAP2K1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.43292999754884365,0.9591373470414111,0.5334846765039728,1.0,1.0,10/33,15.17%,AXIN1;HDAC6;DDRGK1;H3-3A;PARK7;TRIM68;CBFB;LATS1;KDM4C;RUNX1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.2656530504143845,-0.9591249753216784,0.5726495726495726,0.8054001306151042,1.0,22/35,35.92%,CSF1R;F11R;SEMA3E;BAIAP2;FES;CDK5;MDK;CDC42;ABL2;RAPGEF3;HRAS;PTK2B;HCK;TJP1;TRPM2;PDGFRA;NOTCH2;ABI3;TEK;STAP1;PHPT1;BAIAP2L2
prerank,protein methylation (GO:0006479),0.4229704525106199,0.9589117304173826,0.5423728813559322,1.0,1.0,14/40,22.95%,EZH2;LCMT1;EHMT1;NSD3;GSPT1;PRMT3;RAB6A;ICMT;SNRPB;PRMT7;TRMT112;EEF1AKMT2;ATPSCKMT;NSD1
prerank,epidermis development (GO:0008544),0.4175694464974501,0.9588476357850912,0.54957805907173,1.0,1.0,4/56,12.90%,NTF4;PTHLH;LAMB3;EMP1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4821870499711175,0.9583648745138725,0.5178082191780822,1.0,1.0,3/13,13.19%,TPST1;BPNT2;SULT6B1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4341911674961404,0.9582039418566113,0.5304948216340621,1.0,1.0,9/30,18.42%,POLR1B;POLR1A;ERCC3;POLR1F;POLR1C;POLR2K;TAF1C;TAF1D;POLR1G
prerank,negative regulation of multicellular organismal process (GO:0051241),0.39905416278041794,0.9580389166282077,0.617,1.0,1.0,46/199,21.04%,FOXA2;HEY2;BRCA2;RB1;NRDC;LRP4;VASN;MAP2K6;PPP1R11;CRHBP;RPS6KA5;RPS19;ARHGDIB;STK11;ACOT11;NR1D1;PAEP;NOTCH1;LAMA4;SFMBT1;NOVA2;ACOT13;EGFR;ASB1;RPS6KA6;ADIPOR1;PTEN;TIFAB;ROCK2;SPRED2;DDIT3;GSK3B;F2R;SLAMF8;LGR4;CHSY1;ADAMTS5;FCGR2B;TLE3;PTGER4;SOX9;PPP2CA;ACVR2B;RBPJ;PLCL1;ROCK1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.429699715926958,0.9579619408997323,0.5381903642773208,1.0,1.0,6/30,15.83%,LBR;LSS;IDI1;NSDHL;FDPS;DHCR7
prerank,transition metal ion transport (GO:0000041),0.4273778216796565,0.9578754065288813,0.5435028248587571,1.0,1.0,4/35,5.04%,TFR2;CUTC;HEPH;TFRC
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4684821711987444,0.9578237140460025,0.5312101910828025,1.0,1.0,6/17,16.94%,TWIST1;CD74;CD44;DYRK1A;YJU2;SIRT1
prerank,glucose import (GO:0046323),0.48543756357509293,0.9575553668132,0.5576407506702413,1.0,1.0,4/13,18.59%,SLC2A4;ZDHHC7;SLC2A3;SLC2A1
prerank,ribosome biogenesis (GO:0042254),0.39476086471876537,0.9573505820142811,0.5971943887775552,1.0,1.0,61/187,23.39%,MRPL36;XPO1;RPL7;RPL18A;EIF2A;UTP3;RPL36;RPL14;RPS19;DDX49;RPS7;HELQ;EXOSC8;RPL23A;MRPL22;RPL28;EXOSC10;URB2;RPS14;RPL41;NOL11;RPLP2;RPS27;EMG1;UTP6;RPLP0;FBL;RPL27A;PELP1;DHX29;WDR74;RPS9;NOL8;RPL12;NOP58;POP4;RPL3;UBA52;RPL18;DKC1;PES1;RIOK1;MPHOSPH6;RPL5;RPS6;RPS17;DDX54;RPL21;RPL17;RPL23;EIF6;RPL24;RPL8;RPL27;RPL13A;DIS3;RPL15;RPL10;RPF1;NOP14;ABCE1
prerank,intermediate filament organization (GO:0045109),0.4612746262064779,0.9571772878263521,0.5393401015228426,1.0,1.0,3/17,16.42%,DES;MTM1;VIM
prerank,blood vessel morphogenesis (GO:0048514),0.41362601053091974,0.9569838270711193,0.5429184549356223,1.0,1.0,13/54,21.85%,CYP1B1;HEY2;GLMN;CAV1;CCM2;AGGF1;NRP1;CCBE1;COL4A1;PROX1;RBPJ;SYK;EGFL7
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4546295671014527,0.9569095820776561,0.5240443896424167,1.0,1.0,4/21,11.99%,CEL;ACBD5;NUDT19;FAH
prerank,regulation of feeding behavior (GO:0060259),0.4977527289223588,0.9568704195748994,0.5346534653465347,1.0,1.0,1/11,3.13%,AGRP
prerank,embryonic heart tube morphogenesis (GO:0003143),0.4194563853068849,0.9565818584023006,0.560622914349277,1.0,1.0,1/43,0.26%,STIL
prerank,positive regulation of cellular component movement (GO:0051272),0.4404253458921058,0.9565304218226386,0.5174488567990373,1.0,1.0,4/24,4.80%,NTN1;TWIST1;RPS19;STK11
prerank,positive regulation of inflammatory response (GO:0050729),0.4005681940184258,0.9565209462568756,0.5699588477366255,1.0,1.0,13/86,11.45%,CD47;CCN4;IL16;S100A9;RPS19;GPRC5B;CCR2;S100A8;TRADD;PDE2A;IL17RA;NAPEPLD;DHX9
prerank,regulation of neurotransmitter transport (GO:0051588),0.47072354578136766,0.9560981993118921,0.532133676092545,1.0,1.0,1/16,0.81%,CHRNB4
prerank,establishment of protein localization to organelle (GO:0072594),0.40308771639111163,0.9558625716844046,0.5504682622268471,1.0,1.0,28/72,23.66%,NEURL1B;POM121;NUP107;TNPO1;IPO13;NUP50;NUP214;SEC13;IPO7;NUP188;RANBP6;IL10RA;RPAIN;E2F3;APPL1;IPO5;KPNB1;EIF4ENIF1;NUP85;MMP12;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2;LRSAM1;IPO8
prerank,import into cell (GO:0098657),0.4203045678120401,0.9554749263760733,0.5455531453362256,1.0,1.0,8/41,13.93%,NEURL1B;SLC7A1;SLC12A7;LRRC8C;SLC19A1;IL10RA;SLC12A6;SLC29A1
prerank,response to estrogen (GO:0043627),0.4277044009140898,0.9554677170218485,0.5438799076212472,1.0,1.0,6/31,16.33%,BRCA1;CRHBP;CAV1;PELP1;RBBP5;CD24
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4165141782359436,0.9552950566392112,0.5612134344528711,1.0,1.0,13/49,21.45%,CD2;CD74;HMGB1;PARK7;MYD88;F3;TLR5;DDIT3;F2R;LGALS9;PRKD2;RIPK1;SYK
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.2993046847527481,-0.955094513149797,0.5470588235294118,0.8137874749857814,1.0,7/25,10.56%,FBXL17;NGLY1;CLPP;RNF185;AUP1;ZER1;BAG6
prerank,metal ion homeostasis (GO:0055065),0.4227357138134534,0.9546031957994566,0.5523059617547806,1.0,1.0,8/40,13.98%,SLC12A3;CAV1;SLC12A7;SLC12A1;KCNA1;TMTC2;SLC12A6;FAM20A
prerank,calcineurin-mediated signaling (GO:0097720),0.5020676293893513,0.9544575674412957,0.5301027900146843,1.0,1.0,4/10,21.59%,PPP3CA;PPP3CC;NFATC3;ADGRB2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5020676293893513,0.9544575674412957,0.5301027900146843,1.0,1.0,4/10,21.59%,PPP3CA;PPP3CC;NFATC3;ADGRB2
prerank,smooth muscle cell differentiation (GO:0051145),0.49627511003135366,0.9542303343615477,0.5358126721763086,1.0,1.0,2/12,13.54%,HEY2;TMEM204
prerank,COPII-coated vesicle budding (GO:0090114),0.41021081836262374,0.954221240077356,0.549163179916318,1.0,1.0,26/68,21.62%,F5;SEC23B;RAB1B;STX5;ANKRD28;PEF1;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;VAPA;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3;SCAP;TMED10;TRAPPC10
prerank,MAPK cascade (GO:0000165),0.39561363942086974,0.9538342029709144,0.633,1.0,1.0,72/295,19.39%,CDK1;SPTA1;MEN1;MAPK1;IL2RG;IL2RA;ERBB3;PSMB7;FYN;ABHD17A;PTPRA;PSMD11;FBXW11;PSMF1;RASGRP1;GFRA2;PPP1CB;IKBKG;CCM2;SETX;ZFP36L1;PSMC1;TGFA;MAP3K5;GRB2;JAK2;SOS1;ITGAV;LYPLA1;EGFR;CUL3;PDE6D;ACTN2;PSMC3;RIT2;ABHD17B;PSMA4;PTPN7;PPP1CC;FGF9;FLT3;PSMC4;FGF13;PSMD13;PSME1;MYC;GFRA1;PSMB1;IRS1;LAMTOR3;MAP3K20;SPTAN1;EGF;PSMD8;MAP2K1;ZFP36L2;FGFR1;PSME4;JAK3;PIK3CA;PSMD4;UBA52;YWHAE;KITLG;MAP3K7;TAOK1;LRRK2;PTGER4;ICMT;KSR1;LGALS9;SOX9
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4855516316490965,0.9535522344375685,0.5156462585034014,1.0,1.0,3/11,14.97%,FAP;BOK;TP53
prerank,regulation of amyloid-beta formation (GO:1902003),-0.2772615720849403,-0.9532765888823628,0.5,0.8169464271257295,1.0,10/34,16.30%,RTN4;APOE;GGA3;RELA;IGF1;BIN1;GSK3A;CASP3;PRNP;EPHA4
prerank,cytoplasmic microtubule organization (GO:0031122),0.41404557243102647,0.9532465732166115,0.5580645161290323,1.0,1.0,13/54,13.42%,TUBGCP6;CCDC88A;SLK;EZR;TUBGCP4;CLASP1;CCDC88C;DYNC1H1;CIB1;PCM1;SLAIN2;TUBGCP3;NUMA1
prerank,protein maturation (GO:0051604),0.39695944217440493,0.9532377999147976,0.5834186284544524,1.0,1.0,22/95,19.90%,TMPRSS4;KEL;NAA40;CIAO2A;CPM;CASP2;DNAJB11;METAP2;TSPAN33;PITRM1;NAA16;F3;PSEN1;PCSK1;NDUFAB1;CPD;TSPAN5;ADAM10;CLN3;GCSH;PCSK7;MME
prerank,negative regulation of cyclase activity (GO:0031280),0.4761259566559767,0.9529074589845855,0.5334224598930482,1.0,1.0,4/14,19.24%,PALM;CCR2;ADGRV1;GRM3
prerank,muscle contraction (GO:0006936),0.3929585924556832,0.9520360388957324,0.5985915492957746,1.0,1.0,17/126,17.45%,TMOD4;DES;ITGA1;SSPN;MYL1;MYOM1;SORBS1;SNTB1;MYBPC1;GNAO1;ACTN2;EMD;ROCK2;TPM4;VIM;CALD1;UTRN
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.41890573401406933,0.9520211075626522,0.5434298440979956,1.0,1.0,12/36,22.08%,LEF1;PPP3CA;TNRC6C;TNRC6B;GNAO1;PLCB1;PLCB3;TCF7L2;MAP3K7;AGO2;GNB1;AGO1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.39507049670710986,0.9519870993619812,0.6034136546184738,1.0,1.0,45/132,21.51%,EIF4B;PRPF19;GEMIN8;SCAF11;RPS19;SNRPF;SNRPC;SETX;CRNKL1;RPL23A;SNRNP200;TXNL4A;RPS14;SART3;NCBP1;RPS27;MRPS7;RPS5;RPLP0;DHX9;DHX29;PRKDC;CLNS1A;LUC7L2;SRSF10;SART1;TARBP2;GEMIN7;SRPK1;RPL3;DDX39B;SNRPG;GCFC2;CLP1;EIF2D;RPL5;SF3A2;SNRPB;CPSF7;PRMT7;EIF6;RSL24D1;RPL24;KHDC4;CELF1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.45156120233754193,0.9516268355336726,0.5348837209302325,1.0,1.0,8/22,20.52%,MED30;PSMC3;PSMC4;PAXIP1;MED14;TP53;MED1;MED13
prerank,detection of mechanical stimulus (GO:0050982),-0.3268971320196174,-0.9513257590899432,0.5151515151515151,0.8204048727136851,1.0,9/19,24.14%,CTNNB1;CDH2;JUP;PKD1;PTK2;PIEZO2;PKD2L1;PKD1L2;PKD2L2
prerank,cartilage development (GO:0051216),0.4154935769008079,0.9500375209826697,0.5589473684210526,1.0,1.0,7/49,10.65%,SOX6;CD44;SULF2;RUNX3;DDRGK1;ZBTB16;ATP7A
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4774913581981878,0.9499372676629646,0.538866930171278,1.0,1.0,5/14,12.22%,SEC23B;SEC24B;SEC24A;SEC13;SEC31A
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3900405384629625,0.9497428460580688,0.648,1.0,1.0,58/327,15.55%,MYB;EZH2;MYBL1;SPIN4;HMGA1;SOX6;CHEK2;BRCA2;E2F1;NSD2;RB1;NIF3L1;PML;NUP107;POLR2A;HDAC10;RPS6KA5;ACTR5;EDF1;NFXL1;LIN54;ATF7;TCF7L1;TCF3;RUNX3;PHF19;NOTCH1;MLF2;AHR;PSPC1;DMTF1;PHF1;UBE2V1;ERC1;PLAG1;RALY;NONO;SRRT;PFDN5;SPTY2D1;NR2C2;NFYC;CCAR2;ATF5;NSD3;HCFC1;SP3;ING2;REXO4;ACTN4;DDIT3;CREBBP;NFX1;RNF20;TP53;GON4L;LIMD1;SRSF10
prerank,phosphate ion transport (GO:0006817),-0.3293087110626655,-0.9497063748558098,0.4888888888888889,0.8228290591394751,1.0,4/16,21.50%,SLC25A3;SLC25A11;SLC37A1;SLC37A2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4686138599912817,0.9493518291704468,0.5393858477970628,1.0,1.0,3/15,11.60%,FAP;CLASP1;DPP4
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4124989740053065,0.9492107291823991,0.5479302832244008,1.0,1.0,10/45,15.34%,PML;CD44;SP100;IRF9;GBP2;JAK2;B2M;TRIM68;TRIM5;IRF8
prerank,pyroptosis (GO:0070269),-0.35755515392008624,-0.9489712468495254,0.5048076923076923,0.8232423159638832,1.0,2/15,2.92%,TREM2;CASP4
prerank,visual system development (GO:0150063),0.4188009413515537,0.9488025881140797,0.5550611790878754,1.0,1.0,8/37,16.38%,PBX4;PBX3;SALL2;HIPK2;ATF6;SMG9;PBX2;TGFB2
prerank,cytoplasmic translational initiation (GO:0002183),-0.32968200150993343,-0.9487685373244938,0.5168067226890757,0.8223162111220755,1.0,5/17,9.55%,EIF4A2;EIF2B3;MCTS1;EIF3M;RBM4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4922058363947136,0.9485846289059005,0.5389972144846796,1.0,1.0,5/11,19.38%,RUNX3;HMGB1;CBFB;RUNX1;LGALS9
prerank,tRNA aminoacylation (GO:0043039),-0.2582314259749537,-0.9481765988111708,0.4883720930232558,0.8223051157011182,1.0,12/37,12.87%,IARS2;CARS1;WARS2;SARS1;NARS1;AIMP1;FARSA;IARS1;HARS2;HARS1;QRSL1;TARS1
prerank,regulation of protein import into nucleus (GO:0042306),0.42616231833522605,0.9480374694124845,0.5620842572062085,1.0,1.0,10/36,20.21%,ECT2;FLNA;EFCAB7;PSEN1;BAG3;IPO5;TRIM28;HCLS1;SUFU;TPR
prerank,organelle fission (GO:0048285),-0.29584578704558967,-0.9474453653941405,0.5310734463276836,0.8225812498243867,1.0,9/24,16.72%,DNM2;DNM3;CORO1C;DNM1L;PEX19;MIEF1;PRKN;MFF;MTFR1L
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4160789931667477,0.9466085171763589,0.5498866213151927,1.0,1.0,14/37,20.04%,PML;RPS7;TAF1;DDRGK1;HIPK2;PARK7;CCAR2;UCHL5;TAF9;UBXN1;CAMLG;USP7;RPL5;RPL23
prerank,cellular response to unfolded protein (GO:0034620),-0.2919931886306859,-0.9464608099277876,0.4934210526315789,0.8236499985455391,1.0,8/26,19.83%,HSPD1;OPTN;ERN1;TM7SF3;PRKN;HSPA5;DAB2IP;HSPA13
prerank,regulation of T cell mediated immunity (GO:0002709),0.5080817556425464,0.9464306833385328,0.551048951048951,1.0,1.0,4/10,22.91%,CCR2;HMGB1;TRPM4;ZBTB1
prerank,eye development (GO:0001654),0.4079464225324553,0.9463241991952606,0.574761399787911,1.0,1.0,11/54,16.38%,PBX4;PBX3;SHROOM2;SALL2;HIPK2;ATF6;SMG9;NIPBL;SKI;PBX2;TGFB2
prerank,positive regulation of bone resorption (GO:0045780),0.4849164540428793,0.9457451893216993,0.543661971830986,1.0,1.0,5/11,21.45%,PRKCA;TNFRSF11A;ATP6AP1;PLEKHM1;SYK
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.38114977961938445,-0.9452578660046101,0.5302013422818792,0.8253028843810316,1.0,3/11,12.52%,RC3H2;ZC3H12A;SMAD7
prerank,cellular response to interleukin-1 (GO:0071347),0.3891058385587181,0.9452478981918988,0.6072507552870091,1.0,1.0,32/143,17.72%,ADAMTS7;CD47;PSMB7;PSMD11;FBXW11;TANK;RPS6KA5;PSMF1;NR1D1;IKBKG;PSMC1;GBP2;TAB1;UBE2V1;TAB3;EGR1;PSMC3;IL1R1;PSMA4;PLCB1;MYD88;PSMC4;PSMD13;PSME1;PSMB1;RC3H1;PSMD8;PSME4;CCL25;PSMD4;UBA52;MAP3K7
prerank,regulation of proteolysis (GO:0030162),0.40867338825183996,0.9451711787196553,0.5674814027630181,1.0,1.0,7/48,6.75%,PLK1;AURKAIP1;FBXW11;CYFIP2;CAV1;HDAC6;TRAF3
prerank,ERBB signaling pathway (GO:0038127),0.3958345938085863,0.9449013721452368,0.562564632885212,1.0,1.0,16/64,19.39%,MAPK1;ERBB3;RPS6KA5;TGFA;PRKCA;GRB2;SOS1;EGFR;PDPK1;DGKD;EGF;PLCG1;PIK3CA;IQGAP1;KIF16B;SOX9
prerank,positive regulation of interleukin-12 production (GO:0032735),0.43033840261359907,0.9448346278121224,0.5535097813578826,1.0,1.0,5/31,11.64%,IL16;HMGB1;MAPK14;PLCG2;PLCB1
prerank,iron ion transmembrane transport (GO:0034755),-0.3949298896069373,-0.9447144072856418,0.535593220338983,0.825302109066813,1.0,4/10,16.70%,ABCC5;SLC11A2;SLC39A14;SLC39A8
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.43189167248180915,0.9445303448577363,0.5636574074074074,1.0,1.0,5/27,13.93%,PISD;CHKB;PCYT2;NAPEPLD;SELENOI
prerank,cellular protein catabolic process (GO:0044257),0.405899940902234,0.9442864491641338,0.5616291532690246,1.0,1.0,16/59,21.10%,ADAMTS7;PISD;CHEK2;FAP;CLTC;LONP1;AP2B1;CTSK;CTSO;MYLIP;UBE2G1;MALT1;CASP8;BNIP3;RIPK1;MDM2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.43565141448599604,0.9440616979202433,0.538647342995169,1.0,1.0,5/25,10.22%,PML;PSMF1;RPS7;TAF1;HIPK2
prerank,positive regulation of protein deacetylation (GO:0090312),0.47489805159999665,0.9440228389804692,0.530638852672751,1.0,1.0,4/14,13.53%,DYRK1A;ZBTB7B;ING2;NIPBL
prerank,protein-containing complex disassembly (GO:0032984),0.40927524430996703,0.9439004181968906,0.5835117773019272,1.0,1.0,18/54,21.47%,AXIN1;STX17;CAV1;CSNK1A1;LIX1;UBQLN1;VPS16;MYC;VPS33B;GSK3B;RUBCNL;PYM1;CHMP3;EPG5;PPP1CA;CLN3;RPL23;VPS4A
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.40787272000757335,0.9438444652818458,0.5797254487856388,1.0,1.0,6/57,13.80%,IL12A;TNFRSF18;JAK2;PARP14;FLT3;PIBF1
prerank,insulin secretion (GO:0030073),-0.31952707839573946,-0.9436824961364767,0.5,0.8263149854206913,1.0,6/19,16.65%,RIMS2;SELENOT;CYB5R4;CAMK2G;PTPRN;RAB11FIP5
prerank,mitochondrial transcription (GO:0006390),0.49085386784112084,0.9434061703781002,0.5479651162790697,1.0,1.0,3/10,12.35%,TFB1M;TFB2M;TEFM
prerank,development of primary male sexual characteristics (GO:0046546),0.4210353541479328,0.9432505367049618,0.5756880733944955,1.0,1.0,6/34,19.39%,SRD5A2;CSDE1;FGF9;TGFB2;KITLG;SOX9
prerank,negative regulation of transmembrane transport (GO:0034763),-0.39255621942254204,-0.9431123176175832,0.4842105263157895,0.8262260562333869,1.0,4/10,18.07%,AKT2;CTTNBP2NL;IRS2;THBS1
prerank,cardiolipin metabolic process (GO:0032048),-0.3603441126921646,-0.9430834502310547,0.5231316725978647,0.8248936760680758,1.0,7/13,27.24%,SLC27A1;CRLS1;PLA2G6;PGS1;PLSCR3;TAMM41;PLA2G4A
prerank,protein homooligomerization (GO:0051260),0.3964365452392808,0.9430602877148747,0.6139112903225806,1.0,1.0,14/114,11.13%,ECT2;POLQ;TK1;BLM;SLC1A5;ATL2;CBR4;ACOT13;MPP2;TIFA;CARD9;SIGMAR1;KCNC2;B2M
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4704642687075744,0.943023988131071,0.5427069645203679,1.0,1.0,6/15,16.74%,MEFV;MYD88;TLR6;USP50;NLRC3;NLRP2B
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4685146350427983,0.9429626414929084,0.541005291005291,1.0,1.0,3/15,16.38%,BRCA1;FGFR1;TGFB2
prerank,neuron development (GO:0048666),0.3900270417499457,0.9426200073363284,0.608257804632427,1.0,1.0,30/141,17.18%,BLK;STMN1;PPP1R9B;SAMD14;RB1;PBX4;BLOC1S4;PBX3;FRY;MAP4;RUNX3;GBA2;HMGB1;TDP2;FRYL;ATP7A;TOR1A;VAPA;RAB35;ADCYAP1;CDK16;DTNBP1;GSK3B;PBX2;RUNX1;THOC2;LRP12;TGFB2;XBP1;LGI4
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4432292579672277,0.9425872240829013,0.5443037974683544,1.0,1.0,4/19,13.19%,TPST1;BPNT2;PAPSS2;SULT6B1
prerank,regulation of cellular component movement (GO:0051270),0.405202759619513,0.9423046145443023,0.5681818181818182,1.0,1.0,20/49,23.97%,ERBB3;RPS19;CDK6;SP100;HDAC6;PKN2;ZSWIM4;EGFR;ROCK2;ACTN4;DIAPH1;EGF;MEMO1;INPP5F;ROCK1;CADM4;ARHGAP18;ACTN1;ADAM17;DAPK3
prerank,cation transport (GO:0006812),0.3949853349256395,0.942233370271025,0.6218655967903711,1.0,1.0,13/167,9.21%,RHAG;SLC38A5;SLC12A3;SLC5A5;AQP1;SLC7A1;ANO10;KCNN4;TAF7;TRPM7;NEDD4L;KCNA1;KCNJ3
prerank,regulation of cellular component biogenesis (GO:0044087),0.42104576933269816,0.9420598742782372,0.563457330415755,1.0,1.0,9/39,13.59%,HJURP;EZR;NOTCH1;SPTY2D1;MSN;RDX;HCFC1;ROCK2;LATS1
prerank,regulation of phosphatase activity (GO:0010921),0.43874063728401214,0.9416791351712965,0.5618374558303887,1.0,1.0,6/24,17.46%,PTPA;PPP1R35;CDK5RAP3;PPP6R3;PPP1R2;HSP90B1
prerank,Ras protein signal transduction (GO:0007265),0.3928199913751293,0.9415182240138997,0.6182364729458918,1.0,1.0,41/137,19.84%,CCNA2;GPSM2;PHACTR4;RB1;GRAP2;TIAM1;NTN1;ARHGDIB;RASGRP1;CDKN2A;CRKL;ARHGEF3;COL1A2;MAPK14;DBNL;GRB2;SOS1;DNMT1;RIT2;PARK7;JUN;CDC42EP3;ROCK2;RAC2;BRK1;PLD1;TP53;RIPOR1;USP50;TRIM28;ARHGDIA;RAC1;KPNB1;RASSF1;SETDB1;CDC42EP1;CDKN1A;KSR1;SGSM3;ARHGAP1;G3BP1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.285447527469371,-0.9412624466629391,0.5071428571428571,0.8277924839928504,1.0,8/28,10.56%,ERO1A;CASP4;QRICH1;ERN1;ATF4;TMEM117;SELENOK;BAG6
prerank,phosphatidylserine metabolic process (GO:0006658),-0.27366504657966195,-0.9411941379097415,0.5467625899280576,0.8265681986417047,1.0,7/32,11.46%,PLA2G15;ABHD12;SLC27A1;MBOAT1;ABHD16A;OSBPL10;PTDSS2
prerank,regulation of chromatin binding (GO:0035561),0.49133332800847385,0.9405788118890654,0.5484330484330484,1.0,1.0,6/10,26.52%,DDX11;GMNN;WAPL;BTAF1;MED25;PARP9
prerank,erythrocyte differentiation (GO:0030218),0.4079057617064143,0.9405219070157912,0.575192096597146,1.0,1.0,12/44,18.12%,ALAS2;ZFPM1;RPS19;ABCB10;RPS14;JAK2;HIPK2;CDK5RAP3;CEBPG;JAK3;HCLS1;MED1
prerank,sterol biosynthetic process (GO:0016126),0.4173908620784329,0.9401452344221597,0.5719257540603249,1.0,1.0,7/33,15.83%,LBR;LSS;IDI1;PRKAG2;NSDHL;FDPS;DHCR7
prerank,cellular response to drug (GO:0035690),0.43314658026210195,0.9398261230464707,0.5588942307692307,1.0,1.0,10/25,25.10%,CRHBP;TFRC;DPEP1;MYC;TP53;SLAMF8;AIM2;PPM1E;RBM22;PDE4B
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4453888978776195,0.9396035183551134,0.5374841168996188,1.0,1.0,4/19,16.67%,PPP3CA;INPP5A;PPP3CC;NFATC3
prerank,cellular response to hormone stimulus (GO:0032870),0.39959269154207994,0.9394283134277529,0.6010416666666667,1.0,1.0,11/69,12.73%,SLC5A5;RAMP1;CRHBP;BRD8;CAV1;ZFP36L1;SOCS2;RDX;SLIT3;PELP1;STAT5B
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.3884210608382151,-0.9390856660895512,0.5415282392026578,0.828914763186734,1.0,4/10,20.12%,NSMAF;SIRT3;PLA2G6;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3884210608382151,-0.9390856660895512,0.5415282392026578,0.828914763186734,1.0,4/10,20.12%,NSMAF;SIRT3;PLA2G6;SPHK2
prerank,response to interleukin-1 (GO:0070555),0.3929576445967671,0.938788361931787,0.610134436401241,1.0,1.0,17/73,19.39%,ADAMTS7;CD47;TANK;NR1D1;GBP2;PRKCA;IL1R1;MYD88;RC3H1;TNFRSF11A;TAF9;CCL25;SNCA;HDAC4;TRAF6;LGALS9;SOX9
prerank,neuron projection development (GO:0031175),0.39030398332347127,0.9386313791792026,0.6392785571142284,1.0,1.0,25/168,14.77%,KIF20B;BLK;NTF4;STMN1;PPP1R9B;SAMD14;RB1;BLOC1S4;FRY;MAP4;HMGB1;DBNL;FRYL;MARK2;ATP7A;TOR1A;VASH2;PTEN;VAPA;RAB35;ADCYAP1;CDK16;DTNBP1;GSK3B;ADGRV1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4334704446573018,0.9383339647125603,0.5771495877502945,1.0,1.0,10/27,19.36%,MAP3K1;TAB1;TAB3;BTK;MYD88;TLR5;TLR6;UBA52;MAP3K7;TRAF6
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.47801151725335955,0.9378369646831609,0.553133514986376,1.0,1.0,7/13,26.60%,JAK2;CANX;IL27;TYK2;IL6ST;JAK1;OAS2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.38695739519374545,0.9377839887025292,0.6322645290581163,1.0,1.0,42/161,19.39%,JADE1;PSMB7;LRP4;PSMD11;AXIN1;PSMF1;STK11;CAV1;CCDC88C;CSNK1A1;PSMC1;FUZ;TLE4;CUL3;PFDN5;PSMC3;AMFR;RUVBL2;EMD;PSMA4;PSMC4;TMEM131L;PSMD13;PSME1;DDIT3;LATS1;PSMB1;GSK3B;STK4;LIMD1;PTPRU;PSMD8;TCF7L2;PSME4;PSMD4;LMBR1L;TMEM170B;AMER2;TLE3;HDAC1;STK3;SOX9
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4109160140964841,0.9376554881278701,0.5759219088937093,1.0,1.0,13/44,21.34%,AQP1;CD44;DPEP1;ARL6IP1;CDKN2D;XIAP;SH3RF1;YWHAE;SNCA;CAST;PAX2;USP47;RPS6KA3
prerank,protein localization to cell junction (GO:1902414),0.4423375170640403,0.9374378630090154,0.5672009864364982,1.0,1.0,6/22,16.20%,TJP3;ARHGEF18;BSN;HEG1;NECTIN1;PAK2
prerank,ATP transport (GO:0015867),0.4991197131581509,0.9373666601269606,0.5676429567642957,1.0,1.0,1/10,2.56%,CD47
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2695228542637465,-0.9372336841985431,0.5,0.8319586158708625,1.0,5/32,6.52%,HK2;ERBB4;BCL2L1;HSPD1;DNM1L
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2915546800026454,-0.9372232467579406,0.5664739884393064,0.8305872932182837,1.0,9/24,16.88%,APOE;PSMD14;CTSC;UBE3A;NUB1;PKD1;PINK1;EPHA4;GPX1
prerank,autophagosome assembly (GO:0000045),0.40848839766249445,0.9372067293197076,0.5757575757575758,1.0,1.0,12/52,16.90%,EMC6;ATG13;STX17;RAB1B;UBQLN1;TMEM41B;BECN1;AMBRA1;RAB43;TP53INP2;ATG101;ATG2B
prerank,activation of protein kinase B activity (GO:0032148),0.4244006169772934,0.9366283894008761,0.5693181818181818,1.0,1.0,6/29,14.11%,CCDC88A;PDPK1;TXN;PARK7;MLST8;PPIA
prerank,calcium ion import (GO:0070509),0.4314907301976056,0.9365412220858382,0.5576470588235294,1.0,1.0,5/28,14.01%,MS4A1;CACNA1I;MICU3;MICU1;MCU
prerank,sphingolipid catabolic process (GO:0030149),-0.3450002580603167,-0.9364150935084171,0.5040983606557377,0.8311547139075544,1.0,7/15,30.63%,ENPP2;PPT1;SMPDL3A;GLA;ACER2;SMPD2;SGPL1
prerank,positive regulation of insulin secretion (GO:0032024),0.41296009337178197,0.9360355208844945,0.5625,1.0,1.0,7/36,17.28%,BLK;BAIAP3;MCU;TCF7L2;CAPN10;TRPM4;ADCY8
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4347148967264839,0.9358888718781058,0.5546218487394958,1.0,1.0,10/26,22.05%,CDK5RAP2;CLASP1;SLAIN2;NUMA1;RAC1;DRG1;RPS3;MET;MAPT;DCTN1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.43778856454408555,0.9358323968608954,0.5564803804994055,1.0,1.0,5/23,11.28%,CCDC88A;TUBA1C;CCDC88C;TUBA1B;TUBB
prerank,lymphocyte mediated immunity (GO:0002449),0.4758406879862918,0.9356515945085764,0.5491251682368775,1.0,1.0,5/12,27.64%,KLRD1;BTN3A3;CD55;MYO1G;MSH2
prerank,heart development (GO:0007507),-0.2090929219447311,-0.9356137410145469,0.75,0.8316851836228968,1.0,39/150,18.84%,ACVR1;ADAP2;TGFBR1;ERBB4;CACNA1C;SGCD;SALL1;ZFPM2;BMPR2;NDUFV2;PCSK5;SGCZ;ECE1;NF1;PKD1;FBN1;GPC3;NDRG4;TCF25;MEF2A;FGF12;MICAL2;PTK2;KAT2A;VEGFA;ID2;PDLIM2;TGFBR3;SOX4;ACVRL1;TSC2;LDB3;CXADR;PDLIM4;TGFBR2;PDLIM1;ZDHHC16;CHD7;KDM6B
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.494553221230724,0.9349963866970308,0.5598227474150664,1.0,1.0,4/10,20.50%,PCGF5;MECP2;PCGF3;PRMT7
prerank,dendritic spine morphogenesis (GO:0060997),-0.345239345634725,-0.9346757311034742,0.5555555555555556,0.8325864386072083,1.0,5/15,18.87%,PAK3;WASL;SHANK3;DLG4;CDC42
prerank,cellular response to cytokine stimulus (GO:0071345),0.3858820950366497,0.934179846693101,0.707,1.0,1.0,81/416,17.75%,BIRC5;PRTN3;IL12A;ADAMTS7;BRCA1;IL2RG;LEF1;CD47;GBP4;IL2RA;GRAP2;OXSR1;FYN;BATF;TWIST1;CRHBP;RIPOR2;IL16;TANK;CCR2;NR1D1;CRKL;LAMA5;FOXO1;TRADD;COL1A2;PDE12;ZFP36L1;PDE2A;GBP2;UBE2K;CIB1;PRKACA;GRB2;JAK2;IL20RA;SOS1;PIM1;EGR1;ZEB1;SOCS2;IL22;RHOU;IL1R1;PTPN7;PTPN14;DHX9;IL10RA;FLT3;CRK;F3;STAT5B;NFE2L2;HNRNPU;STK39;MYC;BCL6;GSK3B;TP53;JUNB;PTPN5;RC3H1;IRF8;POU2F1;ZFP36L2;VIM;JAK3;MAOA;CCL25;PIK3CA;SIRT1;XBP1;HCLS1;HSP90B1;FN1;UBA52;LDLRAP1;CXCR4;EPRS1;F13A1;PTPN13
prerank,positive regulation of vasculature development (GO:1904018),0.3897279604102473,0.9341479058172565,0.6138211382113821,1.0,1.0,19/94,17.05%,CYP1B1;BRCA1;AQP1;TWIST1;EMC10;PGF;PRKCA;SMOC2;PDPK1;HIPK2;VASH2;PRKCB;F3;AGGF1;MYDGF;RUNX1;PLCG1;SIRT1;XBP1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3955126049267335,0.9337724796931467,0.5787321063394683,1.0,1.0,16/75,17.78%,MEN1;PLK1;RB1;CDKN2A;STK38;PKIG;HEG1;NR2F2;IPO7;PTEN;CDK5RAP3;LATS1;IPO5;TFAP4;SIRT1;HEXIM1
prerank,C4-dicarboxylate transport (GO:0015740),0.46699424829032243,0.9335058646913404,0.5626666666666666,1.0,1.0,3/14,14.50%,SLC25A12;SLC25A22;SLC25A13
prerank,positive regulation of hydrolase activity (GO:0051345),0.3891852754577382,0.9332157209298527,0.6475327291037261,1.0,1.0,13/137,9.31%,ECT2;PRTN3;HMGB2;EZH2;ARHGAP11A;NET1;RCN3;RASGRP1;EVI5;PIN1;SNX9;LARS1;CAV2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.40084428774514974,0.9331983932825823,0.5900621118012422,1.0,1.0,17/76,17.64%,GFI1;CYP1B1;DAP;CDKN2A;FAF1;TRAF3;LRRC14;ARRB2;CDK5RAP3;DDIT3;RBCK1;NLRC3;COMMD6;NLRP2B;SIRT1;TRIM37;USP7
prerank,female gamete generation (GO:0007292),0.4250354602233113,0.9330675832676852,0.5820045558086561,1.0,1.0,2/29,4.56%,TRIP13;MCM9
prerank,positive regulation of behavior (GO:0048520),0.5026787047947409,0.9330133448073934,0.5550906555090656,1.0,1.0,1/10,3.13%,AGRP
prerank,positive regulation of sodium ion transport (GO:0010765),-0.3634883283470031,-0.9327540164690256,0.5274725274725275,0.8359958545695468,1.0,3/12,9.12%,ANK3;CNKSR3;SCN1B
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2298477326471579,-0.9322277697304245,0.6666666666666666,0.8358876801773556,1.0,12/76,11.60%,CMKLR1;C3AR1;GNA15;HTR2C;P2RY12;CX3CR1;GRM5;GNA14;GPR157;C5AR1;TGM2;ADRA1A
prerank,response to chemokine (GO:1990868),0.47972429408995965,0.9322176117480785,0.55,1.0,1.0,2/13,4.11%,OXSR1;RIPOR2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4507364402161299,0.9317866155190415,0.55625,1.0,1.0,6/18,13.00%,EZR;FAF1;MSN;RDX;CDK5RAP3;NELL1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4143261802584858,0.9314158367283735,0.5797752808988764,1.0,1.0,4/40,11.15%,SLC38A5;SLC25A21;SLC16A1;SLC19A1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4777499621026482,0.9308819864858101,0.5687830687830688,1.0,1.0,4/13,14.45%,SNX33;GPD1L;ABCA7;TYROBP
prerank,regulation of inclusion body assembly (GO:0090083),-0.3664520947711499,-0.9308810383601683,0.5444839857651246,0.8377627367135002,1.0,2/11,5.08%,SNCAIP;DNAJB6
prerank,negative regulation of cilium assembly (GO:1902018),0.4744812952860039,0.9308632860820862,0.5681198910081744,1.0,1.0,2/12,4.87%,TCHP;MAP4
prerank,negative regulation of growth (GO:0045926),0.3867742200116115,0.9308160713292547,0.6364551863041289,1.0,1.0,23/121,16.94%,TMPRSS4;CDKN2C;JADE1;PPP1R9B;RB1;TCHP;PML;STK11;CDKN2A;NOTCH1;SMARCA4;CDKN2D;SMAD4;CCAR2;SLIT3;RACK1;ING5;SERTAD2;BCL6;TP53;NDRG3;TGFB2;SIRT1
prerank,regulation of protein localization to cell surface (GO:2000008),0.4207976481079724,0.9301972798862939,0.562429696287964,1.0,1.0,10/33,15.38%,SNX33;GPD1L;NEDD4L;ABCA2;ACTN2;ABCA7;TOR1A;RAB11B;TYROBP;EGF
prerank,negative regulation of interleukin-12 production (GO:0032695),0.4675419410416193,0.9296799605725343,0.5512321660181583,1.0,1.0,3/14,16.70%,MEFV;PIBF1;JAK3
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.4762175954659395,0.9296488028066917,0.5726256983240223,1.0,1.0,3/12,9.92%,IAPP;VBP1;PFDN5
prerank,cobalamin metabolic process (GO:0009235),-0.32349664480521234,-0.9293549854560939,0.49,0.8401556900955826,1.0,7/17,28.86%,MMADHC;ABCC1;MMUT;MTRR;TCN2;LMBRD1;CD320
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.28919803324909177,-0.9291665697005529,0.5757575757575758,0.8392576044699439,1.0,11/24,33.41%,TNFAIP3;KRIT1;ANGPT1;TNIP2;SERPINE1;MAPK7;NDNF;KDR;ICAM1;PAK4;TEK
prerank,tetrapyrrole metabolic process (GO:0033013),-0.31379020440378047,-0.9286645471265167,0.48148148148148145,0.8391323988039738,1.0,7/18,28.86%,MMADHC;ABCC1;MMUT;MTRR;TCN2;LMBRD1;CD320
prerank,electron transport chain (GO:0022900),-0.34350880305435294,-0.9285560072164083,0.5462555066079295,0.8379794269023094,1.0,7/15,26.64%,POR;SDHB;UQCRFS1;SDHA;PDIA5;PPARGC1A;NDOR1
prerank,cholesterol biosynthetic process (GO:0006695),0.4144455299498192,0.9275987214092452,0.5796252927400468,1.0,1.0,6/31,15.83%,LBR;LSS;IDI1;NSDHL;FDPS;DHCR7
prerank,regulation of steroid metabolic process (GO:0019218),0.4328110919114129,0.9275516962484452,0.5705812574139977,1.0,1.0,4/23,10.05%,PANK2;EPHX2;ABCA2;FMO5
prerank,myeloid cell differentiation (GO:0030099),0.40330053774920954,0.9275458717472198,0.5913621262458472,1.0,1.0,12/47,17.44%,ALAS2;ZFPM1;RPS19;PRKX;RPS14;ZBTB16;JAK2;HIPK2;KAT6A;RUNX1;JAK3;HCLS1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3929039440197677,0.9274049055218447,0.6264073694984647,1.0,1.0,14/95,10.93%,CHST3;FMOD;HSPG2;CSGALNACT2;HAS1;EXT1;ST3GAL1;DCN;SLC35D2;ST3GAL2;SLC10A7;B3GNT2;CHST12;OGN
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.38662102103396867,0.9272360682873133,0.6354481369587109,1.0,1.0,28/124,17.72%,LEF1;PSMB7;TIAM1;PPP3CA;PSMD11;PSMF1;CCDC88C;TNRC6C;PSMC1;TNRC6B;CLTC;GNAO1;PSMC3;PSMA4;PLCB1;PSMC4;ARRB2;AP2B1;PLCB3;PSMD13;PSME1;PSMB1;PSMD8;TCF7L2;PSME4;RAC1;PSMD4;MAP3K7
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.4225664180906473,0.927197370488532,0.5672514619883041,1.0,1.0,6/29,10.27%,KRI1;UTP3;RPS19;NOL10;RPS14;UTP6
prerank,regulation of response to biotic stimulus (GO:0002831),0.4224639695037674,0.9269824248463099,0.5758293838862559,1.0,1.0,12/28,19.40%,DHX58;PTPN22;FOXP1;TRAF3;BIRC2;XIAP;TRIM5;APPL1;FCGR2B;ERAP1;CD55;CASP8
prerank,positive regulation of axon extension (GO:0045773),-0.29208413218571544,-0.9267496126247667,0.5783783783783784,0.8408769820843806,1.0,9/22,20.29%,RUFY3;MACF1;MAP3K13;LIMK1;GOLGA4;VEGFA;L1CAM;TWF2;SEMA7A
prerank,positive regulation of viral process (GO:0048524),0.3952723862579647,0.9266804436150409,0.5881731784582893,1.0,1.0,18/60,18.59%,RSF1;POLR2I;POLR2A;PDE12;PKN2;RAD23A;NELFA;DHX9;CCNT1;PPIA;STAU1;NELFB;TARBP2;POLR2K;SRPK1;POLR2J;PPIE;PPIH
prerank,sodium-independent organic anion transport (GO:0043252),0.48734982502752794,0.9266251122902462,0.577683615819209,1.0,1.0,6/10,25.16%,SLCO4C1;SLCO4A1;SLCO2A1;SLCO3A1;SLCO5A1;SLCO1C1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4072283977522358,0.9249866515815073,0.5678733031674208,1.0,1.0,5/34,9.44%,E2F1;ZFPM1;FOXO1;LRP3;ASXL1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.3836361039149323,0.924655341219936,0.6281661600810537,1.0,1.0,25/94,17.72%,PSMB7;PSMD11;FBXW11;RPS6KA5;PSMF1;IKBKG;PSMC1;TAB1;UBE2V1;TAB3;EGR1;PSMC3;IL1R1;PSMA4;PLCB1;MYD88;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4;UBA52;MAP3K7
prerank,heterochromatin organization (GO:0070828),0.4673377206927563,0.9242513651844383,0.5837837837837838,1.0,1.0,6/14,23.92%,SMCHD1;SETDB2;SIRT1;SETDB1;SETD7;HMGA2
prerank,mitochondrial transport (GO:0006839),0.39867655275207387,0.923926876995665,0.5667022411953042,1.0,1.0,13/53,14.50%,PMAIP1;ABCB10;TOMM34;TMEM14C;SLC25A16;TSPO;PITRM1;TIMM9;GDAP1;FIS1;TOMM70;TIMM23;SLC25A13
prerank,renal filtration (GO:0097205),0.4944157122021844,0.9232559657417689,0.5760869565217391,1.0,1.0,2/10,3.96%,TBC1D8B;SULF2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3990472857289466,0.9231455932658285,0.5882352941176471,1.0,1.0,6/51,10.57%,IL12A;MAPK1;PGF;CCR2;HMGB1;CCR6
prerank,regulation of primary metabolic process (GO:0080090),0.38022626788646025,0.9223786337066534,0.6509528585757272,1.0,1.0,39/126,20.75%,PSMB7;PSMD11;PSMF1;AZIN1;LSS;NR1D1;EDF1;PSMC1;SIN3B;IDI1;PSMC3;NFYC;ABCA7;PSMA4;FASN;ADIPOR1;PSMC4;OAZ1;ROCK2;PSMD13;BBS4;PSME1;HELZ2;CREBBP;PSMB1;RUBCNL;FDPS;PSMD8;DHCR7;SIN3A;PSME4;PSMD4;MED1;CERS2;TBL1XR1;SREBF2;NCOA6;NCOA2;PPARD
prerank,COPII vesicle coating (GO:0048208),0.39850812072440034,0.9222231026792648,0.608421052631579,1.0,1.0,21/61,19.38%,F5;RAB1B;STX5;ANKRD28;PEF1;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.39850812072440034,0.9222231026792648,0.608421052631579,1.0,1.0,21/61,19.38%,F5;RAB1B;STX5;ANKRD28;PEF1;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3
prerank,vesicle coating (GO:0006901),0.39850812072440034,0.9222231026792648,0.608421052631579,1.0,1.0,21/61,19.38%,F5;RAB1B;STX5;ANKRD28;PEF1;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3889614312111001,0.9221251103469894,0.6153050672182007,1.0,1.0,19/67,16.96%,PSMB7;PSMD11;PSMF1;IKBKG;PSMC1;TAP1;ITGAV;PSMC3;PSMA4;B2M;PSMC4;PSMD13;PSME1;PSMB1;CYBB;PSMD8;PSME4;PSMD4;CYBA
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4217724884744549,0.9218460808671248,0.5845799769850403,1.0,1.0,7/30,16.74%,NET1;LPAR4;ARHGEF3;F2R;LPAR1;GPR35;RAC1
prerank,catecholamine metabolic process (GO:0006584),-0.3310762136560452,-0.9214839112682381,0.5688888888888889,0.8522172870215866,1.0,3/14,12.28%,SNCAIP;RNF180;PRKN
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3765803024780086,-0.9209392044367087,0.5290322580645161,0.8520471290939506,1.0,3/10,10.19%,DIP2B;PRKAA2;FLCN
prerank,regulation of glucose metabolic process (GO:0010906),0.4123688847779459,0.9208683004585182,0.5891647855530474,1.0,1.0,9/34,17.64%,PMAIP1;ADIPOR1;SIRT7;SDHAF3;IRS1;RUBCNL;FOXK2;SIRT1;USP7
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.45535175538837114,0.92076258048204,0.5570469798657718,1.0,1.0,3/15,6.96%,REEP4;ATL2;ARL6IP1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2400428210139016,-0.9206237837307716,0.640625,0.8514134457951869,1.0,19/52,18.06%,SRPRA;ERN1;WIPI1;ADD1;ZBTB17;HDGF;GSK3A;HYOU1;GOSR2;TATDN2;EXTL3;TSPYL2;SRPRB;PARP16;SERP1;EXTL2;LMNA;HSPA5;WFS1
prerank,early endosome to late endosome transport (GO:0045022),-0.29914909075787766,-0.9205342911536597,0.5459183673469388,0.8502351524895584,1.0,7/20,20.29%,WDR91;EEA1;ANKRD27;SNX16;HOOK2;HOOK3;PTPN23
prerank,fatty acid elongation (GO:0030497),0.4707649191384518,0.9203016858084836,0.5643835616438356,1.0,1.0,4/13,16.26%,HACD4;ABCD1;ELOVL5;ELOVL4
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.28309671342467296,-0.9202938063715714,0.5434782608695652,0.8494889978197278,1.0,11/26,18.87%,FHOD1;ASAP3;PFN1;SLC9A1;LIMK1;TSC1;PRKN;PFN2;SHANK3;PLEK;CDC42
prerank,membrane assembly (GO:0071709),-0.27249906861680245,-0.9197514710893268,0.5922330097087378,0.8494074526573,1.0,8/34,7.67%,ANK3;GAK;PTPRD;UBXN2A;STX4;SPAST;UBXN2B;STX2
prerank,sterol metabolic process (GO:0016125),0.3922755400392678,0.9195111668119832,0.6085106382978723,1.0,1.0,14/60,21.22%,LBR;CYP1B1;OSBPL5;GBA2;CYP27A1;CYP46A1;PRKAG2;NSDHL;DHCR7;LDLRAP1;FDXR;PPARD;OSBPL1A;SCAP
prerank,regulation of cilium movement (GO:0003352),0.4846524696748474,0.9189612921736516,0.5552282768777614,1.0,1.0,1/10,3.22%,CFAP206
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4138987206842885,0.9188473879514689,0.5872291904218928,1.0,1.0,12/38,19.88%,ATG13;SAE1;UBL5;ABLIM3;RHOU;BAP1;RAC2;ARIH2;LMAN1;LRRK2;SREBF2;HPS4
prerank,positive regulation of cartilage development (GO:0061036),0.4458755810680911,0.9182713809045571,0.5667963683527886,1.0,1.0,3/17,11.80%,SOX6;ZBTB16;TAPT1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.2567390039104037,-0.9182550237927853,0.624,0.8517413103980183,1.0,9/35,20.99%,ADCY7;ADCY2;CAP2;LGR5;ADORA3;ADRB1;ADRB2;ADCY5;EDNRA
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.36645430349051805,-0.917886869007342,0.5537974683544303,0.8511814452596015,1.0,3/10,12.80%,IMPACT;ENG;MVP
prerank,negative regulation of cell population proliferation (GO:0008285),0.3780787670172856,0.9171176704874738,0.749,1.0,1.0,60/351,16.71%,E2F7;CDKN3;IL12A;MEN1;CYP1B1;CDKN2C;HMGA1;ITGA1;E2F1;GLMN;FAP;S100A11;PPM1D;PML;ARID2;CTCF;STK11;CDK6;CDKN2A;PTHLH;MDM4;RBBP4;RUNX3;TFDP1;KLF10;NOTCH1;PIM2;FUZ;CIB1;JAK2;STRN;CDKN2D;EMD;OGN;B2M;PTPN14;MTSS1;PEX2;ATF5;KAT2B;PTEN;BAP1;PDS5B;NELL1;ING5;SLURP1;TMEM115;SKI;MYC;E2F3;ADAMTS1;TP53;F2R;PTPRU;HGS;MAP2K1;TFAP4;TGFB2;NLRC3;VHL
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4644971952929081,0.9169886382501801,0.5966277561608301,1.0,1.0,3/15,12.61%,IL16;PGF;F3
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2822451431463727,-0.9168939752246108,0.6078431372549019,0.8522890704952023,1.0,7/26,15.09%,GAK;SNAP91;SIGLEC1;CLTB;AP2S1;AP2M1;PIP5K1C
prerank,lipid biosynthetic process (GO:0008610),0.3897453064769439,0.9167509282080836,0.6300518134715026,1.0,1.0,14/77,18.63%,HSD17B3;SRD5A2;LSS;AGPAT4;PCYT2;CBR4;AGPAT3;ACSL5;PDSS2;NDUFAB1;ELOVL4;XBP1;AGPS;FDXR
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.409970962903382,0.9164843628873607,0.5975336322869955,1.0,1.0,1/34,0.38%,CD19
prerank,response to glucocorticoid (GO:0051384),0.4228175879915613,0.916379563768064,0.5969267139479906,1.0,1.0,5/26,15.99%,ZFP36L1;SLIT3;HNRNPU;PDCD7;ZFP36L2
prerank,microvillus organization (GO:0032528),0.46951638041805355,0.9162909798391726,0.5822102425876011,1.0,1.0,3/13,7.33%,STK26;EZR;FXYD5
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3800844168688952,0.9157142918378062,0.6659959758551308,1.0,1.0,40/138,22.88%,E2F2;NR4A2;TEAD4;GTF2E1;POLR2I;POLR2A;HDAC10;NR1D1;TAF1;TAF7;NOTCH1;TAF15;GTF2A1;ERCC3;NR2C2;TAF6;KAT2B;TAF2;CREBBP;NRBP1;E2F3;TAF9;POLR2K;POLR2J;RXRB;RARG;MED1;HDAC1;TBL1XR1;GTF2A2;TAF3;NRBF2;RBPJ;PPARD;TAF11;NR1H3;MED23;POLR2B;HDAC9;RXRG
prerank,regulation of cellular protein localization (GO:1903827),-0.24695293377046204,-0.9154091703432374,0.625,0.8545317279839203,1.0,12/45,16.65%,KDM1A;CSNK1E;GBF1;HSP90AA1;CTNNB1;PRKAA2;MAP1A;DVL3;GPC3;PPM1F;GPC5;RAB11FIP5
prerank,protein localization to cell-cell junction (GO:0150105),0.4388770745968499,0.9153992657374166,0.564875491480996,1.0,1.0,2/15,4.46%,TJP3;ARHGEF18
prerank,positive regulation of coagulation (GO:0050820),-0.3783456402885673,-0.9147655773578593,0.5642633228840125,0.8532771303478444,1.0,4/10,18.07%,ST3GAL4;SERPINE1;HPSE;THBS1
prerank,positive regulation of hemostasis (GO:1900048),-0.3783456402885673,-0.9147655773578593,0.5642633228840125,0.8532771303478444,1.0,4/10,18.07%,ST3GAL4;SERPINE1;HPSE;THBS1
prerank,positive regulation of hormone secretion (GO:0046887),0.4456679239043489,0.9143376190350798,0.5883870967741935,1.0,1.0,1/17,1.86%,TFR2
prerank,regulation of heart contraction (GO:0008016),-0.21066850578264468,-0.9139410285950395,0.7391304347826086,0.8538669119312529,1.0,24/90,20.72%,ITPR2;ASPH;ANK2;SLC8A3;ATP2B2;ATP1A1;TRPC1;CELF2;SRI;ATP1B2;RYR2;GSK3A;ATP1B1;SMAD7;ASB3;ADORA3;CALM1;ATP2B3;SLC8A1;ITPR3;ATP1A2;P2RX4;STIM1;AGT
prerank,maturation of 5.8S rRNA (GO:0000460),0.4451066042952518,0.9136598561004149,0.5803108808290155,1.0,1.0,8/17,23.00%,EXOSC10;URB1;PRKDC;NSA2;PES1;MPHOSPH6;EIF6;RPF1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.28939175443057913,-0.9135714931364081,0.5619047619047619,0.8533982738906379,1.0,6/22,16.00%,PTPRK;PRKD1;SRSF6;EPB41L4B;ZFP36;MDK
prerank,retinoid metabolic process (GO:0001523),0.38806917395197715,0.9131900658652964,0.6414708886618999,1.0,1.0,3/71,3.42%,LRAT;CYP1B1;HSPG2
prerank,regulation of sensory perception of pain (GO:0051930),-0.37109346323669945,-0.9130108768731379,0.5614035087719298,0.8533742641417227,1.0,4/11,22.01%,MGLL;ZFHX2;CCL3;TMEM100
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4330022894870903,0.9129751937043633,0.5845588235294118,1.0,1.0,4/20,8.28%,CDK6;ZFP36L1;CIB1;ZBTB16
prerank,negative regulation of ossification (GO:0030279),0.4250791779149876,0.9129445702368214,0.5878136200716846,1.0,1.0,6/23,20.56%,LRP4;NOTCH1;CHSY1;TRPM4;SOX9;RBPJ
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4795771864200707,0.9126141740691847,0.5884016973125884,1.0,1.0,4/11,14.97%,MBTPS2;ATF6;DDIT3;TP53
prerank,positive regulation of glucose import (GO:0046326),-0.29804137235922534,-0.9121156574998497,0.5902439024390244,0.8542520038799253,1.0,6/21,14.52%,PRKCI;PIK3R1;IGF1;AKT2;IRS2;RHOQ
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4514275957102535,0.9119645778344673,0.5680317040951123,1.0,1.0,5/15,15.40%,IL17RA;CARD9;MYD88;TLR6;APPL1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.48319542948748323,0.911815725292256,0.5874125874125874,1.0,1.0,2/10,9.85%,RB1;EGR1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.3180998835221589,-0.9116322421453672,0.5493562231759657,0.8540490627913705,1.0,7/17,35.96%,ADRA1A;ADRA1B;ADRB1;ADRB2;ADRA2A;DRD2;GPR101
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.3292792160315323,-0.9114459788347923,0.5551470588235294,0.8531325206510278,1.0,3/14,12.16%,ANK2;ATP1B2;ATP1B1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3869480064021014,0.9114389419792884,0.6097560975609756,1.0,1.0,18/59,21.11%,TANK;IKBKG;TRADD;BIRC2;TAB1;ERC1;TAB3;TIFA;ROCK2;RBCK1;NLRC3;UBA52;MAP3K7;NKIRAS1;TRAF6;RIPK1;ROCK1;IKBKB
prerank,'de novo' posttranslational protein folding (GO:0051084),0.4125492866187924,0.9110172607699695,0.5891203703703703,1.0,1.0,15/30,26.80%,CHCHD4;CCT2;DNAJC18;ENTPD5;DNAJC7;BAG1;SDF2;DNAJB4;DNAJB1;DNAJB12;DNAJB14;HSPE1;HSPA9;UGGT1;ST13
prerank,fatty acid transport (GO:0015908),-0.3110298583963711,-0.9107583032073435,0.5844748858447488,0.8534082101793482,1.0,3/17,5.48%,APOE;SLC27A1;GOT2
prerank,tRNA wobble base modification (GO:0002097),-0.33919495742674477,-0.9102576085491535,0.6044776119402985,0.8532386343582434,1.0,10/14,39.31%,MTO1;ALKBH1;DPH3;GTPBP3;TRMT9B;CTU2;CTU1;MOCS3;ADAT2;KTI12
prerank,regulation of cholesterol metabolic process (GO:0090181),0.43544689885363763,0.9099118019551746,0.5895610913404508,1.0,1.0,10/20,23.22%,MBTPS2;EPHX2;SEC14L2;ABCA2;FMO5;KPNB1;LDLRAP1;SREBF2;TTC39B;LPCAT3
prerank,negative regulation of T cell proliferation (GO:0042130),0.41736161747965983,0.9096444225075607,0.5910693301997649,1.0,1.0,2/28,3.02%,SPN;GLMN
prerank,regulation of neuron apoptotic process (GO:0043523),0.3867141265663422,0.9096096404398223,0.6666666666666666,1.0,1.0,4/96,3.65%,KIF14;NTF4;ERBB3;LIG4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.44107540369510906,0.9095003259148875,0.5717948717948718,1.0,1.0,5/18,17.59%,PMAIP1;BOK;DDIT3;XBP1;FCGR2B
prerank,regulation of myoblast differentiation (GO:0045661),0.4118328023488816,0.9094896816263622,0.5955710955710956,1.0,1.0,7/32,19.39%,RIPOR2;ZFP36L1;NOTCH1;MAPK14;PLCB1;FLOT2;SOX9
prerank,embryonic digit morphogenesis (GO:0042733),0.436278838403483,0.9088847400464668,0.571608040201005,1.0,1.0,7/18,23.10%,TWIST1;WDPCP;CREBBP;MAP3K20;HDAC1;OSR1;INTU
prerank,regulation of MAPK cascade (GO:0043408),0.3763082987786033,0.9086245014167046,0.6606243705941591,1.0,1.0,34/157,18.06%,FAM83D;ARHGEF5;IAPP;MAPK1;CCN1;CD74;ULK4;CAV1;RASGRP1;HMGB1;PLCG2;EGFR;CAV2;RIT2;ABCA7;FLT3;FAS;ROCK2;MYDGF;TRIM5;DAG1;STK4;EGF;F2R;LPAR1;PAK5;MAP2K1;FGFR1;STYX;PAK2;CD24;FN1;IQGAP1;TAOK1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.46621887330723566,0.908362950295555,0.5759577278731837,1.0,1.0,5/12,22.89%,SORBS1;ZBTB7B;IRS1;SIRT1;PTPN11
prerank,negative regulation of cellular component organization (GO:0051129),0.38200226435342155,0.9083264937026775,0.6333676622039135,1.0,1.0,17/74,17.62%,IAPP;FAP;SNX33;LCMT1;TERF2;HDAC6;MTMR2;RTEL1;EPHA3;RIOK3;ABCA7;RDX;TFIP11;GSK3B;AIDA;DNAJB1;MCTP1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.44066762931582404,0.9082700451401193,0.588,1.0,1.0,3/16,6.71%,PIGH;PIGF;PIGA
prerank,pulmonary valve morphogenesis (GO:0003184),0.44313930180959116,0.907899611817988,0.5881612090680101,1.0,1.0,2/17,7.15%,HEY2;NOTCH1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3766427057470834,0.907572500022587,0.7207207207207207,1.0,1.0,66/234,21.11%,NKX6-1;ARHGEF5;IL18RAP;PIDD1;S100A9;RPS6KA5;TFRC;CAV1;TAF1;MBTPS2;IKBKG;S100A8;TRADD;TCF3;TFDP1;NFAM1;DDRGK1;CIB1;TAB1;SMARCA4;UBE2V1;PLCG2;ERC1;MTPN;TAB3;ZBTB7A;HIPK2;CARD9;PARK7;ARID5B;BTK;RELN;DHX9;PRKCB;MYD88;PTEN;TRIM68;FLOT1;BEX1;DDIT3;CEBPG;CFLAR;PPIA;TLR6;TRIM5;RBCK1;TNFRSF11A;ADCY8;HCLS1;TRIM37;UBA52;MAP3K7;HDAC4;FLOT2;MALT1;RPS3;STK3;TRAF6;LGALS9;PRKD2;ALK;UBE2N;AIM2;SLCO3A1;RIPK1;IKBKB
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.33174115983332403,-0.9075337305222804,0.5833333333333334,0.8583174935403268,1.0,4/15,14.75%,DAGLB;GRM5;GRM8;DAGLA
prerank,regulation of interleukin-13 production (GO:0032656),0.4634543648150014,0.9073608503923523,0.6008119079837618,1.0,1.0,1/13,2.33%,LEF1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.3737256363519385,-0.9073124482635818,0.5645756457564576,0.8574285780564942,1.0,6/10,21.75%,NAGK;GNE;NPL;GNPDA1;GNPDA2;AMDHD2
prerank,regulation of adaptive immune response (GO:0002819),-0.30672570449236536,-0.9070830353560005,0.5477386934673367,0.8566114294151538,1.0,4/18,7.88%,ADCY7;PYCARD;TRIM27;IRF1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3196887568764245,-0.9070365680548301,0.5627906976744186,0.8553766391934157,1.0,7/16,22.95%,GPR137C;RRAGD;FLCN;LAMTOR5;PIH1D1;SIK3;CLEC16A
prerank,cellular response to leucine starvation (GO:1990253),-0.3788074616449767,-0.9069125126725895,0.568561872909699,0.8543401093800356,1.0,5/10,21.53%,IMPACT;RRAGD;SESN3;GCN1;SESN2
prerank,cellular protein metabolic process (GO:0044267),0.37395982641134684,0.9067855997762022,0.772,1.0,1.0,107/396,22.29%,MRPL36;F5;MEN1;NAPSA;CHEK2;RPL7;RPL18A;RPS20;MRPL18;PIGH;CCN1;RPL36;RPL14;L2HGDH;UBE2I;RPS19;RPS7;RPS4X;MSRA;RPS18;MRPL10;LCMT1;RPL23A;UBL5;ST3GAL1;RPL28;SPCS1;SLC35A1;MRPL37;RPS14;RPL41;STK38;LAMC1;LAMB2;RPLP2;ST8SIA4;TMEM208;RPS27;SEPHS1;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;LTA4H;RPLP0;RPS11;MRPS17;IGF2BP3;RPL27A;PHKA2;BAP1;FBXO11;RPS9;RPS15A;CHRM3;PRKDC;MRPL24;PSEN1;RPL12;PRKCSH;PRSS23;NTAQ1;DARS1;USP25;DUSP12;RPL3;SCG3;ADPRH;HSP90B1;FN1;GSPT1;UBA52;SPPL3;UBE2M;RPL18;SDC2;UBE2G1;ADAM10;CKAP4;FDXR;YARS2;ICMT;RPL5;RPS6;RPS17;RPS3;RPL21;AGO2;SRBD1;RPL17;RPL23;ARAF;SPCS3;RIPK1;DNAJC3;RSL24D1;RPL24;RPL8;RPL27;PADI4;RPL13A;IGFBP7;MRPS12;RPS12;NEDD8
prerank,response to iron ion (GO:0010039),0.4711672609310763,0.906766056075318,0.5906666666666667,1.0,1.0,3/12,17.91%,TFR2;B2M;SNCA
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.39892507355962603,0.9067111699268283,0.6182618261826183,1.0,1.0,8/46,15.90%,IL12A;CCN4;FOXP1;XRCC6;OGN;PRKDC;ELN;TCF7L2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.40403478276724636,0.9066416320426788,0.6173245614035088,1.0,1.0,5/37,9.29%,BRCA1;RIN3;MTMR2;ITGAV;ABCA2
prerank,sensory perception of sound (GO:0007605),0.3764303006971541,0.9064264972463534,0.6215666327568667,1.0,1.0,11/88,17.34%,BIRC5;RIPOR2;CLIC5;TIMM9;NIPBL;ADGRV1;EYA1;CCDC50;LRTOMT;HOMER2;TSPEAR
prerank,spliceosomal complex assembly (GO:0000245),0.39573511338438905,0.9062366121935211,0.6153005464480874,1.0,1.0,16/46,21.51%,PRPF19;SCAF11;SETX;CRNKL1;SNRNP200;TXNL4A;NCBP1;LUC7L2;SRSF10;SRPK1;DDX39B;SNRPG;GCFC2;SF3A2;KHDC4;CELF1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.47846293876500323,0.9062342280322296,0.5887445887445888,1.0,1.0,1/11,1.29%,CD177
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.47796478423155747,0.9059897259909429,0.5852601156069365,1.0,1.0,3/10,15.73%,CLTC;AP2B1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.47796478423155747,0.9059897259909429,0.5852601156069365,1.0,1.0,3/10,15.73%,CLTC;AP2B1;MYLIP
prerank,regulation of keratinocyte differentiation (GO:0045616),0.41819030013103337,0.9059153625479807,0.5929095354523227,1.0,1.0,9/24,23.17%,ZFP36L1;CBFB;CTSK;ROCK2;NUMA1;RUNX1;MED1;ROCK1;NCOA3
prerank,vesicle organization (GO:0016050),0.3936517499675422,0.9058591406093972,0.6293103448275862,1.0,1.0,13/46,19.43%,RNF26;SNX33;CAV1;WASHC4;RAB22A;CAV2;DNAJC13;PI4K2B;VPS33B;USP50;CHMP2B;SAR1B;AKTIP
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4244346311812472,0.9057536941926759,0.6120996441281139,1.0,1.0,10/27,21.66%,CCDC88A;ULK4;DISC1;NTNG2;PTEN;PSEN1;GSK3B;FCGR2B;MARK1;BRSK1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.38217427721122804,0.9055969220302819,0.6358974358974359,1.0,1.0,24/78,21.72%,CDC20;PLK1;CAV1;TAF1;CSNK1A1;DDRGK1;UBQLN1;SUMO1;RAD23A;FZR1;NFE2L2;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;RNF19A;LRRK2;KEAP1;MDM2;CBFA2T3;UBQLN2;HECTD1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.43228771369352675,0.9055914730165167,0.5800256081946222,1.0,1.0,8/18,23.12%,HMGB1;AKT3;PDPK1;FGFR1;PLCG1;APLN;ITGA4;ADAM17
prerank,positive regulation of filopodium assembly (GO:0051491),-0.290829299021696,-0.9051585886678802,0.5849056603773585,0.8568686545029832,1.0,9/24,18.87%,TENM2;ARAP1;RALA;PIK3R1;WASL;TENM1;RHOQ;AGRN;CDC42
prerank,cellular response to amino acid stimulus (GO:0071230),0.4032386440530587,0.9049327237560851,0.5972222222222222,1.0,1.0,11/33,20.73%,FYN;LARS1;CPEB3;UBR2;LAMTOR4;LAMTOR3;IPO5;KLHL22;XBP1;GLRA1;RRAGB
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.46801926940593375,0.9049324040627927,0.5720461095100865,1.0,1.0,4/11,16.71%,CAV1;ADIPOR1;HGS;VHL
prerank,glycogen metabolic process (GO:0005977),0.41284659912458765,0.9046880513914376,0.5928074245939675,1.0,1.0,6/27,15.37%,PGM2;NR1D1;PHKA2;PRKAG2;GSK3B;GBE1
prerank,sodium ion transmembrane transport (GO:0035725),0.38623176877688375,0.9040738585686624,0.6467611336032388,1.0,1.0,6/84,6.86%,SLC6A12;SLC12A3;SLC6A2;SLC6A5;HCN3;SLC12A1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4339753770825135,0.9040174011079891,0.5880923450789793,1.0,1.0,4/19,12.32%,POLD1;POLD2;TYMS;POLD3
prerank,cAMP biosynthetic process (GO:0006171),-0.38163375568877433,-0.9035648012466624,0.5953947368421053,0.8593467277987741,1.0,2/10,4.86%,ADCY7;ADCY2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.37643430820681884,0.9035070262100288,0.6401630988786952,1.0,1.0,11/85,17.34%,BIRC5;RIPOR2;CLIC5;TIMM9;NIPBL;ADGRV1;EYA1;CCDC50;LRTOMT;HOMER2;TSPEAR
prerank,regulation of viral release from host cell (GO:1902186),0.42759023201907154,0.9032287253348599,0.6012121212121212,1.0,1.0,13/21,29.38%,PML;TRIM11;TRIM5;TRIM28;CHMP3;CHMP2B;VPS4A;TRIM35;TSG101;TRIM62;TRIM21;VPS37B;TRIM13
prerank,mammary gland development (GO:0030879),0.4239204314702642,0.9031825347186154,0.5982694684796045,1.0,1.0,5/21,17.20%,CAV1;ARHGAP35;JAK2;ZBTB7B;APLN
prerank,microvillus assembly (GO:0030033),0.45856207848191843,0.902836930335673,0.5962815405046481,1.0,1.0,3/14,7.33%,STK26;EZR;FXYD5
prerank,histone H3 deacetylation (GO:0070932),0.4354849104102304,0.9028340466729081,0.5973856209150327,1.0,1.0,8/15,22.56%,ELK4;SIRT7;SIRT1;HDAC4;HDAC1;HDAC8;SMARCAD1;HDAC9
prerank,regulation of kinase activity (GO:0043549),0.3793584177183903,0.9026969560740208,0.6485655737704918,1.0,1.0,26/89,22.74%,ECT2;RB1;ERBB3;LMO4;CD74;RBL1;SMG8;EGFR;EPHA3;FLT3;LMTK2;HNRNPU;RAD50;SLAMF8;FGFR1;ALK;EPHA7;DSTYK;MET;MAPT;EPHA10;FGR;NTRK3;DDR2;CDKN1B;FGFR2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.29885013868706833,-0.9026056795116573,0.589041095890411,0.8601938786257451,1.0,11/19,29.01%,ITGAM;TLR4;NMI;LY96;TIRAP;ITGB2;TICAM2;PIK3AP1;SCIMP;CD14;TNIP3
prerank,cellular response to gamma radiation (GO:0071480),0.44380492421149553,0.9023846418136497,0.5997425997425997,1.0,1.0,8/17,24.23%,ATM;XRCC6;TP53;MAP3K20;TMEM109;WRN;MDM2;TLK2
prerank,ncRNA processing (GO:0034470),0.37101018332388586,0.9023557775438118,0.722,1.0,1.0,67/200,23.10%,RPL7;RPL18A;UTP3;RPL36;RPL14;INTS4;RPS19;DDX49;RPS7;INTS9;HELQ;EXOSC8;RPL23A;RPL28;EXOSC10;HNRNPA2B1;RPS14;RPL41;NOL11;RPLP2;RPS27;EMG1;SRRT;UTP6;INTS1;RPLP0;TUT4;FBL;RPL27A;PELP1;WDR74;RPS9;NOL8;RPL12;NOP58;TARBP2;POP4;TUT1;RPL3;UBA52;RPL18;DKC1;PES1;MPHOSPH6;RPL5;RPS6;RPS17;DDX54;ZCCHC8;RPL21;AGO2;RPL17;RPL23;INTS12;SMAD2;RPL24;RPL8;RPL27;RPL13A;AGO1;DIS3;RPP30;RPL15;RPL10;INTS11;RPF1;NOP14
prerank,protein lipidation (GO:0006497),-0.22842109152144097,-0.9019043247876904,0.6938775510204082,0.860593180203873,1.0,26/59,28.87%,GLUL;ZDHHC17;ATG10;ZDHHC13;ZDHHC5;PIGB;PIGN;WIPI1;ZDHHC8;SELENOK;PIGP;MPPE1;GPLD1;ZDHHC16;ZDHHC20;PIGC;ZDHHC15;PIGG;WDR45;PGAP4;ZDHHC3;ZDHHC12;DPM3;PIGQ;PIGZ;HHAT
prerank,regulation of microglial cell activation (GO:1903978),-0.32994303960123217,-0.9006468974657442,0.5591836734693878,0.862016646304215,1.0,5/15,19.64%,TREM2;GRN;TTBK1;CST7;CCL3
prerank,alpha-amino acid catabolic process (GO:1901606),0.4081295429571659,0.9004952600535219,0.6214953271028038,1.0,1.0,4/29,11.99%,HAAO;KMO;PRODH;FAH
prerank,leukotriene metabolic process (GO:0006691),0.4333515330908729,0.9003973278565245,0.587641866330391,1.0,1.0,4/19,13.05%,DPEP2;DPEP1;LTA4H;ABCC10
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.34908788854681205,-0.9002404760440352,0.6007462686567164,0.8615852940531794,1.0,8/13,26.26%,UBAC2;OS9;EDEM2;BCAP31;ERLEC1;UBE2G2;BRSK2;EDEM1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3831529512655678,0.9000668728888654,0.6343975283213182,1.0,1.0,11/64,15.05%,CYP1B1;ABCD1;EPHX2;HPGD;ACOT2;SLC27A2;LTA4H;CPT1A;ACSL5;ELOVL5;CPT2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3837203784939099,0.8999623829835068,0.6459627329192547,1.0,1.0,16/68,17.97%,POU2AF1;TWIST1;CD74;IL16;HMGB1;PLCG2;IL17RA;CARD9;DHX9;MYD88;TLR6;TYROBP;F2R;CYBA;XBP1;POU2F2
prerank,dendritic cell migration (GO:0036336),0.44999871250291357,0.8998487199595395,0.5897755610972568,1.0,1.0,5/16,17.65%,CCR2;HMGB1;CCR6;TRPM4;CXCR4
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.2802007748317591,-0.899753172964102,0.6291390728476821,0.8613873946909191,1.0,7/27,18.08%,PTPN2;PTPRE;PIP4K2B;GSK3A;GRB10;TSC2;SLC27A4
prerank,regulation of activated T cell proliferation (GO:0046006),-0.26059639014536945,-0.8990326871654113,0.6044776119402985,0.8616957431708991,1.0,6/30,14.27%,PRKAR1A;CD274;PYCARD;IGF1;IL18;PRNP
prerank,mitochondrial genome maintenance (GO:0000002),0.46488253812720204,0.8988561424328274,0.6083916083916084,1.0,1.0,4/11,14.69%,AKT3;LONP1;TOP3A;MPV17
prerank,regulation of vasculogenesis (GO:2001212),0.45792921220411187,0.8986580313835508,0.5932203389830508,1.0,1.0,1/14,2.10%,HEY2
prerank,establishment of protein localization to membrane (GO:0090150),-0.2197961675459996,-0.898233471293374,0.7741935483870968,0.8621924517277098,1.0,21/66,24.57%,RAB3IP;PRKCI;GOLGA7;AFDN;MYO1C;RAB3GAP2;RABGEF1;NCF1;RAB11A;RTP4;NPC1;ARL6;ZDHHC24;ZDHHC20;COX18;ZDHHC15;MICALL1;PARD3;VPS37C;REEP1;ZDHHC3
prerank,defense response to symbiont (GO:0140546),0.37854037094438286,0.8979056776005715,0.6639593908629442,1.0,1.0,8/92,6.58%,RNASE6;PMAIP1;SKP2;FLNA;CGAS;SERINC5;SERINC3;PDE12
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.376938311989132,0.8977152644310978,0.6559251559251559,1.0,1.0,27/72,24.83%,CD74;AGPAT1;IKBKG;TRADD;BIRC2;JAK2;TRIM44;SUMO1;CBFB;SPATA2;RACK1;CFLAR;RBCK1;ELF1;RUNX1;PIAS1;CD24;CASP8;RIPK1;IKBKB;SYK;PTPN11;HIPK1;ABCE1;VRK2;MADD;IFNGR1
prerank,Golgi to endosome transport (GO:0006895),-0.3193470776843255,-0.8976228930018206,0.6090909090909091,0.8623095717729066,1.0,6/16,17.74%,RAB14;GBF1;VPS13C;WIPI1;EPS15;SORT1
prerank,membrane depolarization during action potential (GO:0086010),-0.2736542025144529,-0.8976067269009675,0.6165413533834586,0.8610120075423024,1.0,10/26,18.69%,SCN8A;CACNA1C;SCN1A;SCN9A;SCN3A;SCN1B;HCN2;SLC8A1;CACNA1G;ATP1A2
prerank,regulation of dendrite development (GO:0050773),-0.24904293000839217,-0.8974169578031114,0.6698113207547169,0.8600767226964544,1.0,14/37,24.35%,CAMSAP2;TNIK;HECW1;RAP2A;KNDC1;PACSIN1;LRP8;DAB2IP;RTN4IP1;VLDLR;ZDHHC15;LZTS1;DCC;SEMA4D
prerank,regulation of regulated secretory pathway (GO:1903305),-0.256487493906592,-0.8973020331692632,0.656,0.8590281831413983,1.0,9/34,16.32%,RIMS1;RIMS2;SYT1;PREPL;SYT4;SYT7;SYT9;SNAPIN;SYT6
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.47034916354868267,0.8972015482247382,0.616991643454039,1.0,1.0,3/11,11.17%,FOXO1;NOTCH1;SMAD4
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3832390629543163,0.8969915819447114,0.6588832487309645,1.0,1.0,15/98,9.96%,PMAIP1;CNPY4;E2F1;C2CD5;FYN;PRKCE;YWHAH;SORBS1;TFDP1;CIB1;EFCAB7;EGFR;EPHA3;PDPK1;TFDP2
prerank,ovarian follicle development (GO:0001541),-0.34004599776638805,-0.8969312926131003,0.5671641791044776,0.858616029736082,1.0,4/13,21.75%,VEGFA;EIF2B4;ANG;EIF2B2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.44509774229289006,0.8961390298187301,0.6013333333333334,1.0,1.0,5/15,22.74%,TWIST1;EIF4A3;NIPBL;MTHFD1L;FGFR2
prerank,regulation of insulin secretion (GO:0050796),0.36953861252379694,0.8959641820811148,0.6666666666666666,1.0,1.0,14/101,16.72%,BLK;FOXA2;ITPR1;NR1D1;PRKCA;PICK1;KCNC2;DPP4;EIPR1;CDK16;MCU;IRS1;TCF7L2;CAPN10
prerank,negative regulation by host of viral transcription (GO:0043922),0.45601556117940556,0.8955115415449357,0.5991792065663475,1.0,1.0,6/12,23.92%,PSMC3;JUN;TFAP4;HDAC1;TARDBP;HMGA2
prerank,regulation of defense response to virus by host (GO:0050691),0.4074052667967065,0.8953072931790226,0.6143024618991794,1.0,1.0,8/30,16.47%,PTPN22;CGAS;TRIM44;DHX9;TOMM70;TARBP2;SIN3A;TRAF3IP2
prerank,carnitine metabolic process (GO:0009437),0.4600471165490246,0.8951947156845451,0.5994277539341917,1.0,1.0,4/12,15.05%,ACADM;CPT1B;CPT1A;CPT2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.37246200466398655,0.8947038537365508,0.6848484848484848,1.0,1.0,26/113,19.26%,ERCC4;RPA2;CHD1L;TFRC;FAF1;ATM;TERF1;RPA1;ERCC3;PSMC3;PARK7;SUMO1;MYD88;PSMC4;RACK1;TLR6;RPA3;GSK3B;BRK1;TP53;USP50;DDB2;SNCA;GNL3L;SLF1;RPS3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41742570678939744,0.8946416982735574,0.608058608058608,1.0,1.0,6/24,16.47%,PTPN22;CGAS;TRIM44;TOMM70;SIN3A;TRAF3IP2
prerank,histone deubiquitination (GO:0016578),-0.3119032899841562,-0.8943175973915751,0.6069651741293532,0.8631838579014145,1.0,8/18,23.95%,ENY2;USP3;USP22;KAT2A;USP49;ATXN7;TRRAP;TAF10
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3175817081614823,-0.8939726434520225,0.6313559322033898,0.8626440446397488,1.0,1/15,0.14%,ACVR1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3962664067542779,0.8938256029468087,0.6170703575547867,1.0,1.0,9/29,21.11%,TANK;IKBKG;TRAF3;BIRC2;TLR6;UBA52;CASP8;RIPK1;IKBKB
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3843030136342957,0.8937536663331795,0.6232657417289221,1.0,1.0,13/47,20.48%,FLNA;NEDD9;CRKL;CIB1;CRK;NRP1;ACTN4;LIMS1;TRIOBP;RAC1;ARHGEF7;S100A10;ILK
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3760957203250717,0.8937183596097047,0.6900406504065041,1.0,1.0,19/95,14.62%,MEN1;VASN;STK11;CAV1;PMEPA1;PIN1;ZBTB7A;PDPK1;HIPK2;TRIM33;SMAD4;SNX25;BCL9L;SPRED2;ING2;LATS1;CREBBP;SKI;RNF111
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.4123126578660887,0.8935783565762511,0.6146458583433373,1.0,1.0,4/23,16.20%,EPHX2;HPGD;LTA4H;GSTM1
prerank,positive regulation of B cell activation (GO:0050871),0.38519108650938105,0.8927576509994943,0.6321961620469083,1.0,1.0,10/50,17.05%,TNFSF13B;CD38;CD74;TFRC;PPP2R3C;BTK;KMT5C;PAXIP1;RIF1;XBP1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.4722466110610276,0.8924830667892402,0.6084507042253521,1.0,1.0,3/10,13.56%,EIF2S1;NFE2L2;DDIT3
prerank,endoplasmic reticulum organization (GO:0007029),-0.22273664548022717,-0.8922135505127097,0.78125,0.8655041130903081,1.0,18/72,14.27%,RTN4;APP;GAK;SEC16A;REEP3;TOR1B;DNM1L;REEP5;SGTA;MIA3;VAMP2;SEC61G;SEC61A1;HMOX1;STX1A;TRAM1;SERP1;PRNP
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.4184692085336194,0.8916384838008726,0.6319526627218935,1.0,1.0,8/26,18.13%,FYN;TXN;PARK7;NFE2L2;PPIA;PDE8A;SIRT1;LRRK2
prerank,negative regulation of translational initiation (GO:0045947),0.4489834374421138,0.8915810100705671,0.5967741935483871,1.0,1.0,5/13,24.69%,EIF3E;EIF4EBP3;AGO2;TPR;EIF2AK1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.39309127655242543,0.890380537794982,0.6518918918918919,1.0,1.0,6/47,10.86%,UHRF1;EIF2A;RBM3;MTPN;PUM3;TCOF1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3850588643483754,0.8902683304556022,0.6451953537486801,1.0,1.0,13/61,16.74%,NET1;LPAR4;MMD2;RASGRP1;CRKL;ARHGEF3;NOTCH1;GRB2;JAK2;F2R;LPAR1;GPR35;RAC1
prerank,activation of GTPase activity (GO:0090630),0.38164750769890404,0.8902392546211971,0.6848049281314168,1.0,1.0,9/89,5.61%,ECT2;ARHGEF5;TBC1D1;TIAM1;TBC1D8B;TBC1D22B;RASGRP1;RANGAP1;EVI5
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3184081818384176,-0.8899382648715655,0.6196078431372549,0.8695886192293264,1.0,3/16,7.70%,PADI2;PPARGC1B;AR
prerank,aminoglycan metabolic process (GO:0006022),-0.3628970648013823,-0.8898625908658013,0.5930599369085173,0.8684453959375975,1.0,6/10,32.37%,B3GAT3;XYLT2;B4GALT7;CLN6;CHST9;B3GALT6
prerank,regulation of isotype switching (GO:0045191),0.4381982261254599,0.8897334479811653,0.5986486486486486,1.0,1.0,4/14,16.84%,TFRC;KMT5C;PAXIP1;RIF1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.34026667902310637,-0.8893659697059665,0.5954198473282443,0.8682777189701884,1.0,4/13,16.40%,ANK3;SRI;CALM1;SLC8A1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.4648078013925569,0.8891736048037291,0.5968436154949784,1.0,1.0,4/10,23.33%,NCBP1;CPEB3;NCBP2;LEO1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3713852411595501,0.8891426038079621,0.6514994829369183,1.0,1.0,15/73,17.59%,BLK;MAPK1;FYN;PRKCE;CYFIP2;GRB2;PLCG2;CRK;PLD2;BRK1;ELMO2;PLCG1;RAC1;PIK3CA;FCGR2B
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4011281293864039,0.88877256354355,0.6237054085155351,1.0,1.0,12/30,21.95%,FOXP1;HDAC6;H3-3A;SMARCA4;ZBTB7A;PARK7;TRIM68;KDM4C;SIRT1;HDAC1;NCOA2;RNF6
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.38197288866993695,0.8882904063360558,0.655099894847529,1.0,1.0,15/63,17.29%,PML;TNFSF10;SP100;CAV1;TRADD;BCL2L12;BIRC6;ITGAV;PARK7;FAS;CFLAR;TCF7L2;FGFR1;PAK2;SH3RF1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4414365148133257,0.8881713884076364,0.5915119363395226,1.0,1.0,3/16,11.64%,RIPOR2;MAPK14;PLCB1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.3293626643000923,-0.887064684934428,0.5886524822695035,0.8723209619023495,1.0,4/12,21.50%,SLC25A3;SLC25A11;SLC37A1;SLC37A2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.37023612486292445,0.8869855681309295,0.7024539877300614,1.0,1.0,21/102,17.66%,NR4A2;C2CD5;SLC2A4;USF1;CRHBP;CAV1;FOXO1;DENND4C;SORBS1;ZFP36L1;RAB8A;PRKACA;PDPK1;KAT2B;RAB8B;PRKDC;IRS1;CAPN10;XBP1;ADCY8;EPRS1
prerank,phospholipid translocation (GO:0045332),0.40551849544973434,0.8867551098415353,0.6271981242672919,1.0,1.0,9/28,20.69%,ATP11C;ATP8B4;ABCA7;ATP8A1;ATP11B;TMEM30A;ANO6;ATP11A;ATP8B2
prerank,negative regulation of cell junction assembly (GO:1901889),-0.2715547618278322,-0.8867204440287444,0.6516129032258065,0.8717813351631646,1.0,8/25,20.33%,ARHGAP6;APOD;CLASP2;CORO1C;RCC2;ACVRL1;THBS1;PHLDB2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.2961666518771111,-0.8861063428277718,0.6287128712871287,0.8718175177738208,1.0,7/20,19.52%,NUMB;BCL2L1;AP2M1;RHOQ;PPFIA1;PKDCC;CSK
prerank,ruffle organization (GO:0031529),-0.31356289599120424,-0.88596401664413,0.6359447004608295,0.8708166294797007,1.0,6/16,22.81%,CSF1R;AIF1;ARFIP2;PLEK;CORO1B;CYFIP1
prerank,cellular response to metal ion (GO:0071248),0.3723387274379004,0.8852228582333884,0.7135678391959799,1.0,1.0,15/123,11.47%,ECT2;SLFN14;TFR2;AQP1;MAPK1;CRHBP;SYT8;DPEP1;PLCG2;KCNA1;EGFR;SUMO1;B2M;SYT3;JUN
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4288041184927842,0.8850455759055937,0.6029776674937966,1.0,1.0,6/18,21.12%,CCR2;CACNG5;RELN;CACNG8;NRXN1;CACNG4
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.2571761820272391,-0.8848782816652067,0.6301369863013698,0.8720605986560782,1.0,5/30,7.25%,CD274;CD34;HSPD1;PYCARD;TLR4
prerank,negative regulation of macroautophagy (GO:0016242),-0.26792741583137447,-0.8848619390777396,0.6258503401360545,0.8707845594086079,1.0,11/26,27.69%,FEZ2;FEZ1;TSC1;PINK1;TSC2;CHMP4B;CHMP4A;LZTS1;CLEC16A;SEC22B;RUBCN
prerank,cardiac muscle cell contraction (GO:0086003),-0.29142090826616784,-0.8845068964476581,0.6218905472636815,0.8702058551583749,1.0,7/19,21.88%,CACNA1C;SCN1A;ATP1A1;SCN1B;FGF12;CACNA1G;SCN3B
prerank,negative regulation of response to wounding (GO:1903035),-0.2915299305922083,-0.8842963959638992,0.6086956521739131,0.8693314905775288,1.0,6/19,16.30%,PTPRS;ALOX5;FGF2;SERPINE1;MDK;EPHA4
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.44287108955463234,0.8840362392832537,0.6068965517241379,1.0,1.0,4/13,13.32%,PIM1;NAPEPLD;ZBTB7B;HNRNPU
prerank,potassium ion import across plasma membrane (GO:1990573),0.39427937303450367,0.8839557570677211,0.6527472527472528,1.0,1.0,6/41,13.00%,SLC12A3;SLC12A7;SLC12A1;KCNJ3;SLC12A6;KCNJ2
prerank,camera-type eye development (GO:0043010),0.4073799210192064,0.883909729923636,0.6220657276995305,1.0,1.0,3/25,13.77%,CYP1B1;SHROOM2;SKI
prerank,cellular response to chemokine (GO:1990869),0.3895220429017649,0.8838484147589553,0.6208791208791209,1.0,1.0,7/46,16.77%,OXSR1;RIPOR2;CCR2;GPR75;STK39;GPR35;CCL25
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.318888899992691,-0.8838477775088835,0.6085106382978723,0.8690967461783604,1.0,6/15,16.19%,ABHD12;GOT2;ABHD16A;GGT5;HOGA1;CHAC2
prerank,regulation of T cell proliferation (GO:0042129),0.3830714831639891,0.8837568214089432,0.6491596638655462,1.0,1.0,4/61,5.04%,SPN;SLC7A1;GLMN;TFRC
prerank,protein modification process (GO:0036211),0.3745613287055279,0.8835447434679012,0.6776859504132231,1.0,1.0,22/76,18.89%,PIGH;UBE2I;MSRA;LCMT1;UBL5;ST3GAL1;SLC35A1;STK38;ST8SIA4;SEPHS1;PHKA2;BAP1;FBXO11;CHRM3;PRKDC;NTAQ1;USP25;DUSP12;ADPRH;UBA52;UBE2M;ICMT
prerank,cell-cell junction assembly (GO:0007043),-0.22110932690220744,-0.8834828520054882,0.75,0.8686816319969134,1.0,17/63,15.98%,CDH11;CDH8;PATJ;CTNNB1;CTNND1;CDH2;CLDN11;CDH12;JUP;FLCN;EPB41L3;ACTB;SMAD7;GJA1;PIP5K1C;TLN2;TRPV4
prerank,positive regulation of peptidase activity (GO:0010952),0.41695756109222876,0.8833891473276635,0.6085365853658536,1.0,1.0,4/20,13.47%,RCN3;TANK;DDRGK1;PSME1
prerank,calcium ion transport into cytosol (GO:0060402),0.4145095799174161,0.8832353386854152,0.6076732673267327,1.0,1.0,1/21,1.22%,MS4A1
prerank,acute-phase response (GO:0006953),0.4537222728075338,0.8831586356498137,0.5952712100139083,1.0,1.0,1/12,10.39%,IL22
prerank,axonal transport of mitochondrion (GO:0019896),-0.3518124625783944,-0.8830975511452228,0.5813148788927336,0.8682090031387528,1.0,3/11,8.49%,ACTR10;SPAST;SYBU
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.37142944333407146,0.8826697660941383,0.6783505154639176,1.0,1.0,19/70,16.96%,PSMB7;PSMD11;PSMF1;IKBKG;PSMC1;TAP1;ITGAV;PSMC3;PSMA4;B2M;PSMC4;PSMD13;PSME1;PSMB1;CYBB;PSMD8;PSME4;PSMD4;CYBA
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.44631476262132413,0.8824983114144335,0.5966277561608301,1.0,1.0,4/13,16.94%,SORBS1;ZBTB7B;IRS1;SIRT1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.23609148870334906,-0.8822859819980877,0.676923076923077,0.868604349016695,1.0,14/42,16.55%,IARS2;CARS1;WARS2;SARS1;NARS1;AIMP1;FARSA;IARS1;HARS2;HARS1;NARS2;TARS1;QARS1;TARS3
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.45364777154828784,0.8822130224461724,0.6248256624825662,1.0,1.0,6/11,27.73%,BIRC2;CASP8;RIPK1;SLC25A4;ARHGEF2;NUPR1
prerank,positive regulation of protein modification process (GO:0031401),0.36158631293352256,0.8822056700511725,0.7427427427427428,1.0,1.0,59/203,23.41%,CDCA2;PECAM1;RAMP1;PTPA;CCN1;CD74;ANKLE2;AXIN1;BRAT1;PGF;CEP295;TFRC;RASGRP1;CRKL;PPP2R5A;PIN1;NIBAN1;CIB1;EGFR;P2RY1;TXN;DYRK1A;WDFY2;FGF9;FAS;CNEP1R1;FXR1;ROCK2;RACK1;FLOT1;FAM20A;PPIA;MYDGF;CAMTA1;STK4;LIMK2;RAC1;PDE8A;SIRT1;SPPL3;TAOK1;LRRK2;FAM161A;SOX9;AKTIP;SVIP;CCND3;ILK;UBE2N;SLCO3A1;RIPK1;CALM3;PPP1R16B;EFNA1;NTRK3;ASPSCR1;ADAM17;PRKCD;C3
prerank,defense response to tumor cell (GO:0002357),-0.3704935920365133,-0.8817578642551737,0.6242038216560509,0.8685253219888873,1.0,6/10,33.91%,SPI1;PRDX2;KLF4;RBMS3;ABI3;DLEC1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3120401877654262,-0.881660060016131,0.5884615384615385,0.867402571147593,1.0,3/15,6.99%,WHRN;SCN1A;COL11A1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.22324114689895339,-0.8815535898504434,0.7619047619047619,0.8663595547005352,1.0,21/77,18.07%,ACVR1;TGFBR1;BCL2L1;GHITM;RELA;HGF;PLAUR;MCL1;IGF1;CX3CR1;AR;PRKN;BCL2L2;PINK1;NDUFS3;NOC2L;QARS1;ACAA2;GPX1;PIH1D1;THBS1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3708831957532828,0.8814575450508118,0.7351460221550856,1.0,1.0,28/151,16.79%,KNSTRN;ADAMTS7;SOX6;CD44;HAS1;CRKL;KIDINS220;SETX;ZFP36L1;PDE2A;NOTCH1;CIB1;MAPK14;EGFR;PDPK1;EMD;SMAD4;BMPR1A;STAT5B;NRP1;RACK1;RAB35;LIMS1;APPL1;ZFP36L2;DUSP22;PLCG1;PDE8A
prerank,glutamine family amino acid catabolic process (GO:0009065),0.4485732130511488,0.8813456363026665,0.6226666666666667,1.0,1.0,2/13,7.18%,GLS2;PRODH
prerank,homotypic cell-cell adhesion (GO:0034109),-0.23715824125536936,-0.8809834956955624,0.7244897959183674,0.866340306638493,1.0,17/39,26.03%,UBASH3B;FERMT3;P2RY12;GNAS;RAP2B;TJP2;ITGB3;ACTB;PIK3CB;METAP1;MEGF11;PLEK;STXBP1;PLPP3;MEGF10;MYL12A;TYRO3
prerank,cellular component maintenance (GO:0043954),0.4538977669164934,0.8809422126951193,0.6098901098901099,1.0,1.0,3/12,8.51%,FYN;MTMR2;PICK1
prerank,heart morphogenesis (GO:0003007),0.38559356119619104,0.8809406653627194,0.6476399560922064,1.0,1.0,8/50,16.38%,HEY2;ZFPM1;FLRT2;MDM4;NOTCH1;BMPR1A;NIPBL;TGFB2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.446355098316639,0.8805852156228258,0.6065128900949797,1.0,1.0,5/14,21.45%,PTPN22;CCR2;CD55;LGALS9;SYK
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3661093265932644,0.8802200253181827,0.7321965897693079,1.0,1.0,45/149,21.11%,IL18RAP;PIDD1;S100A9;RPS6KA5;TFRC;CAV1;IKBKG;S100A8;TRADD;DDRGK1;CIB1;TAB1;UBE2V1;ERC1;MTPN;TAB3;ZBTB7A;CARD9;BTK;DHX9;PRKCB;MYD88;TRIM68;FLOT1;CFLAR;PPIA;TLR6;TRIM5;RBCK1;TNFRSF11A;TRIM37;UBA52;MAP3K7;FLOT2;MALT1;RPS3;TRAF6;LGALS9;PRKD2;ALK;UBE2N;AIM2;SLCO3A1;RIPK1;IKBKB
prerank,polyamine metabolic process (GO:0006595),0.44938618188673796,0.8801333913433143,0.6169354838709677,1.0,1.0,4/13,12.57%,HDAC10;HDAC6;DHPS;SMS
prerank,proteolysis (GO:0006508),0.3624987121595732,0.8799946796592767,0.787,1.0,1.0,53/252,21.10%,PRTN3;TMPRSS4;TMPRSS3;ADAMTS7;KEL;NAPSA;SENP1;FAP;FBXO3;CPA6;CPM;CASP2;CTSE;DESI2;DESI1;METAP2;SPCS1;PITRM1;CAPN1;LONP1;ATG4B;VASH2;FAM111A;DPP4;PSMC4;CTSK;CTSO;F3;MMP19;PSEN1;PCSK1;ADGRV1;CPD;VHL;CAPN10;USP25;NAALAD2;SPPL3;MALT1;SENP6;ADAM10;ERAP1;RNPEP;SUFU;CLN3;PCSK7;CASP8;MMP12;MME;SPCS3;PRCP;CAPN15;MDM2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.3683193301034506,0.8795384046112795,0.6993865030674846,1.0,1.0,24/93,22.95%,NTF4;CD44;AXIN1;TFRC;CAV1;GPD1L;HDAC6;EGFR;TXN;PARK7;PTEN;RACK1;LATS1;STK4;PDCD10;NLRP2B;HCLS1;SNCA;PRKD2;ARAF;CAPRIN2;ATP2B4;NTRK3;NSD1
prerank,endoderm development (GO:0007492),0.4454702332121805,0.8790513346247478,0.6239782016348774,1.0,1.0,2/13,18.37%,LAMC1;KIF16B
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4599413164965862,0.8790328217018791,0.6270270270270271,1.0,1.0,5/11,22.61%,ABCA2;ABCA7;AGO2;NECAB1;SOAT1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.22200835104696498,-0.8789522025177756,0.6888888888888889,0.8697682753003461,1.0,15/63,13.04%,TREM2;TBC1D14;TIMP2;KDM4A;HGF;MCL1;ATRAID;TIMP3;FOXK1;EIF4G3;GSK3A;GOLGA2;WASHC1;STAT3;ZKSCAN3
prerank,carboxylic acid catabolic process (GO:0046395),-0.33576886419664187,-0.8789037148825345,0.6374501992031872,0.8685720717327114,1.0,7/12,29.61%,NAGK;NPL;GNPDA1;GNPDA2;AMDHD2;IL4I1;RENBP
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.45271248253270713,0.8787296063397947,0.6243169398907104,1.0,1.0,4/12,18.63%,TSPO;STARD3NL;TSPOAP1;FDXR
prerank,response to zinc ion (GO:0010043),-0.2677034312710665,-0.8785988621180431,0.6405228758169934,0.8679600557580723,1.0,12/25,20.09%,GLRA2;SLC30A4;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;MT2A;P2RX4
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4060693352961089,0.8785482651803187,0.6261467889908257,1.0,1.0,10/28,20.53%,MAP2K6;IKBKG;TAB1;UBE2V1;TAB3;UBA52;MAP3K7;TRAF6;CASP8;UBE2N
prerank,ketone body metabolic process (GO:1902224),0.44415080298052795,0.8783065478424947,0.6025641025641025,1.0,1.0,2/10,9.66%,ACSS3;BDH1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3699811939589158,0.8782168425882816,0.6663244353182751,1.0,1.0,23/75,23.12%,HMGB2;EMC10;PGF;HMGB1;AKT3;PRKCA;PDPK1;VASH2;F3;AGGF1;NRP1;MYDGF;EGF;FGFR1;PLCG1;SIRT1;APLN;PROX1;PRKD2;EGFL7;PPP1R16B;ITGA4;ADAM17
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.404975259934405,0.8782038260898943,0.6032863849765259,1.0,1.0,4/27,7.95%,GPD1L;YWHAH;FXYD5;NEDD4L
prerank,protein stabilization (GO:0050821),0.364454350657326,0.8781296435443996,0.743,1.0,1.0,46/168,20.40%,GTSE1;USP27X;CHEK2;TSPAN1;FLNA;FKBPL;CRTAP;NAPG;CCT7;RPS7;TAF1;MDM4;CCT2;PIN1;TCP1;PIM2;TRIM44;PARK7;SUMO1;CCT5;PTEN;NAA16;HCFC1;FLOT1;BAG1;BAG3;TYROBP;ATF7IP;STK4;PDCD10;TAF9;VHL;PARVA;CAMLG;USP7;SYVN1;MORC3;FLOT2;CREB1;RPL5;CDKN1A;STK3;CCT6A;HPS4;RPL23;NCLN
prerank,regulation of ion transmembrane transport (GO:0034765),0.39523943905065534,0.8776097044079062,0.6506300114547537,1.0,1.0,9/33,23.60%,NEDD4L;KCNJ3;KCNJ2;CHRM3;ANO6;YWHAE;KCNJ10;NEDD4;WNK3
prerank,autophagosome organization (GO:1905037),0.38413926291399636,0.8774355130499023,0.6550218340611353,1.0,1.0,11/50,16.90%,EMC6;ATG13;RAB1B;UBQLN1;TMEM41B;BECN1;AMBRA1;RAB43;TP53INP2;ATG101;ATG2B
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.389759720184828,0.8772443721928498,0.6312718786464411,1.0,1.0,9/31,19.92%,PEX26;CHCHD4;DNAJC15;PEX2;TOMM70;TIMM23;GRPEL2;PEX14;TOMM40L
prerank,clathrin coat assembly (GO:0048268),-0.31736333985028875,-0.8768171072758904,0.6309523809523809,0.8705118722143035,1.0,9/15,30.78%,CLTB;AP2S1;NSG1;EPS15;HIP1R;PICALM;NSG2;CALY;SGIP1
prerank,regulation of RNA metabolic process (GO:0051252),0.3693275412014058,0.8764723246570396,0.6571428571428571,1.0,1.0,17/59,21.51%,MBNL3;HNRNPL;ZNF326;NOVA2;METTL4;CLK4;PCBP2;RBM38;IGF2BP3;PCBP3;RC3H1;AHNAK;MED1;HNRNPLL;AFF2;PTBP2;CELF1
prerank,membrane lipid biosynthetic process (GO:0046467),0.37311868737606346,0.8764254533503525,0.6451271186440678,1.0,1.0,16/58,20.15%,SGMS2;HACD4;PRKD3;CSNK1G2;ST3GAL2;VAPA;CERS4;SGMS1;ELOVL5;ELOVL4;CERS6;ACER3;GBGT1;CERS2;PRKD2;ST8SIA6
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.36048896506089967,0.8762228431321856,0.7637637637637638,1.0,1.0,46/186,19.39%,JADE1;PSMB7;LRP4;PSMD11;AXIN1;PSMF1;STK11;NXN;CAV1;CCDC88C;CSNK1A1;PSMC1;FUZ;TLE4;CUL3;HMGXB4;PFDN5;PSMC3;AMFR;RUVBL2;EMD;PSMA4;PSMC4;TMEM131L;RACK1;PSMD13;PSME1;DDIT3;LATS1;PSMB1;GSK3B;STK4;LIMD1;PTPRU;PSMD8;TCF7L2;PSME4;PSMD4;LMBR1L;TMEM170B;AMER2;TLE3;RNF43;HDAC1;STK3;SOX9
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.29896158542905865,-0.8759554821930285,0.625,0.8711612886901642,1.0,5/18,15.55%,APOE;PSEN2;ADAM19;NSG1;APH1A
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.36579108462995197,0.8759323902474413,0.7233400402414487,1.0,1.0,16/121,13.80%,IL12A;TNFRSF18;PECAM1;ERBB3;CD74;CD44;NEDD9;GPRC5B;BANK1;PLCG2;JAK2;PARP14;RELN;FLT3;NRP1;PIBF1
prerank,regulation of interleukin-8 production (GO:0032677),0.3720722549273228,0.8755396445446759,0.6735751295336787,1.0,1.0,11/69,15.39%,CD2;CD74;PTPN22;HMGB1;PARK7;MYD88;F3;TLR5;DDIT3;TLR6;F2R
prerank,mesonephros development (GO:0001823),0.44636363044413285,0.8755153238537926,0.6284530386740331,1.0,1.0,3/11,23.07%,ZBTB16;PAX2;OSR1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.37587111404251994,0.8754036680169704,0.6608884073672806,1.0,1.0,14/48,23.12%,NUS1;HMGB1;AKT3;CIB1;MAPK14;PRKCA;PDPK1;FGFR1;PLCG1;SIRT1;ATP5F1B;PRKD2;HDAC9;ADAM17
prerank,protein N-linked glycosylation (GO:0006487),0.3761405158039755,0.8753699716393213,0.6854166666666667,1.0,1.0,15/66,16.97%,MAGT1;KRTCAP2;ALG8;ALG14;STT3A;MGAT2;ST3GAL1;ENTPD5;FUT8;OST4;GFPT2;SRD5A3;PMM2;TUSC3;LMAN1
prerank,microtubule anchoring (GO:0034453),0.45374690779747806,0.8751107192217996,0.6304945054945055,1.0,1.0,4/12,17.48%,CLASP1;PCM1;DAG1;PEX14
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.2839892871832068,-0.8748896741385284,0.6467065868263473,0.8722000922175431,1.0,7/21,18.07%,CSF1R;CMKLR1;AKIRIN1;PTK2;CSF1;MDK;THBS1
prerank,morphogenesis of an epithelium (GO:0002009),0.4030675988438783,0.8746206940494696,0.6211764705882353,1.0,1.0,9/25,23.42%,TIMELESS;LAMA5;PRKX;DAG1;KDM2B;SOX9;ACTG1;FGFR2;VCL
prerank,N-glycan processing (GO:0006491),-0.2998680416019053,-0.8745667470200162,0.6188118811881188,0.8716440571373998,1.0,4/18,3.24%,ST8SIA1;MAN1C1;MAN2A2;GANAB
prerank,regulation of transmembrane transport (GO:0034762),0.4040224643618493,0.874052010307254,0.648960739030023,1.0,1.0,8/31,18.69%,NEDD4L;KCNJ3;PIM1;PRKCB;KCNJ2;SNCA;SLC2A1;KCNJ10
prerank,regulation of lipid metabolic process (GO:0019216),0.36624860429411704,0.8740061189711797,0.693564862104188,1.0,1.0,26/88,20.75%,PANK2;LSS;CAV1;NR1D1;EDF1;SIN3B;IDI1;NFYC;ABCA7;FASN;ADIPOR1;BBS4;HELZ2;PRKAG2;CREBBP;RUBCNL;FDPS;DHCR7;SIN3A;MED1;CERS2;TBL1XR1;SREBF2;NCOA6;NCOA2;PPARD
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.24269670284371853,-0.8737443151904652,0.6805555555555556,0.8721692308661179,1.0,13/46,17.38%,SIRPA;PTPN2;CNKSR3;CAMK2N1;TLR4;TIMP3;DUSP3;DUSP10;FLCN;DLG1;SPRED1;DAB2IP;RANBP9
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.3943861134154443,0.8737139385340583,0.6556442417331813,1.0,1.0,4/35,10.29%,IL12A;CAV1;CAV2;NR2F2
prerank,primary miRNA processing (GO:0031053),-0.36633675713151925,-0.8736610713266332,0.6337579617834395,0.8710526429264437,1.0,3/10,4.32%,SMAD1;PUS10;SMAD3
prerank,neutrophil degranulation (GO:0043312),0.36240635673687344,0.8734955163961803,0.86,1.0,1.0,94/425,18.60%,PRTN3;RAB44;MS4A3;CHRNB4;CD177;P2RX1;PGLYRP1;PGM2;ABCA13;MAPK1;CD47;PECAM1;CLEC12A;MAGT1;ATP8B4;PSMB7;S100A11;PSMD11;CAMP;CD44;GALNS;APAF1;PA2G4;S100A9;SLPI;FRMPD3;CNN2;GMFG;TUBB4B;S100A8;GSN;CCT2;NFAM1;XRCC6;HMGB1;DYNC1H1;ILF2;SLCO4C1;MAPK14;FAF2;DBNL;DNASE1L1;ITGAV;KCMF1;CAPN1;IMPDH2;IRAG2;SLC27A2;PSMC3;LTA4H;ORMDL3;B2M;TUBB;ATP8A1;VAPA;CRACR2A;DNAJC13;ARHGAP9;PSMD13;ARHGAP45;ARSB;PSEN1;PPIA;ATP11B;DIAPH1;COMMD9;TYROBP;PSMB1;SCAMP1;LAMTOR3;PLD1;DYNLL1;ARMC8;SPTAN1;GCA;CYBB;HVCN1;NBEAL2;PDXK;EEF2;SLC2A3;RAC1;GLIPR1;KPNB1;CYBA;CANT1;TMEM30A;ANO6;IQGAP1;ADAM10;FUCA1;PPIE;RAB6A;CKAP4
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4159830665589659,0.8732341522963205,0.6251604621309371,1.0,1.0,7/20,23.12%,CCNYL1;MAPRE3;EGFR;PROX1;PKD2;CCND3;ADAM17
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.355750791289039,-0.8726649511868425,0.603225806451613,0.8719882525697504,1.0,2/10,5.93%,TSNAX;TSN
prerank,regulation of microtubule-based process (GO:0032886),0.3959425061523863,0.8726055434938357,0.6464646464646465,1.0,1.0,15/36,22.27%,AURKA;CLASP1;HDAC6;MARK2;EPHA3;ATF5;DIAPH1;GSK3B;MARK4;TAOK1;MEMO1;ROCK1;MAPT;KLHL42;PHLDB1
prerank,amyloid fibril formation (GO:1990000),0.3833844351620119,0.8725785072416099,0.6605603448275862,1.0,1.0,16/51,21.28%,IAPP;HSPG2;GSN;H3-3A;TSPAN33;B2M;GGA1;TGFBI;UBA52;GGA2;SNCA;TSPAN5;ADAM10;RIPK1;MDM2;MAPT
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.39609843037382664,0.8724370106484305,0.6307151230949589,1.0,1.0,9/26,25.69%,BRCA1;ADIPOR1;PRKAG2;ELOVL5;WDTC1;EIF6;NR1H3;PRKAB2;NR1H2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2698966442844444,-0.8722091988860452,0.6598639455782312,0.8716918044416417,1.0,3/27,1.89%,C3AR1;GNA15;HTR2C
prerank,mitochondrion distribution (GO:0048311),0.4394366383871775,0.8721554501952428,0.6085164835164835,1.0,1.0,7/12,25.71%,HAP1;MTM1;LRRK2;TRAK2;MAPT;ATCAY;TRAK1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.37017839633006705,0.8714465431239972,0.6833855799373041,1.0,1.0,11/69,14.45%,CD2;SPN;TWIST1;CCR2;RASGRP1;HMGB1;PLCG2;JAK2;DHX9;PSEN1;TYROBP
prerank,UV protection (GO:0009650),0.46349622522761963,0.8714133460703368,0.64,1.0,1.0,1/10,4.82%,FEN1
prerank,response to retinoic acid (GO:0032526),0.37237051373009267,0.8710956977799766,0.6631016042780749,1.0,1.0,12/59,19.39%,AQP1;ATM;SETX;EPHA3;CDKN2D;ASXL1;PTK7;RXRB;RARG;CREB1;PAX2;SOX9
prerank,AMP metabolic process (GO:0046033),0.43925314567891083,0.8710904201849661,0.6364883401920439,1.0,1.0,3/13,16.87%,AK9;ADSL;AK3
prerank,respiratory chain complex IV assembly (GO:0008535),0.40733468729838596,0.8710239073875184,0.6121212121212121,1.0,1.0,3/21,9.89%,PET100;COA6;COX10
prerank,neutrophil activation involved in immune response (GO:0002283),0.36138427844443854,0.870754768642076,0.864,1.0,1.0,94/428,18.60%,PRTN3;RAB44;MS4A3;CHRNB4;CD177;P2RX1;PGLYRP1;PGM2;ABCA13;MAPK1;CD47;PECAM1;CLEC12A;MAGT1;ATP8B4;PSMB7;S100A11;PSMD11;CAMP;CD44;GALNS;APAF1;PA2G4;S100A9;SLPI;FRMPD3;CNN2;GMFG;TUBB4B;S100A8;GSN;CCT2;NFAM1;XRCC6;HMGB1;DYNC1H1;ILF2;SLCO4C1;MAPK14;FAF2;DBNL;DNASE1L1;ITGAV;KCMF1;CAPN1;IMPDH2;IRAG2;SLC27A2;PSMC3;LTA4H;ORMDL3;B2M;TUBB;ATP8A1;VAPA;CRACR2A;DNAJC13;ARHGAP9;PSMD13;ARHGAP45;ARSB;PSEN1;PPIA;ATP11B;DIAPH1;COMMD9;TYROBP;PSMB1;SCAMP1;LAMTOR3;PLD1;DYNLL1;ARMC8;SPTAN1;GCA;CYBB;HVCN1;NBEAL2;PDXK;EEF2;SLC2A3;RAC1;GLIPR1;KPNB1;CYBA;CANT1;TMEM30A;ANO6;IQGAP1;ADAM10;FUCA1;PPIE;RAB6A;CKAP4
prerank,maturation of LSU-rRNA (GO:0000470),0.4015685697031153,0.8704002517995201,0.6584216725559482,1.0,1.0,6/26,14.43%,RPL7;DDX18;URB1;NIFK;ZNHIT6;NSA2
prerank,neutrophil mediated immunity (GO:0002446),0.3609171121636088,0.8703213451183477,0.864,1.0,1.0,95/432,18.60%,PRTN3;RAB44;MS4A3;CHRNB4;CD177;P2RX1;PGLYRP1;PGM2;ABCA13;MAPK1;CD47;PECAM1;CLEC12A;MAGT1;ATP8B4;PSMB7;S100A11;PSMD11;CAMP;CD44;GALNS;APAF1;PA2G4;S100A9;SLPI;FRMPD3;CNN2;GMFG;TUBB4B;S100A8;GSN;CCT2;NFAM1;XRCC6;HMGB1;DYNC1H1;ILF2;SLCO4C1;MAPK14;FAF2;DBNL;DNASE1L1;ITGAV;KCMF1;CAPN1;IMPDH2;IRAG2;SLC27A2;PSMC3;CARD9;LTA4H;ORMDL3;B2M;TUBB;ATP8A1;VAPA;CRACR2A;DNAJC13;ARHGAP9;PSMD13;ARHGAP45;ARSB;PSEN1;PPIA;ATP11B;DIAPH1;COMMD9;TYROBP;PSMB1;SCAMP1;LAMTOR3;PLD1;DYNLL1;ARMC8;SPTAN1;GCA;CYBB;HVCN1;NBEAL2;PDXK;EEF2;SLC2A3;RAC1;GLIPR1;KPNB1;CYBA;CANT1;TMEM30A;ANO6;IQGAP1;ADAM10;FUCA1;PPIE;RAB6A;CKAP4
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.22500645348365222,-0.8703091409179149,0.8666666666666667,0.8745145952269578,1.0,17/57,19.83%,APP;DLGAP4;GRIA1;GRIA4;DLG2;MINK1;SHISA6;CACNG7;CACNG2;DLGAP2;LRRC7;CAMK2B;DLG1;DLGAP3;DLG4;GSG1L;PRRT1
prerank,phospholipid homeostasis (GO:0055091),0.4506451574712355,0.8702291640124981,0.6185852981969486,1.0,1.0,1/11,3.54%,RCN3
prerank,membrane lipid metabolic process (GO:0006643),0.4128314304079365,0.8701201533681221,0.6551297898640297,1.0,1.0,1/22,1.40%,CYP1B1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4608425231496944,0.8698170737243662,0.6071964017991005,1.0,1.0,4/10,15.39%,PRKD3;PICK1;DGKD;F2R
prerank,histone ubiquitination (GO:0016574),0.4041861593181791,0.8697898112469217,0.6399506781750924,1.0,1.0,4/21,14.30%,UHRF1;UBR2;RNF8;RNF20
prerank,regulation of RNA splicing (GO:0043484),0.3661684004643189,0.8695193448716072,0.6835573940020683,1.0,1.0,27/69,25.88%,MBNL3;POLR2A;HNRNPL;SETX;SRSF3;ZNF326;METTL4;CLK4;RBM38;DYRK1A;METTL16;SRSF10;AHNAK;SRPK1;HNRNPLL;AFF2;PTBP2;CELF1;ZPR1;HNRNPK;CLK2;PTBP1;RBM22;HNRNPH1;YTHDC1;KHDRBS3;HNRNPH3
prerank,cellular response to sterol (GO:0036315),-0.3221847643202588,-0.8694315739285178,0.6563706563706564,0.875176971138904,1.0,5/13,18.99%,SMO;OSBPL7;GRAMD1B;GPLD1;INSIG1
prerank,positive regulation of defense response (GO:0031349),0.3628729283151705,0.8694186004049224,0.7033639143730887,1.0,1.0,13/89,11.45%,CD47;CCN4;IL16;S100A9;GPRC5B;CCR2;S100A8;TRADD;PDE2A;IL17RA;RIOK3;NAPEPLD;DHX9
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4008954388756802,0.8683671789228388,0.64,1.0,1.0,7/25,16.74%,RIN3;MTMR2;ITGAV;ABCA2;PSEN1;ANKRD13A;RAC1
prerank,cytosolic calcium ion transport (GO:0060401),-0.25726291811650415,-0.8680887527527965,0.6821192052980133,0.8768921464848018,1.0,11/28,22.15%,CACNA1C;MCUR1;RYR2;ADRA1A;ATP2B3;JPH4;SLC8A1;ITPR3;MAIP1;AFG3L2;SMDT1
prerank,regulation of biosynthetic process (GO:0009889),-0.3389542853261768,-0.8679572920300518,0.6348684210526315,0.8759013127547904,1.0,5/11,34.05%,ALOX5;SPHK2;MID1IP1;THRSP;SLC25A33
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2607002070611946,-0.8677409262091517,0.6503067484662577,0.8750492033301944,1.0,13/26,31.77%,BCL2L1;MCL1;HTRA2;PPP2R1B;IL1A;UNC5B;EYA2;MAPK7;BCL2;PF4;RET;INHBA;IL1B
prerank,external encapsulating structure organization (GO:0045229),0.36060000488685917,0.8675038449550673,0.7957957957957958,1.0,1.0,35/205,17.49%,ADAMTS7;ICAM4;ITGA1;ECM2;ITGB7;CD47;PECAM1;HSPG2;CD44;LAMA5;COL1A2;LAMA4;DCN;COL4A4;LAMC1;LAMB2;LAMB3;ITGAV;SMOC2;JAM2;ATP7A;NID1;BSG;ITGA8;COL23A1;MMP19;DAG1;ADAMTS1;TGFBI;ELN;ST7;ADAMTSL3;ADAMTS5;COL4A1;FN1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4177866433079915,0.8671767210135098,0.62905317769131,1.0,1.0,7/18,22.66%,SUV39H1;EHMT1;KMT2A;KMT2B;ASH1L;SETD7;EEF1AKMT2
prerank,sulfur compound catabolic process (GO:0044273),0.3849990954427651,0.8671597908878992,0.6759156492785794,1.0,1.0,6/38,13.73%,FMOD;GALNS;DPEP1;DCN;OGN;ARSB
prerank,entry into host (GO:0044409),0.4506939303404557,0.8667356271897166,0.6272108843537415,1.0,1.0,8/13,26.00%,GRB2;ITGAV;CBLL1;PPIA;CXCR4;MET;SRC;CBL
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3852713785055452,0.8665881059453983,0.6554132712456344,1.0,1.0,9/30,21.11%,TANK;IKBKG;TRAF3;BIRC2;TLR6;UBA52;CASP8;RIPK1;IKBKB
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3680085059712037,0.8662873820952188,0.673469387755102,1.0,1.0,11/48,19.06%,NPPC;PANK2;GUCY1A1;SLC25A16;IMPDH2;PAPSS2;DCAKD;ADSL;AK5;ADCY8;PANK1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.381963246672426,0.8660781332801097,0.6632768361581921,1.0,1.0,4/33,12.53%,IL12A;OGN;PTEN;EFEMP2
prerank,regulation of p38MAPK cascade (GO:1900744),0.3914124824977432,0.8658935679541108,0.6473265073947668,1.0,1.0,5/35,5.36%,EZR;ULK4;EMC10;PTPN22;RASGRP1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3582948806020936,-0.8655458984902965,0.6277602523659306,0.8785729425636801,1.0,5/10,33.94%,IL18;RARA;SPHK2;IRF4;PRKCZ
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.2449493757501236,-0.864802954835205,0.717391304347826,0.8788794539907597,1.0,9/40,14.36%,AHI1;PPT1;CD63;ARRB1;WASL;TBC1D5;ANGPT1;VEGFA;SERPINE1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.40567353377936743,0.8644679860013967,0.6533333333333333,1.0,1.0,6/26,18.87%,RNF26;DHX58;PCBP2;NLRC3;TRAFD1;PPM1B
prerank,histone H3-K36 demethylation (GO:0070544),-0.35276830607456866,-0.8638020476963614,0.6230031948881789,0.8797413437447434,1.0,4/10,6.81%,KDM7A;KDM4A;PHF8;KDM4B
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.30536294015761156,-0.8633973720184731,0.6204081632653061,0.879337335689602,1.0,5/15,17.88%,SLC27A1;SCARB1;CTDNEP1;FBXW7;GPLD1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.43704850565851644,0.8632102594713523,0.6194331983805668,1.0,1.0,3/14,10.74%,RASGRP1;PAEP;CARD9
prerank,cardiac conduction system development (GO:0003161),0.4061359963876626,0.862498200405353,0.6430288461538461,1.0,1.0,3/24,12.63%,HEY2;SMAD4;BMPR1A
prerank,response to cytokine (GO:0034097),0.3611705361494724,0.8624448992918691,0.7620481927710844,1.0,1.0,32/141,19.90%,FOXA2;AFF3;MEFV;LEF1;CD74;PML;MAPKAPK3;SP100;PRKCA;JAK2;XAF1;IL1R1;PTPN7;PTPN14;FLT3;MYD88;IFITM3;PTPN5;TNFRSF11A;TAF9;JAK3;HCLS1;LDLRAP1;CXCR4;PTPN13;SNCA;HDAC4;ADAM10;TRAF6;LGALS9;CASP8;MME
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.35594516964658923,0.862133579776033,0.7683049147442327,1.0,1.0,42/152,21.58%,DEPDC1B;PSMB7;PSMD11;SULF2;AXIN1;PSMF1;GPRC5B;CAV1;DISC1;PSMC1;PIN1;CSNK1G2;SMARCA4;EGFR;PSMC3;PSMA4;RUVBL1;XIAP;CCAR2;PSMC4;PSMD13;LRRK1;PSME1;SKI;PSMB1;EGF;PSMD8;LGR4;PSME4;PSMD4;TRPM4;PTK7;LRRK2;PPM1B;TBL1XR1;USP34;RSPO2;ILK;SPIN1;USP47;CAPRIN2;ZEB2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.45169243774057727,0.8619455264049939,0.6309859154929578,1.0,1.0,3/11,14.76%,ATL2;ARL6IP1;VCPIP1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3546060498261288,0.8615216349304388,0.7590361445783133,1.0,1.0,17/152,15.96%,ADGRD1;S1PR4;VIPR2;IAPP;RAMP1;AKAP12;PTHLH;PDE2A;GNAI1;INSL3;GNAO1;CALCRL;S1PR2;ADCYAP1;ADGRL3;LPAR1;LGR4
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.35656484983185943,0.8615200447959906,0.7280080889787665,1.0,1.0,5/110,5.66%,ADGRD1;S1PR4;IAPP;RAMP1;PTHLH
prerank,positive regulation of blood coagulation (GO:0030194),0.41910881848018994,0.8614310465601123,0.6540469973890339,1.0,1.0,6/17,23.95%,USF1;F3;F2R;ANO6;APOH;ENPP4
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4314360416384416,0.8612310914700078,0.642023346303502,1.0,1.0,5/15,16.94%,CD74;CD44;ING2;TAF9;SIRT1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.3999297167978251,0.8608573789198165,0.6446078431372549,1.0,1.0,8/23,19.72%,MTMR12;MTMR2;PIP4P2;MTMR6;PTEN;MTM1;OCRL;INPP5F
prerank,positive regulation of neurogenesis (GO:0050769),-0.21727226929188875,-0.8607089501132423,0.8421052631578947,0.8838024442004089,1.0,21/68,20.45%,NUMB;KDM1A;PTPRD;PLXNA4;CTNNB1;CX3CR1;ROBO1;MAP6;FZD3;TGM2;TIAM2;CUX2;VEGFA;PLXNA1;SHANK3;CAPRIN1;PLXNB3;SOX11;CDKL3;SOX8;TRIM32
prerank,negative regulation of stem cell differentiation (GO:2000737),0.439205670284036,0.8606634338563167,0.6281879194630873,1.0,1.0,4/12,15.99%,NOTCH1;HNRNPU;NELFB;ZFP36L2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3949140519348283,0.8603278402791137,0.6601382488479263,1.0,1.0,7/30,16.94%,BATF;TNFRSF13B;FLT3;PRRC2C;TP53;HOXB4;LMBR1L
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4529679343512845,0.8601549697385217,0.6481481481481481,1.0,1.0,3/10,19.08%,PTPN22;AIDA;HIPK3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4341793493312104,0.860010993865523,0.6355140186915887,1.0,1.0,5/13,22.60%,KPNA3;RANBP2;IPO5;KPNB1;KPNA4
prerank,protein homotrimerization (GO:0070207),0.4336846549231143,0.8599530553380554,0.6245259165613148,1.0,1.0,4/14,20.20%,SLC1A5;SIGMAR1;DISP1;PNPT1
prerank,protein trimerization (GO:0070206),0.4336846549231143,0.8599530553380554,0.6245259165613148,1.0,1.0,4/14,20.20%,SLC1A5;SIGMAR1;DISP1;PNPT1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4035071640058058,0.8588410959645503,0.6587112171837709,1.0,1.0,4/27,8.62%,CD47;CD44;CCR2;CYRIB
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4364658212047675,0.8584857499840476,0.6174142480211082,1.0,1.0,2/13,5.06%,ALG8;ALG14
prerank,regulation of microtubule-based movement (GO:0060632),0.4399762989428948,0.8581563381909639,0.635343618513324,1.0,1.0,4/11,21.43%,HDAC6;HAP1;DYNLT2B;NEFH
prerank,anterior/posterior axis specification (GO:0009948),0.4250693903876184,0.857900643852461,0.6340482573726541,1.0,1.0,3/15,16.19%,DDIT3;SKI;TASOR
prerank,postsynaptic membrane organization (GO:0001941),0.4239644129641109,0.8578856551870416,0.625,1.0,1.0,5/17,18.91%,CEL;LRP4;NRXN2;GPHN;NRXN1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3914992608099905,0.8577755149136774,0.6522753792298717,1.0,1.0,8/28,18.99%,SMCHD1;MRNIP;KMT5C;SIRT7;PRKDC;TFIP11;RIF1;WRAP53
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4128469582407657,0.8575950362472056,0.6275946275946276,1.0,1.0,2/18,9.74%,PMAIP1;ALKBH7
prerank,substrate-dependent cell migration (GO:0006929),0.4320114308292654,0.8567186383890121,0.6481481481481481,1.0,1.0,3/14,13.01%,NTN1;ANKS1A;NRP1
prerank,T cell receptor signaling pathway (GO:0050852),0.35389548139551713,0.8564745372345715,0.7492477432296891,1.0,1.0,38/138,21.11%,ERMAP;GRAP2;PSMB7;FYN;PSMD11;FBXW11;PTPN22;PSMF1;IKBKG;PSMC1;PLCG2;BTN3A3;PDPK1;PSMC3;PSMA4;PSMC4;PRAM1;DENND1B;PSMD13;PSME1;THEMIS;PSMB1;RBCK1;RC3H1;PSMD8;PAK2;PSME4;PLCG1;PIK3CA;PSMD4;SPPL3;MAP3K7;MALT1;TRAF6;PRKD2;UBE2N;EIF2B5;IKBKB
prerank,regulation of ossification (GO:0030278),0.38030104429644096,0.8560616901698848,0.6367763904653803,1.0,1.0,12/36,22.89%,LRP4;SGMS2;TWIST1;NOTCH1;ZBTB16;CHSY1;TGFB2;SOX9;RBPJ;NBR1;DDR2;PTPN11
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3828439572850933,0.8560249445430732,0.6617812852311161,1.0,1.0,6/35,9.71%,STMN1;RIPOR2;ARHGAP35;TNFAIP1;CUL3;HEG1
prerank,neuron differentiation (GO:0030182),0.35924738789042754,0.8559545081148072,0.7877877877877878,1.0,1.0,13/165,9.42%,FOXA2;VAX2;NR4A2;PBX4;NIF3L1;PBX3;RUNX3;PIN1;TDP2;IER2;MYEF2;MTPN;ERCC3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4164238880278502,0.8556620633222535,0.6266149870801033,1.0,1.0,4/16,15.99%,ZFP36L1;CPEB3;RC3H1;ZFP36L2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.36330414615842627,0.8555760781148778,0.7075664621676891,1.0,1.0,13/76,12.48%,BRCA1;SAE1;AXIN1;TANK;CAV1;UBA2;BIRC2;UBQLN1;CUL3;PIAS3;XIAP;PAXIP1;CDK5RAP3
prerank,acute inflammatory response (GO:0002526),0.40084215773676707,0.8555463502179528,0.6476997578692494,1.0,1.0,3/23,17.46%,IL22;F3;ANO6
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4105227185492939,0.855413731655597,0.6469135802469136,1.0,1.0,7/20,19.36%,IL1R1;B2M;DENND1B;MAP3K7;MALT1;CD55;TRAF6
prerank,T cell activation involved in immune response (GO:0002286),0.4355583352012609,0.8553137714212116,0.6372688477951636,1.0,1.0,1/12,3.68%,CD74
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.36324587723638313,0.8552374711535795,0.7304526748971193,1.0,1.0,18/85,16.92%,PSMB7;TIAM1;PSMD11;PSMF1;PSMC1;CLTC;PSMC3;PSMA4;PSMC4;ARRB2;AP2B1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;RAC1;PSMD4
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.2690151603020241,-0.8548471666373806,0.6758241758241759,0.8949617864657572,1.0,9/23,28.67%,UBASH3B;PSEN2;ANK2;PRNP;ATP1A2;CBARP;CACNB1;PTK2B;CAMK2D
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.45294962697690533,0.8546366703618777,0.6556195965417867,1.0,1.0,5/10,20.79%,JUN;BAG3;VHL;DNAJB1;CITED2
prerank,regulation of GTPase activity (GO:0043087),0.3551676478172463,0.8545657631781928,0.7857857857857858,1.0,1.0,28/177,15.39%,ECT2;PRTN3;EZH2;ARHGEF5;ARHGAP15;ARHGAP11A;NET1;RASGRP1;EVI5;PIN1;SNX9;PLXNA2;LARS1;FGD6;EPHA3;CAV2;GMIP;RDX;CRK;FGD3;ARHGAP9;RACK1;RSU1;ADAP1;ADCYAP1;GSK3B;LIMS1;F2R
prerank,defense response to virus (GO:0051607),0.35821813724489726,0.8545473819579296,0.7378542510121457,1.0,1.0,13/100,14.46%,RNASE6;PMAIP1;SKP2;FLNA;CGAS;SERINC5;SERINC3;PDE12;CLPB;MYD88;NT5C3A;IFITM3;TRIM5
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.2657615306270252,-0.8543700268715523,0.7341772151898734,0.894713271447911,1.0,7/26,15.83%,KCNAB1;ANK2;ATP1B2;VAMP2;FHL1;ATP1B1;DLG1
prerank,glycolipid metabolic process (GO:0006664),-0.2199466068809536,-0.8539788993611314,0.7321428571428571,0.8942250739420681,1.0,12/47,18.92%,HEXB;CTSA;PSAP;ST3GAL6;ST6GALNAC4;ST6GALNAC6;ST3GAL4;B4GALNT1;GALC;CERK;GLA;ST6GALNAC3
prerank,protein localization to cell surface (GO:0034394),0.39642703233921084,0.8537552023732947,0.6504739336492891,1.0,1.0,6/26,17.84%,CD177;FLNA;GGA1;PIGU;PTPRU;GGA2
prerank,extracellular structure organization (GO:0043062),0.3547331483867027,0.8536985503220091,0.8128128128128128,1.0,1.0,35/204,17.49%,ADAMTS7;ICAM4;ITGA1;ECM2;ITGB7;CD47;PECAM1;HSPG2;CD44;LAMA5;COL1A2;LAMA4;DCN;COL4A4;LAMC1;LAMB2;LAMB3;ITGAV;SMOC2;JAM2;ATP7A;NID1;BSG;ITGA8;COL23A1;MMP19;DAG1;ADAMTS1;TGFBI;ELN;ST7;ADAMTSL3;ADAMTS5;COL4A1;FN1
prerank,regulation of establishment of planar polarity (GO:0090175),0.3607869580213958,0.853649756074923,0.7320328542094456,1.0,1.0,18/88,16.92%,PSMB7;TIAM1;PSMD11;PSMF1;PSMC1;CLTC;PSMC3;PSMA4;PSMC4;ARRB2;AP2B1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;RAC1;PSMD4
prerank,carnitine shuttle (GO:0006853),0.43776492446076987,0.8535433309508625,0.6438746438746439,1.0,1.0,4/11,15.05%,CPT1B;CPT1A;PRKAG2;CPT2
prerank,regulation of endocytic recycling (GO:2001135),0.45085872362449864,0.8535194844632844,0.6550218340611353,1.0,1.0,6/11,23.73%,ACTN2;EIPR1;RAB11B;ARHGAP1;INPP5F;EHD1
prerank,intracellular protein transmembrane transport (GO:0065002),0.3718039257723277,0.8533244925835031,0.6685082872928176,1.0,1.0,11/42,17.48%,PEX26;C2CD5;CHCHD4;DNAJC15;PEX2;TOMM70;TIMM23;GRPEL2;ZFAND2B;SEC63;PEX14
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.391918048559076,0.8531769887421888,0.6594036697247706,1.0,1.0,8/30,18.79%,HACD4;ABCD1;ACOT2;SLC27A2;PEX2;ELOVL5;ELOVL4;ABCD4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3796015035913665,0.8530219823541492,0.678082191780822,1.0,1.0,12/37,22.51%,DNMT1;JUN;FGF9;PTEN;EFEMP2;BMPR1A;ADAMTS1;APLN;LDLRAP1;CDKN1A;MEF2D;CDKN1B
prerank,positive regulation of TOR signaling (GO:0032008),-0.23119003939080698,-0.8528013402496374,0.696078431372549,0.8954272955153455,1.0,10/40,14.33%,TREM2;GPR137C;RRAGD;HDAC3;WDR59;FLCN;FNIP1;LAMTOR5;NCKAP1L;RRAGC
prerank,hippo signaling (GO:0035329),0.38855751168585106,0.8527953621141645,0.6516990291262136,1.0,1.0,10/26,20.15%,TEAD4;AMOTL2;LATS1;MOB1A;STK4;YWHAE;AMOTL1;MOB1B;STK3;NPHP4
prerank,negative regulation of lyase activity (GO:0051350),0.4226223668248645,0.852771642953005,0.6666666666666666,1.0,1.0,4/16,19.24%,PALM;CCR2;ADGRV1;GRM3
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.41650261943924605,0.8527639109838385,0.6551724137931034,1.0,1.0,5/18,11.59%,EZR;FAF1;ABCA2;MSN;RDX
prerank,negative regulation of receptor internalization (GO:0002091),0.43912445393936717,0.8524941250041514,0.6460905349794238,1.0,1.0,4/12,21.60%,RIN3;MTMR2;ANKRD13A;UBQLN2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.40050153293476864,0.8522715727630154,0.6354916067146283,1.0,1.0,7/23,22.09%,MAPK1;PRKACA;GABPA;SNCA;LRRK2;GNB1;ATP2B4
prerank,myelin assembly (GO:0032288),0.441226371480105,0.8522333261172659,0.6473906911142454,1.0,1.0,2/10,9.64%,ABCA2;PMP22
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4259826180547978,0.8515656029840819,0.6459459459459459,1.0,1.0,4/14,16.84%,TFRC;KMT5C;PAXIP1;RIF1
prerank,icosanoid metabolic process (GO:0006690),0.3792600530357604,0.8515007961173159,0.6732456140350878,1.0,1.0,7/40,13.14%,CYP1B1;DPEP2;DPEP1;HPGD;LTA4H;ABCC10;PON3
prerank,skeletal muscle contraction (GO:0003009),0.41185187740948476,0.8514694520975222,0.6444444444444445,1.0,1.0,1/19,4.08%,CCDC78
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.2998231847975936,-0.851131391925947,0.6807511737089202,0.8976820775660415,1.0,4/18,7.90%,SBNO2;PYCARD;FCER1G;NMI
prerank,cellular response to retinoic acid (GO:0071300),0.3706257945227072,0.8508905899538973,0.6877076411960132,1.0,1.0,8/42,19.39%,AQP1;ATM;SETX;EPHA3;PTK7;CREB1;PAX2;SOX9
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.25600935761393906,-0.8506171633112116,0.6923076923076923,0.8974763745967622,1.0,9/24,24.58%,EPN2;ARNT;ITGA5;ITGB3;GRB10;DAB2IP;HIF1A;MT3;VTN
prerank,protein O-linked mannosylation (GO:0035269),-0.2883342881486207,-0.8501986883272628,0.6635514018691588,0.8970774585912505,1.0,3/18,6.82%,CRPPA;LARGE1;FKTN
prerank,regulation of T cell migration (GO:2000404),0.4121752200404723,0.8496279773889723,0.6529338327091136,1.0,1.0,3/18,10.57%,SPN;RIPOR2;CCR6
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.433959225778831,0.8492896991150924,0.6615598885793872,1.0,1.0,2/12,10.14%,DCN;CHST12
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.27446569125361303,-0.8478836559097914,0.6702127659574468,0.9007716554673183,1.0,4/20,7.84%,ACLY;PPT1;ACACA;PPT2
prerank,inner mitochondrial membrane organization (GO:0007007),-0.21943677946597384,-0.8471763034340352,0.8285714285714286,0.9010219278332636,1.0,25/47,32.78%,MICOS10;GHITM;APOO;AGK;MTX2;LETM1;ATP5F1C;MTX3;SPG7;ATP5MC3;MAIP1;TIMM22;TIMM10B;AFG3L2;ATP5MC1;MTX1;TIMM13;CHCHD6;TIMM8B;TMEM11;ROMO1;TIMM29;UQCC3;IMMT;ATP5MG
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4243050444143249,0.8470063349220338,0.6446173800259404,1.0,1.0,5/15,17.78%,NPLOC4;FAF2;DERL2;HSP90B1;SYVN1
prerank,dermatan sulfate metabolic process (GO:0030205),0.42660834237485235,0.8468739812801103,0.6644113667117727,1.0,1.0,2/13,10.14%,DCN;CHST12
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.37647486633843075,0.8466105577090488,0.6842684268426843,1.0,1.0,12/39,23.60%,GPD1L;YWHAH;FXYD5;NEDD4L;CHRM3;STK39;UTRN;YWHAE;RIPK1;PHB2;NEDD4;WNK3
prerank,focal adhesion assembly (GO:0048041),0.40033528505029004,0.8464893638553598,0.6580246913580247,1.0,1.0,8/21,23.20%,SORBS1;WHAMM;ACTN2;TESK2;BCR;ARHGEF7;ACTN1;SRC
prerank,neutrophil activation (GO:0042119),-0.33430051846009357,-0.8462980209039617,0.6605166051660517,0.9016853078820092,1.0,2/12,6.74%,KMT2E;FCER1G
prerank,cellular response to ATP (GO:0071318),0.4181658500310246,0.8462904155577597,0.6617842876165113,1.0,1.0,3/14,17.46%,TAF1;P2RY1;HSP90B1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.40276658233074564,0.8462706509167639,0.6629072681704261,1.0,1.0,2/20,4.25%,PRKCE;PTPN22
prerank,dendritic spine organization (GO:0097061),-0.2508120824121838,-0.8460225867880589,0.7621951219512195,0.9009743563452209,1.0,3/26,0.60%,IGF1R;PAK3;TREM2
prerank,renal absorption (GO:0070293),0.44036474629475175,0.8458290516357634,0.6568047337278107,1.0,1.0,1/10,5.93%,GSN
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3929717351811112,0.845628247440269,0.6572104018912529,1.0,1.0,11/26,26.85%,CIB1;PLCG2;CAMTA1;GSK3B;STIMATE;HOMER2;SPPL3;ATP2B4;PTBP1;DYRK2;AKAP6
prerank,inorganic anion transmembrane transport (GO:0098661),0.3611127304427536,0.845478329136317,0.7126315789473684,1.0,1.0,8/63,12.59%,SLC12A3;SLC5A5;SLC12A7;SLC12A1;GABRA4;GABRA5;ANO3;SLC12A6
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.21838704043736798,-0.8452975484321481,0.8085106382978723,0.9012361026267564,1.0,19/59,24.46%,OSBPL2;ACLY;LPL;ACACA;OSBPL9;OSBPL7;ALOX5;SCP2;OSBP;OSBPL6;CH25H;HOGA1;LIPH;PER2;CYP39A1;MLYCD;AMACR;OXSM;MCAT
prerank,megakaryocyte differentiation (GO:0030219),0.4337389680157407,0.8452532033986049,0.6613603473227206,1.0,1.0,1/11,3.56%,ZFPM1
prerank,endothelial cell migration (GO:0043542),0.3786604837337059,0.844811659859164,0.6791208791208792,1.0,1.0,5/37,13.01%,CYP1B1;FAP;PRKX;DPP4;NRP1
prerank,regulation of response to external stimulus (GO:0032101),0.3514841667639724,0.844619434775714,0.7591093117408907,1.0,1.0,32/121,21.87%,FOXA2;DHX58;PTPN22;FOXP1;CAV1;CCR2;TRAF3;BIRC2;BRD4;METAP2;JAK2;CYRIB;STK24;IL1R1;PARK7;XIAP;MYD88;USP14;SPATA2;BCL6;TRIM5;F2R;APPL1;FCGR2B;CXCR4;ERAP1;CD55;CASP8;NMT2;CELF1;AKNA;FGR
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4217582433511543,0.844365077012202,0.6449086161879896,1.0,1.0,5/14,16.59%,SAP18;SRSF4;RNPS1;SRSF10;SRSF7
prerank,cardiac muscle tissue development (GO:0048738),0.3679066468242997,0.8441097811681197,0.7003188097768331,1.0,1.0,6/50,12.63%,HEY2;ZFPM1;CSRP3;NOTCH1;SMAD4;BMPR1A
prerank,chemical homeostasis (GO:0048878),0.36238784187129824,0.8439805635048973,0.702845100105374,1.0,1.0,3/61,7.95%,SLC4A1;USF1;NEDD4L
prerank,positive regulation of isotype switching (GO:0045830),0.4173272174270156,0.8437378754676427,0.6609271523178808,1.0,1.0,4/15,16.84%,TFRC;KMT5C;PAXIP1;RIF1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4060547839977097,0.8434959416662983,0.6495619524405507,1.0,1.0,3/17,12.63%,HEY2;NOTCH1;BMPR1A
prerank,positive regulation of glucose metabolic process (GO:0010907),0.41865589066782694,0.8433573305455256,0.6639892904953146,1.0,1.0,3/14,16.94%,PMAIP1;IRS1;SIRT1
prerank,bile acid biosynthetic process (GO:0006699),-0.264969767002149,-0.8432161565504842,0.7368421052631579,0.9042854486454638,1.0,7/24,12.45%,OSBPL2;OSBPL9;OSBPL7;SCP2;OSBP;OSBPL6;CH25H
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.2554972205679773,-0.8428714393757917,0.6802721088435374,0.9037742432868804,1.0,14/27,33.72%,CACNB2;ANK2;DMD;CACNB4;CALM1;JPH4;SELENON;CACNB1;FKBP1B;CAMK2D;CALM2;ADRA2A;NOS1;JPH3
prerank,cellular response to glucose stimulus (GO:0071333),-0.2556113509232058,-0.8422884659609694,0.736,0.9038329230601742,1.0,8/30,16.65%,IGF1R;SELENOT;PRKAA2;ERN1;PTPRN;SLC39A14;SOX4;RAB11FIP5
prerank,cholesterol metabolic process (GO:0008203),0.3539556341306714,0.8422593844413323,0.7123572170301142,1.0,1.0,15/68,21.22%,LBR;CEL;LSS;OSBPL5;GBA2;IDI1;CYP27A1;CYP46A1;NSDHL;FDPS;DHCR7;LDLRAP1;PPARD;OSBPL1A;SCAP
prerank,cellular response to glucose starvation (GO:0042149),0.36945689110315266,0.8421159870290585,0.6823144104803494,1.0,1.0,14/41,22.68%,PMAIP1;TBL2;SIK2;PICK1;SZT2;BECN1;PRKAG2;TP53;XBP1;HNRNPA1;NIM1K;PRKAG1;BRSK1;MYBBP1A
prerank,positive regulation of catalytic activity (GO:0043085),0.3766918966683827,0.8420089308905692,0.704772475027747,1.0,1.0,7/37,14.04%,PHACTR4;MSH6;CAV1;CIB1;MAPK14;ATP7A;PSEN1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3565014983441971,0.8418304149715164,0.7069864442127216,1.0,1.0,12/67,16.70%,BLK;FYN;JAK2;EGFR;EPHA3;DYRK1A;BTK;RELN;FLT3;PIBF1;FGFR1;JAK3
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.424535501289154,0.8417610292836948,0.65625,1.0,1.0,3/14,19.36%,TYROBP;ATP6AP1;TRAF6
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.43823231871459856,0.8416761032230162,0.6503496503496503,1.0,1.0,4/11,19.06%,PANK2;SLC25A16;DCAKD;PANK1
prerank,coenzyme A biosynthetic process (GO:0015937),0.43823231871459856,0.8416761032230162,0.6503496503496503,1.0,1.0,4/11,19.06%,PANK2;SLC25A16;DCAKD;PANK1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.43823231871459856,0.8416761032230162,0.6503496503496503,1.0,1.0,4/11,19.06%,PANK2;SLC25A16;DCAKD;PANK1
prerank,lamellipodium assembly (GO:0030032),0.38844876758309665,0.8416122787769843,0.6658878504672897,1.0,1.0,12/26,25.84%,CCDC88A;ABLIM3;WHAMM;PARVB;RAC1;ARHGEF7;ABLIM2;GOLPH3;VCL;SRGAP2;ABLIM1;ARHGEF6
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4118988352865452,0.8414993964211785,0.6867627785058977,1.0,1.0,4/18,15.17%,RB1;CLASP1;EFEMP2;RUNX1
prerank,cellular response to starvation (GO:0009267),0.34929766258553707,0.8412020797780745,0.7845691382765531,1.0,1.0,38/147,20.91%,STK26;PMAIP1;DAP;MAPK1;EIF2S1;TBL2;SIK2;FOXO1;KLF10;MAP3K5;PICK1;LARS1;STK24;SEC13;SZT2;MLST8;BECN1;FAS;RNF152;ATP6V0E1;PRKAG2;LAMTOR4;LAMTOR3;TP53;RIPOR1;NPRL3;SIRT1;XBP1;ATP6V0D1;LRRK2;HNRNPA1;NIM1K;CDKN1A;SREBF2;RRAGB;WDR45B;PRKAG1;WRN
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.276730388270739,-0.8410822318750562,0.7251184834123223,0.9050926146423284,1.0,9/20,24.49%,MBTPS1;PSEN2;RELA;HM13;ADAM9;APH1A;SPPL2B;APH1B;SPPL2A
prerank,negative regulation of cholesterol transport (GO:0032375),0.4379364227881156,0.8408148901570661,0.6657183499288762,1.0,1.0,2/10,19.50%,ABCA2;SREBF2
prerank,negative regulation of chemokine production (GO:0032682),0.4157627327912904,0.8407768152971615,0.644474034620506,1.0,1.0,1/14,2.08%,MEFV
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.40469308817974115,0.8405867395138662,0.6632911392405063,1.0,1.0,5/17,22.51%,PTEN;EFEMP2;APLN;CDKN1A;CDKN1B
prerank,regulation of macrophage differentiation (GO:0045649),-0.30426411644187573,-0.8405625566124848,0.691358024691358,0.9048541752647047,1.0,4/15,14.46%,PTPN2;C1QC;CSF1;ID2
prerank,receptor catabolic process (GO:0032801),0.3821956875475417,0.8402024504197654,0.6576151121605667,1.0,1.0,7/24,18.62%,CLTC;BECN1;SNX25;AP2B1;MYLIP;KIF16B;RNF43
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.23797184025425205,-0.8396826570228769,0.7795275590551181,0.9053562838238963,1.0,8/35,11.78%,NRP2;FARP2;PLXNA4;SEMA3D;SEMA3E;SEMA4C;SH3BP1;SEMA4G
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3571485593545931,0.8395486496021715,0.7316821465428277,1.0,1.0,15/76,20.08%,SPAG5;GPSM2;PRKCE;SYNPO2;DYNC1H1;SNX9;CFL2;CDC42EP3;NRP1;NUMA1;KATNBL1;HCLS1;CDC42EP1;PROX1;PLK4
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3566604554853198,0.8394122873271459,0.7286742034943474,1.0,1.0,13/80,12.48%,PLK1;BRCA1;AXIN1;CAV1;PEF1;BIRC2;PIN1;UBQLN1;CUL3;XIAP;SPSB4;PAXIP1;CDK5RAP3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.2726685818901131,-0.8391549164424659,0.6721311475409836,0.9051541334488066,1.0,6/22,13.92%,MAN1C1;EDEM3;RNF185;OS9;EDEM2;RNF139
prerank,positive regulation of biosynthetic process (GO:0009891),0.36920829128914506,0.838685942113383,0.6684841875681571,1.0,1.0,12/40,21.03%,SORBS1;PLCG2;MTPN;TLR6;RUNX1;F2R;VIM;CYBA;CREB1;ZBTB20;RAB27A;SIRT4
prerank,protein processing (GO:0016485),0.34564056600142423,0.838365470169271,0.7489878542510121,1.0,1.0,21/102,20.44%,TMPRSS4;KEL;MYRFL;PIDD1;CPM;CASP2;METAP2;SPCS1;PITRM1;TMEM208;FAM111A;F3;PSEN1;PCSK1;CPD;SPPL3;ADAM10;CLN3;PCSK7;MME;SPCS3
prerank,ventricular septum development (GO:0003281),0.37494240221111697,0.8383204581285668,0.6782511210762332,1.0,1.0,8/37,12.63%,HEY2;ZFPM1;MDM4;PDE2A;NOTCH1;SMAD4;SLIT3;BMPR1A
prerank,monosaccharide transmembrane transport (GO:0015749),0.40915928079207875,0.8382437534727581,0.6653225806451613,1.0,1.0,2/16,10.96%,SLC2A8;SLC2A12
prerank,ganglioside metabolic process (GO:0001573),-0.274146922628209,-0.8380012878393989,0.7112299465240641,0.9062104013233306,1.0,7/20,20.65%,HEXB;ST6GALNAC4;ST6GALNAC6;B4GALNT1;ST6GALNAC3;CLN6;ST8SIA3
prerank,nucleotide metabolic process (GO:0009117),-0.2634489507403237,-0.8379616366221052,0.7484662576687117,0.9050175285581242,1.0,15/23,35.35%,CMPK1;ME1;NMNAT3;DCK;NMNAT1;FHIT;DCTD;AK1;NMNAT2;AK7;GUK1;ENPP3;AK4;AK8;NME2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.37140253478192103,0.8379266014569167,0.7002212389380531,1.0,1.0,12/38,22.62%,DHX58;PUM2;PRKCA;RIOK3;PUM1;DHX9;USP15;CYBA;IFI35;POLR3B;SASH1;AKIRIN2
prerank,ether lipid biosynthetic process (GO:0008611),-0.3418927044782363,-0.837433415332178,0.6310679611650486,0.9048209182267898,1.0,7/10,35.93%,DHRS7B;GNPAT;CHPT1;PEDS1;PLA2G4A;PEX7;PLA2G4C
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3470377730552917,0.8372585431943058,0.789,1.0,1.0,22/140,19.21%,S1PR4;CXCR5;IAPP;LPAR4;CAV1;CCR2;HMGB1;P2RY1;CCR6;FIS1;ADCYAP1;JPH1;F2R;LPAR1;GPR35;CD24;TRPM4;ADCY8;SPPL3;CXCR4;PTGER4;CD55
prerank,negative regulation of protein polymerization (GO:0032272),0.38318670842890934,0.83715492996308,0.6702380952380952,1.0,1.0,9/27,23.15%,STMN1;CYRIB;DYRK1A;SNCA;TBCD;EML2;SSH2;TWF1;PRKCD
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.2881023007840869,-0.8371508041160601,0.7168949771689498,0.9040564635120529,1.0,6/17,25.43%,ATP1A1;AR;TFPI;ATP1A2;ATP1A3;URI1
prerank,regulation of metal ion transport (GO:0010959),0.4153423436143503,0.8368885438435787,0.6649937264742786,1.0,1.0,2/16,4.45%,IL16;EPB41
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.2592415111700487,-0.8366789238899613,0.6791044776119403,0.9037839623510783,1.0,3/28,1.47%,APP;SQSTM1;APOE
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.29715216680775564,-0.836622978562979,0.6919831223628692,0.9026368165053431,1.0,2/16,3.68%,VSIR;CD274
prerank,response to insulin (GO:0032868),0.35240674316815834,0.8365958315124681,0.7319587628865979,1.0,1.0,18/80,17.66%,C2CD5;SLC2A4;USF1;FOXO1;DENND4C;SORBS1;ZFP36L1;RAB8A;PDPK1;KAT2B;RAB8B;ZBTB7B;PRKDC;IRS1;CAPN10;SIRT1;XBP1;EPRS1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3879076630647226,0.836148144377916,0.6629491945477075,1.0,1.0,4/24,8.37%,ITPR1;HTR2A;IBTK;PLCG2
prerank,positive regulation of cell motility (GO:2000147),0.3476247056020141,0.8360899130528042,0.844,1.0,1.0,31/205,15.51%,GTSE1;ARHGEF39;LEF1;PECAM1;SYNE2;TIAM1;NTN1;SUN2;PPP3CA;CCN1;TWIST1;NEDD9;CAV1;ATM;TRADD;NOTCH1;DDRGK1;CIB1;PRKCA;EGFR;CBLL1;RDX;F3;ROCK2;RACK1;ACTN4;PDCD10;RIPOR1;EGF;F2R;SPAG9
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.2655271409410276,-0.8359584363056372,0.7015706806282722,0.902702470549599,1.0,2/21,1.27%,TGFBR1;RBPMS
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.34807824321548125,0.8356410196888255,0.7127991675338189,1.0,1.0,19/74,17.60%,PSMB7;PSMD11;PSMF1;PSMC1;NOTCH1;PSMC3;PSMA4;PSMC4;NFE2L2;PSMD13;PSME1;CREBBP;PSMB1;LIMD1;PSMD8;PSME4;VHL;PSMD4;UBA52
prerank,protein tetramerization (GO:0051262),0.35424982646399783,0.8355477807189742,0.726895119418484,1.0,1.0,12/67,20.18%,MS4A1;TK1;CUTC;CBR4;ACOT13;B2M;KCNJ2;TRPM4;SNCA;PKD2;KCNC1;CPSF7
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.24974075827769182,-0.8354939389436449,0.7007874015748031,0.902353438351474,1.0,5/29,7.84%,ACLY;PPT1;ACACA;ELOVL7;PPT2
prerank,pinocytosis (GO:0006907),0.43577328621481426,0.8351351801773365,0.6595135908440629,1.0,1.0,2/10,4.96%,SNX33;MAPKAPK3
prerank,negative regulation by host of viral process (GO:0044793),0.4419893877912695,0.834486969812085,0.6680497925311203,1.0,1.0,3/10,14.75%,PSMC3;VAPA;CCNK
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3993733693009718,0.8343444996557239,0.6658415841584159,1.0,1.0,5/18,18.96%,SOX6;NOTCH1;XBP1;HDAC4;HDAC1
prerank,epidermal cell differentiation (GO:0009913),-0.22650102136904032,-0.8341033037431401,0.7341772151898734,0.9039704880200908,1.0,7/41,16.46%,CTNNB1;HDAC2;ST14;CASP3;ADAM9;ERCC2;JAG1
prerank,dicarboxylic acid transport (GO:0006835),0.38025763159619314,0.8340641593327726,0.6816568047337278,1.0,1.0,6/28,17.48%,SLC25A12;ABCC2;SLC19A1;SLC25A22;SLC25A13;ARL6IP5
prerank,cortical cytoskeleton organization (GO:0030865),-0.22912210299523783,-0.8338354838273024,0.7792207792207793,0.9032156620861036,1.0,18/41,23.46%,FHOD1;RHOBTB1;FMNL2;RHOBTB2;STRIP1;RHOG;EPB41L3;NCKAP1L;RHOQ;RHOH;FHOD3;DLG1;TRPV4;LLGL1;PLEK;RHOC;FMNL3;RHOF
prerank,regulation of muscle contraction (GO:0006937),0.3789864953459586,0.8333959159601215,0.6926605504587156,1.0,1.0,3/26,8.88%,CAV1;PPP1R12B;KCNA1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.2889570728313012,-0.8333848602402567,0.6881188118811881,0.9029028101875431,1.0,6/19,15.07%,TGFBR1;ERBB4;ZFPM2;FGF2;VGLL4;TGFBR3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.39269308272764897,0.8333261261435615,0.6707021791767555,1.0,1.0,3/22,7.99%,NRDC;SNX33;SNX9
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.42873091494571375,0.8333225537311346,0.6648793565683646,1.0,1.0,7/12,22.80%,ABCA2;ABCA7;ROCK2;FLOT2;ROCK1;TMED10;FKBP1A
prerank,cell projection assembly (GO:0030031),0.3935737939567911,0.8331434045903346,0.6642685851318945,1.0,1.0,6/22,16.79%,GSN;RHOU;RAC2;PARVB;RAC1;PARVA
prerank,regulation of neurotransmitter secretion (GO:0046928),0.37334276002420075,0.8328992064385402,0.697594501718213,1.0,1.0,10/32,21.64%,CHRNB4;BAIAP3;DTNBP1;GSK3B;RAB5A;MCTP1;LRRK2;HCRT;RIMS3;MCTP2
prerank,protein targeting to lysosome (GO:0006622),-0.27349263081451275,-0.8321158933116293,0.7083333333333334,0.9041085073647017,1.0,5/20,14.09%,GGA3;LAMP2;SNX16;SCARB2;NAGPA
prerank,response to estradiol (GO:0032355),0.3784122227136739,0.8320681155431227,0.689173457508731,1.0,1.0,5/31,12.73%,CRHBP;EGFR;SOCS2;RUVBL2;STAT5B
prerank,response to lipopolysaccharide (GO:0032496),0.34596912357178883,0.8320347099509181,0.8038229376257545,1.0,1.0,13/138,8.54%,GFI1;IL12A;HMGB2;PTPN22;S100A9;MAPKAPK3;SLPI;FOXP1;NR1D1;S100A8;HMGB1;MAPK14;JAK2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3960066817001077,0.8317187706641067,0.6699386503067485,1.0,1.0,7/22,25.99%,CHD1L;ERCC3;UBA52;DDB2;XPA;PARP1;RBX1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.421488273021711,0.8315632281982374,0.655266757865937,1.0,1.0,8/13,26.21%,CNOT1;RC3H1;CNOT8;PNPT1;PRR5L;CNOT7;ZC3HAV1;KHSRP
prerank,amide biosynthetic process (GO:0043604),0.3603177024299594,0.8312739188328396,0.7056277056277056,1.0,1.0,9/47,16.35%,RHD;SGMS2;NMRAL1;CERS4;SGMS1;PCSK1;ASL;ASS1;CERS6
prerank,cranial nerve development (GO:0021545),0.4304864561475473,0.8312410435657375,0.657967032967033,1.0,1.0,3/11,19.35%,ERBB3;TIFAB;PAX2
prerank,programmed necrotic cell death (GO:0097300),-0.27678946628739354,-0.8307894449453382,0.6818181818181818,0.9055083784176012,1.0,9/18,27.42%,ITPK1;DNM1L;TLR4;LY96;TICAM1;IPMK;TICAM2;MLKL;CD14
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3656106406693136,0.8307415644653535,0.7063318777292577,1.0,1.0,12/39,23.60%,PRKCE;GPD1L;YWHAH;FXYD5;NEDD4L;FGF13;STK39;UTRN;HECW2;NEDD4;OSR1;WNK3
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2861535504511707,-0.8306809592177634,0.6868686868686869,0.9045168411518125,1.0,5/18,8.49%,HEATR1;PHF8;WDR75;DHX33;ATF4
prerank,regulation of sodium ion transport (GO:0002028),-0.2429915915797009,-0.8306139571864198,0.7647058823529411,0.9034077858610541,1.0,9/34,15.83%,NKAIN2;ANK3;CNKSR3;ATP1A1;SNTA1;SCN1B;FGF12;PER1;DLG1
prerank,adipose tissue development (GO:0060612),0.43750163365373795,0.830511648577053,0.6715542521994134,1.0,1.0,3/11,17.05%,PGRMC2;ARID5B;XBP1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.35264883179741024,0.8303947506633066,0.7481865284974093,1.0,1.0,10/71,12.38%,ADAMTS7;PMAIP1;FAP;PRPF19;NR1D1;FBXO44;HDAC6;LONP1;CTSK;CTSO
prerank,positive regulation of catabolic process (GO:0009896),0.35555049122496835,0.830276852296608,0.7193347193347194,1.0,1.0,8/65,12.14%,BARD1;DTL;AXIN1;FOXO1;STX5;NEDD4L;FZR1;OAZ1
prerank,transcription preinitiation complex assembly (GO:0070897),0.42494601075162,0.8296000274538423,0.6642651296829971,1.0,1.0,4/12,21.60%,TAF1;TAF7;GTF2A2;TAF11
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3435971102099849,0.8293404831964413,0.7759838546922301,1.0,1.0,26/116,23.65%,VIPR2;IAPP;RAMP1;FYN;PTHLH;DPEP1;NPSR1;MAPK14;PRKACA;INSL3;PLCG2;CALCRL;ADCYAP1;PLCG1;ADCY8;FCGR2B;CREB1;PTGER4;PRKAR2A;SYK;ADCY9;FGR;GNB1;ADAM17;SRC;MYH9
prerank,Rho protein signal transduction (GO:0007266),0.3605550845705426,0.8286454603234977,0.7336197636949516,1.0,1.0,13/53,21.04%,PHACTR4;NTN1;ARHGDIB;ARHGEF3;COL1A2;RHOU;CDC42EP3;ROCK2;RIPOR1;ARHGDIA;CDC42EP1;ARHGAP1;ROCK1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.37153923486005946,0.8284013321204804,0.6927437641723356,1.0,1.0,5/35,8.81%,AQP1;PDE7B;PDE2A;AHR;NUDT4
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3516198317336737,0.8282089673638223,0.7510416666666667,1.0,1.0,11/73,14.45%,CD2;SPN;TWIST1;CCR2;RASGRP1;HMGB1;PLCG2;JAK2;DHX9;PSEN1;TYROBP
prerank,positive regulation of lymphocyte migration (GO:2000403),0.426525749730821,0.8279895412480088,0.6823855755894591,1.0,1.0,2/12,9.15%,SPN;JAM2
prerank,JNK cascade (GO:0007254),0.36934081054575346,0.8279453621510301,0.6982182628062361,1.0,1.0,13/40,20.53%,CRKL;IKBKG;MAP3K5;MAP4K2;TAB1;UBE2V1;TAB3;MAP3K11;UBA52;MAP3K7;PTGER4;TRAF6;UBE2N
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3137472753202175,-0.8278324246195008,0.6776859504132231,0.9075647790645989,1.0,4/13,10.44%,IGF1;AKT2;PHKG2;IRS2
prerank,regulation of protein phosphorylation (GO:0001932),0.34117322756175755,0.8276591156546622,0.873,1.0,1.0,68/256,23.12%,ECT2;MEN1;PECAM1;CCDC88A;FYN;CCN1;CD74;PML;AXIN1;BRAT1;PGF;PPP2R5E;TFRC;RASGRP1;CRKL;PPP2R5A;CCDC88C;SMG8;BRD4;PIN1;NIBAN1;CIB1;IBTK;EGFR;P2RY1;PARK7;WDFY2;FGF9;FAS;PTEN;CDK5RAP3;FXR1;ROCK2;RACK1;FLOT1;PRKDC;FAM20A;PPIA;MYDGF;STK4;FKBP8;PPP2R5D;LIMK2;RAC1;PDE8A;SIRT1;FN1;PTPN13;LRRK2;MOB1B;SOX9;AKTIP;PPP2CA;EPHA7;CCND3;PRR5L;ILK;SLCO3A1;RIPK1;CADM4;FGR;PPP1R15B;EFNA1;NTRK3;NSD1;TWF1;TARDBP;ADAM17
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3423052506101169,0.8276208027815726,0.7865055387713998,1.0,1.0,11/117,8.37%,VIPR2;IAPP;RAMP1;FYN;PTHLH;DPEP1;NPSR1;MAPK14;PRKACA;INSL3;PLCG2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.2820401430498589,-0.8273878287356737,0.7242990654205608,0.9073084911423336,1.0,8/19,27.59%,APP;TMEM106A;MAPK8;WFS1;KLF2;MAPK7;KLF4;CHRNA7
prerank,detection of visible light (GO:0009584),0.4051340988831264,0.8267632934537743,0.6675224646983312,1.0,1.0,1/16,8.02%,CEP250
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.30878002636608987,-0.8266737381695151,0.656934306569343,0.9074699829810127,1.0,1/13,0.15%,HEXB
prerank,homocysteine metabolic process (GO:0050667),-0.33227293082117804,-0.8265496901983997,0.6666666666666666,0.9064083212692782,1.0,4/11,14.45%,MTHFR;MMUT;MTRR;NOX4
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3573484934276755,0.8265057171258481,0.7308510638297873,1.0,1.0,11/53,13.47%,XPO1;GLMN;PSMF1;DESI1;DDRGK1;PRKACA;PSMC3;RAD23A;UCHL5;USP14;PSME1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4415837020688524,0.8264896690660309,0.6736111111111112,1.0,1.0,5/10,24.50%,ACADM;IVD;ETFDH;ETFB;ETFA
prerank,camera-type eye morphogenesis (GO:0048593),0.43898010979772595,0.8262391360344291,0.67007299270073,1.0,1.0,3/10,18.10%,SHROOM2;SKI;KDM2B
prerank,organophosphate biosynthetic process (GO:0090407),-0.2312750437293608,-0.8260845588869639,0.7848101265822784,0.9060887763893613,1.0,9/37,14.30%,AGPAT5;ITPKB;MBOAT1;IP6K1;GNPAT;TPI1;MOCS2;LPCAT1;FGF2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.39631873057215333,0.8257021478824552,0.6801470588235294,1.0,1.0,4/20,16.31%,TMPRSS3;NEDD4L;KCNJ2;ATP6AP1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.34664271458879936,0.8256206117174649,0.7671092951991828,1.0,1.0,23/91,18.53%,RAB33B;CD177;MAPK1;STON1;ARFGAP1;RAB8A;LGI3;ITGAV;RIT2;RAB8B;DNAJC13;HAP1;PACSIN2;RAB11B;NRP1;STON2;PLD1;MAP2K1;RAB5A;CHMP3;USP7;LRRK2;RUFY1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.29608691333305537,-0.82558883614944,0.6607929515418502,0.9058667494517159,1.0,11/17,36.66%,DGKQ;SMAD7;CALM1;SPRED1;SPRED3;PARD3;CALM2;DDIT4;SPRY2;SIRT2;PPEF2
prerank,positive regulation of angiogenesis (GO:0045766),0.34256931689954323,0.8254258944904761,0.7745197168857432,1.0,1.0,19/108,17.05%,CYP1B1;BRCA1;AQP1;TWIST1;EMC10;PGF;PRKCA;SMOC2;PDPK1;HIPK2;VASH2;PRKCB;F3;AGGF1;MYDGF;RUNX1;PLCG1;SIRT1;XBP1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.3023750907386965,-0.8250816684134459,0.6715328467153284,0.9056083658840873,1.0,6/13,26.62%,FEZ2;FEZ1;PINK1;CHMP4B;CHMP4A;SEC22B
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.42760389896366763,0.8250769695881366,0.6849865951742627,1.0,1.0,1/13,2.29%,CACNA1I
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.4052760143367243,0.8249983704208053,0.6836086404066074,1.0,1.0,8/15,27.42%,HAP1;CNTNAP4;BAIAP3;CLN3;USP46;SYN3;NLGN2;NLGN1
prerank,extracellular matrix organization (GO:0030198),0.34173188464416376,0.8248710283923975,0.886,1.0,1.0,47/276,17.49%,ADAMTS7;ICAM4;CYP1B1;ITGA1;ECM2;ITGB7;CD47;PECAM1;HSPG2;CD44;PLOD3;HAS1;FLRT2;CRTAP;LAMA5;GSN;COL1A2;LAMA4;DCN;COL4A4;LAMC1;LAMB2;LAMB3;ITGAV;SMOC2;JAM2;CAPN1;ATP7A;NID1;TLL2;BSG;CTSK;ITGA8;FLOT1;COL23A1;MMP19;DAG1;P3H4;ADAMTS1;TGFBI;ELN;ST7;TGFB2;ADAMTSL3;ADAMTS5;COL4A1;FN1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.2360829893627085,-0.8246396827984523,0.7653061224489796,0.9052686595237183,1.0,4/35,7.02%,CDH11;CDH8;CDH13;CDH12
prerank,regulation of cytoskeleton organization (GO:0051493),0.34359193290927736,0.824591306121679,0.7772177419354839,1.0,1.0,23/108,18.69%,ARHGEF5;MAPK1;CCDC88A;EZR;S100A9;S100A8;CLASP1;RND3;ARHGAP35;MARK2;EPHA3;MLST8;CRK;ROCK2;RAC2;DIAPH1;GSK3B;PAK2;RAC1;KATNBL1;IQGAP1;TAOK1;CLN3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.31915925932497213,-0.8244408994103393,0.6830188679245283,0.9044179073217559,1.0,5/13,19.72%,ENTPD7;GNAI3;RHOQ;RAN;GTPBP1
prerank,regulation of phospholipase activity (GO:0010517),0.43851869213025957,0.8243570084234109,0.6637806637806638,1.0,1.0,5/10,22.74%,RASGRP1;PDPK1;FGFR1;SNCA;FGFR2
prerank,regulation of tissue remodeling (GO:0034103),-0.285432010062303,-0.8243065394789868,0.7401960784313726,0.9034283551565696,1.0,5/18,22.24%,SYT7;IL18;MDK;LEPR;CEACAM1
prerank,positive regulation of response to external stimulus (GO:0032103),0.34484023052280705,0.8241645998288765,0.8118712273641852,1.0,1.0,18/128,11.45%,CD47;DHX58;USF1;CCN4;IL16;S100A9;GPRC5B;CCR2;S100A8;TRADD;PDE2A;PUM2;PRKCA;IL17RA;RIOK3;NAPEPLD;PUM1;DHX9
prerank,negative regulation of MAPK cascade (GO:0043409),0.3471656325897482,0.8238054808571239,0.7538304392236976,1.0,1.0,15/87,14.47%,FOXM1;EZR;CAV1;FOXO1;PIN1;STK38;ABCA7;SMAD4;RPS6KA6;PTEN;CDK5RAP3;SPRED2;MYC;PPIA;DAG1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.34084832000562637,-0.8237614051135154,0.6835016835016835,0.9033094758340247,1.0,7/10,33.72%,NEXMIF;PPM1F;VEGFA;BMP6;RGCC;NOTCH4;MAD2L2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3381011049123853,-0.8236346977418653,0.68,0.9023016722042603,1.0,6/10,27.51%,DLGAP4;DLGAP2;DLGAP3;NPTX1;DLGAP1;BEGAIN
prerank,amyloid precursor protein catabolic process (GO:0042987),0.41062429828723335,0.8236332997051354,0.6731301939058172,1.0,1.0,6/14,23.12%,ABCA7;DYRK1A;PSEN1;ADAM10;CLN3;ADAM17
prerank,glucan catabolic process (GO:0009251),0.41233733219235236,0.8235090235043935,0.6809338521400778,1.0,1.0,2/15,12.06%,PGM2;PHKA2
prerank,presynapse organization (GO:0099172),-0.33915910018900963,-0.8234413366470547,0.6948051948051948,0.9014167670323365,1.0,5/10,37.66%,C5AR1;DVL1;LRRTM3;WNT5A;WNT7A
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.30980527414991277,-0.8234360396145262,0.6948529411764706,0.9002108405289835,1.0,5/13,18.90%,NRP2;PLXNA4;PLXNA1;SEMA3A;PLXNB3
prerank,muscle cell migration (GO:0014812),-0.3447581857483185,-0.8234185479472225,0.6778523489932886,0.899036607071459,1.0,4/10,23.54%,ITGB3;AAMP;MEGF10;PLAT
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3695553760338786,0.8232062558180376,0.6983240223463687,1.0,1.0,4/33,9.62%,CARD10;NOTCH1;HMGB1;MECP2
prerank,smooth muscle contraction (GO:0006939),-0.29780011562179076,-0.823145598514145,0.706766917293233,0.8983889074584204,1.0,4/14,20.99%,TPCN2;ADRA1A;SLC8A1;EDNRA
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3950883071223974,0.8228879032877088,0.6923076923076923,1.0,1.0,7/19,21.11%,PRKACA;CBFB;ROCK2;RUNX1;NPHP4;ROCK1;IKBKB
prerank,negative regulation of protein secretion (GO:0050709),0.36112287105748164,0.8227383730965938,0.7101769911504425,1.0,1.0,1/38,0.73%,IL12A
prerank,positive regulation of GTPase activity (GO:0043547),0.34427551710932885,0.8226435341406831,0.8386773547094188,1.0,1.0,19/188,9.52%,ECT2;PRTN3;EZH2;ARHGEF5;ARHGAP11A;TBC1D1;TIAM1;NET1;TBC1D8B;TBC1D22B;RASGRP1;RANGAP1;EVI5;PIN1;SNX9;RAP1GAP2;LARS1;CAV2;GMIP
prerank,mitochondrial membrane organization (GO:0007006),-0.23286233505862872,-0.8223983483701842,0.7192982456140351,0.8986748335719001,1.0,17/32,28.91%,BCL2L1;MICOS10;GHITM;MFN2;APOO;MTX2;MTX3;SPG7;MAIP1;BAD;MTX1;SLC25A5;CHCHD6;BCL2;TMEM11;MFN1;TIMM50
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.28482513981854096,-0.8218526890180311,0.6896551724137931,0.8984886068798812,1.0,10/19,29.80%,PTPRJ;GRM5;RYR2;BCAP31;PRNP;FKBP1B;KDR;VCAM1;ADGRL1;TRPM2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3416703542881433,0.8215104883281931,0.8184553660982948,1.0,1.0,25/142,19.21%,S1PR4;CXCR5;IAPP;CAV1;CCR2;HMGB1;PRKACA;CAV2;P2RY1;CCR6;SLC35G1;FIS1;ADCYAP1;F2R;LPAR1;GPR35;CD24;TRPM4;ADCY8;SPPL3;CXCR4;YWHAE;PTGER4;CLN3;CD55
prerank,ncRNA 3'-end processing (GO:0043628),0.4116277601564376,0.8214711241285211,0.6824324324324325,1.0,1.0,5/14,20.67%,INTS14;ERI1;TRNT1;PTCD1;INTS12
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.35851227746446823,0.8212153700271213,0.700218818380744,1.0,1.0,13/42,21.04%,PLEKHA2;CDK6;CIB1;GFUS;EFEMP2;NRP1;GSK3B;LIMS1;RAC1;CCL25;UTRN;S100A10;ROCK1
prerank,negative regulation of immune response (GO:0050777),0.3404053985109328,0.8210296268366869,0.8114343029087262,1.0,1.0,26/154,18.87%,RNF26;VIPR2;IAPP;RAMP1;FYN;DHX58;CCR2;PTHLH;DPEP1;NPSR1;MAPK14;PRKACA;INSL3;PLCG2;PCBP2;CALCRL;ADCYAP1;RC3H1;NLRC3;PLCG1;ADCY8;TRAFD1;FCGR2B;CREB1;PTGER4;PPM1B
prerank,positive regulation of developmental process (GO:0051094),0.3421592289940025,0.8209310479111538,0.845,1.0,1.0,45/164,23.20%,FOXA2;CDC20;SOX6;AURKA;FBXO5;PA2G4;TFRC;CLASP1;DCN;ZBTB16;LLPH;RBM19;CPEB3;NR2C2;RELN;KMT5C;PLCB1;TAPT1;FIS1;PAXIP1;BMPR1A;NUMA1;MCU;PSEN1;DAG1;FGFR1;VHL;RIF1;SIRT1;XBP1;TRPM4;ARHGEF7;NRXN1;PAX2;SOX9;AGO2;ALK;BNIP3;RPS6KA3;ZDHHC6;PHLDB1;ACVR1B;NIBAN2;NCOA3;SRC
prerank,toxin transport (GO:1901998),0.4385994971185254,0.8209158008248121,0.6927536231884058,1.0,1.0,2/10,18.32%,ANTXR2;ADAM10
prerank,acidic amino acid transport (GO:0015800),0.4061069585408771,0.8208709996618133,0.6829896907216495,1.0,1.0,4/17,17.48%,SLC25A12;SLC25A22;SLC25A13;ARL6IP5
prerank,regulation of peptide hormone secretion (GO:0090276),0.34656389494638834,0.8207959277142254,0.7447478991596639,1.0,1.0,8/67,11.88%,TFR2;ITPR1;CRHBP;PRKCA;PICK1;KCNC2;DPP4;EIPR1
prerank,response to calcium ion (GO:0051592),0.3419341220150859,0.8207213159278397,0.7863682604272635,1.0,1.0,14/102,14.77%,ECT2;SLC25A12;PPP3CA;CRHBP;SYT8;CAV1;DPEP1;PEF1;PLCG2;SYT3;SEC31A;SLC25A13;ANXA11;ADGRV1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.40834182134357916,0.8205934382918072,0.6788124156545209,1.0,1.0,3/15,15.99%,ZFP36L1;HNRNPU;ZFP36L2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.3094372500051043,-0.8202524949304175,0.7122302158273381,0.9004687409035189,1.0,2/13,1.27%,TGFBR1;RBPMS
prerank,ceramide transport (GO:0035627),0.4153090355357205,0.8195427244840184,0.6793002915451894,1.0,1.0,2/12,9.29%,ABCA13;ABCA2
prerank,regulation of ruffle assembly (GO:1900027),-0.2573730238436703,-0.8195357144792186,0.7588235294117647,0.9006337035150613,1.0,7/23,20.09%,EVL;PFN1;P2RY12;EPS8;PFN2;ARHGAP24;P2RX4
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3363343118198244,0.8186035408713993,0.8918918918918919,1.0,1.0,67/248,21.58%,JADE1;PSMB7;LRP4;PSMD11;AXIN1;PSMF1;STK11;GPRC5B;CAV1;CCDC88C;CSNK1A1;PSMC1;PIN1;CSNK1G2;FUZ;TLE4;EGFR;CUL3;PFDN5;PSMC3;AMFR;RUVBL2;EMD;PSMA4;RUVBL1;XIAP;CCAR2;PSMC4;TMEM131L;PSMD13;LRRK1;PSME1;DDIT3;LATS1;PSEN1;PSMB1;GSK3B;STK4;LIMD1;EGF;PTPRU;PSMD8;TCF7L2;CTNND2;LGR4;PSME4;PSMD4;LMBR1L;TRPM4;PTK7;TMEM170B;PPP1CA;AMER2;LRRK2;TLE3;PPM1B;HDAC1;STK3;TBL1XR1;SOX9;USP34;NPHP4;ILK;KREMEN1;USP47;CAPRIN2;ZEB2
prerank,cellular response to interferon-gamma (GO:0071346),0.3445331062130236,0.8181883103874288,0.7633744855967078,1.0,1.0,21/88,21.77%,CD47;GBP4;PML;CD44;SP100;IRF9;PDE12;GBP2;JAK2;B2M;TRIM68;TRIM5;IRF8;CCL25;EPRS1;LGALS9;DAPK1;SYNCRIP;GAPDH;CIITA;RPL13A
prerank,cellular iron ion homeostasis (GO:0006879),0.35290613146281713,0.8170477766069439,0.7302423603793466,1.0,1.0,5/55,5.04%,TFR2;HEPH;ALAS2;CYBRD1;TFRC
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.33621742869642685,0.8169975511770924,0.8008048289738431,1.0,1.0,40/129,24.09%,PSMB7;PSMD11;AXIN1;PSMF1;GPRC5B;CAV1;PSMC1;PIN1;CSNK1G2;EGFR;PSMC3;PSMA4;RUVBL1;XIAP;CCAR2;PSMC4;PSMD13;LRRK1;PSME1;PSMB1;EGF;PSMD8;LGR4;PSME4;PSMD4;TRPM4;PTK7;LRRK2;PPM1B;TBL1XR1;USP34;ILK;USP47;CAPRIN2;ZEB2;PSME2;FGFR2;DAAM2;DAPK3;PSME3
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3615645768583833,0.8169906622894865,0.7089305402425579,1.0,1.0,6/41,11.03%,ERBB3;FYN;NEDD9;GPRC5B;TGFA;RELN
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4007253555666408,0.8169227003564,0.6932114882506527,1.0,1.0,1/16,1.57%,BRCA1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.34904316565667026,0.8166973470222004,0.7552742616033755,1.0,1.0,10/59,17.07%,SDK1;PECAM1;HMCN1;IGSF21;BSG;PALLD;NECTIN1;KIRREL3;CDH4;EMB
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2706787836376598,-0.8166688401924639,0.7476635514018691,0.9047334865832706,1.0,8/18,25.51%,ENY2;SARNP;DDX19A;DDX19B;NUP133;PABPN1;ZC3H11A;MCM3AP
prerank,melanosome localization (GO:0032400),0.38272399663094253,0.8165589509056156,0.6925925925925925,1.0,1.0,9/21,24.62%,SHROOM2;RAB11B;BBS4;VPS33B;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,actin filament depolymerization (GO:0030042),0.41971488314041,0.8165193326896735,0.6962750716332379,1.0,1.0,2/11,8.94%,GSN;CFL2
prerank,negative regulation of cell adhesion (GO:0007162),0.3503852659305023,0.8164958227677738,0.7476828012358393,1.0,1.0,8/72,9.97%,CYP1B1;SPN;ERBB3;RIPOR2;ARHGDIB;NOTCH1;PLXNA2;CBLL1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.26364713937729156,-0.8162554708198593,0.7318435754189944,0.9043167918358546,1.0,6/24,15.01%,SEMA3D;SEMA3E;SEMA4C;SEMA4G;VEGFA;SEMA3A
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.21804740106539047,-0.8162205638972769,0.8488372093023255,0.9031596663602784,1.0,11/46,13.86%,OPHN1;SYT1;CDH2;GRM5;DGKI;CACNG7;CACNG2;DGKZ;CDK5;UNC13A;GRM8
prerank,heart contraction (GO:0060047),-0.23495622342241357,-0.8155374946649847,0.8064516129032258,0.9033502651191203,1.0,9/41,18.69%,SGCD;SGCZ;DMD;SCN1B;RYR2;ATP1B1;SLC8A1;GPX1;ATP1A2
prerank,regulation of actin filament-based process (GO:0032970),0.34238050515802826,0.8153400475944962,0.7541152263374485,1.0,1.0,11/70,13.16%,ARHGEF5;CCDC88A;EZR;CNN2;RND3;ARHGAP35;EPHA3;MLST8;CRK;ROCK2;RAC2
prerank,protein targeting (GO:0006605),-0.19669677071275626,-0.8152452149825458,1.0,0.9027226219245852,1.0,48/118,27.21%,SRPRA;RAB3IP;TOMM40;PRKCI;DNAJC19;SPCS2;AP4S1;ZFAND2A;GOLGA7;LAMP2;MFN2;MYO1C;FUT10;RABGEF1;TIMM17A;PEX19;SEC61G;GIPC1;SEC61A1;BCAP31;NCF1;SRPRB;CDC37;LONP2;RTP4;ARL6;MFF;ZDHHC24;AIP;PEX1;ZDHHC20;SRP14;TIMM22;TIMM10B;ZDHHC15;FBXO7;MICALL1;PARD3;VPS37C;TIMM13;ZDHHC3;TOMM7;TOMM22;KIF13B;EDEM1;ZDHHC12;TIMM8B;PEX16
prerank,regulation of translation (GO:0006417),0.3378409926078026,0.8144863139209053,0.855,1.0,1.0,59/173,23.97%,ZCCHC4;EIF4B;EIF2A;RBM3;EIF3E;RPS4X;CSDE1;EIF4A3;NIBAN1;MTG2;MTPN;NCBP1;CPEB3;PUM3;TCOF1;TYMS;DHX9;IGF2BP3;UPF3B;FXR1;RACK1;PRKDC;LSM14A;PAIP1;NSUN3;CNOT1;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;NAT10;LARP4B;POLDIP3;GSPT1;EPRS1;ELAVL1;EIF4ENIF1;RPL5;NCBP2;RPS3;DAPK1;CNOT8;RBM4B;SYNCRIP;EIF6;CNOT7;GLE1;GAPDH;RPS6KA3;RPL13A;EIF4E2;RPL10;YBX1;NCL;CIRBP;NPM1;DAPK3
prerank,endodermal cell differentiation (GO:0035987),-0.2365091919669923,-0.8142036998360838,0.7730496453900709,0.9034397119796203,1.0,5/31,7.92%,ITGB5;CTR9;ITGA5;COL11A1;MMP14
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3891063530286216,0.814069661897155,0.707196029776675,1.0,1.0,2/21,4.01%,PGM2;H6PD
prerank,regulation of lamellipodium assembly (GO:0010591),-0.2278656788807678,-0.8140195732775172,0.8571428571428571,0.9025797425245059,1.0,10/34,24.06%,AKIRIN1;PIK3R1;ARPC2;ABI2;TWF2;CDC42;PLXNB3;CAPZB;CYFIP1;FER
prerank,RNA polyadenylation (GO:0043631),0.3673240647470112,0.8139765058091297,0.7213114754098361,1.0,1.0,12/26,23.33%,CPSF2;CSTF3;TUT1;SCAF8;PCF11;CPSF1;CLP1;TENT2;PNPT1;WDR33;PAPOLA;LEO1
prerank,mRNA polyadenylation (GO:0006378),0.3673240647470112,0.8139765058091297,0.7213114754098361,1.0,1.0,12/26,23.33%,CPSF2;CSTF3;TUT1;SCAF8;PCF11;CPSF1;CLP1;TENT2;PNPT1;WDR33;PAPOLA;LEO1
prerank,cellular response to organic substance (GO:0071310),0.34098612903512043,0.8139681878660311,0.8004032258064516,1.0,1.0,27/116,20.41%,CYP1B1;LEF1;RAMP1;DCPS;HDAC6;CIB1;SOCS2;PARK7;EMD;PTPN7;PTPN14;FLT3;SLIT3;BMPR1A;STAT5B;RACK1;PTPN5;HCLS1;ARL6IP5;LDLRAP1;CXCR4;PTPN13;LRRK2;TRAF6;MME;NCOA2;ACVR2B
prerank,mesenchyme morphogenesis (GO:0072132),0.394828531805032,0.8138466300415057,0.703989703989704,1.0,1.0,6/17,20.76%,MDM4;NOTCH1;BMPR1A;TGFB2;SOX9;SMAD2
prerank,regulation of fibroblast migration (GO:0010762),0.38004582680430643,0.8137779143385254,0.6915544675642595,1.0,1.0,9/20,24.01%,PRKCE;HAS1;APPL1;RAC1;ARHGEF7;CLN3;PRR5L;DDR2;ITGB1BP1
prerank,7-methylguanosine RNA capping (GO:0009452),0.3699782983183043,0.8137320326555352,0.7222222222222222,1.0,1.0,10/31,22.39%,POLR2I;POLR2A;CMTR2;NCBP1;ERCC3;POLR2K;POLR2J;NCBP2;RNMT;POLR2B
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3699782983183043,0.8137320326555352,0.7222222222222222,1.0,1.0,10/31,22.39%,POLR2I;POLR2A;CMTR2;NCBP1;ERCC3;POLR2K;POLR2J;NCBP2;RNMT;POLR2B
prerank,regulation of protein kinase B signaling (GO:0051896),0.33549500156686074,0.813268785048854,0.8598598598598599,1.0,1.0,35/193,17.70%,CD19;IAPP;PHLPP2;ERBB3;FYN;RCN3;PHLDA3;BANK1;TGFA;CIB1;GRB2;STRN;EGFR;PDPK1;TXN;PARK7;FGF9;FLT3;PTEN;ARRB2;F3;RACK1;RAC2;DDIT3;MYDGF;DAG1;IRS1;EGF;TCF7L2;FGFR1;RAC1;PIK3CA;SIRT1;HCLS1;KITLG
prerank,excitatory postsynaptic potential (GO:0060079),0.38539424878799095,0.8131374733986937,0.6945812807881774,1.0,1.0,5/19,21.57%,MPP2;ARRB2;GSK3B;LRRK2;GRIN2D
prerank,glycogen catabolic process (GO:0005980),0.4020303294931178,0.812727896596844,0.6709677419354839,1.0,1.0,2/15,12.06%,PGM2;PHKA2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3156896213892468,-0.812680707587584,0.6990595611285266,0.9038600662076743,1.0,3/11,6.36%,RREB1;ENPP2;CORO1C
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.42581418659957526,0.8123808467712691,0.6773255813953488,1.0,1.0,3/10,22.29%,TUT4;UBA52;NEDD8
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3849396158025692,0.811741003031237,0.7,1.0,1.0,6/19,16.35%,DHX9;CBFB;ELF1;RUNX1;CD24;TAF9
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3372525955121875,0.8114653431693293,0.8306451612903226,1.0,1.0,39/132,21.04%,MEFV;NRDC;EZR;TWIST1;SNX33;STK11;ABCD1;ZC3H18;FOXO1;FAF1;PIM2;HMGB1;DCN;SNX9;ENTPD5;MSN;ORMDL3;ATF6;RDX;TRIM68;RNF152;DXO;PSEN1;TRIM5;IRS1;GSK3B;CNOT1;RC3H1;SNCA;LRRK2;ZBTB20;DAPK1;SVIP;CNOT8;PNPT1;PRR5L;CNOT7;BNIP3;ROCK1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.3374632318480766,-0.8112773158795791,0.6782006920415224,0.9053263933782926,1.0,6/10,34.22%,CD300A;CD200;HMOX1;HOXA7;BMP5;EMILIN1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4047010902556898,0.8110204855510211,0.6826265389876881,1.0,1.0,2/14,7.70%,SULF2;FUZ
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3464803547127443,0.8109376061343294,0.7356687898089171,1.0,1.0,16/56,17.72%,S100A9;MAPKAPK3;S100A8;TRAF3;HMGB1;TAB1;PLCG2;TAB3;TIFA;MYD88;CTSK;TLR5;TLR6;HSP90B1;UBA52;MAP3K7
prerank,response to reactive oxygen species (GO:0000302),0.3499805081443156,0.8109237809392199,0.7274633123689728,1.0,1.0,14/54,21.28%,STK26;MAPK1;FYN;STK24;EGFR;JUN;APTX;MPV17;PDCD10;ERCC6L2;SIRT1;RPS3;PKD2;MAPT
prerank,myotube cell development (GO:0014904),0.4145199883587949,0.8099540042677635,0.6834532374100719,1.0,1.0,2/10,13.77%,CAV2;SKI
prerank,lamellipodium organization (GO:0097581),0.3702729047335169,0.809706527048679,0.702576112412178,1.0,1.0,16/29,29.18%,CCDC88A;ABLIM3;WHAMM;PARVB;RAC1;ARHGEF7;ABLIM2;GOLPH3;VCL;ABLIM1;ARHGEF6;WASF1;SNX1;ARHGEF4;CARMIL1;KIT
prerank,protein transport (GO:0015031),0.33702544889598385,0.8093734940119808,0.933,1.0,1.0,66/332,17.84%,CENPF;NEURL1B;TFR2;TBC1D1;NDC1;RAMP1;TBC1D8B;RCN3;CD74;STX17;SNX33;TBC1D22B;ARL5C;NAPG;TFRC;TLK1;EVI5;ARL11;SYS1;RAB1B;RAB22A;YWHAH;STX5;ARF4;HDAC6;ARFGAP3;SNX9;RAB8A;SLC10A7;CLTC;PICK1;BLZF1;SEC13;MIA2;STX11;CALCRL;GGA1;KIF13A;IL10RA;RAB8B;PRKCB;ARF3;SEC31A;RAB11B;RAB43;CANX;LMTK2;CHMP1B;ATP6V0E1;COPZ1;VPS33B;SCAMP1;TBC1D25;ARL4C;ATP6AP1;RAB5A;STEAP3;CHMP3;NAPB;ATP6V0D1;CHMP2B;ADPRH;HSP90B1;ARL6IP5;EIF2D;GGA2
prerank,epithelial tube morphogenesis (GO:0060562),-0.24119833805861962,-0.8091093786168877,0.8257575757575758,0.9081924930428289,1.0,5/32,10.27%,ACVR1;CSF1R;CTNNB1;RYR2;PKD1
prerank,protein localization to organelle (GO:0033365),0.33709230700309645,0.8089718096707539,0.8264794383149449,1.0,1.0,30/133,18.44%,RAB33B;RPA2;CNTLN;CSRP3;SYS1;STX5;GBP2;DDRGK1;CEP250;ZBTB7A;RPA1;PPP1R15A;ABCA7;EMD;TOR1A;DHX9;VAPA;DCP1A;CNEP1R1;PACSIN2;BBS4;RAB35;RIPOR1;SCG3;IFT140;BBS9;TMEM30A;YWHAE;LRRK2;RAB6A
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.33805465707979776,0.8085669349438088,0.7650663942798774,1.0,1.0,23/86,17.60%,PSMB7;PSMD11;PSMF1;CHEK1;PSMC1;PSMC3;PSMA4;PSMC4;NFE2L2;PSMD13;PSME1;DDIT3;CREBBP;BAG3;PSMB1;TP53;LIMD1;PSMD8;PSME4;VHL;PSMD4;DNAJB1;UBA52
prerank,axoneme assembly (GO:0035082),-0.23112553060372198,-0.8085014188883579,0.7416666666666667,0.908048589059634,1.0,23/30,46.29%,CFAP74;TOGARAM1;DCX;TTC12;CCDC39;SPAG16;TTLL3;DNAAF3;CFAP46;CCDC40;RSPH9;FOXJ1;JHY;DNAJB13;DRC1;SPAG17;GAS8;DNAAF2;RSPH1;RP1;RSPH4A;DNAAF1;CCDC65
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3833225985971806,0.8083470996843569,0.704093567251462,1.0,1.0,4/24,12.03%,C2CD5;FYN;CIB1;FIS1
prerank,negative regulation of synaptic transmission (GO:0050805),0.37770162825042225,0.8077202770628372,0.7058111380145279,1.0,1.0,7/23,21.20%,MTMR2;PICK1;PTEN;SLC24A2;LRRK2;ATAD1;GRIK3
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3425646465185438,0.8076131900152509,0.8002049180327869,1.0,1.0,18/80,20.49%,ANLN;CCDC88A;PALM;RIPOR2;ARHGAP35;FUZ;TAPT1;CDC42EP3;NRP1;RAC2;BBS4;BRK1;MARK4;RAC1;PIK3CA;CDC42EP1;PLEKHM1;CROCC
prerank,negative regulation of cell growth (GO:0030308),0.33535497961395094,0.8074006605087332,0.8119312436804853,1.0,1.0,21/121,16.94%,CDKN2C;JADE1;PPP1R9B;RB1;TCHP;PML;STK11;CDKN2A;SMARCA4;CDKN2D;SMAD4;CCAR2;SLIT3;FGF13;RACK1;SERTAD2;BCL6;TP53;NDRG3;TGFB2;SIRT1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3318854758902476,0.8070639549424834,0.862,1.0,1.0,48/182,22.09%,HEY2;RB1;AURKA;PTPN22;RBL1;FOXP1;CRKL;RIN3;TAF1;TERF2;TNRC6C;LRP3;TNRC6B;NOTCH1;MTMR2;DDRGK1;ABCC2;ZNF148;PARP14;MECP2;DNMT1;PARK7;SETDB2;BMPR1A;ROCK2;RACK1;PSEN1;PDCD10;RUNX1;MAP2K1;TGFB2;ANKRD13A;VHL;SIRT1;CNPY2;APLN;FLOT2;ADAM10;SETDB1;HDAC1;LGALS9;AGO2;CNOT7;CITED2;MAPT;CELF1;AGO1;ATP2B4
prerank,regulation of cytoplasmic translation (GO:2000765),0.39742780471429856,0.8070610941862985,0.6811397557666214,1.0,1.0,2/14,11.45%,CPEB3;DHX9
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.41006358850600544,0.80693284497515,0.6740947075208914,1.0,1.0,2/12,4.94%,TWIST1;ABCD1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.4267489818548857,0.8069230569337971,0.6805157593123209,1.0,1.0,6/10,29.48%,ACTN4;RXRB;RARG;RXRG;RXRA;SNW1
prerank,protein prenylation (GO:0018342),-0.3241984677133617,-0.8068101338692235,0.7030716723549488,0.9099563362415641,1.0,1/10,0.93%,PGGT1B
prerank,sulfur compound biosynthetic process (GO:0044272),0.3363809173726059,0.8066586622045536,0.7981744421906694,1.0,1.0,16/104,16.29%,CHST3;FMOD;CSGALNACT2;ST3GAL1;DCN;SLC35D2;ST3GAL2;SLC10A7;B3GNT2;CHST12;OGN;METTL16;PAPSS2;TPK1;GSTM1;CHSY1
prerank,negative regulation of receptor binding (GO:1900121),-0.33157314122255765,-0.8065652960519094,0.6986301369863014,0.9092294317105345,1.0,1/10,2.03%,ADAM15
prerank,receptor metabolic process (GO:0043112),0.34782834428484694,0.8064742027010114,0.7585470085470085,1.0,1.0,15/53,18.37%,RAMP1;TFRC;CAV1;CLTC;GRB2;CALCRL;BECN1;SNX25;ARRB2;RAB11B;LMTK2;GRK2;LDLRAP1;SNCA;KIF16B
prerank,response to organophosphorus (GO:0046683),-0.2815862408800499,-0.8064716111976258,0.7260869565217392,0.9081994405684339,1.0,6/16,28.15%,DGKQ;TRPC3;P2RX4;VGF;NDUFS4;ABCC9
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.35980499857602033,0.8060130716350704,0.7438752783964365,1.0,1.0,6/36,9.19%,DDAH2;CAV1;TERF2;NUS1;LYPLA1;EGFR
prerank,long-term synaptic potentiation (GO:0060291),-0.26456802929422485,-0.8059162577289366,0.7473684210526316,0.9080562838499002,1.0,4/21,9.84%,STX4;SLC8A3;VAMP2;SHANK2
prerank,toll-like receptor signaling pathway (GO:0002224),0.3367233120974981,0.8057267927858722,0.7922210849539406,1.0,1.0,27/84,21.34%,S100A9;MAPKAPK3;IKBKG;S100A8;TRAF3;BIRC2;HMGB1;MAP3K1;TAB1;PLCG2;TAB3;BTK;MYD88;CTSK;TLR5;TLR6;HSP90B1;EPG5;UBA52;MAP3K7;COLEC12;TRAF6;LGALS9;CASP8;RIPK1;IKBKB;RPS6KA3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3878977104620298,0.805072396190569,0.6961178045515395,1.0,1.0,2/17,7.95%,GPD1L;NEDD4L
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.26020641215575024,-0.8049031259526703,0.7666666666666667,0.9086937535373747,1.0,6/20,18.06%,RAP1GDS1;SELENOK;TGM2;BCAP31;THADA;WFS1
prerank,pseudouridine synthesis (GO:0001522),0.40232264525433736,0.8040489614069609,0.7048022598870056,1.0,1.0,4/13,17.98%,NOP10;PUS3;TRUB2;DKC1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.334967843797438,0.8035735889950877,0.7925478348439073,1.0,1.0,26/110,20.40%,HJURP;IAPP;RB1;TFRC;FAF1;GSN;LCMT1;HDAC6;RIOK3;PARK7;SUMO1;HCFC1;RACK1;TFIP11;LATS1;GSK3B;BRK1;ATF7IP;AIDA;NAPB;GNL3L;SAR1B;SLF1;RPS3;SVIP;NCLN
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.229957114575693,-0.8032345230269916,0.8632478632478633,0.9105723717025437,1.0,12/33,28.46%,TNFAIP3;KRIT1;ANGPT1;TNIP2;SERPINE1;MDK;WFS1;MAPK7;NDNF;YAP1;KDR;ICAM1
prerank,positive regulation of transporter activity (GO:0032411),0.40317239964264284,0.8032073904016073,0.6986666666666667,1.0,1.0,5/13,27.37%,KMT2A;STK39;NR1H3;WNK3;RXRA
prerank,intracellular protein transport (GO:0006886),0.3349946439354427,0.8032011840230463,0.926,1.0,1.0,82/304,21.73%,ANKLE1;XPO1;POM121;TBC1D1;C2CD5;TBC1D8B;CD74;STX17;NUP107;CCHCR1;TBC1D22B;ARL5C;NAPG;TNPO1;TLK1;EVI5;NUP42;IPO13;ARL11;RAB1B;RAB22A;YWHAH;NUP50;STX5;AP4B1;ARF4;AP1S3;HDAC6;DESI1;NUP214;ARFGAP3;SNX9;CLTC;PICK1;SEC13;IPO7;AP4E1;NUP188;STX11;RANBP6;GGA1;KIF13A;ARF3;SEC31A;HAP1;RAB43;RPAIN;COPZ1;VPS33B;BAG3;E2F3;TBC1D25;APPL1;ARL4C;IPO5;RAB5A;XPO4;KPNB1;LMAN1;NAPB;ADPRH;EIF2D;GGA2;STAM;RAB6A;EIF4ENIF1;SAR1B;NUP85;TRAK2;SGSM3;HPS4;MMP12;TPR;TNPO2;ARL5B;TBC1D15;SNX13;TNPO3;TMED10;SYK;EVI5L;AP3B1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.37879831454586577,0.8031017859365436,0.7203907203907204,1.0,1.0,2/20,7.15%,HEY2;NOTCH1
prerank,steroid catabolic process (GO:0006706),0.42132342717052484,0.802953930820472,0.6657342657342658,1.0,1.0,1/10,6.13%,YWHAH
prerank,protein acylation (GO:0043543),-0.22014513703488578,-0.8028908398534762,0.8461538461538461,0.9100287014619387,1.0,16/38,26.31%,GLUL;ZDHHC17;ZDHHC13;ZDHHC5;ZDHHC8;SELENOK;KAT2A;NAT9;ZDHHC16;ING4;ZDHHC20;ZDHHC15;GTF2B;ZDHHC3;NAA10;ZDHHC12
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.2692610902061727,-0.8024517726451912,0.75,0.909610409604689,1.0,3/18,8.99%,PAG1;DUSP3;MIA3
prerank,dephosphorylation (GO:0016311),0.3356319564258446,0.8023607439966601,0.8366733466933868,1.0,1.0,32/147,18.15%,PLPPR3;ALPL;PPM1D;PTPRA;PPP3CA;FBXW11;PTPN22;PPP2R5E;STK11;PPP1CB;PPP2R5A;EPHX2;MTMR2;TAB1;PPP2CB;PTPN7;PTPN14;PPP1CC;MTMR6;PTEN;PPP3CC;PPP1R12A;PLPPR4;PTPN5;PPP6C;MTM1;PTPRU;PPP2R5D;DUSP12;PTPN13;PPP1CA;ILKAP
prerank,neuromuscular process controlling balance (GO:0050885),0.40317278345545554,0.8019473118267969,0.680672268907563,1.0,1.0,4/12,18.91%,PAFAH1B1;TIFAB;CLN3;NRXN1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3781197129329275,0.8014141150641365,0.7110552763819096,1.0,1.0,7/21,21.25%,DNMT1;JUN;FGF9;BMPR1A;ADAMTS1;LDLRAP1;MEF2D
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.253504994904146,-0.799888659429932,0.7668393782383419,0.9130151410511811,1.0,10/20,23.11%,SMAD1;RELA;CARF;ATF4;VEGFA;SESN2;SMAD9;CREB3;HIF1A;MT3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.39647126010788175,0.7998535420011622,0.7122762148337596,1.0,1.0,2/16,12.06%,PGM2;PHKA2
prerank,positive regulation of cell differentiation (GO:0045597),0.33180212476996335,0.7990126366895159,0.891,1.0,1.0,44/237,19.63%,ECT2;EZH2;SOX6;LEF1;FBXO5;CTNNA1;TIAM1;CCN1;TWIST1;CCN4;RIPOR2;PA2G4;GPRC5B;MMD2;TCF3;ZFP36L1;LRP3;MMD;MAPK14;ZBTB16;ZEB1;SMAD4;WDFY2;PLCB1;BCL9L;BMPR1A;NELL1;NRCAM;HOXB4;SPAG9;SIN3A;TCF4;FGFR1;ATP6AP1;TGFB2;VHL;XBP1;TRPM4;KITLG;CREB1;AAMDC;PAX2;SOX9;ZHX3
prerank,chondrocyte differentiation (GO:0002062),0.35986709971621644,0.7988060477614456,0.7165354330708661,1.0,1.0,3/32,6.66%,SOX6;SULF2;RUNX3
prerank,iron ion homeostasis (GO:0055072),0.34249971082554237,0.7987802090796673,0.7551867219917012,1.0,1.0,10/58,17.11%,TFR2;HEPH;ALAS2;CYBRD1;TFRC;B2M;SMAD4;MYC;ATP6AP1;ATP6V0D1
prerank,embryonic hemopoiesis (GO:0035162),0.4127322780593681,0.7985833832051675,0.6875852660300137,1.0,1.0,4/12,17.70%,ZFPM1;KMT2A;THOC5;KITLG
prerank,linoleic acid metabolic process (GO:0043651),0.3935556673474496,0.798460671101483,0.7022397891963109,1.0,1.0,2/17,14.45%,ABCD1;ELOVL5
prerank,phosphate ion homeostasis (GO:0055062),0.4170851117248304,0.7983645735218844,0.6991404011461319,1.0,1.0,10/10,58.32%,XPR1;SFRP4;ENPP1;SLC34A2;SLC34A3;SLC34A1;GCM2;FGF23;FGFR4;TFAP2B
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.32333974523556097,-0.7983063025385048,0.7416107382550335,0.9147389945196599,1.0,4/11,17.88%,SLC27A1;SCARB1;CTDNEP1;GPLD1
prerank,response to laminar fluid shear stress (GO:0034616),-0.32924848585388516,-0.7982503641684991,0.7111801242236024,0.9136792404805538,1.0,6/10,25.28%,ABCA1;SMAD6;SMAD7;KLF2;MAPK7;KLF4
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.39459039646192773,0.7982298638816183,0.6937669376693767,1.0,1.0,3/14,10.95%,ENTPD3;ENTPD5;NUDT9
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.36984761663821386,0.7970291135465999,0.7053990610328639,1.0,1.0,3/23,12.08%,PMAIP1;TIMM9;TOMM70
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.36308444749283275,0.7970215763042466,0.7323943661971831,1.0,1.0,7/25,17.53%,SCAF11;TXNL4A;SRSF4;PRPF4;SRSF10;SNRNP40;PRPF8
prerank,cell differentiation in hindbrain (GO:0021533),-0.3216860358363131,-0.795760762031454,0.7084870848708487,0.9170928011451694,1.0,3/11,8.46%,OPHN1;KNDC1;FAIM2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.27005244033680653,-0.7953795819030745,0.7289719626168224,0.9165233964569335,1.0,2/18,1.45%,RGS10;GNA15
prerank,cellular response to fluid shear stress (GO:0071498),0.4056456263511472,0.7950372044643701,0.7210599721059973,1.0,1.0,5/12,19.98%,MTSS1;NFE2L2;ASS1;SREBF2;PKD2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3315909097959489,0.7950214456061746,0.8116089613034623,1.0,1.0,32/100,23.35%,PLK1;XPO1;GLMN;TAF1;CSNK1A1;DESI1;DDRGK1;PARK7;SUMO1;RAD23A;CCAR2;UCHL5;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;TAF9;UBXN1;CAMLG;RNF19A;USP7;LRRK2;ARAF;KEAP1;MDM2;CBFA2T3;HECTD1;DDA1;BBS7;UFL1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.31163654966192633,-0.794932103074168,0.7707509881422925,0.9161194586598654,1.0,7/14,31.66%,PRKCI;ECSCR;THBS1;PDCD4;CD40;RGCC;CCL2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.24904310982268157,-0.7946889417768908,0.831081081081081,0.9153656157320512,1.0,13/25,30.65%,EVL;CDK10;TBC1D30;ARHGAP44;CEP97;PFN2;ARHGAP24;PLXNB3;CAPZB;YAP1;ODF2L;TBC1D7;KANK1
prerank,maintenance of protein localization in organelle (GO:0072595),0.38004237948165204,0.7945242995593975,0.715,1.0,1.0,7/19,19.94%,PML;TAPT1;CHCHD10;HNRNPU;BBS4;MORC3;TAF3
prerank,regulation of cell migration (GO:0030334),0.3297116008992426,0.794437064984598,0.95,1.0,1.0,58/382,15.53%,KIF14;GTSE1;ARHGEF39;CYP1B1;STK26;LEF1;PECAM1;SYNE2;TIAM1;FLNA;SLK;SUN2;PPP3CA;CCN1;LMO4;CD74;ULK4;NEDD9;ARID2;DACH1;AMOTL2;CAV1;ATM;TRADD;DPEP1;NOTCH1;DDRGK1;FUZ;CIB1;PRKX;PRKCA;PLXNA2;CYRIB;STK24;EGFR;NTNG2;CBLL1;KIF2A;ZMYND8;FGF9;RDX;PTEN;F3;ROCK2;RACK1;ACTN4;SLURP1;ARSB;RNF20;DAG1;SGK3;PDCD10;RIPOR1;EGF;F2R;APPL1;SPAG9;PTPRU
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3625607299983149,0.7944232197481342,0.7026378896882494,1.0,1.0,4/26,8.37%,ITPR1;HTR2A;IBTK;PLCG2
prerank,aorta morphogenesis (GO:0035909),0.3895946989987154,0.794195626643797,0.7111959287531806,1.0,1.0,5/17,20.56%,HEY2;EFEMP2;BMPR1A;PROX1;RBPJ
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.25917090799181275,-0.7940720558437157,0.774390243902439,0.9152816158672231,1.0,2/22,0.92%,MBP;GCNT2
prerank,peptidyl-proline modification (GO:0018208),0.36644413498915096,0.7939781348183752,0.7096018735362998,1.0,1.0,11/25,23.78%,PPIL3;PIN1;PPWD1;PPIG;PPIA;PPIE;PPIH;PPIL1;FKBP1A;CWC27;NKTR
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3941823978930999,0.7939598978847101,0.6968876860622463,1.0,1.0,2/14,4.94%,TWIST1;ABCD1
prerank,peptidyl-amino acid modification (GO:0018193),0.41356576713904003,0.7935607632724202,0.7015558698727016,1.0,1.0,2/10,10.65%,METAP2;ATP7A
prerank,odontogenesis (GO:0042476),0.36427542702623583,0.7934037052899087,0.7454545454545455,1.0,1.0,7/35,23.07%,AQP1;COL1A2;ANKRD11;TGFB2;HDAC1;FGFR2;OSR1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.40665486214497903,0.7918596450134802,0.71045197740113,1.0,1.0,3/11,17.98%,EXOSC10;FBL;DKC1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.39373503885007266,0.791425733640206,0.7093791281373845,1.0,1.0,3/14,15.12%,RFK;IMPDH2;ADSL
prerank,regulation of RNA export from nucleus (GO:0046831),0.41047485960470137,0.7907125979300375,0.7171717171717171,1.0,1.0,6/11,27.05%,IWS1;DHX9;NCBP2;TPR;SETD2;CPSF6
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.34388578793848906,0.7905803540600005,0.750816104461371,1.0,1.0,11/46,14.03%,CHCHD4;TOMM34;TSPO;PITRM1;TIMM9;DNAJC15;GDAP1;FIS1;TOMM70;TIMM23;GRPEL2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.32942482389719235,0.7900182084542324,0.8216818642350557,1.0,1.0,27/108,21.18%,DEPDC1B;TIAM1;SULF2;AXIN1;SNX3;NXN;DISC1;TCF7L1;SMARCA4;TMEM237;HMGXB4;EMD;CBFB;RACK1;SKI;PSEN1;RUNX1;CTNND2;PTK7;PPP1CA;AMER2;LRRK2;RNF43;PPP2CA;RSPO2;SPIN1;KREMEN1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3768549482760371,0.7900155324568319,0.720754716981132,1.0,1.0,4/20,13.01%,S100A11;CCN4;BMPR1A;NRP1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3481963527371273,0.7893082671375761,0.7461368653421634,1.0,1.0,6/36,10.29%,SP100;NOTCH1;HMGB1;DCN;MECP2;NR2F2
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.19112798763775218,-0.7891288806136066,0.9411764705882353,0.9226265605293607,1.0,10/70,13.75%,PLA2G15;LPIN1;PLA2G7;ENPP2;SLC27A1;MBOAT1;CHPT1;ABHD3;PLA2G6;LPCAT1
prerank,protein localization to Golgi apparatus (GO:0034067),0.3708877306840391,0.7885149856107275,0.7371495327102804,1.0,1.0,9/27,21.38%,RAB33B;ARL5C;SYS1;RIPOR1;VPS13A;RAB6A;GOLPH3;ARL5B;TMED10
prerank,cellular defense response (GO:0006968),0.3458825910330724,0.7885000966108172,0.7358695652173913,1.0,1.0,6/40,14.45%,SPN;LSP1;ZNF148;CCR6;BECN1;TYROBP
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.31007090227067247,-0.7883738710171916,0.7209302325581395,0.9227509330600824,1.0,3/11,10.56%,RNF185;AUP1;BAG6
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.3850462041336893,0.7880875805027564,0.7002583979328165,1.0,1.0,6/18,18.66%,CTNNA1;POLR1A;LATS1;GSK3B;SIN3A;SUFU
prerank,receptor internalization (GO:0031623),0.3430532258085609,0.7880382561167226,0.772972972972973,1.0,1.0,11/44,17.91%,RAMP1;TFRC;CAV1;CLTC;GRB2;CALCRL;ARRB2;GRK2;RAB5A;LDLRAP1;SNCA
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3893584695097889,0.7875345574000606,0.7239583333333334,1.0,1.0,6/16,24.65%,ATP5F1E;ATP5F1D;ATP5MC2;ATP5F1B;ATP5MF;ATP5ME
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3689028460496255,0.7871882133665095,0.7340686274509803,1.0,1.0,5/22,16.34%,PSMB7;PSMA4;NFE2L2;PSMB1;PSME4
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.4058724894077496,0.787120891277478,0.7136871508379888,1.0,1.0,3/12,21.89%,ABCD1;ELOVL5;ACOT8
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3988114494454654,0.7868674021357727,0.7116402116402116,1.0,1.0,6/14,26.12%,DDRGK1;DNAJB9;UFL1;TMEM33;BCL2L11;BAK1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.2905748116779707,-0.786555837037182,0.7550200803212851,0.9248612183463589,1.0,3/14,8.97%,ACOX3;ECI2;SCP2
prerank,type I interferon signaling pathway (GO:0060337),0.3409259670234318,0.7857192263403887,0.76,1.0,1.0,8/41,15.34%,SP100;IRF9;GBP2;XAF1;EGR1;MYD88;IFITM3;IRF8
prerank,cellular response to type I interferon (GO:0071357),0.3409259670234318,0.7857192263403887,0.76,1.0,1.0,8/41,15.34%,SP100;IRF9;GBP2;XAF1;EGR1;MYD88;IFITM3;IRF8
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3921768975776735,0.7856678969690178,0.7172236503856041,1.0,1.0,5/15,21.73%,BLOC1S4;AP3M2;DTNBP1;AP3M1;AP3B1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3921768975776735,0.7856678969690178,0.7172236503856041,1.0,1.0,5/15,21.73%,BLOC1S4;AP3M2;DTNBP1;AP3M1;AP3B1
prerank,platelet degranulation (GO:0002576),0.32569996720798194,0.7850233986999378,0.8373737373737373,1.0,1.0,17/118,17.71%,BLK;F5;PECAM1;FLNA;PHACTR2;CYRIB;ACTN2;APOOL;BRPF3;ABCC4;OLA1;ACTN4;EGF;TGFB2;SCG3;FN1;F13A1
prerank,regulation of interleukin-4 production (GO:0032673),0.37320842370920426,0.7839883763813135,0.7187112763320942,1.0,1.0,2/21,3.56%,LEF1;ZFPM1
prerank,GPI anchor metabolic process (GO:0006505),0.35977735536805694,0.7838340101588029,0.7302709069493521,1.0,1.0,8/26,22.43%,PIGH;PIGF;PIGA;PGAP1;PIGU;PIGM;PGAP2;DPM2
prerank,cardiac cell development (GO:0055006),-0.32318871799863286,-0.7838155814053369,0.7132616487455197,0.9283511587335654,1.0,4/11,16.69%,VEGFA;SLC8A1;JAG1;CXADR
prerank,pulmonary valve development (GO:0003177),0.37392514261193444,0.7837251734786983,0.7180124223602484,1.0,1.0,2/18,7.15%,HEY2;NOTCH1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.21536131476626985,-0.7834503744059778,0.8790322580645161,0.927788615766819,1.0,8/39,17.39%,SALL1;CTNNB1;SEMA3E;ENG;PKD1;VEGFA;FGF2;TGFBR2
prerank,T cell migration (GO:0072678),-0.29697308717296983,-0.7832429513690563,0.7559055118110236,0.9269241599312434,1.0,3/13,9.53%,SLC12A2;PIK3CD;S1PR1
prerank,positive regulation of cellular component organization (GO:0051130),0.328438321407881,0.7829998964901315,0.8540816326530613,1.0,1.0,25/107,19.26%,CDC20;TFR2;RB1;LRP4;TFRC;FAF1;NEDD4L;PPP1R15A;CBLL1;PARK7;SUMO1;RELN;RACK1;FLOT1;GSK3B;BRK1;RUNX1;TGFB2;LMAN1;TMEM30A;SNCA;GNL3L;NRXN1;SLF1;RPS3
prerank,cellular amide metabolic process (GO:0043603),0.3277944716684789,0.7829750663803914,0.8414634146341463,1.0,1.0,24/102,23.87%,DNPEP;PANK2;ACOT11;CPM;ST3GAL1;MTHFD2L;ACOT13;ACOT2;ABCA2;NAPEPLD;ORMDL3;SLC19A1;MCCC1;CPD;ALDH1L1;MTHFD1L;PPP2CA;MME;NAAA;HLCS;ACOT8;ACSL6;PLPP1;SMPD1
prerank,melanosome organization (GO:0032438),0.3655809425262868,0.7828678482070187,0.745920745920746,1.0,1.0,6/26,21.73%,BLOC1S4;SHROOM2;KIF13A;DTNBP1;HPS4;AP3B1
prerank,dopamine metabolic process (GO:0042417),0.3788119940305411,0.7828662132941124,0.7116336633663366,1.0,1.0,5/18,17.91%,ATP7A;LRTOMT;TGFB2;MAOA;SNCA
prerank,secretory granule organization (GO:0033363),0.4150113468570335,0.7828032952881725,0.7250712250712251,1.0,1.0,3/10,15.39%,VPS33B;DTNBP1;F2R
prerank,NAD biosynthetic process (GO:0009435),0.3770275344128563,0.7826223987688943,0.7296954314720813,1.0,1.0,1/20,2.64%,HAAO
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.30850707914737685,-0.7826207407688458,0.7297297297297297,0.9266987328289711,1.0,3/12,11.76%,APOD;PTPRJ;NDRG4
prerank,regulation of smooth muscle contraction (GO:0006940),0.36560540438085376,0.7824333382725653,0.7355889724310777,1.0,1.0,4/20,15.39%,CAV1;CHRM3;NMU;F2R
prerank,purine nucleotide catabolic process (GO:0006195),0.4008109968228834,0.7824145038712176,0.7058823529411765,1.0,1.0,3/13,19.49%,GDA;NT5C2;PNP
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3535360324865637,0.7823754587547067,0.7308584686774942,1.0,1.0,10/29,22.08%,ZC3H7A;PUM2;HNRNPA2B1;SRRT;TUT4;PUM1;TARBP2;AGO2;SMAD2;AGO1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.20382029009807276,-0.7823156997971,0.8548387096774194,0.9260653032427921,1.0,9/44,13.28%,APOE;PTPRJ;CD300A;NF1;DUSP10;SH2B3;PIK3CB;DUSP7;PAQR3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.33684041690053346,0.7820584011872727,0.77491961414791,1.0,1.0,15/52,22.43%,HAAO;L2HGDH;MTHFD2L;ME3;SLC19A1;PHYH;SDHAF3;IDH2;ASS1;ALDH1L1;MDH2;MTHFD1L;GCLM;ACOT8;GCLC
prerank,bone development (GO:0060348),0.34657372162088607,0.7814935326683021,0.7605790645879733,1.0,1.0,6/39,14.97%,SULF2;MBTPS2;SLC10A7;DYM;SKI;TP53
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3223273234889297,0.7811226499606536,0.951,1.0,1.0,82/348,22.34%,BRCA1;HEY2;MAPK1;LEF1;E2F1;EZR;TWIST1;CD74;PTPN22;CTCF;TFRC;RPS7;GSN;ATM;TERF2;MYOM1;EPHX2;PDE2A;TNRC6C;LRP3;TNRC6B;NOTCH1;DDRGK1;MAPK14;PLCG2;PICK1;MTPN;EGR1;DNMT1;MSN;PARK7;FGF9;RDX;MYD88;ARRB2;SETDB2;HCFC1;F3;NFE2L2;ROCK2;ZBTB7B;MYC;GABPA;PSEN1;TLR6;DTNBP1;TYROBP;GSK3B;TADA3;LIMS1;ATF7IP;PDCD10;TP53;EGF;HGS;MAP2K1;TASOR;TRIM28;FN1;SNCA;MED1;ATAD1;SETDB1;RPL5;RPS3;LGALS9;SOX9;DNMT3B;AGO2;INPP5F;RPL23;RAB27A;RBPJ;CITED2;PRKAG1;ROCK1;CELF1;CALCOCO1;AGO1;ACTG1;MED23;NTRK3
prerank,response to peptide hormone (GO:0043434),0.3424132199191866,0.7811003513937057,0.7540983606557377,1.0,1.0,13/43,21.04%,CAV1;ZFP36L1;GNAI1;STAT5B;ROCK2;ZBTB7B;IRS1;SIRT1;XBP1;CREB1;EIF6;EIF2B5;ROCK1
prerank,response to leucine (GO:0043201),0.4089887881380667,0.7810948283019189,0.7164404223227753,1.0,1.0,3/10,16.77%,LARS1;UBR2;KLHL22
prerank,cellular response to leucine (GO:0071233),0.4089887881380667,0.7810948283019189,0.7164404223227753,1.0,1.0,3/10,16.77%,LARS1;UBR2;KLHL22
prerank,negative regulation of heart contraction (GO:0045822),-0.30953631982599056,-0.7809273625625655,0.7622377622377622,0.9271138427695851,1.0,5/11,33.12%,ZC3H12A;SRI;ATP1A2;FKBP1B;SPTBN4
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.2821202502185153,-0.7806327034965909,0.7899159663865546,0.9264238307778847,1.0,4/15,20.72%,SMO;VEGFA;SOX8;AGT
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3767847701532691,0.7805598150170131,0.7223650385604113,1.0,1.0,7/18,17.99%,EMD;PEX2;SKI;MYC;TP53;NLRC3;MORC3
prerank,regulation of TOR signaling (GO:0032006),0.3297730949316797,0.7805302804103539,0.7931747673216132,1.0,1.0,15/67,20.73%,FAM83D;TTI1;GPAT3;LARS1;SEC13;UBR2;MLST8;LAMTOR4;LAMTOR3;NPRL3;PIK3CA;SIRT1;GOLPH3;ARAF;RRAGB
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3615343303567722,0.7797944901491369,0.7276166456494325,1.0,1.0,1/21,3.29%,FLNA
prerank,ventricular septum morphogenesis (GO:0060412),0.3584612383550924,0.7797881202187283,0.7416267942583732,1.0,1.0,9/27,20.79%,HEY2;ZFPM1;NOTCH1;SMAD4;SLIT3;BMPR1A;TGFB2;PROX1;CITED2
prerank,response to steroid hormone (GO:0048545),0.35510538953302895,0.7795981094622949,0.748564867967853,1.0,1.0,3/31,9.29%,CATSPERB;CAV1;ABCA2
prerank,maintenance of blood-brain barrier (GO:0035633),0.3508492048920545,0.7793428145787049,0.7614155251141552,1.0,1.0,4/30,9.15%,PECAM1;TJP3;LAMC1;JAM2
prerank,regulation of amyloid fibril formation (GO:1905906),0.3832922930162189,0.7784348233734638,0.7246376811594203,1.0,1.0,4/15,14.04%,IAPP;VBP1;PFDN5;PSEN1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3544754370710707,0.7780714446407853,0.7360285374554102,1.0,1.0,9/30,22.43%,PIGH;PIGF;PIGA;PIGT;PGAP1;PIGU;PIGM;PGAP2;DPM2
prerank,regulation of fat cell differentiation (GO:0045598),0.3272646182994921,0.7780280353725895,0.8031088082901554,1.0,1.0,16/74,18.48%,E2F1;ZFPM1;NR1D1;FOXO1;FTO;ZFP36L1;LRP3;ZBTB16;ASXL1;WDFY2;ZFP36L2;SIRT1;XBP1;TRPM4;CREB1;AAMDC
prerank,cytoplasmic sequestering of protein (GO:0051220),0.39699396092561484,0.7777873314369405,0.7280453257790368,1.0,1.0,5/13,20.36%,FLNA;LATS1;SUFU;PKD2;KEAP1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.323400540968416,0.7771126940621466,0.951,1.0,1.0,40/308,13.65%,FOXA2;NKX6-1;EZH2;PLA2R1;SOX6;LEF1;FBXO5;GLMN;TIAM1;BATF;TWIST1;RPS19;TFRC;AGPAT1;CAV1;CCR2;NFAM1;DYNC1H1;ALMS1;ZBTB16;JAK2;UCP2;RBM19;NR2C2;ABCA7;CARD9;EHMT1;SMAD4;KMT5C;PLCB1;TAPT1;ADIPOR1;PAXIP1;BCL9L;HAP1;BMPR1A;ZBTB7B;FLOT1;NUMA1;ADCYAP1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.34223396569949727,0.7769604918819112,0.7543859649122807,1.0,1.0,8/38,16.74%,CD47;DDAH2;CAV1;JAK2;ROCK2;TLR6;ASS1;RAC1
prerank,negative regulation of signal transduction (GO:0009968),0.320290768893128,0.7767542455393771,0.924,1.0,1.0,38/249,18.66%,IL12A;EZH2;NR4A2;PHACTR4;CD47;RB1;ERBB3;PALM;NTN1;SULF2;CRHBP;NXN;MTMR2;DCN;RNF157;LRRC14;ZBTB7A;EGFR;ASXL1;KCTD21;HMGXB4;PRKCB;PTEN;HHIP;RACK1;IRS1;CNOT1;EGF;APPL1;HGS;LGR4;NLRP2B;APLN;PIP4K2A;SNCA;LRRK2;RNF43;SUFU
prerank,regulation of tumor necrosis factor production (GO:0032680),0.32558145657139015,0.7765960085118969,0.8591691995947315,1.0,1.0,11/112,8.54%,CD2;SPN;CD47;TWIST1;PTPN22;FOXP1;CCR2;RASGRP1;HMGB1;PLCG2;JAK2
prerank,ncRNA metabolic process (GO:0034660),0.3432096605809462,0.775551246054354,0.7555555555555555,1.0,1.0,8/37,23.36%,NIFK;TUT4;DTD2;TARBP2;ZCCHC8;AGO2;MAPT;DTD1
prerank,sphingoid metabolic process (GO:0046519),-0.30612979527107376,-0.7755419087386606,0.7757352941176471,0.9337722314338074,1.0,4/12,23.92%,SGPP1;SPHK2;PLPP3;DEGS2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3516581550362412,0.7754397308909902,0.7508813160987075,1.0,1.0,6/26,14.89%,TFDP1;MTBP;EGFR;RDX;PLCB1;ADAMTS1
prerank,cellular response to cadmium ion (GO:0071276),0.36538415368085053,0.7750159210759532,0.7567251461988304,1.0,1.0,4/24,11.47%,MAPK1;EGFR;SUMO1;JUN
prerank,regulation of vasculature development (GO:1901342),-0.24055952107640488,-0.7748995025723782,0.8175182481751825,0.9336142967755994,1.0,8/26,22.05%,EGLN1;CTNNB1;NF1;HMOX1;FGF2;VASH1;BMPER;TSPAN12
prerank,regulation of neutrophil migration (GO:1902622),-0.31415243933725445,-0.7748244752575596,0.7368421052631579,0.9325720325612701,1.0,4/10,14.57%,MPP1;RHOG;NCKAP1L;RHOH
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.3044692407680741,-0.7748244622183422,0.7572463768115942,0.9313870617448008,1.0,4/12,20.72%,SMO;VEGFA;SOX8;AGT
prerank,positive regulation of protein secretion (GO:0050714),0.32724789240768115,0.774499106390261,0.7989583333333333,1.0,1.0,9/69,16.72%,BLK;EZR;MYOM1;MYH10;MCU;PPIA;TCF7L2;TGFB2;CAPN10
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3224672500981356,0.7741161012195901,0.8997995991983968,1.0,1.0,35/173,15.33%,SPTA1;F5;STX17;ATL2;RAB1B;ANK1;STX5;PEF1;ARF4;TGFA;DYNC1H1;ARFGAP3;ARFGAP1;SEC24B;ZW10;SEC24A;CUL3;SEC13;ERGIC2;WHAMM;TRAPPC4;MIA2;BET1;COG6;VAPA;SEC31A;TMEM115;KDELR2;COPZ1;PGAP1;RAB2A;NRBP1;DYNLL1;CNIH1;SPTAN1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.40948692826838734,0.7739810665397301,0.7212643678160919,1.0,1.0,3/10,21.75%,PTPN22;IFI35;NR1H3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.36794135199882894,0.7739585056171323,0.7647058823529411,1.0,1.0,2/25,4.43%,PMAIP1;TNFSF10
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3687151959974905,0.773696302586799,0.7563329312424608,1.0,1.0,5/22,13.07%,NOTCH1;PRKCA;MTPN;SMAD4;ROCK2
prerank,cell-substrate junction assembly (GO:0007044),0.33982674171042454,0.7735498006867418,0.7426966292134831,1.0,1.0,9/33,18.18%,SORBS1;LAMC1;LAMB3;WHAMM;ACTN2;TESK2;BCR;FN1;ARHGEF7
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.4027690618299319,0.7734834372914134,0.7329545454545454,1.0,1.0,2/11,5.83%,TJP3;RAB1B
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.2258085801978666,-0.7730847834563807,0.8278688524590164,0.9330741327611174,1.0,9/30,19.03%,SMAD3;PCSK6;FSTL1;ENG;LATS2;SMAD7;TGFBR3;SMURF2;SOX11
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.31952911681012947,0.7728743357833814,0.907,1.0,1.0,51/208,21.16%,ECT2;TRIM59;FLNA;CD74;PIDD1;TANK;TNFSF10;GPRC5B;TFRC;NR1D1;IKBKG;TRADD;TRAF3;BIRC2;BRD4;PIM2;UBE2V1;PLCG2;TAB3;PDPK1;RIOK3;TIFA;CARD9;PRKCB;MYD88;TRIM68;VAPA;CC2D1A;CFLAR;TLR6;TRIM5;RBCK1;F2R;LPAR1;NLRC3;TRAF3IP2;SIRT1;NLRX1;CANT1;MAP3K7;MALT1;PPM1B;TRAF6;LGALS9;CASP8;UBE2N;SLC44A2;RIPK1;IKBKB;OTUD7A;GAPDH
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.32105571597406624,0.7728049256299226,0.832995951417004,1.0,1.0,26/101,23.92%,EZH2;INCENP;CCNYL1;RASGRP1;MAPRE3;CIB1;EGFR;FLT3;PDCD10;EGF;MAP2K1;FGFR1;CD24;SIRT1;SNCA;LRRK2;PROX1;PPP2CA;PKD2;CCND3;CALM3;ATP2B4;ADAM17;SRC;TELO2;HMGA2
prerank,negative regulation of JNK cascade (GO:0046329),0.34340909490972243,0.7717109689267792,0.7401574803149606,1.0,1.0,2/31,4.25%,MEN1;PTPN22
prerank,regulation of monooxygenase activity (GO:0032768),0.3608555676168746,0.7715200726276498,0.7581620314389359,1.0,1.0,7/23,18.68%,DDAH2;CAV1;LYPLA1;EGFR;NOSIP;SNCA;NOSTRIN
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.32357145369796336,0.7714869540349919,0.8258196721311475,1.0,1.0,17/87,19.07%,SDHAF4;PET100;NDUFS8;CHCHD4;NDUFAF8;NDUFB7;NDUFAF1;NDUFAF7;NDUFA1;NDUFAF5;FOXRED1;SDHAF3;UQCC1;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.23287170178731986,-0.7704425028532674,0.7971014492753623,0.9361304869258349,1.0,6/28,14.37%,ARRDC1;ARRB1;YTHDF2;MMP14;TSPAN15;FBXW7
prerank,eye morphogenesis (GO:0048592),0.37071051969686786,0.7699728099816339,0.7343358395989975,1.0,1.0,5/19,18.03%,AGTPBP1;SHROOM2;NIPBL;SKI;RARG
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3619000191071817,0.7697201432798035,0.7275,1.0,1.0,2/21,6.63%,OSBPL5;MBOAT2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.3873814503700104,0.7696914708057033,0.7410958904109589,1.0,1.0,3/13,14.99%,L2HGDH;PHYH;IDH2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3852339791361405,0.7696593823118618,0.7440318302387268,1.0,1.0,2/14,5.73%,KCNN4;IKBKG
prerank,protein insertion into ER membrane (GO:0045048),0.3445718753995316,0.7693819809327358,0.7764449291166848,1.0,1.0,7/37,12.02%,EMC6;EMC10;STX5;EMC3;GET3;EMD;VAPA
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.36343328230566024,0.7692763118143321,0.7527539779681762,1.0,1.0,5/21,16.74%,CAV1;GPD1L;PTEN;RACK1;NLRP2B
prerank,regulation of interleukin-6 production (GO:0032675),0.32528689774903624,0.7691469258892146,0.8485772357723578,1.0,1.0,19/96,17.97%,POU2AF1;CD47;TWIST1;CD74;IL16;PTPN22;HMGB1;PLCG2;IL17RA;CARD9;DHX9;MYD88;TLR6;TYROBP;F2R;NLRC3;CYBA;XBP1;POU2F2
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3596579107435016,0.7690949796577307,0.7394366197183099,1.0,1.0,7/23,17.78%,NPLOC4;FAF2;SEC13;DERL2;LMAN1;HSP90B1;SYVN1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.31906434740868167,0.7686022007495206,0.8858858858858859,1.0,1.0,38/158,21.16%,ECT2;FLNA;CD74;TNFSF10;GPRC5B;TFRC;IKBKG;TRADD;BIRC2;BRD4;PIM2;UBE2V1;TAB3;TIFA;CARD9;PRKCB;MYD88;TRIM68;VAPA;CC2D1A;CFLAR;TLR6;TRIM5;RBCK1;F2R;LPAR1;TRAF3IP2;CANT1;MAP3K7;MALT1;TRAF6;LGALS9;CASP8;UBE2N;SLC44A2;RIPK1;IKBKB;GAPDH
prerank,rRNA pseudouridine synthesis (GO:0031118),0.3983777976148806,0.7684239183636664,0.7309417040358744,1.0,1.0,1/10,3.55%,NOP10
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3389680854789019,0.7679958741630905,0.744874715261959,1.0,1.0,6/33,15.38%,CCDC88A;SHKBP1;TGFA;HAP1;DGKD;EGF
prerank,lipoprotein catabolic process (GO:0042159),0.4027122679589241,0.7679403423094864,0.7451523545706371,1.0,1.0,3/11,10.64%,ABHD17A;LYPLA1;ABHD17B
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.35678176320596555,0.7678907249370361,0.748792270531401,1.0,1.0,8/25,17.78%,BRD4;RNF168;RNF8;NELFA;HNRNPU;NELFB;TCERG1;HEXIM1
prerank,regulation of protein polymerization (GO:0032271),-0.2290772595204988,-0.7673392187850758,0.8852459016393442,0.9399888589036753,1.0,10/35,19.57%,PAK3;CAMSAP2;HSP90AA1;PFN1;COTL1;PFN2;TTBK1;ARL2;RASA1;CTTN
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2808694468994123,-0.7668586866305138,0.7721518987341772,0.9395749833766711,1.0,9/14,35.35%,CMPK1;SMPDL3A;ITPA;AK1;AK7;ENPP3;AK4;AK8;NME2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3473095300470524,0.7666989271385991,0.7491408934707904,1.0,1.0,8/29,20.19%,CCR2;JAK2;SOCS2;STAT5B;PIAS1;JAK3;PKD2;SOCS6
prerank,sensory perception of smell (GO:0007608),0.3952905504586045,0.7665490049405169,0.7524071526822559,1.0,1.0,2/11,15.69%,BBS4;SLC24A4
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.36061491719648303,0.7664421227021947,0.7412333736396615,1.0,1.0,4/20,18.14%,BRCA1;ABCA2;WDTC1;PRMT3
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.2652692854086969,-0.7663544269350131,0.7956521739130434,0.9391621529898867,1.0,8/18,43.95%,SLC8B1;MDK;LYN;PTK2B;MTUS1;F7;SLIT2;IL6
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.37397651835284174,0.7663537649523661,0.7532637075718016,1.0,1.0,5/16,18.99%,SMCHD1;KMT5C;PRKDC;RIF1;WRAP53
prerank,regulation of calcium ion import (GO:0090279),-0.254574204433052,-0.7659001431604353,0.8095238095238095,0.9386345797567444,1.0,8/21,22.63%,CTNNB1;PSEN2;PLPP4;TRIM27;PRNP;CCL3;SPHK2;SLC30A1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2863919315957283,-0.7657474721411697,0.7590361445783133,0.9377519422547542,1.0,3/13,11.47%,ASPH;TBC1D10A;LGMN
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3386023664184133,0.7648554007387824,0.7809110629067245,1.0,1.0,3/44,2.78%,ARHGEF5;CD47;CCDC88A
prerank,spinal cord development (GO:0021510),-0.30129518809339806,-0.7646427686065539,0.7598566308243727,0.9383331712021147,1.0,5/12,19.03%,NF1;PKD1;SOX4;LOXL3;SOX11
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3415739443714879,0.7646274630980135,0.7838745800671892,1.0,1.0,10/37,19.34%,IFT80;TNPO1;SSX2IP;PCM1;IFT57;DYNLL1;KIFAP3;IFT172;IFT140;DYNLRB1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.360776917520577,0.7645066824808916,0.7405602923264312,1.0,1.0,6/24,14.97%,MBTPS2;NOTCH1;ATF6;NFE2L2;DDIT3;TP53
prerank,positive regulation of mitochondrion organization (GO:0010822),0.33447878769127687,0.7642852216420895,0.789308176100629,1.0,1.0,11/57,14.97%,PMAIP1;AURKA;TNFSF10;BOK;DCN;PARK7;FIS1;CHCHD10;MCU;GSK3B;TP53
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3287118164130846,0.7629090173450439,0.7983104540654699,1.0,1.0,14/50,19.79%,FBXO5;NXN;CAV1;TAF1;PRR7;PARK7;ARRB2;SIRT7;UBXN1;CAMLG;PRMT3;GNL3L;RPS3;HDAC8
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3343999979672236,0.7628823466335217,0.7730812013348165,1.0,1.0,16/45,23.08%,POLR2A;ZC3H18;SETX;EGFR;DYRK1A;DXO;SIRT7;TP53;DIMT1;MAP2K1;RIOK1;HNRNPLL;PNPT1;RIPK1;TRMT112;ZPR1
prerank,fatty acid metabolic process (GO:0006631),0.322281900411833,0.7626902471853344,0.8610271903323263,1.0,1.0,21/115,17.05%,CEL;ACADM;ACOT11;ACBD5;CPT1B;CBR4;NUDT19;HPGD;ACOT2;ALKBH7;SLC27A2;PEX2;FASN;ADIPOR1;CPT1A;PON3;ACSL5;CPT2;NDUFAB1;ELOVL4;XBP1
prerank,regulation of mitochondrion organization (GO:0010821),0.33694523307754254,0.7620863878230532,0.7899343544857768,1.0,1.0,11/47,19.75%,PISD;IAPP;HDAC6;PDE2A;CYRIB;FIS1;SIRT7;GSK3B;LRRK2;SREBF2;GOLPH3
prerank,myoblast differentiation (GO:0045445),0.38292754728698913,0.7619843038095276,0.7396373056994818,1.0,1.0,1/14,2.67%,RB1
prerank,protein mannosylation (GO:0035268),-0.250088457240951,-0.7617989072847838,0.8352272727272727,0.9415394627382483,1.0,3/22,6.82%,CRPPA;LARGE1;FKTN
prerank,negative regulation of kinase activity (GO:0033673),0.32353447444460326,0.7611021689116227,0.794577685088634,1.0,1.0,14/62,17.91%,RB1;PPP2R5A;TAF7;CEP85;TAB1;PDPK1;PARK7;HNRNPU;PRKAG2;PPIA;DTNBP1;TARBP2;PAK2;SNCA
prerank,glycoprotein catabolic process (GO:0006516),-0.27552995753589116,-0.7598431287929585,0.8084112149532711,0.9434931389779481,1.0,3/17,3.74%,MANBA;NGLY1;STT3B
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2781848085390944,-0.7597176129317079,0.792,0.9424956649412168,1.0,10/14,35.35%,CMPK1;ME1;NMNAT3;NMNAT1;AK1;NMNAT2;AK7;AK4;AK8;NME2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.32946252233057477,0.7592363514041157,0.78125,1.0,1.0,8/46,14.93%,AGPAT1;AGPAT4;GPD1L;GPAT3;AGPAT3;PLD2;DGKD;PLD1
prerank,protein targeting to mitochondrion (GO:0006626),0.3270340075559805,0.7584391054498274,0.7955742887249737,1.0,1.0,11/52,14.03%,CHCHD4;TOMM34;TSPO;PITRM1;TIMM9;DNAJC15;GDAP1;FIS1;TOMM70;TIMM23;GRPEL2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.3630820803689138,0.7579141011584885,0.7355889724310777,1.0,1.0,7/17,23.22%,MBTPS2;SEC14L2;ABCA2;KPNB1;SREBF2;SCAP;LPCAT3
prerank,calcium ion transport (GO:0006816),0.31826769704228053,0.7575038873397418,0.8499496475327291,1.0,1.0,20/113,17.46%,MS4A1;CACNA1I;RAMP1;ITPR1;FYN;KCNN4;CAV1;ORAI2;TRPM7;ITGAV;CALCRL;CRACR2A;MICU1;PSEN1;TPT1;SLC24A4;SLC24A2;TRPM4;CACNA1B;ANO6
prerank,regulation of protein modification process (GO:0031399),0.3281583652018072,0.7574539880761249,0.7814854682454252,1.0,1.0,15/50,22.66%,CCDC88A;PML;CCDC88C;PIN1;ABCA2;PUM3;CCAR2;KAT2B;SPRED2;FN1;PPP1R16A;PPP2CA;CADM4;PPP1R16B;ASPSCR1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.2823848204552836,-0.757338432736779,0.7674418604651163,0.9449029123912528,1.0,1/13,0.52%,EPN2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.36007556757628756,0.7571090033548277,0.7638376383763837,1.0,1.0,4/20,13.28%,LY6H;PLCB1;GRK2;CHRM3
prerank,negative regulation of GTPase activity (GO:0034260),-0.2435809982954522,-0.7569877820730572,0.8544303797468354,0.9442053268173488,1.0,7/22,20.89%,F11R;RASA4;RCC2;DAB2IP;ARL2;PLXNB3;TMED2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.24080070505296228,-0.7567662595514434,0.881578947368421,0.943317810586492,1.0,7/23,19.03%,SMAD3;ENG;LATS2;SMAD7;TGFBR3;SMURF2;SOX11
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3586130404802052,0.7567499625885118,0.7518610421836228,1.0,1.0,5/21,13.07%,SLK;PTPRA;CLASP1;EPHA3;ROCK2
prerank,stem cell development (GO:0048864),0.3685062698223803,0.7566287726182516,0.741514360313316,1.0,1.0,3/16,11.80%,PEF1;TCOF1;TAPT1
prerank,Golgi organization (GO:0007030),0.31313564909534974,0.7565737744899947,0.8580060422960725,1.0,1.0,31/112,21.38%,CDK1;ATP8B4;STX17;ATL2;CLASP1;STX5;NPLOC4;CSNK1A1;ZW10;BLZF1;DYM;BET1;VRK1;RAB43;PI4K2B;RAB2A;VCPIP1;PDCD10;FAM174B;SYNE1;LMAN1;GORASP1;LRRK2;ARHGEF7;VTI1A;FBXW8;GOLPH3;GORASP2;ATP8B2;VAMP4;TMED10
prerank,regulation of synapse organization (GO:0050807),0.3437966019730473,0.7565065653401828,0.7494089834515366,1.0,1.0,8/26,23.00%,ABHD17A;ABHD17B;MDGA1;PDLIM5;CLN3;SLITRK2;SETD5;NEDD4
prerank,modified amino acid transport (GO:0072337),0.36950987345481656,0.7558543196693013,0.7467018469656992,1.0,1.0,2/15,11.15%,SLC16A12;SLC19A1
prerank,positive regulation of bone mineralization (GO:0030501),-0.2111404800675332,-0.7556865206600385,0.9166666666666666,0.9437894329539621,1.0,8/35,17.78%,ACVR1;BMPR2;ATRAID;ALOX5;BMPR1B;SLC8A1;PKDCC;BMP6
prerank,female gonad development (GO:0008585),0.36587595746345913,0.7555366625587175,0.7556962025316456,1.0,1.0,2/19,10.29%,NUP107;NR2F2
prerank,autophagosome maturation (GO:0097352),0.3442865196036953,0.7551980397324052,0.786697247706422,1.0,1.0,16/32,27.16%,STX17;LIX1;UBQLN1;VPS16;VPS33B;RUBCNL;CHMP3;EPG5;CLN3;VMP1;TSG101;VCP;VIPAS39;ATG14;GABARAP;ATP2A2
prerank,regulation of protein targeting to membrane (GO:0090313),0.35112849809866076,0.7551939011142101,0.7906178489702517,1.0,1.0,4/28,12.03%,C2CD5;FYN;CIB1;FIS1
prerank,negative regulation of RNA splicing (GO:0033119),0.3567489503825515,0.7551275695077805,0.7432762836185819,1.0,1.0,10/19,28.16%,SAP18;SRSF4;RNPS1;SRSF10;SRSF7;PTBP2;PTBP1;SFSWAP;RPS13;PTBP3
prerank,ESCRT III complex disassembly (GO:1904903),0.3941877215291499,0.7550639918101336,0.7349228611500701,1.0,1.0,6/10,27.75%,CHMP1B;CHMP2B;VTA1;VPS4A;CHMP5;VPS4B
prerank,ESCRT complex disassembly (GO:1904896),0.3941877215291499,0.7550639918101336,0.7349228611500701,1.0,1.0,6/10,27.75%,CHMP1B;CHMP2B;VTA1;VPS4A;CHMP5;VPS4B
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3446473431325948,0.7550501219157627,0.7517084282460137,1.0,1.0,7/29,19.38%,RAB33B;NAPG;COG6;COPZ1;VTI1A;RAB6A;TRAPPC3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4030732714797817,0.7548829922276273,0.7754800590841949,1.0,1.0,3/10,20.56%,CSGALNACT2;B3GAT2;B3GAT1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.31915757601849487,0.7547629372371113,0.8360824742268042,1.0,1.0,23/76,23.21%,PLK1;AXIN1;TAF1;CSNK1A1;DDRGK1;SUMO1;RAD23A;PTEN;CDK5RAP3;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;RNF19A;LRRK2;KEAP1;MDM2;CBFA2T3;HECTD1;DDA1;BBS7
prerank,autophagy of peroxisome (GO:0030242),0.39029874446466273,0.7544470735424719,0.7589531680440771,1.0,1.0,2/12,5.98%,ACBD5;ATM
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.2728277807175399,-0.7541211188171533,0.7796610169491526,0.9449478079681342,1.0,6/15,24.06%,CDH13;MVB12B;LGMN;CEACAM1;RHBDF2;FER
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.34532756788135166,0.7538185276988518,0.781582054309327,1.0,1.0,6/25,21.57%,MPP2;ARRB2;GSK3B;LRRK2;GLRA1;GRIN2D
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.28959809005682124,-0.7537947172717133,0.7884615384615384,0.9442424043496628,1.0,3/12,16.46%,BASP1;PTPRO;JAG1
prerank,cAMP-mediated signaling (GO:0019933),0.3518040816140268,0.75369621547853,0.7560679611650486,1.0,1.0,7/24,20.63%,PDE7B;PDE2A;AHR;ADCYAP1;KSR1;SOX9;PDE7A
prerank,early endosome to Golgi transport (GO:0034498),0.3862105413882375,0.7526393763507544,0.7464788732394366,1.0,1.0,4/11,21.62%,STX5;LMAN1;RAB6A;TRAPPC10
prerank,genitalia development (GO:0048806),-0.2901803626276534,-0.7525337345221719,0.7635658914728682,0.9448850123502696,1.0,3/12,18.79%,DNAJC19;PKD1;CHD7
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3282380183117706,0.7524838632503695,0.7963362068965517,1.0,1.0,11/45,17.24%,EIF2A;RBM3;ZC3H7A;PUM2;MTPN;PUM3;TCOF1;PUM1;METTL16;RC3H1;TDRD7
prerank,chloride transmembrane transport (GO:1902476),0.3300188799544135,0.7521936481183221,0.8035126234906695,1.0,1.0,7/48,12.59%,SLC12A3;SLC12A7;SLC12A1;GABRA4;GABRA5;ANO3;SLC12A6
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3505541289222325,0.7521610558662386,0.7743979721166033,1.0,1.0,5/21,15.17%,ZFP36L1;CBFB;CTSK;ROCK2;RUNX1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.35058053787890725,0.7517517988538536,0.7602905569007264,1.0,1.0,3/22,13.13%,CARD9;MYD88;ZBTB7B
prerank,limb morphogenesis (GO:0035108),-0.2617528088196631,-0.7515090469507224,0.8413461538461539,0.9452216258331299,1.0,4/20,12.88%,PCSK5;IQCE;BMPR1B;GLI3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.31161403430463036,0.7513852563130107,0.972,1.0,1.0,91/390,22.53%,SHCBP1;BLK;NTF4;STMN1;MAPK1;ERBB3;FYN;TIAM1;POLR2I;SULF2;POLR2A;NEDD9;FLRT2;PGF;MAPKAPK3;CYFIP2;GFRA2;HNRNPM;FOXO1;SORBS1;SETX;NUS1;MAPK14;GRB2;JAK2;SOS1;ITGAV;NCBP1;EGFR;EPHA3;CAV2;ANKS1A;SOCS2;MTSS1;FGF9;PLCB1;FLT3;CRK;ARHGEF28;AP2B1;HAP1;LMTK2;NRP1;ROCK2;SPRED2;ATP6V0E1;PSEN1;IRS1;GSK3B;BRK1;CEP57;APPL1;CYBB;ELMO2;ANKS1B;FGFR1;FIBP;PAK2;ATP6AP1;POLR2K;RAC1;PIK3CA;CYBA;ATP6V0D1;POLR2J;SDC2;ARHGEF7;KIF16B;POLR1G;HNRNPA1;NCBP2;NCF4;GRB14;PRKD2;ALK;EPHA7;MET;SIPA1L1;ROCK1;SH2D2A;VAV3;EPHA10;SYK;FGR;RBFOX2;ACTG1;EFNA1;NTRK3;DDR2;POLR2B;PXN
prerank,positive regulation of monooxygenase activity (GO:0032770),0.34715205302907126,0.7509326438185339,0.775842044134727,1.0,1.0,4/26,10.75%,TERF2;NUS1;ATP7A;PARK7
prerank,muscle tissue development (GO:0060537),0.3835806485141234,0.7508680504487215,0.7557980900409277,1.0,1.0,2/13,9.10%,CSRP3;CSRP1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.35090848799629576,0.7501801900768897,0.754257907542579,1.0,1.0,3/24,5.95%,STMN1;ARHGEF18;CLASP1
prerank,positive regulation of endocytosis (GO:0045807),0.33062440473858584,0.7500625853548768,0.8139281828073993,1.0,1.0,11/45,18.69%,TFR2;ABCA13;NEDD4L;CBLL1;TOR1A;B2M;FLOT1;ANO6;LDLRAP1;SNCA;CLN3
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.3430420862089859,0.7500516975480201,0.7827626918536009,1.0,1.0,2/29,7.15%,ZFPM1;NOTCH1
prerank,fatty acid transmembrane transport (GO:1902001),0.35678962478002696,0.7497874432709484,0.7496871088861077,1.0,1.0,7/19,18.79%,ABCD1;CPT1B;CPT1A;PRKAG2;CPT2;SLC2A1;ABCD4
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.23732442678391374,-0.7495932478851242,0.8979591836734694,0.9468592939452364,1.0,7/24,22.81%,AKIRIN1;PIK3R1;ARPC2;ABI2;TWF2;CDC42;CYFIP1
prerank,carbohydrate derivative transport (GO:1901264),-0.25323474919912586,-0.7495314940186467,0.8428571428571429,0.9458010729600754,1.0,5/18,18.30%,SLC15A3;PLTP;SCARB1;NPC2;VLDLR
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.36700175349518466,0.7493369575584528,0.7680412371134021,1.0,1.0,5/18,16.94%,NONO;PARK7;NFE2L2;PPIA;SIRT1
prerank,cellular response to oxygen levels (GO:0071453),0.3943632964290727,0.749149391388765,0.7524339360222532,1.0,1.0,3/10,17.11%,PICK1;ATP6AP1;ATP6V0D1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.23469992515646476,-0.7490375311472469,0.8502994011976048,0.9453724765598985,1.0,3/23,7.92%,MAML1;IGF1;MMP14
prerank,positive regulation of histone deacetylation (GO:0031065),-0.2859174381184605,-0.7489626080681853,0.7777777777777778,0.9443019796827983,1.0,3/12,6.27%,PRKD1;AKAP8L;SAP30BP
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3084187971118585,0.7489340370371519,0.993,1.0,1.0,114/509,21.16%,CD19;ECT2;PMAIP1;IAPP;RPS20;ERBB3;FYN;FLNA;DHX58;CD74;S100A9;TNFSF10;GPRC5B;TFRC;CGAS;CAV1;IKBKG;S100A8;TRADD;TGFA;BIRC2;BRD4;PUM2;PIM2;HMGB1;BOK;DCN;UBE2V1;HCST;GRB2;PLCG2;JAK2;ITGAV;STRN;TAB3;LARS1;EGFR;CAV2;PDPK1;SEC13;TXN;RIT2;TIFA;TRIM44;CARD9;PARK7;RELN;PUM1;MLST8;FGF9;BECN1;FLT3;PRKCB;MYD88;TRIM68;VAPA;FIS1;CDK5RAP3;F3;ROCK2;RACK1;RAC2;CC2D1A;ACTN4;DDIT3;LAMTOR4;CFLAR;MYDGF;TLR6;USP15;TRIM5;IRS1;RBCK1;LAMTOR3;ADGRV1;LIMS1;TP53;EGF;F2R;LPAR1;TCF7L2;FGFR1;TGFB2;TRAF3IP2;RAC1;PIK3CA;SIRT1;CANT1;HCLS1;FN1;KITLG;MAP3K7;HEXIM1;IQGAP1;MALT1;KSR1;RPS3;TRAF6;LGALS9;SOX9;CASP8;IFI35;GOLPH3;PRKD2;RPL23;MET;ILK;UBE2N;SLC44A2;RRAGB;RIPK1;ROCK1;IKBKB;GAPDH
prerank,membrane depolarization (GO:0051899),0.33749765850574254,0.7486014227825162,0.7738636363636363,1.0,1.0,3/32,6.13%,CACNA1I;CAV1;YWHAH
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3084664086702113,0.7485969541357267,0.9229229229229229,1.0,1.0,32/190,16.99%,CIT;PHLPP2;TRIM59;ITPR1;TWIST1;TANK;PHLDA3;CAV1;BANK1;NR1D1;GPD1L;PDE2A;CIB1;MAPK14;RNF157;CYRIB;RIOK3;ABCA7;UBR2;ADIPOR1;PTEN;ARRB2;RACK1;DGKD;DDIT3;UACA;DAG1;LIMD1;NPRL3;NLRC3;SIRT1;NLRX1
prerank,glial cell differentiation (GO:0010001),-0.22735692041769573,-0.7483556926136014,0.8676470588235294,0.9439969268013803,1.0,12/28,23.66%,PTPRZ1;SLC8A3;CDH2;GPR157;STAT3;CDK5;SOX4;ADGRG6;SOX11;SOX8;SOX10;NFIB
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3543040476265465,0.7481349772698637,0.7654921020656136,1.0,1.0,9/24,19.06%,SEC24B;TAP1;SEC24A;SEC13;B2M;SEC31A;CANX;ERAP1;SAR1B
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.34471080294118955,0.7479867498461947,0.7606132075471698,1.0,1.0,8/26,21.75%,PTPN22;CAV1;HMGB1;FLOT1;TLR5;CYBA;IFI35;NR1H3
prerank,retina homeostasis (GO:0001895),0.3509499228250523,0.7479581786459751,0.7640718562874251,1.0,1.0,3/23,13.42%,POC1B;B2M;BBS4
prerank,positive regulation of neuron death (GO:1901216),0.3293999327682608,0.7472415085679676,0.798918918918919,1.0,1.0,13/46,21.28%,FYN;EIF2S1;MAP3K5;EGR1;DDIT3;TLR6;TYROBP;GSK3B;TGFB2;FCGR2B;SNCA;EPHA7;MAPT
prerank,regulation of epithelial cell differentiation (GO:0030856),0.36216029723472315,0.7471583801718003,0.7615979381443299,1.0,1.0,5/17,23.07%,CAV1;PRKX;CD24;SOX9;OSR1
prerank,snRNA 3'-end processing (GO:0034472),0.3601428784712326,0.74661781653203,0.770595690747782,1.0,1.0,5/19,20.67%,EXOSC8;INTS1;INTS14;TUT1;INTS12
prerank,regulation of secretion (GO:0051046),0.37323471923390117,0.7462734768176279,0.7458333333333333,1.0,1.0,1/13,2.98%,ERBB3
prerank,sodium ion import across plasma membrane (GO:0098719),-0.26181182231955663,-0.7451951748466619,0.8149779735682819,0.9473573610262676,1.0,4/17,16.40%,SLC12A2;SLC9A1;HCN2;SLC8A1
prerank,myotube differentiation (GO:0014902),0.36749337936980286,0.745036807413479,0.7454545454545455,1.0,1.0,4/17,16.93%,MYEF2;JAM2;SKI;ADAMTS5
prerank,embryonic appendage morphogenesis (GO:0035113),0.37954891104630356,0.74471901791032,0.7665706051873199,1.0,1.0,3/12,22.36%,SKI;TGFB2;MEGF8
prerank,establishment of melanosome localization (GO:0032401),0.35344371740941144,0.7445880061129027,0.7669172932330827,1.0,1.0,8/19,24.62%,SHROOM2;RAB11B;BBS4;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.38953106888848343,0.7442860464830222,0.7541208791208791,1.0,1.0,3/11,13.08%,NONO;PARK7;RACK1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.30652593311574067,-0.7442562585918189,0.7954545454545454,0.9475491798290006,1.0,5/10,32.25%,BIN1;ATP1A2;CBARP;FKBP1B;ADRA2A
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3390365710387186,0.7440836961660185,0.7962747380675204,1.0,1.0,3/29,8.69%,ACOT11;ACOT13;ACOT2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3390365710387186,0.7440836961660185,0.7962747380675204,1.0,1.0,3/29,8.69%,ACOT11;ACOT13;ACOT2
prerank,regulation of signal transduction (GO:0009966),0.30957127341870844,0.7439779004546637,0.93,1.0,1.0,51/190,23.20%,CD177;RGS12;ERBB3;FYN;AXIN1;NUCKS1;SNX3;SP100;GRK6;SIK2;TCF7L1;GIT2;FUZ;TMEM237;MFNG;SOCS2;AMFR;PLCB1;CRK;CBFB;HHIP;GRK2;ZDHHC7;TMEM204;ADCYAP1;CREBBP;PPIA;ZFAND2B;DTNBP1;TRIM5;ELF1;RUNX1;CD24;SIRT1;TSPEAR;LRRK2;CD55;SREBF2;PPP2CA;NCLN;ILK;POFUT1;GRK3;CDC42SE2;IGFBP7;YWHAG;PXN;FGFR2;INTU;IGFBP2;SRC
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3670422453714186,0.7437269972246991,0.7647058823529411,1.0,1.0,5/17,17.78%,NPLOC4;FAF2;DERL2;HSP90B1;SYVN1
prerank,body fluid secretion (GO:0007589),-0.2756462207986208,-0.7437056995054931,0.7869565217391304,0.9471062754874605,1.0,3/15,14.08%,ERBB4;PRLR;VEGFA
prerank,ERBB2 signaling pathway (GO:0038128),0.3364821234070675,0.7436995465125918,0.7807118254879449,1.0,1.0,7/31,16.78%,ERBB3;PRKCA;GRB2;SOS1;EGFR;EGF;PIK3CA
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3301393021181493,0.7428671501018027,0.8166311300639659,1.0,1.0,9/52,13.08%,CNPY4;PRKCE;SORBS1;CIB1;EGFR;EPHA3;PDPK1;CNST;RACK1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.37033309867080244,0.742769371736081,0.7637362637362637,1.0,1.0,1/13,2.20%,XPO1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.23999554335124865,-0.7426061453464963,0.8571428571428571,0.9474161308093887,1.0,9/22,27.74%,RELA;GSK3A;CASP3;EPHA4;RANBP9;LYN;PICALM;CHRNA7;LRRTM3
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.3914982465049394,0.7424452661993569,0.7642956764295676,1.0,1.0,2/10,17.91%,HDAC6;SNCA
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.36466832663018667,0.7423415344969165,0.7751937984496124,1.0,1.0,1/17,2.29%,CACNA1I
prerank,endoderm formation (GO:0001706),-0.20896136050189484,-0.7420914680659528,0.9217391304347826,0.9468822451399619,1.0,4/35,7.92%,ITGB5;ITGA5;COL11A1;MMP14
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.378065740346727,0.7419020504478961,0.7622377622377622,1.0,1.0,2/12,10.83%,PAFAH1B1;SZT2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.3826683832260009,0.7417747947051857,0.7672176308539945,1.0,1.0,4/12,17.63%,CIB1;CAMTA1;STIMATE;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.3826683832260009,0.7417747947051857,0.7672176308539945,1.0,1.0,4/12,17.63%,CIB1;CAMTA1;STIMATE;SPPL3
prerank,positive regulation of cell growth (GO:0030307),0.3093948565482753,0.7417193258340493,0.8777777777777778,1.0,1.0,15/96,11.37%,NTN1;S100A9;BRAT1;DDX49;S100A8;H3-3A;CIB1;NEDD4L;DBNL;RNF157;MTPN;NCBP1;EGFR;DERL2;SYT3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.35036283929295103,0.7416423286739686,0.7803970223325062,1.0,1.0,3/22,8.41%,DDX11;SMARCA4;NOL11
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.36808033154657327,0.7415461244500616,0.7690288713910761,1.0,1.0,4/15,14.45%,RIPOR2;MAPK14;FLOT1;TYROBP
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.20037275018059042,-0.7414871696010922,0.9313725490196079,0.946541269854325,1.0,8/39,17.78%,MBP;NEXMIF;MIA3;PPM1F;PTK2;VEGFA;JAG1;BMP6
prerank,negative regulation of defense response (GO:0031348),0.3118980932027712,0.7414257646979074,0.8341915550978373,1.0,1.0,5/77,5.37%,RNF26;MEFV;RB1;DHX58;NR1D1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3058085585623949,0.7412062705388823,0.9027081243731193,1.0,1.0,41/150,23.15%,MEN1;RB1;TWIST1;CAV1;CRKL;GPD1L;PMEPA1;TAF7;NIBAN1;CEP85;CIB1;TAB1;IBTK;PDPK1;PARK7;SNX25;PTEN;CDK5RAP3;RACK1;SPRED2;PRKDC;PRKAG2;PPIA;DTNBP1;FKBP8;TARBP2;PAK2;NLRP2B;PTPN13;SNCA;LRRK2;PRR5L;DNAJC3;CADM4;CALM3;PPP1R15B;YWHAG;NTRK3;TARDBP;PPM1E;PRKCD
prerank,receptor recycling (GO:0001881),-0.3034371105629893,-0.7411591419146127,0.7973421926910299,0.9457999889475202,1.0,1/10,0.16%,ARFGEF2
prerank,divalent inorganic cation homeostasis (GO:0072507),0.34314272336457763,0.7408946801950383,0.770059880239521,1.0,1.0,6/25,17.91%,CAV1;TRPM7;KCNA1;TMTC2;FAM20A;SNCA
prerank,sterol homeostasis (GO:0055092),0.31472164300895605,0.740655905487099,0.8395833333333333,1.0,1.0,17/65,23.73%,ABCD1;CAV1;NR1D1;EPHX2;RALY;ABCA2;LIMA1;CD24;SIRT1;XBP1;LDLRAP1;NR1H3;HDAC9;LDLR;SOAT1;TTC39B;EHD1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3563117562339096,0.7405742067702793,0.7800511508951407,1.0,1.0,7/19,22.91%,XRCC6;PPP2R3C;BTK;PRKDC;XBP1;SYK;ZBTB1
prerank,DNA catabolic process (GO:0006308),0.3837339057929726,0.7405398492267492,0.7593123209169055,1.0,1.0,2/11,13.47%,DNASE1L1;REXO4
prerank,nucleotide-sugar metabolic process (GO:0009225),0.3784458811454586,0.7393546499124103,0.7771664374140302,1.0,1.0,4/12,18.81%,GFUS;FUT8;GFPT2;GMDS
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.38289135915471284,0.7390251764766884,0.767277856135402,1.0,1.0,5/12,24.05%,PLCG2;TLR6;CYBA;RAB27A;SLC5A3
prerank,negative regulation of myotube differentiation (GO:0010832),0.376702215151383,0.7390081276753727,0.7816901408450704,1.0,1.0,6/12,26.76%,NOTCH1;XBP1;HDAC4;HDAC1;BDNF;TMEM119
prerank,positive regulation of protein depolymerization (GO:1901881),-0.29736542857756343,-0.7389576170917772,0.8235294117647058,0.9476849563251518,1.0,6/11,35.49%,STMN2;TRPV4;PLEK;NES;KATNB1;PDXP
prerank,sensory perception of chemical stimulus (GO:0007606),-0.2721374704629311,-0.738916563213058,0.8411214953271028,0.9465898177808901,1.0,7/15,33.13%,GNAS;C5AR1;CD36;UBR3;GNAL;MKKS;DRD2
prerank,heterocycle biosynthetic process (GO:0018130),0.3745146312032293,0.7387628205790078,0.7691309987029832,1.0,1.0,1/14,2.57%,PYCR3
prerank,retrograde axonal transport (GO:0008090),0.36723121281113114,0.738746609980592,0.7772087067861716,1.0,1.0,4/16,12.37%,FBXW11;DYNC1H1;PAFAH1B1;HAP1
prerank,regulation of angiogenesis (GO:0045765),0.30685863040633427,0.7383932192973351,0.93993993993994,1.0,1.0,32/192,17.58%,CYP1B1;BRCA1;AQP1;HSPG2;TWIST1;EMC10;PML;PGF;SP100;CCR2;DCN;PRKCA;SMOC2;MECP2;PDPK1;HIPK2;CEMIP2;VASH2;PRKCB;F3;AGGF1;ROCK2;MYDGF;HTATIP2;ADAMTS1;RUNX1;HGS;TGFB2;PLCG1;SIRT1;XBP1;PGK1
prerank,negative regulation of cell death (GO:0060548),0.3090188119793087,0.7378874473947487,0.8738461538461538,1.0,1.0,18/88,19.48%,FYN;CCN1;CCN4;DCPS;IKBKG;INPP5A;PDE12;RAD18;NENF;PARK7;BECN1;GSK3B;TMEM109;PDE8A;SNCA;LRRK2;PAX2;NPAS2
prerank,bone morphogenesis (GO:0060349),-0.2767693238536589,-0.7377494575047909,0.8352941176470589,0.9469567053602853,1.0,2/14,8.93%,BMPR2;BMPR1B
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3650833387157773,0.7375078247938182,0.7927927927927928,1.0,1.0,6/17,24.65%,ATP5F1E;ATP5F1D;ATP5MC2;ATP5F1B;ATP5MF;ATP5ME
prerank,regulation of protein neddylation (GO:2000434),0.38901792495759957,0.7370507709591628,0.7655367231638418,1.0,1.0,1/10,4.63%,COPS9
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.38296449614179234,0.7368389795258264,0.759018759018759,1.0,1.0,3/10,18.39%,CAV1;SUMO1;KCNRG
prerank,I-kappaB phosphorylation (GO:0007252),-0.31309999039800257,-0.73655289100068,0.7959866220735786,0.9475515920613191,1.0,4/10,16.98%,TLR7;TLR4;CHUK;DAB2IP
prerank,embryonic skeletal system development (GO:0048706),0.33521264109712007,0.7364652832475501,0.7905935050391937,1.0,1.0,3/35,7.70%,DEAF1;SULF2;FUZ
prerank,actin filament capping (GO:0051693),0.3453353452219637,0.736174533718979,0.7665816326530612,1.0,1.0,6/18,23.01%,GSN;FLII;ADD2;TRIOBP;SVIL;TWF1
prerank,barbed-end actin filament capping (GO:0051016),0.3453353452219637,0.736174533718979,0.7665816326530612,1.0,1.0,6/18,23.01%,GSN;FLII;ADD2;TRIOBP;SVIL;TWF1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.28986702502892836,-0.7360052463704284,0.8058608058608059,0.9472214338679281,1.0,8/11,29.61%,NAGK;PGM3;GNPDA1;GNPDA2;AMDHD2;GNPNAT1;GFPT1;RENBP
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.30662703825974336,0.7359772045854946,0.879837067209776,1.0,1.0,24/100,17.75%,MAPK1;ERBB3;TWIST1;PIP5K1B;DCN;HCST;ENTPD5;JAK2;EGFR;BECN1;FLT3;PTEN;MYDGF;EGF;F2R;FGFR1;TGFB2;NLRC3;PIK3CA;SIRT1;PIP4K2A;HCLS1;FN1;PTPN13
prerank,membrane raft organization (GO:0031579),0.3653980944815337,0.735702391693103,0.7788079470198676,1.0,1.0,5/15,19.13%,ABCA7;FLOT1;FLOT2;CLN3;S100A10
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2567345545534432,-0.7356325282399886,0.8535564853556485,0.9465577927893198,1.0,10/16,39.99%,GSK3A;SLC39A14;PRMT5;PDE6H;MRAP2;CHGA;ACP3;GRP;PDE6G;NECAB2
prerank,regulation of NMDA receptor activity (GO:2000310),0.33008659094738624,0.7354732732981663,0.7826576576576577,1.0,1.0,6/32,11.51%,CRHBP;CCR2;CAPN1;ACTN2;RELN;GRIA3
prerank,cellular response to amino acid starvation (GO:0034198),0.31097753807650197,0.7354642826102297,0.8526970954356846,1.0,1.0,15/71,17.11%,DAP;MAPK1;EIF2S1;MAP3K5;LARS1;SEC13;SZT2;MLST8;FAS;RNF152;ATP6V0E1;LAMTOR4;LAMTOR3;NPRL3;ATP6V0D1
prerank,protein dephosphorylation (GO:0006470),0.3074003526609431,0.735463123256184,0.8981854838709677,1.0,1.0,37/135,20.52%,PPM1D;PTPRA;PPP3CA;FBXW11;PTPN22;PPP2R5E;STK11;PPP1CB;PPP2R5A;MTMR2;EYA3;TAB1;PPP2CB;PPP1R15A;PTPN7;PTPN14;PPP1CC;RPRD1B;MTMR6;PTEN;PPP3CC;PPP1R12A;EYA1;PTPN5;PPP6C;MTM1;PTPRU;PPP2R5D;DUSP22;DUSP12;PTPN13;PPP1CA;ILKAP;PPM1B;PPP2CA;RPAP2;DUSP16
prerank,cellular response to calcium ion (GO:0071277),0.3140837174757871,0.7354472427179265,0.8482613277133825,1.0,1.0,5/67,8.37%,ECT2;CRHBP;SYT8;DPEP1;PLCG2
prerank,cellular response to copper ion (GO:0071280),0.36581571945064684,0.7353799004705702,0.7761006289308177,1.0,1.0,1/16,1.86%,AQP1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.35054500462798444,0.7351464458186956,0.759493670886076,1.0,1.0,8/21,20.77%,PNLDC1;TUT4;CNOT4;CNOT1;CNOT6;SAMD4A;CNOT8;CNOT7
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.31386736561881523,0.7350623034924313,0.8367983367983368,1.0,1.0,21/67,21.23%,FYN;PGF;MAPKAPK3;CYFIP2;MAPK14;ITGAV;CRK;NRP1;ROCK2;BRK1;CYBB;ELMO2;PAK2;RAC1;PIK3CA;CYBA;NCF4;PRKD2;ROCK1;SH2D2A;VAV3
prerank,inositol phosphate dephosphorylation (GO:0046855),0.38416547932183254,0.7350341440251102,0.7943661971830986,1.0,1.0,6/11,25.22%,IMPA1;INPP5A;PTEN;OCRL;IMPA2;INPP5B
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.38416547932183254,0.7350341440251102,0.7943661971830986,1.0,1.0,6/11,25.22%,IMPA1;INPP5A;PTEN;OCRL;IMPA2;INPP5B
prerank,ganglioside biosynthetic process (GO:0001574),0.3638611622915235,0.7350335352443761,0.7597402597402597,1.0,1.0,5/15,20.15%,ST3GAL1;ST3GAL2;ST8SIA4;ST3GAL5;ST8SIA6
prerank,receptor-mediated endocytosis (GO:0006898),0.3020554709644808,0.7346981594460116,0.8993963782696177,1.0,1.0,27/132,18.69%,TFR2;RAMP1;HSPG2;AP1G2;TFRC;CAV1;LRP3;SNX9;CLTC;GRB2;PDLIM7;CAV2;M6PR;AP4E1;CALCRL;DNAJC13;ARRB2;AP2B1;CANX;GRK2;LMBR1L;HSP90B1;FCGR2B;LDLRAP1;COLEC12;SNCA;CLN3
prerank,regulation of interleukin-2 production (GO:0032663),0.325216355655701,0.7342603641098626,0.8261826182618262,1.0,1.0,12/43,19.97%,GLMN;EZR;CCR2;PLCG2;RUNX1;HOMER2;MAP3K7;MALT1;RPS3;TRAF6;PNP;PRKD2
prerank,regulation of receptor binding (GO:1900120),-0.29892534161766215,-0.7339928147351088,0.799373040752351,0.9477129383017714,1.0,2/10,12.61%,ADAM15;GREM2
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.3010491948094033,-0.7338340733305253,0.7792642140468228,0.946802480767837,1.0,5/10,27.92%,SMOX;ALDH7A1;SARDH;CHDH;HNMT
prerank,copper ion homeostasis (GO:0055070),0.3571884965542564,0.7337160571935749,0.7586649550706034,1.0,1.0,3/17,11.30%,CUTC;ATP7A;XIAP
prerank,tetrahydrofolate metabolic process (GO:0046653),0.38402335829990586,0.7336148729874682,0.7816091954022989,1.0,1.0,3/10,19.10%,MTHFD2L;TYMS;MTHFD1L
prerank,negative regulation of cytokine production (GO:0001818),0.30575450870520193,0.7329492190481217,0.9168336673346693,1.0,1.0,29/163,17.59%,IL12A;MEFV;LEF1;EZR;DHX58;ZFPM1;PPP1R11;PTPN22;RPS6KA5;ABCD1;NPLOC4;PIN1;HMGB1;ASB1;PCBP2;DDIT3;PIBF1;TLR6;TYROBP;GPATCH3;OTUD5;LGR4;NLRC3;HOMER2;JAK3;RAC1;NLRX1;FN1;FCGR2B
prerank,purine nucleotide metabolic process (GO:0006163),-0.22165926426796287,-0.7328127810043932,0.8859060402684564,0.947024484432327,1.0,10/24,25.03%,HPRT1;PRPS2;PPAT;GPX1;FHIT;ITPA;NT5C;GART;PRPSAP2;NT5E
prerank,response to amino acid starvation (GO:1990928),0.3090017394180911,0.7318839867626242,0.8538860103626943,1.0,1.0,15/72,17.11%,DAP;MAPK1;EIF2S1;MAP3K5;LARS1;SEC13;SZT2;MLST8;FAS;RNF152;ATP6V0E1;LAMTOR4;LAMTOR3;NPRL3;ATP6V0D1
prerank,negative regulation of viral transcription (GO:0032897),-0.27440019996544573,-0.7313351780869368,0.8293650793650794,0.9478185794091348,1.0,6/13,20.45%,MID2;TRIM27;ZFP36;LARP7;UBP1;TRIM32
prerank,B cell homeostasis (GO:0001782),0.3812628230913812,0.7307214809982531,0.7595307917888563,1.0,1.0,4/10,23.23%,PPP2R3C;TNFRSF13B;CAMLG;DOCK10
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.35454002233064413,0.7304306251531458,0.7682619647355163,1.0,1.0,3/17,14.64%,GMFG;PICK1;BRK1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3131132006617775,0.730105810166857,0.8336776859504132,1.0,1.0,15/67,19.50%,CDKL1;TBC1D1;TBC1D22B;CAV1;EVI5;RDX;FXR1;PLD1;DYNLT2B;SDCCAG8;RAB5A;RAC1;IFT140;RABEP2;SGSM3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.31428224065171984,0.7296317413015955,0.8310160427807487,1.0,1.0,16/54,23.30%,IKBKG;TRADD;TRAIP;BIRC2;UBE2K;SPATA2;RACK1;CFLAR;RBCK1;NLRP2B;CASP8;RIPK1;IKBKB;SYK;ADAM17;HIPK1
prerank,regulation of blood circulation (GO:1903522),0.32708243023894157,0.729420674015155,0.8047404063205418,1.0,1.0,1/34,1.71%,DES
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.34436700837244677,0.7292660001517389,0.7826633165829145,1.0,1.0,2/21,6.31%,NPPC;GUCY1A1
prerank,protein ADP-ribosylation (GO:0006471),0.33480100772055477,0.7289746235406367,0.7873090481786134,1.0,1.0,9/28,26.52%,ART3;ARF4;PARP14;SIRT1;SIRT4;PARP11;ZC3HAV1;PARP1;PARP9
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.22345659834797427,-0.7288415739416683,0.8805031446540881,0.9497292127984271,1.0,9/25,22.41%,TMEM50B;UBXN6;LEPROTL1;TMEM50A;SORT1;CHMP7;LEPROT;CHMP4B;CHMP4A
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.38198367666905064,0.7288281871272937,0.7612809315866085,1.0,1.0,3/10,23.17%,NUMA1;MED1;NCOA3
prerank,regulation of BMP signaling pathway (GO:0030510),0.3113937079420524,0.7286064856380357,0.8593429158110883,1.0,1.0,11/73,13.77%,FBXL15;CCN1;UBE2O;NOTCH1;HIPK2;TRIM33;SMAD4;XIAP;BMPR1A;NUMA1;SKI
prerank,proton transmembrane transport (GO:1902600),-0.20546658603591744,-0.7283583675081704,0.94,0.9491525814927395,1.0,13/36,29.42%,SLC9A1;ATP1A1;ATP6V1H;ATP6V1A;ATP6V1F;ATP1A2;NNT;ATP6V0C;SLC36A1;ATP1A3;SLC25A27;ATP6V0E2;SLC46A1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3077014872926673,0.7277444893039375,0.8773006134969326,1.0,1.0,10/75,13.65%,PPP1R9B;RGS12;GRK6;GIT2;METAP2;RNF157;PLCB1;ROCK2;ZDHHC7;ADCYAP1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3323754488127593,0.7276616038518515,0.7920193470374849,1.0,1.0,9/26,24.09%,MEFV;FYN;ROCK2;PSME1;USP50;AIM2;EFNA1;PSME2;PSME3
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3509692487611476,0.7275517593852412,0.7887139107611548,1.0,1.0,7/17,23.42%,S1PR2;ROCK2;PPP1R12A;ROCK1;IKBKB;ZDHHC21;VCL
prerank,calcium import into the mitochondrion (GO:0036444),0.39001837378805826,0.7274805191223847,0.7964601769911505,1.0,1.0,3/10,14.01%,MICU3;MICU1;MCU
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.34469291910948247,0.7273896403825763,0.7829360100376411,1.0,1.0,6/20,22.08%,ZC3H7A;PUM2;PUM1;TARBP2;AGO2;AGO1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.31722669536687703,0.7262008433020845,0.8311965811965812,1.0,1.0,8/51,16.74%,ARHGEF5;CD47;CCDC88A;SYNPO2;NRP1;ROCK2;LPAR1;RAC1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.2250838752713738,-0.7260901233337336,0.8857142857142857,0.9509483330356151,1.0,8/25,19.83%,MINK1;SHISA6;CACNG7;CACNG2;SHANK3;ADRB2;GSG1L;PRRT1
prerank,receptor signaling pathway via STAT (GO:0097696),0.33664445909358454,0.7259143832505531,0.7961399276236429,1.0,1.0,7/25,20.19%,CCR2;JAK2;SOCS2;STAT5B;PIAS1;PKD2;SOCS6
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.24867145652668496,-0.7257095488876824,0.8113207547169812,0.9502956393026643,1.0,8/17,26.19%,CD180;CARD16;LY96;CD36;BMP6;TRIB1;CACTIN;SCIMP
prerank,endocardial cushion morphogenesis (GO:0003203),0.3488495735337501,0.724479906677637,0.7908745247148289,1.0,1.0,5/18,19.39%,MDM4;NOTCH1;BMPR1A;TGFB2;SOX9
prerank,phosphatidic acid metabolic process (GO:0046473),0.3124955026196179,0.7244695857675005,0.8201284796573876,1.0,1.0,8/48,14.93%,AGPAT1;AGPAT4;GPD1L;GPAT3;AGPAT3;PLD2;DGKD;PLD1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.17634617930085764,-0.7244490755943725,1.0,0.9507883143483418,1.0,21/79,22.42%,EPN2;VWC2L;SMAD1;BMPR2;SPART;SMAD6;BMPR1B;UBE2D1;SKIL;SULF1;LEMD2;SMAD7;FGF2;HTRA3;DAB2IP;SMURF2;THBS1;BMPER;AGT;ADAMTS12;SMAD9
prerank,regulation of mitochondrial fission (GO:0090140),0.3361833915016133,0.724292170988863,0.772289156626506,1.0,1.0,8/24,21.28%,AURKA;DCN;CYRIB;FIS1;MCU;LRRK2;BNIP3;MAPT
prerank,regulation of small molecule metabolic process (GO:0062012),0.33526591095298375,0.7241985851289509,0.8088064889918888,1.0,1.0,6/28,16.94%,PANK2;EPHX2;FMO5;ADIPOR1;FOXK2;SIRT1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3108041698293292,0.7237742787411601,0.8681771369721936,1.0,1.0,15/68,19.10%,PANK2;MTHFD2L;RFK;SLC52A1;SLC19A1;MTR;MCCC1;TPK1;PDXK;MMAA;SLC2A3;ALDH1L1;SLC2A1;ABCD4;MTHFD1L
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.2355690690672113,-0.7236741682593901,0.8456375838926175,0.9506138414863711,1.0,5/24,11.50%,IGF1;AKT2;IRS2;GSK3A;SELENOS
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.36653608737834675,0.7236430006559004,0.7865311308767471,1.0,1.0,3/15,22.47%,TGFB2;JAK3;CUEDC2
prerank,diterpenoid metabolic process (GO:0016101),0.31184427365642253,0.7235278032767289,0.8515789473684211,1.0,1.0,2/55,3.42%,LRAT;HSPG2
prerank,regulation of cellular catabolic process (GO:0031329),0.31182297336638765,0.7234944765665569,0.85068349106204,1.0,1.0,15/62,21.28%,DAPK2;ITPR1;ABCD1;ATM;HDAC6;BOK;RAB8A;DDIT3;PIP4K2A;LRRK2;DAPK1;KEAP1;RRAGB;ROCK1;MAPT
prerank,positive regulation of cation channel activity (GO:2001259),-0.204118410261105,-0.7234629611088629,0.9666666666666667,0.9497547887730953,1.0,3/40,4.90%,CTSS;ANK3;ANK2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.30286613315496175,0.7233083419245203,0.8714285714285714,1.0,1.0,21/84,20.34%,EMC10;FOXP1;NUS1;HMGB1;AKT3;MAPK14;PRKCA;GFUS;SMOC2;PDPK1;NRP1;ROCK2;EGF;FGFR1;PLCG1;RAC1;SIRT1;ATP5F1B;PROX1;PRKD2;MET
prerank,modulation by host of viral genome replication (GO:0044827),0.3640527196459384,0.7228329539106083,0.7677852348993288,1.0,1.0,3/13,14.75%,NUCKS1;VAPA;CCNK
prerank,dorsal/ventral pattern formation (GO:0009953),0.34208389617412294,0.7221406304060687,0.7959697732997482,1.0,1.0,3/20,15.71%,FBXL15;BMPR1A;AIDA
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.301558966858167,0.7218416768925041,0.9106425702811245,1.0,1.0,13/138,12.67%,BLK;NTF4;ERBB3;FYN;NPPC;NEDD9;GFRA2;JAK2;EGFR;EPHA3;MTSS1;FLT3;LMTK2
prerank,endothelial cell differentiation (GO:0045446),-0.27764177780397586,-0.7210543211094713,0.85,0.9515192746680384,1.0,7/12,27.63%,BMPR2;FSTL1;ACVRL1;JAG1;KDM6B;SCUBE1;KDR
prerank,actin cytoskeleton reorganization (GO:0031532),0.31028340708897617,0.7208463777684737,0.8625,1.0,1.0,14/63,17.35%,FLNA;EZR;NEDD9;GSN;GRB2;WHAMM;S1PR2;NRP1;MCU;DTNBP1;PARVB;CAPN10;PARVA;PTK7
prerank,cellular response to heat (GO:0034605),0.32066281194306806,0.7206729870003489,0.804932735426009,1.0,1.0,8/35,21.28%,HSBP1L1;PRKACA;SUMO1;CLPB;BAG3;YWHAE;TPR;MAPT
prerank,autonomic nervous system development (GO:0048483),0.34980952865064785,0.7201420051273729,0.7866161616161617,1.0,1.0,3/17,17.49%,PHACTR4;NRP1;FN1
prerank,amino sugar biosynthetic process (GO:0046349),-0.2720217016386529,-0.7199485087447431,0.8058608058608059,0.9516538645962651,1.0,8/12,29.61%,NAGK;PGM3;GNPDA1;GNPDA2;AMDHD2;GNPNAT1;GFPT1;RENBP
prerank,cellular response to oxidative stress (GO:0034599),0.3007451607424565,0.718967428245446,0.9204431017119838,1.0,1.0,28/118,20.36%,PLA2R1;MAPK1;EIF2S1;FOXO1;MSRA;SETX;EGFR;LONP1;PARK7;JUN;NFE2L2;PPIA;RAD52;MPV17;TP53;CYBB;ERCC6L2;FANCC;CYBA;SNCA;LRRK2;RPS3;NCF4;PKD2;DAPK1;PNPT1;PRR5L;KEAP1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.35619703326788327,0.7188587031854942,0.7979669631512071,1.0,1.0,7/17,27.73%,PDE12;FIS1;HDAC4;CBFA2T3;PARP1;PID1;NUPR1
prerank,"phototransduction, visible light (GO:0007603)",-0.26073014548486095,-0.718752044794327,0.8191881918819188,0.9520701323656552,1.0,8/14,49.99%,GNAQ;SAG;PDE6G;PDE6B;ABCA4;RP1;PDE6A;CNGB1
prerank,mesonephric tubule development (GO:0072164),-0.2602008672916019,-0.7187361138054541,0.8455882352941176,0.9509640691313727,1.0,2/15,10.27%,SALL1;PKD1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3404618971253072,0.7186733699569383,0.7910085054678008,1.0,1.0,7/22,17.17%,BRD4;CCNT1;THOC5;CCNK;TCERG1;SCAF8;DDX39B
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.3739453037882611,0.7185098480057143,0.7838616714697406,1.0,1.0,3/11,23.93%,CARD9;MALT1;PRKCQ
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.36922953117844104,0.7182416295563281,0.7884097035040432,1.0,1.0,4/14,16.78%,PGF;NUS1;NRP1;PIK3CA
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3141602493649195,0.7166457096506345,0.8174778761061947,1.0,1.0,8/41,22.80%,HEY2;NOTCH1;BMPR1A;TGFB2;PROX1;RBPJ;FGFR2;FKBP1A
prerank,regulation of endothelial cell proliferation (GO:0001936),0.30108720966816416,0.7163308811244237,0.8819938962360122,1.0,1.0,14/88,15.38%,HMGB2;EMC10;PGF;CAV1;AKT3;PRKCA;CAV2;NR2F2;VASH2;F3;AGGF1;NRP1;MYDGF;EGF
prerank,regulation of programmed necrotic cell death (GO:0062098),0.33863007343028617,0.7162407651399694,0.7893432465923172,1.0,1.0,7/20,20.98%,BIRC2;SPATA2;FLOT1;CFLAR;FLOT2;CASP8;RIPK1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.26135082337143783,-0.7160461204706798,0.8514056224899599,0.953193565465282,1.0,4/15,16.60%,KCNN2;ATP1A1;ATP1B1;KCND3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3071783841667556,0.71583401575376,0.8630705394190872,1.0,1.0,11/62,18.13%,DDIAS;CDKN2D;PARK7;CCAR2;NFE2L2;PPIA;TPT1;SIRT1;XBP1;SYVN1;LRRK2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.31379170929260974,0.7154501052234654,0.8174863387978142,1.0,1.0,9/39,18.34%,ITGA1;TGFA;GRB2;EGFR;EGF;HGS;RNF115;ARHGEF7;STAM
prerank,negative regulation of inflammatory response (GO:0050728),0.29483111378974103,0.7154249617924013,0.933,1.0,1.0,15/182,8.37%,VIPR2;IAPP;MEFV;RB1;RAMP1;FYN;RPS19;NR1D1;PTHLH;DPEP1;NPSR1;MAPK14;PRKACA;INSL3;PLCG2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3057913180175767,0.715026503666419,0.8716075156576201,1.0,1.0,18/66,23.76%,BRCA2;CDK6;CAV1;RUNX3;CAV2;NR2F2;B2M;MTSS1;PEX2;TGFB2;NLRC3;MED1;SOX9;CASK;FGFR2;APOH;KLF9;WDR77
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3641860701994954,0.7150126498651905,0.7858117326057299,1.0,1.0,3/13,16.26%,HACD4;ELOVL5;ELOVL4
prerank,negative regulation of neuron differentiation (GO:0045665),0.3336440412369396,0.7149581019529782,0.8024844720496894,1.0,1.0,5/22,22.56%,B2M;GSK3B;MED1;SOX9;CNTN4
prerank,negative regulation of TOR signaling (GO:0032007),0.3133934710717467,0.7139402625441925,0.8061674008810573,1.0,1.0,7/36,16.94%,STK11;ATM;SZT2;UBR2;RNF152;NPRL3;SIRT1
prerank,positive regulation of tissue remodeling (GO:0034105),0.3741286755141806,0.7135575926256745,0.7784256559766763,1.0,1.0,2/10,21.04%,ROCK2;ROCK1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.368144436111331,0.713538483857005,0.8064066852367688,1.0,1.0,6/12,26.12%,BOK;ATF6;XBP1;TMEM33;BCL2L11;BAK1
prerank,anterior/posterior pattern specification (GO:0009952),-0.18465259962483233,-0.7131058977456484,0.9672131147540983,0.9556575883060934,1.0,5/53,3.97%,TGFBR1;BASP1;BMPR2;WLS;PCSK5
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3445499341363633,0.7129484396398564,0.7869458128078818,1.0,1.0,5/21,17.59%,PTPN22;BANK1;PIBF1;JAK3;FCGR2B
prerank,cellular response to oxygen-containing compound (GO:1901701),0.29323325785597476,0.712825307042647,0.973,1.0,1.0,49/291,20.04%,GFI1;HMGB2;SLC5A5;AQP1;MAPK1;EZR;HCN3;CRHBP;NR1D1;TAF1;FOXO1;ATM;DPEP1;SETX;ZFP36L1;PDE2A;HMGB1;AHR;MAPK14;LARS1;EGFR;EPHA3;P2RY1;EGR1;CPEB3;RUVBL2;KCNC2;JUN;MYD88;ROCK2;LAMTOR4;MTR;IRS1;MPV17;LAMTOR3;IPO5;ERCC6L2;VIM;XBP1;PTK7;HSP90B1;CREB1;RPS3;GLRA1;PAX2;TRAF6;SOX9;PKD2;DAPK1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.32771448963158323,0.7126505763486196,0.7945368171021377,1.0,1.0,5/26,16.72%,C2CD5;SORBS1;IRS1;APPL1;CAPN10
prerank,endothelial tube morphogenesis (GO:0061154),0.37353785942516143,0.7125638102360738,0.8053977272727273,1.0,1.0,3/10,20.56%,CCM2;PRKD2;RBPJ
prerank,response to muscle stretch (GO:0035994),0.3610051542918584,0.7123531937098355,0.7942708333333334,1.0,1.0,2/15,5.93%,CSRP3;GSN
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3157833376594893,0.7122176920244379,0.8361970217640321,1.0,1.0,1/33,0.60%,E2F2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2955102736766114,0.7118122626221961,0.958,1.0,1.0,41/172,21.31%,PISD;MTMR12;CHKB;PLEKHA2;AGPAT1;AGPAT4;PCYT2;IMPA1;GPD1L;GPAT3;PIP5K1B;MTMR2;PLCG2;AGPAT3;CDIPT;MTMR14;MTMR6;PTEN;ARF3;SLC44A1;INPP4A;PLD2;PI4K2B;DGKD;SELENOI;PLD1;MTM1;RAB5A;PIK3CA;PIP4K2A;FAR1;PTPN13;RUFY1;CLN3;OCRL;INPP5F;GPD1;SLC44A2;CHKA;PTDSS1;DGKE
prerank,positive regulation of lipid catabolic process (GO:0050996),0.34525345184939027,0.7116822160433043,0.7871536523929471,1.0,1.0,2/19,4.94%,TWIST1;ABCD1
prerank,amino sugar metabolic process (GO:0006040),0.37663414967078535,0.7110080052080292,0.7860199714693296,1.0,1.0,2/10,13.51%,ST3GAL1;GFPT2
prerank,triglyceride biosynthetic process (GO:0019432),0.34405309213847124,0.7104060881546137,0.7902813299232737,1.0,1.0,2/18,7.36%,GPAT3;MOGAT2
prerank,transferrin transport (GO:0033572),0.31958505277932653,0.7102751866767593,0.8407281001137656,1.0,1.0,9/33,17.11%,TFR2;TFRC;CLTC;RAB11B;LMTK2;ATP6V0E1;ATP6AP1;STEAP3;ATP6V0D1
prerank,TOR signaling (GO:0031929),0.33050586516366076,0.7101538095131599,0.8112058465286236,1.0,1.0,6/26,20.29%,CCDC88A;MLST8;NPRL3;RPS6;MAPKAP1;PRR5L
prerank,peptidyl-lysine methylation (GO:0018022),0.3186045641655928,0.7095402189778618,0.8267441860465117,1.0,1.0,1/26,1.50%,SUV39H1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.29460160191136875,0.7091859072247444,0.9619619619619619,1.0,1.0,32/214,16.79%,FAM83D;ARHGEF5;EZR;HTR2A;CCN1;CD74;CD44;PTPN22;RASGRP1;CRKL;NOTCH1;PIN1;HMGB1;CIB1;PRKCA;EGFR;P2RY1;ABCA7;CARD9;SMAD4;RPS6KA6;PTEN;ARRB2;NRP1;SPRED2;ADCYAP1;F2R;MAP2K1;STYX;ATP6AP1;CCL25;PDE8A
prerank,negative regulation of myoblast differentiation (GO:0045662),0.35670316983838346,0.7084350817939754,0.7941585535465925,1.0,1.0,2/13,19.39%,NOTCH1;SOX9
prerank,eye photoreceptor cell development (GO:0042462),-0.2582787223715097,-0.7082657457652655,0.8487394957983193,0.9603074043387984,1.0,3/15,17.91%,MYO7A;VEGFA;THY1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.300473279474359,0.7076967505643559,0.8957055214723927,1.0,1.0,20/88,15.64%,EXOC2;STXBP6;BLOC1S4;EXOC4;AP1G2;SYS1;OSBPL5;AP4B1;AP1S3;RP2;CLTC;AP4E1;PUM1;STEAP2;EXOC5;AP1S2;DTNBP1;SCAMP1;VPS13A;HGS
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.35379110211543374,0.7076504961355001,0.7875507442489851,1.0,1.0,5/14,22.05%,PPP3CA;PPP2CB;PPP1CA;PPP2CA;PPP1R15B
prerank,glycolipid biosynthetic process (GO:0009247),0.3126861492053411,0.7075577416245442,0.8168701442841287,1.0,1.0,11/38,22.43%,PIGH;PIGF;PIGA;ST3GAL2;PIGU;ST3GAL5;GBGT1;PIGM;ST8SIA6;PGAP2;DPM2
prerank,artery morphogenesis (GO:0048844),0.3269503773736967,0.7073999116435717,0.8134243458475541,1.0,1.0,6/30,16.38%,HEY2;NOTCH1;HPGD;BMPR1A;NRP1;TGFB2
prerank,positive regulation of dendritic spine development (GO:0060999),0.3380457509055512,0.7071905973388471,0.8063725490196079,1.0,1.0,5/20,14.04%,DBNL;LLPH;CPEB3;RELN;PSEN1
prerank,phagosome-lysosome fusion (GO:0090385),-0.29660800179730007,-0.7070349734953335,0.8338658146964856,0.9605805950908375,1.0,2/10,10.81%,RAB20;SYT7
prerank,autophagy of nucleus (GO:0044804),0.3428927357261786,0.7068910126462666,0.7903645833333334,1.0,1.0,1/16,2.51%,ATG13
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3796502428400321,0.7068388463728096,0.8029850746268656,1.0,1.0,3/10,16.70%,JAK2;STAT5B;JAK3
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3136123430163813,0.7068254574388345,0.827354260089686,1.0,1.0,7/40,18.13%,PMAIP1;ABCD1;PPA2;PARK7;ARL6IP5;NDUFS1;LRRK2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.32508913938625095,0.706280528302742,0.8193624557260921,1.0,1.0,9/26,24.05%,ABCD1;PLCG2;PARK7;TLR6;CYBA;SNCA;RAB27A;ABCB7;SLC5A3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.32674332515932303,0.7062498253418562,0.8153846153846154,1.0,1.0,3/27,5.95%,STMN1;ARHGEF18;CLASP1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2944979445032274,0.7059754870025793,0.9094567404426559,1.0,1.0,28/109,19.72%,MTMR12;PLEKHA2;IMPA1;PIP5K1B;MTMR2;PLCG2;PIP4P2;CDIPT;PLBD1;MTMR14;PLCB1;MTMR6;PTEN;ARF3;INPP4A;PLCB3;PI4K2B;PGAP1;PLCD1;MTM1;RAB5A;PLCG1;PIK3CA;PIP4K2A;PTPN13;RUFY1;OCRL;INPP5F
prerank,mRNA splice site selection (GO:0006376),0.3235671896445469,0.7059000636413231,0.8285385500575374,1.0,1.0,11/30,26.09%,SNRPC;SETX;PSIP1;LUC7L2;SRSF10;SF3A2;KHDC4;CELF1;SFSWAP;YTHDC1;PRPF39
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.2918155635714028,-0.7058393042015165,0.8122977346278317,0.9609012903618049,1.0,5/10,21.59%,UBAC2;OS9;INSIG1;ERLEC1;UBE2G2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.369391601832554,0.705808753480474,0.8152610441767069,1.0,1.0,2/12,13.25%,CD44;FLOT1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.302695216125801,0.7057257930274106,0.8439790575916231,1.0,1.0,15/54,19.79%,COPS9;NXN;CAV1;PIAS3;PRR7;PARK7;ARRB2;SIRT7;UBXN1;CAMLG;PRMT3;GNL3L;RPL5;RPS3;HDAC8
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.29374659454957835,0.7050686560211402,0.9112008072653885,1.0,1.0,24/113,19.97%,HMGB2;EMC10;PGF;TGFA;AKT3;PRKCA;LAMC1;EGFR;VASH2;FGF9;F3;AGGF1;NRP1;MYC;MYDGF;EGF;TCF7L2;SIRT1;XBP1;PROX1;PAX2;SOX9;MMP12;PRKD2
prerank,regulation of aerobic respiration (GO:1903715),0.3460682460443838,0.7049696235775857,0.8111533586818758,1.0,1.0,2/15,10.65%,ABCD1;ATP7A
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.24546893046906682,-0.7047913294849342,0.8686440677966102,0.961021721795896,1.0,2/17,4.62%,VSIR;HDAC2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2906367309799285,0.7042124151777204,0.9379379379379379,1.0,1.0,24/150,17.70%,CD19;IAPP;ERBB3;FYN;TGFA;GRB2;STRN;EGFR;PDPK1;TXN;PARK7;FGF9;FLT3;F3;RAC2;MYDGF;IRS1;EGF;TCF7L2;FGFR1;RAC1;PIK3CA;HCLS1;KITLG
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.35463680775715944,0.7041828383855986,0.788515406162465,1.0,1.0,3/12,13.15%,LAMA5;FUZ;ZDHHC7
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.25679762538672524,-0.7041729960636258,0.8834586466165414,0.9606170082792862,1.0,8/13,29.61%,NAGK;PGM3;GNPDA1;GNPDA2;AMDHD2;GNPNAT1;GFPT1;RENBP
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.2848395000996068,-0.7040106484805881,0.8372093023255814,0.9596463597489866,1.0,7/10,42.32%,DNAJB6;SACS;SORL1;DNAJA4;HSPA1A;HSPA2;HSPA1B
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3429540689964771,0.7039982964145418,0.7984595635430038,1.0,1.0,4/18,14.01%,AURKA;DCN;FIS1;MCU
prerank,sterol transport (GO:0015918),0.333343308018912,0.703962781668177,0.7979924717691342,1.0,1.0,2/19,6.20%,CAV1;OSBPL5
prerank,regulation of stress fiber assembly (GO:0051492),0.29852488508272246,0.7039442434300942,0.874361593462717,1.0,1.0,7/74,7.68%,ARHGEF5;STMN1;CD47;CCDC88A;ARHGEF18;CLASP1;ALMS1
prerank,regulation of inflammatory response (GO:0050727),0.2899137413995493,0.7036981915824747,0.948948948948949,1.0,1.0,23/190,11.92%,MEFV;CD47;RB1;CCN4;IL16;S100A9;GPRC5B;FOXP1;CCR2;NR1D1;S100A8;TRADD;PDE2A;BIRC2;BRD4;JAK2;IL17RA;NAPEPLD;IL1R1;PARK7;XIAP;DHX9;MYD88
prerank,muscle cell differentiation (GO:0042692),0.3151786741452296,0.7036156034407194,0.8235294117647058,1.0,1.0,2/32,3.02%,HEY2;GLMN
prerank,metanephros development (GO:0001656),-0.21653043070544628,-0.7035927967532436,0.9263803680981595,0.958988623920886,1.0,3/26,10.27%,BASP1;NF1;PKD1
prerank,sensory perception of pain (GO:0019233),-0.2253306297681549,-0.7033824133336667,0.8911917098445595,0.9581179165830224,1.0,12/21,40.01%,SCN9A;KCNA2;NIPSNAP1;P2RX4;PTGES;CHRNA4;CCL2;OPRL1;OPRK1;ALOXE3;KCNK4;CHRNB2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3230763988982359,0.7033501346718669,0.8188319427890346,1.0,1.0,11/25,25.62%,GLMN;EGFR;NRP1;PSEN1;EGF;SNCA;ILK;SRC;DSCAM;MIF;ITGA6
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.2989443495923309,0.7030928344244407,0.8524762908324552,1.0,1.0,8/57,17.28%,FLNA;AKAP12;PDE2A;GNAI1;INSL3;CHRM3;LPAR1;ADCY8
prerank,protein catabolic process (GO:0030163),0.3038526877930686,0.7028582141019245,0.875392670157068,1.0,1.0,6/59,8.46%,PMAIP1;CHEK2;PRPF19;NR1D1;FBXO44;FBXO17
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3144904190431651,0.7025377018860743,0.8167053364269141,1.0,1.0,11/30,20.09%,DDRGK1;PARK7;CCAR2;UCHL5;USP14;STYX;TAF9;UBXN1;CAMLG;USP7;SVIP
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2698140756451355,-0.7015607688037201,0.8637992831541219,0.9589456983722017,1.0,3/12,16.81%,MIA3;MDK;SKAP1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.329448202193659,0.7010511540870804,0.8002421307506054,1.0,1.0,5/22,21.03%,SORBS1;CREB1;ZBTB20;PPARD;SIRT4
prerank,protein hydroxylation (GO:0018126),0.34508076035957325,0.700966801710923,0.7874015748031497,1.0,1.0,4/15,14.65%,PLOD3;JMJD4;VPS33B;P3H4
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.29742511160406115,0.7007477392956611,0.8722280887011615,1.0,1.0,15/54,23.12%,NUS1;HMGB1;AKT3;MAPK14;PRKCA;MECP2;PDPK1;FGFR1;PLCG1;SIRT1;ATP5F1B;PRKD2;PRCP;ATP2B4;ADAM17
prerank,positive regulation of calcium ion transport (GO:0051928),-0.19998712477500458,-0.700536456537514,0.9405940594059405,0.9588712492471755,1.0,9/36,20.12%,CACNB2;ANK2;CCL4;TRPC3;WFS1;CCL3;ORAI1;P2RX4;SPHK2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.28599837234367187,-0.699182330212892,0.8557692307692307,0.959298705693743,1.0,4/10,25.50%,BAG6;BTLA;CD40;LYN
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.28572384354413566,-0.6991201449967542,0.8309352517985612,0.958237613339244,1.0,4/11,26.60%,PRDX2;GPX1;PRDX3;PRDX4
prerank,cellular response to lipopolysaccharide (GO:0071222),0.29179665439353325,0.6990902889818048,0.9114954221770092,1.0,1.0,7/101,8.10%,GFI1;HMGB2;PRKCE;PTPN22;NR1D1;HMGB1;MAPK14
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3138387931261882,0.6985747908825175,0.8312428734321551,1.0,1.0,9/32,24.16%,SORBS1;ADIPOR1;PRKAG2;CREB1;ZBTB20;EIF6;SIRT4;C3;PRKAB2
prerank,oxoacid metabolic process (GO:0043436),0.31685588983042734,0.698210179860281,0.8167053364269141,1.0,1.0,4/27,13.19%,TPST1;PPA2;BPNT2;SULT6B1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.29229679187883195,0.697894295199844,0.865625,1.0,1.0,21/70,23.20%,MAPK1;FYN;PRKCE;CYFIP2;GRB2;PLCG2;CRK;PLD2;BRK1;ELMO2;PLCG1;RAC1;PIK3CA;FCGR2B;VAV3;SYK;FGR;ACTG1;NCKIPSD;PRKCD;SRC
prerank,metanephric mesenchyme development (GO:0072075),-0.295637086746227,-0.697718444227616,0.819935691318328,0.9586207476691669,1.0,1/10,2.30%,BASP1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.28379587684286794,-0.696515401332836,0.8365019011406845,0.95772264057228,1.0,5/11,31.41%,SRI;CALM1;GSTO1;FKBP1B;CALM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.28379587684286794,-0.696515401332836,0.8365019011406845,0.95772264057228,1.0,5/11,31.41%,SRI;CALM1;GSTO1;FKBP1B;CALM2
prerank,central nervous system neuron differentiation (GO:0021953),0.31331240309976816,0.6964947559634164,0.8214689265536723,1.0,1.0,6/33,15.85%,NR4A2;AGTPBP1;GBA2;ATP7A;MDGA1;SIN3A
prerank,cellular response to misfolded protein (GO:0071218),0.3317443852944706,0.6959367498097325,0.816708229426434,1.0,1.0,12/20,28.06%,DNAJC18;CUL3;TOR1A;KLHL15;DNAJB12;DNAJB14;DERL1;POMT2;VCP;UBE2W;UGGT1;UGGT2
prerank,metal ion transport (GO:0030001),0.29638313569093233,0.695749431073403,0.913491246138002,1.0,1.0,18/86,19.98%,RAMP1;MAGT1;ITPR1;FYN;KCNN4;CAV1;TRPM7;CALCRL;PSEN1;TPT1;TUSC3;NIPAL4;CACNA1B;SLC30A5;CACNG8;NIPA2;NIPAL3;PKD2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2902267562074224,0.6953759720815257,0.9010204081632653,1.0,1.0,23/93,21.70%,EMC10;AXIN1;RASGRP1;TRAF3;MAP3K5;HMGB1;MAP4K2;HIPK2;MAP3K11;CARD9;PLCB1;PDCD10;DUSP22;TGFB2;SH3RF1;RELL1;ARL6IP5;FCGR2B;TAOK1;TRAF6;RIPK1;SASH1;MTURN
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.35262698967364375,0.6951813531107179,0.8024193548387096,1.0,1.0,5/14,22.45%,PKIG;SIRT1;PRKAR2A;ATP2B4;PKIA
prerank,membrane organization (GO:0061024),0.2838391512148723,0.6950934349623406,0.9719719719719719,1.0,1.0,38/227,17.61%,CEP55;KIF20A;NEMP1;IL7R;CCDC88A;REEP4;SUN2;SNX3;TMCC1;NAPG;TFRC;SLC2A8;TGFA;SNX9;CLTC;GRB2;PICK1;EGFR;M6PR;STX11;EMD;TOR1A;VAPA;ARRB2;AP2B1;PACSIN2;CHMP1B;STON2;VPS33B;REPS1;GCA;EGF;HGS;RAB5A;CHMP3;CHMP2B;UBA52;LDLRAP1
prerank,positive regulation of ERAD pathway (GO:1904294),0.3534139783299216,0.6950604186646415,0.7924263674614306,1.0,1.0,3/13,12.99%,CAV1;UBQLN1;NFE2L2
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.23711287574346745,-0.6945901928269388,0.8771929824561403,0.9586547723337723,1.0,8/17,31.08%,BCL2L1;DNM1L;MFF;BAD;BCL2;SOD2;TIMM50;BBC3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.22069655225803733,-0.6944397867728908,0.8810810810810811,0.9565629281537326,1.0,9/21,31.77%,BCL2L1;MCL1;IL1A;UNC5B;EYA2;MAPK7;BCL2;PF4;IL1B
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.22069655225803733,-0.6944397867728908,0.8810810810810811,0.9565629281537326,1.0,9/21,31.77%,BCL2L1;MCL1;IL1A;UNC5B;EYA2;MAPK7;BCL2;PF4;IL1B
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.34172041483391447,0.694201906050063,0.7874519846350833,1.0,1.0,2/16,7.04%,TERF2;NUS1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2912839724649725,0.6940685826859498,0.9075025693730729,1.0,1.0,30/84,25.28%,PIN1;EIF4A3;CPEB3;ABCA7;ORMDL3;TYMS;IGF2BP3;HAP1;FXR1;RACK1;LSM14A;CNOT1;SAMD4A;RTN3;EPRS1;EIF4ENIF1;RPS3;DAPK1;CNOT8;SYNCRIP;CNOT7;ROCK1;GAPDH;RPL13A;EIF4E2;YBX1;NCL;DAPK3;EIF2AK2;GIGYF2
prerank,iron ion transport (GO:0006826),0.29991988746146286,0.6940595773244855,0.8623265741728922,1.0,1.0,10/47,17.11%,TFR2;HEPH;TFRC;CLTC;RAB11B;LMTK2;ATP6V0E1;ATP6AP1;STEAP3;ATP6V0D1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.2381610350458485,-0.6936012722123827,0.9052631578947369,0.956355511357986,1.0,20/20,76.22%,GSK3A;CRY1;WNT4;EP300;C1QTNF3;CDA;UGT1A8;C1QTNF12;SLC22A13;MST1;ACMSD;ERFE;DKKL1;ADIPOQ;NCOR1;SIK1;GCK;BCKDK;PGP;CLK2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3518152482447331,0.6932292662903826,0.8125854993160054,1.0,1.0,2/13,8.29%,ENTPD3;ENTPD5
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.30396957169621464,0.6929625531280663,0.8430296377607025,1.0,1.0,11/38,21.14%,TRIM59;TANK;NR1D1;RIOK3;NLRC3;SIRT1;NLRX1;PPM1B;CASP8;RIPK1;OTUD7A
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2938041524426082,0.6927386353526334,0.8657648283038502,1.0,1.0,14/62,17.19%,POLR2I;POLR2A;IWS1;NCBP1;ERCC3;RTF1;NELFA;CCNT1;CCNK;ELOF1;NELFB;POLR2K;MLLT1;POLR2J
prerank,purine-containing compound catabolic process (GO:0072523),0.3573578218395992,0.6924493897612948,0.8179384203480589,1.0,1.0,2/13,9.67%,GDA;NT5C2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.2562569602984708,-0.6922459999362068,0.8683127572016461,0.9566485589840628,1.0,5/14,30.17%,SLC8A3;TRPV4;SLC8A1;TRPM2;SLC8A2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.23581782488501388,-0.6921871547633572,0.9025641025641026,0.9556033658990826,1.0,9/18,29.21%,PTPRZ1;TNFRSF1B;NF1;MDK;TNFRSF21;TMEM98;TENM4;SLC45A3;IL34
prerank,cellular protein localization (GO:0034613),0.2872335267506823,0.6921690113577826,0.986986986986987,1.0,1.0,68/285,21.73%,CD177;CNTLN;HEY2;TBC1D1;ATG13;TBC1D8B;FLNA;ABHD17A;CSRP3;CD74;PRPF19;STX17;TBC1D22B;ARL5C;NAPG;TLK1;EVI5;ARL11;RAB1B;RAB22A;YWHAH;STX5;ARF4;HDAC6;ARFGAP3;SNX9;CEP250;CLTC;PICK1;EGFR;SEC13;STX11;GGA1;KIF13A;ARF3;SEC31A;RAB43;BBS4;NIPBL;COPZ1;VPS33B;PIGU;LAMTOR3;TBC1D25;ARL4C;PTPRU;HGS;RAB5A;SEPTIN9;NAPB;ADPRH;EIF2D;GGA2;LRRK2;RAB6A;SAR1B;TM9SF1;SGSM3;CROCC;FBLN5;RRAGB;WDR45B;ARL5B;TBC1D15;SNX13;TMED10;EVI5L;AP3B1
prerank,negative regulation of cell projection organization (GO:0031345),0.2995335683640064,0.6919112770711169,0.8503767491926802,1.0,1.0,8/48,17.16%,GFI1;FYN;YWHAH;CIB1;PTEN;LPAR1;MYLIP;GORASP1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.35644107497228383,0.6915358136967483,0.819672131147541,1.0,1.0,1/12,5.28%,CAV1
prerank,negative regulation of immune system process (GO:0002683),-0.23476615258642816,-0.6904809478091185,0.9074889867841409,0.9561791565414788,1.0,12/16,48.01%,CD200;HMOX1;PDCD1;HOXA7;LYN;COL3A1;IL17D;ADTRP;FOXP3;FADD;FCRLB;SPINK5
prerank,regulation of viral genome replication (GO:0045069),0.2970332067291383,0.6897683839836879,0.8713080168776371,1.0,1.0,14/56,20.77%,SLPI;PDE12;PKN2;RAD23A;FAM111A;IFITM3;PPIA;STAU1;TARBP2;SRPK1;PPIE;PPIH;PROX1;CNOT7
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3381169648373326,0.6897087844595631,0.8236808236808236,1.0,1.0,3/16,17.71%,HNRNPM;DHX9;RSRC1
prerank,regulation of cell death (GO:0010941),0.2897379080719175,0.689086071210732,0.9145473041709054,1.0,1.0,16/94,18.13%,CCN1;NOA1;CCN4;FAF1;PDE12;GPR75;PRODH;RAD18;PRR7;PARK7;BECN1;TMEM109;ACER3;PDE8A;SNCA;LRRK2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.29329305207667183,0.6886292486669051,0.9002057613168725,1.0,1.0,20/86,22.05%,CDK5RAP2;RB1;PRKCE;CLASP1;SYNPO2;SNX9;CFL2;SLAIN2;CDC42EP3;EFEMP2;NUMA1;PSEN1;RAC1;DRG1;CDC42EP1;PROX1;RPS3;MET;MAPT;DCTN1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.29106889550095455,0.6880278515252198,0.8892307692307693,1.0,1.0,13/74,17.29%,BRCA1;TNFSF10;TRADD;EYA3;BIRC6;ITGAV;PARK7;FAS;CFLAR;GSK3B;EYA1;TCF7L2;SH3RF1
prerank,ameboidal-type cell migration (GO:0001667),0.2970578904501577,0.6879590159738753,0.8489525909592062,1.0,1.0,4/51,7.47%,PHACTR4;ITGB7;AMOTL2;PKN2
prerank,protein targeting to membrane (GO:0006612),0.2875406469120359,0.6878904599846788,0.9102040816326531,1.0,1.0,25/83,24.22%,PEX26;ABCD1;ACBD5;ARL6IP1;PEX11B;PXMP4;GET3;GDAP1;PEX2;RAB8B;FIS1;ZDHHC7;SSR1;SEC63;PEX14;ATAD1;ICMT;SEC62;ZDHHC6;NACA;SSR2;CHM;ZDHHC21;PEX3;YIF1B
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.35620025654788295,0.6869113998124224,0.8115942028985508,1.0,1.0,3/11,17.66%,KCNJ3;KCNJ2;YWHAE
prerank,positive regulation of interleukin-1 production (GO:0032732),0.299847241113153,0.686888313087041,0.8606911447084233,1.0,1.0,13/51,21.38%,IL16;HMGB1;JAK2;EGR1;MYD88;TLR6;TYROBP;USP50;MALT1;LGALS9;CASP8;AIM2;TMED10
prerank,positive regulation of T cell differentiation (GO:0045582),0.30758369962993226,0.6863195253491826,0.8618346545866364,1.0,1.0,6/36,19.49%,LEF1;NKAP;BCL6;SART1;XBP1;PNP
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.3507884326625951,0.6861118732641549,0.820476858345021,1.0,1.0,2/12,6.44%,JMJD4;SETX
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.20412300024342755,-0.6854516565476095,0.9448818897637795,0.9601908187968053,1.0,10/30,24.84%,PTPN2;PTPN6;CD300A;SH2B3;MVP;THY1;PPP2R1A;SH3BP5L;SEMA4D;SAMSN1
prerank,extracellular matrix disassembly (GO:0022617),0.29341165381420586,0.6850541495961855,0.8914893617021277,1.0,1.0,12/53,19.90%,CD44;GSN;LAMC1;CAPN1;TLL2;BSG;CTSK;FLOT1;MMP19;ADAMTS5;ADAM10;MMP12
prerank,regulation of cellular amide metabolic process (GO:0034248),0.308946382678,0.6849626764478195,0.8538812785388128,1.0,1.0,5/32,10.86%,EIF2A;RBM3;MTPN;PUM3;TCOF1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.3594637953931796,0.6848073438429326,0.7988338192419825,1.0,1.0,4/10,23.93%,ZBTB7B;CD55;LGALS9;PRKCQ
prerank,neuron projection fasciculation (GO:0106030),-0.2871344852794573,-0.6844670405056344,0.8461538461538461,0.9600343501611929,1.0,3/10,16.30%,RTN4;CDK5R1;EPHA4
prerank,nervous system development (GO:0007399),0.28293906760614196,0.6844203126056714,0.998,1.0,1.0,54/429,15.93%,STIL;ECT2;VAX2;NTF4;SDK1;CDK5RAP2;WDR62;SOX6;ERBB3;LIG4;ANKLE2;WDPCP;APAF1;LRCH4;LY6H;HAPLN2;GFRA2;GSN;GDA;GBA2;NRSN2;DBNL;ZBTB16;ST8SIA4;PMP22;IRF2BPL;NR2C2;RBFOX3;DYRK1A;SZT2;DNER;RELN;TRIM3;IGF2BP3;RPS6KA6;PTEN;CYP46A1;HAP1;NELL1;FGF13;CHRM3;NRCAM;ADGRL3;GFRA1;MTR;KIRREL3;ADGRV1;NRXN2;ARHGAP26;LPAR1;JARID2;MYLIP;PPP2R5D;MARK4
prerank,arachidonic acid metabolic process (GO:0019369),0.308298248921153,0.6840282927329363,0.8514739229024944,1.0,1.0,3/35,6.72%,CYP1B1;CYP2A6;EPHX2
prerank,fat cell differentiation (GO:0045444),0.2899355434062121,0.6840190344604784,0.8760775862068966,1.0,1.0,10/57,18.40%,NR4A2;FOXO1;ZBTB7A;ATF5;BBS4;TCF7L2;SIRT1;BBS9;MED1;ERAP1
prerank,cellular response to peptide (GO:1901653),0.2951243163785264,0.6836379027815799,0.8842105263157894,1.0,1.0,13/56,17.59%,DDX11;FYN;TIMELESS;PTPN22;CAV1;ZFP36L1;PSEN1;TLR6;GSK3B;TP53;VIM;XBP1;FCGR2B
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3201554397892734,0.6835857484836474,0.8343634116192831,1.0,1.0,5/21,21.54%,TEDC2;UCHL5;TUBD1;TXNDC15;RAB34
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2899336700229259,0.683237800644726,0.8840125391849529,1.0,1.0,14/64,17.19%,POLR2I;POLR2A;IWS1;NCBP1;ERCC3;RTF1;NELFA;CCNT1;CCNK;ELOF1;NELFB;POLR2K;MLLT1;POLR2J
prerank,protein neddylation (GO:0045116),-0.25812550807152146,-0.6831404157608648,0.8976377952755905,0.9602519338450751,1.0,6/13,32.13%,UBE2F;DCUN1D2;RNF7;DCUN1D1;NAE1;UBA3
prerank,regulation of cholesterol esterification (GO:0010872),-0.28556168874112675,-0.6823281729830433,0.8620689655172413,0.9598874245303425,1.0,5/10,33.64%,APOE;APOC1;AGT;LAMTOR1;STARD4
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.31958431648977204,0.6822418364734462,0.8299155609167672,1.0,1.0,5/20,17.46%,MEFV;ENTPD5;TXN;PSTPIP1;ANO6
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3151637394141733,0.6820185299688035,0.8394077448747153,1.0,1.0,5/28,12.48%,AXIN1;DDRGK1;PSMC3;PTEN;CDK5RAP3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.28659998811576987,0.6819949853502891,0.9093686354378818,1.0,1.0,16/87,18.06%,ARHGEF5;CCDC88A;EZR;ARHGDIB;RND3;ARHGAP35;EPHA3;MLST8;CRK;ROCK2;RAC2;ARHGDIA;RAC1;PIK3CA;IQGAP1;TAOK1
prerank,negative regulation of neurogenesis (GO:0050768),0.30868410027744464,0.6819355900556991,0.8526434195725534,1.0,1.0,8/34,17.16%,LRP4;YWHAH;NOTCH1;PCM1;B2M;PTEN;ARHGDIA;GORASP1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.31222674142014895,0.6816476317305201,0.8329326923076923,1.0,1.0,6/25,19.36%,PLCG2;B2M;MAP3K7;MALT1;CD55;TRAF6
prerank,protein localization to membrane (GO:0072657),0.28239989749154965,0.6805085450205375,0.951,1.0,1.0,30/187,15.80%,ITGB7;C2CD5;NDC1;RAMP1;FLNA;ABHD17A;EZR;ARL5C;CAV1;ANK1;DENND4C;RAB8A;PICK1;TSPAN33;P2RY1;ACTN2;SYNE3;BSG;RDX;RAB8B;CYP46A1;PRAM1;RAB11B;FGF13;ROCK2;FLOT1;TTC7A;NRXN2;HGS;PACS1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3545783907026995,0.6803981394596726,0.8125,1.0,1.0,2/10,9.01%,SNX3;TERF1
prerank,catecholamine biosynthetic process (GO:0042423),0.3582053979100194,0.6803255401096738,0.8191780821917808,1.0,1.0,2/11,17.91%,TGFB2;SNCA
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.30412254208002576,0.6801235852452824,0.8662983425414365,1.0,1.0,4/38,5.28%,ERBB3;NEDD9;GPRC5B;CAV1
prerank,amino acid import (GO:0043090),0.3268331099575132,0.6796137947955037,0.8351783517835178,1.0,1.0,3/21,18.18%,SLC7A1;SFXN1;SLC22A4
prerank,positive regulation of response to wounding (GO:1903036),0.3157019206824455,0.6795191994201035,0.8251497005988024,1.0,1.0,2/24,8.36%,PRKCE;INSL3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2834570623817752,0.6792502838932972,0.8880829015544042,1.0,1.0,21/71,23.20%,MAPK1;FYN;PRKCE;CYFIP2;GRB2;PLCG2;CRK;PLD2;BRK1;ELMO2;PLCG1;RAC1;PIK3CA;FCGR2B;VAV3;SYK;FGR;ACTG1;NCKIPSD;PRKCD;SRC
prerank,protein O-linked glycosylation (GO:0006493),0.28553373662699405,0.6789428005318857,0.9133537206931702,1.0,1.0,8/96,10.98%,MUC19;GALNT10;PLOD3;GXYLT1;ST3GAL1;ST3GAL2;B3GNT2;TMTC2
prerank,cellular component disassembly (GO:0022411),0.29171416905136965,0.6789367155216487,0.8959660297239915,1.0,1.0,12/53,19.90%,CD44;GSN;LAMC1;CAPN1;TLL2;BSG;CTSK;FLOT1;MMP19;ADAMTS5;ADAM10;MMP12
prerank,positive regulation of JNK cascade (GO:0046330),0.28623062185544673,0.6786291107837448,0.9030239833159541,1.0,1.0,17/70,21.70%,AXIN1;RASGRP1;TRAF3;MAP3K5;HMGB1;MAP4K2;HIPK2;MAP3K11;CARD9;PLCB1;DUSP22;SH3RF1;FCGR2B;TAOK1;TRAF6;RIPK1;MTURN
prerank,coenzyme A metabolic process (GO:0015936),0.33911629245811,0.6783271418868646,0.8179419525065963,1.0,1.0,3/14,12.95%,PANK2;SLC25A16;DCAKD
prerank,circulatory system development (GO:0072359),0.2825263736992411,0.6780493156380515,0.9251012145748988,1.0,1.0,31/118,23.40%,HEY2;ERBB3;HSPG2;ZFPM1;STK11;NXN;NOTCH1;PDLIM7;HEG1;SMYD4;KAT2B;PTEN;SMG9;POU6F1;TGFB2;CRIP1;PIK3CA;FN1;PDLIM5;CDKN1A;SOX9;CASP8;NCOA6;PKD2;CITED2;NTRK3;CDKN1B;HDAC9;PTPN11;OSR1;KDM6A
prerank,cholesterol transport (GO:0030301),0.293695276589499,0.6775495297357736,0.8693304535637149,1.0,1.0,6/45,11.42%,CEL;CAV1;OSBPL5;LIMA1;ABCA7;STARD5
prerank,energy reserve metabolic process (GO:0006112),0.3264427475336906,0.677124310819264,0.8385481852315394,1.0,1.0,5/19,15.37%,GFPT2;PRKAG2;MYC;GSK3B;GBE1
prerank,positive regulation of signal transduction (GO:0009967),0.28274877752615424,0.6767504775374712,0.976,1.0,1.0,57/238,21.74%,DEPDC1B;FGFBP3;IL7R;SLC2A4;FLNA;CD74;TEDC2;SULF2;AGPAT1;DISC1;SORBS1;NOTCH1;SMARCA4;PRKCA;JAK2;ITGAV;SMOC2;CAV2;ASXL1;TRIM44;RELN;KAT2B;FAS;PRKCB;PTEN;HAP1;F3;UCHL5;NRP1;ZBTB7B;ING5;CREBBP;SKI;IRS1;CCBE1;TUBD1;LIMS1;PDCD10;TGFB2;SIRT1;XBP1;TSPAN5;TXNDC15;LRRK2;NRXN1;RPS3;RSPO2;PRKD2;PKD2;DSTYK;ILK;RBPJ;SPIN1;CITED2;SASH1;RAB34;ADAMTS3
prerank,regulation of cell killing (GO:0031341),0.3316969903864355,0.6766822890042848,0.8180661577608143,1.0,1.0,5/16,19.21%,CR1L;TGFB2;RAC1;CYBA;CD55
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.29903659930465126,0.6766541741061022,0.8514412416851441,1.0,1.0,2/41,4.94%,CYP1B1;ABCD1
prerank,myelination in peripheral nervous system (GO:0022011),-0.25768805944847084,-0.6765879386364144,0.9057971014492754,0.9642404871223914,1.0,9/13,38.67%,NF1;ADGRG6;ARHGEF10;PARD3;CNTNAP1;NCMAP;SIRT2;MYOC;PRX
prerank,hematopoietic stem cell proliferation (GO:0071425),0.34903452300833987,0.6763166813177389,0.8492957746478873,1.0,1.0,3/11,15.17%,ETV6;ARIH2;RUNX1
prerank,transcription by RNA polymerase III (GO:0006383),0.3050800618625883,0.6753387255597774,0.8290094339622641,1.0,1.0,3/27,9.11%,GTF3C5;BRF1;SNAPC3
prerank,positive regulation of macrophage differentiation (GO:0045651),0.34935431964162694,0.6751947778727718,0.844632768361582,1.0,1.0,3/11,20.98%,PRKCA;CASP8;RIPK1
prerank,Golgi to plasma membrane transport (GO:0006893),0.2953011317819521,0.6751047528590433,0.8756698821007503,1.0,1.0,10/47,14.33%,EXOC2;STXBP6;EXOC4;SYS1;OSBPL5;BLZF1;GGA1;KIF13A;STEAP2;EXOC5
prerank,cellular response to chemical stress (GO:0062197),0.2813564370238328,0.6750664823328324,0.9208121827411168,1.0,1.0,23/96,20.36%,EIF2S1;CAV1;FOXO1;MSRA;ATM;SETX;LONP1;PARK7;FAS;NFE2L2;PPIA;RAD52;CYBB;FANCC;PIK3CA;CYBA;SNCA;LRRK2;NCF4;PKD2;PNPT1;PRR5L;KEAP1
prerank,glucose homeostasis (GO:0042593),0.2830792917430872,0.6749948221911142,0.9192229038854806,1.0,1.0,14/83,17.28%,SLC2A4;USF1;NUCKS1;STK11;NR1D1;FOXO1;PARK7;ADIPOR1;MCU;IRS1;TCF7L2;FOXK2;SIRT1;ADCY8
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3496626551260712,0.6748703865042573,0.8122448979591836,1.0,1.0,3/12,16.76%,ATP7A;SMS;MAOA
prerank,aerobic respiration (GO:0009060),0.3289626852778874,0.6747262841305148,0.84,1.0,1.0,5/20,20.69%,NDUFS8;ME3;ATP5F1D;MDH2;UQCRH
prerank,heart process (GO:0003015),0.3379558207124669,0.6745795293212419,0.8350923482849604,1.0,1.0,1/14,3.04%,FYN
prerank,regulation of protein localization (GO:0032880),0.2874763208936668,0.6745287861690936,0.8789144050104384,1.0,1.0,10/58,14.46%,BORA;WDPCP;MMD2;MMD;SUMO1;TRIM68;RACK1;ZDHHC7;ADCYAP1;TRIM5
prerank,myelin maintenance (GO:0043217),0.358772435655793,0.6744692310960205,0.8447293447293447,1.0,1.0,3/10,17.65%,ABCD1;PTEN;CXCR4
prerank,peptide metabolic process (GO:0006518),0.28187657690019097,0.6742292591419993,0.9181166837256909,1.0,1.0,15/75,21.63%,DNPEP;RHD;CPM;DPEP1;SPCS1;LTA4H;PSEN1;PCSK1;GSTM1;CPD;SPPL3;ERAP1;MME;SPCS3;ETHE1
prerank,glutamate metabolic process (GO:0006536),0.3185462423141544,0.674122834006144,0.82625,1.0,1.0,2/19,7.18%,GLS2;PRODH
prerank,stress fiber assembly (GO:0043149),0.3375530646937801,0.674103871097155,0.8190224570673712,1.0,1.0,5/15,14.92%,SORBS1;TNFAIP1;CUL3;FAM171A1;PDCD10
prerank,contractile actin filament bundle assembly (GO:0030038),0.3375530646937801,0.674103871097155,0.8190224570673712,1.0,1.0,5/15,14.92%,SORBS1;TNFAIP1;CUL3;FAM171A1;PDCD10
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2834177089115265,0.6737993549378963,0.9146090534979424,1.0,1.0,20/88,22.48%,SLX4;TFRC;FAF1;SYNPO2;PRKCA;PARK7;SUMO1;RACK1;FLOT1;GSK3B;BRK1;HGS;STAM;GNL3L;SLF1;RPS3;TPR;SYK;VPS4A;SPIDR
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2863631534119215,0.6733764410890826,0.890738813735692,1.0,1.0,16/69,17.78%,NPLOC4;FBXO44;UBE4B;FAF2;DNAJC18;FBXO17;UBQLN1;DERL2;AMFR;RHBDD2;YOD1;DNAJB9;RNF103-CHMP3;HSP90B1;FAM8A1;SYVN1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.28532455256182016,0.6733579068609419,0.8906414300736067,1.0,1.0,13/65,18.34%,ITGA1;CCDC88A;SHKBP1;TGFA;GRB2;EGFR;HAP1;DGKD;EGF;HGS;RNF115;ARHGEF7;STAM
prerank,cell-matrix adhesion (GO:0007160),0.2837051348365342,0.6724894172743937,0.9349593495934959,1.0,1.0,25/95,24.19%,ITGA1;ECM2;ITGB7;TIAM1;CD44;SORBS1;ITGAV;WHAMM;ACTN2;TESK2;ITGA8;BCR;RAC1;FN1;ARHGEF7;ZYX;ILK;FBLN5;ITGA4;ACTN1;SRC;VCL;ITGB1BP1;NPNT;ADAMTS9
prerank,protein deneddylation (GO:0000338),0.35682627535323963,0.6724465284874834,0.8267045454545454,1.0,1.0,4/10,22.07%,TOR1A;COPS3;COPS2;COPS4
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.3170055533177819,0.6720481993077108,0.8569682151589242,1.0,1.0,3/24,8.10%,CTNNA1;TCF3;MAPK14
prerank,response to amino acid (GO:0043200),0.298126908919685,0.6717820600762043,0.8599537037037037,1.0,1.0,8/31,20.73%,LARS1;CPEB3;LAMTOR4;LAMTOR3;IPO5;XBP1;GLRA1;RRAGB
prerank,axon guidance (GO:0007411),0.2773700538457868,0.6709921100733912,0.965,1.0,1.0,49/201,23.30%,SPTA1;MAPK1;FYN;NTN1;EZR;PTPRA;RPS6KA5;GFRA2;LAMA5;NOTCH1;ARHGAP35;PRKCA;GRB2;PLXNA2;SOS1;PDLIM7;EPHA3;DOK2;RELN;BSG;SLIT3;SLIT1;TMEFF1;NRP1;RAC2;PALLD;GFRA1;DAG1;SPTAN1;PLCG1;RAC1;PIK3CA;EMB;CXCR4;NRXN1;SEMA4A;TUBB3;EPHA7;EPHA10;ALCAM;SEMA6A;EFNA1;PLXNC1;CNTN4;NIBAN2;PTPN11;SRC;DSCAM;SPTB
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3437714342672412,0.6709677933105921,0.8335625859697386,1.0,1.0,4/12,26.84%,GSK3B;HOMER2;ATP2B4;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3437714342672412,0.6709677933105921,0.8335625859697386,1.0,1.0,4/12,26.84%,GSK3B;HOMER2;ATP2B4;DYRK2
prerank,inositol phosphate catabolic process (GO:0071545),0.34492422497715564,0.670938881200256,0.8370165745856354,1.0,1.0,3/12,11.97%,IMPA1;INPP5A;PTEN
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.27523365559572543,-0.6705693407675247,0.8975155279503105,0.9685817990612652,1.0,5/10,22.55%,ATRAID;EPHA4;DAB2IP;ANXA2;RGP1
prerank,cell projection organization (GO:0030030),0.30512074036500475,0.6703417938186689,0.8346727898966705,1.0,1.0,7/30,16.79%,GSN;RHOU;PACSIN2;RAC2;PARVB;RAC1;PARVA
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.2960071774216654,0.6703230248210922,0.8607456140350878,1.0,1.0,12/43,23.93%,NUCKS1;SIK2;SORBS1;PRKCB;ZBTB7B;IRS1;SIRT1;PIP4K2A;GRB14;PTPN11;PRKCD;PRKCQ
prerank,ERAD pathway (GO:0036503),0.2836386784775092,0.6701162370971985,0.9035897435897436,1.0,1.0,18/83,17.78%,RCN3;NPLOC4;FBXO44;UBE4B;FAF2;DNAJC18;FBXO17;UBQLN1;DERL2;AMFR;TOR1A;RHBDD2;YOD1;DNAJB9;RNF103-CHMP3;HSP90B1;FAM8A1;SYVN1
prerank,serine family amino acid catabolic process (GO:0009071),-0.27415847049910697,-0.6695385364325018,0.90625,0.9683854429535385,1.0,8/10,47.47%,AMT;SHMT2;SHMT1;CBS;THNSL2;DAO;GLDC;SDS
prerank,positive regulation of MAPK cascade (GO:0043410),0.27678493848601443,0.6692665036322925,0.988,1.0,1.0,41/245,18.13%,EZH2;IAPP;HTR2A;CD74;CD44;PTPN22;RASGRP1;CRKL;NOTCH1;HMGB1;CIB1;PRKCA;PLCG2;EGFR;CAV2;P2RY1;RIT2;ABCA7;CARD9;FLT3;ARRB2;NRP1;ROCK2;ADCYAP1;MYDGF;TRIM5;PDCD10;EGF;F2R;LPAR1;MAP2K1;FGFR1;ATP6AP1;CD24;TGFB2;CCL25;PDE8A;ARL6IP5;IQGAP1;TAOK1;LRRK2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.34839892115825416,0.6689698216037976,0.8232695139911634,1.0,1.0,3/10,22.74%,MYC;SOX9;FGFR2
prerank,lipid catabolic process (GO:0016042),0.32394071462000135,0.6686018266676115,0.8431618569636136,1.0,1.0,1/18,3.01%,CEL
prerank,polyol metabolic process (GO:0019751),0.2890035811054129,0.6679516017094863,0.8732240437158469,1.0,1.0,10/46,16.54%,IMPA1;INPP5A;PLCG2;NUDT4;PLCB1;PTEN;INPP4A;PLCB3;PLCD1;PLCG1
prerank,cholesterol homeostasis (GO:0042632),0.2830948547366593,0.667568316369042,0.9032258064516129,1.0,1.0,16/64,23.73%,CAV1;NR1D1;EPHX2;RALY;ABCA2;LIMA1;CD24;SIRT1;XBP1;LDLRAP1;NR1H3;HDAC9;LDLR;SOAT1;TTC39B;EHD1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.30832524776720854,0.6673999262812089,0.8479041916167664,1.0,1.0,10/25,24.76%,DNAJC18;DNAJC7;BAG1;SDF2;DNAJB4;DNAJB1;DNAJB12;DNAJB14;HSPE1;HSPA9
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.27825974721510344,0.6673800279480618,0.945619335347432,1.0,1.0,34/119,22.43%,PIGH;MTMR12;PIGF;PLEKHA2;IMPA1;PIGA;PIP5K1B;MTMR2;PLCG2;SOCS2;CDIPT;MTMR14;MTMR6;PTEN;ARF3;INPP4A;PI4K2B;TTC7A;PIGU;MTM1;RAB5A;PIK3CA;PIP4K2A;PTPN13;RUFY1;PIGM;OCRL;INPP5F;SOCS6;SOCS4;PGAP2;PLEKHA1;EFR3A;DPM2
prerank,establishment of epithelial cell polarity (GO:0090162),0.320847046592516,0.6672576712901355,0.8576732673267327,1.0,1.0,5/19,19.75%,EZR;CLASP1;MSN;CYTH1;GOLPH3
prerank,vitamin transport (GO:0051180),0.2997119738470106,0.6672356978566926,0.8526682134570766,1.0,1.0,3/29,11.15%,SLC2A8;SLC52A1;SLC19A1
prerank,regulation of lamellipodium organization (GO:1902743),0.332045826207606,0.6671541612537374,0.8495339547270306,1.0,1.0,1/14,3.89%,CD44
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.29688422815225635,0.6670245498893669,0.8758389261744967,1.0,1.0,8/43,17.61%,CCN4;FOXP1;DNMT1;JUN;FGF9;BMPR1A;ADAMTS1;LDLRAP1
prerank,cellular glucose homeostasis (GO:0001678),0.2954466901310284,0.6666934822677311,0.8656387665198237,1.0,1.0,12/41,21.24%,NUCKS1;NR1D1;FOXO1;PRKACA;RACK1;FOXK2;SIRT1;XBP1;ADCY8;ZBTB20;PAX2;PCK2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.31092481575469266,0.6659402162088751,0.8514007308160779,1.0,1.0,7/22,23.05%,PPM1D;PPP2CB;PPP1CA;PPM1B;PPP2CA;DUSP16;PPM1E
prerank,lipid modification (GO:0030258),0.29784890270651604,0.6659039307358003,0.8571428571428571,1.0,1.0,3/37,6.72%,PLPPR3;MBOAT2;EPHX2
prerank,intracellular lipid transport (GO:0032365),0.31120794532618556,0.6658842648663271,0.8609756097560975,1.0,1.0,6/21,18.79%,ABCD1;CPT1B;CPT1A;PRKAG2;CPT2;ABCD4
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3363790066285094,0.6658214289481783,0.8319783197831978,1.0,1.0,2/12,14.89%,FGF9;ADAMTS1
prerank,blood circulation (GO:0008015),0.28764287221326523,0.6653244571538314,0.8735262593783494,1.0,1.0,9/49,24.01%,F5;GUCY1A1;ROCK2;ELN;SGCG;ROCK1;GCLM;GCLC;ITGB1BP1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.29257831840813975,0.6653089165965617,0.8694196428571429,1.0,1.0,9/37,16.46%,MEFV;ABCD1;MAPK14;IL17RA;CARD9;MYD88;TLR6;APPL1;NLRC3
prerank,peptidyl-lysine acetylation (GO:0018394),0.3460628692449901,0.6648144501048832,0.8480662983425414,1.0,1.0,3/10,16.94%,KAT2B;CREBBP;SIRT1
prerank,positive regulation of type I interferon production (GO:0032481),0.28008923452832735,0.6646381761616176,0.9166666666666666,1.0,1.0,14/73,16.44%,DHX58;PTPN22;CGAS;XRCC6;RIOK3;DHX9;MYD88;TOMM70;FLOT1;PRKDC;CREBBP;POLR1C;LRRFIP1;POLR2K
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.26496524169673286,-0.6645647546651994,0.8857142857142857,0.9714695092742669,1.0,4/11,26.19%,UNC93B1;TNIP2;TICAM1;SCIMP
prerank,positive regulation of phosphorylation (GO:0042327),0.27289028512594027,0.6641409253710926,0.984984984984985,1.0,1.0,61/240,23.41%,PECAM1;ERBB3;GLMN;CCN1;LMO4;CD74;AXIN1;BRAT1;PGF;TFRC;RASGRP1;CRKL;PIN1;NIBAN1;CIB1;ENTPD5;EGFR;EPHA3;P2RY1;WDFY2;FGF9;FLT3;FAS;LMTK2;FXR1;NRP1;ROCK2;RACK1;FLOT1;FAM20A;PSEN1;PPIA;MYDGF;STK4;RAD50;EGF;FGFR1;LIMK2;RAC1;PDE8A;SIRT1;LRRK2;ZBTB20;SOX9;AKTIP;ALK;EPHA7;DSTYK;CCND3;MET;ILK;SLCO3A1;RIPK1;EPHA10;EFNA1;NTRK3;DDR2;FGFR2;ADAM17;DSCAM;C3
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3077810454390123,0.6632891162575802,0.8539192399049881,1.0,1.0,9/24,23.22%,PARK7;RACK1;USP25;XBP1;UBXN1;SYVN1;LRRK2;NR1H3;LPCAT3
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.32588608245813133,0.6629513438469156,0.8455598455598455,1.0,1.0,3/18,10.75%,RFK;ATP7A;PARK7
prerank,striated muscle tissue development (GO:0014706),0.29934192024149786,0.6625865751613429,0.875,1.0,1.0,6/29,21.08%,CSRP3;CAV1;CFLAR;SGCG;ZBTB18;SVIL
prerank,positive regulation of innate immune response (GO:0045089),0.29686353149779615,0.662346872289734,0.8634259259259259,1.0,1.0,4/30,11.45%,RPS19;UBE2K;RIOK3;DHX9
prerank,fatty acid biosynthetic process (GO:0006633),0.28496240724301064,0.6621905111920369,0.9137214137214137,1.0,1.0,10/63,17.05%,HACD4;ABCD1;EPHX2;CBR4;HPGD;LTA4H;ELOVL5;NDUFAB1;ELOVL4;XBP1
prerank,neural crest cell migration (GO:0001755),-0.1902105341395945,-0.6618663022789899,0.9590163934426229,0.9727547706982452,1.0,5/36,6.36%,ERBB4;SEMA3D;SEMA3E;SEMA4C;CORO1C
prerank,inositol phosphate metabolic process (GO:0043647),0.28583254076103964,0.6618529608253029,0.8822246455834242,1.0,1.0,10/46,16.54%,IMPA1;INPP5A;PLCG2;NUDT4;PLCB1;PTEN;INPP4A;PLCB3;PLCD1;PLCG1
prerank,presynaptic endocytosis (GO:0140238),0.31204998184495525,0.6613807309992349,0.8687350835322196,1.0,1.0,5/24,13.27%,CEL;SYT8;STON1;CANX;STON2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.33231501171008426,0.6613709956420142,0.8292682926829268,1.0,1.0,2/13,12.09%,CIAO2A;ISCA2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3146191955753305,0.6610174357388207,0.8424317617866005,1.0,1.0,2/18,7.77%,AKT3;CIB1
prerank,inflammatory response (GO:0006954),0.2735384940254142,0.6606923488397105,0.964,1.0,1.0,29/195,17.98%,MEFV;LY75;IL2RA;HSPG2;CD44;CRHBP;S100A9;CCR2;IKBKG;S100A8;NFAM1;HMGB1;TPST1;IL22;HNRNPA0;TLR5;NFX1;TLR6;F2R;CYBB;TRAF3IP2;NFATC3;RAC1;CCL25;CYBA;ADCY8;FCGR2B;CXCR4;HDAC4
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3443652720994499,0.6604768665865979,0.8193832599118943,1.0,1.0,3/10,23.12%,TGFA;EGF;ADAM17
prerank,dendrite self-avoidance (GO:0070593),0.32208545377617886,0.6600075435954087,0.8529801324503311,1.0,1.0,5/16,23.28%,BSG;PALLD;EMB;CNTN4;DSCAM
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.31155412667871163,0.6599090565647795,0.8519900497512438,1.0,1.0,5/19,17.68%,MPI;UAP1;GFPT2;PMM2;UAP1L1
prerank,fatty acid catabolic process (GO:0009062),0.28256607093031466,0.6596117554386969,0.9230769230769231,1.0,1.0,18/67,21.89%,CEL;ACADM;ABCD1;ACBD5;NUDT19;AUH;SLC27A2;PEX2;PHYH;CPT2;HADHA;MMAA;HADHB;ABCD4;DECR1;PPARD;ABHD2;ACOT8
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3011681868459478,0.6590661151808563,0.8671328671328671,1.0,1.0,7/28,26.83%,TRADD;DELE1;BAG3;CASP8;CRADD;CASP8AP2;GABARAP
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.31408166267231985,0.6590563552100099,0.8443337484433375,1.0,1.0,4/18,20.98%,EGFR;TP53;MAP2K1;RIPK1
prerank,sulfur amino acid metabolic process (GO:0000096),0.3063710043721264,0.6587888751411669,0.86810551558753,1.0,1.0,4/24,14.41%,MSRA;DPEP1;SMS;MTR
prerank,regulation of JNK cascade (GO:0046328),0.2738938709379649,0.6587098115441499,0.9350253807106599,1.0,1.0,13/101,11.64%,MEN1;ULK4;AXIN1;RASGRP1;TRAF3;MAP3K5;HMGB1;MAP4K2;EGFR;HIPK2;MAP3K11;CARD9;PLCB1
prerank,cellular amino acid catabolic process (GO:0009063),0.27698548928265976,0.658539084861585,0.9213483146067416,1.0,1.0,9/87,14.97%,SLC25A21;HAAO;KMO;GLS2;PRODH;AUH;FAH;IVD;MCCC1
prerank,membrane repolarization during action potential (GO:0086011),-0.2526631655784061,-0.6584017810273901,0.910958904109589,0.9745836466421898,1.0,3/13,16.60%,ATP1A1;ATP1B1;KCND3
prerank,SNARE complex assembly (GO:0035493),0.35085864067049705,0.6579179111373222,0.838150289017341,1.0,1.0,1/10,2.92%,STXBP6
prerank,tRNA wobble uridine modification (GO:0002098),-0.242283559907865,-0.6574923389652632,0.9382239382239382,0.9742866017398014,1.0,9/14,39.31%,MTO1;DPH3;GTPBP3;TRMT9B;CTU2;TRMU;CTU1;MOCS3;KTI12
prerank,regulation of cellular biosynthetic process (GO:0031326),0.29796095508687787,0.6571800671086244,0.8833718244803695,1.0,1.0,10/28,24.16%,CD47;JAK2;ADIPOR1;PRKAG2;RAC1;SIRT1;MED1;EIF6;C3;PRKAB2
prerank,mitochondrion transport along microtubule (GO:0047497),0.33273308671702684,0.6570742563288041,0.8328877005347594,1.0,1.0,1/13,2.47%,UXT
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.316038451634035,0.6558387659309148,0.8628205128205129,1.0,1.0,3/18,14.59%,BOK;CHCHD10;GSK3B
prerank,cellular response to insulin stimulus (GO:0032869),0.27178769489909216,0.6552260319591661,0.947261663286004,1.0,1.0,25/124,17.66%,C2CD5;SLC2A4;USF1;FOXO1;DENND4C;SORBS1;ZFP36L1;RAB8A;GRB2;SOS1;CAV2;PDPK1;KAT2B;RAB8B;ZDHHC7;ATP6V0E1;PRKDC;IRS1;GSK3B;APPL1;ATP6AP1;CAPN10;XBP1;ATP6V0D1;EPRS1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.2951091605461704,0.6552075753327219,0.8798185941043084,1.0,1.0,8/33,24.01%,CYP1B1;CIB1;DPP4;TGFB2;SYK;EFNA1;PTPN11;ITGB1BP1
prerank,positive regulation of autophagy (GO:0010508),0.27442005317519946,0.6550977627020952,0.9191402251791198,1.0,1.0,24/81,23.35%,MEFV;STK11;IKBKG;FOXO1;PIM2;HMGB1;DCN;PARK7;ORMDL3;ATF6;TRIM68;RNF152;TRIM5;GSK3B;SIRT1;MAP3K7;LRRK2;DAPK1;SVIP;BNIP3;ROCK1;PHB2;TRIM65;UFL1
prerank,synaptic vesicle recycling (GO:0036465),0.30025906086631227,0.6550021355634734,0.8883826879271071,1.0,1.0,8/31,17.91%,CEL;SYT8;STON1;PLD2;CANX;STON2;RAB5A;SNCA
prerank,mitochondrion organization (GO:0007005),0.2721145510301488,0.65473593068069,0.9689067201604814,1.0,1.0,28/165,15.29%,PISD;PTCD2;CHCHD4;TOMM34;AGTPBP1;TSPO;AKT3;TFB1M;GABPB1;TFB2M;PITRM1;NRF1;CAV2;LONP1;TIMM9;ATP7A;PARK7;GDAP1;FIS1;TOMM70;HAP1;HCFC1;CHCHD10;TIMM23;GABPA;MPV17;ATP5F1D;MTM1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.24303816136361214,-0.6545133295089325,0.9230769230769231,0.9755814392180818,1.0,7/15,30.27%,NSMAF;SIRT3;PLA2G6;SPHK2;ORMDL2;ORMDL1;SMPD2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.29769422063598383,0.6539374705104236,0.8809234507897934,1.0,1.0,9/23,26.52%,JAK2;PARP14;SUMO1;PIAS1;NR1H3;IFNGR1;NR1H2;JAK1;PARP9
prerank,inorganic cation import across plasma membrane (GO:0098659),0.27854874864067225,0.6538339965842406,0.9271794871794872,1.0,1.0,12/75,19.26%,SLC12A3;SLC12A7;SLC12A1;KCNJ3;SLC12A6;KCNJ2;SLC24A2;SLC9A9;TRPM4;KCNJ10;SLC9A7;SLC9A6
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3210558355424682,0.6531759875130947,0.8429530201342282,1.0,1.0,4/15,20.34%,NOTCH1;SMOC2;PRKD2;MET
prerank,endocardial cushion development (GO:0003197),0.30605806665595153,0.6530403179179435,0.8485958485958486,1.0,1.0,5/21,19.39%,MDM4;NOTCH1;BMPR1A;TGFB2;SOX9
prerank,regulation of defense response (GO:0031347),0.27406843013520416,0.6528481082755534,0.9306418219461697,1.0,1.0,15/76,15.40%,DHX58;PTPN22;FOXP1;CCR2;TRAF3;BIRC2;BRD4;JAK2;IL1R1;PARK7;XIAP;MYD88;SPATA2;BCL6;APPL1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3123897868866935,0.6526794040769505,0.8673218673218673,1.0,1.0,3/21,9.67%,PDE2A;NUDT4;NT5C2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.25604055606603315,-0.6526480708943149,0.9,0.9759076604658817,1.0,4/12,17.88%,STX4;PLA2G6;C2CD2L;GPLD1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.3312108162900204,0.6526376598347096,0.836241610738255,1.0,1.0,5/13,22.74%,NOTCH1;PIM1;BMPR1A;RBPJ;FGFR2
prerank,cellular response to acid chemical (GO:0071229),0.29545146345968887,0.6525482980383529,0.8621103117505995,1.0,1.0,8/27,20.73%,LARS1;CPEB3;LAMTOR4;LAMTOR3;IPO5;XBP1;GLRA1;RRAGB
prerank,regulation of myotube differentiation (GO:0010830),0.30231682354049505,0.6525344379232204,0.8643649815043156,1.0,1.0,10/24,26.76%,NOTCH1;MAPK14;XBP1;HDAC4;HDAC1;ATP11A;HDAC9;PIEZO1;BDNF;TMEM119
prerank,regulation of smoothened signaling pathway (GO:0008589),0.28046609378986254,0.6524816283262619,0.8856837606837606,1.0,1.0,15/50,23.10%,TEDC2;FUZ;KCTD21;UCHL5;HHIP;RACK1;CREBBP;TUBD1;TXNDC15;SUFU;RAB34;MEGF8;FGFR2;BTRC;INTU
prerank,RNA interference (GO:0016246),0.31243756931187094,0.6524346285803048,0.8588082901554405,1.0,1.0,6/17,22.08%,DHX9;TARBP2;CLP1;AGO2;CELF1;AGO1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3253641027432821,0.651884352074144,0.8454301075268817,1.0,1.0,4/14,16.70%,JAK2;SOCS2;STAT5B;JAK3
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.3295178906636838,0.6513352094268262,0.8582574772431729,1.0,1.0,6/15,25.04%,PRKCA;MTPN;ROCK2;ROCK1;IL6ST;PARP1
prerank,autophagy of mitochondrion (GO:0000422),0.2896605113455322,0.6511834203439899,0.8945615982241953,1.0,1.0,6/38,12.38%,ATG13;MARK2;BECN1;AMBRA1;FIS1;CTSK
prerank,response to ATP (GO:0033198),0.30961752133954157,0.6511444320289484,0.8391521197007481,1.0,1.0,3/18,17.46%,TAF1;P2RY1;HSP90B1
prerank,negative regulation of anoikis (GO:2000811),0.3243295840574777,0.6505534009278408,0.8369272237196765,1.0,1.0,2/14,7.15%,CAV1;NOTCH1
prerank,positive regulation of rRNA processing (GO:2000234),-0.2682823690944014,-0.6505035288903814,0.9051987767584098,0.9764631215568708,1.0,5/10,23.28%,HEATR1;WDR75;BUD23;RIOK2;WDR43
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.32661730084823865,0.6503837588767998,0.8525280898876404,1.0,1.0,1/13,3.12%,KRI1
prerank,hemopoiesis (GO:0030097),0.275603551523962,0.6498058697861679,0.9327217125382263,1.0,1.0,18/87,17.70%,ZFPM1;RUNX3;PRKX;ZBTB16;ETV6;KAT6A;MELK;TNFRSF13B;FLT3;KMT2A;ARIH2;PRRC2C;KIRREL3;TP53;RUNX1;ZFP36L2;TGFB2;KITLG
prerank,phospholipid metabolic process (GO:0006644),0.27583089000951905,0.6493640284652257,0.9367875647668393,1.0,1.0,9/71,15.04%,PLPPR3;AGPAT1;AGPAT4;PCYT2;ABCA2;AGPAT3;PLBD1;PLCD1;PLPPR4
prerank,regulation of necroptotic process (GO:0060544),0.3045794481538966,0.6492567814122724,0.8682926829268293,1.0,1.0,7/23,20.98%,BIRC2;SPATA2;FLOT1;CFLAR;FLOT2;CASP8;RIPK1
prerank,protein heterooligomerization (GO:0051291),0.3185260955358095,0.6492148765873563,0.8506900878293601,1.0,1.0,5/17,21.79%,CBR4;KCNC2;PKD2;CPSF7;MAT2A
prerank,regulation of phospholipase C activity (GO:1900274),0.320250681049432,0.6489593987679624,0.8543956043956044,1.0,1.0,4/15,22.34%,RASGRP1;FGFR1;PLCG1;NTRK3
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.34251329599287167,0.6485999049458414,0.8401697312588402,1.0,1.0,3/10,17.64%,SIRT7;SDHAF3;USP7
prerank,regulation of autophagy (GO:0010506),0.2696153683178367,0.6480824536103841,0.983,1.0,1.0,51/216,21.60%,DAP;MEFV;ATG13;DAPK2;ITPR1;PTPN22;STK11;EXOC4;FOXO1;ATM;HDAC6;PIM2;HMGB1;BOK;DCN;RAB8A;PRKACA;UBQLN1;TAB3;CAPN1;ORMDL3;ATF6;MLST8;IL10RA;TRIM68;RNF152;ATP6V0E1;DDIT3;PRKAG2;LAMTOR4;TRIM5;GSK3B;LAMTOR3;ATG101;FOXK2;KLHL22;ATP6V0D1;PIP4K2A;LRRK2;SREBF2;DAPK1;SVIP;MET;KEAP1;RRAGB;PRKAG1;BNIP3;ROCK1;GAPDH;MAPT;UBQLN2
prerank,response to copper ion (GO:0046688),0.31286110930412103,0.6477887252675191,0.8645083932853717,1.0,1.0,1/20,1.86%,AQP1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.276755070145943,0.6474040719346713,0.9178794178794178,1.0,1.0,12/65,17.60%,VASN;CAV1;PMEPA1;PIN1;ZBTB7A;PDPK1;SNX25;BCL9L;SPRED2;SKI;SIRT1;UBA52
prerank,alanine transport (GO:0032328),-0.27013586594729966,-0.6473482560515446,0.8817567567567568,0.9778676310769047,1.0,9/10,54.15%,SLC36A4;SLC36A1;SLC7A10;SLC6A17;SLC36A2;SLC36A3;SLC6A6;SLC6A14;SLC38A3
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2858676682296553,0.6455371864206232,0.8821548821548821,1.0,1.0,9/41,22.09%,ITPR1;HTR2A;IBTK;PLCG2;F2R;SLC24A2;PKD2;GRIN2D;ATP2B4
prerank,acyl-CoA metabolic process (GO:0006637),0.2864460448298876,0.6454739198287266,0.8856502242152466,1.0,1.0,3/35,8.69%,ACOT11;ACOT13;ACOT2
prerank,stabilization of membrane potential (GO:0030322),0.3140011387400783,0.6447746210846057,0.855146124523507,1.0,1.0,4/16,16.65%,KCNN4;CHCHD10;KCNK12;KCNK2
prerank,response to interferon-alpha (GO:0035455),-0.227149653166994,-0.6442503065269234,0.9188034188034188,0.9792055864003841,1.0,5/16,18.04%,ADAR;BST2;AXL;RO60;IFNAR1
prerank,negative regulation of viral process (GO:0048525),0.27908628641828565,0.6442497474012115,0.9017951425554382,1.0,1.0,12/57,18.94%,PML;SLPI;TRIM11;FAM111A;IFITM3;PPIA;TRIM5;TRIM28;SRPK1;CHMP3;HEXIM1;PROX1
prerank,regulation of cellular respiration (GO:0043457),0.3098725735496398,0.6440042466479269,0.8821243523316062,1.0,1.0,5/17,26.48%,NOA1;PNPT1;CBFA2T3;VCP;TRAP1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3038552507446015,0.6438739396372674,0.8663426488456865,1.0,1.0,2/22,5.31%,PALM;CCR2
prerank,protein glycosylation (GO:0006486),0.27015341567110357,0.6438680301494376,0.9617321248741189,1.0,1.0,20/125,16.23%,MAGT1;GALNT10;KRTCAP2;PLOD3;ALG8;MPI;STT3A;NUS1;MGAT2;ST3GAL1;ST3GAL2;ENTPD5;ST8SIA4;B3GNT2;FUT8;GFPT2;ST3GAL5;PMM2;TUSC3;POMT1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.28065080539800785,0.643559396369664,0.9050772626931567,1.0,1.0,10/43,20.20%,ITGA1;TGFA;GRB2;EGFR;EGF;HGS;RNF115;ARHGEF7;STAM;SOCS4
prerank,regulation of ion transport (GO:0043269),0.27101504059368786,0.6429425693589264,0.9193877551020408,1.0,1.0,12/76,14.43%,NKAIN4;SYT8;YWHAH;NEDD4L;KCNJ3;TOR1A;B2M;SYT3;RAB11B;NKAIN3;KCNJ2;DTNBP1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.26811118689659064,0.6429414256431852,0.9618856569709128,1.0,1.0,23/151,16.79%,HTR2A;CD74;CD44;PTPN22;RASGRP1;CRKL;NOTCH1;HMGB1;CIB1;PRKCA;EGFR;P2RY1;ABCA7;CARD9;ARRB2;NRP1;ADCYAP1;F2R;MAP2K1;TNFRSF11A;ATP6AP1;CCL25;PDE8A
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.31229730938768746,0.6426133791769503,0.8472400513478819,1.0,1.0,5/18,26.58%,CRHBP;IRS1;SIRT4;KCNB1;PSMD9
prerank,polarized epithelial cell differentiation (GO:0030859),0.32660446344086375,0.6421396609423716,0.8585034013605443,1.0,1.0,3/13,13.15%,EZR;MSN;ZDHHC7
prerank,protein localization to plasma membrane (GO:0072659),0.26644415581224484,0.6418416106431368,0.950852557673019,1.0,1.0,19/129,13.69%,C2CD5;RAMP1;CCDC88A;FLNA;EZR;ANK1;DENND4C;RAB8A;TSPAN33;P2RY1;ACTN2;BSG;RDX;RAB8B;PRAM1;FGF13;ROCK2;FLOT1;TTC7A
prerank,regulation of supramolecular fiber organization (GO:1902903),0.30181699943211243,0.6416070991213791,0.8583333333333333,1.0,1.0,8/22,24.24%,MAPRE3;GBA2;PARK7;EFEMP2;PIK3CA;MAPT;CAMSAP1;AKAP13
prerank,cellular metal ion homeostasis (GO:0006875),0.26705836525883403,0.6412878728339958,0.9428571428571428,1.0,1.0,7/102,8.24%,TMPRSS3;HTR2A;CSRP3;CAV1;CCR2;NEDD4L;SLC10A7
prerank,reticulophagy (GO:0061709),-0.25711505743298646,-0.6412662565124375,0.9270833333333334,0.9803831398900428,1.0,5/12,20.47%,ULK1;UFC1;TEX264;UBA5;ULK2
prerank,regulation of axon regeneration (GO:0048679),-0.25087726103447233,-0.6407188644516616,0.8954703832752613,0.9796325356383352,1.0,2/12,4.64%,GRN;PTPRS
prerank,negative regulation of cell motility (GO:2000146),0.26802013518514334,0.6401173902793007,0.9434343434343434,1.0,1.0,17/108,16.22%,CYP1B1;STK26;CD74;ARID2;DACH1;DPEP1;PIN1;FUZ;STK24;ZMYND8;CRK;PTEN;SLURP1;RNF20;DAG1;PTPRU;DUSP22
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.31153018056500925,0.6401165447143693,0.8687258687258688,1.0,1.0,7/17,24.68%,CARD9;PDCD10;TGFB2;ARL6IP5;TAOK1;STK25;EIF2AK2
prerank,histone lysine demethylation (GO:0070076),0.28808711890174754,0.6400793156511481,0.8643274853801169,1.0,1.0,3/25,7.94%,RIOX1;KDM3B;PHF2
prerank,regulation of vacuole organization (GO:0044088),0.3087342388743923,0.6398127675113447,0.8651960784313726,1.0,1.0,6/20,17.28%,RAB1B;ENO4;MTM1;NPRL3;RAB5A;ADPRH
prerank,cell part morphogenesis (GO:0032990),0.32387321591933765,0.6395234335377524,0.8879551820728291,1.0,1.0,6/13,26.88%,FIS1;PACSIN2;MTM1;PNPT1;PID1;WASF1
prerank,Rac protein signal transduction (GO:0016601),0.31128475704070513,0.6389674677634594,0.8660714285714286,1.0,1.0,5/18,16.74%,TIAM1;DBNL;RAC2;BRK1;RAC1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.18731509862298648,-0.6385217487431741,0.9682539682539683,0.9801311341885562,1.0,8/31,19.83%,OPTN;ERN1;TM7SF3;PRKN;ATXN3;HSPA5;DAB2IP;HSPA13
prerank,positive regulation of biomineral tissue development (GO:0070169),0.28128643306814743,0.6384256850984391,0.8882743362831859,1.0,1.0,6/40,17.46%,FBXO5;CCN1;BMPR1A;NELL1;ADGRV1;ANO6
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.27858868175264684,0.6380700533502963,0.8820960698689956,1.0,1.0,6/43,13.00%,FBXO5;CCN1;CCN4;LRP3;BMPR1A;NELL1
prerank,positive regulation of T cell activation (GO:0050870),0.2774473300980292,0.6380679432522322,0.9258098223615465,1.0,1.0,5/62,8.62%,CD47;SLC7A1;TFRC;CCR2;CYRIB
prerank,ureteric bud development (GO:0001657),-0.22468410226822474,-0.6377613822900396,0.9347826086956522,0.9795921855229196,1.0,2/17,10.53%,SALL1;GPC3
prerank,sulfation (GO:0051923),-0.2515906541753689,-0.637335989438562,0.9146757679180887,0.9787769150609353,1.0,4/11,31.39%,UST;HS3ST5;SULT1A1;SULT4A1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.28106801444539425,0.6370823872124035,0.8841394825646794,1.0,1.0,10/36,17.64%,PSMF1;DDRGK1;PARK7;CCAR2;UCHL5;TAF9;USP25;UBXN1;CAMLG;USP7
prerank,cardiac muscle contraction (GO:0060048),0.2919771882347033,0.6356962051303745,0.8961937716262975,1.0,1.0,4/34,16.78%,CSRP3;GSN;GRK2;PIK3CA
prerank,regulation of osteoblast proliferation (GO:0033688),0.3078865159037196,0.6355783816414217,0.8857142857142857,1.0,1.0,2/17,13.00%,CCN1;NELL1
prerank,regulation of histone deacetylation (GO:0031063),0.32529758004177556,0.6353054216113615,0.8791208791208791,1.0,1.0,3/13,13.53%,ZBTB7B;ING2;NIPBL
prerank,axonal fasciculation (GO:0007413),0.3278438536261732,0.6349683449508012,0.8550135501355014,1.0,1.0,5/12,22.56%,ARHGAP35;EPHA3;NRCAM;MEGF8;CNTN4
prerank,bile acid metabolic process (GO:0008206),0.29265288180526283,0.6347269402573668,0.8800475059382423,1.0,1.0,5/27,12.04%,GBA2;OSBPL3;CYP27A1;SLC27A2;CYP46A1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2906486282460927,0.634709122378145,0.8717339667458432,1.0,1.0,4/25,13.37%,CCDC88A;SHKBP1;HAP1;DGKD
prerank,positive regulation of exocytosis (GO:0045921),0.28316037556116275,0.6341934121608773,0.9083710407239819,1.0,1.0,11/35,24.87%,CLASP1;HGS;ATP6AP1;RAB5A;SNCA;STAM;RAB27A;VPS4A;RAB27B;RAB9A;TSG101
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.21515955850241145,-0.6341815419634994,0.9653679653679653,0.9799091820851842,1.0,7/18,27.74%,RELA;GSK3A;CASP3;EPHA4;PICALM;CHRNA7;LRRTM3
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2753663761433733,0.6338186335299689,0.9010869565217391,1.0,1.0,10/39,20.64%,RCN3;ARFGAP3;RAB8A;MIA2;RAB8B;CANX;STEAP3;PPY;GOLPH3;TVP23A
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2643224442218052,0.632192293565681,0.943762781186094,1.0,1.0,29/88,25.42%,HDAC6;EIF4A3;CPEB3;TYMS;IGF2BP3;CDK5RAP3;FXR1;NELL1;RACK1;LSM14A;CNOT1;SAMD4A;EPRS1;CLN3;EIF4ENIF1;RPS3;DAPK1;CNOT8;SYNCRIP;CNOT7;GAPDH;RPL13A;EIF4E2;YBX1;NCL;DAPK3;EIF2AK2;GIGYF2;CST3
prerank,cellular response to superoxide (GO:0071451),-0.2620748245008606,-0.632170449145614,0.9323308270676691,0.980172473182927,1.0,4/10,26.53%,ADPRS;PRDX2;MT3;SOD2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2881525384736351,0.6315494698675422,0.8897818599311137,1.0,1.0,3/31,11.37%,CACNA1I;SYT8;SYT3
prerank,protein localization to cell periphery (GO:1990778),0.26181686397106996,0.6309690783525187,0.963855421686747,1.0,1.0,19/133,13.69%,C2CD5;RAMP1;FLNA;EZR;CAV1;ANK1;DENND4C;RAB8A;TSPAN33;P2RY1;ACTN2;BSG;RDX;RAB8B;PRAM1;FGF13;ROCK2;FLOT1;TTC7A
prerank,cellular response to interferon-beta (GO:0035458),-0.23017182274967524,-0.6307143209613697,0.9505703422053232,0.9800397818485846,1.0,3/14,9.35%,IRF1;IRGM;HTRA2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.33426111632749567,0.6305094573160599,0.8773448773448773,1.0,1.0,4/10,19.72%,PARP14;PIBF1;PPP2CA;INPP5F
prerank,histone H4 deacetylation (GO:0070933),0.3278804074607403,0.6300719508081413,0.8875562218890555,1.0,1.0,5/10,22.56%,HDAC4;HDAC1;HDAC8;SMARCAD1;HDAC9
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3052489315367998,0.6300356938579816,0.8608582574772432,1.0,1.0,2/17,9.77%,BACH2;BTN3A3
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3257142280648435,0.6298385874001501,0.8838526912181303,1.0,1.0,4/11,22.08%,TNRC6C;AGO2;EIF6;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3257142280648435,0.6298385874001501,0.8838526912181303,1.0,1.0,4/11,22.08%,TNRC6C;AGO2;EIF6;AGO1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.19790003301608106,-0.6282130579011274,0.9548387096774194,0.9806074394492232,1.0,11/24,33.72%,SRI;DMD;CALM1;JPH4;SELENON;GSTO1;FKBP1B;CAMK2D;CALM2;NOS1;JPH3
prerank,response to peptide (GO:1901652),0.285169235431138,0.6280211143256685,0.8997722095671982,1.0,1.0,7/33,20.89%,FYN;GNAI1;STAT5B;IRS1;CACNA1B;MMP12;EIF2B5
prerank,cellular response to estrogen stimulus (GO:0071391),0.3099467344796034,0.6279390197007523,0.8682795698924731,1.0,1.0,2/14,11.94%,CRHBP;PELP1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.28089440300353286,0.6277612344610718,0.9085841694537347,1.0,1.0,9/38,19.07%,NDUFS8;NDUFB7;NDUFAF1;NDUFA1;NDUFA4;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.3123228428245294,0.6273891501833718,0.8766756032171582,1.0,1.0,5/14,23.52%,FAF1;SUFU;PKD2;KEAP1;G3BP2
prerank,regulation of interleukin-10 production (GO:0032653),0.2783501224805372,0.6271628078635026,0.8947939262472885,1.0,1.0,9/44,21.45%,CD47;HMGB1;PLCG2;PIBF1;TYROBP;JAK3;FCGR2B;LGALS9;SYK
prerank,regulation of actomyosin structure organization (GO:0110020),0.320393328910469,0.6271343569143676,0.8607764390896921,1.0,1.0,7/13,24.24%,ALMS1;ROCK2;RAC1;PTGER4;ROCK1;ACTG1;AKAP13
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.19937328262306653,-0.6271241177588153,0.9700598802395209,0.9802612229977056,1.0,8/23,35.64%,GSK3A;TIGAR;PLEK;CRY1;GIT1;PFKFB1;EP300;C1QTNF3
prerank,regulation of cell junction assembly (GO:1901888),0.28794763961174935,0.6263387061313345,0.8899521531100478,1.0,1.0,8/27,22.73%,PRKACA;CBFB;ROCK2;FLOT1;RUNX1;PDLIM5;ROCK1;SETD5
prerank,integrin-mediated signaling pathway (GO:0007229),0.2660566066112456,0.6262172482681135,0.9457523029682702,1.0,1.0,10/73,13.01%,ITGB7;CD47;PTPRA;NEDD9;LAMA5;CCM2;ITGAV;CUL3;PRAM1;NRP1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2712071789318478,0.6256742281067053,0.9229957805907173,1.0,1.0,16/54,23.75%,RPL7;RPL14;RPL23A;RPLP0;WDR74;NSA2;RPL3;PES1;RPL5;EIF6;RSL24D1;RPL24;RPL10;RPF1;MRPL20;NPM1
prerank,cellular response to lipid (GO:0071396),0.25677164659013413,0.6255224748559668,0.985,1.0,1.0,16/191,10.64%,GFI1;HMGB2;AQP1;CRHBP;MAP4K1;NR1D1;ATM;SETX;HMGB1;AHR;GNAI1;MAPK14;EGFR;EPHA3;RUVBL2;MSN
prerank,integrated stress response signaling (GO:0140467),0.32003892799141503,0.625458142606139,0.8803191489361702,1.0,1.0,3/14,13.56%,EIF2S1;NFE2L2;DDIT3
prerank,positive regulation of potassium ion transport (GO:0043268),0.2766088300359808,0.6253147478126082,0.9156355455568054,1.0,1.0,5/38,13.00%,FLNA;KCNN4;KCNJ3;ACTN2;KCNJ2
prerank,sphingolipid biosynthetic process (GO:0030148),0.26268988127010395,0.6252419316641131,0.9336099585062241,1.0,1.0,12/71,16.65%,SGMS2;HACD4;PRKD3;CSNK1G2;VAPA;CERS4;SGMS1;ELOVL5;ST3GAL5;ELOVL4;CERS6;ACER3
prerank,regulation of protein secretion (GO:0050708),0.2592394143547359,0.625033840868995,0.9656912209889001,1.0,1.0,10/119,11.88%,IL12A;ITPR1;EZR;MYOM1;PRKCA;PICK1;MYH10;KCNC2;DPP4;EIPR1
prerank,response to UV-A (GO:0070141),0.30945643217114593,0.6244259673495578,0.8780141843971632,1.0,1.0,2/14,19.90%,EGFR;MME
prerank,oligodendrocyte differentiation (GO:0048709),0.29831725543406873,0.6239895893713395,0.8781094527363185,1.0,1.0,1/19,1.98%,SOX6
prerank,negative regulation of angiogenesis (GO:0016525),0.26343971968718655,0.62385073324455,0.9468845760980592,1.0,1.0,17/84,22.88%,E2F2;HSPG2;PML;CCR2;DCN;MECP2;ROCK2;ADAMTS1;HGS;TGFB2;PGK1;ROCK1;SEMA6A;AGO1;ATP2B4;NIBAN2;APOH
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.28138128841335885,0.623287316743097,0.9159953970080552,1.0,1.0,6/33,16.78%,ERBB3;HTR2A;ZFP36L1;PTEN;IRS1;PIK3CA
prerank,cardiac myofibril assembly (GO:0055003),0.30632580713680535,0.6232178304077228,0.8707571801566579,1.0,1.0,1/15,3.63%,CSRP3
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.28133299634976106,0.6231560253011916,0.9045454545454545,1.0,1.0,5/35,11.79%,ACSS3;CBR4;HPGD;BDH1;FASN
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.28334518783854956,0.6231377690922368,0.9016018306636155,1.0,1.0,3/31,7.70%,TWIST1;EIF4A3;FUZ
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.21809438101562761,-0.6230159245834574,0.9487179487179487,0.9819317276739445,1.0,9/16,43.33%,IGF1;IGFBP4;IGFBP6;IGFBP3;BMP5;PHIP;BMP2;IGFBP5;CDH3
prerank,glial cell development (GO:0021782),0.2929934105446723,0.6230004742370497,0.8976470588235295,1.0,1.0,3/25,8.51%,S100A9;CDK6;PICK1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.29644957491582496,0.6228131960690296,0.884318766066838,1.0,1.0,3/20,9.55%,CCT2;NDUFAF1;LONP1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2618581838943277,0.6227993048055075,0.934984520123839,1.0,1.0,19/76,22.65%,EZR;PTPN22;TRADD;EGFR;TRIM44;ADIPOR1;ACTN4;UACA;LIMS1;NLRC3;PPM1B;RPS3;TRAF6;LGALS9;IFI35;ILK;SASH1;RTKN2;PHB2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.30335644666579525,0.622620546568876,0.8845671267252195,1.0,1.0,5/18,19.38%,ITGAV;SMAD4;TGFB2;FN1;LGALS9
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.1998745866932209,-0.6221397376266508,0.9580838323353293,0.9813736359042814,1.0,7/23,26.89%,CALM1;METAP1;CAMKMT;NMT1;FNTB;SAG;GUCA1B
prerank,central nervous system development (GO:0007417),0.2584079294865437,0.6219807547452703,0.992992992992993,1.0,1.0,49/250,21.98%,VAX2;CDK5RAP2;NR4A2;SOX6;PBX4;HSPG2;LIG4;UTP3;ANKLE2;PBX3;HAPLN2;GSN;GBA2;SHROOM2;ZBTB16;SHROOM4;SZT2;DNER;RELN;RPS6KA6;PTEN;HAP1;CDK5RAP3;SMG9;MDGA1;NRCAM;NIPBL;POU6F1;ADGRL3;PBX2;JARID2;COL4A1;PHGDH;CXCR4;SLC2A1;PROX1;SOX9;NPAS2;ELP3;NCOA6;AFF2;PKD2;EPHA7;NHEJ1;EIF2B5;RPS6KA3;GRIN2D;TMX2;RNF103
prerank,ethanol metabolic process (GO:0006067),-0.2396735718769617,-0.6219124032076013,0.917910447761194,0.9803966240333543,1.0,12/12,76.06%,ALDH1A1;SULT1A1;ALDH1B1;SULT2A1;SULT1C4;ADH7;ADH1A;ADH4;ACSS2;ACSS1;ALDH2;ADH5
prerank,neuron projection morphogenesis (GO:0048812),0.2620345754387694,0.6219055855996757,0.9798590130916415,1.0,1.0,29/137,23.23%,KIF20B;NTF4;LRP4;RAB8A;DBNL;NTNG2;ATP7A;PTEN;LMTK2;NRCAM;DTNBP1;PLPPR4;CTNND2;SDC2;IQGAP1;TAOK1;LRRK2;SLC9A6;PAX2;SLITRK2;ROCK1;NEFH;BRSK1;ALCAM;CNTN4;FGFR2;S100A6;RAB10;DOCK10
prerank,fatty acid oxidation (GO:0019395),0.26594704960146914,0.6218190791708287,0.9200841219768665,1.0,1.0,13/57,20.75%,ACADM;ABCD1;AUH;SLC27A2;PEX2;ADIPOR1;PHYH;CPT2;HADHA;HADHB;ABCD4;DECR1;PPARD
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.21551286146727788,-0.6213474334915845,0.948,0.9796796888307278,1.0,10/16,39.76%,PPAT;LHPP;AMPD2;GART;NUDT2;AMPD3;ADSS1;ADSS2;IMPDH1;ATIC
prerank,lung development (GO:0030324),-0.17797416164106206,-0.6213039124959259,0.9666666666666667,0.9786175234612341,1.0,19/33,38.56%,PKD1;BAG6;NPHP3;VEGFA;FGF2;LOXL3;SOX11;CCDC39;RBP4;PDPN;ERRFI1;ITGA3;CCDC40;ABCA3;GLI2;FOXJ1;WNT7B;FGF7;BMP4
prerank,regulated exocytosis (GO:0045055),0.2556322144535566,0.6210797748339145,0.979,1.0,1.0,37/173,23.65%,BLK;F5;PECAM1;FLNA;CRHBP;SYT8;PHACTR2;CYRIB;ACTN2;APOOL;SYT3;BRPF3;ABCC4;OLA1;RAB11B;STEAP2;ACTN4;EGF;TGFB2;SCG3;FN1;F13A1;SNCA;NHLRC2;TAGLN2;ENDOD1;SYT2;RIMS3;TMED10;STXBP2;RAB27B;ACTN1;APOH;RAB10;VCL;DNAJC5;MYH9
prerank,regulation of protein localization to membrane (GO:1905475),0.28076213640597203,0.6208344498695195,0.8947368421052632,1.0,1.0,7/28,21.47%,FYN;GSN;ZDHHC7;APPL1;LDLRAP1;CLN3;VPS4A
prerank,polyol biosynthetic process (GO:0046173),-0.21208464299406765,-0.62004465561851,0.9726027397260274,0.9783818034761776,1.0,5/16,22.93%,ITPKB;IP6K1;FGF2;IPMK;IPPK
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.26540700117473054,0.6198733776746203,0.9420289855072463,1.0,1.0,13/69,19.07%,SDHD;NDUFS8;COA6;NDUFB7;NDUFAF1;COX10;COX4I1;NDUFA1;NDUFA4;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,regulation of axon guidance (GO:1902667),0.32743637360033534,0.6195781048744254,0.8625180897250362,1.0,1.0,2/10,13.01%,ZSWIM4;NRP1
prerank,positive regulation of T cell proliferation (GO:0042102),0.26981528645095576,0.6192449880825487,0.9292502639915523,1.0,1.0,4/55,7.33%,SLC7A1;TFRC;CCR2;HMGB1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.18184513332463947,-0.6188429449323909,0.9927007299270073,0.9779836591325595,1.0,5/32,13.75%,LPIN1;SLC27A1;CHPT1;ABHD3;LPCAT1
prerank,relaxation of muscle (GO:0090075),0.31570377746937595,0.6184939001251686,0.889795918367347,1.0,1.0,3/13,16.78%,GSN;KCNJ2;PIK3CA
prerank,regulation of mitochondrial translation (GO:0070129),0.29335144997376905,0.6183517692622734,0.9045226130653267,1.0,1.0,4/21,16.57%,MPV17L2;MTG2;NSUN3;TRUB2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.299719313619789,0.6181895888480422,0.8836317135549873,1.0,1.0,10/18,29.17%,JAK2;SMAD4;PTPN11;SRC;IL6ST;CBL;JAK1;ST18;CEBPA;IL6R
prerank,protein kinase B signaling (GO:0043491),0.2894371300227121,0.6179272555167483,0.8990384615384616,1.0,1.0,3/23,11.97%,SETX;ZFP36L1;PTEN
prerank,positive regulation of heart contraction (GO:0045823),-0.21110051919911424,-0.6178063124672497,0.9392523364485982,0.9774957889224177,1.0,5/19,21.88%,RYR2;GSK3A;ADRA1A;ATP1A2;SCN3B
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.25799745608242625,0.6174959377569496,0.9490835030549898,1.0,1.0,6/95,8.62%,GFI1;HMGB2;NR1D1;HMGB1;MAPK14;CYRIB
prerank,response to glucose (GO:0009749),0.2683475618116142,0.6169653618439112,0.9173819742489271,1.0,1.0,10/46,21.24%,NKX6-1;PRKACA;RACK1;TCF7L2;XBP1;ADCY8;ZBTB20;PAX2;EIF2B5;PCK2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.3097037718404069,0.6167458586636148,0.8899456521739131,1.0,1.0,1/14,10.75%,PARK7
prerank,synapse assembly (GO:0007416),0.2608297144689287,0.6163901443067488,0.9409326424870467,1.0,1.0,9/67,14.88%,SDK1;DBNL;DNER;PTEN;FGF13;NRCAM;ADGRL3;KIRREL3;NRXN2
prerank,lipid homeostasis (GO:0055088),0.2673612547789417,0.6160091112939331,0.9185185185185185,1.0,1.0,6/57,10.93%,RCN3;USF1;POLD1;ABCD1;ABCA2;ORMDL3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3032133765687131,0.6154446126141382,0.8877005347593583,1.0,1.0,1/15,3.11%,TIAM1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.2929925917399555,0.6153512213503152,0.9226869455006337,1.0,1.0,4/18,19.97%,RPS6KA5;RELN;ADCY8;PRKD2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.25749118791864584,0.614263053415783,0.9587525150905433,1.0,1.0,21/112,17.72%,SOX6;ARHGEF18;CRKL;COL1A2;ZFP36L1;PDE2A;HPGD;SMAD4;JUN;ARRB2;BMPR1A;SKI;USP15;LIMS1;APPL1;ZFP36L2;DUSP22;TGFB2;SIRT1;UBA52;MAP3K7
prerank,peptidyl-lysine trimethylation (GO:0018023),0.27946399354843643,0.6134638712004346,0.8962264150943396,1.0,1.0,3/26,12.75%,SUV39H1;KMT5C;KMT2A
prerank,visual perception (GO:0007601),0.2599349887942268,0.613426225088873,0.9422680412371134,1.0,1.0,8/84,14.77%,CRYBG3;CRYBA1;EYA3;RP2;CEP250;ATF6;RDH10;ADGRV1
prerank,urogenital system development (GO:0001655),0.31482783382158164,0.6129940254847264,0.8834269662921348,1.0,1.0,4/11,25.12%,PAX2;SOX9;OSR1;AMH
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2831409628374621,0.6125868614862637,0.8840579710144928,1.0,1.0,8/24,25.04%,AGTPBP1;TTLL1;TTLL9;TTLL10;TTLL5;TTLL11;TTLL4;PARP1
prerank,mesoderm formation (GO:0001707),-0.2112772056051359,-0.6110271780458999,0.9506726457399103,0.9804501634664965,1.0,7/17,37.47%,BMPR2;ITGB3;KDM6B;ITGB4;ITGA3;ITGB1;SCX
prerank,positive regulation of type 2 immune response (GO:0002830),0.3054834002535365,0.6103080851951214,0.8874172185430463,1.0,1.0,2/14,12.47%,CD74;DENND1B
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.26277110923701485,0.6096817428429181,0.932475884244373,1.0,1.0,12/56,19.07%,NDUFS8;NDUFAF8;NDUFB7;NDUFAF1;NDUFAF7;NDUFA1;NDUFAF5;FOXRED1;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.26277110923701485,0.6096817428429181,0.932475884244373,1.0,1.0,12/56,19.07%,NDUFS8;NDUFAF8;NDUFB7;NDUFAF1;NDUFAF7;NDUFA1;NDUFAF5;FOXRED1;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,regulation of innate immune response (GO:0045088),0.25965692280056807,0.6092196749773514,0.9345300950369588,1.0,1.0,19/57,24.31%,DHX58;PTPN22;BIRC2;RIOK3;XIAP;DHX9;APPL1;NLRC3;TRAFD1;FCGR2B;ERAP1;CASP8;IFI35;POLR3B;FGR;AKIRIN2;PTPN11;ABCE1;SAMHD1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.29754504928737385,0.6089387291084485,0.8857901726427623,1.0,1.0,15/15,70.27%,NUMA1;MED1;NCOA3;PRKCH;SFRP4;CYP27B1;VDR;KDF1;SULT2B1;TRIM16;SFN;BMP4;NME2;FOXC1;ETV4
prerank,carboxylic acid metabolic process (GO:0019752),-0.17286219332768807,-0.6088530825342352,0.9908256880733946,0.9806638394795548,1.0,7/33,22.45%,TBXAS1;LIAS;GLUD1;GNE;CYB5R3;AGXT;GSTO1
prerank,respiratory system development (GO:0060541),0.2728715271704935,0.6087330802498077,0.9219457013574661,1.0,1.0,3/32,11.48%,SMCHD1;SPEF2;FGF9
prerank,aminoglycan biosynthetic process (GO:0006023),0.2661246712659196,0.6086527861493004,0.9113513513513514,1.0,1.0,5/49,9.89%,HSPG2;HAS1;EXT1;SLC35D2;B3GNT2
prerank,hemidesmosome assembly (GO:0031581),0.3145196724722201,0.608611711410796,0.8952802359882006,1.0,1.0,2/11,8.60%,LAMC1;LAMB3
prerank,positive regulation of secretion by cell (GO:1903532),0.2597093666382046,0.6086096171794613,0.9398963730569948,1.0,1.0,17/70,22.85%,EZR;CLASP1;MYOM1;MYH10;GRK2;BAIAP3;PPIA;DTNBP1;ATP6AP1;TGFB2;RAB5A;SNCA;GOLPH3;RAB27A;TMED10;RAB27B;RAB9A
prerank,superoxide anion generation (GO:0042554),0.3099143579936189,0.6083966281179257,0.8955613577023499,1.0,1.0,3/13,19.36%,CYBB;CYBA;NCF4
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.28104339356561125,0.607800948470747,0.9074733096085409,1.0,1.0,7/25,17.17%,ZNF326;CCAR2;CCNT1;THOC5;CCNK;SCAF8;DDX39B
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2526519722087332,0.6075470325417726,0.9769307923771314,1.0,1.0,29/151,21.62%,RHD;SGMS2;ALAS2;HACD4;CHKB;PRKD3;CSNK1G2;ST3GAL2;NMRAL1;VAPA;SLC44A1;CERS4;SGMS1;ELOVL5;PCSK1;ASL;GPHN;ASS1;GSTM1;ELOVL4;CERS6;ACER3;CERS2;GOLPH3;PRKD2;SLC44A2;GCNT1;CHKA;MGST3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.2612012456824866,0.6075027017621604,0.9422875131164743,1.0,1.0,8/64,9.24%,SLK;PTPRA;PLEKHA2;CDK6;CDKN2A;CLASP1;CIB1;EPHA3
prerank,positive regulation of protein polymerization (GO:0032273),0.2585815244081389,0.607317613226734,0.937178166838311,1.0,1.0,14/65,22.05%,CDK5RAP2;PRKCE;CLASP1;SNX9;SLAIN2;CDC42EP3;NUMA1;RAC1;DRG1;CDC42EP1;RPS3;MET;MAPT;DCTN1
prerank,regulation of cell communication (GO:0010646),0.2731919699591077,0.6072927289400721,0.9204035874439462,1.0,1.0,9/35,22.27%,GRK6;SOCS2;CRK;GRK2;NCLN;GRK3;CDC42SE2;IGFBP7;YWHAG
prerank,glycosaminoglycan metabolic process (GO:0030203),0.261125371726705,0.6072487807377124,0.9287234042553192,1.0,1.0,5/54,7.95%,HSPG2;HAS1;HPSE2;EXT1;SLC35D2
prerank,macroautophagy (GO:0016236),0.25236519737599195,0.606928575885489,0.9726443768996961,1.0,1.0,30/118,21.47%,ATG13;STX17;HDAC10;ACBD5;LIX1;UBQLN1;ATG4B;VPS16;MTMR14;BECN1;AMBRA1;TOMM70;PRKAG2;VPS33B;RUBCNL;DYNLL1;ATG101;HGS;YOD1;CHMP3;PIP4K2A;CHMP2B;EPG5;VTA1;STAM;CLN3;PLEKHM1;PRKAG1;NBR1;VPS4A
prerank,monocarboxylic acid metabolic process (GO:0032787),0.25778437495702505,0.6066745501398754,0.9768611670020121,1.0,1.0,15/117,14.97%,PANK2;ACOT11;PDHA1;CPT1B;GBA2;SLC16A1;ACOT2;ME3;DLAT;ALKBH7;BSG;FASN;CPT1A;GLO1;MCCC1
prerank,inorganic cation transmembrane transport (GO:0098662),0.25230168483886356,0.6060603969759296,0.998998998998999,1.0,1.0,36/268,20.05%,RHAG;SLC6A12;SLC12A3;RHD;SLC6A2;SLC6A5;HCN3;KCNN4;SLC12A1;TRPM7;ITGAV;UCP2;KCNA1;KCNC2;KCNH7;KCNJ2;ATP6V0E1;KCNK12;SLC9A8;SLC24A4;SLC24A2;HVCN1;SLC9A9;KCNK2;ATP6V0D1;TRPM4;ANO6;SLC30A5;KCNQ5;ATP5F1B;KCNJ10;SLC9A7;SLC9A6;PKD2;KCNC1;SLC30A6
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.27799888508382237,0.6053297178738821,0.9067296340023613,1.0,1.0,6/28,17.44%,GBA2;ARHGAP35;DBNL;LATS1;BRK1;HCLS1
prerank,long-chain fatty acid transport (GO:0015909),0.27431906225190644,0.6052198932312599,0.9145106861642295,1.0,1.0,6/30,15.05%,ABCD1;CPT1B;SLC27A2;CPT1A;PRKAG2;CPT2
prerank,negative regulation of blood pressure (GO:0045776),-0.2312074262943919,-0.6048699438443266,0.917910447761194,0.9817316554673182,1.0,1/13,3.19%,BMPR2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.19083140116963548,-0.6046530836567984,0.9533678756476683,0.9807489702950024,1.0,7/23,24.22%,ZFYVE28;ZGPAT;MVP;SNX6;THY1;SH3BP5L;SOCS5
prerank,ribosomal large subunit assembly (GO:0000027),0.28223205438779914,0.6040064954280706,0.9140164899882215,1.0,1.0,10/24,26.05%,RPL23A;RPLP0;RPL3;RPL5;RSL24D1;RPL24;RPL10;MRPL20;DDX28;FASTKD2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.27419858094145333,0.6037327239722167,0.9034157832744405,1.0,1.0,8/29,23.15%,CLASP1;CYRIB;LIMA1;SMAD4;PIK3CA;SSH2;TWF1;PRKCD
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.32045498015150997,0.6036873173451199,0.908029197080292,1.0,1.0,4/10,25.69%,ABCD1;ELOVL5;NR1H3;NR1H2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.18964759092907843,-0.6033324049020683,0.9763313609467456,0.9803191441810569,1.0,23/23,81.07%,SMAD7;ID2;TGFBR3;DSG2;PKP2;MYL2;MYBPC3;ISL1;TNNI3;TNNC1;TNNT2;MYH6;MYL3;IRX3;MYH7;TBX5;TPM1;TGFB1;ADAMTS9;FKBP1A;FGFR2;HOPX;PROX1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.28016396621013173,0.602176207048068,0.910271546635183,1.0,1.0,2/26,5.15%,ZFPM1;CDK6
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3128459527663596,0.6006063351901816,0.9007194244604316,1.0,1.0,2/11,15.88%,RIN3;SLAMF8
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.20320929863950077,-0.60008081929469,0.9730941704035875,0.9810954241309258,1.0,9/17,35.92%,BAIAP2;FES;CDK5;CDC42;HRAS;HCK;TEK;STAP1;BAIAP2L2
prerank,endomembrane system organization (GO:0010256),0.24680234178496416,0.599780311681171,0.9849699398797596,1.0,1.0,34/178,18.50%,RNF26;ATP8B4;REEP4;SUN2;STX17;SNX33;ATL2;TMCC1;WASHC4;RAB22A;CLASP1;NPLOC4;CSNK1A1;ZW10;BLZF1;CAV2;DYM;TOR1A;VAPA;DNAJC13;SEC31A;RAB43;PI4K2B;RAB2A;VPS33B;FAM174B;USP50;SYNE1;LMAN1;GORASP1;CHMP2B;LRRK2;ARHGEF7;FBXW8
prerank,epithelial cell morphogenesis (GO:0003382),0.29341077764666107,0.5987556592613826,0.8953341740226987,1.0,1.0,1/17,6.10%,CCDC88C
prerank,proteoglycan metabolic process (GO:0006029),0.2761073167277481,0.5984044220813951,0.9126328217237308,1.0,1.0,5/26,17.96%,CSGALNACT2;SULF2;CHST12;CANT1;FAM20B
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.23802648923482517,-0.598309619341281,0.9283276450511946,0.9809458917402328,1.0,11/11,76.22%,CRY1;EP300;C1QTNF3;C1QTNF12;MST1;ERFE;ADIPOQ;SIK1;GCK;PGP;CLK2
prerank,long-chain fatty acid import into cell (GO:0044539),-0.24779606033225643,-0.5982125858642623,0.9386281588447654,0.9799201854895595,1.0,3/10,18.08%,SLC27A1;CD36;SLC27A4
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3167239617674443,0.5980712928097862,0.8936170212765957,1.0,1.0,4/10,27.36%,FTO;ALKBH5;ASCC3;MGMT
prerank,DNA dealkylation (GO:0035510),0.3167239617674443,0.5980712928097862,0.8936170212765957,1.0,1.0,4/10,27.36%,FTO;ALKBH5;ASCC3;MGMT
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.21691358236036334,-0.5980043291793974,0.9488188976377953,0.9789665206233876,1.0,5/15,26.36%,ERN1;TSEN15;RTRAF;FAM98B;DDX1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.23337173384083743,-0.5979139194605386,0.9516728624535316,0.977928663170252,1.0,5/12,24.88%,RER1;OS9;HSPA5;INSIG1;GPAA1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.3104338058591423,0.5972540861797258,0.9043600562587905,1.0,1.0,2/12,11.97%,ARHGAP35;PTEN
prerank,regulation of TORC1 signaling (GO:1903432),0.2680537048285349,0.5967361731306453,0.9333333333333333,1.0,1.0,5/33,12.60%,STK11;ATM;LARS1;SZT2;RNF152
prerank,regulation of trophoblast cell migration (GO:1901163),0.2989497092178872,0.5955270604106386,0.8976063829787234,1.0,1.0,1/14,4.79%,ARHGDIB
prerank,modulation of chemical synaptic transmission (GO:0050804),0.2502435484375717,0.5947873895968394,0.9635995955510617,1.0,1.0,22/107,21.64%,CHRNB4;NTF4;CEL;CACNG5;RELN;PTEN;CNTNAP4;BAIAP3;NMU;BCR;BTBD9;CACNA1B;MCTP1;LRRK2;CLN3;GRM3;HCRT;RIMS3;GRIK5;GRIK3;USP46;MCTP2
prerank,protein import into mitochondrial matrix (GO:0030150),0.2807754169090071,0.5946269358770898,0.896551724137931,1.0,1.0,4/18,14.03%,DNAJC15;TOMM70;TIMM23;GRPEL2
prerank,aminoglycan catabolic process (GO:0006026),0.2701256772277538,0.5944887358695695,0.9119047619047619,1.0,1.0,2/28,4.74%,HSPG2;HPSE2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2814902437140092,0.5938073898151469,0.9154411764705882,1.0,1.0,8/23,25.99%,UBA52;DDB2;COPS3;COPS2;COPS4;XPA;PARP1;RBX1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.24839732003461326,0.5935543053513337,0.96875,1.0,1.0,15/104,13.77%,VASN;CAV1;PMEPA1;NOTCH1;PIN1;ZBTB7A;PDPK1;HIPK2;TRIM33;SMAD4;SNX25;BCL9L;BMPR1A;SPRED2;SKI
prerank,regulation of steroid biosynthetic process (GO:0050810),0.30710941354099075,0.5935348393483195,0.8990450204638472,1.0,1.0,2/11,16.94%,EGR1;SIRT1
prerank,sphingosine metabolic process (GO:0006670),-0.20498641578998414,-0.5933905126774295,0.9705882352941176,0.9790795992454231,1.0,2/17,5.29%,SPTLC1;SGPP1
prerank,positive regulation of cellular respiration (GO:1901857),-0.23176985110821513,-0.5933576492291108,0.9595959595959596,0.9780190627492804,1.0,4/11,26.75%,PINK1;ISCU;IFNAR1;PRELID1
prerank,regulation of bone mineralization (GO:0030500),0.25542297204147735,0.5924783621084735,0.9388830347734457,1.0,1.0,12/55,23.07%,SGMS2;CCN1;TWIST1;BMPR1A;NELL1;ADGRV1;TRPM4;ANO6;ACVR2B;NBR1;DDR2;OSR1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.28787410749857845,0.5913356141997766,0.8875816993464052,1.0,1.0,6/16,20.99%,HDAC6;TBC1D25;GSPT1;CLN3;BNIP3;GLE1
prerank,multivesicular body organization (GO:0036257),0.263167121784581,0.5909778509853284,0.9327146171693735,1.0,1.0,14/31,28.71%,CHMP1B;HGS;CHMP3;CHMP2B;VTA1;STAM;RAB27A;VPS4A;CHMP5;TSG101;VPS37A;STAM2;VPS4B;VPS37B
prerank,neuron cell-cell adhesion (GO:0007158),0.29543542519759225,0.5908509051268975,0.8875661375661376,1.0,1.0,6/14,27.42%,CEL;NRXN2;NRXN1;CNTN4;NLGN2;NLGN1
prerank,regulation of anoikis (GO:2000209),0.2830996468886783,0.5906388288736462,0.9031446540880503,1.0,1.0,2/19,7.15%,CAV1;NOTCH1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.2730547700558384,0.5903853092768458,0.9163591635916359,1.0,1.0,7/22,24.76%,CIAO2A;ISCA2;CIAO3;MMS19;ABCB7;FXN;HSPA9
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2491334533714653,0.5898338645768503,0.9572471324296142,1.0,1.0,8/68,13.19%,ACOT11;PTHLH;TPST1;ACOT13;ACOT2;NT5C2;BPNT2;SULT6B1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.25216881211605713,0.5897493400720214,0.9572916666666667,1.0,1.0,14/66,20.57%,MEFV;FOXP1;JAK2;EGR1;MYD88;TLR6;TYROBP;F2R;USP50;NLRP2B;MALT1;LGALS9;CASP8;AIM2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2686622640981654,0.5897224878609225,0.9272727272727272,1.0,1.0,6/31,17.05%,TFRC;KMT5C;PAXIP1;DNAJB9;RIF1;XBP1
prerank,regulation of muscle cell differentiation (GO:0051147),0.26916152993620346,0.5893934576752151,0.9233449477351916,1.0,1.0,3/31,8.10%,CTNNA1;TCF3;MAPK14
prerank,relaxation of cardiac muscle (GO:0055119),0.3047896453237304,0.5887059248691052,0.9039780521262003,1.0,1.0,3/13,16.78%,GSN;KCNJ2;PIK3CA
prerank,protein homotetramerization (GO:0051289),0.2544024246911915,0.5886871303999632,0.9406688241639698,1.0,1.0,5/49,13.00%,TK1;CBR4;ACOT13;B2M;KCNJ2
prerank,organic hydroxy compound transport (GO:0015850),0.2645418272152129,0.5885788281822271,0.9322799097065463,1.0,1.0,4/36,11.68%,SLC16A1;ABCC2;STARD5;ABCC4
prerank,positive regulation of cell killing (GO:0031343),-0.2215006752530711,-0.5883483683622147,0.9624060150375939,0.9792848080447347,1.0,6/13,31.67%,NOX1;MAPK8;DVL2;NOXO1;FZD7;WNT5A
prerank,T cell differentiation (GO:0030217),0.25881159990208674,0.5877254944576734,0.927536231884058,1.0,1.0,3/40,6.62%,LIG4;PTPN22;ZFP36L1
prerank,regulation of lipid catabolic process (GO:0050994),0.2836814316931927,0.5872464044267682,0.9146800501882058,1.0,1.0,1/19,4.94%,ABCD1
prerank,keratinocyte differentiation (GO:0030216),-0.17072628044775384,-0.586704181737326,0.9863945578231292,0.9790029283038302,1.0,4/29,16.46%,ST14;CASP3;ADAM9;JAG1
prerank,protein polyglutamylation (GO:0018095),0.3038101515317536,0.5866790460774293,0.9084507042253521,1.0,1.0,5/11,24.14%,TTLL1;TTLL9;TTLL5;TTLL11;TTLL4
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.29162815196710323,0.5866735919156784,0.9036458333333334,1.0,1.0,4/17,16.94%,UBQLN1;NFE2L2;PPIA;SIRT1
prerank,regulation of exocytosis (GO:0017157),0.25425011296576217,0.5860615082374674,0.9399563318777293,1.0,1.0,14/46,22.98%,STXBP6;CLASP1;RAB8A;LGI3;RAB8B;HAP1;ATP6AP1;RAB5A;CHMP3;SNCA;RAB27A;RAB27B;RAB9A;RAB10
prerank,aorta development (GO:0035904),0.29249555219529594,0.5851057306549913,0.9106217616580311,1.0,1.0,5/14,24.19%,PDE2A;EFEMP2;PKD2;HECTD1;ADAMTS9
prerank,potassium ion transmembrane transport (GO:0071805),0.2433924274068489,0.584588699415418,0.9828629032258065,1.0,1.0,23/135,19.98%,SLC12A3;HCN3;KCNN4;SLC12A7;SLC12A1;KCNA1;KCNJ3;KCNC2;KCNH7;SLC12A6;KCNJ2;KCNK12;SLC9A8;SLC24A4;SLC24A2;SLC9A9;KCNK2;KCNQ5;KCNJ10;SLC9A7;SLC9A6;PKD2;KCNC1
prerank,cellular glucan metabolic process (GO:0006073),0.3075525811229107,0.5843188100831871,0.9076923076923077,1.0,1.0,4/11,22.44%,PRKAG2;GSK3B;GBE1;PHKB
prerank,lipoxygenase pathway (GO:0019372),0.2964564173393024,0.5839903454128076,0.8902275769745649,1.0,1.0,3/14,20.51%,HPGD;PON3;PON2
prerank,negative regulation of locomotion (GO:0040013),0.2968558293558381,0.5836910974882423,0.9155124653739612,1.0,1.0,2/12,11.74%,PIN1;CRK
prerank,cellular response to BMP stimulus (GO:0071773),0.24949329150619995,0.5836295740986756,0.9543568464730291,1.0,1.0,10/66,20.76%,ADAMTS7;SMAD4;BMPR1A;SLC33A1;USP15;HIVEP1;TGFB2;SOX9;ACVR2B;SMAD2
prerank,fatty acid beta-oxidation (GO:0006635),0.2544485509790064,0.5833608434252833,0.940677966101695,1.0,1.0,17/51,24.50%,ACADM;ABCD1;AUH;SLC27A2;PEX2;IVD;CPT2;HADHA;HADHB;ABCD4;DECR1;PPARD;ACOT8;DECR2;ETFDH;ETFB;ETFA
prerank,peroxisome organization (GO:0007031),0.269955888153227,0.5829338024555899,0.9216646266829865,1.0,1.0,8/25,23.59%,ABCD1;PEX11B;PEX2;FIS1;PEX14;ABCD4;ACOT8;PEX3
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.27777544772815477,0.5828534964026199,0.914249684741488,1.0,1.0,1/18,3.58%,PET100
prerank,positive regulation of fat cell differentiation (GO:0045600),0.2523803771675872,0.5826976791103221,0.9396551724137931,1.0,1.0,11/47,18.48%,ZFP36L1;ZBTB16;PIM1;NAPEPLD;WDFY2;ZBTB7B;HNRNPU;XBP1;TRPM4;CREB1;AAMDC
prerank,hexose metabolic process (GO:0019318),0.2611595392310309,0.5825112987295478,0.9393258426966292,1.0,1.0,8/39,22.16%,BRAT1;DCXR;SLC35A2;GALM;PMM2;FUCA1;PPARD;GDPGP1
prerank,response to fatty acid (GO:0070542),0.27942296303448755,0.5821319732598657,0.9093198992443325,1.0,1.0,6/17,28.72%,FOXO1;IRS1;SOX9;FOXO3;PID1;PPP5C
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.2643749457825341,0.5819264980330715,0.9292343387470998,1.0,1.0,6/33,17.20%,SMARCA4;EGR1;JUN;TP53;TGFB2;APLN
prerank,positive regulation of wound healing (GO:0090303),0.2574031511071676,0.5816172627622178,0.9304152637485971,1.0,1.0,8/36,23.95%,PRKCE;INSL3;SMOC2;F2R;XBP1;ACTG1;APOH;ENPP4
prerank,regulation of protein ubiquitination (GO:0031396),0.2442311440265623,0.5815914795685404,0.9768844221105528,1.0,1.0,24/108,20.53%,BRCA1;AXIN1;NXN;CAV1;BIRC2;UBQLN1;CUL3;PRR7;PARK7;XIAP;PAXIP1;ARRB2;CDK5RAP3;SIRT7;UBXN1;CAMLG;LRRK2;PRMT3;MALT1;GNL3L;RPS3;TRAF6;HDAC8;UBE2N
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.28383039705302904,0.5814887079828428,0.9128137384412153,1.0,1.0,4/15,18.99%,ENTPD3;ENTPD5;AK5;CMPK2
prerank,amyloid-beta metabolic process (GO:0050435),0.28170097842626585,0.5808081784127879,0.9072164948453608,1.0,1.0,4/16,19.90%,ABCA7;DYRK1A;PSEN1;MME
prerank,renal water homeostasis (GO:0003091),0.27222748619536535,0.5806704318054529,0.9111389236545682,1.0,1.0,2/23,8.22%,AQP1;PRKACA
prerank,regulation of cell-substrate adhesion (GO:0010810),0.25527947212538726,0.5803964403346391,0.9372972972972973,1.0,1.0,8/42,18.22%,ECM2;NOTCH1;JAK2;RAC2;RSU1;LIMS1;RAC1;TBCD
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.24885282243331616,0.5802826450155333,0.9475935828877006,1.0,1.0,13/54,23.00%,FLNA;KCNN4;CAV1;NEDD4L;KCNJ3;KCNJ2;STK39;YWHAE;KCNJ10;GNB1;KCNN3;KCNIP1;NEDD4
prerank,regulation of response to interferon-gamma (GO:0060330),0.288894616003538,0.5788811603730947,0.9319444444444445,1.0,1.0,7/14,28.49%,JAK2;SUMO1;PIAS1;IFNGR1;JAK1;PARP9;HSP90AB1
prerank,macrophage migration (GO:1905517),0.2940379998052606,0.5788770540019313,0.9079837618403248,1.0,1.0,1/13,5.31%,CCR2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.26837919145619415,0.5779091290120226,0.9167643610785463,1.0,1.0,3/25,10.32%,ITPR1;PLCG2;RIT2
prerank,platelet aggregation (GO:0070527),0.2633218720022749,0.5774511878076378,0.9435665914221218,1.0,1.0,11/33,23.65%,FLNA;CSRP1;CLIC1;PPIA;FIBP;FN1;ILK;ACTG1;ACTN1;VCL;MYH9
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.29122012412989795,0.5773537511477422,0.9236842105263158,1.0,1.0,7/16,26.85%,PRKCA;MTPN;ROCK2;ROCK1;IL6ST;PARP1;AKAP6
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.24955882928707845,0.5769847881996737,0.9392624728850325,1.0,1.0,10/44,23.60%,FLNA;KCNN4;KCNJ3;ACTN2;KCNJ2;ANO6;KCNJ10;GNB1;KCNN3;WNK3
prerank,melanosome transport (GO:0032402),0.2774972314702551,0.576614823331126,0.938382541720154,1.0,1.0,7/18,24.62%,RAB11B;BBS4;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,pigment granule transport (GO:0051904),0.2774972314702551,0.576614823331126,0.938382541720154,1.0,1.0,7/18,24.62%,RAB11B;BBS4;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,negative regulation of ion transport (GO:0043271),0.2686895338610378,0.5764979752823877,0.9297619047619048,1.0,1.0,24/24,73.17%,ACTN2;SNCA;NEDD4;PXK;WNK3;CD33;WNK1;INPP5K;LILRB1;CAV3;GPM6B;WNK4;CASQ2;HRH3;VIP;STC1;PLN;HTR1B;NOS1;ADRA2A;PACSIN3;SYT11;PTK2B;WNK2
prerank,negative regulation of response to external stimulus (GO:0032102),0.2396740547772132,0.576249300714692,0.9725888324873097,1.0,1.0,5/105,5.37%,RNF26;MEFV;RB1;DHX58;NR1D1
prerank,androgen receptor signaling pathway (GO:0030521),0.29850403739646136,0.5760900462670362,0.9219653179190751,1.0,1.0,3/11,23.38%,PMEPA1;TMF1;PLPP1
prerank,negative chemotaxis (GO:0050919),0.2599506545663437,0.5760430222970215,0.943089430894309,1.0,1.0,4/33,11.67%,NTN1;ITGAV;SLIT3;SLIT1
prerank,carbohydrate homeostasis (GO:0033500),0.24186700389289834,0.5752314848902325,0.9583333333333334,1.0,1.0,10/67,19.03%,SLC2A4;USF1;STK11;PARK7;ADIPOR1;MCU;IRS1;TCF7L2;ADCY8;RPS6
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.25204810978035813,0.5741136090737674,0.9384615384615385,1.0,1.0,9/43,20.75%,SMARCA4;EGR1;JUN;TP53;TGFB2;NFATC3;APLN;SOX9;PPARD
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.22554236525556026,-0.5739834036034491,0.9621212121212122,0.9833742297098886,1.0,1/12,6.32%,ZC3H12A
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.28017136802546533,0.5738181352057525,0.9336801040312094,1.0,1.0,2/17,7.33%,CCR2;HMGB1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.2643991254215879,0.5735589381901658,0.9253208868144691,1.0,1.0,8/29,22.59%,SORBS1;CNEP1R1;ELOVL5;CREB1;ZBTB20;SIRT4;NR1H3;LDLR
prerank,positive regulation of phospholipase activity (GO:0010518),0.2687147526276512,0.5734065995028576,0.9355638166047088,1.0,1.0,6/22,22.74%,ARF4;PDPK1;FGFR1;PLCG1;NTRK3;FGFR2
prerank,regulation of exosomal secretion (GO:1903541),-0.18846090980253224,-0.5733884519557332,0.963963963963964,0.9825263080421871,1.0,3/19,12.28%,ATP9A;PDCD6IP;PRKN
prerank,anterograde trans-synaptic signaling (GO:0098916),0.23794058072258564,0.5713235329512723,0.992992992992993,1.0,1.0,21/224,13.28%,CHRNB4;MAPK1;CEL;PDE7B;SLC6A2;SLC6A5;HTR2A;EXOC4;SLC12A7;GABRA4;PRKACA;KCNA1;BSN;PMP22;GABRA5;RIT2;PAFAH1B1;GRIA3;HAP1;SLC12A6;CHRM3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.26530977434684416,0.5709066302051821,0.9242788461538461,1.0,1.0,7/23,22.86%,KCTD21;HHIP;RACK1;RFX4;SUFU;MEGF8;BTRC
prerank,positive regulation of ossification (GO:0045778),0.2507365578483311,0.570142857528738,0.9370860927152318,1.0,1.0,10/39,23.07%,CCN1;ZBTB16;BMPR1A;NELL1;ADGRV1;TGFB2;ANO6;ACVR2B;PTPN11;OSR1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.24070871302387936,0.569910939178589,0.9682702149437052,1.0,1.0,20/86,23.20%,PECAM1;FYN;CD74;CD44;BANK1;PLCG2;JAK2;EGFR;RELN;NRP1;TP53;PAK2;HCLS1;EPHA7;CNOT7;CADM4;EFNA1;PTPN11;PRKCD;SRC
prerank,bile acid and bile salt transport (GO:0015721),0.26461967326427555,0.5698286875896066,0.9329411764705883,1.0,1.0,3/24,11.68%,ABCC2;STARD5;ABCC4
prerank,epithelial cell development (GO:0002064),0.26633126053322254,0.5695011935067287,0.9300873907615481,1.0,1.0,19/20,62.82%,LRTOMT;SLC4A7;CLDN3;RAB25;EXPH5;ROS1;POF1B;RILPL2;PDZD7;TMEM79;GRHL2;ACTA2;PKHD1;DACT2;RILPL1;BFSP1;WNT7A;WNT7B;SIPA1L3
prerank,regulation of macroautophagy (GO:0016241),0.23691044174755832,0.569457434414846,0.9697275479313825,1.0,1.0,36/105,26.73%,ATG13;EXOC4;IKBKG;HDAC6;DCN;PRKACA;UBQLN1;CAPN1;MLST8;ATP6V0E1;PRKAG2;LAMTOR4;LAMTOR3;TBC1D25;ATG101;PIK3CA;SIRT1;ATP6V0D1;MAP3K7;LRRK2;CLN3;RRAGB;PRKAG1;BNIP3;GAPDH;UBQLN2;NEDD4;SMG1;PRKAB2;USP36;QSOX1;SESN1;UCHL1;SMCR8;ATP6V1G1;BNIP3L
prerank,response to endoplasmic reticulum stress (GO:0034976),0.23948987478273254,0.569416061254276,0.9887983706720977,1.0,1.0,20/107,17.78%,ITPR1;EIF2S1;RCN3;MBTPS2;MAP3K5;DDRGK1;NIBAN1;UBQLN1;PPP1R15A;ATF6;JUN;CDK5RAP3;FLOT1;DDIT3;TMX1;GSK3B;TP53;DNAJB9;HSP90B1;SYVN1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.2828126238485022,0.5688097588026859,0.9296875,1.0,1.0,4/14,18.13%,PARK7;XBP1;SYVN1;LRRK2
prerank,response to growth factor (GO:0070848),0.2508478314742709,0.5673060740751491,0.9357997823721437,1.0,1.0,7/41,13.88%,HDAC6;CIB1;EMD;BMPR1A;STAT5B;RACK1;MYC
prerank,GTP metabolic process (GO:0046039),-0.2122320182264502,-0.5670432417509214,0.9700854700854701,0.9838919194930151,1.0,5/15,19.72%,ENTPD7;GNAI3;RHOQ;RAN;GTPBP1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.25781078451644307,0.5667614313040485,0.9279907084785134,1.0,1.0,8/27,24.42%,PML;PPP1CB;PPP1CC;TP53;PPP1CA;RBM4B;BHLHE40;FBXL12
prerank,folic acid metabolic process (GO:0046655),0.2725870531979384,0.5663898201489743,0.9360100376411543,1.0,1.0,4/18,19.10%,MTHFD2L;SLC19A1;ALDH1L1;MTHFD1L
prerank,cellular response to purine-containing compound (GO:0071415),0.30177993676344184,0.5660236532998875,0.9217391304347826,1.0,1.0,1/10,9.48%,P2RY1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.2955501077947692,0.5655775457076659,0.9225543478260869,1.0,1.0,1/10,8.54%,JAK2
prerank,ephrin receptor signaling pathway (GO:0048013),0.2373663159638996,0.5652644122820664,0.9672131147540983,1.0,1.0,22/82,23.20%,FYN;TIAM1;EPHA3;ANKS1A;CRK;ARHGEF28;AP2B1;ROCK2;PSEN1;ANKS1B;RAC1;SDC2;ARHGEF7;EPHA7;SIPA1L1;ROCK1;VAV3;EPHA10;ACTG1;EFNA1;PTPN11;SRC
prerank,cellular calcium ion homeostasis (GO:0006874),0.23318016369893518,0.5650071673135755,0.9868951612903226,1.0,1.0,19/133,17.66%,HTR2A;CSRP3;PML;CAV1;CCR2;PRKACA;SLC10A7;CAV2;SLC35G1;PDZD8;MICU3;MICU1;MCU;PSEN1;TPT1;SLC24A4;SLC24A2;ADCY8;YWHAE
prerank,photoperiodism (GO:0009648),0.25521746656153,0.5647160200591868,0.9330254041570438,1.0,1.0,8/28,24.42%,PML;PPP1CB;PPP1CC;TP53;PPP1CA;RBM4B;BHLHE40;FBXL12
prerank,neural crest cell differentiation (GO:0014033),0.27109005121604357,0.5633610719308231,0.9102402022756005,1.0,1.0,3/18,11.80%,PEF1;TCOF1;TAPT1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.29304368326255004,0.5631639519467081,0.9386331938633193,1.0,1.0,2/11,12.08%,TIMM9;TOMM70
prerank,myoblast fusion (GO:0007520),0.2911418272233256,0.5631207515821746,0.9243466299862448,1.0,1.0,2/12,16.93%,JAM2;ADAMTS5
prerank,phosphate-containing compound metabolic process (GO:0006796),0.23430752431151902,0.5629394211060603,0.996996996996997,1.0,1.0,37/198,20.52%,PLPPR3;ALPL;PPP3CA;PANK2;AGPAT1;IMPA1;INPP5A;EPHX2;PPA2;PLCG2;NUDT4;PLBD1;PLCB1;PTEN;INPP4A;PLCB3;GFPT2;PLCD1;GPD2;PLPPR4;LIMD1;LIMK2;PAK2;PLCG1;PIK3CA;DUSP12;PIP4K2A;PGK1;PPP1CA;TAOK1;LRRK2;ACYP1;OCRL;NADK;ALK;EPHA7;DUSP16
prerank,negative regulation of biosynthetic process (GO:0009890),0.2791035297543214,0.5627290727160726,0.9258278145695364,1.0,1.0,2/16,10.75%,ABCD1;PARK7
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.25154117717013047,0.5626732274806865,0.9598163030998852,1.0,1.0,8/34,21.57%,GABRA4;MPP2;GABRA5;ARRB2;GSK3B;LRRK2;GLRA1;GRIN2D
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.26911692175330987,0.5626239182366584,0.9259259259259259,1.0,1.0,4/20,16.87%,IMPDH2;NT5C2;ADSL;AK3
prerank,regulation of MAP kinase activity (GO:0043405),0.23501829874658942,0.5622155198435425,0.9755600814663951,1.0,1.0,11/92,16.33%,EZH2;RASGRP1;STK38;EGFR;FLT3;CDK5RAP3;PDCD10;EGF;HGS;FGFR1;CD24
prerank,positive regulation of neuron projection development (GO:0010976),0.2368620136002661,0.5621989447626017,0.9802083333333333,1.0,1.0,10/85,11.03%,S100A9;SNX3;KIDINS220;SETX;ARHGAP35;DBNL;MARK2;EPHA3;RIT2;RELN
prerank,T cell mediated immunity (GO:0002456),0.281369243375113,0.5615459200931544,0.9213630406290957,1.0,1.0,4/13,25.95%,BTN3A3;CD55;MYO1G;CTSH
prerank,axonogenesis (GO:0007409),0.23202542004348742,0.5604596107335228,0.997,1.0,1.0,56/237,23.30%,SPTA1;MAPK1;FYN;EZR;PTPRA;RPS6KA5;GFRA2;LAMA5;NOTCH1;ARHGAP35;RAB8A;PRKCA;GRB2;SOS1;NTNG2;PDLIM7;EPHA3;DOK2;RELN;BSG;SLIT3;SLIT1;PTEN;LMTK2;NRP1;NRCAM;PALLD;GFRA1;DAG1;PLPPR4;SPTAN1;PLCG1;PIK3CA;EMB;CXCR4;NRXN1;SEMA4A;SLC9A6;PAX2;TUBB3;SLITRK2;EPHA7;EPHA10;NEFH;BRSK1;SEMA6A;EFNA1;CNTN4;NIBAN2;FGFR2;PTPN11;S100A6;RAB10;SRC;DSCAM;SPTB
prerank,neuromuscular junction development (GO:0007528),0.26219411280837324,0.5602283413072153,0.9359430604982206,1.0,1.0,8/24,24.31%,LRP4;F2R;GPHN;PPFIBP1;LRRK2;DCTN1;NEDD4;DNAJA3
prerank,positive regulation of axonogenesis (GO:0050772),0.2483818660104988,0.5601139512616631,0.9515418502202643,1.0,1.0,4/43,8.45%,TIAM1;NTN1;DBNL;PLXNA2
prerank,purine ribonucleotide transport (GO:0015868),0.2801198539224435,0.5600294023718686,0.9474358974358974,1.0,1.0,3/16,11.68%,LRRC8C;SLC19A1;ABCC4
prerank,lipid transport (GO:0006869),0.23447985737297153,0.5597164047735483,0.9726996966632963,1.0,1.0,12/97,12.39%,ABCA13;ABCD1;OSBPL5;ABCC2;ABCA2;NME4;PRELID3B;ABCA7;STARD5;ATP8A1;ABCC4;SLCO2A1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.27262416008599205,0.5592487479536394,0.9431818181818182,1.0,1.0,5/18,21.98%,DERL2;AMFR;UBA52;SYVN1;RNF103
prerank,limb development (GO:0060173),0.2551168149197336,0.5586109500169593,0.9477351916376306,1.0,1.0,7/28,23.10%,LRP4;KAT2B;MAP3K20;RSPO2;KREMEN1;MEGF8;INTU
prerank,ceramide biosynthetic process (GO:0046513),0.24398255412393294,0.5583867571815144,0.9435840707964602,1.0,1.0,8/40,20.15%,SGMS2;ST8SIA4;CERS4;SGMS1;ST3GAL5;CERS6;CERS2;ST8SIA6
prerank,positive regulation of actin filament polymerization (GO:0030838),0.24785208497065972,0.5582492443613577,0.9627601314348302,1.0,1.0,5/44,11.94%,PRKCE;GSN;SNX9;WHAMM;CDC42EP3
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.26073673301578804,0.5580355767392252,0.947239263803681,1.0,1.0,2/23,10.99%,MBOAT2;PLBD1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.2852696743517401,0.5576395447254144,0.9211267605633803,1.0,1.0,3/11,21.46%,ARRB2;GRK2;GRK3
prerank,folic acid-containing compound metabolic process (GO:0006760),0.26638448944761906,0.5571094535971401,0.9321608040201005,1.0,1.0,4/19,19.10%,MTHFD2L;SLC19A1;ALDH1L1;MTHFD1L
prerank,organic cation transport (GO:0015695),0.2682575855829325,0.5568131873482552,0.9367888748419722,1.0,1.0,4/20,20.66%,SLC44A1;SLC22A4;SEC14L1;SLC44A2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.2523819459544905,0.5565765623933968,0.9518900343642611,1.0,1.0,8/31,22.80%,NOTCH1;SMAD4;BMPR1A;TGFB2;PROX1;RBPJ;FGFR2;FKBP1A
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.28648575234993245,0.5561158772827313,0.9327731092436975,1.0,1.0,2/11,15.36%,NT5C3A;TPK1
prerank,regulation of response to oxidative stress (GO:1902882),0.28994827878432605,0.5560448932382747,0.9309859154929577,1.0,1.0,1/11,4.94%,ABCD1
prerank,regulation of pseudopodium assembly (GO:0031272),0.2892472876603092,0.5556574841792143,0.9236311239193083,1.0,1.0,3/10,23.90%,CDC42EP3;CDC42EP1;CDC42EP4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.2892472876603092,0.5556574841792143,0.9236311239193083,1.0,1.0,3/10,23.90%,CDC42EP3;CDC42EP1;CDC42EP4
prerank,regulation of leukocyte activation (GO:0002694),0.27735807007993957,0.5549890957520026,0.9246753246753247,1.0,1.0,1/14,3.68%,CD74
prerank,negative regulation of innate immune response (GO:0045824),0.24905653987551096,0.5546614840778352,0.9445073612684032,1.0,1.0,6/34,17.54%,DHX58;RPS19;USP15;SLAMF8;NLRC3;TRAFD1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.24892132247955084,0.554583807295567,0.9537767756482526,1.0,1.0,4/34,8.10%,PGF;NUS1;NOTCH1;MAPK14
prerank,regulation of dendrite morphogenesis (GO:0048814),0.24679395799168813,0.5540364061958625,0.946590909090909,1.0,1.0,10/32,23.00%,YWHAH;NEDD4L;CUX1;GSK3B;GORASP1;SDC2;FBXW8;CAPRIN2;HECW2;NEDD4
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2536905705798051,0.5537744143876653,0.9457627118644067,1.0,1.0,2/33,5.04%,IAPP;TFRC
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.229407458453482,-0.5537687707529513,0.9455128205128205,0.9875065770718794,1.0,5/10,35.13%,GNB5;CALM1;CBARP;DRD2;CRHR1
prerank,regulation of glycogen metabolic process (GO:0070873),0.27934714375392344,0.5536068790511446,0.9246298788694481,1.0,1.0,12/12,72.09%,RUBCNL;INPP5K;PPP1R3B;PPP1R3G;GCGR;AKT1;PPP1R3A;PPP1R3E;PPP1R3C;PPP1R3D;KHK;PPP1R3F
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.22809963296067698,0.5522368598797337,0.9919678714859438,1.0,1.0,17/159,17.07%,CD177;SDK1;CLDN18;PECAM1;MILR1;HMCN1;CDH18;CDH24;IGSF21;BSG;PALLD;ADGRL3;NECTIN1;KIRREL3;CDH4;TGFB2;EMB
prerank,cristae formation (GO:0042407),0.2525503638006817,0.5518225859950322,0.9529411764705882,1.0,1.0,6/27,20.51%,ATP5F1E;APOOL;ATP5F1D;ATP5MC2;ATP5F1B;ATP5MF
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.23215748971551248,0.5516109408449728,0.9723643807574207,1.0,1.0,21/85,23.21%,PLK1;TAF1;CSNK1A1;DDRGK1;PSMC3;SUMO1;RAD23A;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;RNF19A;LRRK2;KEAP1;MDM2;CBFA2T3;HECTD1;DDA1;BBS7
prerank,positive regulation of exosomal secretion (GO:1903543),0.2733921692455865,0.551508087478281,0.9354838709677419,1.0,1.0,6/15,29.31%,HGS;STAM;VPS4A;TSG101;VPS4B;SMPD3
prerank,cellular response to nutrient levels (GO:0031669),0.23640601581821313,0.5511620720568267,0.9778481012658228,1.0,1.0,12/62,20.91%,STK26;FOXO1;KLF10;STK24;RIPOR1;SIRT1;XBP1;LRRK2;SREBF2;RRAGB;WDR45B;WRN
prerank,neuron projection regeneration (GO:0031102),-0.22313689254617158,-0.55090332146559,0.9607250755287009,0.9874078741333733,1.0,4/10,26.58%,GAP43;MAPK8IP3;OMG;DHFR
prerank,neuron projection organization (GO:0106027),0.2732683295008693,0.5508417251348661,0.9295039164490861,1.0,1.0,4/15,14.59%,ABCD1;PICK1;PSEN1;GSK3B
prerank,triglyceride metabolic process (GO:0006641),0.23936036435201302,0.5505138512369854,0.9425162689804772,1.0,1.0,3/48,7.36%,CAV1;GPAT3;MOGAT2
prerank,vasculature development (GO:0001944),0.2650119774951113,0.5504339308287594,0.9384615384615385,1.0,1.0,3/16,20.41%,STK11;PIK3CA;ACVR2B
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.2700741861877987,0.5503096058389197,0.9366106080206986,1.0,1.0,3/16,12.63%,NOTCH1;PIM1;BMPR1A
prerank,cell junction assembly (GO:0034329),0.23049166721486386,0.5494132881470378,0.9797160243407708,1.0,1.0,28/100,25.62%,SDK1;FLNA;DBNL;CDH18;CDH24;DNER;PTEN;NRCAM;ADGRL3;KIRREL3;GJA4;LIMS1;NRXN2;CTNND2;FN1;NRXN1;CDH19;CDH20;CDH7;ILK;ACTG1;ARVCF;DSCAM;VMP1;PKP4;DCHS1;BDNF;ITGA6
prerank,collagen fibril organization (GO:0030199),0.23089723357633252,0.5489180507897515,0.9887755102040816,1.0,1.0,12/88,17.16%,CYP1B1;PLOD3;CRTAP;COL1A2;COL4A4;LAMB3;ATP7A;TLL2;COL23A1;P3H4;TGFB2;COL4A1
prerank,aerobic electron transport chain (GO:0019646),0.23521343082670837,0.5488366199612792,0.9751295336787564,1.0,1.0,12/68,19.07%,SDHD;NDUFS8;NDUFB7;NDUFAF1;COX10;COX4I1;NDUFA1;NDUFA4;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.26194656295878294,0.5484882022201292,0.9486552567237164,1.0,1.0,6/22,21.75%,PTPN22;NR1D1;FLOT1;APPL1;IFI35;NR1H3
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2552384725507118,0.5479484529381137,0.9451219512195121,1.0,1.0,3/22,17.11%,CCR2;BTK;TRPM4
prerank,positive regulation of translational initiation (GO:0045948),0.26684841147160054,0.5471706611596012,0.9399249061326659,1.0,1.0,10/18,30.51%,BOLL;EIF2B5;CDC123;YTHDF1;YTHDF3;RPS6KB1;KHDRBS1;HABP4;POLR2G;MTOR
prerank,positive regulation of protein processing (GO:0010954),0.26412458343506245,0.5468438494297173,0.9427480916030534,1.0,1.0,5/19,25.60%,GSN;CCBE1;LPCAT3;MYH9;NLRC4
prerank,multivesicular body assembly (GO:0036258),0.2441274076190066,0.5467708470208723,0.9582850521436849,1.0,1.0,13/30,28.71%,CHMP1B;HGS;CHMP3;CHMP2B;VTA1;STAM;VPS4A;CHMP5;TSG101;VPS37A;STAM2;VPS4B;VPS37B
prerank,regulation of axonogenesis (GO:0050770),0.23885707198310369,0.5447205832816735,0.9743863393810032,1.0,1.0,9/51,16.37%,TIAM1;LRP4;ARHGAP35;PLXNA2;MARK2;PTEN;GSK3B;PAK2;ARHGDIA
prerank,negative regulation of cation channel activity (GO:2001258),-0.16704961971877386,-0.5446511581315109,0.9877300613496932,0.9883270738224363,1.0,11/26,35.42%,KCNAB1;SRI;GNB5;CALM1;CBARP;GSTO1;FKBP1B;CALM2;DRD2;CRHR1;EPHB2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.26552528507541784,0.5446183368773962,0.9462227912932138,1.0,1.0,3/17,13.44%,COX10;COX4I1;NDUFA4
prerank,response to muramyl dipeptide (GO:0032495),0.2828687411946905,0.5442765631426434,0.9482517482517483,1.0,1.0,1/12,4.25%,PTPN22
prerank,protein heterotetramerization (GO:0051290),0.27698014898988393,0.5432283086680396,0.9400798934753661,1.0,1.0,3/13,20.18%,CBR4;PKD2;CPSF7
prerank,regulation of translational initiation (GO:0006446),0.23525884169658756,0.542922840956817,0.9666666666666667,1.0,1.0,14/63,22.05%,EIF4B;EIF3E;BOLL;CSDE1;EIF4EBP3;NCBP1;PAIP1;NCBP2;AGO2;TPR;EIF2B5;GLE1;DNAJC3;PPP1R15B
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.28062783364550287,0.5429079849072577,0.9437412095639943,1.0,1.0,2/12,15.12%,IMPDH2;ADSL
prerank,leukotriene biosynthetic process (GO:0019370),-0.20406650308600593,-0.5424049339302918,0.9807692307692307,0.987976826731507,1.0,5/14,30.94%,ALOX5;GGT5;ALOX5AP;PLA2G4A;LTC4S
prerank,tRNA methylation (GO:0030488),0.2432245382431509,0.5422598943705232,0.9552238805970149,1.0,1.0,9/34,23.20%,TRMO;TRDMT1;TRMT5;TYW3;PRORP;THUMPD3;TRMT112;TRMT10C;DALRD3
prerank,skin development (GO:0043588),0.2314878610421152,0.5415985082347547,0.9779411764705882,1.0,1.0,3/65,10.65%,STMN1;COL1A2;ATP7A
prerank,negative regulation of viral genome replication (GO:0045071),0.24084235053827047,0.54085464719829,0.9646799116997793,1.0,1.0,11/40,24.68%,SLPI;FAM111A;IFITM3;TASOR;SRPK1;SETDB1;PROX1;ZC3HAV1;HMGA2;RESF1;EIF2AK2
prerank,central nervous system myelination (GO:0022010),0.2783763202580814,0.5387368669944482,0.9300411522633745,1.0,1.0,2/11,11.97%,ABCA2;PTEN
prerank,negative regulation of actin filament polymerization (GO:0030837),0.2489226366510069,0.5362318966557593,0.9510664993726474,1.0,1.0,2/22,8.62%,GSN;CYRIB
prerank,striated muscle cell differentiation (GO:0051146),0.2662623571094598,0.5357994168965835,0.958656330749354,1.0,1.0,2/16,13.77%,MYEF2;SKI
prerank,nucleotide catabolic process (GO:0009166),0.26791008646880765,0.5357964708165455,0.9571428571428572,1.0,1.0,2/16,9.67%,GDA;NT5C2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.22673674104119804,0.5355220712386539,0.9815005138746146,1.0,1.0,16/75,22.88%,HSPG2;PML;CCR2;DCN;MECP2;ROCK2;ADAMTS1;HGS;TGFB2;PGK1;ROCK1;SEMA6A;AGO1;ATP2B4;NIBAN2;APOH
prerank,peptidyl-lysine monomethylation (GO:0018026),0.2760409129708917,0.5354660885880085,0.9514978601997147,1.0,1.0,4/10,26.06%,EHMT1;SETD7;EEF1AKMT2;SETD2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.26459636642600265,0.5350337448578811,0.9533954727030626,1.0,1.0,3/16,16.42%,RUNX1;F2R;VIM
prerank,Golgi localization (GO:0051645),0.2786276807776601,0.5342106735326517,0.9498607242339833,1.0,1.0,6/11,28.36%,PDCD10;RIPOR1;STK25;TBCCD1;YWHAZ;COPG1
prerank,regulation of vasoconstriction (GO:0019229),0.2438866607998367,0.5336247582876507,0.9661610268378062,1.0,1.0,4/27,17.11%,CAV1;CHRM3;F2R;TRPM4
prerank,quinone biosynthetic process (GO:1901663),0.2689036518336278,0.5311601093848386,0.9436435124508519,1.0,1.0,4/14,18.63%,COQ10B;PDSS2;COQ5;FDXR
prerank,adenine nucleotide transport (GO:0051503),0.2638089733543141,0.5305388741671889,0.9605095541401274,1.0,1.0,3/17,11.68%,LRRC8C;SLC19A1;ABCC4
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.25670619474399864,0.5302420401792499,0.9483627204030227,1.0,1.0,5/19,21.56%,DBNL;CUX1;RELN;FBXW8;CAPRIN2
prerank,ubiquinone biosynthetic process (GO:0006744),0.26544480378408514,0.5300705008175555,0.9561855670103093,1.0,1.0,4/15,18.63%,COQ10B;PDSS2;COQ5;FDXR
prerank,icosanoid secretion (GO:0032309),0.27382297551789064,0.5288432345446991,0.9388335704125178,1.0,1.0,12/12,72.64%,ABCC4;PLA2G1B;DRD4;NOS2;ACE;DRD3;PLA2G5;BDKRB2;NMUR2;PNPLA8;DRD2;ANXA1
prerank,acylglycerol biosynthetic process (GO:0046463),0.24697892357181497,0.5283768402896245,0.9589371980676329,1.0,1.0,2/23,7.36%,GPAT3;MOGAT2
prerank,iron-sulfur cluster assembly (GO:0016226),0.24058256789959964,0.5270998180964027,0.9608076009501187,1.0,1.0,7/24,24.76%,CIAO2A;ISCA2;CIAO3;MMS19;ABCB7;FXN;HSPA9
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.24173861564776888,0.5270995881409125,0.9525462962962963,1.0,1.0,4/25,19.98%,DDAH2;TLR6;ASS1;PKD2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.22847019994056758,0.5268997677273732,0.9732047159699893,1.0,1.0,13/50,22.65%,TRADD;EGFR;TRIM44;ACTN4;LIMS1;RPS3;TRAF6;LGALS9;IFI35;ILK;SASH1;RTKN2;PHB2
prerank,sphingosine biosynthetic process (GO:0046512),0.27283627272113614,0.5264572158521739,0.9510791366906475,1.0,1.0,2/11,16.65%,ABCA2;ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.27283627272113614,0.5264572158521739,0.9510791366906475,1.0,1.0,2/11,16.65%,ABCA2;ACER3
prerank,regulation of secretion by cell (GO:1903530),0.22570186550824495,0.5259872453000455,0.9745222929936306,1.0,1.0,5/54,12.37%,CHRNB4;RAB8A;LGI3;RAB8B;HAP1
prerank,neuropeptide signaling pathway (GO:0007218),0.2225511298092926,0.525920914243492,0.9746568109820486,1.0,1.0,6/58,19.48%,AGRP;SORCS2;NMU;ADCYAP1;GLRA1;PPY
prerank,positive regulation of cell projection organization (GO:0031346),0.21820080598302496,0.5253405070266213,0.9868951612903226,1.0,1.0,12/115,11.03%,TIAM1;S100A9;SNX3;KIDINS220;SETX;ARHGAP35;PLXNA2;MARK2;EPHA3;RIT2;CUX1;RELN
prerank,glucose metabolic process (GO:0006006),0.22489769477343283,0.5251694153681616,0.9829424307036247,1.0,1.0,11/58,22.16%,SLC25A12;BRAT1;DCXR;GALM;SLC25A13;PGK1;MDH2;PPARD;GAPDH;PCK2;GDPGP1
prerank,negative regulation of insulin secretion (GO:0046676),0.25677289825525673,0.5249643139149203,0.9460847240051348,1.0,1.0,5/17,26.58%,PIM3;IRS1;SIRT4;KCNB1;PSMD9
prerank,positive regulation of mitochondrial translation (GO:0070131),0.26207052105270684,0.524611046485529,0.964769647696477,1.0,1.0,4/14,26.05%,MPV17L2;TRUB2;TRMT10C;FASTKD2
prerank,cognition (GO:0050890),0.23141469378778776,0.5243800321476283,0.9740540540540541,1.0,1.0,8/42,17.24%,MAGT1;JAKMIP1;SHROOM4;BBS4;NIPBL;SOBP;TUSC3;CHMP2B
prerank,vitamin D metabolic process (GO:0042359),-0.19556831381991446,-0.524176560147295,0.9742489270386266,0.9918726724155694,1.0,2/13,21.18%,LGMN;PIAS4
prerank,response to interferon-beta (GO:0035456),0.24671635934119823,0.5235772212316893,0.9663865546218487,1.0,1.0,5/22,20.57%,UBE2K;XAF1;IFITM3;PNPT1;AIM2
prerank,neutrophil chemotaxis (GO:0030593),0.22978188880651862,0.5232787823572641,0.9764453961456103,1.0,1.0,6/53,16.77%,S100A9;S100A8;BSG;PPIA;TGFB2;CCL25
prerank,negative regulation of interleukin-8 production (GO:0032717),0.2564367004627068,0.521264448114393,0.9590268886043534,1.0,1.0,2/17,14.19%,PTPN22;TLR6
prerank,regulation of cell-cell adhesion (GO:0022407),0.23215755453685405,0.5184528800584657,0.9700332963374029,1.0,1.0,9/39,23.57%,CD47;DPP4;MAGI1;MDGA1;FLOT2;EPHA7;CITED2;SRC;FUT9
prerank,inner ear morphogenesis (GO:0042472),0.24624478137561517,0.5177542261714964,0.9695493300852619,1.0,1.0,4/22,22.74%,TIFAB;PAX2;SOX9;FGFR2
prerank,regulation of mitochondrial fusion (GO:0010635),0.2698917777994386,0.5168372386186924,0.9506346967559943,1.0,1.0,1/11,5.04%,TFRC
prerank,regulation of phospholipid metabolic process (GO:1903725),0.26853764708953787,0.5157772552413598,0.9582210242587601,1.0,1.0,1/10,7.28%,MTMR2
prerank,cellular response to hexose stimulus (GO:0071331),0.23783586362679893,0.5151313135157597,0.9702380952380952,1.0,1.0,7/23,21.24%,PRKACA;RACK1;XBP1;ADCY8;ZBTB20;PAX2;PCK2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.19367191914118903,-0.5143033412630114,0.9882352941176471,0.9930098005365062,1.0,13/13,80.65%,RELA;MDK;ITGB2;ETS1;IL6;FUT7;TNF;NFAT5;RHOA;IRAK1;FUT9;ZDHHC21;TRAF6
prerank,secondary alcohol metabolic process (GO:1902652),0.22446768894085015,0.5126495275346443,0.9712070874861573,1.0,1.0,10/42,22.61%,OSBPL5;GBA2;CYP27A1;NSDHL;IDH2;LDLRAP1;PPARD;OSBPL1A;SCAP;SOAT1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.2629630799767284,0.5108749778086393,0.9648173207036536,1.0,1.0,2/12,14.53%,SORBS1;IRS1
prerank,regulation of stem cell population maintenance (GO:2000036),0.2476851703545775,0.5108200357317113,0.9604449938195303,1.0,1.0,6/18,25.75%,MYC;CNOT1;ELAVL1;NCOA3;HMGA2;PTN
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.2135524860518146,-0.5101626622112858,0.9773462783171522,0.9928402860824964,1.0,1/10,3.21%,FERMT3
prerank,cellular response to UV-A (GO:0071492),0.2608122528403741,0.5100271025870692,0.9659763313609467,1.0,1.0,11/11,73.94%,MME;MMP1;OPN1SW;MMP3;OPN5;PPID;MMP9;TIMP1;OPN3;MMP2;CERS1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.23357013794849346,0.5088452301050755,0.9732685297691372,1.0,1.0,4/24,17.46%,CCR2;HMGB1;SLAMF8;ANO6
prerank,granulocyte chemotaxis (GO:0071621),0.22186732390463298,0.5074521305311679,0.9776833156216791,1.0,1.0,6/55,16.77%,S100A9;S100A8;BSG;PPIA;TGFB2;CCL25
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.24040808845330505,0.5062447761734418,0.9633375474083439,1.0,1.0,5/18,25.58%,HMGB1;CD24;RPS3;IGFBP2;ICOSLG
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.2546468466958203,0.5061788803513723,0.9543568464730291,1.0,1.0,7/13,28.94%,MBTPS2;FCGR2B;NR1H3;LPCAT3;NR1H2;NUPR1;CLU
prerank,gastrulation (GO:0007369),-0.1844598856938146,-0.5045938498662436,0.9746376811594203,0.992909488681613,1.0,7/15,38.63%,GPC3;NPHP3;UGDH;LMBRD1;MKKS;LRP5;LHX1
prerank,tyrosine metabolic process (GO:0006570),0.25887111114601963,0.5037796821584465,0.9661246612466124,1.0,1.0,1/11,11.99%,FAH
prerank,ubiquinone metabolic process (GO:0006743),0.25101317558247965,0.5021711148220177,0.9575835475578406,1.0,1.0,4/15,18.63%,COQ10B;PDSS2;COQ5;FDXR
prerank,endodermal cell fate commitment (GO:0001711),0.2654875079398174,0.5016961305418632,0.9708879184861717,1.0,1.0,2/10,23.33%,RTF1;LEO1
prerank,positive regulation of phospholipid transport (GO:2001140),0.2667585878534184,0.5015734994114079,0.9527896995708155,1.0,1.0,2/10,17.42%,ABCA7;TMEM30A
prerank,regulation of fatty acid oxidation (GO:0046320),0.2488132941458689,0.5014715330281228,0.9624352331606217,1.0,1.0,4/16,21.03%,ABCD1;PRKAG2;SOX9;SIRT4
prerank,potassium ion transport (GO:0006813),0.20934389932071693,0.5006696996761114,0.9969758064516129,1.0,1.0,20/120,19.98%,AQP1;HCN3;KCNN4;KCNA1;KCNJ3;KCNC2;KCNH7;KCNJ2;KCNK12;SLC9A8;SLC24A4;SLC24A2;SLC9A9;KCNK2;KCNQ5;KCNJ10;SLC9A7;SLC9A6;PKD2;KCNC1
prerank,mitochondrion morphogenesis (GO:0070584),0.2605778163228256,0.5000461604221172,0.9565217391304348,1.0,1.0,5/11,26.88%,FIS1;MTM1;PNPT1;PID1;WASF1
prerank,regulation of viral life cycle (GO:1903900),0.2343333929179236,0.4991690222702499,0.9713216957605985,1.0,1.0,7/21,28.15%,TRIM68;PPIA;TRIM5;VPS4A;TSG101;TRIM62;TRIM21
prerank,striated muscle contraction (GO:0006941),0.2177174580715906,0.49909107948602754,0.9914255091103966,1.0,1.0,2/53,4.08%,CSRP3;CCDC78
prerank,inner dynein arm assembly (GO:0036159),0.2585571131996459,0.49883343648055994,0.9583333333333334,1.0,1.0,1/10,10.61%,CFAP73
prerank,regulation of actin filament polymerization (GO:0030833),0.2130474293667332,0.49796844791326883,0.9906152241918665,1.0,1.0,8/69,13.59%,PRKCE;GBA2;SNX9;DBNL;CYRIB;MTPN;CDC42EP3;LATS1
prerank,cAMP metabolic process (GO:0046058),0.25095672363682203,0.4968958255150654,0.9596662030598053,1.0,1.0,3/13,21.63%,PTHLH;ADCY8;ADCY9
prerank,pre-miRNA processing (GO:0031054),0.24581920910324057,0.4963217268682639,0.959731543624161,1.0,1.0,4/14,22.08%,TUT4;TARBP2;AGO2;AGO1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.2283281461700727,0.4955770919140478,0.9705521472392638,1.0,1.0,6/25,27.29%,CRHBP;CNRIP1;SOCS4;TSG101;CBL;SLC6A9
prerank,ureteric bud morphogenesis (GO:0060675),0.24240787507276568,0.49090799122782963,0.9644808743169399,1.0,1.0,5/16,24.11%,MYC;PAX2;PKD2;GDNF;NPNT
prerank,cardiocyte differentiation (GO:0035051),0.2578611765427463,0.4903064278083451,0.9605077574047954,1.0,1.0,5/10,30.76%,TGFB2;AKAP13;CBY1;NRG1;SIK1
prerank,calcium ion homeostasis (GO:0055074),0.20447935746696433,0.49020614294698306,0.9917780061664954,1.0,1.0,10/95,15.70%,HTR2A;CSRP3;CAV1;CCR2;SLC10A7;TMTC2;FAM20A;TPT1;SLC24A4;SLC24A2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.21584234358655957,0.490131191891461,0.9835886214442013,1.0,1.0,10/45,20.57%,JAK2;EGR1;MYD88;TLR6;TYROBP;USP50;MALT1;LGALS9;CASP8;AIM2
prerank,sensory perception of light stimulus (GO:0050953),0.20599369957327374,0.4896931719425625,0.989648033126294,1.0,1.0,7/87,14.77%,CRYBG3;CRYBA1;EYA3;RP2;ATF6;RDH10;ADGRV1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.23505099213749733,0.48965610059417025,0.9758883248730964,1.0,1.0,2/20,11.70%,ST3GAL2;FUT8
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.22430473676702883,0.48937511168052333,0.9814814814814815,1.0,1.0,4/26,19.98%,DDAH2;TLR6;ASS1;PKD2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.2569043434597037,0.4886785053458833,0.9554234769687965,1.0,1.0,10/10,74.33%,GNB1;RHO;CNGA1;GRK1;GNAT1;CNGB1;PDE6A;PDE6B;PDE6G;SAG
prerank,eye photoreceptor cell differentiation (GO:0001754),0.24825197037322477,0.4871800094253655,0.9768392370572208,1.0,1.0,1/12,6.05%,AGTPBP1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.2395193703640069,0.4867487520222023,0.9727272727272728,1.0,1.0,5/16,24.11%,MYC;PAX2;PKD2;GDNF;NPNT
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.21502134420495528,0.4851197130536971,0.9782110091743119,1.0,1.0,11/35,23.38%,PMEPA1;TADA3;TMF1;MED1;SAFB;DDX54;CALCOCO1;RBFOX2;NEDD4;SRC;PLPP1
prerank,negative regulation of complement activation (GO:0045916),0.2516730156301503,0.48286428883781785,0.9770773638968482,1.0,1.0,2/10,19.21%,CR1L;CD55
prerank,negative regulation of protein kinase activity (GO:0006469),0.20144497695090585,0.48212214838634565,0.9959141981613892,1.0,1.0,13/88,16.20%,RB1;CAV1;TAF7;CEP85;TAB1;PDPK1;PARK7;CDK5RAP3;PRKAG2;PPIA;DTNBP1;TARBP2;PAK2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.23710784817360459,0.4817586802274033,0.9781491002570694,1.0,1.0,3/16,16.94%,ADIPOR1;FOXK2;SIRT1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.16064432826585712,-0.4817089049187491,0.9897435897435898,0.9956024358169127,1.0,6/19,26.92%,NOX1;PRDX2;GPX1;PRDX3;PRDX4;MAOB
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.23573240154895214,0.48080872300432975,0.9795918367346939,1.0,1.0,4/15,20.34%,SMOC2;FGFR1;PRKD2;MET
prerank,regulation of autophagosome maturation (GO:1901096),0.24384129682588998,0.4803295950064331,0.9676113360323887,1.0,1.0,5/13,26.66%,TBC1D25;FYCO1;CLN3;PHF23;SMCR8
prerank,regulation of protein processing (GO:0070613),0.22350794283272093,0.4802010643357603,0.9759326113116726,1.0,1.0,6/21,25.60%,CCBE1;RUNX1;LRRK2;CLN3;TMEM59;NLRC4
prerank,regulation of melanin biosynthetic process (GO:0048021),0.2564588383729315,0.4763470787242961,0.9683908045977011,1.0,1.0,3/10,21.58%,ATP7A;APPL1;ZEB2
prerank,ceramide metabolic process (GO:0006672),0.2053880899470082,0.4762515750062227,0.9914346895074947,1.0,1.0,9/49,19.69%,SGMS2;ABCA2;ORMDL3;CERS4;SGMS1;CERS6;ACER3;CERS2;PPP2CA
prerank,tRNA metabolic process (GO:0006399),0.22931207227156264,0.47447318628055624,0.9742331288343559,1.0,1.0,5/17,23.50%,DTD2;YARS2;RPP30;DTD1;KARS1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.22871960799557015,0.47438586714348147,0.9821428571428571,1.0,1.0,4/19,21.48%,RUNX1;F2R;VIM;CIITA
prerank,aromatic amino acid family metabolic process (GO:0009072),0.24980947353116667,0.47336432069482814,0.9785714285714285,1.0,1.0,3/10,26.92%,ATP7A;QDPR;ASRGL1
prerank,chemical synaptic transmission (GO:0007268),0.1958643979104698,0.47075690821595856,1.0,1.0,1.0,45/284,21.66%,CHRNB4;MAPK1;CEL;PDE7B;SLC6A2;SLC6A5;HTR2A;CRHBP;EXOC4;SLC12A7;GABRA4;PRKACA;ERC1;KCNA1;BSN;PMP22;GABRA5;RIT2;PAFAH1B1;GRIA3;PTEN;HAP1;SLC12A6;CHRM3;NRXN2;GRIA2;NAPB;CACNA1B;SNCA;TSPOAP1;ERC2;NRXN1;GRM3;GLRA1;PRKAR2A;GABRB2;HCRT;NAAA;APBA1;GRIK5;GRIK3;SLC1A4;RPS6KA3;GRIN2D;BRSK1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.23942878003845497,0.47016938640430195,0.9692513368983957,1.0,1.0,1/13,9.89%,B3GNT2
prerank,neural crest cell development (GO:0014032),0.20400633771440424,0.4690792622118127,0.991130820399113,1.0,1.0,4/44,11.80%,PHACTR4;PEF1;TCOF1;TAPT1
prerank,digestive tract morphogenesis (GO:0048546),0.2393973398047572,0.46904090596706627,0.979002624671916,1.0,1.0,3/14,23.21%,NIPBL;FGFR2;BBS7
prerank,regulation of rRNA processing (GO:2000232),0.23039990218345707,0.4667984013139595,0.9787516600265604,1.0,1.0,6/16,24.71%,KAT2B;SIRT7;DIMT1;RIOK1;TRMT112;USP36
prerank,negative regulation of hydrolase activity (GO:0051346),0.2069389334000582,0.4667151064370377,0.9935622317596566,1.0,1.0,5/49,11.59%,TERF2;NEIL1;GMIP;PPP1R35;RDX
prerank,mitochondrion disassembly (GO:0061726),0.2103345080884544,0.4664697038236632,0.9897610921501706,1.0,1.0,8/34,20.91%,MARK2;BECN1;AMBRA1;FIS1;CTSK;ATG2B;WDR45B;BNIP3
prerank,carbohydrate biosynthetic process (GO:0016051),0.22206277595607957,0.4660849260795661,0.9850187265917603,1.0,1.0,7/21,29.71%,ST3GAL2;FUT8;ST8SIA6;FUT9;B3GALT1;MPDU1;ST3GAL3
prerank,sphingolipid metabolic process (GO:0006665),0.1953055753918793,0.46479685961794637,1.0,1.0,1.0,27/108,25.10%,SGMS2;HACD4;PRKD3;GBA2;CSNK1G2;ABCA2;ORMDL3;VAPA;CERS4;SUMF1;SGMS1;ELOVL5;ELOVL4;CERS6;ACER3;SUMF2;CERS2;PPP2CA;PRKD2;GLTP;NEU1;PLPP1;SMPD1;PPM1L;ESYT2;PDXDC1;B3GALNT1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.23943499090110398,0.4613538693802718,0.9740437158469946,1.0,1.0,1/12,9.89%,B3GNT2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.23540349817448575,0.4604013933192081,0.9770773638968482,1.0,1.0,3/11,22.74%,MYC;SOX9;FGFR2
prerank,regulation of catecholamine secretion (GO:0050433),0.20953436543842013,0.4600373548917883,0.9848308051341891,1.0,1.0,6/29,20.94%,SYT8;SYT3;GRK2;DTNBP1;SNCA;SYT2
prerank,protein alkylation (GO:0008213),0.2173808795118837,0.45920048760750104,0.98661800486618,1.0,1.0,5/22,22.66%,LCMT1;GSPT1;PRMT3;SNRPB;EEF1AKMT2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.22821932829961897,0.4578162943179572,0.9782016348773842,1.0,1.0,3/14,18.88%,CPSF1;CLP1;RTCB
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.24126256597304857,0.4556853446225391,0.9758522727272727,1.0,1.0,2/10,16.52%,ATP5F1D;ATP5MC2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.2239593143718212,0.45404790350161184,0.9812332439678284,1.0,1.0,15/15,77.63%,ELOVL5;PPARD;NR1H3;NR1H2;LPGAT1;ADIPOQ;APOA1;NR4A3;PPARA;PPARG;MLXIPL;SLC45A3;MID1IP1;PPARGC1A;MLYCD
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.2198430141287285,0.45084265109736144,0.9897435897435898,1.0,1.0,17/17,78.04%,PLBD1;LCLAT1;PLAAT3;LPGAT1;PLA2G1B;PLA2G2F;PLA2G2E;PLA2G4D;PLA2G10;PLA2G2D;PLA2G4F;PLA2G5;PLA2G4C;MBOAT7;PLA2G4A;PLA2G12A;PLA2G4E
prerank,protein localization to synapse (GO:0035418),0.234361345100381,0.4502621872640767,0.980528511821975,1.0,1.0,6/12,28.12%,BSN;NRXN2;NRXN1;NLGN2;NLGN1;SHANK1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.19536318252229168,0.45011578150644727,0.9946409431939979,1.0,1.0,3/53,13.28%,HTR2A;CALCRL;CHRM3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.20116352429227086,0.4429183295392547,0.9918509895227008,1.0,1.0,2/29,10.99%,MBOAT2;PLBD1
prerank,superoxide metabolic process (GO:0006801),0.20204841434380325,0.4384430900987856,0.9909706546275395,1.0,1.0,6/29,22.29%,ATP7A;CYBB;CYBA;NCF4;SH3PXD2A;NRROS
prerank,negative regulation of lipid metabolic process (GO:0045833),0.2075156868473651,0.43811753010760096,0.9926918392204629,1.0,1.0,1/22,5.70%,PPP2R5A
prerank,regulation of dopamine secretion (GO:0014059),0.2023699343072589,0.4377448471746424,0.9867149758454107,1.0,1.0,7/25,25.34%,SYT8;SYT3;DTNBP1;SNCA;SYT2;GDNF;SYT10
prerank,heart trabecula morphogenesis (GO:0061384),0.21231546866615858,0.4367299147427687,0.9886506935687264,1.0,1.0,5/18,22.80%,NOTCH1;BMPR1A;TGFB2;RBPJ;FKBP1A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.2234383065532206,0.43633229585012173,0.9745649263721553,1.0,1.0,1/13,8.54%,JAK2
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.22031935739156464,0.43368130420120204,0.980309423347398,1.0,1.0,2/12,15.88%,PLCB1;SLAMF8
prerank,tRNA 5'-end processing (GO:0099116),0.21296465497440448,0.43337614101279276,0.9935483870967742,1.0,1.0,4/15,22.79%,PRORP;POP4;TRMT10C;RPP30
prerank,monocyte chemotaxis (GO:0002548),0.1972290755700463,0.4331377279861114,0.9883313885647608,1.0,1.0,3/32,16.77%,RPS19;TNFRSF11A;CCL25
prerank,peptide hormone secretion (GO:0030072),0.2034613525966503,0.4308522451902414,0.9916267942583732,1.0,1.0,3/26,13.66%,PARK7;ADCYAP1;CDK16
prerank,protein mono-ADP-ribosylation (GO:0140289),0.22406584566371177,0.42938716199276955,0.9873239436619718,1.0,1.0,5/11,29.59%,PARP14;PARP11;PARP9;TIPARP;PARP8
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.19456897243385687,0.42374907050977684,0.993006993006993,1.0,1.0,6/26,22.80%,UBQLN1;GPR35;YWHAE;PKD2;CALM3;FKBP1A
prerank,response to prostaglandin E (GO:0034695),0.22046461915947102,0.4232059390420401,0.9915611814345991,1.0,1.0,2/10,22.07%,PTGER4;GNB1
prerank,lysosome localization (GO:0032418),0.19012300908479962,0.4208325097080706,0.995475113122172,1.0,1.0,8/37,24.73%,MILR1;HDAC6;VPS33B;SPAG9;PLEKHM1;RAB34;MYH9;BORCS5
prerank,lymphocyte migration (GO:0072676),0.1887456588747804,0.41916310751067754,0.9953810623556582,1.0,1.0,3/32,16.77%,CCR6;MSN;CCL25
prerank,negative regulation of ATPase activity (GO:0032780),-0.14975511741805853,-0.41904574271326356,1.0,0.9993044186520057,1.0,16/16,85.05%,TSC1;THADA;PAM16;IFIT1;PPIF;TLR9;PLN;LTF;VCPKMT;TNNI3;TNNT2;OXA1L;ATP5IF1;PXK;SIRT1;TP53
prerank,icosanoid biosynthetic process (GO:0046456),0.21825434560853857,0.4142146111791136,0.9897959183673469,1.0,1.0,2/10,21.62%,LTA4H;MGST3
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.20600796186324905,0.41127271422076006,0.9958333333333333,1.0,1.0,4/13,23.38%,MED1;ABHD2;CALCOCO1;PLPP1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.19877324691135526,0.4103455355622839,0.9937264742785445,1.0,1.0,4/17,23.58%,CIB1;TGFB2;SYK;PIEZO1
prerank,miRNA metabolic process (GO:0010586),0.1906835007511056,0.4031154760568982,0.9951040391676866,1.0,1.0,3/20,19.65%,TUT4;TARBP2;AGO2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.21122340091645225,0.3988876015001443,0.9901685393258427,1.0,1.0,11/11,78.89%,TGFB2;TGFB1;WNT3A;TBX5;GATA4;MYOCD;GPER1;GREM1;DHX36;MEF2C;EFNB2
prerank,regulation of gluconeogenesis (GO:0006111),0.17860782711055745,0.395021699140177,0.9988452655889145,1.0,1.0,6/27,23.84%,SIRT7;SDHAF3;SIRT1;USP7;CLK2;PGP
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.19633992599805694,0.3891250706741563,0.9931318681318682,1.0,1.0,3/13,20.75%,NFATC3;SOX9;PPARD
prerank,diol biosynthetic process (GO:0034312),0.18990714397828307,0.3858892507827877,0.9986945169712794,1.0,1.0,2/15,16.65%,ABCA2;ACER3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.2022511108791087,0.37839540769326613,0.9971910112359551,1.0,1.0,3/10,27.73%,HDAC4;CBFA2T3;NUPR1
prerank,negative regulation of glycolytic process (GO:0045820),0.2022511108791087,0.37839540769326613,0.9971910112359551,1.0,1.0,3/10,27.73%,HDAC4;CBFA2T3;NUPR1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.18211674844018663,0.3769345241337312,0.9962025316455696,1.0,1.0,6/18,28.16%,KAT2B;PTBP2;PTBP1;NCOR2;RPS13;PTBP3
prerank,tRNA 5'-leader removal (GO:0001682),0.18627126199737584,0.37227932198041885,0.9960212201591512,1.0,1.0,3/13,22.79%,PRORP;POP4;RPP30
prerank,phasic smooth muscle contraction (GO:0014821),0.19611526142991972,0.3700218004890125,0.9956268221574344,0.9998966673242535,1.0,2/10,23.62%,TIFAB;GDNF
prerank,response to organonitrogen compound (GO:0010243),0.16176251575144784,0.3688446418744186,1.0,0.9996055544528787,1.0,8/38,25.74%,RCN3;SYVN1;GLRA1;CCDC47;HLCS;DNAJB12;DERL1;VCP
prerank,embryonic eye morphogenesis (GO:0048048),0.19027992790219792,0.36653280678153366,0.9959072305593452,0.9993610712277009,1.0,2/11,18.10%,RARG;KDM2B
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.15908266838153012,0.33613330364072097,1.0,0.9999374810544448,1.0,6/23,27.93%,ACSL5;ELOVL5;FAR1;ACSL6;ACSL4;ACOT7
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.15494411093311045,0.31696829334869825,1.0,0.9998354053302617,1.0,2/18,14.45%,ACSL5;ELOVL5
